Citrus Sinensis ID: 007064
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 619 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SJG9 | 606 | Mitogen-activated protein | yes | no | 0.977 | 0.998 | 0.754 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | yes | no | 0.978 | 0.991 | 0.746 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.914 | 0.994 | 0.673 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.914 | 0.994 | 0.680 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.969 | 0.857 | 0.677 | 0.0 | |
| Q9LUC3 | 598 | Mitogen-activated protein | no | no | 0.959 | 0.993 | 0.680 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 0.970 | 0.977 | 0.649 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.870 | 0.950 | 0.671 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.830 | 0.948 | 0.692 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.756 | 0.939 | 0.732 | 0.0 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 914 bits (2362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/620 (75%), Positives = 521/620 (84%), Gaps = 15/620 (2%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD+RKKN+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKD+MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++HS
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 NTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAKPGKVVGPVV 479
V Q L + N + ++ IP N + T+ AQQR AKP +GPV
Sbjct: 421 TAVARGGQPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPVA 473
Query: 480 PYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVPQCG 539
P++N + RDAYDPR+FIRST LP + +A + GKQ+ R K Q
Sbjct: 474 PFDNGRISRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQ--ERRTTMEPEKQARQIS 528
Query: 540 MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAA 599
++A D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + GV AAA AAA
Sbjct: 529 QYNRYAPDVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAG-IGVAAAAAAAAP 587
Query: 600 TAAAHRKIGTVQYGMTTRMY 619
+AHRK+G V+YGM ++MY
Sbjct: 588 GGSAHRKVGAVRYGM-SKMY 606
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 891 bits (2303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/624 (74%), Positives = 516/624 (82%), Gaps = 18/624 (2%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKK+S E +FF+EYGDASRYKIQEVIGKGSYGVVCSAID HTGEKVAIKKIHDIF
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN+NCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPS+DTISRVRNDKARRYL+SMRKK+P+ FSQKFP+ADP AL LL++LLAFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALA PYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDY+NGTERT FLYPSAVDQFRKQFAHLEEN G +GPVIP +RKH SLPRSTIVHS
Sbjct: 361 PQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEEN-GGNGPVIPMDRKHTSLPRSTIVHS 419
Query: 421 NTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVP 480
+P KEQ + R + N +E + N RT A QR P A+PG+VVGPV+P
Sbjct: 420 TPIPAKEQPRIGPSRDKPSDEPYSNPREFDRFSGNAPRTSQAPQRVPTARPGRVVGPVLP 479
Query: 481 YENASVRRDAYDPRTFIRSTVLP--QAIPAAYCYRK---SSTGKQEMDSEREMPSQVKHV 535
YEN + +D+YD R ++ P Q IP AY Y + S + +ER Q +
Sbjct: 480 YENGAT-KDSYDARRLAMNSGYPPQQQIPQAYGYYQIPGKSACSELSQAERYTLHQQAYT 538
Query: 536 PQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAAT 595
C +A TD+A++M + PF ++ G K + E +++ +TNL T+S G AAT
Sbjct: 539 --CANSAT-VTDVALDMRAPPFHLS--GGPKSDSSE-RLAAETNLY-TRSLN---GLAAT 588
Query: 596 AAAATAAAHRKIGTVQYGMTTRMY 619
AA A+AHRK+G V YGM +RMY
Sbjct: 589 AAGVAASAHRKVGVVPYGM-SRMY 611
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/610 (67%), Positives = 493/610 (80%), Gaps = 44/610 (7%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
DT++R+RN+KARRYL+SMRKKQPV FS++FP ADP+AL+LL+RLLAFDPKDRPTAEEALA
Sbjct: 241 DTVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFKGL+K EREPSCQPI+KMEFEFERR+VTKED++ELIFREILEYHPQLLKDYMNGTE
Sbjct: 301 DPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
+TNFLYPSA+D FR+QFA+LEEN GK+G +P +RKHVSLPR+T VHS +PPK+ QN++
Sbjct: 361 KTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPRTTTVHSAPIPPKDHQNIT 420
Query: 433 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAYD 492
+P QR P + G+ PV+P+EN S Y+
Sbjct: 421 SQ-----------------VP----------QRIP-GRTGRGACPVIPFENLSA-MGPYN 451
Query: 493 PRTFIRSTVLPQAIP--AAYCY-RKSSTGKQEMDSEREMPSQVKHVPQCGMAAKFATDIA 549
R +R+ VLP A +AY Y RKS + ++E+ E E + M AK + ++
Sbjct: 452 QRRVVRNPVLPPATTNLSAYAYHRKSDSSERELQQELEKDRMRYQPSEHFMDAKVVSHMS 511
Query: 550 INMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIGT 609
++ ++ +++++A + + D+ ++ +N++Q + G+ AA + K+ T
Sbjct: 512 HDLRASSYYVSKAKSD----VADRAALQSNMMQGIGPFNGI-------AAVGGNYNKVST 560
Query: 610 VQYGMTTRMY 619
VQYG+ +RMY
Sbjct: 561 VQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 823 bits (2127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/610 (68%), Positives = 481/610 (78%), Gaps = 44/610 (7%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGD+SRYKIQE++GKGSYGVVCSAID HTG+KVAIKKIH+IFEH+SDAARILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM++DLHQVIKANDDLT+EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQ+LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT+FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
D ISR+RNDKARRYL+SMR+KQPV FS+KFPN DP AL+LL+RLLAFDPKDRPTAEEALA
Sbjct: 241 DAISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFKGL+KVEREPSCQPISKMEFEFERR+VTK+DI+ELIFREILEYHPQLLKDYMNG+E
Sbjct: 301 DPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
T+FLYPSAVD FR+QFA LEEN GKSG + +RKHVSLPR+T VHS ++PP E
Sbjct: 361 NTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNE----- 412
Query: 433 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAYD 492
L T QR P A+PG+ VGPV+P+EN D +
Sbjct: 413 ----------------------GLDATSQVTQRIPTARPGRTVGPVLPFENPGA-ADPHS 449
Query: 493 PRTFIRSTVLPQAIP--AAYCYRKSSTGKQEMDSEREMPSQVKHVP-QCGMAAKFATDIA 549
R +R+ ++P A + Y Y S E +V++ P Q M AK A D A
Sbjct: 450 ARRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEELEKDRVQYRPAQHLMDAKVAPDTA 509
Query: 550 INMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKIGT 609
++ S+ ++ TR+ + D+ ++ ++L + + G+ AA A + K+G
Sbjct: 510 PDIRSSQYYFTRSAPRT--DLTDRAALQGSMLYGIAPFNGI-------AAVAGGYSKVGA 560
Query: 610 VQYGMTTRMY 619
VQYG+ +RMY
Sbjct: 561 VQYGV-SRMY 569
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/623 (67%), Positives = 481/623 (77%), Gaps = 23/623 (3%)
Query: 8 KNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
+ S EFF+EYGDA+RY+IQEVIGKGSYGVVCSAID HT +KVAIKK+H+IFEH+SDAA
Sbjct: 90 RTSSAEEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAA 149
Query: 68 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT+EH
Sbjct: 150 RILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEH 209
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
YQFFLYQLLRALKYIHTA+VYHRDLKPKNILAN+NCKLKICDFGLARVAFNDTPTT+FWT
Sbjct: 210 YQFFLYQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWT 269
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL
Sbjct: 270 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 329
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 307
GTPS+DTISRVRN+KARRYL+SMRKK PV FSQKFPNADP AL+LL+RLLAFDPKDRPTA
Sbjct: 330 GTPSMDTISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTA 389
Query: 308 EEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY 367
EEAL DPYFKGLSK++REPSCQPI K+EFEFE+++++KEDIRELIF+EILEYHPQL K+Y
Sbjct: 390 EEALTDPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNY 449
Query: 368 MNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKE 427
NG ER FLYPSAVDQF+KQF++LEE+ G SG IP ERKH SLPRST VHS +PPKE
Sbjct: 450 RNGRERATFLYPSAVDQFKKQFSNLEESNG-SGSAIPMERKHASLPRSTTVHSTPIPPKE 508
Query: 428 Q---QNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENA 484
Q +L R ++E KN G N+ + Q PG+ VG V PYE
Sbjct: 509 QPLAASLKSSRPVSDEPC-KNPWVMGGFSGNIPTSSQVSQVAKPVAPGRPVGSVFPYETG 567
Query: 485 SVRRDAYDPRTFIRSTVLP--QAIPAAYCYRK------SSTGKQEMDSEREMPSQVKHVP 536
S D Y PR + S+ P Q I AY Y + Q MD+ + M SQ +
Sbjct: 568 ST-NDPYGPRGPVMSSGYPPQQQISQAYGYHQVPARMNCVEQSQAMDAYK-MHSQSQTQA 625
Query: 537 QCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATA 596
+K D+A++M + F + N D++ T++ T+S G V AA +A
Sbjct: 626 YAYPNSKVTADVALDMRGSTFHHSAGSKNGS---LDRMVTQTDIY-TRSLNGIVAAATSA 681
Query: 597 AAATAAAHRKIGTVQYGMTTRMY 619
T +RK+G V T+RMY
Sbjct: 682 GVGT---NRKVGAVPIS-TSRMY 700
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/619 (68%), Positives = 480/619 (77%), Gaps = 25/619 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ+ KKN EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DL+TDLLGTP +TI+ VRN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTA EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYMN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VHS
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VHS 418
Query: 421 NTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVP 480
+ V Q +L+ + + A ++ L R P KPG+VV V
Sbjct: 419 SAVNSNAQPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVT 478
Query: 481 YEN-ASVRRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HVP 536
YEN +++ +YD RT + RSTVLP + CY +T QE S E SQ K VP
Sbjct: 479 YENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFVP 538
Query: 537 QCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATA 596
+AK A ++ NP+ + + ++ ID LL +SQYG A A
Sbjct: 539 TQCNSAKPA-----ELNPNPYVQS----------QHKVGIDAKLLHAQSQYG----PAGA 579
Query: 597 AAATAAAHRKIGTVQYGMT 615
AA AAHR IG V YGM+
Sbjct: 580 AAVAVAAHRNIGAVGYGMS 598
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/630 (64%), Positives = 475/630 (75%), Gaps = 29/630 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQ+ KK + EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
+L+TDLLGTP +TIS VRNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPT EALADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYM+G+E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VHS
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VHS 419
Query: 421 NTVPPKEQQNL-SRDRQAAEEVFNKNSKESEGIPANLSRTL----PAQQRFPLAKPGKVV 475
V Q NL + D + +KN S G P+ + P + P +PG+VV
Sbjct: 420 TVVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRVV 479
Query: 476 GPVVPYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPSQ 531
V YEN ++AY RS A+ + +CY + +T + +++ P
Sbjct: 480 ESSVSYENGRNLKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPKP 529
Query: 532 VKHVPQCG-----MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQ 586
V Q A D+ NP+F + + ++ID LLQ +SQ
Sbjct: 530 QNPVHQFSPTEPPAATTNQADVETMNHPNPYFQPQLPKTDQLNNNTHMAIDAKLLQAQSQ 589
Query: 587 YGGVGAAATAAAATAAAHRKIGTVQYGMTT 616
+G A AAA AAHR IGT+ Y +
Sbjct: 590 FG----PAGAAAVAVAAHRNIGTISYSAAS 615
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/563 (67%), Positives = 448/563 (79%), Gaps = 24/563 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTD+LGTPS + I RVRN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPER-KHVSLPRSTIVH 419
P++LK+Y++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER +H SLPR+ +++
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SNTVPPKEQQNLS-----------RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL 468
S+ P QQ+ + RD + N S IP N+ +T+ Q +
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSR-IPINVPQTI---QGAAV 476
Query: 469 AKPGKVVGPVVPYENA----SVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQEMDS 524
A+PGKVVG V+ Y N V R +R+ P KS+ G ++ +
Sbjct: 477 ARPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCAT 536
Query: 525 EREMPSQVK----HVPQCGMAAK 543
E PS++K ++PQ AA+
Sbjct: 537 AAEGPSRLKPNTQYIPQKVSAAQ 559
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/526 (69%), Positives = 431/526 (81%), Gaps = 12/526 (2%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTG+KVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+TISR+RN+KARRYL SMR+K+P+ F+QKFPNADP A+RLLER+LAFDPKDRP+AEEALA
Sbjct: 241 ETISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFK ++ V+REPS QPI+K+EFEFERRR+TKEDIRELI+REILEYHP++L++++ GTE
Sbjct: 301 DPYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
T F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR +V+S+ P Q S
Sbjct: 361 STGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRP---QSTAS 417
Query: 433 RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVR--RDA 490
+ + N+ +S+ + + +P A+PGK VG V+ Y N S
Sbjct: 418 VTEDLSRCLIRDNNLKSQDSASVGASRIPQGA---AARPGKAVGSVLRYGNCSTSAAEQQ 474
Query: 491 YDPRTFIRSTVLP--QAIPAAYCY-RKSSTGKQEM-DSEREMPSQV 532
Y+ R +R+ + ++P Y R++ T K E D ER SQ
Sbjct: 475 YEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGDVERIDSSQT 520
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 740 bits (1911), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/475 (73%), Positives = 411/475 (86%), Gaps = 7/475 (1%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FF+EYG+ +RYKI+EVIGKGSYGVVCSA+DTHTGEKVAIKKI+DIFEH+SDA RILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAF+DTPT IFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ ISR+RN+KARRYL+SMR+K+P+ F+QKFPNADP ALRLLER+L+F+PKDRP AEEALA
Sbjct: 241 EAISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYF+ ++ V+REPS QP++K+EFEFERRR+TKEDIRELI+R+ILEYHP +L++Y+ GTE
Sbjct: 301 DPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
F+YPSAVD F+KQFA+LEE+ K PPER+H SLPR ++++S+ P+ N++
Sbjct: 361 SAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDR-PQNTANIA 419
Query: 433 RDRQAAEEVFNKNS-KESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASV 486
D ++ V N+ K +G + + +P A+PGKVVG + Y N S
Sbjct: 420 ED--LSKCVLGDNTQKMHQGSASVCANRVPQGG---AARPGKVVGSALRYGNCST 469
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 619 | ||||||
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 0.993 | 0.990 | 0.859 | 0.0 | |
| 359485144 | 610 | PREDICTED: mitogen-activated protein kin | 0.977 | 0.991 | 0.848 | 0.0 | |
| 356567418 | 614 | PREDICTED: mitogen-activated protein kin | 0.980 | 0.988 | 0.824 | 0.0 | |
| 255575287 | 627 | big map kinase/bmk, putative [Ricinus co | 0.987 | 0.974 | 0.830 | 0.0 | |
| 356526989 | 615 | PREDICTED: mitogen-activated protein kin | 0.980 | 0.986 | 0.819 | 0.0 | |
| 399106790 | 610 | MAP kinase [Nicotiana tabacum] | 0.974 | 0.988 | 0.817 | 0.0 | |
| 357463659 | 614 | Mitogen activated protein kinase 20-4 [M | 0.980 | 0.988 | 0.809 | 0.0 | |
| 350539497 | 621 | mitogen-activated protein kinase 12 [Sol | 0.993 | 0.990 | 0.803 | 0.0 | |
| 224085324 | 577 | predicted protein [Populus trichocarpa] | 0.922 | 0.989 | 0.818 | 0.0 | |
| 115345808 | 606 | mitogen-activated protein kinase 20 [Ara | 0.964 | 0.985 | 0.794 | 0.0 |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/625 (85%), Positives = 581/625 (92%), Gaps = 10/625 (1%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKKNS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDQRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
P+TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PSTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTIS VRNDKARRYLTSMRKKQPV +QKFPNADP ALRLLERLLAFD
Sbjct: 241 DLMTDLLGTPSLDTISLVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL++VEREPSCQPI+KMEFEFERRRVTKED+RELIFREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDY+NGTERTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKH SLPRSTIVHS
Sbjct: 361 PQLLKDYLNGTERTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHASLPRSTIVHS 420
Query: 421 NTVPPKEQQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 478
+++P KEQQNL+ +DR AEE +NKN +++EGIP N+SRTL AQQR PLAKPGKVVG V
Sbjct: 421 SSIPTKEQQNLASFKDRHTAEEAYNKNPRDTEGIPVNISRTLQAQQRVPLAKPGKVVGQV 480
Query: 479 VPYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKH 534
V YEN S+ +DA DPRT+IRS VL P A P+AYCYRKS++GKQE M+++ ++ SQ K
Sbjct: 481 VSYENGSIVKDARDPRTYIRSAVLPPHAAPSAYCYRKSNSGKQEGSTMEADSDLSSQ-KQ 539
Query: 535 VPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAA 594
V QCGMAAK+A D+AIN+DSNPFFMTR GVNKVEH++D++ IDT+LLQ K+QYGG+ +A
Sbjct: 540 VQQCGMAAKYAPDVAINIDSNPFFMTRIGVNKVEHVDDRVMIDTSLLQAKAQYGGI--SA 597
Query: 595 TAAAATAAAHRKIGTVQYGMTTRMY 619
+AAAA+ AAHRK+GTVQYGM TRMY
Sbjct: 598 SAAAASTAAHRKVGTVQYGM-TRMY 621
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485144|ref|XP_002283794.2| PREDICTED: mitogen-activated protein kinase 20-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/612 (84%), Positives = 568/612 (92%), Gaps = 7/612 (1%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEV+GKGSYGVVCSA+DT TGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVVGKGSYGVVCSAVDTLTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDTPTTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
DTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDPKDRPTAEEALA
Sbjct: 241 DTISRVRNEKARRYLTSMRKKQPVIFAQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGTE
Sbjct: 301 DPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGTE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
RTNFLYPSAVDQFRKQFAHLEEN GK+GPVIP ERKHVSLPRST+VHSNT+P KE ++
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENSGKTGPVIPLERKHVSLPRSTVVHSNTIPAKEPHIIA 420
Query: 433 -RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDAY 491
+DRQ AEE +++S++++GIP NLSR+L A QR P+AKPGKVVGP+ P EN S +DAY
Sbjct: 421 FKDRQIAEESCSRSSRDTDGIPGNLSRSLQASQRIPMAKPGKVVGPLAPPENGSAIKDAY 480
Query: 492 DPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEM---DSEREMPSQVKHVPQCGMAAKFATD 547
D RT IR+ VLP QA+P AYCYR++S GKQE ++ER++ SQ K VPQCGM AK A D
Sbjct: 481 DHRTLIRNAVLPSQALPPAYCYRRTSAGKQERCVGEAERDLSSQAKQVPQCGMTAKLAPD 540
Query: 548 IAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRKI 607
IAIN+D+NPF+MTRAGV KV+H++D+I+ID NLLQ K+Q+GG+G AA AAAATAAAHRK+
Sbjct: 541 IAINIDTNPFYMTRAGVTKVDHVDDRITIDANLLQAKAQFGGIG-AAAAAAATAAAHRKV 599
Query: 608 GTVQYGMTTRMY 619
GTVQ+GM +RMY
Sbjct: 600 GTVQFGM-SRMY 610
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567418|ref|XP_003551917.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1032 bits (2669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/626 (82%), Positives = 570/626 (91%), Gaps = 19/626 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PK+RPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYH
Sbjct: 301 PKNRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVHS
Sbjct: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVHS 419
Query: 421 NTVPPKEQQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 478
NTV PKEQ N+ S++R AEE +NK+ +++E IP + R++ QR PLAKPGKVVGPV
Sbjct: 420 NTVHPKEQTNIASSKNRPTAEE-YNKHPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGPV 475
Query: 479 VPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKH 534
VPYE ++ +D+YDPR+FIR +VLP Q +P AY Y++SSTG QE ++++ +P Q KH
Sbjct: 476 VPYEYGNIVKDSYDPRSFIRGSVLPTQPVPPAYYYQRSSTGNQERPSTEADKSVPLQAKH 535
Query: 535 VPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVGAA 593
QCG+ AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QYGG+
Sbjct: 536 AQQCGVNAKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQYGGI--- 591
Query: 594 ATAAAATAAAHRKIGTVQYGMTTRMY 619
+AAA A AHRK+G VQYGM TRM+
Sbjct: 592 --SAAAGATAHRKVGPVQYGM-TRMF 614
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575287|ref|XP_002528547.1| big map kinase/bmk, putative [Ricinus communis] gi|223532049|gb|EEF33859.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1026 bits (2652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/625 (83%), Positives = 560/625 (89%), Gaps = 14/625 (2%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
QQDHRKKNS EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE
Sbjct: 3 QQDHRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 62
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAND
Sbjct: 63 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND 122
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP
Sbjct: 123 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 182
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
TIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD
Sbjct: 183 ATIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 242
Query: 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 301
LMTDLLGTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFDP
Sbjct: 243 LMTDLLGTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFDP 302
Query: 302 KDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
KDRPTAEEALADPYFKGLSKVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHP
Sbjct: 303 KDRPTAEEALADPYFKGLSKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHP 362
Query: 362 QLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSN 421
QLLKDY+NGTERT+FLYPS VDQFR+QFAHLEEN GKSGPV+P ERKHVSLPRSTIVHSN
Sbjct: 363 QLLKDYVNGTERTHFLYPSVVDQFRRQFAHLEENCGKSGPVVPLERKHVSLPRSTIVHSN 422
Query: 422 TVPPKEQQNLSR--DRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVV 479
VPP+E QN+S DRQ+AEE +NK+S++SEGI N+ L A QR PL K GKV GPVV
Sbjct: 423 IVPPRE-QNVSSLGDRQSAEETYNKSSRDSEGIHVNI-LALQATQRIPLDKSGKVAGPVV 480
Query: 480 PYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHV 535
PY+N ++ +D DPRTF+R T L PQA+ AY Y+KSSTG QE ++S+R++ SQ K
Sbjct: 481 PYDNGNITKDVNDPRTFVRGTALPPQAVLPAYSYQKSSTGSQERSALESQRQLSSQ-KQT 539
Query: 536 PQCGMA----AKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTK-SQYGGV 590
QCGM+ AKFA DIAIN+DSNPFFMTR G+NKVEH++D+I+I+ +LLQ K G
Sbjct: 540 QQCGMSEKVGAKFAPDIAINIDSNPFFMTRTGMNKVEHVDDRITINASLLQAKAQYGGIG 599
Query: 591 GAAATAAAATAAAHRKIGTVQYGMT 615
G A+A AA HRKIGTVQ GMT
Sbjct: 600 GGGGAASATAAATHRKIGTVQCGMT 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526989|ref|XP_003532097.1| PREDICTED: mitogen-activated protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2608), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/627 (81%), Positives = 564/627 (89%), Gaps = 20/627 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTG+KVAIKKIHDIF
Sbjct: 1 MQQDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGDKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKFPNADP ALRLLE+LLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFPNADPLALRLLEKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV+P +RKHVSLPRSTIVHS
Sbjct: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVMPLDRKHVSLPRSTIVHS 419
Query: 421 NTVPPKEQQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 478
NTV KEQ N S++R EE +NKN +++E IP + R++ QR PLAKPGKVVGPV
Sbjct: 420 NTVHSKEQTNNAASKNRPTVEE-YNKNPRDTE-IP--VPRSMQGPQRIPLAKPGKVVGPV 475
Query: 479 VPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKH 534
VPYE+ ++ +D+YDPR+FIR +VLP QA+P AY Y++SSTG QE ++ + +P Q KH
Sbjct: 476 VPYEHGNIVKDSYDPRSFIRGSVLPTQAVPPAYYYQRSSTGNQERPATEANKSVPLQAKH 535
Query: 535 V-PQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKS-QYGGVGA 592
QCG+ AK A DIAIN+D+NPFFMTRAGVNK+E DQI+I+TN+LQ K+ QY
Sbjct: 536 AQQQCGVNAKMAPDIAINIDTNPFFMTRAGVNKLEQ-GDQIAIETNMLQPKAHQY----- 589
Query: 593 AATAAAATAAAHRKIGTVQYGMTTRMY 619
AAA A AHRK+G VQYGM TRM+
Sbjct: 590 GGIGAAAGATAHRKVGPVQYGM-TRMF 615
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|399106790|gb|AFP20228.1| MAP kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 1008 bits (2605), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/614 (81%), Positives = 553/614 (90%), Gaps = 11/614 (1%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS+
Sbjct: 181 RWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
DTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP AL+LLERLLAFDPKDRPTAEEALA
Sbjct: 241 DTISRVRNDKARRYLTSMRKKQPVSFAQKFPNADPLALKLLERLLAFDPKDRPTAEEALA 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFKGL+K EREPSC+PISKMEFEFERRRVTKED+RELIFREILEYHPQL KDYMNG E
Sbjct: 301 DPYFKGLAKSEREPSCKPISKMEFEFERRRVTKEDLRELIFREILEYHPQLRKDYMNGVE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
RTNFLYPSAVDQFRKQFAHLEEN G GPV+P +RKHVSLPRST++HSNT+P KEQ +
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENGGNGGPVVPMDRKHVSLPRSTVLHSNTIPSKEQPIAA 420
Query: 433 ---RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRD 489
RDRQ EE ++N ++SEG+ +L+RT+ AQ R LAK GKVVGPV+ Y++ + ++
Sbjct: 421 ANMRDRQNGEESCSRNCRDSEGLANSLTRTMQAQPRIALAKTGKVVGPVLAYDSGN--KE 478
Query: 490 AYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAKFA 545
YDPR+ +R+TV P Q +P+AYCY +S KQE +++ER++ S K +P CGMAAK A
Sbjct: 479 KYDPRSQVRNTVFPSQIMPSAYCYDRSGMVKQERPVVETERDVSSHAKPMPPCGMAAKLA 538
Query: 546 TDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHR 605
DIAIN+DSNPF+M RAGV K + +ED+I+IDTNLLQ KSQYGG+G A AAA TAAAHR
Sbjct: 539 PDIAINIDSNPFYMMRAGVTKPDRVEDRITIDTNLLQAKSQYGGIG-VAAAAATTAAAHR 597
Query: 606 KIGTVQYGMTTRMY 619
K+GTVQYG+ +RMY
Sbjct: 598 KVGTVQYGI-SRMY 610
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463659|ref|XP_003602111.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] gi|355491159|gb|AES72362.1| Mitogen activated protein kinase 20-4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1000 bits (2586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/626 (80%), Positives = 554/626 (88%), Gaps = 19/626 (3%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQDHRKK S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQQDHRKKGSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR+DFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRKDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFSDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRN+KARRYLTSMRKKQPV F+QKF NADP ALRLLERLLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKQPVPFAQKFSNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKE+IRELIFREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEEIRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDY+NGTERTNFLYPSAVDQFRKQFAHLEEN GK+GPV P +RKHVSLPRSTIVHS
Sbjct: 361 PQLLKDYINGTERTNFLYPSAVDQFRKQFAHLEEN-GKNGPVAPLDRKHVSLPRSTIVHS 419
Query: 421 NTVPPKEQQNL--SRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 478
NTVP KEQ ++ S++RQ +EE +NK S+++E IP + R + QR PLAKPGKVVGPV
Sbjct: 420 NTVPQKEQTSIASSKNRQTSEE-YNKLSRDNE-IP--VPRPIQGPQRIPLAKPGKVVGPV 475
Query: 479 VPYENASVRRDAYDPRTFIRS--TVLPQAIPAAYCYRKSSTGKQE---MDSEREMPSQVK 533
VP+E +V +D+YDPR FIR PA Y R ST QE +++ +P Q K
Sbjct: 476 VPFEYGNVVKDSYDPRAFIRGPVLPPQPVPPAYYYQRPGSTANQERPTAGADKGVPLQAK 535
Query: 534 HVPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAA 593
H QCG+ AK +IAIN+D+NPFFMTR GVNKVE +DQI+I+TNLLQ+K+QYGGVG
Sbjct: 536 HGQQCGINAKIGHEIAINIDTNPFFMTRVGVNKVEK-DDQIAIETNLLQSKAQYGGVG-- 592
Query: 594 ATAAAATAAAHRKIGTVQYGMTTRMY 619
AAA +HRK+G +QYGM TRM+
Sbjct: 593 ---AAAGTNSHRKVGPIQYGM-TRMF 614
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350539497|ref|NP_001234664.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] gi|335353080|gb|AEH42669.1| mitogen-activated protein kinase 12 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2577), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/625 (80%), Positives = 554/625 (88%), Gaps = 10/625 (1%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S EM+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF
Sbjct: 1 MQPDHRKKSSAEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPS+DTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP +L+LLERLLAFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLTSMRKKQPVSFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL+K EREPSC+ ISKMEFEFERRRVTKED+RELIFREILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKSEREPSCKSISKMEFEFERRRVTKEDLRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQL KDY+NG ERTNFLYPSAVDQFRKQFAHLEEN G PV+P +RKHVSLPRST+VHS
Sbjct: 361 PQLRKDYLNGVERTNFLYPSAVDQFRKQFAHLEENGGNGVPVVPMDRKHVSLPRSTVVHS 420
Query: 421 NTVPPKEQQNLS--RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL-AKPGKVVGP 477
N P KEQ ++ RDRQ EE ++N ++SEG+ ++L+RTL AQ R L AKPGKVVGP
Sbjct: 421 NPNPLKEQPIVANMRDRQNGEESCSRNCRDSEGLASSLTRTLQAQPRNALAAKPGKVVGP 480
Query: 478 VVPYENASVRRDAYDPRTFIRSTVL-PQAIPAAYCYRKSSTGKQE--MDSEREMPSQVKH 534
+ Y++ + R+ YDPR+ +R+ V PQ + + Y Y +S KQE +++ER+M K
Sbjct: 481 GLAYDSGN--REKYDPRSQVRNAVGPPQIMSSVYSYDRSGVVKQERSVETERDMNCHSKP 538
Query: 535 VPQCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAA 594
+ CGMAAK A DIAIN+DSNPF+M RAGV K + ++D+I+IDTNLLQ KSQYGG+G A
Sbjct: 539 MAPCGMAAKLAPDIAINIDSNPFYMMRAGVTKPDRVDDRITIDTNLLQAKSQYGGIG-VA 597
Query: 595 TAAAATAAAHRKIGTVQYGMTTRMY 619
AAA + AAHRK+GTVQYGM +RMY
Sbjct: 598 AAAATSGAAHRKVGTVQYGM-SRMY 621
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224085324|ref|XP_002307544.1| predicted protein [Populus trichocarpa] gi|222856993|gb|EEE94540.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 984 bits (2545), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/613 (81%), Positives = 539/613 (87%), Gaps = 42/613 (6%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M+FFSEYGDA+RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 120
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP+TIFWTDYVAT
Sbjct: 121 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPSTIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV+TGKPLFPGKNVVHQLDLMTDLLGTPSL
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVITGKPLFPGKNVVHQLDLMTDLLGTPSL 240
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
DTISRVRNDKARRYLTSMRKK PV F+QKF NADP AL LLERLLAFDPKDRPTAEEAL
Sbjct: 241 DTISRVRNDKARRYLTSMRKKAPVPFAQKFLNADPLALCLLERLLAFDPKDRPTAEEALG 300
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTE 372
DPYFKGL+KVEREPSCQPI+KMEFEFERRRVTKEDIRELIFREILEYHPQLLKDY+NGTE
Sbjct: 301 DPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYVNGTE 360
Query: 373 RTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
RTNFLYPSAVDQFRKQFAHLEEN GKSGPVIP ERKHVSLPRST+VHS+++P KEQQNL+
Sbjct: 361 RTNFLYPSAVDQFRKQFAHLEENGGKSGPVIPLERKHVSLPRSTVVHSSSIPSKEQQNLA 420
Query: 433 --RDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPVVPYENASVRRDA 490
+DR +AEEV VG VVPYEN S +DA
Sbjct: 421 SFKDRHSAEEV---------------------------------VGSVVPYENGSNTKDA 447
Query: 491 YDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQE---MDSEREMPSQVKHVPQCGMAAKFAT 546
YDPRT+IRSTVLP QA+P+AYCYRKSSTGK E M++ER++ SQ K V QCGMAAK+A
Sbjct: 448 YDPRTYIRSTVLPLQAVPSAYCYRKSSTGKLERSTMEAERDLSSQ-KQVQQCGMAAKYAP 506
Query: 547 DIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGAAATAAAATAAAHRK 606
D+AIN+DSNPFFMTR G +K EH++D++ IDT+ +QTK+Q G AA AA A+ AA+RK
Sbjct: 507 DVAINIDSNPFFMTRVGGSKEEHVDDRVMIDTSSMQTKAQ-YGGIGAAAAATASRAAYRK 565
Query: 607 IGTVQYGMTTRMY 619
+GTVQYGM RMY
Sbjct: 566 VGTVQYGM-ARMY 577
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115345808|gb|ABI95363.1| mitogen-activated protein kinase 20 [Arachis diogoi] | Back alignment and taxonomy information |
|---|
Score = 975 bits (2520), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/628 (79%), Positives = 546/628 (86%), Gaps = 31/628 (4%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD RKK+S EMEFFS+YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSMEMEFFSDYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDVF 60
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAARILREIKLLRLLRHPDIVEIKH+M+PPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHVMMPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT+EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFTDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLLGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPV F+QKFPNADP ALRLLERLLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVPFAQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTA+EALADPYFKGL+KVEREPSC PI+KMEFEFERRRVTKE+IRELIFREILEYH
Sbjct: 301 PKDRPTAQEALADPYFKGLAKVEREPSCHPITKMEFEFERRRVTKEEIRELIFREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDY+NGTER NFLYPSAVDQF+KQFAHLEEN GKS PV+P ERKHVSLPRST+VHS
Sbjct: 361 PQLLKDYINGTERANFLYPSAVDQFKKQFAHLEENGGKSSPVMPLERKHVSLPRSTVVHS 420
Query: 421 NTVPPKEQQN--LSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAKPGKVVGPV 478
N V KEQ N S++RQ AEE +N N QR P AKPGKVVGPV
Sbjct: 421 NMVAQKEQSNNASSKNRQPAEE-YNNN------------------QRIPPAKPGKVVGPV 461
Query: 479 VPYENASVRRDAYDPRTFIRSTVLP-QAIPAAYCYRKSSTGKQEMDSEREMPSQVKHVP- 536
VPYE S+ +D++DPRTFIR + +P Q +P Y Y++S+TG Q D+E+ +P + KH P
Sbjct: 462 VPYEYGSIVKDSFDPRTFIRGSFVPSQTVPPTYYYQRSTTGHQ--DTEKGVPLKPKHGPQ 519
Query: 537 QCGMAAKFATDIAINMDSNPFFMTRA-GVNKVEHIED----QISIDTNLLQTKSQYGGVG 591
QCG+ AK A DIAIN+D+NPFFMTRA GVNK+E ++ +I+IDTNLLQ+K+ G
Sbjct: 520 QCGVNAKIAPDIAINIDTNPFFMTRAIGVNKIEQDDNNNNHRIAIDTNLLQSKAHQYGGI 579
Query: 592 AAATAAAATAAAHRKIGTVQYGMTTRMY 619
AA AA A AHRK+G VQYGM TRM+
Sbjct: 580 GAAATAATGATAHRKVGPVQYGM-TRMF 606
|
Source: Arachis diogoi Species: Arachis diogoi Genus: Arachis Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 619 | ||||||
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.975 | 0.996 | 0.713 | 2.5e-232 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.925 | 0.958 | 0.659 | 8.4e-200 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.961 | 0.967 | 0.617 | 2.6e-196 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.872 | 0.952 | 0.638 | 1.9e-186 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.689 | 0.837 | 0.740 | 4e-177 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.726 | 0.781 | 0.708 | 6.5e-177 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.722 | 0.758 | 0.698 | 1.4e-174 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.660 | 0.841 | 0.692 | 1.2e-159 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.525 | 0.864 | 0.490 | 7.7e-87 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.550 | 0.644 | 0.485 | 9.9e-87 |
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2241 (793.9 bits), Expect = 2.5e-232, P = 2.5e-232
Identities = 443/621 (71%), Positives = 496/621 (79%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQD+RKKN+ EMEFFS+YGDA+R+K+QEVIGKGSYGVVCSAIDT TGEKVAIKKIHDIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDAA HPDIVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTTIFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTDLLGTPSLDTISRVRN+KARRYLTSMRKK P+ F+QKFPNADP +L+LLERLLAFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALADPYFKGL+KVEREPSCQPI+KMEFEFERR+VTKEDIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKD+MNG ++ +FLYPSAVDQFR+QFAHLEEN GK+GPV P ERKH SLPRST++HS
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 NTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQR-FPLAXXXXXXXXXX 479
V Q L + N + ++ IP N + T+ AQQR A
Sbjct: 421 TAVARGGQPKLMNNTNTL------NPETTQNIPFNHA-TIQAQQRNLSAAKPSTFMGPVA 473
Query: 480 XYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSSTGKQ-EMDSEREMPSQVKHVPQC 538
++N + RDAYDPR+FIRST LP + +A + GKQ E + E Q + + Q
Sbjct: 474 PFDNGRISRDAYDPRSFIRSTNLPFSQQSAATV---AMGKQQERRTTMEPEKQARQISQY 530
Query: 539 GMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVGXXXXXXX 598
++A D+AIN+D+NPF M R G+NK E+I D+I IDTNLLQ + G V
Sbjct: 531 N---RYAPDVAINIDNNPFIMARTGMNKAENISDRIIIDTNLLQATAGIG-VAAAAAAAA 586
Query: 599 XXXXXHRKIGTVQYGMTTRMY 619
HRK+G V+YGM+ +MY
Sbjct: 587 PGGSAHRKVGAVRYGMS-KMY 606
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1934 (685.9 bits), Expect = 8.4e-200, P = 8.4e-200
Identities = 393/596 (65%), Positives = 449/596 (75%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ+ KKN EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDT TGEKVAIKKI+D+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DL+TDLLGTP +TI+ VRN+KAR+YL MRKK V FSQKFPNADP ALRLL+RLLAFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTA EALADPYFK L+KVEREPSCQPISKMEFEFERRR+TK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYMN +E ++FLYPSA+ RKQFA+LEEN GKSGPVIPP+RKH SLPRS VHS
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSA-VHS 418
Query: 421 NTVPPKEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPLAXXXXXXXXXXX 480
+ V Q +L+ + + A ++ L R P
Sbjct: 419 SAVNSNAQPSLNASDSRRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVT 478
Query: 481 YEN-ASVRRDAYDPRT-FIRSTVLPQAIPAAYCYRKSSTGKQEMDSEREMPSQVK--HVP 536
YEN +++ +YD RT + RSTVLP + CY +T QE S E SQ K VP
Sbjct: 479 YENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAASQPKPQFVP 538
Query: 537 -QCGMAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQISIDTNLLQTKSQYGGVG 591
QC +AK A ++ NP+ + +H ++ ID LL +SQYG G
Sbjct: 539 TQCN-SAKPA-----ELNPNPYVQS-------QH---KVGIDAKLLHAQSQYGPAG 578
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1901 (674.2 bits), Expect = 2.6e-196, P = 2.6e-196
Identities = 388/628 (61%), Positives = 456/628 (72%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQQ+ KK + EMEFF+EYGDA+RY+I EVIGKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EHISDA HPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLTREH+QFFLYQ+LRALK++HTANVYHRDLKPKNILANANCKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PTT+FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
+L+TDLLGTP +TIS VRNDKAR+YLT MRKK PV FSQKF ADP ALRLL+RLLAFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPT EALADPYFKGLSK+EREPS Q ISKMEFEFERRR+TK+DIRELI+REILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHS 420
PQLLKDYM+G+E +NF+YPSA+ R+QF +LEEN ++GPVIP ERKH SLPRST VHS
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRST-VHS 419
Query: 421 NTVPPKEQQNL-SRDRQAAEEVFNKNSKESEGIPANLS---RTLPAQQRFPLAXX-XXXX 475
V Q NL + D + +KN S G P+ + +++ R P +
Sbjct: 420 TVVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRVV 479
Query: 476 XXXXXYENASVRRDAYDPRTFIRSTVLPQAIPAAYCYRKSST----GKQEMDSEREMPSQ 531
YEN ++AY RS A+ + +CY + +T + +++ P
Sbjct: 480 ESSVSYENGRNLKEAY-----FRS-----AVSSPHCYFRPNTMTNPENRNIEASSFPPKP 529
Query: 532 VKHVPQCG-----MAAKFATDIAINMDSNPFFMTRAGVNKVEHIEDQ--ISIDTNLLQTK 584
V Q A D+ NP+F + + K + + + ++ID LLQ +
Sbjct: 530 QNPVHQFSPTEPPAATTNQADVETMNHPNPYFQPQ--LPKTDQLNNNTHMAIDAKLLQAQ 587
Query: 585 SQYGGVGXXXXXXXXXXXXHRKIGTVQY 612
SQ+G G HR IGT+ Y
Sbjct: 588 SQFGPAGAAAVAVAA----HRNIGTISY 611
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1808 (641.5 bits), Expect = 1.9e-186, P = 1.9e-186
Identities = 359/562 (63%), Positives = 433/562 (77%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
MQ DHRKK+S E++FF+EYG+ SRY+I+EVIGKGSYGVVCSA DTHTGEKVAIKKI+DIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIKHI+LPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTD+LGTPS + I RVRN+KARRYL+SMRKK+P+ FS KFP+ DP ALRLLE++L+F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDRPTAEEALAD YFKGL+KVEREPS QP++K+EFEFERRR+TKED+RELI+RE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERK-HVSLPRSTIVH 419
P++LK+Y++G+E TNF+YPSAV+ F+KQFA+LEE+ PPER+ H SLPR+ +++
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 420 SNTVPPKEQQN-------LSRD--RQAAEEVFNKNSK-ESEGIPANLSRTLPAQQRFPLA 469
S+ P QQ+ LS+ R ++N++ IP N+ +T+ Q +A
Sbjct: 421 SDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTI---QGAAVA 477
Query: 470 XXXXXXXXXXXYEN--ASVRRDAYDP--RTFIRSTVLPQAIPAAYCYRKSSTGKQEMDSE 525
Y N A+ +A + R +R+ P KS+ G ++ +
Sbjct: 478 RPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQPCKSNRGDEDCATA 537
Query: 526 REMPSQVK----HVPQCGMAAK 543
E PS++K ++PQ AA+
Sbjct: 538 AEGPSRLKPNTQYIPQKVSAAQ 559
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 319/431 (74%), Positives = 369/431 (85%)
Query: 4 DHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
D KK + E EFF+EYG+ASRY+IQEVIGKGSYGVV SAIDTH+GEKVAIKKI+D+FEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDL 123
SDA HPDIVEIKH+MLPPSRR+F+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T EHYQFFLYQLLR LK+IHTANV+HRDLKPKNILAN++CKLKICDFGLARV+FND P+
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+M
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 303
TDLLGTP + I+R+RN+KARRYL +MR+K PV F+ KFP+ DP ALRLL RLLAFDPKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 363
RP+AEEALADPYF GL+ V+REPS QPI K+EFEFERR++TKED+RELI+REILEYHPQ+
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTV 423
L++Y+ G E+T+F+YPS VD+F++QFAHLEEN GK P +R+H SLPR +
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERV----PA 417
Query: 424 PPKEQQNLSRD 434
P KE + + D
Sbjct: 418 PKKENGSHNHD 428
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1718 (609.8 bits), Expect = 6.5e-177, P = 6.5e-177
Identities = 324/457 (70%), Positives = 379/457 (82%)
Query: 2 QQDH---RKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD 58
Q++H KK P EFF+EYG+A+RY+IQEV+GKGSYGVV SAIDTHTGE+VAIKKI+D
Sbjct: 64 QRNHLPMEKKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKIND 123
Query: 59 IFEHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK 118
+F+HISDA HPD+VEIKHIMLPPSRR+F+D+YVVFELMESDLHQVIK
Sbjct: 124 VFDHISDATRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIK 183
Query: 119 ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
ANDDLT EH+QFFLYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FN
Sbjct: 184 ANDDLTPEHHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFN 243
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
D PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVH
Sbjct: 244 DAPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVH 303
Query: 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 298
QLD+MTD LGTP + IS++RNDKARRYL +MRKKQPV FS+KFP ADPSALRLLERL+A
Sbjct: 304 QLDIMTDFLGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIA 363
Query: 299 FDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILE 358
FDPKDRP+AEEALADPYF GLS REPS QPISK+EFEFER+++TK+DIRELI+REILE
Sbjct: 364 FDPKDRPSAEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILE 423
Query: 359 YHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIV 418
YHPQ+L++Y+ G + +F+YPS VD+FR+QFAHLEEN G G +R+H SLPR +
Sbjct: 424 YHPQMLEEYLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERVP 483
Query: 419 HSNTVPPKEQQN-LSRDRQAA-EEVFN--KNSKESEG 451
S +E+ N + R AA + K S+++EG
Sbjct: 484 ASKNETVEERSNDIERRTTAAVASTLDSPKASQQAEG 520
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1696 (602.1 bits), Expect = 1.4e-174, P = 1.4e-174
Identities = 318/455 (69%), Positives = 373/455 (81%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
+ D KK E EFF+EYG+A+RY+IQEV+GKGSYGVV SA+D+HTGE+VAIKKI+D+F
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAAXXXXXXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPD+VEIKHIMLPPSRR+F+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKY+H ANV+HRDLKPKNILANA+CKLKICDFGLARV+FND
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
DLMTD LGTP ++ISR+RN+KARRYL+SMRKKQPV FS KFP ADP ALRLLERLLAFD
Sbjct: 320 DLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFD 379
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
PKDR +AE+ALADPYF GLS EREP+ QPISK+EF+FER+++ K+D+RELI+REILEYH
Sbjct: 380 PKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYH 439
Query: 361 PQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPV-----IPPERKHVSLPRS 415
PQ+L++Y+ G ++ +F+YPS VD+F++QFAHLEEN GK G R H SLPR
Sbjct: 440 PQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRE 499
Query: 416 TIVHSNTVPPKEQQNLSRDRQAAEEVFNKNSKESE 450
+ N +E ++ R R AA S+E++
Sbjct: 500 RVPAPNGETAEESSDVER-RAAAAVASTLESEEAD 533
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1555 (552.4 bits), Expect = 1.2e-159, P = 1.2e-159
Identities = 286/413 (69%), Positives = 350/413 (84%)
Query: 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXX 71
E EFF+EYG+AS+Y+IQEV+GKGSYGVV SA HTG KVAIKK+ ++FEH+SDA
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 XXXXXXXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 131
HPDIVEIKHIMLPP R++FKDIYVVFELMESDLH V+K NDDLT +H+QFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
LYQLLR LK++H+A+V+HRDLKPKNILANA+CK+KICD GLARV+F D+P+ +FWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
T+SR+RN+KAR+YL +MR+K PV F+ KFPN DP AL+LL+RL+AFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 312 ADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGT 371
ADPYF+GL+ V+ EPS QPISK+EFEFERR++T++D+REL++REILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 372 ERTN--FLYPSAVDQFRKQFAHLEE-NVGKSGPVIPP-ERKHVSLPRSTIVHS 420
E N FLYPS VDQF+++FA LEE N + PP +RK+ SLPR + S
Sbjct: 363 ENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSS 415
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
Identities = 163/332 (49%), Positives = 230/332 (69%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXXXXXXHPDIVEIKHI 90
IG+G+YG+VC+A ++ TGE+VAIKKI + F++I DA H +++ +K I
Sbjct: 49 IGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDI 108
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
+ PP R +F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQLLR LKY+H+ANV HR
Sbjct: 109 IKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHR 168
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
DLKP N+L NANC LK+ DFGLAR T F T+YV TRWYRAPEL + S+YT
Sbjct: 169 DLKPSNLLLNANCDLKLGDFGLARTKSE----TDFMTEYVVTRWYRAPELLLNC-SEYTA 223
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 270
AIDIWS+GCI E +T +PLFPGK+ VHQL L+T+L+G+P ++ +R+D ARRY+ +
Sbjct: 224 AIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQL 283
Query: 271 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQP 330
+ F+ +FPN A+ LLE++L FDP R T +EAL PY L + EP C
Sbjct: 284 PQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVC-- 341
Query: 331 ISKMEFEFERRRVTKEDIRELIFREILEYHPQ 362
+ F+FE+ +T+E+I+ELI+RE ++++PQ
Sbjct: 342 VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
Identities = 168/346 (48%), Positives = 232/346 (67%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAXXXXXXXXX 76
S++ RY I + IG G+YGVVCSA D TGEKVAIKKI F+++ D
Sbjct: 141 SQFTVPRRYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLL 200
Query: 77 XXXXHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
H +++ IK I+ P S+ F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+L
Sbjct: 201 RHFKHENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQML 260
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R LK+IH+ANV HRDLKP N+L N +C LKICD GLARV D F T+YVATRWYR
Sbjct: 261 RGLKHIHSANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYR 318
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
APE+ S+ +KYT AIDIWS+GCIFAE+L KPLF GK+ +HQ+ L+ + +G+PS + I
Sbjct: 319 APEVILSW-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDIC 377
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ N++AR+++ +M + V F+ FP A+P A+ LLER+L FDP R T EEALA PYF
Sbjct: 378 NIANEQARQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYF 437
Query: 317 KGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 362
+ L EP C + K FE + ++ ++ELI+ E+L YHP+
Sbjct: 438 QSLHDPSDEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7467 | 0.9789 | 0.9918 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7389 | 0.6898 | 0.8438 | N/A | no |
| Q5VN19 | MPK11_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7005 | 0.8045 | 0.8736 | no | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7548 | 0.9773 | 0.9983 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pm.C_LG_II0282 | hypothetical protein (621 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 619 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-160 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-148 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-143 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-122 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-121 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-118 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-105 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-102 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-102 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-91 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-90 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-89 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-88 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-87 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-86 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-84 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-79 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-74 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-72 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-67 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-67 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-65 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-65 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-65 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-63 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-62 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-61 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-61 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-61 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-59 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-59 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-58 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-57 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-53 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-52 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-48 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-46 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-42 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-39 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-28 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 750 bits (1937), Expect = 0.0
Identities = 314/338 (92%), Positives = 331/338 (97%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI+D+FEH+SDA RILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IVEIKHIMLPPSRR+FKDIYVVFELMESDLHQVIKANDDLT EH+QFFLYQLLRALKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT IFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL+TDLLGTPS +TISRVRN+KA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323
RRYL+SMRKKQPV FSQKFPNADP ALRLLERLLAFDPKDRPTAEEALADPYFKGL+KVE
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
REPS QPI+K+EFEFERRR+TKED+RELI+REILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 187/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY++ + IG G+YGVVCSA+D TG KVAIKKI ++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
I+ + I+ PPS DF D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
S+YT AIDIWS+GCIFAE+LT KPLFPG++ + QL+L+ ++LGTPS + + + ++KA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323
R YL S+ KK S+ FP A P A+ LLE++L FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSCQPISKMEFEFERRRVTKEDIRELIFRE 355
EP +P +F F+ +T+E+++ELI+ E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 463 bits (1193), Expect = e-160
Identities = 188/339 (55%), Positives = 247/339 (72%), Gaps = 6/339 (1%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+++ IK IM PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLR LKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ANV HRDLKP N+L NANC LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+ S+YT AID+WS+GCIFAE+L KPLFPGK+ VHQL L+T+LLG+PS + + +RN+K
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
ARRY+ S+ F++ FP+A+P A+ LLE++L FDP R T EEALA PY L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
Query: 323 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
EP CQ + F+FE +T+EDI+ELI+ E+L YHP
Sbjct: 301 SDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 430 bits (1108), Expect = e-148
Identities = 174/341 (51%), Positives = 237/341 (69%), Gaps = 14/341 (4%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY+ IG+G+YG+VCSA TG KVAIKKI FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N NC LKICDFGLAR+A + T F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+L+ +LGTPS + ++ + +
Sbjct: 182 LNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+AR Y+ S+ K V +++ FPNADP AL LL+++L F+P R T EEALA PY
Sbjct: 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY------ 294
Query: 322 VER--EPSCQPISKMEFEFE---RRRVTKEDIRELIFREIL 357
+E+ +PS +P+++ F F+ + KE ++ELIF EI+
Sbjct: 295 LEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 417 bits (1075), Expect = e-143
Identities = 175/334 (52%), Positives = 241/334 (72%), Gaps = 5/334 (1%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
SRYK E IG G+YGVVCSAIDT +G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+I+ I+ I+ PP DFKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLR LKYI
Sbjct: 65 NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELC 201
H+ANV HRDLKP N+L N +C+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL L+ +LG+PS + ++R+ +D
Sbjct: 184 LSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+ R+Y+ ++ +KQPV +S+ FP A P AL LL ++L FDP++R T E+AL P+
Sbjct: 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFRE 355
+ EP+C P +F+FE +++E ++E I +E
Sbjct: 303 PDDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 364 bits (938), Expect = e-122
Identities = 148/338 (43%), Positives = 212/338 (62%), Gaps = 11/338 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
+Y+I + +GKG+YG+V AID T E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
P+IV++ +++ + D KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ALKY
Sbjct: 67 PNIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKY 122
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVA--FNDTPTTIFWTDYVATRWYRAPE 199
IH+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS + I +
Sbjct: 183 ILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
++ A L S+ + + P A AL LL++LL F+P R TAEEAL PY
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
Query: 319 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 356
EP + + + +++ + R ++ EI
Sbjct: 301 FHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 361 bits (928), Expect = e-121
Identities = 164/338 (48%), Positives = 222/338 (65%), Gaps = 11/338 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLR- 80
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
H +I + + M +F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L LK
Sbjct: 61 HKNITCL-YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK 119
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP--TTIFWTDYVATRWYRAP 198
YIH+ANV HRDLKP N+L NA+C+LKICDFGLAR F++ P F T+YVATRWYRAP
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ SF YT AID+WS+GCI AE+L KP+F GK+ V QL+ + +LGTP +T+SR+
Sbjct: 179 EIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
+ KA+ Y+ S+ F FPNA+P AL LLE+LLAFDP R + EEAL PY
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297
Query: 319 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 356
+ EP CQ FE E + E++R++I E+
Sbjct: 298 WHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 354 bits (910), Expect = e-118
Identities = 146/339 (43%), Positives = 212/339 (62%), Gaps = 12/339 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA DT TG KVAIKK+ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S DF+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LR LKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
++ Y +DIWS+GCI AE+LTGK LFPG + + QL + +L+GTP + + ++ ++
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
AR Y+ S+ + F + F A+P A+ LLE++L DP R TA EALA PY
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307
Query: 323 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
E EP P + FE R +T ++ +EL+++EI+ + P
Sbjct: 308 EDEPVAPP---YDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-105
Identities = 154/335 (45%), Positives = 221/335 (65%), Gaps = 18/335 (5%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ+LR LKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A V HRDLKP NIL N NC LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
++ KY +DIWS GCIFAE+L GKPLFPGK+ V+Q ++TDLLGTP D I+ + ++
Sbjct: 179 TW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
R++ S+ K++PV FS+KF NADPSA+ LLE++L FDP+ R +A EALA PY
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY----LAP 293
Query: 323 EREPSCQPISKMEFE--FERRRVTKEDIRELIFRE 355
+P+ +P+++ +F+ F + + + +++ E
Sbjct: 294 YHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-102
Identities = 125/296 (42%), Positives = 173/296 (58%), Gaps = 18/296 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHP 82
Y+ E +G+G+YGVV A D TGE VA+KKI E I A LREI LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKY 141
+IV++ ++ + +Y+VFE + DL + + L+ + +YQLLR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF +T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AF--GIPLRTYTHEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ ++ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
K Y + K P + P DP + LL ++L ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 133/294 (45%), Positives = 177/294 (60%), Gaps = 13/294 (4%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIH 143
+++ + R D+Y+VFE M++DL+++IK L + +LYQLL+ L + H
Sbjct: 61 IKLLDVF-----RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y+ +DIWS+GCIFAE+L+ +PLFPGK+ + QL + LGTP + + +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL- 229
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
AR Y S KK + + FPNA P AL LL ++L +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 298 bits (764), Expect = 8e-96
Identities = 140/354 (39%), Positives = 207/354 (58%), Gaps = 32/354 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG G++GVV S D G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTS 269
A+DIWS+GCIFAE+L + LF ++ + QLDL+TDLLGTPSL+ + + AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKQPVQFSQKFPNADPS---ALRLLERLLAFDPKDRPTAEEALADPYFKG-------- 318
K P + + + A+ LL R+L FDP R +A +ALA PY
Sbjct: 243 GPHKPPS-LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTC 301
Query: 319 ------------LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360
+ + EPS P E+E+ + ++E + + ILE
Sbjct: 302 MCKCCYTTSGGRVYTSDFEPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 5e-91
Identities = 109/293 (37%), Positives = 153/293 (52%), Gaps = 40/293 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y+I E +G+GS+G V A D TG+ VAIK I + D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + + D +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKL---TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
Y A+DIWS+G I E+LTGKP FPG + QL + +G P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP------------- 212
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
F + P A L+ +LL DP+ R TAEEAL P+F
Sbjct: 213 -----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 6e-90
Identities = 136/340 (40%), Positives = 207/340 (60%), Gaps = 12/340 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
RY+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 83 DIVEIKHIMLPPSRRD-FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P D F D Y+V M +DL +++K ++ L+ + QF +YQ+L+ LKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS + + +++++
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
A+ Y+ + + + F PNA+P A+ +LE++L D + R TA EALA PYF+
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
E E P + F+ + E+ + L F EIL + P
Sbjct: 307 PEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 279 bits (714), Expect = 6e-89
Identities = 137/339 (40%), Positives = 210/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
++ Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + + ++ ++
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
+ EP P + FE R + ++ + L + E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 3e-88
Identities = 132/339 (38%), Positives = 198/339 (58%), Gaps = 13/339 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY + +G G+YG VCSAID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + S +F+D Y+V M++DL +++ L+ + Q+ +YQ+L LKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + ++ +
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
A+ Y+ S+ K FS FP A P A+ LLE++L D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
+ E QP E +++ ++ ++ I++E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 1e-87
Identities = 115/302 (38%), Positives = 172/302 (56%), Gaps = 29/302 (9%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPD 83
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKY 141
IV++K + R+ ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 200
IH +HRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
S Y+ +DIW++GCI AE+ T +PLFPG + + QL + +LGTP+
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE- 225
Query: 259 RNDKARRYLTSMR----KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ + + + P Q PNA P A+ L++ +L +DPK RPTA +AL P
Sbjct: 226 ----GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (699), Expect = 3e-87
Identities = 115/298 (38%), Positives = 171/298 (57%), Gaps = 17/298 (5%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
Y+ IG+G+YG V A + TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL L+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+H+ + HRD+K NIL N + LK+ DFGLAR + + + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
G+ ++Y P +D+WS+GCI AE+ GKP+F G + QL+ + +L G+P+ + V
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV-- 229
Query: 261 DKARRYLT-SMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 316
K + +K + + F + DPSAL LL++LL DPK R +A++AL YF
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 6e-86
Identities = 137/339 (40%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
++ + + P S +F ++Y+V LM +DL+ ++K L+ EH QF +YQLLR LKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
++ Y +DIWS+GCI AE+L GK LFPG + + QL + +++GTPS + + ++ ++
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322
AR+Y+ S+ + F A+P A+ LLE++L D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
E EP +P + E + T E+ +EL + E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 5e-84
Identities = 119/302 (39%), Positives = 162/302 (53%), Gaps = 24/302 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRL 78
RY+ + +G+G+Y VV A D TG VAIKKI +A LREIKLL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQE 58
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLR 137
L+HP+I+ + + + I +VFE ME+DL +VIK LT + ++ LR
Sbjct: 59 LKHPNIIGLLDVF---GHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRA
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRA 170
Query: 198 PELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
PEL F Y +D+WS+GCIFAE+L P PG + + QL + + LGTP+ +
Sbjct: 171 PEL---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
V + + P Q FP A AL LL+RLL +P R TA +AL PY
Sbjct: 228 PGV---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 316 FK 317
F
Sbjct: 285 FS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-82
Identities = 121/301 (40%), Positives = 177/301 (58%), Gaps = 24/301 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
RYKI IG+G++G+V A D TGE VA+KK+ + I + A LREIK L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ LL+ +
Sbjct: 59 PYVVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y+H + HRDLKP N+L +A+ LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
G+ KY P +D+W++GCIFAE+L G PLFPG+N + QL ++ LGTP+ +T +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 260 N----DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ +K + +P+ + FP+A P AL LL+ LL +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 316 F 316
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 256 bits (657), Expect = 3e-80
Identities = 127/348 (36%), Positives = 198/348 (56%), Gaps = 24/348 (6%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
RY+ + IG G+ G+VC+A DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ + ++ P S +F+D+Y+V ELM+++L QVI DL E + LYQ+L +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS + +SR+
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARRYLTSMRKKQPVQFSQKFP-------NADPSALR------LLERLLAFDPKDRPTAE 308
R Y+ + K F + FP + + L+ LL ++L DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 356
+AL PY E P + + + R T E+ +ELI++E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 2e-79
Identities = 96/293 (32%), Positives = 140/293 (47%), Gaps = 34/293 (11%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + D +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
+ Y P +D+WS+G I E+LTGKP F G+N LD + +R
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGEN---------------ILDQLQLIRRILG 216
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
K+ + A L+++ L DP RPTAEE L P+F
Sbjct: 217 PPLEFD---------EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 2e-79
Identities = 114/296 (38%), Positives = 168/296 (56%), Gaps = 12/296 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
IV +K RR + +Y+VFE +E L ++++A+ L + + +++QLL+A+ Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 201
H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
G + Y +D+W+IGCI AE+L G+PLFPG + + QL L+ LG ++
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 262 KARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ QP +++P AL L+ L DPK+R T +E L PYF
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 5e-77
Identities = 126/337 (37%), Positives = 182/337 (54%), Gaps = 27/337 (8%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---LREIKL 75
+ SRY +G GS G+V SA+D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKHIMLPPSRRD---------FKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIF 185
H + F+YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + + Q+ L+ +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 ---LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 302
++ + + V R R+ P +P AL LE++L F+P
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRP----LRDLLPGVNPEALDFLEQILTFNPM 289
Query: 303 DRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 339
DR TAEEAL PY S EP +E E +
Sbjct: 290 DRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 6e-74
Identities = 120/299 (40%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
Y+ I +G+YGVV A D TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 141
+IV +K +++ + IY+V E +E DL +++ + + + QLL + +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGK+ + QL+ + LLGTP+
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 DKARRYLTSMRKKQPV-QFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEEALADPYF 316
+ T K P Q +KFP S LL RLL +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT--FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 8e-72
Identities = 128/309 (41%), Positives = 173/309 (55%), Gaps = 30/309 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIK 88
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANV 147
+++ + I++V E E DL ++ + + + QLLR L+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFS 206
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI----SRVRNDK 262
YT AID+W++GCI AE+L KPL PGK+ + QLDL+ LLGTP+ ++I S +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDLPL-- 241
Query: 263 ARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
++ KQP KFP + LRLL LL +DPK R TAEEAL YFK
Sbjct: 242 VGKFTL---PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK---- 294
Query: 322 VEREPSCQP 330
E+ C+P
Sbjct: 295 -EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 4e-71
Identities = 112/310 (36%), Positives = 164/310 (52%), Gaps = 22/310 (7%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 80
Y+I +G+G++G V A TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 81 HPDIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLL 136
HP++V + + + S+R +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT--------TIFWTD 188
+ Y+H ++ HRD+K NIL + LKI DFGLAR P T +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL L+ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 248 GTPSLDTISRVRN-DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
GTP+ +T R+ + P ++F P L LL +LL+ DP R T
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNY--PRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 307 AEEALADPYF 316
A +AL PYF
Sbjct: 302 ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 2e-67
Identities = 120/297 (40%), Positives = 165/297 (55%), Gaps = 19/297 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA--ARILREIKLLRLLRHP 82
Y+ E IG+G+YGVV A D TGE VA+KKI E + + +REI LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALK 140
+IV + ++ ++ +Y+VFE ++ DL + + L + +LYQLL+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP D V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
Y + K S+ PN D L LL ++L +DP R +A+ AL PYF
Sbjct: 229 --SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 2e-67
Identities = 110/302 (36%), Positives = 175/302 (57%), Gaps = 30/302 (9%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD 83
YKI IG+G++ V A TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKHIML-PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY------QFFLYQLL 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQLL
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
++L ++H ++HRD+KP+NIL + LK+ DFG R ++ P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP +
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ + R + Y + K+ + PNA L LL++LLA+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 315 YF 316
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-67
Identities = 127/366 (34%), Positives = 206/366 (56%), Gaps = 29/366 (7%)
Query: 12 EMEFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD 65
+ +F+S + D++ RY+ + IG G+ G+VC+A DT G VA+KK+ F++ +
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLT 124
A R RE+ LL+ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI +L
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELD 121
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNF 177
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244
T YV TR+YRAPE+ Y +DIWS+GCI E++ G +F G + + Q + +
Sbjct: 178 MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235
Query: 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPS-----------ALRL 292
+ LGTPS + ++R++ R Y+ + + + F + FP+ PS A L
Sbjct: 236 EQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294
Query: 293 LERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELI 352
L ++L DP R + +EAL PY + E P + + E R E+ +ELI
Sbjct: 295 LSKMLVIDPDKRISVDEALRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELI 353
Query: 353 FREILE 358
++E+++
Sbjct: 354 YKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 115/297 (38%), Positives = 168/297 (56%), Gaps = 19/297 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
+K E +G+G+Y V + TGE VA+K+IH D E A +REI L++ L+H +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHEN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRALK 140
IV + ++ ++ + +VFE M+ DL + + + L + F YQLL+ +
Sbjct: 60 IVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
L GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ T +
Sbjct: 172 LLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ Q +Q Q FP+ADP + LL RLL +P+ R +A +AL P+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQ--QLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 3e-65
Identities = 110/306 (35%), Positives = 160/306 (52%), Gaps = 33/306 (10%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR- 80
Y+ IG+G+YG V A D +TG VA+KK+ +S+ LREI LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLL 136
HP+IV + + P + +VFE ++ DL + L E + + QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWY 195
R + ++H+ + HRDLKP+NIL ++ ++KI DFGLAR+ +F T++ V T WY
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV-----VVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD- 253
RAPE L S Y +D+WS+GCIFAE+ +PLF G + QLD + D++G PS +
Sbjct: 173 RAPEVLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 254 ---TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
+S R +S P F P L LL+++L F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 311 LADPYF 316
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 216 bits (553), Expect = 3e-65
Identities = 119/322 (36%), Positives = 166/322 (51%), Gaps = 37/322 (11%)
Query: 22 ASRYK-IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR------------ 68
+ RY +G+G+YG V A DT TG+ VAIKK+ I E +D +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHF 65
Query: 69 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH 127
LRE+K++ ++H +I+ + + + DF I +V ++M SDL +V+ LT
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQ 120
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------- 179
+ L Q+L L +H HRDL P NI N+ KI DFGLAR
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 180 ---TPTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG+N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 295
+ QL + +LLGTP+ D + + T ++P FPNA A+ LL+
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPL---YTEFTPRKPKDLKTIFPNASDDAIDLLQS 295
Query: 296 LLAFDPKDRPTAEEALADPYFK 317
LL +P +R +A+EAL YFK
Sbjct: 296 LLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-63
Identities = 120/326 (36%), Positives = 168/326 (51%), Gaps = 43/326 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRL 78
+Y+I+ IG+G+YG V A + G++ AIKK E IS +A REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-----LY 133
L+H ++V + + L + K +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTD- 188
Q+L + Y+H+ V HRDLKP NIL +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VH 238
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS--------QKFPNADPSAL 290
QL+ + ++LGTP+ ++ K Y T M+ + + +K D
Sbjct: 233 QLERIFEVLGTPTEKDWPDIK--KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 291 RLLERLLAFDPKDRPTAEEALADPYF 316
LL +LL +DP R TAEEAL PYF
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 116/301 (38%), Positives = 172/301 (57%), Gaps = 24/301 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRH 81
+Y+ IG+GSYGVV + TG+ VAIKK + + I A LREI++L+ L+H
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKH 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P++V + + RR K +++VFE + + L+++ K + + ++Q L+A+
Sbjct: 60 PNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
+ H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAPEL
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAPEL 171
Query: 201 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
G ++Y P +D+W+IGC+FAE+LTG+PL+PGK+ V QL L+ LG D I R +
Sbjct: 172 LVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQ 225
Query: 260 ND-KARRYLTSMRKKQP---VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
++ + +P KFPN AL L+ L DP +R + EE L PY
Sbjct: 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
Query: 316 F 316
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 3e-62
Identities = 113/292 (38%), Positives = 166/292 (56%), Gaps = 16/292 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV + TG+ VA+KKI E + +REI LL+ L+HP+IV ++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQ---VIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+++ SR +Y++FE + DL + + + E + +LYQ+L+ + + H+
Sbjct: 66 DVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L GS
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLLGS- 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264
+Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ D V
Sbjct: 177 -PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV--TSLP 233
Query: 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
Y + K + N D L LLE++L +DP R +A++AL PYF
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 2e-61
Identities = 114/301 (37%), Positives = 171/301 (56%), Gaps = 25/301 (8%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ D E + +A LREI LL+ L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV + ++ + + +VFE + DL + + N D+ E + F++QLL+ L
Sbjct: 59 KNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPDV 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT---I 255
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ ++ +
Sbjct: 171 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
S++ + K + P + + LL+ LL +P R +AEEAL PY
Sbjct: 229 SKLPDYKPYPMYPAT-----TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
Query: 316 F 316
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 3e-61
Identities = 127/366 (34%), Positives = 207/366 (56%), Gaps = 35/366 (9%)
Query: 14 EFFS-EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
+F+S E GD++ RY+ + IG G+ G+VC+A D VAIKK+ F++ + A
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 68 RILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTRE 126
R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+ +L E
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHE 119
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186
+ LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T+
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 175
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + +
Sbjct: 176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLE 294
LGTP + + +++ R Y+ + K + F + FP++ A LL
Sbjct: 234 LGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 295 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPS---CQPISKMEFEFERRRVTKEDIREL 351
++L DP R + +EAL PY V +P+ P + + + R T E+ +EL
Sbjct: 293 KMLVIDPAKRISVDEALQHPYI----NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
Query: 352 IFREIL 357
I++E++
Sbjct: 349 IYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 4e-61
Identities = 127/363 (34%), Positives = 202/363 (55%), Gaps = 34/363 (9%)
Query: 18 EYGDAS-----RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
E GD++ RY+ + IG G+ G+VC+A D VAIKK+ F++ + A R RE
Sbjct: 14 EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE 73
Query: 73 IKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF 131
+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+ +L E +
Sbjct: 74 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYL 131
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T+ T YV
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVV 187
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q + + + LGTP
Sbjct: 188 TRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN----AD--------PSALRLLERLLAF 299
+ + +++ R Y+ + K F + FP+ AD A LL ++L
Sbjct: 246 PEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 300 DPKDRPTAEEALADPYFK---GLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI 356
D R + +EAL PY S+ E P P + + + R T E+ +ELI++E+
Sbjct: 305 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIP----DKQLDEREHTIEEWKELIYKEV 360
Query: 357 LEY 359
++
Sbjct: 361 MDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 5e-61
Identities = 115/291 (39%), Positives = 163/291 (56%), Gaps = 15/291 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTAN 146
++ +Y+VFE + DL + + A+ + + +L+QLL+ L + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
V HRDLKP+N+L N +K+ DFGLAR AF T +T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRT--YTHEVVTLWYRAPEILLGCKY 177
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V +
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--D 233
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 117/300 (39%), Positives = 172/300 (57%), Gaps = 16/300 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY--QFFLYQLLRALKY 141
IV ++ ++ R +Y+VFE ++ DL + + ++ D + + +LYQ+LR + Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 142 IHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ +T V
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
+ Y ++ K P + P +P+ + LL ++L DP R TA AL YFK L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 3e-59
Identities = 112/302 (37%), Positives = 164/302 (54%), Gaps = 20/302 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHP 82
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 83 DIVEIKHIMLPPS-----RRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLL 136
+IV +K I+ ++D Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
PE L G +Y PAID+WS GCI E+ T KP+F + QL+L++ L G+P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 256 SRVRNDKARRYLTSMRKKQPVQ--FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
V Y +M+ K+ + ++F AL LL+ +L DP R TAEEAL
Sbjct: 243 PDVIK---LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 314 PY 315
P+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 4e-59
Identities = 112/305 (36%), Positives = 166/305 (54%), Gaps = 21/305 (6%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLR 77
+G YK + +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLL 136
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLL
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 ISRV-RNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEAL 311
V N + + Y S P P D P L + L ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 1e-58
Identities = 113/310 (36%), Positives = 178/310 (57%), Gaps = 42/310 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-LREIKLLRLLRHP 82
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLY 133
++V ++ RR K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN--- 219
Query: 253 DTISRVRN--DKARRY----LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
I R + K + L +++ +P++ ++FP L L ++ L DP DRP+
Sbjct: 220 -LIPRHQEIFQKNPLFAGMRLPEVKEIEPLE--KRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 307 AEEALADPYF 316
+ + L +F
Sbjct: 277 SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 1e-57
Identities = 110/315 (34%), Positives = 156/315 (49%), Gaps = 33/315 (10%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ S+Y+ IG+G++G V A T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 79 LRHPDIV---EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQ 134
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTDYVA 191
LL L YIH + HRD+K NIL + LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG-- 248
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 249 TPS-------LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 301
TP L+ ++ + ++ R K V+ DP AL L+++LL DP
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK--------DPHALDLIDKLLVLDP 295
Query: 302 KDRPTAEEALADPYF 316
R A+ AL +F
Sbjct: 296 AKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 2e-57
Identities = 111/300 (37%), Positives = 162/300 (54%), Gaps = 16/300 (5%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PD 83
Y+ E IG+G+YG V A D +TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRA 138
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LKI D GL R AF + +T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AF--SIPVKSYTHEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
V R + +P S+ P+ P L LL+++L +DP R +A+ AL PYF
Sbjct: 238 GVSK---LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 8e-53
Identities = 115/305 (37%), Positives = 166/305 (54%), Gaps = 18/305 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y E +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L L+ LLGTP+ +T
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ ND+ + Y K QP P D + LL + L ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNYNFPKYKPQP--LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 YFKGL 319
YF+ L
Sbjct: 288 YFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-52
Identities = 111/302 (36%), Positives = 165/302 (54%), Gaps = 18/302 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLL
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L L+ LLGTP+ +T
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ N++ R YL + QP+ P D + LL LL ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYRAQPLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 315 YF 316
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 35/294 (11%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV + + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+Y A DIWS+GC E+ TGKP + + + + + + + I
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSSGEPPEI------- 225
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
P S A L + L DPK RPTA+E L P+
Sbjct: 226 ------------PEHLS-------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 7e-52
Identities = 111/307 (36%), Positives = 163/307 (53%), Gaps = 18/307 (5%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLR 77
+G Y + +G+G+Y V T VA+K+I EH A +RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREH-YQFFLYQLL 136
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLL
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 SRV-RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ N++ + Y + + P D LL +LL F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSYNYPKYRADCLH--NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 YFKGLSK 321
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 7e-50
Identities = 71/196 (36%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V A D TG+KVAIK I + S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVY 148
D +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (438), Expect = 2e-48
Identities = 88/352 (25%), Positives = 140/352 (39%), Gaps = 35/352 (9%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA-RILREIKLLRLLRHPD 83
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LTREHYQFFLYQLLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDT---PTTIFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE+ G + + + DIWS+G E+LTG P F G+ T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ + + + P +A LL++LLA DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 366
L E + S + + L D
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLD 328
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 101/296 (34%), Positives = 166/296 (56%), Gaps = 11/296 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKY 141
+IVE+K RR K +Y+VFE +E ++ ++++ + + E + ++YQL++A+ +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ Y A+D+WS+GCI E+ G+PLFPG++ + QL + +LG + + ++
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSA-LRLLERLLAFDPKDRPTAEEALADPYF 316
L P +++ L L++ LL +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKHIMLPPS-RRDFKDIY--VVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLR 137
+ +K +++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL YIH+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ D +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLAFDPKDRPTAEEALADP 314
+ + A ++ K + FP P A+ + + L ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 351
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-47
Identities = 115/305 (37%), Positives = 170/305 (55%), Gaps = 21/305 (6%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLR 77
+G A+ Y E +G+GSY V I G+ VA+K I E + A +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLK 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQ-VIKANDDLTREHYQFFLYQLL 136
L+H +IV + I+ F VFE M +DL Q +I+ L + + F++QLL
Sbjct: 59 GLKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 114 RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT 254
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ DT
Sbjct: 171 PPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 255 ---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
+S++ N K +L K Q ++ K + P A L ++L PKDR +A++AL
Sbjct: 229 WPGVSKLPNYKPEWFLPC--KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 89/304 (29%), Positives = 140/304 (46%), Gaps = 57/304 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHP 82
+Y+I + IGKGS+G V G+ +K+I D+ + L E+K+L+ L HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHP 59
Query: 83 DIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLY 133
+I IK+ F++ + +V E + DL Q IK + + +
Sbjct: 60 NI--IKYYE------SFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFV 110
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
QL ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V + T V T
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSS--TVDLAKTVVGTP 167
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-GTPSL 252
+Y +PELC + Y DIWS+GC+ E+ T K F G+N L+L +L G
Sbjct: 168 YYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQY-- 220
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
P Q+S + N L+ LL DP++RP+ + L
Sbjct: 221 -------------------PPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQ 254
Query: 313 DPYF 316
P+
Sbjct: 255 SPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 58/306 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
Y++ E IGKGS+G V G+ + K+I + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHY--QFFLYQL 135
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 136 LRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
L AL H + V HRDLKP NI +AN +K+ DFGLA++ +D + F YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYV 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T +Y +PE Y DIWS+GC+ E+ P F +N QL L
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL-------- 218
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEE 309
S+++ K RR P ++S S L +++ +L DP RP+ EE
Sbjct: 219 ----ASKIKEGKFRRI--------PYRYS--------SELNEVIKSMLNVDPDKRPSTEE 258
Query: 310 ALADPY 315
L P
Sbjct: 259 LLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 82/293 (27%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I E IGKG +G V A TG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V+ L +++V E L ++K+ + LT + +LL+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y DIWS+G E+ GKP + +L M L +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY------SELPPMKALFKIATNGP-------- 214
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ P ++S +F + L++ L +P+ RPTAE+ L P+
Sbjct: 215 -------PGLRNPEKWSDEFKD-------FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 4e-42
Identities = 106/299 (35%), Positives = 152/299 (50%), Gaps = 17/299 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--- 80
+Y+ IG G+YG V A D H+G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 81 HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLR 137
HP+IV + + SR D + + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDV-CATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P D
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 232
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
R+ R S R +PVQ P + S +LL +L F+P R +A AL P+F
Sbjct: 233 -RDVTLPRGAFSPRGPRPVQ--SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 90/298 (30%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 81
Y++ ++IG+G++GVV ++ TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+IV K+I S +Y++ E E+ L Q+IK ++YQ+L+ L
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPE 199
Y+H V HRD+K NIL + +K+ DFG+A ++ V T ++ APE
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAPE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ S + A DIWS+GC E+LTG P + DL +L I V+
Sbjct: 170 VIE--MSGASTASDIWSLGCTVIELLTGNPPY------------YDLNPMAALFRI--VQ 213
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYF 316
+D P L+ L + DP RPTA++ L P+
Sbjct: 214 DDHPP-----------------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 9e-41
Identities = 102/301 (33%), Positives = 157/301 (52%), Gaps = 20/301 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLR-- 80
+Y+ IG+G+YG V A D G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKHIMLPPSRRDFK-DIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLL 136
HP++V + + SR D + + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
APE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 257 RVRNDKA-RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
D A R + QP++ + + D LL + L F+P R +A AL+ PY
Sbjct: 235 ---RDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
Query: 316 F 316
F
Sbjct: 290 F 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 109/307 (35%), Positives = 166/307 (54%), Gaps = 19/307 (6%)
Query: 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 78
+G A Y+ E +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMTDLLGTPSLDT- 254
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ DT
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 255 --ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ + + K R+ T K Q K + A L +LL PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERF-TLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFPKNRLSAQAALS 287
Query: 313 DPYFKGL 319
YF L
Sbjct: 288 HEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 83 DIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 139
+IV+ S +++VV E M+ L +I N + + ++L+ L
Sbjct: 76 NIVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRA 197
+Y+H+ NV HRD+K NIL + + +K+ DFG A ++ V T ++ A
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGTPYWMA 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y P +DIWS+G + E+ G+P + + + L L+T G P L +
Sbjct: 185 PEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKNPEK 241
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+S +F L + L DP+ RP+AEE L P+ K
Sbjct: 242 --------------------WSPEF-------KDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 48/292 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
+ + + + +Y+V E +L + + E +F+ +++ AL+Y+H+ +
Sbjct: 60 Y-----AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLKP+NIL +A+ +K+ DFGLA+ ++ T + T Y APE+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG--KG 169
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 267
Y A+D WS+G + E+LTGKP F ++ + + +
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKI-------------------- 205
Query: 268 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYF 316
K P++F + P A L+ LL DP R AEE A P+F
Sbjct: 206 ----LKDPLRFPEFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 113/319 (35%), Positives = 162/319 (50%), Gaps = 43/319 (13%)
Query: 31 IGKGSYGVVCSA--IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 139
+ L S R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 194
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 244
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 245 DLLGTPSLDTISRVRNDKARRYL------TSMRKKQPVQFSQKFP-NADPSALRLLERLL 297
++G P+ +R L T+ +++ +K D LL++LL
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298
Query: 298 AFDPKDRPTAEEALADPYF 316
DP R T+E+AL DPYF
Sbjct: 299 TMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 67/301 (22%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 79
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 137
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT----- 192
++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 193 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----------- 210
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
+ + ++N R QP PN P L+ + A DP+DRPT
Sbjct: 211 ----EVLEYLKNGY--------RLPQP-------PNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 309 E 309
E
Sbjct: 252 E 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-38
Identities = 113/321 (35%), Positives = 164/321 (51%), Gaps = 47/321 (14%)
Query: 31 IGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 HIMLPPSRRDFKDIYVVFELMESDL------HQVIKAND---DLTREHYQFFLYQLLRAL 139
+ L + R ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVAFNDTPTTIFWTD-YVATRW 194
Y+H V HRDLKP NIL ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVH--QLDLMT 244
YRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 245 DLLGTPS---------LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 295
+++G P+ + S + D R T+ + ++ + P D A LL++
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP--DSKAFHLLQK 296
Query: 296 LLAFDPKDRPTAEEALADPYF 316
LL DP R T+E+A+ DPYF
Sbjct: 297 LLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 96/321 (29%), Positives = 148/321 (46%), Gaps = 72/321 (22%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRH 81
+K ++IG+GS+ V A + T ++ AIK K I E +I +E+ L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61
Query: 82 PDIVEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR 137
P I+++ + F+D +Y V E + +L Q I+ L + +F+ ++L
Sbjct: 62 PGIIKLYYT--------FQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--------AFNDTPTTIFWTD- 188
AL+Y+H+ + HRDLKP+NIL + + +KI DFG A+V + T I
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 189 --------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
+V T Y +PEL + D+W++GCI ++LTGKP F G N
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN----- 226
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAF 299
YLT +K +++S FP N P A L+E+LL
Sbjct: 227 ------------------------EYLT-FQKILKLEYS--FPPNFPPDAKDLIEKLLVL 259
Query: 300 DPKDRPTA----EEALADPYF 316
DP+DR +E A P+F
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 68/302 (22%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLL 79
+ + +G+G++G V +VA+K + + + I + LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE---FLREARIMRKL 58
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 136
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 192
R ++Y+ + N HRDL +N L N +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 193 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---------- 211
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 307
+ + ++ R +P PN P +L+ + A DP+DRPT
Sbjct: 212 -----EVLEYLKKGY--------RLPKP-------PNCPPELYKLMLQCWAEDPEDRPTF 251
Query: 308 EE 309
E
Sbjct: 252 SE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 81/288 (28%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG G++G V +A++ TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 91 MLPPSRRDFKDIYVVFEL-MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYH 149
+ R+ +Y+ E L ++++ L + + QLL L Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 150 RDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSK 207
RD+KP NI + N +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 267
+ A DIWS+GC+ E+ TGK + +LD N+ +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPW------SELD------------------NEFQIMFH 218
Query: 268 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
P L+R L DPK RPTA E L P+
Sbjct: 219 VGA--GHKPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
V+G+GS GVV TG+ A+KKIH + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 90 IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANV 147
I +V E M+ L ++K + + Q+L+ L Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWYRAPELCGSFFS 206
HRD+KP N+L N+ ++KI DFG+++V T+ + +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKV----LENTLDQCNTFVGTVTYMSPERIQG--E 175
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266
Y+ A DIWS+G E GK F +LM + P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------ 223
Query: 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
+FS +F + + L DPK RP+A E L P+ K
Sbjct: 224 -------PAEEFSPEFRD-------FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I I ++ D R+I L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
+ S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
++ +D WS+GCI E L G P F G+ + + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---------------EIFQNILNG 216
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFKG 318
K +++ + A+ L+ +LL DP+ R A EE P+FKG
Sbjct: 217 K-------------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 319 L 319
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRAL 139
P+IV + + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQG-----EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +KI DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
K+T D+WS G + E+ T G+ +PG + + + +
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM---------------SNEEVLELL 217
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
+ R +P N L+ + A+DP+DRPT E
Sbjct: 218 EDGY--------RLPRP-------ENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 88/304 (28%), Positives = 130/304 (42%), Gaps = 58/304 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ + E IGKGS+G V AID T + VAIK I D+ E + I +EI+ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
I + L + K ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFL----KGSK-LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+Y+H HRD+K NIL + +K+ DFG V+ T T +V T ++ AP
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMAP 167
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ S Y DIWS+G E+ G+P P + L M
Sbjct: 168 EVIKQ--SGYDEKADIWSLGITAIELAKGEP--P----LSDLHPM--------------- 204
Query: 259 RNDKARRYLTSMRKKQP-----VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
R L + K P +FS+ F + + L DPK+RP+A+E L
Sbjct: 205 ------RVLFLIPKNNPPSLEGNKFSKPFKD-------FVSLCLNKDPKERPSAKELLKH 251
Query: 314 PYFK 317
+ K
Sbjct: 252 KFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 47/285 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHP 82
+++ VIGKG++G VC T + A+K ++ E S +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS-VRNVLNERRILQELNHP 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V + + S +D +++Y+V +L+ DL + + E +F++ +++ AL+Y
Sbjct: 61 FLVNLWY-----SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+KP NIL + + I DF +A DT T T T Y APE+
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMAPEV- 170
Query: 202 GSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
+ Y+ A+D WS+G E L GK + G SR
Sbjct: 171 --LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH---------------------SRTIR 207
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDR 304
D+ R ++ +P + + +LL DP+ R
Sbjct: 208 DQIRA----KQETA----DVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 81/303 (26%), Positives = 139/303 (45%), Gaps = 57/303 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 77
R++ E++G GS+G V ++ G+ A+K++ E + ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
L+HP+IV+ + R+ ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWY 195
L+Y+H N HRD+K NIL + N +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL---GTPSL 252
APE+ Y A DIWS+GC E+ TGKP + QL+ + + + L
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKEL 220
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
I +D+A+ ++ L+ L+R DP RPTA E L
Sbjct: 221 PPIPDHLSDEAKDFI----------------------LKCLQR----DPSLRPTAAELLE 254
Query: 313 DPY 315
P+
Sbjct: 255 HPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR---ILREIKLLRLLRHPDIVEI 87
IG+GS G+VC A D TG +VA+KK+ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
L +++VV E +E I + + E +L+AL ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRD+K +IL ++ ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 267
Y +DIWS+G + E++ G+P + P L + R+R++ +
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQAMKRIRDNLPPKL- 235
Query: 268 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
K + S P L+R+L DP R TA E L P+
Sbjct: 236 -----KNLHKVS-------PRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 90/314 (28%), Positives = 132/314 (42%), Gaps = 76/314 (24%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI---------HDIFEHISDAARILR-EIKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D + LR EI+ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPT--- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ KI DFG+++ + ND
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---------- 212
Query: 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 301
S A L + R P+ N P AL L +P
Sbjct: 213 --------------SDEEAIAAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINP 257
Query: 302 KDRPTAEEALADPY 315
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 54/299 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+ I E +G+GSYG V AI TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELME-------SDLHQVIKANDDLTREHYQFFLYQLLR 137
V+ S D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H+ HRD+K NIL N + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y DIWS+G E+ GKP + + + + M P+L
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTL----- 219
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
P ++S +F + +++ L DP++RP+A + L P+
Sbjct: 220 ---------------SDPEKWSPEFND-------FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
+KI++ IGKG + VV AI G VA+KK+ IFE + AR L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK--ANDDLTREHYQF--FLYQLLR 137
++ IK++ S + ++ +V EL ++ DL ++IK + QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+++H+ + HRD+KP N+ A +K+ D GL R + T V T +Y +
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAE 223
PE + Y DIWS+GC+ E
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 53/307 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ EVIG G+ VV +AI EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKHIMLPPSRRDF---KDIYVVFELMES-DLHQVIK---ANDDLTREHYQFFLYQL 135
++V+ F ++++V + L ++K L L ++
Sbjct: 60 NVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRW 194
L+ L+Y+H+ HRD+K NIL + +KI DFG+ A +A T +V T
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT----- 249
+ APE+ Y DIWS G E+ TG + + M L+ T
Sbjct: 172 WMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPY------SKYPPMKVLMLTLQNDP 224
Query: 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
PSL+T + KK +S+ F ++ L DP RPTAEE
Sbjct: 225 PSLET-------------GADYKK----YSKSFRK-------MISLCLQKDPSKRPTAEE 260
Query: 310 ALADPYF 316
L +F
Sbjct: 261 LLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 73/283 (25%), Positives = 130/283 (45%), Gaps = 54/283 (19%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVEI 87
+G G +G V A+K + HI + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV--KKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
R FKD ++ LME +L +++ +F++ ++ A +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+N+L ++N +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 204 FFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+K Y ++D WS+G + E+LTG+P F G++ +++ D+ L ++
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDI-----LKGNGKL---- 213
Query: 263 ARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDR 304
+FPN D +A L+++LL +P++R
Sbjct: 214 ------------------EFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 83
+ +G+G++G V K VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN---------DDLTREHYQFFLY 133
+V + + + + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+ + ++Y+ + HRDL +N L + +KI DFGL+R ++D + R
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 194 WYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPS 251
W APE S +T D+WS G + E+ T G +PG
Sbjct: 173 WM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG------------------ 210
Query: 252 LDTISRVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
+ N++ YL R +P L+ DP+DRPT E
Sbjct: 211 ------LSNEEVLEYLRKGYRLPKP-------EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 85/307 (27%), Positives = 133/307 (43%), Gaps = 50/307 (16%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-R 80
+++ EVIG+G+YG V A TG+ VAIK + I + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKHIML---PPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTREHYQFFL 132
HP+I + PP D +++V EL +DL + + K L E + L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDD--QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVA 191
+ LR L Y+H V HRD+K +NIL N ++K+ DFG++ +T+ + ++
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIG 175
Query: 192 TRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
T ++ APE C + Y D+WS+G E+ GKP D+
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL------------CDMHP 223
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
+L I RN K P +S+KF + + L + + RP E
Sbjct: 224 MRALFKI--PRNP-------PPTLKSPENWSKKFND-------FISECLIKNYEQRPFME 267
Query: 309 EALADPY 315
E L P+
Sbjct: 268 ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH 81
Y V+GKG++G T V K+++ + E A L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 82 PDIVE-IKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 134
P+I+ H F D + ME L+ I E ++L+Q
Sbjct: 59 PNIIAYYNH---------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++ A+ YIH A + HRD+K NI +K+ DFG++++ ++ V T +
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPY 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
Y +PELC KY DIW++GC+ E+LT K F N L+L+ +
Sbjct: 167 YMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKI-------- 213
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ Y + + L+ LL DP+ RPTA+E L P
Sbjct: 214 VQGNYTPVVSVYSSELIS-------------------LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 85/304 (27%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-------ILREIKLLRLLRHP 82
+IG GS+G V ++ +GE +A+K++ S R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+IV+ L + YV + + L+ + L R F+ Q+L+ L Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNYL 122
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPELC 201
H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK--------TNGAR-PSLQ 173
Query: 202 GSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
GS F + YT DIWS+GC+ E+LTGK FP L
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---------------QL 218
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEAL 311
I ++ S + P N A+ LE+ D RPTA E L
Sbjct: 219 QAIFKIGE----------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 83/299 (27%), Positives = 127/299 (42%), Gaps = 53/299 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+K+ + +GKGSYG V + A+K++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR-----EHYQFFLYQL 135
P+I+ K L D + +V E DL + I + E ++ F+ QL
Sbjct: 59 PNIISYKEAFL-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +KI D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE+ Y+ DIWS+GC+ E+ T P F ++ M DL
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL--------- 209
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
R R + P +SQ N + +L PK RP ++ LA P
Sbjct: 210 ---RYKVQRGKYPPI----PPIYSQDLQN-------FIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + HTG++VA+KK+ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 270
+DIWS+G + E++ G+P + P L + R+R++ R
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPR----- 237
Query: 271 RKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 328
V+ S K S LR L+ +L +P R TA+E L P+ K+ PSC
Sbjct: 238 -----VKDSHKV----SSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G G+ GVV + TG+ +A+K I +I E I +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNSPYIVGFY 65
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRALKYIHTA- 145
+ DI + E M+ L +++K E +L+ L Y+H
Sbjct: 66 GAFY-----NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ N T +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQG-- 173
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+ Y+ DIWS+G E+ TG+ FP + + + N+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR--FPYPP--ENDPPDGI------FELLQYIVNEPP-- 221
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
P S KF P + L DP++RP+ +E L P+ K
Sbjct: 222 ---------PRLPSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 38/303 (12%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
S Y+ E+IG+G+YG V TG VA+K I ++ D + I RE+ LL LR
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQS 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I S ++++ E E + ++KA + ++ + ++L ALKY
Sbjct: 60 QPPNI--TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKY 116
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH V HRD+K NIL +K+CDFG VA + + +V T ++ APE+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
Y DIWS+G E+ TG P + + + L+ S+
Sbjct: 174 TE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----------SKPPRL 222
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+ Y +R + A L E +PK+R +AEE L + K SK
Sbjct: 223 EDNGYSKLLR--------------EFVAACLDE-----EPKERLSAEELLKSKWIKAHSK 263
Query: 322 VER 324
Sbjct: 264 TPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKLLR 77
++ + +G GS+G V +G+ A+K I EH+ + RIL+ I
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
RHP +V L S +D ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +KI DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 59/302 (19%)
Query: 24 RYKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLL 79
+Y+ V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLL 136
HP+I+E L + K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL ++HT + HRDLK +NIL + + +KI DFG++++ + + V T Y
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+PELC Y DIW++GC+ E+ + K F N+ P+L
Sbjct: 168 ISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL-------------PAL--- 209
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNAD---PSALRLLERLLAFDPKDRPTAEEALA 312
L M P +D P +L+ +L DP RP + +A
Sbjct: 210 ----------VLKIMSGTFA-------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
Query: 313 DP 314
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 88/298 (29%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
+IV L RRD +++V E D++QV L+ + + L+
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L Y+H HRD+K NIL + +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E Y DIW++G E+ +P P M DL +L IS+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP--P----------MFDLHPMRALFLISK 218
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
N + K ++S F + +++ L DPK RPTA + L P+
Sbjct: 219 -SNFPPPKL------KDKEKWSPVFHD-------FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKY 141
I++ S D + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +KI D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y D+W++G + E TGK F N
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 44/298 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-----ILREIKLLRLL 79
++ +++G+G++G V D TG ++A+K++ F+ S + + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
+H IV+ + RD + + + E M + +KA LT + + Q+L
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y D+WS+GC E+LT KP P + M +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP--PWAE----FEAMAAIFKI--------- 219
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
QP Q + P A L R + K RP+AEE L +
Sbjct: 220 -------------ATQPTNP-QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 46/227 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
D S I++VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND +F + Q
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDG------KFTVGQ 107
Query: 135 LLRAL-------KYIHTANVYHRDLKPKNILANANCKLKICDFGLARV--AFNDTPTT-- 183
L+ L KY+ N HRDL +NIL N+N K+ DFGL+R T TT
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
I WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 59/299 (19%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 90 IMLPPSRRDFKDIYVVFELME-------SDLHQV----IKANDDLTREHYQFFLYQLLRA 138
+ S F I+ ME S L + +K N+ F+ Q+L
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTII----FYTKQILEG 120
Query: 139 LKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
LKY+H + HRD+K N+L N + +KI DFG ++ P T + T Y A
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT---ETFTGTLQYMA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y DIWS+GC E+ TGKP F + LG P
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP------- 217
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPY 315
+A + M K P + P + + + + R DP R +A + L DP+
Sbjct: 218 ----QAAMFKVGMFKIHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 270
+DIWS+G + E++ G+P + + V + + D
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------------------- 231
Query: 271 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
P + P LER+L +P++R TA+E L P+
Sbjct: 232 ---SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 44/297 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY+I + IG+GS+G + A E IK+I + + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY--QLLRALK 140
IV S ++ +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+IH + HRD+K +NI + N + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+C + Y DIWS+GC+ E+ T K F G N +HQL L I +
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL-----------KICQGY 218
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
F+ PN L+ +L P+DRP+ L P+
Sbjct: 219 ------------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A +G+ VA+KK+ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSM 270
+DIWS+G + E++ G+P + P L + +R++ + L ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLPPK-LKNL 239
Query: 271 RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
K PS L+RLL DP R TA E L P+
Sbjct: 240 HK------------VSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 66/265 (24%), Positives = 124/265 (46%), Gaps = 36/265 (13%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAARILREIKL 75
+ + +G G++G V D + A+K I ++ +H+ + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
HP I+ L + D + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++ AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSL 252
Y APE+ S + A+D W++G + E+L G P F N +++ L L L
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHL 221
Query: 253 DTISR------VRNDKARRYLTSMR 271
D ++ + D+ RR L +M+
Sbjct: 222 DLYAKDLIKKLLVVDRTRR-LGNMK 245
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 79/304 (25%), Positives = 128/304 (42%), Gaps = 56/304 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----ILREIKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ + S+ + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKHIMLPPSRRDFKDIYVVF-ELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRA 138
+ ML + D + +F E M L + + + + QLLR
Sbjct: 66 IR----MLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRG 115
Query: 139 LKYIHTANVYHRDLKPKNILANANCK-LKICDFGLA-RVAFNDTPTTIFWTDYVATRWYR 196
L Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T +
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL---LGTPSLD 253
APE+ +Y + D+WS+GC+ E+ T KP + + + L L+ + PS+
Sbjct: 176 APEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI- 232
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
P S P LR LE P+DRP + E L
Sbjct: 233 ---------------------PEHLS---PGLRDVTLRCLEL----QPEDRPPSRELLKH 264
Query: 314 PYFK 317
P F+
Sbjct: 265 PVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 93/299 (31%), Positives = 132/299 (44%), Gaps = 54/299 (18%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
K P + +Y+V + E H + DL+R +F+ +LL AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264
YT A+D W++G + E+LTG P F +NV N+ R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGLS 320
+ L +P++F F D A LL LL+ DP R A+E P+F LS
Sbjct: 204 KILQ-----EPLRFPDGF---DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y + V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALK 140
IV K S +Y+V E + DL Q IK + + Q+ ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
+IH V HRD+K KNI N K+K+ DFG AR+ + P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y DIWS+GCI E+ T K F
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 9e-21
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 75
DAS KI++VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 135 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
L LR +KY+ HRDL +NIL N+N K+ DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 43/300 (14%)
Query: 20 GDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL 78
GD + Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
+HP+IV L +++VV E + + + + L+A
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 127
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRA 197
L+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ A
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 184 PEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL----- 235
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P + S F + L R L D + R +A+E L P+ K
Sbjct: 236 ---------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 42/295 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +AID TG++VAIK+I+ + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL---------- 235
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P + S F + L R L D + R +A+E L P+ K
Sbjct: 236 ----------QNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 42/295 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +AID TG++VAIK+++ + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL---------- 235
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P + S F + L R L D R +A+E L P+ K
Sbjct: 236 ----------QNPERLSAVFRD-------FLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 84/302 (27%), Positives = 127/302 (42%), Gaps = 53/302 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLR 80
RY +Q+ +GKGS+G V D + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRA 138
HP IV+ L R F I E + D L ++ L+ + QLL
Sbjct: 61 HPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 196
+ Y+H + HRDLK KNI N LKI DFG++R+ D TT + T +Y
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-----FTGTPYYM 172
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL--GTPSLDT 254
+PE Y DIWS+GCI E+ F G+N L ++ ++ TPSL
Sbjct: 173 SPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL-- 225
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALAD 313
P L +++ +L DP RP+A E L +
Sbjct: 226 ----------------------------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257
Query: 314 PY 315
P+
Sbjct: 258 PF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 74/222 (33%), Positives = 111/222 (50%), Gaps = 33/222 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAAR--ILREIKL 75
D S KI+EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
+ HP+I+ ++ + + SR + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGV-VTKSR----PVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 L---LRA----LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PT-TI 184
L LR +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 8e-20
Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 42/295 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGL-ARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y P +DIWS+G + E++ G+P + +N + L L+ GTP L
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL---------- 236
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 ----------QNPEKLSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 87/331 (26%), Positives = 137/331 (41%), Gaps = 74/331 (22%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE-IKLLRLLRH 81
+++ +VIG+G++G V D TG+ A+K + + I R I +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAER- 52
Query: 82 PDI-VEIKHIMLPPSRRDFKD---IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
DI + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 53 -DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------------RVAFNDT 180
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 181 PTTIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFP 228
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 289
F +T +++ + K+ ++F P P A
Sbjct: 229 PFYSDT---------------LQETYNKI-----------INWKESLRFPPD-PPVSPEA 261
Query: 290 LRLLERLLAFDPKDR-PTAEEALADPYFKGL 319
+ L+ RLL DP+DR + EE + P+FKG+
Sbjct: 262 IDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y + IG+GS+G G++ IK+I+ + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALK 140
IV+ + S + ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV + T + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
C + Y DIW++GC+ E+ T K F N M +L+ L I
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLV----LKIIRGSYP 219
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ Y +R L+ +L +P+DRP+ L +
Sbjct: 220 PVSSHYSYDLRN-------------------LVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 69/210 (32%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A + VA+KK+ IFE + AR ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 134
HP++ IK++ S + ++ +V EL ++ DL Q+I K L E +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L A++++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 82/283 (28%), Positives = 132/283 (46%), Gaps = 38/283 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A ++HT E VA+KK+ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
L K+ + + +ME SDL +V K L + L+ L Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL ++K+ DFG A + +P F V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPANSF----VGTPYWMAPEVILA 191
Query: 204 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+Y +D+WS+G E+ KP N + L + +P+L S D
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLQ--SNEWTDS 248
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 305
R ++ QK P P++ LL F +DRP
Sbjct: 249 FRGFVDYCL--------QKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 76/303 (25%), Positives = 122/303 (40%), Gaps = 67/303 (22%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
I KG++G V A TG+ AIK +L++ ++ + ++ + I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAERAI 49
Query: 91 MLPPSRRDF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
M+ + KD +Y+V E L D +IK L + + ++ +++
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y AP
Sbjct: 110 VEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAP 162
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + G D WS+GC+ E L G P F TP
Sbjct: 163 ETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETP------- 198
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADP 314
D + S R P + P A+ L+ RLL DP R A +E + P
Sbjct: 199 ---DAVFDNILSRRINWP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 315 YFK 317
+FK
Sbjct: 253 FFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 88/323 (27%), Positives = 136/323 (42%), Gaps = 73/323 (22%)
Query: 11 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISD 65
PE+ E FS+ + IG GS+G V A D T E VAIKK+ E D
Sbjct: 2 PEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME------SDLHQVIKA 119
I++E++ L+ LRHP+ +E K L R+ + + +ME SD+ +V K
Sbjct: 62 ---IIKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK- 109
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
L + L+ L Y+H+ HRD+K NIL +K+ DFG A +
Sbjct: 110 -KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV--- 165
Query: 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV 237
+P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 166 SPANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------ 215
Query: 238 HQLDLMTDLL-----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 292
++ M+ L +P+L +S F N
Sbjct: 216 -NMNAMSALYHIAQNDSPTL---------------------SSNDWSDYFRN-------F 246
Query: 293 LERLLAFDPKDRPTAEEALADPY 315
++ L P+DRP++EE L +
Sbjct: 247 VDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 65/265 (24%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
++I +G+G YG V A TGE VA+K++ + +++ +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V++ + + +D + +Y+ E + D ++ L+ +H +F++ ++ A+ +
Sbjct: 63 LVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H HRDLKP+N L +A+ +K+ DFGL++ + + DY+ APE+
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APEVLR 171
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL------LGTPSLDTIS 256
Y +D WS+GC+ E L G P F G + +L L P D
Sbjct: 172 G--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVYDDPR 226
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQK 281
+D+A +T + +F
Sbjct: 227 FNLSDEAWDLITKLINDPSRRFGSL 251
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI----HDIFEHISDAARILREIKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ ++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V+ L D I + E + + ++ L + + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE 199
V HRD+K N++ N +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIH--------DIFEHISDAARILREIKL 75
Y + E +G G++G V + G+ +A+K+I+ D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIK-ANDDLTREHYQ 129
++ LRHP+IV L R +Y+V +L+E + +K T E
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 130 FFLYQLLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
Q++ AL+Y+H + HRDL P NI+ + K+ I DFGLA+ ++ T
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTS 172
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
V T Y PE+ + Y D+W+ GCI ++ T +P F N++
Sbjct: 173 VVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 84/300 (28%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHP 82
Y V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 138
+IV + + +Y+V E DL+ +K + ++F+ Q+ A
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN--DTPTTIFWTDYVATRWYR 196
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N D +T+ T Y Y
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-----YM 169
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+PEL F +K Y D+W++GC E+ T K F K+ M L +
Sbjct: 170 SPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSL--------V 211
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
R+ K L M K P L+ +L+ P+ RP+ + L PY
Sbjct: 212 YRIIEGK----LPPMPKDY-----------SPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILR 71
F + D S ++I E IGKG+YG V ++ G K A+K IHDI E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + ++ +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 73/299 (24%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 91 MLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQ-LLRALKYIHTA 145
L S I + E E +++ +K E + + +L+ L Y+H+
Sbjct: 68 FLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
+ HRD+KP NIL ++K+CDFG++ N T + T +Y APE + G
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQG-- 177
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFP--GKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y+ D+WS+G EV + FP G+ + ++L++ ++ P+ + N
Sbjct: 178 -KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG- 235
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+++S++F + +++ L DP RPT + L P+ K K
Sbjct: 236 -------------IKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 68/219 (31%), Positives = 116/219 (52%), Gaps = 20/219 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREH--YQFFLYQ 134
HP++++ + + ++ +V EL ++ DL ++I K L E +++F+ Q
Sbjct: 61 HPNVIKYYASFIEDN-----ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L AL+++H+ V HRD+KP N+ A +K+ D GL R F + TT + V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHS-LVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 75
D S + +G G +GVV H G+ VAIK I E + E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKV 52
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFL-- 132
+ L HP++V++ + + I++V E M + L ++ + ++ L
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDM 105
Query: 133 -YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
+ A++Y+ + HRDL +N L + +K+ DFGLAR +D T+ T +
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-P 164
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+W PE+ +S+++ D+WS G + EV + GK +
Sbjct: 165 VKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Q+VIG G +G V I G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA----L 139
+ ++ ++ FK ++ E ME+ L + ++ +D E + L +LR +
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGM 120
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRA 197
KY+ N HRDL +NIL N+N + K+ DFGL+RV D P + T + RW A
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
PE + K+T A D+WS G + EV++
Sbjct: 179 PEAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 36/214 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEKVAIKKI-HDIFE-HISDAARILREIKLLRLLRHPDI 84
+G+G +G V + +TGE+VA+K + H E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDDLTREHYQFFLYQLLRALK 140
V+ K + P R + ++ E + S D Q + +L R F Q+ + +
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKR--LLLFSSQICKGMD 123
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR------- 193
Y+ + HRDL +NIL + +KI DFGLA+V D DY +
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGESPI 176
Query: 194 -WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE C SK++ A D+WS G E+ T
Sbjct: 177 FWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 21 DASRYKIQ-----EVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIF-----EHISDAAR 68
D S +K+ E +G GS+G V A TGE AIK K +I +H++
Sbjct: 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY 128
IL E L HP IV + +R F +VV + + L + + +D+ +
Sbjct: 71 ILME------LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK--- 121
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
F+ +L+ A +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T
Sbjct: 122 -FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------ 174
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
T Y APE+ S + A+D W++G + E + G P F
Sbjct: 175 LCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 65/308 (21%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLRH 81
+GKG +G VC+ TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
IV + + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + ++I D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y ++D +++GC E++ G+ F R
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPF-------------------------RQ 196
Query: 259 RNDKARRY-LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 312
R +K + L + V++ KF P A L E LL DP+ R +A+E
Sbjct: 197 RKEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253
Query: 313 DPYFKGLS 320
P FK L+
Sbjct: 254 HPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 33/212 (15%)
Query: 31 IGKGSYGVV--C--SAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIV 85
+GKG++G V C + +TGE VA+KK+ H EH+ D REI++L+ L+H +IV
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNIV 68
Query: 86 EIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLY--QLLRALKYI 142
+ K + RR+ + +V E L L ++ + + +H + LY Q+ + ++Y+
Sbjct: 69 KYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR--------W 194
+ HRDL +NIL + ++KI DFGL +V D +Y R W
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIFW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE SK++ A D+WS G + E+ T
Sbjct: 178 Y-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 33/298 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ +G G+ G V TG +A K +H I S +ILRE++++ R
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECR 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 139
P IV L + +I + E M+ L ++ K + E ++ L
Sbjct: 62 SPYIVSFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116
Query: 140 KYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
Y++ + + HRD+KP NIL N+ ++K+CDFG++ N T +V T Y +P
Sbjct: 117 TYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E KYT D+WS+G E+ GK FP D D +G LD + ++
Sbjct: 172 ERIQG--GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGI--LDLLQQI 225
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ P S FP ++ L DP +RPT ++ A P F
Sbjct: 226 VQEPP-----------PRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 90/351 (25%), Positives = 148/351 (42%), Gaps = 62/351 (17%)
Query: 8 KNSPEMEFFSEYG---DAS--RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
++ E F+ G D S R+KI ++G+G++G V A D E A+K + ++ ++
Sbjct: 109 QSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY 168
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD----IYVVFELMESDLHQVIK 118
DA +I EI+ + +R D + +M +R F++ + +V L I
Sbjct: 169 TRDA-KI--EIQFMEKVRQADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIM 223
Query: 119 ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANAN--------------- 162
+ + H ++Q AL Y HT ++ H DLKP+NIL +
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 163 -CKLKICDFG------LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
C+++ICD G +R A V+TR YR+PE+ Y+ D+W
Sbjct: 284 PCRVRICDLGGCCDERHSRTAI------------VSTRHYRSPEVVLGLGWMYS--TDMW 329
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275
S+GCI E+ TGK L+ + + L LM LG + R ++AR S + +P
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
Query: 276 VQFSQKFPN-----------ADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ D L+ LL +D + R A + PY
Sbjct: 390 CTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-17
Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 47 TGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIVE-IKHIMLPPSRRDFKDI 102
TG +VAIK + + + AR RE L L HP+IV + PP +
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-----L 54
Query: 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--- 158
+ VFE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 55 FAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 159 ANANCKLKICDFGLAR----VAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAID 213
K+ DFG+ V D T T+ + T Y APE L G TP D
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSD 171
Query: 214 IWSIGCIFAEVLTGKPLFPGKNV 236
+++ G IF E LTG+ + G +V
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 40/234 (17%)
Query: 26 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K++ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKY 141
V++ + S + IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRW 194
+ + N HRDL +NIL N KI DFGLAR+ +D T I WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLL 79
+ +++ +++G+G++G V D TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRA 138
H IV+ + P R + E M + +K+ LT + + Q+L
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV+ + P + I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y D+WS+ C E+LT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D + E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLV 62
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
++ + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
FSKY+ D+WS G + EV T GK F K+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEI 87
+G G+ GVV + +G +A K IH E I A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
+ +I + E M+ L QV+K + +LR L Y+
Sbjct: 65 YG-----AFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSF 204
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG-- 172
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 -THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKL 75
S + + IG G +G+V G KVAIK I + D + E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEED---FIEEAQV 52
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKAND-DLTREHYQFFLY 133
+ L HP +V++ + S I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCTERS-----PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +K+ DFG+ R +D T+ T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 85/350 (24%), Positives = 147/350 (42%), Gaps = 67/350 (19%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
R +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +KI DFG+ + TT + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
+ Y PA+D W++G + E+L G+ F G + D + + +
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------------DELFQSILEDE 212
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PTAEEALAD-PYFKG 318
RY + K+ A +L+ L +P+ R PT E+ + P+F+
Sbjct: 213 VRYPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
Query: 319 L--SKVER---EPSCQPISKMEF-------EFERRRVTKEDIRELIFREI 356
+ K+ER +P +P K F EF + + E I R I
Sbjct: 258 IDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 48/286 (16%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D T E VAIKK+ + ++ + I++E+K L+ ++HP+ +E K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 90 IMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
L ++V E SDL +V K L + L+ L Y+H+ N
Sbjct: 93 CYLRE-----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF-F 205
+ HRD+K NIL ++K+ DFG A +A +P F V T ++ APE+ +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSF----VGTPYWMAPEVILAMDE 198
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+Y +D+WS+G E+ KP N + L + +P+L
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTL------------- 244
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
Q ++S F N S L+ + P+DRPT+EE L
Sbjct: 245 --------QSNEWSDYFRNFVDSCLQKI-------PQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 81/293 (27%), Positives = 124/293 (42%), Gaps = 41/293 (13%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
L ++ ++++ E + + L + L ++L+ L Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 268
DIWS+G E+ G+P + + L L+ P+L+
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEG-------------- 223
Query: 269 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
Q+S+ F +E L DP+ RPTA+E L + +K
Sbjct: 224 --------QYSKPFKE-------FVEACLNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 29 EVIGKGSYG---VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+V+G+GS+G +V G+ A+K + + D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
++ + + +Y++ + + DL + T E +F+L +L AL ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + +K+ DFGL++ + + + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
+T + D WS G + E+LTG F GK + + MT +L
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 16/212 (7%)
Query: 30 VIGKGSYGVVCSAIDTH---TGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K K I + D A E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 85 VEIKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V++ + + +Y++ E L +L ++ + F+L ++ AL+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL +A +K+ DFGL + + ++ T + T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEILMR 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
S + A+D WS+G + ++LTG P F +N
Sbjct: 175 --SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + A + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+K S D+Y+V + M +L ++ + + +F++ +L+ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ D TT + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 76/300 (25%), Positives = 120/300 (40%), Gaps = 61/300 (20%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIK-KIHDIFEHISDAARILREIKLLRLLR 80
+ IG+G +G V + EK+A+ K S + L+E ++R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLR 137
HP IV+ I I P +++V EL +L ++ N L + YQL
Sbjct: 66 HPHIVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR---- 193
AL Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLP 171
Query: 194 --WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGT 249
W APE F ++T A D+W G E+L KP G
Sbjct: 172 IKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GV 212
Query: 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
+ D I R+ N + R P PN P+ L+ + A+DP RP E
Sbjct: 213 KNNDVIGRIENGE--------RLPMP-------PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+++ + IG G+YG V A + +TGE AIK I E D A + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V L RRD +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y DIW++G E+ +P + + L LMT P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ K +++S F + ++ L +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 52/300 (17%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
K+ R F Y + L + ++D R F+ +++ AL Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALGYLHSCDV 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
Y A+D W +G + E++ G+ F + + +L LM ++
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------- 212
Query: 266 YLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 319
+FP P A LL LL DPK R A+E + +F +
Sbjct: 213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 79/299 (26%), Positives = 123/299 (41%), Gaps = 54/299 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLL----RHPD 83
V+G+G +G V A TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V + + V E DL I D + F+ ++ L+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 200
H + +RDLK N+L + +KI DFGL + + F D +T + T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEFLAPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
+ YT A+D W +G + E+L G+ FPG + D + N
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---------------SIVN 215
Query: 261 DKAR--RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
D+ R R+L+ ++ + ++ +P ER L KD AE+ P+F+
Sbjct: 216 DEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD---AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 77/331 (23%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+VIG+G++G V TG A+KK+ ++ E A + E +L +P +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-EQVAHVRAERDILAEADNPWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFE-LMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D +Y++ E L D+ ++ D T E +F++ + + A+ IH
Sbjct: 66 LYY-----SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTTIFWTDY---- 189
HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 190 -------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
V T Y APE+ + Y D WS+G I E+L G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 290
F ++ Y + K+ +QF + P P A
Sbjct: 239 F--------------------------CSDNPQETYRKIINWKETLQFPDEVP-LSPEAK 271
Query: 291 RLLERLLAFDPKDR---PTAEEALADPYFKG 318
L++RL + + R E + P+FKG
Sbjct: 272 DLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 88/339 (25%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD--AARILREIKLLRLLR 80
+K +++GKG G V TG+ A+K + D E I R+L E ++L L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLD 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD--LTREHYQFFLYQ 134
HP + + F+ + +M+ +L ++++ L+ E +F+ +
Sbjct: 60 HPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE 111
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT------- 187
+L AL+Y+H + +RDLKP+NIL + + + + DF L++ + + P +
Sbjct: 112 VLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRR 170
Query: 188 --------------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEV 224
+V T Y APE+ G + A+D W++G + E+
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEM 225
Query: 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN 284
L G F G N R++ L K+ V F P
Sbjct: 226 LYGTTPFKGSN-----------------------RDETFSNIL-----KKEVTFPGSPP- 256
Query: 285 ADPSALR-LLERLLAFDPKDR----PTAEEALADPYFKG 318
S+ R L+ +LL DP R A E P+F+G
Sbjct: 257 -VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD-IFEHISDAARILREIK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A +DT TT + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
L ++ ++++ E + + L L ++L+ L Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAEVLTGKP 229
DIWS+G E+ G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRH 81
+ ++ +G G +G V + +VAIK + D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
++ + + +Y++ ELME L +++ + L Q+
Sbjct: 62 KHLISL-FAVCSVGE----PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYR 196
+ Y+ N HRDL +NIL + K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244
APE ++ D+WS G + E+ T G+ +PG N D +T
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 20/232 (8%)
Query: 10 SPEMEFFSEYGDAS-RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISD 65
+ M GD + ++I E IGKG+YG V + G A+K I D+ E I
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-----LHQVIKAN 120
IL+ L HP++V+ + + +++V EL + ++
Sbjct: 68 EYNILQS-----LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L + LY L L+++H + HRD+K NIL +K+ DFG V+ T
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLT 179
Query: 181 PTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T ++ APE+ + Y D+WS+G E+ G P
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D E VAIKK+ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 IMLPPSRRDFKDIYVVFELME------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
L + + +ME SDL +V K L + L+ L Y+H
Sbjct: 83 CYLRE--------HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEVILA 185
Query: 204 F-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
+Y +D+WS+G E+ KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
KH L F+ +F +ME DL I+ + +F+ ++ AL ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
V +RDLK NIL +A K+ DFG+ + + TT T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 73/326 (22%), Positives = 123/326 (37%), Gaps = 57/326 (17%)
Query: 30 VIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
+IGK +V A T VA+KKI+ D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY---------QFFLYQLLRA 138
+ ++YVV LM + +DL + H+ F L +L A
Sbjct: 65 VTSFI-----VDSELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDF---------GLARVAFNDTPTTI----F 185
L YIH+ HR +K +IL + + K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
W +PE+ Y DI+S+G E+ G P K++ L+
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEK 222
Query: 246 LLGT-PSL-------DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 297
+ GT P L + ++ + R +++ F + +E L
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTF---SEHFHQFVELCL 279
Query: 298 AFDPKDRPTAEEALADPYFKGLSKVE 323
DP+ RP+A + L +FK +
Sbjct: 280 QRDPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 69/304 (22%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A TG A K I E + + EI +L +HP+IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVG---- 66
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIK-----ANDD--------LTREHYQFFLYQLLR 137
+ Y E+ L +I+ A D LT ++ Q+L
Sbjct: 67 --------LYEAY----FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL ++H+ V HRDLK NIL + +K+ DFG V+ + T ++ T ++ A
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMA 171
Query: 198 PEL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD- 253
PE+ C +F Y DIWS+G E+ +P P H+L+ M LL +
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PH----HELNPMRVLLKILKSEP 225
Query: 254 -TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
T+ QP ++S F + L+ L DP DRPTA E L
Sbjct: 226 PTLD-----------------QPSKWSSSFND-------FLKSCLVKDPDDRPTAAELLK 261
Query: 313 DPYF 316
P+
Sbjct: 262 HPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 64/250 (25%), Positives = 120/250 (48%), Gaps = 19/250 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
K+ R F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
Y A+D W +G + E++ G+ F ++ + +L LM D+ R + A+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-------KFPRTLSADAKS 224
Query: 266 YLTSMRKKQP 275
L+ + K P
Sbjct: 225 LLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 9/205 (4%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH---DIFEHISDAARILREIKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKP 229
Y D+WS+GC E+LT KP
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 51/306 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A KK+ + A L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V LM DL H N E F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H + +RDLKP+NIL + ++I D GLA V + T V T Y APE
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI---RGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + +YT + D W +GC+ E++ GK F R R
Sbjct: 172 VVKN--ERYTFSPDWWGLGCLIYEMIEGKSPF-------------------------RQR 204
Query: 260 NDKARRYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALAD 313
+K +R R K+ ++S+KF +A + +LL DP R AEE A
Sbjct: 205 KEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261
Query: 314 PYFKGL 319
P+F+
Sbjct: 262 PFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V ID T + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTR----EHYQF--FLYQLLRALKYI 142
L ++ ++++ E + + DL R + +Q L ++L+ L Y+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG------SALDLLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
S Y DIWS+G E+ G+P
Sbjct: 175 Q--SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ P R ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + TT + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y P++D W++G + E+L G F +N
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 56/234 (23%)
Query: 29 EVIGKGSYGVV-----CSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 81
+G+G++G V + E VA+K + + S+ AR RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQH 67
Query: 82 PDIVEIKHIML---PPSRRDFKDIYVVFELME-SDLHQVIKAND--------------DL 123
+IV+ + PP +VFE ME DL++ ++++ +L
Sbjct: 68 ENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T Q+ + Y+ + + HRDL +N L + +KI DFG++R
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------D 171
Query: 184 IFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 172 VYTTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEI 87
E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL----YQLLRALKYIH 143
+ R D+++ E+M++ L + K D + L +++AL+Y+H
Sbjct: 66 YGALF---REG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 144 TA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ +V HRD+KP N+L N N ++K+CDFG++ + TI + Y APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPERIN 176
Query: 203 SFFSK--YTPAIDIWSIGCIFAEVLTGKPLFP 232
++ Y D+WS+G E+ TG+ FP
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 66/255 (25%), Positives = 121/255 (47%), Gaps = 25/255 (9%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + A + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
K+ R F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVRNDK 262
Y A+D W +G + E++ G+ P N H +L LM ++ +L +
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLFELILMEEIRFPRTLSP-------E 221
Query: 263 ARRYLTSMRKKQPVQ 277
A+ L + KK P Q
Sbjct: 222 AKSLLAGLLKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 75/309 (24%), Positives = 126/309 (40%), Gaps = 56/309 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD----IFEHISDAARILREIKLLRLLR 80
+ ++ ++G+G +G V + TG+ A+K + E +S E +L +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVS---FFEEERDILSISN 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-QFFLYQLLRA 138
P I ++++ +D ++Y+V E DL ++ +D E QF+L +L+ A
Sbjct: 60 SPWIPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ +H HRD+KP+N+L + +K+ DFG A A + V T Y AP
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAP 172
Query: 199 ELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
E+ G Y D WS+G I E++ G+ F T
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------KT 217
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADP----SALRLLERLLAFDPKDRPTAEEA 310
+ + N + R+L KFP DP L L++ LL K+R E
Sbjct: 218 YNNIMNFQ--RFL-------------KFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260
Query: 311 LADPYFKGL 319
P+F +
Sbjct: 261 CCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 26/256 (10%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + A L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
K+ R F V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLLGTPSLDTISRVRND 261
+ Y A+D W +G + E++ G+ P N H +L LM ++ R +
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEI-------RFPRTLSP 221
Query: 262 KARRYLTSMRKKQPVQ 277
+A+ L+ + KK P Q
Sbjct: 222 EAKSLLSGLLKKDPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
IGKG +G V + G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 89 HIMLPPSRRDFKDIYVVFELME---------SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
++L +Y+V E M S VI T F + +
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVCEGM 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRWYR 196
+Y+ N HRDL +N+L + + K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVV 237
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 79/313 (25%), Positives = 125/313 (39%), Gaps = 74/313 (23%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PD 83
+ IG G+ G V TG +A+K++ + + RIL ++ ++ L H P
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-GNKEENKRILMDLDVV-LKSHDCPY 75
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF--------LYQL 135
IV+ + D D+++ ELM + L D L + +
Sbjct: 76 IVKCYGYFI----TDS-DVFICMELMSTCL-------DKLLKRIQGPIPEDILGKMTVAI 123
Query: 136 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA-TR 193
++AL Y+ V HRD+KP NIL +A+ +K+CDFG++ D A TR
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTR 173
Query: 194 -----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
Y APE KY D+WS+G E+ TG+ FP KN + +++T +
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKI 231
Query: 247 LGT--PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
L PSL ++ FS F ++ L D + R
Sbjct: 232 LQEEPPSLP------PNE--------------GFSPDF-------CSFVDLCLTKDHRKR 264
Query: 305 PTAEEALADPYFK 317
P E L P+ +
Sbjct: 265 PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKC- 137
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVY 148
H M + +I V+ E M+ + D+ Q+L + Y+H ++
Sbjct: 138 HDMFDHN----GEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDT--PTTIFWTDYVATRWYRAPE-----LC 201
HRD+KP N+L N+ +KI DFG++R+ T P V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC----NSSVGTIAYMSPERINTDLN 245
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ Y A DIWS+G E G+ FP
Sbjct: 246 HGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 13/216 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLLRHPDIVE 86
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIK-LLRLLRHPDIV 85
VIGKGS+G V A G+ A+K + + I + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM---ESDLHQVIKANDDLTREHY------QFFLYQLL 136
+ + S + +Y V + + E H L RE +F+ ++
Sbjct: 60 GLHY-----SFQTADKLYFVLDYVNGGELFFH--------LQRERSFPEPRARFYAAEIA 106
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRW 194
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + + T +T + T
Sbjct: 107 SALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPE 161
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y APE+ Y +D W +G + E+L G P F ++ D
Sbjct: 162 YLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 61/311 (19%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 91 MLPPSRRDFKDIYVVFELMES---------DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+Y+ E M++ + D L R Y + + L+ LK
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE 120
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-- 199
H N+ HRD+KP N+L N N ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 121 EH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERI 173
Query: 200 --LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---NVVHQLDLMTDLLGTPSLDT 254
+ YT D+WS+G E+ G+ +P + N+ QL + D G P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP--- 228
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
P +S A + + L P RPT + L P
Sbjct: 229 ------------------TLPSGYS-------DDAQDFVAKCLNKIPNRRPTYAQLLEHP 263
Query: 315 YFKGLSKVERE 325
+ + +
Sbjct: 264 WLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 78/290 (26%), Positives = 122/290 (42%), Gaps = 38/290 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y++ + +G G+YG V A + HTGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V L SR + +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYL--SR---EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y DIW++G E+ +P P M DL +L
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP--P----------MFDLHPMRAL---------- 218
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+L S QP + K + ++ L +PK RPTAE L
Sbjct: 219 ---FLMSKSNFQPPKLKDKT-KWSSTFHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 12/220 (5%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLL 79
A Y + +VIG+G++G V + + +KV K+ FE I SD+A E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 139
P +V+ L + +D K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
IH+ + HRD+KP N+L + + LK+ DFG D + V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
+ S Y D WS+G E+L G F ++V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 31 IGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVE 86
+G G++G V + K VA+K + EHI + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + +V EL L + +K ++ + +Q+ + Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRA 197
+ HRDL +N+L + KI DFG++R + Y AT +WY A
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------DYYRATTAGRWPLKWY-A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNVVHQLD 241
PE C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 167 PE-CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 42/225 (18%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 79
+ + + E+IG+G +G V +TG+KVA+K I D+ A L E ++ L
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL 56
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLR- 137
H ++V + ++L +Y+V ELM + +L ++ TR + QLL+
Sbjct: 57 HHKNLVRLLGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQF 105
Query: 138 ------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV---AFNDTPTTIFWTD 188
++Y+ + + HRDL +NIL + + K+ DFGLARV +++ + WT
Sbjct: 106 SLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT- 164
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232
APE K++ D+WS G + EV + G+ +P
Sbjct: 165 --------APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 64/292 (21%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G YG V + VA+K + E + L+E +++ ++HP++V++ +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 91 ML--PPSRRDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTA 145
PP Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 71 CTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWYRAP 198
N HRDL +N L N +K+ DFGL+R+ DT T I WT AP
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------AP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E ++K++ D+W+ G + E+ T G +PG ++ +L+
Sbjct: 175 E--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 220
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
R ++P P L+ ++P DRP+ E
Sbjct: 221 -----------GYRMERP-------EGCPPKVYELMRACWQWNPSDRPSFAE 254
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCSA--IDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIH 143
+ I LP + + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +K+ DFGLAR I+ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +A +KI DFG+ + TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 82/296 (27%), Positives = 127/296 (42%), Gaps = 54/296 (18%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVE 86
QE++G G+ G V A T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES---DLHQVIKANDDLTREH-YQFFLYQLLRALKYI 142
+R I + E M+ D+++ I EH +++ L Y+
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYL 111
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
+ + HRD+KP N+L N ++K+CDFG++ N T YV T Y APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERIS 166
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG--KNVVHQLDLMTDLLGTPSLDTISRVRN 260
+Y D+WS+G F E+ G+ +P KN Q LM L L I V
Sbjct: 167 G--EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---QGSLMPLQL----LQCI--VDE 215
Query: 261 DKARRYLTSMRKKQPV-QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
D PV QFS+KF + + + + PK+RP E + P+
Sbjct: 216 DPPV---------LPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
E IGKG++G V + +VA+K + + L+E ++L+ HP+IV++
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKL 57
Query: 88 KHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + + IY+V EL+ S L + K + LT + ++Y+ +
Sbjct: 58 IGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LKI DFG++R T + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN--Y 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
+YT D+WS G + E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 80/321 (24%), Positives = 127/321 (39%), Gaps = 58/321 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+ I E G+ G + ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV------VHQLDLMTDLLGT-PS---L 252
Y PA+DIWS G + E+ T LF + Q+ L+ GT P+ +
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE----------RLLAFDPK 302
D + + Y+ +K S + P + P L E ++LAFD
Sbjct: 316 DAQANLD----EIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365
Query: 303 DRPTAE--------EALADPY 315
RP+AE + + DPY
Sbjct: 366 HRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
++ +G G +G V + +T VA+K + D L E ++++ LRHP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHP--- 61
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 142
K I L + IY+V ELM+ L + ++ L Q+ + Y+
Sbjct: 62 --KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIFWTDYVATRWY 195
N HRDL +N+L N K+ DFGLARV D I WT
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT-------- 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 172 -APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ L ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKH 89
IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 90 IMLPPSRRDFK--DIYVVFELMESDLHQVIKANDDLTREHY-QFFL----YQLLRALKYI 142
+ F+ D ++ ELM+ L + K ++ + + L ++AL Y+
Sbjct: 71 AL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 143 HTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
+ HRD+KP NIL + N +K+CDFG++ + +I T R Y APE +
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMAPERI 179
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQL 240
S Y D+WS+G EV TGK +P +V QL
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYI 142
+ ++ + IY++ E ME+ L +K + LT Q+ + +I
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 195
N HRDL+ NIL + KI DFGLAR+ ++ T I WT
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT-------- 170
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 -APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHD--IFEHISDAARILREIKLLRLLRHPDI 84
+VIGKGS+G V A H E+ A+K + I + + + LL+ ++HP +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + + +Y V + + +L ++ +F+ ++ AL Y+H
Sbjct: 59 VGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ N+ +RDLKP+NIL ++ + + DFGL + TT + + T Y APE+
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPEVLHK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F +N D
Sbjct: 171 --QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 75/305 (24%), Positives = 138/305 (45%), Gaps = 45/305 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 83
++I +VIG+G++G V HT E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
I L + +D +Y+V + + DL ++ K D L + +F++ +++ A+
Sbjct: 60 CQWIT--TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH + HRD+KP N+L + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD--GTVQSSVAVGTPDYISPEIL 175
Query: 202 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
+ KY P D WS+G E+L G+ F +++V +T ++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETYGKI 220
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD----P 314
N + R QF + A L++RL+ ++R + + D
Sbjct: 221 MNHEER-----------FQFPSHITDVSEEAKDLIQRLIC--SRERRLGQNGIEDFKKHA 267
Query: 315 YFKGL 319
+F+G+
Sbjct: 268 FFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 45/207 (21%)
Query: 125 REHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
REH+ + ++ +++ AL ++H + +RD+K +NIL ++ + + DFGL++ +
Sbjct: 99 REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158
Query: 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
+ + T Y APE+ + A+D WS+G + E+LTG F
Sbjct: 159 EEERAY--SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-------- 208
Query: 240 LDLMTDLLGTPSLDTISRVRN---DKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLER 295
T+ +N + +RR L K +P FP A +++
Sbjct: 209 --------------TVDGEQNSQSEISRRIL----KSKP-----PFPKTMSAEARDFIQK 245
Query: 296 LLAFDPKDR---PTAEEALADPYFKGL 319
LL DPK R A+E P+F+G+
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 26 KIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K+++ +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF--FLYQLLRALKY 141
V++ ++ + IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
I N HRDL+ NIL +A+ KI DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
F +T D+WS G + E++T G+ +PG
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 75/306 (24%), Positives = 130/306 (42%), Gaps = 49/306 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A KK+ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V LM DL H F+ ++ L
Sbjct: 62 VVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H + +RDLKP+NIL + + ++I D GLA P V T Y APE
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + +YT + D W++GC+ E++ G+ F + +++
Sbjct: 172 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRK--------------------KKIK 209
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADP 314
++ R + K+ ++S+KF P A L + LL DPK+R A E P
Sbjct: 210 REEVERLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262
Query: 315 YFKGLS 320
FK ++
Sbjct: 263 LFKQIN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 53/303 (17%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVY 148
+L D K ++++ E I D LT Q Q+L AL+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK N+L + +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 209 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT-----PSLDTISRVRN 260
TP DIWS+G E+ +P H+L+ M LL P+L
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLLKIAKSEPPTLS------- 236
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320
QP ++S +F + L+ L P+ RP+A + L P+ ++
Sbjct: 237 -------------QPSKWSMEFRD-------FLKTALDKHPETRPSAAQLLEHPFVSSVT 276
Query: 321 KVE 323
Sbjct: 277 SNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 45/305 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-ARILREIKLLRLLRHPD 83
++I +VIG+G++G V + + +KV KI + +E + A RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+ H +D ++Y+V + + DL ++ K D L + +F+L +++ A+
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRD+KP NIL + N +++ DFG D T+ + V T Y +PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYISPEIL 175
Query: 202 GSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
+ KY P D WS+G E+L G+ F +++V +T ++
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETYGKI 220
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD----P 314
N K R QF + + A L+ RL+ ++ + + D P
Sbjct: 221 MNHKER-----------FQFPAQVTDVSEDAKDLIRRLIC--SREHRLGQNGIEDFKQHP 267
Query: 315 YFKGL 319
+F G+
Sbjct: 268 FFTGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 46/338 (13%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +Y I V+G G+ G V A GE A+K + +D R E+ L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTR---EHYQFFLY- 133
IV+ R+ +++ ++ +++ DL Q IK+ R EH L+
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ + T + T
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTP 209
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+Y APE+ Y+ D++S+G + E+LT K F G+N M ++
Sbjct: 210 YYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEV------- 253
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
M K ++ P+ P ++ LL+ DPK RP++ + L
Sbjct: 254 ----------------MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
Query: 314 PYFKGLSKVERE-PSCQPISKMEFEFERRRVTKEDIRE 350
P K E QP F R I++
Sbjct: 298 PICKLFISGLLEIVQTQP----GFSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G +G V KVA+K + L E ++++ LRH +V++ +
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 91 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 147
+ S IY+V E M + L +K + + Q+ + YI N
Sbjct: 70 V---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDL+ NIL KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 208 YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+T D+WS G + E++T G+ +PG N
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 23/246 (9%)
Query: 7 KKNSPEMEFFSEYGD-----------ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKK 55
+KN F + Y D A Y++ +VIG+G++G V + + KV K
Sbjct: 16 RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMK 74
Query: 56 IHDIFEHI--SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDL 113
+ FE I SD+A E ++ P +V++ + +D + +Y+V E M
Sbjct: 75 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGD 129
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ +N D+ + +F+ +++ AL IH+ HRD+KP N+L + + LK+ DFG
Sbjct: 130 LVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLF 231
+ + V T Y +PE+ S Y D WS+G E+L G F
Sbjct: 190 MKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 232 PGKNVV 237
++V
Sbjct: 248 YADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 69/307 (22%), Positives = 134/307 (43%), Gaps = 44/307 (14%)
Query: 25 YKIQEVIGKGSYGVV--CSAIDTH-TGEKVAIK--KIHDIFEHISDAARILREIKLLRLL 79
+++ +V+G G+YG V + H +G+ A+K K I + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRAL 139
R + H + D K ++ + +L + + + Q + +++ AL
Sbjct: 62 RQSPFLVTLHYAF---QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPD 176
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + A+D WS+G + E+LTG F ++D +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-------------------TVDGEKNSQ 217
Query: 260 NDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDR----PT-AEEALAD 313
+ +RR L K +P +P A +++RLL DPK R P+ A+E
Sbjct: 218 AEISRRIL----KSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGLS 320
P+F+ ++
Sbjct: 269 PFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 30 VIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPD 83
+G G++G V A + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFEL-MESDLHQVIKANDD--LTREHYQFFLYQLLRALK 140
IV L + I V+ E DL ++ + LT E F YQ+ + +
Sbjct: 101 IVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +++ EV+G G+YG V TG+ AIK + D+ E + I EI +L+ H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEEEIKLEINMLKKYSH 71
Query: 82 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 133
+ + PP D +++V E +DL + K N L + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICR 128
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 185
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y DIWS+G E+ G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
H R +Y V E + DL I+ F+ ++ L ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ ++ +KI DFG+ + D TT + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 51/307 (16%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPD 83
++ V+GKG +G VC+ TG+ A K++ + + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRAL 139
+V + + + KD + +V +M DL H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+ +H N +RDLKP+NIL + ++I D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + +YT + D W +GC+ E++ G+ F G+ +V+
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK--------------------EKVK 209
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
++ R + + +FS++ A + + LL DPK R +E +G
Sbjct: 210 REEVDRRVLETEEVYSAKFSEE-------AKSICKMLLTKDPKQRLGCQE-------EGA 255
Query: 320 SKVEREP 326
+V+R P
Sbjct: 256 GEVKRHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 78/311 (25%), Positives = 120/311 (38%), Gaps = 37/311 (11%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
Y + + + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKHIMLPPSRRDFKDIY-VVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLF---------PGKNV-VHQLDLMTDLLGTPS 251
KY DIWS G + E+L +F K+ H L +++ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 252 ---LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
D SR+ Y + R+ + N L+ ++L FD RP+AE
Sbjct: 288 EFPRDPGSRLVRGFI-EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE 346
Query: 309 EALADPYFKGL 319
E L P F L
Sbjct: 347 EILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQ 274
S G + E+ + G +PG ++ + +R R +
Sbjct: 261 SFGVLLWEIFSLGASPYPG----------------------VQINEEFCQRLKDGTRMRA 298
Query: 275 PVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
P NA P R++ DPK+RPT
Sbjct: 299 P-------ENATPEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 93 PPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPG 233
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V T KVAIK + L+E ++++ LRH +V + +
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 91 MLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYIHTANV 147
+ + IY+V E M + L +K D + Q Q+ + YI N
Sbjct: 70 V------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK 207
HRDL+ NIL N KI DFGLAR+ D T +W APE + + +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AALYGR 179
Query: 208 YTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
+T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIK 88
+G G+ GVV +G +A K IH I A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN- 146
+I + E M+ L QV+K + E +LR L Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
S + DIWS+G E+ G+ P + + + G P +D
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 59/223 (26%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDD--LTREHYQFFLYQLLRALKYI 142
++ +++ + +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
N HRDL +N+L + + K+ DFGL + A ++ T + +W APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKW-TAPEALR 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVVHQLD 241
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 173 E--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 66/258 (25%), Positives = 116/258 (44%), Gaps = 60/258 (23%)
Query: 11 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIH-DIFEHIS 64
PE E R + + +G+G++G V A +D VA+K + D E
Sbjct: 5 PEWEL-----PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-- 57
Query: 65 DAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAN-- 120
D + ++ E+++++++ +H +I+ +L ++ +YVV E +L ++A
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRP 112
Query: 121 --------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K
Sbjct: 113 PGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMK 172
Query: 167 ICDFGLARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSI 217
I DFGLAR I DY + +W APE + F + YT D+WS
Sbjct: 173 IADFGLAR--------DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSF 220
Query: 218 GCIFAEVLT--GKPLFPG 233
G + E+ T G P +PG
Sbjct: 221 GVLLWEIFTLGGSP-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 4e-12
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +++ E++G G+YG V TG+ AIK + D+ + I +EI +L+ H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTG--DEEEEIKQEINMLKKYSH 61
Query: 82 PDIVEIKHIML----PPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLY 133
+ + PP D +++V E +DL + K N L E +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICR 118
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++LR L ++H V HRD+K +N+L N ++K+ DFG V+ T ++ T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103
+TGE+VA+K K HI+D + +EI++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHYQF-FLYQLLRALKYIHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++KI DFGL + D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 88 KHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
H+ F+ +F +ME DL I+++ +F+ +++ L+++H
Sbjct: 60 -HLFC-----TFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFN-DTPTTIFWTDYVATRWYRAPELCG 202
+ +RDLK N+L + + +KI DFG+ + N + + F T Y APE+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF----CGTPDYIAPEILK 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G++
Sbjct: 170 G--QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 3 QDHRKKNS-----PEMEFFSEYGDASRYKIQEVIGKGSYG-VVCSAIDTHTGEKVAIKKI 56
Q H+KK+S P+ + +Y D + +G GS+G V+ + VAIK+
Sbjct: 8 QLHKKKDSDSTKEPKRKNKMKYED---FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64
Query: 57 HD--IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE-LMESDL 113
I + + E K+L + HP V L S +D +Y+V E ++ +
Sbjct: 65 EKSKIIKQ-KQVDHVFSERKILNYINHPFCVN-----LYGSFKDESYLYLVLEFVIGGEF 118
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG A
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+V T T T Y APE+ + + A D W++G E+L G P F
Sbjct: 179 KVVDTRTYT------LCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 NDTPTTIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPGKNV 236
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+++ +G+G +G V T +VAIK + +S A L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKP--GTMSPEA-FLQEAQVMKKLRHEKLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQF--FLYQLLRALKYI 142
++ ++ + IY+V E M + L +K Q Q+ + Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
N HRDL+ NIL N K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
+ + ++T D+WS G + E+ T G+ +PG
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCSAI-DTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV 147
I + + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKICDFGLARVAFND-----TPTTIFWTDYVATRWYRAPELCG 202
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 54/308 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDAARILREIKLLRLLRHPDIVE 86
+I G+YG V T ++ A+KKI+ I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ S + + +V E +E D ++K L + + + + + AL+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGS 203
+ HRDLKP N+L + +K+ DFGL+++ TT + ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDKQVCGT 179
Query: 204 ---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
Y +D W++G I E L G F G D +L G D
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQVISDD 232
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEAL 311
I D+A A L+ RLL +P +R A E
Sbjct: 233 IEWPEGDEA---------------------LPADAQDLISRLLRQNPLERLGTGGAFEVK 271
Query: 312 ADPYFKGL 319
+F GL
Sbjct: 272 QHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
I + R + IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 --IGVCTQR---QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264
+Y+ D+WS G + E + G +PG MT+ + R +
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG---------MTN----------QQAREQVEK 209
Query: 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
Y S +K P ++++R + P++RP E
Sbjct: 210 GYRMSCPQKCPDDVY-----------KVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
K+ + +G G +G V + KVA+K + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 86 EIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--DLTREHYQFFLYQLLRALKYI 142
+ ++ + IY++ E M + L +K+++ + F Q+ + YI
Sbjct: 65 RLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYVATRWY 195
N HRDL+ N+L + + KI DFGLARV ++ T I WT
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 -APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKL 75
E D KI E +G G+ GVV +G +A K IH I A R I+RE+++
Sbjct: 1 ELKDDDFEKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQV 56
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
L P IV +I + E M+ L QV+K + +
Sbjct: 57 LHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 135 LLRALKYIHTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+++ L Y+ + + HRD+KP NIL N+ ++K+CDFG++ + + +V TR
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTR 166
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 232
Y +PE L G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 167 SYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 17/228 (7%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRL 78
+ + +V+G G++G V + GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMAS 65
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLL 136
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+ + Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243
A E YT D+WS G E++T G + G V DL+
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 35/307 (11%)
Query: 24 RYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+Y I + GS G VC+ +KV +K + + REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ + H + R + +V + DL + + L E +LL AL Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLD-----LMTDLLGTPS 251
L Y DIWS G + E+ GK V QL + L P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPS--ALRLLERLLAFDPKDRPTAEE 309
+ + ++ K +Y ++ + P L+ ++L FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371
Query: 310 ALADPYF 316
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 52/286 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88
E IG+G++G V S VA+K + A+ L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-DLKAKFLQEARILKQYSHPNIVRLI 59
Query: 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR-------ALKY 141
+ + IY+V EL++ L E + + +L++ ++Y
Sbjct: 60 GVCTQK-----QPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ +Y+ D+WS G + E + LG +S N
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS--------------------LGAVPYANLS---NQ 203
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLERLLAFDPKDRPT 306
+ R + + P P A+ RL+ER +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
H+ ++ ++ V E + DL H K DL R F+ +++ L+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK N++ + + +KI DFG+ + F D + F T Y APE+
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KYT ++D WS G + E+L G+ F G +
Sbjct: 171 L--KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 88/340 (25%), Positives = 138/340 (40%), Gaps = 88/340 (25%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA----RILREIKLLRLL 79
RY I +IGKG G V A D +VA+KKI E +S+ R LRE K+ L
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR---EDLSENPLLKKRFLREAKIAADL 59
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA---NDDLTREHYQ-----F 130
HP IV + I D +Y +E L ++K+ + L++E +
Sbjct: 60 IHPGIVPVYSIC-----SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 131 FL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-----------VA 176
FL +++ ++Y+H+ V HRDLKP NIL ++ I D+G A +
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 177 FNDT---------PTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ P I V T Y APE L G S+ T DI+++G I ++LT
Sbjct: 175 VDERNICYSSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
Query: 227 GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 286
FP R K R+ P++ + P +
Sbjct: 227 LS--FP-------------------------YRRKKGRKISYRDVILSPIEVA---PYRE 256
Query: 287 --PSALRLLERLLAFDPKDRPTAEEALAD---PYFKGLSK 321
P ++ + LA DP +R ++ + L P+ +G +
Sbjct: 257 IPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296
|
Length = 932 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 70/299 (23%), Positives = 121/299 (40%), Gaps = 65/299 (21%)
Query: 30 VIGKGSYGVVCSA---IDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKHIMLPPSRRDFKDI-YVVFELME-SDLHQVIKAND------DLTREHYQFFLYQLLR 137
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-------- 189
++Y+ + N HRDL +N + N N + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG--------------- 218
Query: 249 TPSLDTISRVRNDKARRYLTS-MRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
V N + YL R KQP P+ L+ + + +PK RP+
Sbjct: 219 ---------VENSEIYNYLIKGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 49/232 (21%)
Query: 98 DFKDIYVVFELME----SDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTAN 146
DFK + +ME DL++ IK +EH F YQ++ AL +H+
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ HRDLK NI +K+ DFG ++ ++D+ + + + T +Y APEL
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--K 246
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266
+Y+ D+WS+G I E+LT F G + Q ++M +L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVL------------------- 284
Query: 267 LTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEALADPYFK 317
K P FP S ++ LL+ LL+ +P RPT ++ L + K
Sbjct: 285 ---YGKYDP------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSRRDFKDIYVVFELMESDLHQVIKANDDLT--REHYQFFLYQLLRALKYIHTANVYHRD 151
P++ D + ++ D+ I D+L E F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL KICDFGLAR ND+ + + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKNV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 39/216 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDI--FEHISDAARILREIKLLRLLRHPD 83
+ +G GS+GVV + +G K VA+K + + + D L+E ++ L H +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHEN 57
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
++ + ++L + +V EL L + + ++ + Q+
Sbjct: 58 LIRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYR- 196
++Y+ + HRDL +NIL ++ K+KI DFGL R + N+ D+ +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLK 161
Query: 197 ------APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 162 VPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
H+ ++ +++ V E + DL I++ F+ +++ L+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVA-FNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLK NIL + + +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
P IV + + P + F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDT 254
APE+ + Y + D +S+GC+ ++L G F H++D MT + D+
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IS 256
S
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 69/310 (22%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI---------LREIKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
P IV + + P + F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L+++H V +RDLKP NIL + + ++I D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTPSLDT 254
APE+ + Y + D +S+GC+ ++L G F H++D MT
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------- 211
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEE 309
+M + P FS P LLE LL D R A+E
Sbjct: 212 -------------LTMAVELPDSFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQE 251
Query: 310 ALADPYFKGL 319
P+F+ L
Sbjct: 252 VKEHPFFRSL 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 73/307 (23%), Positives = 135/307 (43%), Gaps = 47/307 (15%)
Query: 25 YKIQEVIGKGSYG---VVCSAIDTHTGEKVAIKKIHD--IFEHISDAARILREIKLLRLL 79
+++ +V+G G+YG +V TG+ A+K + + + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 80 RH-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
R P +V + + ++ YV M + L+Q D+ + + +F+ +++ A
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILA 117
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++ + + DFGL++ ++ + + T Y AP
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ + A+D WS+G + E+LTG F +L+
Sbjct: 176 EIIRG-KGGHGKAVDWWSLGILIFELLTGASPF-------------------TLEGERNT 215
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDR-----PTAEEALA 312
+++ +RR L + FP+ P A LL +LL DPK R A E
Sbjct: 216 QSEVSRRIL---------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
Query: 313 DPYFKGL 319
P+FKGL
Sbjct: 267 HPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+VIG+G++G V TG A+K + D+ E A I E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D +++Y++ E + D+ ++ D L+ E QF++ + + A+ IH
Sbjct: 66 MFY-----SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA-------RVAF----NDTPTTIF--------- 185
HRD+KP N+L +A +K+ DFGL R F P + F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 186 ----WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
W V T Y APE+ + Y D WS+G I E+L G P F
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 70 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHYQFFLY--------QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
Y Q+ +KY+ + N HRDL +N L N +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 77/339 (22%), Positives = 136/339 (40%), Gaps = 58/339 (17%)
Query: 23 SRYKIQEVIGKGSYG--VVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL---------- 70
+ +++ + + G++G +C A+ T E A + ++ + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 71 -----REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLH-----QVIKAN 120
EI L L H +I++I+ I+ + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND- 179
D + + + QLL A++YIH + HRD+K +NI N + K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL----------TGKP 229
W VAT +PE+ Y DIWS G I ++L GKP
Sbjct: 322 EAFDYGWVGTVATN---SPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 230 LFPGKNVVHQLDLMTDLLGTPS---LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 286
++ L + + P D I D A + + + + ++P
Sbjct: 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--- 433
Query: 287 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 325
L ++L FD RP A E LA P F ++ E E
Sbjct: 434 ------LVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 24 RY-KIQEVIGKGSYGVVC----SAIDTHTGEKVAIKKIHDIFEHISDAARILR-----EI 73
RY K V+G+G +G V + TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFF 131
+L+ L H +IV+ K S + K + ++ E + S + K +L + F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLF 112
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA----------RVAFN-DT 180
Q+ + Y+H+ + HRDL +N+L + + +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
P +FW A E K++ A D+WS G E+LT
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 46/281 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 89 HIMLPPSRRDFKD-IYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ + KD + +V +M DL H N + F+ +L L+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264
KYT + D W +GC+ E++ G+ F R R ++ +
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF-------------------------RKRKERVK 209
Query: 265 RYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
R R K+ ++S+KF S R+ LL +PK+R
Sbjct: 210 REEVDRRVKEDQEEYSEKFSEDAKSICRM---LLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 40/232 (17%)
Query: 24 RYKIQEVIGKGSYGVV--CSAID------------THTGEKVAIKKIHDIFEHISDAAR- 68
+ +++E +G+G +G V C A VA+K + ++ AR
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR---ADVTKTARN 62
Query: 69 -ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--------- 117
L+EIK++ L++P+I+ + + + D + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCV---SDD--PLCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +KI DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ I + RW + K+T A D+W+ G E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 53/243 (21%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFE-----HISDAARILREIKLLRLLRH 81
+VIG+G++G V TG A+K + D+ E HI IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
+ S +D ++Y++ E + D+ ++ D LT E QF++ + + A+
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLA-------RVAFNDTPTTIFWTDY---- 189
IH HRD+KP N+L ++ +K+ DFGL R F +D+
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 190 ---------------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLRHPDIV 85
+V+G G++G V I GE V I I + + E ++ + HP +V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
+ + L P+ I +V +LM L V + D++ + + Q+ + + Y+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALECI 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 46/293 (15%)
Query: 29 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKHIMLPPSRRD-FKDIYVVFELME-SDLHQVI---KANDD---LTREHYQFFLYQLLRA 138
+ + L + + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
V N + YL R KQP P+ L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI +L HP+IV++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKYIHTANVY 148
+ +++++ E + + LT + Q L AL Y+H +
Sbjct: 71 FYYEN-----NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK NIL + +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 209 TP---AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 27 IQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
I+E +G+GS+G+V + +VAIK +++ + + L E +++
Sbjct: 11 IRE-LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNC 68
Query: 82 PDIVEIKHIML---PPSRRDFKDIYVVFELM-ESDLHQVIKA---NDDLTRE----HYQF 130
+V + ++ P VV ELM + DL +++ + Q
Sbjct: 69 HHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 131 FLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
F+ ++ + Y+ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYET 172
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
DY + RW APE +T D+WS G + E+ T
Sbjct: 173 DYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 30/204 (14%)
Query: 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160
+++V E + DL ++ L EH +F+ ++ AL ++H + +RDLK N+L +
Sbjct: 71 LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
A+ +K+ D+G+ + TT + + T Y APE+ +Y ++D W++G +
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVL 185
Query: 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ 280
E++ G+ F D++TD P ++T YL + ++P++ +
Sbjct: 186 MFEMMAGRSPF---------DIITD---NPDMNT---------EDYLFQVILEKPIRIPR 224
Query: 281 KFPNADPSALRLLERLLAFDPKDR 304
A +L+ L DPK+R
Sbjct: 225 FL---SVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108
VA+K + D SD AR RE +LL L+H IV+ + + + + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +KI DFG++R ++ + + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+W APE F + YT D+WS G + E+ T G P
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHISDAARILREIKLLRLLRHPDIVEI-- 87
+GKG +G VC+ +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 -----KHIMLPPSRRDFKDI-YVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRAL 139
H+ L S + D+ Y ++ + E ++ +VI + Q+ +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
++H+ ++ +RD+KP+N+L + ++ D GLA V D T T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPE 164
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y+ +D +++GC E++ G+ F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 69/308 (22%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDI-------FEHISDAARILREIKLLRLLRHPD 83
+GKG +G V + TG+ A KK++ +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-----DLHQVIKANDDLTREHYQFFLYQLLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
EL +Y ++D +++G E++ + F R
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF-------------------------RA 199
Query: 259 RNDKA-RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 312
R +K + L V + KF A S E LLA DP+ R +
Sbjct: 200 RGEKVENKELKQRILNDSVTYPDKFSPASKS---FCEALLAKDPEKRLGFRDGNCDGLRT 256
Query: 313 DPYFKGLS 320
P F+ L+
Sbjct: 257 HPLFRDLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 9/114 (7%)
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L KICDFGLAR ND+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
+ + +W APE F YT D+WS G + E+ + GK +PG
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 51 VAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108
VA+K + SD AR L+E+K+L L P+I + L D + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVD-PPLCMIMEY 100
Query: 109 ME-SDLHQVIKANDDLTREH--------YQFFLY---QLLRALKYIHTANVYHRDLKPKN 156
ME DL+Q ++ + T + LY Q+ ++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 157 ILANANCKLKICDFGLARVAF-ND-------TPTTIFWTDYVATRWYRAPELCGSFF-SK 207
L N +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 208 YTPAIDIWSIGCIFAEVLT 226
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL-RHPDIVEI 87
VIG+GSY V T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 39/243 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D + ++ E+++++++ +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHK 81
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTR---EHYQF 130
+I+ +L +D +YV+ E + +L + ++A D+ R E F
Sbjct: 82 NIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 131 -----FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185
YQ+ R ++Y+ + HRDL +N+L N +KI DFGLAR N
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 186 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDL 242
+ +W APE + F + YT D+WS G + E+ T G P +PG V L
Sbjct: 197 TNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 251
Query: 243 MTD 245
+ +
Sbjct: 252 LKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEK-----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G+G +G V A + VA+K + + S+ +L E LL+ + HP +
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHV 65
Query: 85 VEI-----------------KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---LT 124
+++ K+ L R+ + + + + + + N D LT
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
F +Q+ R ++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 185 FWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 186 RSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 67/305 (21%), Positives = 112/305 (36%), Gaps = 69/305 (22%)
Query: 26 KIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 82 PDIVEIKHIMLPPSRRD-FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL--- 136
P+++++ + S V+ M+ DLH + + + Q L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKF 118
Query: 137 -----RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY-- 189
++Y+ N HRDL +N + + + + DFGL++ I+ DY
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYR 170
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 171 QGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG--------- 218
Query: 243 MTDLLGTPSLDTISRVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 301
V N + YL R KQP + L+ DP
Sbjct: 219 ---------------VENHEIYDYLRHGNRLKQP-------EDCLDELYDLMYSCWRADP 256
Query: 302 KDRPT 306
KDRPT
Sbjct: 257 KDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--SDAARILREIKLLRLLRHP 82
+ + +VIG+G++G V + + A+K + FE I SD+A E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV++ + +D K +Y+V E M DL ++ +N D+ + +F+ +++ AL
Sbjct: 104 WIVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFG----LARVAFNDTPTTIFWTDYVATRWYRA 197
IH+ HRD+KP N+L + + LK+ DFG + T + DY+ +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI------S 211
Query: 198 PELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
PE+ S Y D WS+G E+L G F
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 41/179 (22%)
Query: 71 REIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ----------VIKA 119
+E +L+ L+HP+IV + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 120 NDDLTREH---YQFFL---YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ D T + FL Q+ ++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 174 RVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRHPDIVEI 87
VIG+GSY V T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L ++ +K+ D+G+ + TT + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266
Y ++D W++G + E++ G+ F D++G S D + D +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF-------------DIVG--SSDNPDQNTEDYLFQV 216
Query: 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
+ + + P S K A +L+ L DPK+R
Sbjct: 217 ILEKQIRIPRSLSVK-------AASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 8e-10
Identities = 83/337 (24%), Positives = 132/337 (39%), Gaps = 86/337 (25%)
Query: 17 SEYGDA----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
+Y D + Y++ + IG G +G V T E K I + ++++ E
Sbjct: 3 GKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK------------A 119
+ ++R L+H +IV L + + +Y++ E ++ DL + I+ A
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 120 NDDLTREHYQFFLYQLLRALKYIHT-------ANVYHRDLKPKNILANANCK-------- 164
D+TR QLL AL Y H V HRDLKP+NI + +
Sbjct: 120 IVDITR--------QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 165 ---------LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
KI DFGL++ + V T +Y +PEL Y D+W
Sbjct: 172 ANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275
++GCI E+ +GK F N Q L+++L P L P
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQ--LISELKRGPDL----------------------P 263
Query: 276 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
++ K N L++ LL K+RP+A + L
Sbjct: 264 IKGKSKELNI------LIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 36/211 (17%)
Query: 31 IGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH 89
+G G +GVV G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 90 IMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT---REHYQFF-LYQLLR-------A 138
+ + IY+V E M +N L REH + F QLL
Sbjct: 67 VCTKQ-----RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKDVCEG 112
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+ + HRDL +N L + +K+ DFGL+R +D T+ + + RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
E+ +SK++ D+W+ G + EV + GK
Sbjct: 171 EVL--LYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 32/222 (14%)
Query: 27 IQEVIGKGSYGVV----CSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
++ +G+G++G V C + T VA+K + D ++ RE +LL L+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA----------------NDDLT 124
IV+ + D + +VFE M+ DL++ ++A +L
Sbjct: 67 EHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
Q+ + Y+ + + HRDL +N L AN +KI DFG++R ++ +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 182 GGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-R 77
+ + K Q+VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFE---------------LMESDLHQVI--KAN 120
L HP+I+ +++ R + +Y+ E ++E+D I
Sbjct: 64 LGHHPNII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 179 KKTM---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 37/250 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKL 75
+R + + +G+G +G V A ID K VA+K + D D + ++ E+++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEM 70
Query: 76 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKA-------------- 119
++++ +H +I+ +L +D +YV+ E + +L + ++A
Sbjct: 71 MKMIGKHKNIIN----LLGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 120 --NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ LT + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
N + +W APE + F + YT D+WS G + E+ T G +PG
Sbjct: 186 NIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241
Query: 236 VVHQLDLMTD 245
V L+ +
Sbjct: 242 VEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 31 IGKGSYGVV----CSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQ 129
+ + + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
Q+ + Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDY 177
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T DIWS G + E+ T
Sbjct: 178 YRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKHIMLPPSRR----------DFKDIYVVFEL-MESDLHQVI-KANDDLTREHYQFFL 132
E + +++ RR D ++Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+++ A+ +H HRD+KP N+L + N +++ DFG D T+ V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD--GTVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +++V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 31 IGKGSYGVVCSA----IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D A ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKAND--------DLTREHYQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEG-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 186 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 194 SNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 70 LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA--------- 119
L+E+K+L L+ P+I+ + + + D + ++ E ME+ DL+Q + +
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 120 -NDDLTREH------YQFFLY---QLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
ND + H Y L+ Q+ +KY+ + N HRDL +N L N +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R + I + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 49/235 (20%)
Query: 31 IGKGSYGVVC--SAID---THTGE-KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL------- 136
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYIHTANVYHRDLKPKNILA-----NANCKLKICDFGLARVAFNDTPTTIFWTDY-- 189
+ Y+ + HRDL +N L +A+ +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 23 SRYKIQE--VIGKGSYGVV----CSAIDTHTGEKVAIKKIHDIFEHISDAARIL---REI 73
R +QE +G+G +G V I+ GE + + K + D RE+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRREL 59
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---------L 123
+ R L H ++V + + R+ + Y++ E + DL Q ++A L
Sbjct: 60 DMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
+ + Q+ + ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS---- 170
Query: 184 IFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
+Y + RW APE ++ D+WS G + EV T G+ F G
Sbjct: 171 ----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-- 221
Query: 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLE 294
++D + ++R++ K P PS L +L+
Sbjct: 222 -------LSD------EEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMT 253
Query: 295 RLLAFDPKDRPTAEEALA 312
R A +PKDRP+ E ++
Sbjct: 254 RCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHP 82
K ++VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFE----------LMESDLHQVIKANDDLTREH---YQ 129
+I+ +++ R + +Y+ E L +S +V++ + +EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 130 FFLYQLLR-------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
QLL+ ++Y+ HRDL +N+L N KI DFGL+R
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
T+ + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 TM---GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 112 DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDF 170
DL ++K L+ + + QL+ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
GL ++ TP+ Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK- 203
Query: 230 LFPGKNVVHQ-LDLMTDLLGTPSLD-TISRVRNDKARRYLTSM 270
P K + LDL LL + + A ++ SM
Sbjct: 204 -HPFKEDEDEELDL-ESLLKRQQKKLPFIKNVSKNANDFVQSM 244
|
Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLL 79
+ +K +V+G G++G V + GEKV I I ++ E S A IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLR 137
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 24/112 (21%)
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK-KIHDIFEHISDAA--RILREIKLLRLLRHPDIVE 86
V+G G++G V I GE V I I + E+ S A IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 87 IKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ I L + + +V +LM L V + D + + + Q+ + + Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--YVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D T + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKNV 236
++T D+WS G E++T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 50/160 (31%), Positives = 70/160 (43%), Gaps = 23/160 (14%)
Query: 72 EIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
QLL A+ YIH + HRD+K +N+L N + + DFG A A + +T
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWST 316
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
F T APE+ YTP++DIWS G + E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSRRDFKDIYVVFELMESD-LHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVY 148
+ + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L KI DFGL++ D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESDL-----HQVIKANDDLTREH---YQFFLYQLLR 137
+++ R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
+ Y+ HRDL +NIL N KI DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 55/250 (22%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G G++G VC A T A+K + D+ + A + E +L + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-NQVAHVKAERDILAEADNEWVVK 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGL----------------ARVAFNDTPTTIFWTD- 188
HRD+KP NIL + + +K+ DFGL + + + + W D
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 189 ---------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
V T Y APE+ YT D WS+G I
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVIL 238
Query: 222 AEVLTGKPLF 231
E+L G+P F
Sbjct: 239 FEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 84/347 (24%), Positives = 133/347 (38%), Gaps = 90/347 (25%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR 80
S + + IG G++G VC T A+K + D+ + AA + E +L
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEAD 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFEL-----MESDLHQVIKANDDLTREHYQFFLYQL 135
+ +V++ + S +D ++Y V + M S L ++ +DL R F++ +L
Sbjct: 60 NEWVVKLYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAEL 110
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------------ARVAF 177
A++ +H HRD+KP NIL + + +K+ DFGL R
Sbjct: 111 TCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 178 NDTPTTIFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIW 215
+ D V T Y APE+ + YT D W
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWW 228
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275
S+G I E+L G+P F L TP +T +V N + ++ S K
Sbjct: 229 SVGVILYEMLVGQPPF--------------LADTP-AETQLKVINWETTLHIPSQAK--- 270
Query: 276 VQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 319
A L+ RL +DR A+E A P+FKG+
Sbjct: 271 ---------LSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEK----VAIKKIHD-----IFEHISDAARILREIKLLRLL 79
+++G G +G V I G+ VAIK I D F+ I+D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 137
H IV + I S + +V +L S L V + D L + + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HR+L +NIL ++ ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDA--ARILREIK 74
R + +++ +G++G + I E+V +K + D H S+ +L+E
Sbjct: 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESC 60
Query: 75 LLRLLRHPDIVEIKH----------IMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDL 123
LL L H +I+ I H ++ P + + K L E++ Q +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS----- 115
Query: 124 TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183
T++ + Q+ + Y+H V H+D+ +N + + ++KI D L+R F
Sbjct: 116 TQQLVHMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + +W L +S A D+WS G + E++T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 59/243 (24%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 24 RYKIQEV--IGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISD--AARILREIK 74
R I+ V IG+G++G V A + VA+K + E S A RE
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAA 60
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------ 121
L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 61 LMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 122 ----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171
L+ Q+ + Y+ HRDL +N L N +KI DFG
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 172 LARVAFNDTPTTIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
L+R I+ DY + RW PE F+++YT D+W+ G + E
Sbjct: 176 LSR--------NIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWE 224
Query: 224 VLT 226
+ +
Sbjct: 225 IFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRL 78
D KI+ ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLL- 136
H +IV ++ ++ + + +V E M + A D R+H Q QL+
Sbjct: 63 FDHSNIVRLEGVITRGN-----TMMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DY 189
+KY+ H+ L +L N++ KI F + D I+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSG 168
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + APE + ++ A D+WS G + EV++
Sbjct: 169 KSPVLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 65/263 (24%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHP 82
+ +VIGKG++G V TG+ A+K + ++F+ A + E +L P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK-DQLAHVKAERDVLAESDSP 61
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLLRA 138
+V + + F+D ++ +ME DL ++ D + + +F++ + + A
Sbjct: 62 WVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLA------------------------- 173
++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 174 ----RVAFNDTPTTIFWTDYVATRW----------------YRAPELCGSFFSK-YTPAI 212
VA + T+ D +AT W Y APE+ F + Y
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQQGYGQEC 229
Query: 213 DIWSIGCIFAEVLTGKPLFPGKN 235
D WS+G I E L G P F +N
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVE 86
+ +G G++G VC A T A+K + D+ + A + E +L + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-NQVAHVKAERDILAEADNEWVVR 65
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + S +D ++Y V + + D+ ++ + +F++ +L A++ +H
Sbjct: 66 LYY-----SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF-----------------WTD 188
HRD+KP NIL + + +K+ DFGL F T + + W D
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 189 ----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
V T Y APE+ + YT D WS+G I
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVI 237
Query: 221 FAEVLTGKPLF 231
E+L G+P F
Sbjct: 238 LYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 29/225 (12%)
Query: 23 SRYKIQEVIGKGSYGVVCSA--IDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
S + E +G+ +G V T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 78 LLRHPDIV----------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLT--- 124
L+HP+IV + I S D + F +M S V +DD T
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE----FLVMRSPHSDVGSTDDDKTVKS 119
Query: 125 -REHYQFF--LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
E F + Q+ ++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ + RW +PE + K++ DIWS G + EV +
Sbjct: 180 YKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 58/226 (25%), Positives = 86/226 (38%), Gaps = 60/226 (26%)
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLA---RVAFNDTPTTI 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY-LTSMRKKQPVQFSQK 281
++ FP L +D + I R K Y L + RK + S
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 282 FPNA-------DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320
+ LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457
|
Length = 566 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ-----LLRALKY 141
+ + +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +KI D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE- 107
VAIK + DI + + +E L+ L HP+IV + ++ + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLT----REHYQFF--LYQLLRALKYIHTANVYHR 150
L + DLH+ + +++D T +H F Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +KI D GL+R ++ + + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
+++ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 31 IGKGSYGVVCSAIDTHTGEKVAIK---KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
I +G++G V + + A+K K I +++ + R+ L L + P IV +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKSPFIVHL 69
Query: 88 KHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ S + ++Y+V E + +S LH ++++ ++ ++ AL Y+
Sbjct: 70 YY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVALALDYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
H + HRDLKP N+L + +K+ DFGL++V N
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 28 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-- 84
QE IG G +G V+ S I T TG + K + L++ R+L+HP+I
Sbjct: 1 QE-IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 85 -----VEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY----Q 134
VE +L VFE E DL + R L +
Sbjct: 60 CLGQCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ + ++H N H DL +N ++ +K+ D+G+ + + V RW
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 195 YRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVL 225
APEL G F ++ T ++W++G E+
Sbjct: 168 L-APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 50/244 (20%)
Query: 30 VIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLR------ 137
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 138 -ALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDY-- 189
KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240
+ +W PE L G F SK D+WS G + E+ + G +PG+ +
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
Query: 241 DLMT 244
+ +T
Sbjct: 232 EFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 75/336 (22%), Positives = 133/336 (39%), Gaps = 60/336 (17%)
Query: 30 VIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHPDIVE 86
VIG+G V A TGE V +++I ++ ++ L+ E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHPNIVP 63
Query: 87 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ---------FFLYQLLR 137
+ + + +++VV M + DL H+ + L +L+
Sbjct: 64 YRATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLK 112
Query: 138 ALKYIHTANVYHRDLKPKNILANANCK---------LKICDFGLARVAFNDTPTTIFWTD 188
AL YIH HR +K +IL + + K L + + G +D P
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY----- 167
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
V + +PE+ Y DI+S+G E+ G P K++ L+ L G
Sbjct: 168 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNG 225
Query: 249 T-PSLDTISRVRNDK-----ARRYLTSMRKKQPVQFSQKFPNADPSA---LR-------- 291
T P L + + ++ +R S + + + N + S+ R
Sbjct: 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285
Query: 292 LLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327
+E+ L +P RP+A L +FK +++R S
Sbjct: 286 FVEQCLQRNPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/101 (26%), Positives = 44/101 (43%), Gaps = 19/101 (18%)
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
++ + Y++ HRDL +N + + +KI DFG+ R I+ TDY
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 84/339 (24%), Positives = 140/339 (41%), Gaps = 74/339 (21%)
Query: 26 KIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILR-EIKLLRLLRHP 82
++Q IG+G + V A T TG V ++ I D+ + + L+ E+ L RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQL 135
+I+ + S ++V+ M + ++K ++ L L+
Sbjct: 60 NIMTSWTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGA 110
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL------------ARVAFNDTPTT 183
LR L Y+H HR++K +IL + + + + GL A+V + D P
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ- 166
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
F T + W +PEL Y DI+S+G E+ TG+ P ++++ L+
Sbjct: 167 -FSTSVLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLL 220
Query: 244 TDLLGTP--SLDTI------SRVRNDKA---------------RRYLTSMRKKQPVQ--F 278
L G P LD SR++N ++ + +TS R + P F
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280
Query: 279 SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
S F N L+E L DP+ RP+A L+ +FK
Sbjct: 281 SPAFQN-------LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR 68
+S + + S K + VI +G G G + +K+I+D+ I +
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV-NSIPSS-- 732
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
EI + L+HP+IV++ + R K Y++ E +E +L +V++ +L+ E
Sbjct: 733 ---EIADMGKLQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWER 781
Query: 128 YQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
+ + +AL+++H + V +L P+ I+ + + + L + DT I
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
+ Y APE + T DI+ G I E+LTGK
Sbjct: 841 -------SSAYVAPETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 17/42 (40%), Positives = 28/42 (66%)
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 19/96 (19%)
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY--------V 190
+ Y++ HRDL +N + + +KI DFG+ R I+ TDY +
Sbjct: 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGKGLL 183
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
RW L F+ + D+WS G + E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 6/102 (5%)
Query: 129 QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
Q ++ L ++H N H DL +N L A+ +KI D+GL+ + +
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162
Query: 189 YVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAEVL 225
+V RW APEL T ++WS+G E+
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 52/221 (23%), Positives = 77/221 (34%), Gaps = 54/221 (24%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
Q I KG + I T K + DI E EIK LR + +I++I
Sbjct: 33 QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITE---------NEIKNLRRIDSNNILKI 83
Query: 88 KHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLY---QLLRALKY--- 141
Y + DL ++ + TR + + L L K
Sbjct: 84 ---------------YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMA 128
Query: 142 ----IHTANVYHRDLKP------KNILANANCKLKICDFGLARV----AFNDTPTTIFWT 187
N+Y KP + L N KLKI GL ++ F +
Sbjct: 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-------- 180
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
V Y + ++ FS+YT DI+S+G + E+ TGK
Sbjct: 181 --VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 16/39 (41%), Positives = 26/39 (66%)
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+L L+YIH + H D+KP+NI+ + N + I D+G+A
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 619 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.34 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.98 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.96 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.8 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.24 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.01 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.0 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.48 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.42 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.37 | |
| PLN02236 | 344 | choline kinase | 96.03 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.49 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.94 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.51 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.67 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.05 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 90.72 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-75 Score=592.21 Aligned_cols=342 Identities=58% Similarity=0.975 Sum_probs=323.2
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..|....+|..++.||+|+||+||.|.++.+|+.||||++.+.+.+..++++.+||+++|+.++|+||+.+++++.+++.
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 33566777888899999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..++++|+|+|+|+.||+++|+++..|+++++++|++|||+||+|+|+.||+||||||.|+|++.+|.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....++|+|+.|+||+|||++.+ +..|+.++||||+||||+|||+|+++|+|++..+|+..|.+.+|+|+.+.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 56677899999999999999876 4899999999999999999999999999999999999999999999999999
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhh
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 336 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (619)
.+.++.+++|+.+++...+.+|...||++++.+.|||++||.+||.+|+|++|+|+||||..++.+++||.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988876543
Q ss_pred hHhhhcCCHHHHHHHHHHHHHHhCchhH
Q 007064 337 EFERRRVTKEDIRELIFREILEYHPQLL 364 (619)
Q Consensus 337 ~~e~~~~~~e~~~~~~~~ei~~~~~~~~ 364 (619)
++.. .+.++|++++|+|+.+|+|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 4445 8999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-59 Score=456.75 Aligned_cols=288 Identities=40% Similarity=0.657 Sum_probs=252.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.+|..+++||+|.||+||+|+|..||+.||||+|+.....+......+|||++|+.++|+||+.++++| ....++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 589999999999999999999999999999999986544444556688999999999999999999999 455779
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
.||+|||+.||..+|+.. ..|+..+++.|+.++++||+|||++.|+||||||.|+||+++|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 999999999999999865 4799999999999999999999999999999999999999999999999999998765433
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
. .+..+.|+||+|||++.+. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|+..+|+|..+.|..+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2444899999999988774 78999999999999999999999999999999999999999999999999887543
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
. .|.+- ...........|+.++.++.||+.+||.+||.+|+|+.|+|+|+||+....+
T Consensus 233 p--dY~~~-~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 P--DYVKI-QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred c--cHHHH-hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 2 22221 1223334455899999999999999999999999999999999999975443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-60 Score=466.76 Aligned_cols=288 Identities=37% Similarity=0.654 Sum_probs=248.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|+.+.++|+|+||+|++|+++.||+.||||++.....+....+-.+|||++|++|+|||+|.++++| +-...+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987666666667778999999999999999999999 556789
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
++|||||+.++.+.+.. ...++++.++.+++|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 99999999776666654 457999999999999999999999999999999999999999999999999999986532
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
....|+|+.|+||+|||++.+. ..|++.+|||++||++.||++|.++|+|+++.+|+..|...+|.-...-...+...
T Consensus 155 -gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2246899999999999998774 78999999999999999999999999999999999999999998777665544332
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....=+.-.....+.++...+|+++..+.||+++||..||.+|++.+++|.||||.++
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 2111111111233445667889999999999999999999999999999999999754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=480.31 Aligned_cols=338 Identities=93% Similarity=1.452 Sum_probs=307.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||+|+||.||+|+++.++..||||++...........++.+|+.+|+.++||||+++++++......+...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667889999999999999999999998776555667799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
+|||||+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 44566789999999999865335789999999999999999999999999999999999999999999999998888888
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHhhhcC
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRV 343 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (619)
..++..+....+..+...++.+++.+.+||.+||..||++|||++|+|+||||+++......+..++++.+++.++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888877888888888999999999999999999999999999999999999988888999999999999999999
Q ss_pred CHHHHHHHHHHHHHHhCc
Q 007064 344 TKEDIRELIFREILEYHP 361 (619)
Q Consensus 344 ~~e~~~~~~~~ei~~~~~ 361 (619)
+.+++++.+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=485.70 Aligned_cols=290 Identities=38% Similarity=0.665 Sum_probs=254.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
....+||.++++||.|.||.||+|..+.+|+.||||++++.+..-.+.. =+||++.|++|. ||||++|++++..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d---- 80 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRD---- 80 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhc----
Confidence 3456899999999999999999999999999999999988766644443 358999999998 9999999999943
Q ss_pred CCCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
.+..+|+|||||+.+|.++++.+ ..|+++.++.|++||++||+|+|.+|++||||||+|||+..+..|||+||||||..
T Consensus 81 ~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 81 NDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred cCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 23389999999999999999865 47999999999999999999999999999999999999998889999999999976
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .+|+|+-|+||+|||++... ..|+.++|||++|||++|+.+-+|+|+|.++.+|+.+|++.+|+|..+.|.
T Consensus 161 ~Skp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccCC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 5544 36899999999999987653 789999999999999999999999999999999999999999999998876
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.- ...+...--.++...+..+...++++++++.+||.+||.+||++||||+++|+||||+.-
T Consensus 236 eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 236 EG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 53 112222333455566777788889999999999999999999999999999999999854
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=454.87 Aligned_cols=292 Identities=38% Similarity=0.602 Sum_probs=252.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|+.++.|++|+||+||+|+|+.|++.||+|+++-.......--.-+|||.+|.+++|||||.+.++..-.+ .+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MD 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cc
Confidence 346799999999999999999999999999999999854444333345679999999999999999999986543 45
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+.||..++.... ++...+++.++.|+|+||+|||.++|+||||||+|+|++..|.+||+|||+||.+.+.
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 699999999999999998765 8999999999999999999999999999999999999999999999999999987655
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ..+|..+.|.||+|||++.+. ..|+.++||||+|||++||++++|+|+|+++.+|+++|+.++|+|+...|..+.
T Consensus 231 ~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 L---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred c---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 3 235788999999999998874 789999999999999999999999999999999999999999999999998876
Q ss_pred chhHHHHHHhhcccCCccccCCCCCC--CHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~--s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.-.....+. ........+...|+.. ++...+|+..+|.+||++|.||+|+|+|.||....
T Consensus 307 ~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 307 ELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 554433221 1222333344556544 59999999999999999999999999999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-57 Score=473.74 Aligned_cols=290 Identities=38% Similarity=0.606 Sum_probs=249.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|+.+++||+|.||.||+|++..||+.||+|++..............|||.||++|.||||++|.+++... ...
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence 44679999999999999999999999999999999986555556667788999999999999999999998654 346
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||+.||.-++... -.|++.+++.||+||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 79999999999999999774 37999999999999999999999999999999999999999999999999999976544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ..+|..+.|+||+|||++.+. ..|+.++|+||+||||.||++|++.|+|.++++|+.+|++++|.|+.+.|....
T Consensus 272 ~~--~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 272 GS--APYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CC--cccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 33 236888999999999998874 789999999999999999999999999999999999999999999999988332
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
-..+..+ .... .-...+.+.|..++..+.+|+..||..||.+|.||.++|.|+||..
T Consensus 349 LP~~~~~-kp~~-~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHATIF-KPQQ-PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCccccc-CCCC-cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 2211111 1000 0112234457788999999999999999999999999999999953
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=460.71 Aligned_cols=263 Identities=35% Similarity=0.563 Sum_probs=222.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..+.|.+.+.||+|+||.|-+|+++.||+.||||++++..... .....+.+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4567999999999999999999999999999999997543222 1234578999999999999999999999
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecC
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFG 171 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFG 171 (619)
+.....|+||||++ |+|++.+..++.+.+..-+.+++|||.||+|||+.||+||||||+|||++.+ +.+||.|||
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 44456899999999 6999999999999999999999999999999999999999999999999766 889999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCC
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGT 249 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~-~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~-~l~~i~~~~g~ 249 (619)
+|+... +..++.+.|||+.|.|||++.+... .|..++||||||||||-+|+|.+||.+..... ..++|
T Consensus 325 lAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 325 LAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred hhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 999864 2346688999999999999865322 34458999999999999999999998765322 22222
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.+.+-......|..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 395 ---------------------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 395 ---------------------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ---------------------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 1222223336788899999999999999999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=439.79 Aligned_cols=286 Identities=38% Similarity=0.660 Sum_probs=246.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|.-.+++|.|+||+||.|+...+++.||||++-... +--.+|+++|+.++|||||+++.+|......+.-.+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 3788999999999999999999999999999985321 1224799999999999999999988766543345677
Q ss_pred EEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCccccccC
Q 007064 104 VVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFN 178 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~~~ 178 (619)
+|||||+.+|.++++. +..++.-+++-+++||++||.|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999974 6789999999999999999999999999999999999999986 9999999999998765
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
..+. ..|..|++|+|||++.+- ..|+.++||||.||+++||+.|++.|+|++..+|+..|.+.+|+|+.++|..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 5543 568999999999998874 89999999999999999999999999999999999999999999999999987
Q ss_pred cchhHHHHHHhhcccCCccccC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
........ .+.-....+.. .+...++++.+|+.++|.++|.+|.++.|+|.||||..+....
T Consensus 254 n~~y~~~~---~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYTEFK---FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Cccccccc---CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 65543221 12223334444 4567899999999999999999999999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=456.86 Aligned_cols=263 Identities=33% Similarity=0.559 Sum_probs=232.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...+|+..+.||+|+|+.||.+++..+|+.||+|++.+. .......+++.+||+|.+.|+|||||+++++| +|.
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs 90 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDS 90 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecC
Confidence 347899999999999999999999999999999999643 34556778899999999999999999999999 778
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+++|||.|+|. ++|.++++.++.++|.++++|++||+.||.|||+.+|+|||||..|||++++.+|||+|||||.....
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC
Confidence 89999999999 79999999999999999999999999999999999999999999999999999999999999988764
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
+.... .+.||||.|.|||++.. ..++..+||||+|||||-||+|+|||..++..+.+.+|..--
T Consensus 171 ~~Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~----------- 234 (592)
T KOG0575|consen 171 DGERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE----------- 234 (592)
T ss_pred ccccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-----------
Confidence 43222 46799999999999986 789999999999999999999999999999888888774310
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 324 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~ 324 (619)
. .....+|.+++|||.+||..||.+|||++++|.|+||+.-..+..
T Consensus 235 -----------------Y---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 235 -----------------Y---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred -----------------c---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 0 111268899999999999999999999999999999954333333
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=433.00 Aligned_cols=294 Identities=38% Similarity=0.658 Sum_probs=249.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCC-CCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPS-RRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~s-~~~~ 99 (619)
...|..+++||+|+||+||+|+++.+|+.||+|++......+..-....+|+.+|+.|+|+| |+.+++++...+ ....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999999999999999999865443233345689999999999999 999999996543 1334
Q ss_pred CcEEEEEecCCccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 100 KDIYVVFELMESDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~----~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..+|+||||++.||..++.... .++...++.|++||+.||.|||+.+|+||||||+||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4799999999999999998755 588899999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..-... ..+..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+|+..|++++|+|+.+.|
T Consensus 170 ~~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 432222 25778999999999998774 57999999999999999999999999999999999999999999999999
Q ss_pred hhhcchhHHHHHHhhccc-CCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 256 SRVRNDKARRYLTSMRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
..+..-..... ..... .+..+...+++.++.+.+|+.+||+.||.+|.|++.+|.||||..+..
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 87653221111 22222 255566677888899999999999999999999999999999997643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=421.29 Aligned_cols=260 Identities=30% Similarity=0.524 Sum_probs=228.9
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.-..+.|+++++||+|+||+||.++.+.|++.||+|++++... ...+.+.+.+|..||..++||+||.++..| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 4457889999999999999999999999999999999975422 224677899999999999999999999988 6
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+|+||+. |+|+..|+..+.++|..+++++..|+.||.|||++|||||||||+|||+|.+|+++|+||||++..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 7788999999999 599999999999999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
......+ .++|||+.|||||++.+ ..|+.++|+||||+++||||+|.+||.+.+.....+.|...
T Consensus 176 ~~~~~~t---~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~---------- 240 (357)
T KOG0598|consen 176 LKDGDAT---RTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG---------- 240 (357)
T ss_pred ccCCCcc---ccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC----------
Confidence 4443332 45899999999999988 69999999999999999999999999999877766666321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCC-CCHHHHHHHHHhccCCCCCCC----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~kRp----Sa~elL~hp~f~~~ 319 (619)
+ ....+. ++.+++|||+++|..||++|. .++++-+||||.++
T Consensus 241 -----------------k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 241 -----------------K----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred -----------------c----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 1 112234 789999999999999999995 78999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=417.12 Aligned_cols=341 Identities=37% Similarity=0.663 Sum_probs=293.2
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~ 97 (619)
+....||.-++.+|.|.- .|+.|.|..++..||||++...+.....+++..+|+.++..+.|+||++++.+|.+.. ..
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 456779999999999999 8999999999999999999888888788899999999999999999999999998753 35
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+.++|+|||+|..+|.+++. -.++.+.+.+|++|++.|++|||+.||+||||||+||+++.+|.+||+|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 578899999999999999998 358999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.+ ..+++|+.|++|+|||++.+ ..|.+.+||||+|||+.||++|..+|+|++..+|..+|.+.+|+|....+..
T Consensus 170 ~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 TD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 22 45689999999999999988 4699999999999999999999999999999999999999999999999887
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPN------------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 325 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~ 325 (619)
+. +..+.|.....+.....|...||+ -+..++||+.+||..||++|.|++++|+||||+-| -..++
T Consensus 244 L~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw-~~~~e 321 (369)
T KOG0665|consen 244 LQ-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW-YDPDE 321 (369)
T ss_pred hh-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee-ccccc
Confidence 64 456666666666666666666653 24568999999999999999999999999999943 22334
Q ss_pred CCCCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCchhHHhhhcc
Q 007064 326 PSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 370 (619)
Q Consensus 326 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~~~~~~~ 370 (619)
+..++....+..++.+..+.++|+++|++|+.+|.+...-+.+++
T Consensus 322 v~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~~~~~I~~~ 366 (369)
T KOG0665|consen 322 VEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEFNKNNIMNG 366 (369)
T ss_pred ccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcccccchhhcC
Confidence 443333345556777888899999999999999998655555544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=419.63 Aligned_cols=258 Identities=28% Similarity=0.483 Sum_probs=222.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++.+.++.||+|..|+|++|+|+.|++.+|+|+|.. .......+++.+|+++|+.++||+||.++++|.... ..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceE
Confidence 467788999999999999999999999999999953 355677889999999999999999999999995432 159
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||+ |+|..+++..+.++|..+..|++++++||.|||. .+||||||||+||||+..|.|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 6999999998999999999999999999999995 99999999999999999999999999999876544
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-----ChhHHHHHHHhhhCCCchhhh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-----NVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-----~~~~~l~~i~~~~g~p~~e~i 255 (619)
...+++||..|||||.+.+ ..|+.++||||||..++||.+|+.||... +..+.+..|++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---------- 296 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---------- 296 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc----------
Confidence 3467899999999999998 79999999999999999999999999774 33333333321
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
..+..+... .+|+++++||..||++||.+|||+.|+|+|||+++...
T Consensus 297 -----------------~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 297 -----------------EPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----------------CCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 111111111 37899999999999999999999999999999986543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=438.17 Aligned_cols=283 Identities=37% Similarity=0.633 Sum_probs=236.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-C-----CCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H-----PDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-H-----pnIv~l~~v~~~~ 94 (619)
...+|.|++.||+|+||.|.+|.|..|++.||||++++ +.....+...|+.+|..|+ | -|||+++++|..
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f- 259 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF- 259 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-
Confidence 34589999999999999999999999999999999985 3455667788999999997 4 389999999944
Q ss_pred CCCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEeec
Q 007064 95 SRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDF 170 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DF 170 (619)
.+++|||+|+++.+|.++|+.+. .|+...++.|+.|||.||.+||..||||+||||||||+.. .+.|||+||
T Consensus 260 ----r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 260 ----RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ----ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 46799999999999999999875 6889999999999999999999999999999999999965 457999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+|...... ...|+.++.|+|||++.+ .+|+.++||||||||++||++|.|+|+|.++.+|+..|.+++|.|
T Consensus 336 GSSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 336 GSSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred ccccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 999764322 137899999999999998 799999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcchhHHHHHHh----------------------------hccc--CC---ccccCCCC-CCCHHHHHHHHHh
Q 007064 251 SLDTISRVRNDKARRYLTS----------------------------MRKK--QP---VQFSQKFP-NADPSALRLLERL 296 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~----------------------------~~~~--~~---~~~~~~~~-~~s~~l~dLI~~m 296 (619)
+...+....+. ..|++. .... .+ ..+....+ .....+.|||++|
T Consensus 408 p~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 408 PPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 99888754332 112211 1111 11 11222223 2345679999999
Q ss_pred ccCCCCCCCCHHHHHcCccccCCCc
Q 007064 297 LAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 297 L~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
|.+||.+|+|+.++|+||||.+...
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred hccCchhcCCHHHHhcCcccccccc
Confidence 9999999999999999999997544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=421.25 Aligned_cols=336 Identities=56% Similarity=0.986 Sum_probs=289.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++++........
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 34678999999999999999999999999999999997654444556678899999999999999999998866544455
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+|+||+.++|.+++...+.+++..++.++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 67999999999999999998889999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....+.++.+|+|||.+... ..++.++|||||||++|+|++|++||.+.+..+.+..+...+|.+..+.+..+.
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 162 G---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred c---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 1 123456789999999987642 358899999999999999999999999999989999999999999888887766
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHh
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 339 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (619)
.....+++..........+...++++++.+.+||++||..||++|||++++|+||||..+......+..+. .++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~ 315 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFE 315 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhh
Confidence 66667776665544444455556789999999999999999999999999999999999877766666543 5678888
Q ss_pred hhcCCHHHHHHHHHHHHHHhCc
Q 007064 340 RRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 340 ~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
+...++++++++++.|++.|||
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 316 EDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhcCHHHHHHHHHHHHhhcCC
Confidence 8889999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=427.54 Aligned_cols=262 Identities=31% Similarity=0.559 Sum_probs=228.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
-...+|++++.||+|+|++|++|+++.+++.||||++.+... .....+.+.+|-.+|.+| .||.|++|+..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 456789999999999999999999999999999999975322 222334577899999999 799999999998 6
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
|...+|+|+||++ |+|.++|++-+.|++...++++.||+.||+|||++|||||||||+|||+|+|+++||+|||.|+..
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 7788999999999 899999999999999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC----------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007064 177 FNDTPT----------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 177 ~~~~~~----------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~ 246 (619)
...... ......+|||..|.+||++.. ...++.+|||+||||||+|+.|.|||.+.++...+.+|.++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 432211 111255899999999999987 68899999999999999999999999999998888888653
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
. ..|. ++.++.++|||+++|..||.+|+|+++|-+||||.++
T Consensus 303 ~----------------------------y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 303 D----------------------------YEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred c----------------------------ccCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 1 2222 3566899999999999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=412.06 Aligned_cols=258 Identities=33% Similarity=0.504 Sum_probs=223.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||++|+.|+|||||.++++. ...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 45689999999999999999999999999999999987655667778889999999999999999999999 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC------CcEEEeecCcc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN------CKLKICDFGLA 173 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~------~~vKL~DFGla 173 (619)
.+|||||||+ |||.++|+..+.+++..++.|+.||+.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 7999999999 7999999999999999999999999999999999999999999999999865 46999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+..... ....+.||++.|||||++.. .+|+.|+|+||+|+|||+|++|++||...+..+.+..+..-
T Consensus 163 R~L~~~----~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~------- 229 (429)
T KOG0595|consen 163 RFLQPG----SMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG------- 229 (429)
T ss_pred hhCCch----hHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc-------
Confidence 986532 23466899999999999976 79999999999999999999999999998877666543210
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
......+ ...+..+.+|+..+|..+|.+|.+..+-+.|+++..
T Consensus 230 ----------------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 230 ----------------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ----------------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 0011111 134567789999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=404.00 Aligned_cols=267 Identities=31% Similarity=0.467 Sum_probs=223.8
Q ss_pred Ccccccc-CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007064 12 EMEFFSE-YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90 (619)
Q Consensus 12 ~~~~~~~-~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 90 (619)
-+++++. ......|+|++.||+|+||.||++.+..+|..+|.|+++-...+....+.+..||.+|++|+|||||++++.
T Consensus 7 ~~~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~ 86 (375)
T KOG0591|consen 7 AMMDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAH 86 (375)
T ss_pred cccCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHH
Confidence 3444433 345567999999999999999999999999999999998655666777889999999999999999999884
Q ss_pred ecCCCCCCCCcEEEEEecCC-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEECC
Q 007064 91 MLPPSRRDFKDIYVVFELME-SDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHT--AN--VYHRDLKPKNILANA 161 (619)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs--~g--IvHrDLKP~NILi~~ 161 (619)
-+. ++..-++||||||+ |||.+.|+ ....++|..+|.++.|+|.||.+||+ .. |+||||||.||+++.
T Consensus 87 ~f~---~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~ 163 (375)
T KOG0591|consen 87 SFI---EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA 163 (375)
T ss_pred hhh---ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC
Confidence 322 33345999999999 89999996 34579999999999999999999999 45 999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHH
Q 007064 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241 (619)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~ 241 (619)
+|.|||+||||++.... .+.+...++|||+||+||++.+ .+|+.++|||||||++|||+.-++||.|++-.....
T Consensus 164 ~gvvKLGDfGL~r~l~s---~~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~ 238 (375)
T KOG0591|consen 164 NGVVKLGDFGLGRFLSS---KTTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK 238 (375)
T ss_pred CCceeeccchhHhHhcc---hhHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH
Confidence 99999999999998643 3445678999999999999998 799999999999999999999999999998766666
Q ss_pred HHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
+|... .++..+ ..+|..+..||..|+..||+.||+. +|++.++.
T Consensus 239 KI~qg------------------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 239 KIEQG------------------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred HHHcC------------------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 65432 112222 2468899999999999999999997 66666554
Q ss_pred c
Q 007064 321 K 321 (619)
Q Consensus 321 ~ 321 (619)
.
T Consensus 284 ~ 284 (375)
T KOG0591|consen 284 S 284 (375)
T ss_pred H
Confidence 3
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=416.17 Aligned_cols=330 Identities=41% Similarity=0.792 Sum_probs=269.6
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
+...++|++++.||.|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 456789999999999999999999999999999999997654444456678899999999999999999998754322 3
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|+++|++.++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3456899999999999888764 469999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .+.++||++|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+..
T Consensus 170 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 2456899999999998652 4688999999999999999999999999999999999999999999888877
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+.......++..+.......+...+...++.+.+||.+||..||++|||+.|+|+||||..+......+...+. ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~ 319 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DES 319 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccc
Confidence 77776666766655444444555566788899999999999999999999999999999987665444433322 222
Q ss_pred HhhhcCCHHHHHHHHHHHHHHh
Q 007064 338 FERRRVTKEDIRELIFREILEY 359 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~ 359 (619)
.+....+.+++++..+.+...+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07878 320 PENKERTIEEWKELTYEEVSSF 341 (343)
T ss_pred hhhhhccHHHHHHHHHHHHHhc
Confidence 2334445566776666655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=402.25 Aligned_cols=295 Identities=39% Similarity=0.627 Sum_probs=243.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
.+...|++++.||+|.||.||+|..+.++- .+|||+++.............||+.+++.|+||||+.+..+|+..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 445679999999999999999997665543 689999986544444455677999999999999999999999753
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEE
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLK 166 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~-----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vK 166 (619)
+..+++++||.+.||+++|+-+ ..++...++.|++||+.|+.|||++.|+||||||.|||+..+ |.||
T Consensus 100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 4679999999999999999643 468999999999999999999999999999999999999887 8999
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---------hh
Q 007064 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VV 237 (619)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~---------~~ 237 (619)
|+|||++|.+.+....-......+.|.||+|||++.+- ..|++++|||++|||++|||+-.|+|.+.. ..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999876554433334567899999999998874 789999999999999999999999998753 45
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHH-HHHHhhcccCCc-----cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKAR-RYLTSMRKKQPV-----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~-~~l~~~~~~~~~-----~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL 311 (619)
+|+++|++++|+|+.+.|..+.+-... ..+..++..... .+...+..-++.+.+||.+||.+||.+|+|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 799999999999999999887654333 333333322111 11223444567799999999999999999999999
Q ss_pred cCccccCC
Q 007064 312 ADPYFKGL 319 (619)
Q Consensus 312 ~hp~f~~~ 319 (619)
+|+||..-
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999853
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=405.56 Aligned_cols=286 Identities=35% Similarity=0.643 Sum_probs=236.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
|+..++|++++.||.|+||.||+|.++.++..||+|+++... .......+.+|+.+|+.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDII-----HT 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cC
Confidence 567789999999999999999999999999999999987432 222334677899999999999999999998 34
Q ss_pred CCcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||+.++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 45799999999999999987644 57999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2211 12445789999999988652 5689999999999999999999999999999999999999999999888776
Q ss_pred hcchh-HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 258 VRNDK-ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 258 ~~~~~-~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+.... ...++ .............+.++++++|||.+||.+||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 54321 11111 11111122223346788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=416.85 Aligned_cols=292 Identities=44% Similarity=0.767 Sum_probs=242.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|++++.||+|+||.||+|.+..+++.||||++...........++.+|+.+|+.++||||+++++++.......+..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999976555555667889999999999999999999998665433445799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
+||||+.++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986432221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
...+..+++++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|..+.+...... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-A 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-H
Confidence 123456789999999988752 45889999999999999999999999999999999999999999998776554322 2
Q ss_pred HHHHHhhcccCCc--cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 264 RRYLTSMRKKQPV--QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 264 ~~~l~~~~~~~~~--~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..++.......+. .........++++.+||.+||..||++|||++|+|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 2222211111111 0112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=419.49 Aligned_cols=260 Identities=33% Similarity=0.539 Sum_probs=220.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~--~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s 95 (619)
...++|.+++.||+|+||+|++|.+..+++.||+|++.+... . ......+.+|+.+|+.++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 456799999999999999999999999999999997765311 1 134556779999999999 99999999999544
Q ss_pred CCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla 173 (619)
..+|+|||||.| +|++.|...+++.|.+++.+|+||+.||.|||+.||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 459999999995 999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~-~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
.... .....+.+.+||+.|+|||++.+. ..|+ .++||||+|++||.|++|+.||...+.......|..
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~-~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGK-GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCC-CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 8763 122345788999999999999873 2164 789999999999999999999998776655544321
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
....+...+. |+++++||.+||..||.+|+|+.+++.||||+.
T Consensus 238 ---------------------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ---------------------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1222222222 999999999999999999999999999999996
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=409.36 Aligned_cols=334 Identities=51% Similarity=0.878 Sum_probs=276.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++.+.||+|+||.||+|++..+|+.||||++... .......++.+|+.+|+.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4567999999999999999999999999999999998642 233455678899999999999999999998866555555
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+|+||+.++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 67999999999999988854 46999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
..........++++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+.+.++.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 2222233456789999999987542 568899999999999999999999999999999999999999999888887776
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHh
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 339 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (619)
......++..........+....+.+++.+.+||.+||..||++|||+.++|+||||+.+..+..++..++..-++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 66666666555544444555556778999999999999999999999999999999999887666665544333444433
Q ss_pred hhcCCHHHHHHHHHHHHH
Q 007064 340 RRRVTKEDIRELIFREIL 357 (619)
Q Consensus 340 ~~~~~~e~~~~~~~~ei~ 357 (619)
..+.++.++++|+.+|+
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 45568889999988874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=411.89 Aligned_cols=327 Identities=35% Similarity=0.652 Sum_probs=259.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 468999999999999999999999999999999999865555566778889999999999999999999886542 2344
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 57899999999999988864 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+..+.
T Consensus 180 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 180 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 1 2245679999999999977 689999999999999999999999999999999999999999998877665543
Q ss_pred chhHHHHHHhhcccCCccccCC------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQK------------FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~------------~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~ 327 (619)
.. ...+...........+... ....+..+++||.+||..||.+|||++++|+||||..+......+.
T Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~ 332 (364)
T cd07875 254 PT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 332 (364)
T ss_pred HH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCC
Confidence 22 2223222221111111111 1224568999999999999999999999999999987765544332
Q ss_pred CCC-CcchhhhHhhhcCCHHHHHHHHHHHHHH
Q 007064 328 CQP-ISKMEFEFERRRVTKEDIRELIFREILE 358 (619)
Q Consensus 328 ~~~-~~~~~~~~e~~~~~~e~~~~~~~~ei~~ 358 (619)
..+ +.. ...+.+....+++++.++++.++
T Consensus 333 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 333 PPPKIPD--KQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCCCCC--ccchhhhccHHHHHHHHHHHHHc
Confidence 222 211 12334567778888888877643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=396.00 Aligned_cols=289 Identities=42% Similarity=0.739 Sum_probs=250.1
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+-.+.||.|+||+||.+.|..+|+.||+|++.+.+......+++.+|+++|.-++|.|++..+++..++.-.-+..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33578999999999999999999999999999988888889999999999999999999999999988776667889999
Q ss_pred EecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 106 FELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 106 ~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
+|+|..||+.+|.+...|+.++++-|++||++||+|||+.||.||||||.|+|+++||.+||||||+++....+. ...
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~~h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--RLN 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--hhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999999864433 334
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
++..+.|.+|+|||++.+. ..|+.++||||+|||+.|||-.+.+|...+..+|++.|.+++|+|+.|.+..-...-..-
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 5778899999999999874 789999999999999999999999999999999999999999999999876544332222
Q ss_pred HHHhhcccCCccccCCC-----CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKF-----PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~-----~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.+..-.+ +..+.... .....+..+++.+||.+||.+|.+.+++|.|+|+...
T Consensus 293 ~LR~~~k--~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLR--APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCC--CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 2222111 11111111 1234578999999999999999999999999998754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=410.72 Aligned_cols=295 Identities=38% Similarity=0.705 Sum_probs=242.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~ 98 (619)
...++|++++.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++..... .+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34689999999999999999999999999999999997655555667788899999999999999999999865432 33
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999999888754 489999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.++.|..+.+...
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2245678999999999877 68999999999999999999999999999999999999999999988766544
Q ss_pred cchhHHHHHHhhcccCCccccCCCC------------CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFP------------NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~------------~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
.. ....+...........+.+.++ ..++.+.+||.+||..||++|||+.|+|+||||..+..+.
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 32 1222322222222222222221 2467899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=391.66 Aligned_cols=260 Identities=30% Similarity=0.504 Sum_probs=228.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|++.+.||+|.|++|+++.+..||+.+|+|+|+.......+.+.+.+|+.|-+.|+||||+++.+.+ ....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 45679999999999999999999999999999999975544555788899999999999999999999987 4556
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecCccccc
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~ 176 (619)
..|||||+|+| +|..-|.++.-++|..+..+++|||++|.|+|.+||||||+||+|+|+-+. .-|||+|||+|...
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 78999999995 998888887789999999999999999999999999999999999998543 45999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
. ....+..++|||.|||||++.. .+|+..+|||+.|+|||-||.|.+||.+.+.....+.|..
T Consensus 164 ~----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----------- 226 (355)
T KOG0033|consen 164 N----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----------- 226 (355)
T ss_pred C----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc-----------
Confidence 5 2335678899999999999987 7999999999999999999999999999877666666532
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.........|+.+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 227 ----------------g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 227 ----------------GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 2222234479999999999999999999999999999999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=369.06 Aligned_cols=286 Identities=39% Similarity=0.631 Sum_probs=243.1
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|.-.++||+|.||+||+|+++.+++.||+|.+.....++..-...++||.+|+.|+|.|||+++++. ..++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 56778899999999999999999999999999976544444456788999999999999999999998 3446799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+|+|||..+|..+..+ ++.++.+.++.++.|+++||.|+|+.++.||||||+|+||+.+|++||+|||+++...-..
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9999999999999875 6789999999999999999999999999999999999999999999999999998754221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......+.|.||++|.++.+- .-|+..+|+||.|||++|+.. |+|+|+|.+..+|+.+|+.++|+|+.+.|..+..-
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 123556889999999998773 679999999999999999986 88999999999999999999999999999876432
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. .|...........+.+..|+++...+||++++|..+|..|++++++|+||||.+..
T Consensus 234 p--dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 234 P--DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred C--CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 1 11110111122334556677888899999999999999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=418.71 Aligned_cols=256 Identities=34% Similarity=0.584 Sum_probs=231.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|-+.+.||+|+||.||+|+.+.|.+.||||.+.+......+.+.+.+|++|++.|+||||+.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 679999999999999999999999999999999998888888899999999999999999999999998 666789
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 103 YVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
++|+|||.|+|+.++...+.++|+.++.|.++++.||.|||+.+|+|||+||.|||++..|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643 2
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
+...+..-|||.|||||+..+ ..|+..+|+||||||+|||..|+|||...+..+....|..
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 344577889999999999987 7999999999999999999999999988876665555532
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.+..+ ....+..+++||+.+|..||.+|+|..++|.|||+++-
T Consensus 215 -----------d~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 215 -----------DPVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -----------CCCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11111 23678999999999999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=420.03 Aligned_cols=261 Identities=31% Similarity=0.512 Sum_probs=229.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...+-|++++.||.|+-|.|.+|.+..||+.+|||+|.+. .........|.+||-||+.|.|||++.++++| ++
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~ 83 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----EN 83 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----cc
Confidence 4567799999999999999999999999999999999765 33344567899999999999999999999999 66
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..++|+|.||+. |.|++++...++|++.++..|++||+.||.|||..+|+||||||+|+|+|.++.+||+|||+|....
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 788999999999 6999999999999999999999999999999999999999999999999999999999999998744
Q ss_pred CCCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y-~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.+ ..+.+.||+|.|.|||++.+ .+| +.++||||+|+|||.||+|+.||.+.+....+.++..
T Consensus 164 ~g----klLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----------- 226 (786)
T KOG0588|consen 164 PG----KLLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----------- 226 (786)
T ss_pred CC----ccccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------
Confidence 33 24577899999999999998 455 6799999999999999999999998887666655532
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
..+ +...++++++++||.+||.+||++|+|.+||++|||+.+....
T Consensus 227 -----------------G~f---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 227 -----------------GVF---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred -----------------Ccc---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 111 2225789999999999999999999999999999999987543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=411.38 Aligned_cols=266 Identities=29% Similarity=0.468 Sum_probs=225.9
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..-.++|+++++||+|+||.||+|+.+.||+.||+|++++.. ........+..|-.+|....+|.||+++-.| +
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----Q 211 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----Q 211 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----c
Confidence 345688999999999999999999999999999999998642 2334567889999999999999999999998 7
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+..++||||||++ ||+..+|...+.|+++++++++.+++.|+..||+.|+|||||||+|+|||..|++||.||||+...
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 7788999999999 599999999999999999999999999999999999999999999999999999999999998532
Q ss_pred cCC-----------------------CCC--cc-------------------ccccccCCccccCcccccccCCCCCCcc
Q 007064 177 FND-----------------------TPT--TI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAI 212 (619)
Q Consensus 177 ~~~-----------------------~~~--~~-------------------~~~~~~gt~~Y~APEll~~~~~~y~~~~ 212 (619)
... ... .. .....+|||.|+|||++.+ .+|+..+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~c 369 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKEC 369 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccc
Confidence 110 000 00 0123589999999999998 7899999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHH
Q 007064 213 DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 292 (619)
Q Consensus 213 DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dL 292 (619)
|+||||||+||||.|.|||.+.+..+...+|..+-.+ ..+.. -..++++++||
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------------------l~fP~-~~~~s~eA~DL 422 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------------------LKFPE-EVDLSDEAKDL 422 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------------------ccCCC-cCcccHHHHHH
Confidence 9999999999999999999999998888877542100 00100 12456899999
Q ss_pred HHHhccCCCCCCC---CHHHHHcCccccCC
Q 007064 293 LERLLAFDPKDRP---TAEEALADPYFKGL 319 (619)
Q Consensus 293 I~~mL~~DP~kRp---Sa~elL~hp~f~~~ 319 (619)
|.+||. ||++|. +++||-+||||+++
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 999999 999997 59999999999976
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=401.38 Aligned_cols=290 Identities=34% Similarity=0.574 Sum_probs=229.6
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
||..++|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++. +
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIH-----T 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEe-----c
Confidence 5788999999999999999999999999999999999874322 223345778999999999999999999983 4
Q ss_pred CCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||.++|.+++... +.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 4679999999999999888754 569999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ......++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+. +..+++..+...++.|..+.+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 221 112446789999999988652 46889999999999999999999999875 4456777888888888766654
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........ .........+..+...+. ..++.+.+||.+||+.||++|||++|+|+||||+++
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 231 GVHSLPHF-KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred chhhcccc-ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 43211000 000000001111111111 346789999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=385.43 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=225.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||.|+||.|.+++++.+|..||+|++++. .-.....+...+|..+|+.+.||+++++...+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 46799999999999999999999999999999999742 23345567788999999999999999999888 6778
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+||||.+ |.|+.++++.+++++.++++++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 8999999999 599999999999999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .+.||||.|+|||++.+ .+|+.++|.||||+++|||+.|.+||...+.....++|...
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------- 256 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------- 256 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence 2 45799999999999998 79999999999999999999999999999988777777431
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC-----CCHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR-----pSa~elL~hp~f~~~ 319 (619)
...| .+..+++++|||+++|+.|-.+| ....+|..||||+++
T Consensus 257 ---------------~v~f---P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 257 ---------------KVKF---PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred ---------------cccC---CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 1111 23468899999999999999999 467899999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=402.90 Aligned_cols=292 Identities=37% Similarity=0.684 Sum_probs=239.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4579999999999999999999999999999999998665556667788899999999999999999999865432 334
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 56899999999999888864 4899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred c----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 1 2245679999999999876 679999999999999999999999999999999999999999988877665543
Q ss_pred chhHHHHHHhhcccCCcccc------------CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 260 NDKARRYLTSMRKKQPVQFS------------QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~------------~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.. ...++..........+. ......+..+.+||.+||..||++|||+.|+|+||||..+..
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 22 22232221111111111 111234678899999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=403.03 Aligned_cols=330 Identities=52% Similarity=0.944 Sum_probs=281.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++.... .+..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 347899999999999999999999999999999999765444455677889999999999999999999875543 3456
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.+|+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999999999999888889999999999999999999999999999999999999999999999999997653322
Q ss_pred CC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 181 PT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .......+++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|..+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 1122345789999999987652 468899999999999999999999999999999999999999999999888877
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHh
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 339 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (619)
.+....++..........+...++..++.+.+||++||+.||.+|||++++|.||||.+....+.++.+. ..++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCP--PPFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCC--CCCCCChh
Confidence 7777777776666666666667788899999999999999999999999999999999988877776643 34567777
Q ss_pred hhcCCHHHHHHHHHH
Q 007064 340 RRRVTKEDIRELIFR 354 (619)
Q Consensus 340 ~~~~~~e~~~~~~~~ 354 (619)
....+.|.+.+.|.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777888877776643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=391.63 Aligned_cols=284 Identities=34% Similarity=0.581 Sum_probs=230.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~~~ 98 (619)
.+|++++.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 568899999875433333344566788777766 6999999999986544344
Q ss_pred CCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999998753 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+.+..|.+..+.|..+.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3221 1234578999999999876 678999999999999999999999999999999999999988888766543
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...... .. .........+....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP-RQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc-ch---hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 321100 00 111222233344556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=399.76 Aligned_cols=330 Identities=56% Similarity=0.967 Sum_probs=283.2
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||+|.+..++..||||++..........+.+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667889999999999999999999998665434456799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 104 VVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998754432211
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
.......++.+|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|..+.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999998772 3789999999999999999999999999999999999999999999888877777777
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHhhhcC
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRV 343 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~ 343 (619)
..++..........+....+.+++.+.+||.+||..||.+|||++++|.||||+++.....++......++. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 777777666666677777788999999999999999999999999999999999988777666554443331 3566788
Q ss_pred CHHHHHHHHHHH
Q 007064 344 TKEDIRELIFRE 355 (619)
Q Consensus 344 ~~e~~~~~~~~e 355 (619)
++++.+++|+.|
T Consensus 319 ~~~~~~~~~~~~ 330 (330)
T cd07834 319 TEEELKELIYEE 330 (330)
T ss_pred CHHHHhHHhhcC
Confidence 999999888653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=391.30 Aligned_cols=285 Identities=35% Similarity=0.640 Sum_probs=227.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999976544444566788999999999999999999988 445679
Q ss_pred EEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+++++.+.+. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9999999976655554 445799999999999999999999999999999999999999999999999999986532221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||++.+..+.+..+....+....+.+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999876 57899999999999999999999999999888888888777777665554332211
Q ss_pred hHHHHHHhhcccCCccc-cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
................. ......++..+.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 10000000000000000 11223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=393.34 Aligned_cols=291 Identities=36% Similarity=0.650 Sum_probs=240.4
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
|+..++|.+++.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++||||+++++++. +
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVH-----T 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEe-----e
Confidence 6778899999999999999999999999999999999874322 223345678999999999999999999983 4
Q ss_pred CCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 4679999999999999988754 458999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345689999999987652 5688999999999999999999999999999999999999999998887766
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
+......... ......+..+....+.+++++++||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 5433211111 1112222233344567899999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=398.30 Aligned_cols=332 Identities=44% Similarity=0.828 Sum_probs=283.7
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
+...++|++.+.||.|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++.+++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 345678999999999999999999999999999999987544444556778899999999999999999988755432 3
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 3456999999999999999876 469999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ...+.++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+..
T Consensus 170 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 22 2445788999999987642 4678999999999999999999999999999899999999999998888888
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+..+....++..+.......+...+...++.+.+||.+||..||++|||+.++|+||||..+...+.++... ..+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~---~~~~~ 319 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP---PYDQS 319 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc---ccCcc
Confidence 877777777777666666666666677899999999999999999999999999999999887766555422 22346
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 338 FERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
++...+..+.|+++++.+|.+|.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 320 FESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhhhcCHHHHHHHhHHHHHhccC
Confidence 778889999999999999998875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=411.39 Aligned_cols=287 Identities=36% Similarity=0.630 Sum_probs=230.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---C
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---R 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~---~ 97 (619)
...+|++++.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999999999999999988542 1223579999999999999999998754322 1
Q ss_pred CCCcEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCc
Q 007064 98 DFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGL 172 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGl 172 (619)
....+|+|||||.++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 223578999999998887775 346799999999999999999999999999999999999999765 799999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
|+....... ...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 986533221 2346789999999987652 47899999999999999999999999999999999999999999988
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
+.+.........-. .....+..+...+| ..++++++||.+||.+||.+|||+.|+|+||||..+..
T Consensus 293 ~~~~~~~~~~~~~~---~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPNYADIK---FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchhhhccc---CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 77654322111000 00111111222233 46789999999999999999999999999999988754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.04 Aligned_cols=283 Identities=35% Similarity=0.587 Sum_probs=229.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+|++++.||+|+||.||+|.++.+++.||+|.+............+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433322233455677777655 699999999998654434456
Q ss_pred cEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....+|..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 211 234578999999999876 67999999999999999999999999999988888899888888766554321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..... ...............+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11000 0011112223334556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=402.86 Aligned_cols=283 Identities=25% Similarity=0.355 Sum_probs=222.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.|+||||+++++++. ....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCe
Confidence 367999999999999999999999999999999753 234678999999999999999999984 3456
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 102 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
.|+|+|++.++|..++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999999975322211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-------ChhHHHHHHHhhhCCCchhh
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------NVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-------~~~~~l~~i~~~~g~p~~e~ 254 (619)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+. +...++..+...+|.+..+.
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11245689999999999876 68999999999999999999999776543 23457777877777765443
Q ss_pred hhhhcchhHHHHHHhhcccCCcc----ccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQ----FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...........+........... .......++.++.+||.+||++||++|||++|+|+||||+.+..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 21111111111111111100000 00111245678999999999999999999999999999987644
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=392.12 Aligned_cols=326 Identities=37% Similarity=0.676 Sum_probs=257.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~ 98 (619)
...++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3468999999999999999999999999999999998765555556677889999999999999999999886543 234
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|+|||||.++|.+.+... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4578999999999999988654 99999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...+...+...++.|..+....+
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 211 234578899999999876 68999999999999999999999999999999999999999999988765554
Q ss_pred cchhHHHHHHhhcccCCccccCC-------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQK-------------FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 325 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~-------------~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~ 325 (619)
... ...+...........+... ....++.+++||.+||..||++|||+.|+|.||||+.+......
T Consensus 245 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 245 QPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred hhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 322 1222221111111112111 11346678999999999999999999999999999877654322
Q ss_pred CCCCCCcchhhhHhhhcCCHHHHHHHHHHH
Q 007064 326 PSCQPISKMEFEFERRRVTKEDIRELIFRE 355 (619)
Q Consensus 326 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 355 (619)
....+ ...+...+.+..+.++|++.++.+
T Consensus 324 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 324 EAPPP-APYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred CCCCC-CccccccccccccHHHHHHHHHhh
Confidence 22111 122334456677788888877654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=403.98 Aligned_cols=258 Identities=30% Similarity=0.514 Sum_probs=223.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+....|...+.||+|+.|.||.|....+++.||||.+... .....+-+++|+.+|+.++|+|||.+++.|+..
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~----- 342 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG----- 342 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----
Confidence 3446789999999999999999999999999999999753 334455688999999999999999999998644
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+++|||||+ |+|.+++... .++|.++..|++++|.||+|||.+||+|||||.+|||++.+|.+||+|||++.....
T Consensus 343 deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 56999999999 5888888765 499999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ...+.+||++|||||+... ..|++++||||||++..||+-|+|||-..+....+.+|.. -|+|.
T Consensus 422 ~~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~------- 488 (550)
T KOG0578|consen 422 EQS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPK------- 488 (550)
T ss_pred ccC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCC-------
Confidence 432 3467899999999999987 7999999999999999999999999988877766666643 22221
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
......+|+.++|||.+||++|+++|++|.|||+||||+.
T Consensus 489 --------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 --------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred --------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 1233568999999999999999999999999999999953
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=388.67 Aligned_cols=332 Identities=41% Similarity=0.766 Sum_probs=276.7
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
+...++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 456789999999999999999999999999999999987544444455678899999999999999999999865432 2
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 2345799999998899888864 569999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....++++|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+....+.+..+....
T Consensus 170 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 170 SE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 21 1345678999999988652 4588999999999999999999999999988888888888888877777776
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+.......+...+.......+...++++++.+.+||.+||..||.+|||+.++|.||||+.+...+.++...+ +..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~~ 319 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDS 319 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---cccc
Confidence 6666666666665554444455556788999999999999999999999999999999998877655554333 4456
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 338 FERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
++....+.|+|+.+.+.||+.|+|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 320 FDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred HHhhccchHHHHHHHHHHHHhcCC
Confidence 677788899999999999998875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=392.99 Aligned_cols=268 Identities=27% Similarity=0.467 Sum_probs=220.2
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC------------ChHHHHHHHHHHHHHHhcCCCCcce
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------------HISDAARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~------------~~~~~~~i~~Ei~iL~~L~HpnIv~ 86 (619)
....++|++++.||+|.||+|-+|++..+++.||||++.+... .....+++.+||.+|++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456889999999999999999999999999999999964211 1123468899999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
|+++.-++ ....+|||+|||. |.+.+. -..+. |++.+++.|+++++.||.|||.+||+||||||+|+|++++|+
T Consensus 173 LiEvLDDP---~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCc---ccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99998554 3478999999999 554432 23334 999999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccC--CCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH
Q 007064 165 LKICDFGLARVAFN--DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240 (619)
Q Consensus 165 vKL~DFGla~~~~~--~~~~~~~~~~~~gt~~Y~APEll~~~--~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l 240 (619)
|||+|||.+..... +......+...+|||.|+|||+|.+. ....+.+.||||+|++||.|+.|+.||-+....+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999875421 12222334557999999999998762 133567899999999999999999999999988888
Q ss_pred HHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
++|.. .+..|. ..+.+.+.++|||++||.+||++|+++.++..|||...-
T Consensus 329 ~KIvn----------------------------~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVN----------------------------DPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhc----------------------------CcccCC-CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 77743 111121 234678899999999999999999999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=410.10 Aligned_cols=285 Identities=27% Similarity=0.428 Sum_probs=225.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC------CcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP------DIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp------nIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.+..+++.||||+++... .....+..|+.+++.++|. +|+.+++++..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-- 202 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-- 202 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc--
Confidence 478999999999999999999999999999999996421 2233456678887777554 57888887742
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC-----------
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC----------- 163 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~----------- 163 (619)
+...+|||||++.++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 --~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 --ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred --CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 23579999999999999999888899999999999999999999998 5999999999999998765
Q ss_pred -----cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH
Q 007064 164 -----KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238 (619)
Q Consensus 164 -----~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~ 238 (619)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754221 1245689999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcccc----C-----CC--CCCCHHHHHHHHHhccCCCCCCCCH
Q 007064 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS----Q-----KF--PNADPSALRLLERLLAFDPKDRPTA 307 (619)
Q Consensus 239 ~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~----~-----~~--~~~s~~l~dLI~~mL~~DP~kRpSa 307 (619)
.+..|...+|.+..++.........+.++.......+.... . .+ ...++.+.|||.+||.+||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999998877665443333333333222111110000 0 00 0125678899999999999999999
Q ss_pred HHHHcCccccCCCc
Q 007064 308 EEALADPYFKGLSK 321 (619)
Q Consensus 308 ~elL~hp~f~~~~~ 321 (619)
+|+|+||||..+..
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987644
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=388.25 Aligned_cols=263 Identities=30% Similarity=0.456 Sum_probs=212.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..++..++.||+|+||.||++.++.+|+.+|||.+... +....+.+.+|+.+|+.|+|||||++++..... ++ ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-ee
Confidence 56688899999999999999999999999999998753 222267789999999999999999999864221 11 36
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~ 178 (619)
++|+|||+. |+|.++++..+ .|++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999 69999999876 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
............||+.|||||++... ..-.+++|||||||++.||+||.+||... .....+-.|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-------------- 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-------------- 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--------------
Confidence 11111223457899999999999841 22335999999999999999999999763 221111111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.... ........+|+++++||.+||.+||++||||+++|+|||.++-
T Consensus 236 ------------g~~~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 236 ------------GRED---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------hccC---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0011 1113345689999999999999999999999999999999764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=383.77 Aligned_cols=275 Identities=29% Similarity=0.429 Sum_probs=228.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...+.|++.+.||.|..++||+|+...+++.||||++.... ...+...+.+|+..|+.++||||++++..|.. .
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk-c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-----~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK-CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-----D 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh-hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-----c
Confidence 46789999999999999999999999999999999997543 33457889999999999999999999999854 4
Q ss_pred CcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|+||.||. |+++++++.. ..++|..+..|++++|+||.|||.+|-||||||+.||||+++|.|||+|||.+...
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 56999999999 7999999863 45999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCCCcccc-ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~-~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.......... .+++||++|||||++...-..|+.|+||||||++..||.+|..||........+ +.++-|.|..-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 5544333333 778999999999996655588999999999999999999999999776654433 4444455432221
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.....+ .....+..++.+|..||..||.+||||+++|+|+||+....
T Consensus 255 ~~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 111111 11234558899999999999999999999999999997543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=384.71 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=215.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 47999999999999999999999999999999986432 1223456688999999999999999999887 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23579999999999877 67899999999999999999999999887765444433210
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. .....+++.+++||++||..||.+|++ ++++++||||..+
T Consensus 214 --------------~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 --------------KL---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred --------------Cc---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 00 111245789999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.23 Aligned_cols=331 Identities=41% Similarity=0.799 Sum_probs=275.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~ 98 (619)
...++|.+++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 45688999999999999999999999999999999997654444456678899999999999999999998854422 23
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|++++++.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4568999999989998887654 699999999999999999999999999999999999999999999999999875422
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. .....++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.+..+
T Consensus 173 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 173 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred c------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 1 2345789999999987652 46888999999999999999999999999888888899898898888887777
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 338 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (619)
.....+.++..+.......+...+...++.+++||.+||..||.+||++.++|.||||.++..++.++... .++..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~ 322 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSF 322 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcc
Confidence 66666666666555444455555567789999999999999999999999999999999987776666433 245555
Q ss_pred hhhcCCHHHHHHHHHHHHHHhCc
Q 007064 339 ERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 339 e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
..+.+..+++....|++...|.|
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 323 ESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred hhcccCHHHHHHHHHHHHHhcCC
Confidence 66677778889999998877654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.24 Aligned_cols=262 Identities=32% Similarity=0.535 Sum_probs=227.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
.....|++.+.||+|.||+||+|+++.||+.+|+|++.+.... ......+.+|+.+|+.|. ||||+.++++| +
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 4557899999999999999999999999999999999764332 234568899999999998 99999999999 5
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEEEeecCc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFGL 172 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFGl 172 (619)
+...+|+|||+|. |+|++.|... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 5568999999999 6999999877 49999999999999999999999999999999999998543 5799999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+..... .......+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......|.
T Consensus 186 a~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------- 251 (382)
T KOG0032|consen 186 AKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------- 251 (382)
T ss_pred ceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--------
Confidence 987654 223467899999999999986 699999999999999999999999999998765554432
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..........|++++..+++||.+||.+||.+|+|+.++|+|||++...
T Consensus 252 -------------------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 252 -------------------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred -------------------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 1222334567899999999999999999999999999999999998753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=381.28 Aligned_cols=291 Identities=35% Similarity=0.640 Sum_probs=235.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
++..++|++++.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++. +
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~ 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIH-----T 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEe-----c
Confidence 5667899999999999999999999999999999999864322 222345778999999999999999999983 4
Q ss_pred CCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 467999999999999998875 3568999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 12344678999999987652 4688899999999999999999999999999999999999999888776654
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
+........ ..........+....+.+++.+.+||.+||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 322110000 00000111111223356788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=388.16 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=215.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence 3578999999999999999999999999999999996432 1223456788999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. ++|.+.+...+.++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 67999999998 59999999888999999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 171 ~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------------- 229 (329)
T PTZ00263 171 RT------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------------- 229 (329)
T ss_pred Cc------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 21 23579999999999887 6789999999999999999999999988765444433321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~ 318 (619)
. ... ....++..+.+||++||..||.+|++ ++++++||||.+
T Consensus 230 --------------~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 --------------G-RLK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred --------------C-CcC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0 001 11236789999999999999999997 799999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=387.97 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=210.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+...+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997532 2233456788999999999999999999988 44567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
|+. ++|.+.+...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 59999998888999999999999999999999999999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 44679999999999876 6899999999999999999999999988765444333211
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
. .. .....+++.+.+||++||..||++|| ++.++|+||||.++
T Consensus 210 ------~-~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 ------E-EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ------C-CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=383.05 Aligned_cols=281 Identities=35% Similarity=0.604 Sum_probs=217.4
Q ss_pred eEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.++||+|+||.||+|.++ .++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 468999999999999865 467899999986432 123467899999999999999999988543 23568999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEeecCc
Q 007064 106 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (619)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFGl 172 (619)
|||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999888632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------hHHHHHH
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 243 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~---------~~~l~~i 243 (619)
++...............++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456899999999988652 4689999999999999999999999976543 4678889
Q ss_pred HhhhCCCchhhhhhhcchhH-HHHHHhhcccC--Cc----cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 244 TDLLGTPSLDTISRVRNDKA-RRYLTSMRKKQ--PV----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~-~~~l~~~~~~~--~~----~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...+|.|....+........ ...+....... .. .+.......+..+.+||.+||++||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999988877665432110 01111111000 00 0111122356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=382.24 Aligned_cols=326 Identities=48% Similarity=0.828 Sum_probs=266.2
Q ss_pred CeEEeEEeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~t--g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.+ .||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999876544444566788999999999 5999999998754321 2345
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.+|+++|+++++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643222
Q ss_pred CC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 181 PT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .......+|+..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112346789999999987552 568899999999999999999999999999999999999999999888877766
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHh
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFE 339 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e 339 (619)
......+...........+...++..+..+.+||.+||+.||++|||+.++|.||||..+..+...+.|.......|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 6655555555544445555666677899999999999999999999999999999999988776777665443333332
Q ss_pred hhcCCHHHHHHHHHH
Q 007064 340 RRRVTKEDIRELIFR 354 (619)
Q Consensus 340 ~~~~~~e~~~~~~~~ 354 (619)
+.+.++++..|..
T Consensus 318 --~~~~~~~~~~~~~ 330 (332)
T cd07857 318 --EDSMEELRDMIIE 330 (332)
T ss_pred --cccHHHHHHHHhh
Confidence 2345666666544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=370.37 Aligned_cols=265 Identities=29% Similarity=0.490 Sum_probs=222.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-----C-hHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-----H-ISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-----~-~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 92 (619)
+....|.-.+.||.|..++|.+++++.+|..+|+|+|..... . ..-.+...+|+.||+++ .||+|+.+.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344567888999999999999999999999999999953211 1 12234566899999998 4999999999995
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
.+ ..+++|+|+|. |.|++++.+.-.+++.+.+.|++||++|+.|||..+||||||||+|||++++.++||.|||
T Consensus 94 s~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred Cc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 44 45899999999 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~----~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|...... ..+.+.||||.|+|||.+... -..|+..+|+|++|+|+|.||.|.+||......-.+..|+.
T Consensus 169 Fa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime-- 242 (411)
T KOG0599|consen 169 FACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME-- 242 (411)
T ss_pred eeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--
Confidence 99875433 235788999999999987532 24689999999999999999999999977655444444432
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..-..-+..|.++|..++|||.+||++||.+|.|++|+|+||||.++.
T Consensus 243 -------------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 243 -------------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -------------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 122223456889999999999999999999999999999999997654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.19 Aligned_cols=330 Identities=39% Similarity=0.745 Sum_probs=265.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
+....+|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 344579999999999999999999999999999999997644333445668899999999999999999998854421 2
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+...+|+|+||+..+|..++. ..++++.++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 335689999999988877653 368999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....++.+|+|||.+.+. ..++.++|||||||++|||++|+.||.+.+....+..+....+.+..+.+..
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 2345788999999988652 4688999999999999999999999999998888999999888888877766
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
........+...........+...++..++.+.+||.+||..||++||+++++|.||||..+...+.++...+ +...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 318 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDS 318 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccch
Confidence 6554444444444333334445556778999999999999999999999999999999999876544443222 2333
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhC
Q 007064 338 FERRRVTKEDIRELIFREILEYH 360 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~ 360 (619)
.+......+++...+++|...+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T cd07879 319 LENEKLSVDEWKKHIYKEVKSFS 341 (342)
T ss_pred hhhhhCCHHHHHHHhhhhhhccC
Confidence 44446667788888888765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=388.91 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=214.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.++..++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 479999999999999999999999999999999974321 223345678899999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999987532211
Q ss_pred CC--------------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007064 181 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (619)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~ 228 (619)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001124589999999999876 68999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC---CC
Q 007064 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD---RP 305 (619)
Q Consensus 229 ~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k---Rp 305 (619)
+||.+.+..+....+.... ....+.. ...+++++++||.+|+. +|.+ ||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWK--------------------------ETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCc--------------------------CcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998887665555443210 0111111 12468899999999886 5554 58
Q ss_pred CHHHHHcCccccCC
Q 007064 306 TAEEALADPYFKGL 319 (619)
Q Consensus 306 Sa~elL~hp~f~~~ 319 (619)
+++|+++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=384.27 Aligned_cols=261 Identities=26% Similarity=0.477 Sum_probs=219.1
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 479999999999999999999999999999999975322 223456788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 59999999888899999999999999999999999999999999999999999999999999976433
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....+.......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 1245679999999999887 589999999999999999999999998887665554443211000
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..+ ........+++++.+||.+||..+|.+||+++++++||||.++
T Consensus 218 ------------~~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 218 ------------QRP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ------------cCC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 0011113578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=375.69 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=222.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
-.||+|.+.||+|.||.|-+|++...|+.||||.|++. .....+.-.|.+||+||..|+||||+.++++| ++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 35799999999999999999999999999999999753 34556778899999999999999999999999 6667
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+.|||||.. |+|.++|...+.|++.+++.||+||..|+.|||.++++|||||.+|||+|.+|.+||+||||+..+..
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 8999999998 79999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y-~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
..+++++||++.|.+||++.+ .+| ++.+|.||||++||.|+.|..||.|.+.......|....
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga----------- 269 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA----------- 269 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-----------
Confidence 346788999999999999988 455 689999999999999999999999998765555543210
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
-.-|.-+..+.-||+.||-++|++|.|+++|-+|=|++
T Consensus 270 ---------------------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 ---------------------YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ---------------------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 01133456789999999999999999999999997765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=388.42 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=215.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999999999999997431 1223455678899999999999999999998 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999987532111
Q ss_pred CCc-----------------------------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007064 181 PTT-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (619)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLl 225 (619)
... ......+||+.|+|||++.. ..++.++|||||||++|||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00113479999999999876 68999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC
Q 007064 226 TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 305 (619)
Q Consensus 226 tG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp 305 (619)
+|.+||.+.+..+....+... .....+. ....+++.+.+||.+||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW--------------------------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC--------------------------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999888765544433211 0001111 112468899999999997 999999
Q ss_pred C---HHHHHcCccccCC
Q 007064 306 T---AEEALADPYFKGL 319 (619)
Q Consensus 306 S---a~elL~hp~f~~~ 319 (619)
+ ++++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=383.77 Aligned_cols=329 Identities=43% Similarity=0.762 Sum_probs=266.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++.+.||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.+ +||||+++++++... +.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 34689999999999999999999999999999999876544555566788999999999 999999999987432 23
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+||||+.++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999999999999776 7899999999999999999999999999999999999999999999999999865433
Q ss_pred CCC--ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 180 TPT--TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 180 ~~~--~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... ......++++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1223456799999999987542 5678899999999999999999999999999999999999999988887776
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+........+..........+...++.++..+.+||.+||+.||.+|||+.++|+||||+++.....++......+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 66555555555555555555666677889999999999999999999999999999999988666555543322222222
Q ss_pred HhhhcCCHHHHHHHHHHH
Q 007064 338 FERRRVTKEDIRELIFRE 355 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~e 355 (619)
+.+++...+.+..+|+|
T Consensus 320 -~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred -ccceeeHHHHHhhhhhc
Confidence 33444555555555554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=398.98 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=221.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~ 98 (619)
....|.++++||+|+||+|++|..+.+++.||||++++. .....+.+..+.|-.|+.... ||.++.++..| +.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence 346799999999999999999999999999999999754 234456777888999988885 99999999998 66
Q ss_pred CCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..++|+||||+.| |+. ++...+.+++..+++|+..|+.||+|||++||||||||.+|||+|.+|.+||+|||+++...
T Consensus 441 ~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 6789999999995 743 44455689999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... ..++||||.|+|||++.+ ..|+.++|+|||||+|||||.|++||+|.++.+..+.|..-
T Consensus 520 ~~g~~---TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------- 583 (694)
T KOG0694|consen 520 GQGDR---TSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------- 583 (694)
T ss_pred CCCCc---cccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 33332 367899999999999998 79999999999999999999999999999998888777420
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
. ..+.-.+|.++.+++++||..||++|.. +++|..||||+.+
T Consensus 584 ----------------~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 584 ----------------E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ----------------C----CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 0 0112257889999999999999999974 6899999999865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.19 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=213.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|+++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence 46999999999999999999999999999999987432 1223456788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CccccccccCCccccCcccccccCCCCCCcccchh
Q 007064 181 P--------------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (619)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWS 216 (619)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999876 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHh
Q 007064 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296 (619)
Q Consensus 217 LG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 296 (619)
|||++|||++|++||.+.+..+....+.... .... ......+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~-~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ--------------------------TSLH-IPPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC--------------------------CCcC-CCCcccCCHHHHHHHHHH
Confidence 9999999999999998877654443332110 0000 011245789999999998
Q ss_pred ccCCCCCCCC---HHHHHcCccccCC
Q 007064 297 LAFDPKDRPT---AEEALADPYFKGL 319 (619)
Q Consensus 297 L~~DP~kRpS---a~elL~hp~f~~~ 319 (619)
+ .||++|++ ++++++||||+.+
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 49999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.32 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=213.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCE
Confidence 36999999999999999999999999999999996432 2334556788999999999999999999998 34567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred CC--------------------------------------------ccccccccCCccccCcccccccCCCCCCcccchh
Q 007064 181 PT--------------------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (619)
Q Consensus 181 ~~--------------------------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWS 216 (619)
.. .......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 00 000124579999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHh
Q 007064 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296 (619)
Q Consensus 217 LG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 296 (619)
|||++|||++|.+||.+.+..+....+..... ... ......+++++.+||.+|
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------------~~~-~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN--------------------------TLH-IPPQVKLSPEAVDLITKL 286 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc--------------------------ccC-CCCCCCCCHHHHHHHHHH
Confidence 99999999999999988775544433321100 000 111235789999999997
Q ss_pred ccCC--CCCCCCHHHHHcCccccCC
Q 007064 297 LAFD--PKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 297 L~~D--P~kRpSa~elL~hp~f~~~ 319 (619)
|..+ +..|++++++++||||.++
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 7554 4459999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.39 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=213.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|.+++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 47999999999999999999999999999999986421 1223456788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999986321100
Q ss_pred CC------------c--------------------------------cccccccCCccccCcccccccCCCCCCcccchh
Q 007064 181 PT------------T--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (619)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWS 216 (619)
.. . ......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012579999999999876 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHh
Q 007064 217 IGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296 (619)
Q Consensus 217 LG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~m 296 (619)
|||++|||++|.+||.+.+..+.+..+.... ....+ .....++.++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~~-p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR--------------------------ETLYF-PDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC--------------------------CccCC-CCCCCCCHHHHHHHHHH
Confidence 9999999999999998877655554443210 00111 11124688999999999
Q ss_pred ccCCCCCC---CCHHHHHcCccccCC
Q 007064 297 LAFDPKDR---PTAEEALADPYFKGL 319 (619)
Q Consensus 297 L~~DP~kR---pSa~elL~hp~f~~~ 319 (619)
|. +|.+| +++.++|.||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77775 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=369.48 Aligned_cols=282 Identities=38% Similarity=0.632 Sum_probs=228.9
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|++++.||.|+||.||+|.++.++..||||++............+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 489999999999999999999999999999998754333334566789999999999999999999984 446799
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888642 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 R---VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c---cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1 12334678999999987652 4678899999999999999999999999988888888877777776655543322
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ..+...........+......+++++.+||++||..||.+|||+.++|+||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11211111111222233345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=372.37 Aligned_cols=282 Identities=37% Similarity=0.596 Sum_probs=227.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||+|.++.+|+.||+|.+............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 69999999999999999999999999999999875322223335677899999999999999999988 3456799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+|+||++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988865 56799999999999999999999999999999999999999999999999999975432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+...++.+....+..+...
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345678999999988652 4578999999999999999998766 6777778888888888888876665433211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
........ ......+.+..+.+++.+.+||.+||..||.+|||++++|.||||
T Consensus 232 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPM--YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCC--CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11000000 011112234456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=378.99 Aligned_cols=248 Identities=32% Similarity=0.500 Sum_probs=208.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999986432 2234556788999999999999999999988 3446799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007064 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (619)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (619)
. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999975432221 1244
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHH
Q 007064 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 268 (619)
Q Consensus 189 ~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (619)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999877 6899999999999999999999999988765443332211
Q ss_pred hhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHHcCccccCC
Q 007064 269 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 319 (619)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp---Sa~elL~hp~f~~~ 319 (619)
.+. .....+++.+.+||.+||..||.+|| ++.++|.||||.+.
T Consensus 208 -----~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 -----EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 011 12245788999999999999999997 68999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=384.74 Aligned_cols=262 Identities=31% Similarity=0.502 Sum_probs=217.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|.+++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 479999999999999999999999999999999975322 123456688999999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred C--------------------------CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007064 181 P--------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (619)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~ 234 (619)
. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234679999999999987 58999999999999999999999999888
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-a~elL~h 313 (619)
+.......+..... ...+ .....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~--------------------------~~~~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKE--------------------------SLRF-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCC--------------------------cccC-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 75554444422100 0001 1112378999999999998 9999999 9999999
Q ss_pred ccccCC
Q 007064 314 PYFKGL 319 (619)
Q Consensus 314 p~f~~~ 319 (619)
|||+++
T Consensus 286 p~~~~~ 291 (350)
T cd05573 286 PFFKGI 291 (350)
T ss_pred CCcCCC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=388.68 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=213.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986431 1223356678999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CccccccccCCccccCcccccccCCCCCCcccchhHHHH
Q 007064 181 P----------------------------------------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (619)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~i 220 (619)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999976 678999999999999
Q ss_pred HHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCC
Q 007064 221 FAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300 (619)
Q Consensus 221 lyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D 300 (619)
+|||++|+.||.+.+..+....+.... .... ......+++.+.+||.+|+ .|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~--------------------------~~~~-~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE--------------------------TTLH-IPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC--------------------------cccc-CCCCCCCCHHHHHHHHHHh-cC
Confidence 999999999998877655443332110 0000 1122457899999999987 49
Q ss_pred CCCCC---CHHHHHcCccccCC
Q 007064 301 PKDRP---TAEEALADPYFKGL 319 (619)
Q Consensus 301 P~kRp---Sa~elL~hp~f~~~ 319 (619)
|.+|+ ++.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=383.09 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=215.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg-~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
...++|++++.||+|+||.||+|.++.++ ..||+|++.... ........+.+|+.+|+.++||||+++++++ .
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~ 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence 45678999999999999999999876655 689999986432 1233456788999999999999999999998 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+|||||. |+|.+++..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 4467999999997 699999998889999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus 182 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~----------- 242 (340)
T PTZ00426 182 DTR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE----------- 242 (340)
T ss_pred CCC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-----------
Confidence 321 134579999999999876 6789999999999999999999999988765444333321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... ...+.+++.+.+||++||..||++|+ +++++++||||.++
T Consensus 243 -----------------~~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 243 -----------------GII---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred -----------------CCC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 000 11234678999999999999999995 99999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=367.31 Aligned_cols=301 Identities=34% Similarity=0.534 Sum_probs=248.2
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
+-....+.|+-+..||+|.||.||+|+.+.+|+.||+|++.-..+....-...++|+++|..|+|+|++.+++++.....
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 33567889999999999999999999999999999999875322333334456899999999999999999998755332
Q ss_pred ---CCCCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 97 ---RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 97 ---~~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
.+...+|+||.+|+.||.-++... ..++..+++.++.+++.||.|||.+.|+|||+|+.|+||+.+|.+||+|||+
T Consensus 91 p~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred CcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 344569999999999999999765 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 173 ARVAFNDT-PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 173 a~~~~~~~-~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
++...... ......+..+.|.||++||++.+. ..|++++|||..|||++||.+|.+.|.+.++..++..|..++|.-+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 97643322 222335778899999999998874 8999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcchhHHHHHHh--hcccCCccccCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 252 LDTISRVRNDKARRYLTS--MRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~--~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.+.|..+.+-.....++. +.+........... .-++++.||+++||..||.+|+.++++|+|.||..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 999988766544444321 11111111111111 23678999999999999999999999999999974
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.80 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=211.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||+.+++++ .+...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 38899999999999999999999999999999864322 222334678999999999999999999988 344679
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+|||||. |+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 589887754 336899999999999999999999999999999999999999999999999999764222
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....+||..|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+...+
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV------------ 217 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh------------
Confidence 1 1234579999999999986 689999999999999999999999998866433222221110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. ........+++.+.+||++||..||++||+ ++++++||||.++
T Consensus 218 -----------~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 218 -----------KE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred -----------hc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 00 011223457889999999999999999997 9999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=378.71 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=209.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997532 2234456788999999999999999999988 44567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
|+. ++|...+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 34679999999999876 6789999999999999999999999987765443332210
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... .....+++.+.+||++||..||++|+ ++.++++||||.+.
T Consensus 210 -------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -------EDI---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------CCc---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11235788999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=363.94 Aligned_cols=279 Identities=31% Similarity=0.492 Sum_probs=227.6
Q ss_pred CCCccccccCCCCCCeEEe-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCccee
Q 007064 10 SPEMEFFSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEI 87 (619)
Q Consensus 10 ~~~~~~~~~~~~~~rY~i~-~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l 87 (619)
.+.|.| .++...++|.|- ++||-|-.|.|..|.++.||+++|+|++.+ ..+..+|+++--.. .|||||.+
T Consensus 49 ~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~I 120 (400)
T KOG0604|consen 49 ESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSI 120 (400)
T ss_pred hhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEe
Confidence 344555 778888889885 589999999999999999999999999863 34566788875544 59999999
Q ss_pred eeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---
Q 007064 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--- 161 (619)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--- 161 (619)
+++|... +.+...+.||||.|+ |+|+..|+.++. ++|.++..|++||+.||.|||+.+|.||||||+|+|...
T Consensus 121 idVyeNs-~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 121 IDVYENS-YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP 199 (400)
T ss_pred ehhhhhh-ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC
Confidence 9998543 456678999999999 599999998775 999999999999999999999999999999999999864
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHH
Q 007064 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241 (619)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~ 241 (619)
|..+||+|||+|+.... ...+.+-+-||+|.|||+++. .+|+..+|+||||+|+|.||+|.|||........
T Consensus 200 na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-- 271 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-- 271 (400)
T ss_pred CcceEecccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccC--
Confidence 56899999999986432 123456789999999999987 6899999999999999999999999987653111
Q ss_pred HHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
+...-. .++...-......|..+|+.++|||++||..+|.+|.|++++++|||+.+...
T Consensus 272 ---------spgMk~------------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 272 ---------SPGMKR------------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ---------ChhHHh------------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 111111 11222333345668889999999999999999999999999999999998766
Q ss_pred CcCCC
Q 007064 322 VEREP 326 (619)
Q Consensus 322 ~~~~~ 326 (619)
+...+
T Consensus 331 vp~tp 335 (400)
T KOG0604|consen 331 VPQTP 335 (400)
T ss_pred CCCCC
Confidence 55443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=371.16 Aligned_cols=294 Identities=41% Similarity=0.629 Sum_probs=235.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 45789999999999999999999999999999999874333333334567899999999999999999998532 235
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+||||++++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 6899999999999888875 357999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ..+...++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+...++.+....+..+.
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12334568899999988652 568899999999999999999999999999999999999999988776654432
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
.-.....+. ........+...+...++.+.+||.+||.+||++|||++++|.||||++...+
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred ccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 211100000 00011111222344568899999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=372.89 Aligned_cols=321 Identities=48% Similarity=0.864 Sum_probs=266.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+...++|++++.||.|+||.||+|.++.+++.||||++............+.+|+.+++.++||||+++.+++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 4567889999999999999999999999999999999875444444566788999999999999999999988432
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|+|+||+.++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 346899999999999888865 4689999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+.+.+|.+..+.+..+
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345678899999987542 46889999999999999999999999999888888889999999988887766
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 338 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (619)
.......++.......+.+....++.+++.+.+||++||..||++|||++++|.||||..+..+..++... .++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCch
Confidence 65555555555555555566666778899999999999999999999999999999998876655444322 3566677
Q ss_pred hhhcCCHHHHHHHHH
Q 007064 339 ERRRVTKEDIRELIF 353 (619)
Q Consensus 339 e~~~~~~e~~~~~~~ 353 (619)
....+..+.|+-.+|
T Consensus 312 ~~~~~~~~~~~~~~~ 326 (328)
T cd07856 312 NDADLPVDTWKVMMY 326 (328)
T ss_pred hcccCCHHHHHHHhc
Confidence 777777777775554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=376.91 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=209.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
+.||+|+||.||++.++.+|..||+|++..... .......+.+|+.+|+.++||||+++++++ .+...+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 479999999999999999999999999975321 233456678899999999999999999988 34467999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
||+ ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 59999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999876 6789999999999999999999999988765544433311
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... .....+++.+.+||.+||..||++|+ ++.++++||||.+.
T Consensus 210 -------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -------EEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -------CCC---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 11235788999999999999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=377.80 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=215.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||+|+||.||+|.++.+++.||||+++.... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 469999999999999999999999999999999975422 223455678899999999999999999988 44567
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|||||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 67999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~----~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 211 12345799999999998631 146789999999999999999999999887765544443221
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.....+ ...+.+++.+.+||++||. ||.+|||++++++||||..+
T Consensus 225 -----------------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 -----------------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -----------------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000111 1224578999999999998 99999999999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=370.63 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=223.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|++++.||.|.-|+||+|..+.++..+|+|++.+.. .......++..|-+||..++||.+..||..| +..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETD 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ecc
Confidence 4467889999999999999999999999999999997643 2234556788899999999999999999998 556
Q ss_pred CcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|+|||||. |||+.+.++. +.++++.+++++..++.||+|||..|||+|||||+||||-++|+|-|.||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 77999999999 5999988754 57999999999999999999999999999999999999999999999999997431
Q ss_pred cC---------------------------------C-C-------------------CCccccccccCCccccCcccccc
Q 007064 177 FN---------------------------------D-T-------------------PTTIFWTDYVATRWYRAPELCGS 203 (619)
Q Consensus 177 ~~---------------------------------~-~-------------------~~~~~~~~~~gt~~Y~APEll~~ 203 (619)
.. . . +.......++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 0 00011234799999999999998
Q ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCC
Q 007064 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP 283 (619)
Q Consensus 204 ~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 283 (619)
...+.++|+|+||++|||||.|..||.|.+..+.+..|.. ++..|... +
T Consensus 310 --~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~~-~ 358 (459)
T KOG0610|consen 310 --EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPEE-P 358 (459)
T ss_pred --CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCCC-C
Confidence 7899999999999999999999999999998888776632 12222222 3
Q ss_pred CCCHHHHHHHHHhccCCCCCCCC----HHHHHcCccccCCC
Q 007064 284 NADPSALRLLERLLAFDPKDRPT----AEEALADPYFKGLS 320 (619)
Q Consensus 284 ~~s~~l~dLI~~mL~~DP~kRpS----a~elL~hp~f~~~~ 320 (619)
.++..++|||+++|.+||.+|.. |.||-+||||+++.
T Consensus 359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 67789999999999999999998 99999999999863
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.35 Aligned_cols=285 Identities=41% Similarity=0.707 Sum_probs=234.9
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 699999999999999999999999999999998754433445567889999999999999999999983 456799
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999864 45799999999999999999999999999999999999999999999999999986543321
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.+....+..+....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999988652 457899999999999999999999999999888999999988888776665432211
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
....+ .........+...+++.+..+.+||++||..||++|||++++|+||||.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11000 0111222233445667889999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.25 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=209.9
Q ss_pred CeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
.|++++.||+|+||.||+|.+. .+++.||+|++.+.. ........+.+|+.+|+.++ ||||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999764 578999999986431 12234566788999999995 99999999988 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+|||||. |+|.+++.....++++.++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 4567999999999 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....+||+.|+|||++.+. ..++.++|||||||++|||++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 332221 12346799999999998752 457889999999999999999999997543221111110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
..+.... ....+.+++.+.+||.+||..||++|| +++++++||||++.
T Consensus 221 -----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -----------RRILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------HHHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0000101 112245788999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.16 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=208.9
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHH---HhcCCCCcceeeeEecCCCCCCCC
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLL---RLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL---~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
|++++.||+|+||.||+|.++.+++.||||+++... ........+.+|+.++ +.++||||+++++++ .+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 789999999999999999999999999999997432 1223445677777665 456799999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||. ++|...+.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588888754 46999999999999999999999999999999999999999999999999998753222
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 11 1245679999999999877 6789999999999999999999999988776555443321
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... .....+++.+.+||.+||..||.+|| +++++++||||+++
T Consensus 216 -------------~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 -------------DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 11235688999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.76 Aligned_cols=281 Identities=35% Similarity=0.595 Sum_probs=215.3
Q ss_pred eEEeeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
...||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 4689999999999998654 66899999986432 223567899999999999999999988543 23568999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEeecCc
Q 007064 106 FELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (619)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFGl 172 (619)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999888532 248899999999999999999999999999999999999 5667999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------hHHHHHH
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------VHQLDLM 243 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~---------~~~l~~i 243 (619)
++...............++|+.|+|||++.+. ..++.++|||||||++|||++|.+||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654332222223456789999999988652 4689999999999999999999999976542 3567788
Q ss_pred HhhhCCCchhhhhhhcchhHH-HHHHhhccc--CCc----cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 244 TDLLGTPSLDTISRVRNDKAR-RYLTSMRKK--QPV----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~-~~l~~~~~~--~~~----~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...+|.+..+.+..+...... ......... ... .........+..+.+||.+||..||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888888887776654321100 000000000 000 0111122356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.37 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=212.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCc
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~s~~~~~~ 101 (619)
.|++++.||+|+||.||+|.++.+++.||||++.... ........+..|+.++..+.|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4899999999999999999999999999999997532 1234456788899999999765 577888887 34467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||+ |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Confidence 1 1234579999999999876 67899999999999999999999999887765554443210
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-----~elL~hp~f~~~ 319 (619)
. ......+++.+.+||.+||..||.+|++. +++++||||..+
T Consensus 217 --------------~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 --------------N---VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred --------------C---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 01123578899999999999999999976 899999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=381.10 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=214.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|..++||||+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46999999999999999999999999999999996432 1223456788899999999999999999988 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999987532111
Q ss_pred CC--------------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007064 181 PT--------------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (619)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~ 228 (619)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999877 68999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC---
Q 007064 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP--- 305 (619)
Q Consensus 229 ~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp--- 305 (619)
+||.+.+.......+... .....+.. ...+++.+++||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999888765554443211 00111111 12468899999999875 999998
Q ss_pred CHHHHHcCccccCC
Q 007064 306 TAEEALADPYFKGL 319 (619)
Q Consensus 306 Sa~elL~hp~f~~~ 319 (619)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=374.74 Aligned_cols=250 Identities=25% Similarity=0.431 Sum_probs=209.3
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999987432 1223456677899998876 699999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999876 6789999999999999999999999988876555444421
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa------~elL~hp~f~~~ 319 (619)
.. . .....+++++.+||++||+.||++|+++ +++++||||..+
T Consensus 211 -------~~-~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 211 -------DE-V---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred -------CC-C---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 00 0 1123468899999999999999999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=371.58 Aligned_cols=278 Identities=24% Similarity=0.385 Sum_probs=218.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||.||+|.+..++..+|+|.+... ........+.+|+++|+.++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence 47899999999999999999999999999999998753 23344567899999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 59999999888899999999999999999999986 6999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh-
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV- 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~- 258 (619)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+... .++.+........
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCc
Confidence 1 234579999999999887 679999999999999999999999998776543322 2222211100000
Q ss_pred ----------------------cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 ----------------------RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ----------------------~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
........+..+....... .....+++++++||.+||..||++|||++++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000011111111111100 0112468899999999999999999999999999999
Q ss_pred cC
Q 007064 317 KG 318 (619)
Q Consensus 317 ~~ 318 (619)
+.
T Consensus 305 ~~ 306 (331)
T cd06649 305 KR 306 (331)
T ss_pred hh
Confidence 85
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=380.30 Aligned_cols=263 Identities=26% Similarity=0.378 Sum_probs=215.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.++..||+|++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4578999999999999999999999999999999996421 2223445577899999999999999999988 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 67999999998 6999988654 589999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~--~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ......+||+.|+|||++.+. ...++.++|||||||++|||++|++||.+.+.......|...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~---------- 262 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH---------- 262 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----------
Confidence 211 112346799999999988642 134889999999999999999999999888765544444210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~ 318 (619)
.....+ .....++.++.+||++||..+|.+ |+|++++++||||++
T Consensus 263 ----------------~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 263 ----------------KNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ----------------CCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 001111 122357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=376.01 Aligned_cols=250 Identities=27% Similarity=0.474 Sum_probs=209.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++||||+++++++ .+...+|||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999997532 2223456678899999999999999999988 44567999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|+. ++|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5999999888889999999999999999999998 7999999999999999999999999999875332211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234679999999999876 6789999999999999999999999988765444333211
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... .....+++.+.+||++||..||++|+ ++.++|+||||.+.
T Consensus 211 --------~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 --------EEI---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------CCC---CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 000 11234688999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.55 Aligned_cols=282 Identities=39% Similarity=0.639 Sum_probs=229.1
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|++++.||.|+||.||+|.++.++..||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 38999999999999999999999999999999875433333445788999999999999999999988 3456799
Q ss_pred EEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 104 VVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12334578899999987652 44688999999999999999999999999988888888888888876554432211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..+...........+....+.+++.+++||.+||..||.+|||++++|+||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111121212222333345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=383.16 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=227.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|..++++|+|+||.+++++++..+..|++|+|...............|+.++++++|||||.+++.|. .+..
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQ 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCc
Confidence 356899999999999999999999999999999999866555566667889999999999999999999983 2334
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+||||+||+ |+|.+.|+.. ..++++.+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 4999999999 5999999754 468999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .+...++||+.|++||+|.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|......|
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P------- 225 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP------- 225 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC-------
Confidence 543 23467899999999999998 799999999999999999999999999999888887776543222
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
....++.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 226 -----------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 -----------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -----------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 22357889999999999999999999999999988764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=372.25 Aligned_cols=250 Identities=29% Similarity=0.487 Sum_probs=208.2
Q ss_pred eEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 28 QEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++.||+|+||.||+|.+. .+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 468999999999999864 578899999987431 1223445678899999999999999999998 344679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+. ++|.+.+...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999 59999999888899999999999999999999999999999999999999999999999999875332221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+..
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1234579999999999876 5788999999999999999999999988765444433321
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKG 318 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~ 318 (619)
. . ....+.+++.+.+||.+||..||++|| +++++++||||..
T Consensus 215 -----------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 215 -----------G-K---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred -----------C-C---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 0 0 112345688999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=371.47 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=213.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 47999999999999999999999999999999986421 2223455678899999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 457999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... .....+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~---------- 223 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---------- 223 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence 211 11234699999999998631 245788999999999999999999999887765554443211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~~ 319 (619)
.....+....+.+++.+++||++||..++++ |++++++|+||||.++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 224 ----------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ----------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 1112223334558899999999999765554 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.33 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=209.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||||++.... ........+..|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999987532 2233455677899999876 799999999998 3446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||+ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~------------------- 211 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD------------------- 211 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999876 68999999999999999999999999988766555444210
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-------CHHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-------TAEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-------Sa~elL~hp~f~~~ 319 (619)
. . .....++.++.+||.+||..||++|+ +++++++||||..+
T Consensus 212 --------~-~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 --------D-V---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred --------C-C---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 0 0 01123678999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.04 Aligned_cols=250 Identities=28% Similarity=0.477 Sum_probs=207.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+|+.||||++.... ........+.+|.. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999986432 12233455666665 46789999999999988 3456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999875322221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 244679999999999876 6799999999999999999999999988775544433321
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f~~~ 319 (619)
.. ....+.+++.+.+||++||+.||.+||++ .++++||||..+
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 --------KP---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred --------CC---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 12235678899999999999999999987 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=379.01 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=213.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 4578999999999999999999999999999999986421 2233455678999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 67999999998 6999998654 589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~--~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ......+||+.|+|||++.... ..++.++|||||||++|+|++|++||.+.+.......|.+..
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~--------- 263 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK--------- 263 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 211 1123567999999999986521 237899999999999999999999998887655554443210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~ 318 (619)
....+. ....++..+++||.+||..++.+ |+|++|+|+||||+.
T Consensus 264 -----------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 264 -----------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred -----------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 011111 12356889999999999865543 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.98 Aligned_cols=258 Identities=36% Similarity=0.601 Sum_probs=213.5
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++++.||+|+||+||++.+..+++.||+|++..............+|+.+++.++||||+++++++. +...+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 89999999999999999999999999999999865443344444567999999999999999999984 3567999
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
|||++.+ +|.+++.....+++..++.++.||++||.+||+.||+|+||||+|||++.++.++|+|||.+...... .
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---N 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c
Confidence 9999997 99999997788999999999999999999999999999999999999999999999999998754111 1
Q ss_pred cccccccCCccccCccccc-ccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 184 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~-~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.......++..|+|||++. + ..++.++|||||||++|+|++|..||...+..+....+............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------- 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------
Confidence 2235568899999999987 4 68899999999999999999999999887555554444332211111000
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
......+..+.+||++||+.||++|||+.++++||||
T Consensus 224 -----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 -----------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.19 Aligned_cols=287 Identities=40% Similarity=0.644 Sum_probs=234.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+|++.+.||.|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++. +..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence 589999999999999999999999999999999754322 233456778999999999999999999984 346
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998766 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578899999987542 467899999999999999999999999998888888888888877766554322
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
... .+. .............+...+..+.+||.+||..||++|||+.|+|.||||.+....
T Consensus 232 ~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 232 SLP--DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccc--ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 211 111 111122233344566778999999999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.72 Aligned_cols=282 Identities=38% Similarity=0.681 Sum_probs=220.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|+||.||+|.++.+++.||+|++..........+.+.+|+.+++.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 479999999999999999999999999999999865433333345678999999999999999999998 344679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555555666799999999999999999999999999999999999999999999999999986533221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999987652 46789999999999999999999999998877777666655544322211111000
Q ss_pred hHHHHHHhhc---ccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMR---KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~---~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.+..... ..........+++++..+.+||.+||..||++|||+.|+|.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000 001111222356778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.49 Aligned_cols=259 Identities=28% Similarity=0.493 Sum_probs=227.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++-|.+.+.||+|.|.+|-+|++..||++||||+|.+...+......++.|+..|+.++|||||++|++. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 56779999999999999999999999999999999988766666677899999999999999999999998 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-CCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi-~~~~~vKL~DFGla~~~~ 177 (619)
.+|||+|+-+ |||+++|.++ ..+.|+..+.+|.||+.|+.|||+..+|||||||+|+++ ..-|-|||.|||++..+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 7999999998 5999999765 469999999999999999999999999999999999975 567899999999987654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~-~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ..+++.||+..|-|||++.+ ..|+ +++||||||+|||.|++|++||...++.+.+.+|++.-.
T Consensus 171 PG----~kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 171 PG----KKLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred Cc----chhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 32 23577899999999999988 4554 789999999999999999999999999999988866321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.....++.+++|||.+||..||++|.|.++|..|+|++....
T Consensus 237 -----------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 -----------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -----------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 112357889999999999999999999999999999997643
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=362.08 Aligned_cols=287 Identities=36% Similarity=0.651 Sum_probs=227.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
||..++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDII-----HT 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEE-----ec
Confidence 56778999999999999999999999999999999998643221 1223467899999999999999999998 34
Q ss_pred CCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 4679999999999999988754 468999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.. ..+++..+.+.++.+..+.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11233568889999987642 468899999999999999999999998776 667778888888888776654
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCC--HHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
........... .............++.++ ..+.+||.+||..||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPY-SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccccc-cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 43221100000 000011112223334445 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=369.21 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=213.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.|.+++.||+|+||.||+|.++.+++.||||++.+... .......+..|..++..+ .|++|+.+++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48999999999999999999999999999999875321 223445677788888877 488999999988 44467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||+. |+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1245679999999999986 68999999999999999999999999888765555444220
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. .....++.++.+||.+||..||.+|++ ..++++||||+.+
T Consensus 217 --------------~~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 --------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred --------------CC---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112357889999999999999999997 4899999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=361.25 Aligned_cols=288 Identities=36% Similarity=0.624 Sum_probs=229.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998754333334456888999999995 699999999885543323345
Q ss_pred EEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCcccc
Q 007064 102 IYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~ 175 (619)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999988642 35899999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...... ..+...++++|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 11234678899999987542 46789999999999999999999999999988888888888888776655
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
.......... ......+..+....+.+++.+.+||.+||..||.+||+++|+|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 4322211100 0111122222333467889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.43 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=210.0
Q ss_pred eEEeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 28 QEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~---~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
++.||+|+||.||++.+ +.+|+.||+|++............+.+|+++|+.++||||+++++++ .+...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence 36799999999999976 46789999999975433344556678899999999999999999998 34567999
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
|||||. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999876433211
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1234679999999999876 67889999999999999999999999887765444333210
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. .....+++.+.+||++||+.||++||+ +++++.||||..+
T Consensus 214 -----------~~---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 -----------KL---GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred -----------CC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 00 112346889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=369.19 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=206.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+|+.||+|+++.... .......+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975321 123445567788888754 899999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987432111 12
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999976 6899999999999999999999999988775444333311
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-~elL~hp~f~~~ 319 (619)
.. ......++.++.+||++||..||++|+++ +++++||||+..
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DT----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 00 01112468899999999999999999998 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.55 Aligned_cols=299 Identities=33% Similarity=0.528 Sum_probs=230.5
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
|.-....++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 34456678899999999999999999999999999999998643333333445678999999999999999999886543
Q ss_pred C---CCCCcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 96 R---RDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 96 ~---~~~~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
. ......|+||||+.++|.+.+.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 2 2235679999999999988887543 68999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 172 LARVAFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 172 la~~~~~~~~~-~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
++......... ........++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+...++..+....|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99765332211 1112345678899999987652 457889999999999999999999999999888888888888776
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccc-cCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQF-SQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~-~~~-~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..+.+...........+. ......... ... ....++.+.+||.+||..||.+|||++++|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred Chhhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 655443332111111000 000000000 001 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=348.09 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=223.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
....++|++++.||+|-||.||+|+.+.++.-||+|++.+... .......+.+|++|...|+||||++++++| -
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----h 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----H 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----e
Confidence 3456789999999999999999999999999999999975421 222345678999999999999999999999 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~--~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
+...+||++||.. |+|+..+. ....+++...+.+++|++.||.|+|.++|+||||||+|+|++..+.+||+|||.+.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 5567999999998 79999998 56789999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....+ ...+.|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+...+|...
T Consensus 173 ~~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------- 237 (281)
T KOG0580|consen 173 HAPSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------- 237 (281)
T ss_pred ecCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------
Confidence 64322 2356799999999999988 78999999999999999999999999998877777666331
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... ....++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 238 --------------------~~~---~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 --------------------DLK---FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------ccc---CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 001 11468899999999999999999999999999999864
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=368.90 Aligned_cols=264 Identities=25% Similarity=0.428 Sum_probs=214.1
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999999999999999986421 1223344577899999999999999999988 44567
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ......+||+.|+|||++... ...++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 21 112335799999999988521 14688999999999999999999999988876555544421
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~~ 319 (619)
......+......+++.+.+||.+||..++.. |++++++++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11111223334567899999999999775554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=378.91 Aligned_cols=280 Identities=24% Similarity=0.320 Sum_probs=218.9
Q ss_pred CCeEEeEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.|+||||+++++++ ....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~ 159 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----RWKS 159 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----eeCC
Confidence 46999999999999999999754 45678999988642 2345799999999999999999988 4456
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.+|+|||++.++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 79999999999999999877889999999999999999999999999999999999999999999999999997644322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---hhHHHHHHHhhhCCCchhhhhh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---VVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~---~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
. .......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+.. ...++..+...++....+....
T Consensus 240 ~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 240 D-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred c-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1 112235679999999999876 679999999999999999999999997764 3456666666666544432221
Q ss_pred hcchhHHHHHHhhc--ccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMR--KKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~--~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
...... ..+.... .+.+..+...+ ...+.++.+||.+||.+||++|||+.|+|.||||..
T Consensus 317 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLC-KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHH-HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 111111 1111111 11111111111 245678999999999999999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=378.51 Aligned_cols=258 Identities=29% Similarity=0.452 Sum_probs=222.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.....|..++.||+|+||.||+|++..+++.||||++... ....+...+.+|+.+|.+++++||.++++.|+..
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g----- 83 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG----- 83 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----
Confidence 3456788899999999999999999999999999999754 3445667899999999999999999999999654
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..++++||||. |++.+.++....+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+.....
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 45999999999 59999999988889999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. ....+++||++|||||++.. ..|+.++||||||++.+||++|.|||.....+..+
T Consensus 164 ~~---~rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------------ 220 (467)
T KOG0201|consen 164 TV---KRRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------------ 220 (467)
T ss_pred hh---hccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------------
Confidence 33 23367899999999999986 79999999999999999999999999776542222
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
-.+.+..+..+.. .+++.+++|+..||..||+.||||.++|+|+|++.
T Consensus 221 ---------flIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 221 ---------FLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---------EeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 1222223322222 67899999999999999999999999999999986
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=367.28 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=205.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999999975321 223445566777777654 799999999988 3446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
||+. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999997543222 12
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999876 6789999999999999999999999988776544433311
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-~elL~hp~f~~~ 319 (619)
..+ .....++.++.+||.+||..||.+||++ .+++.||||..+
T Consensus 211 -------~~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DRP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 000 1113467899999999999999999986 588899999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=368.57 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=205.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975322 233456678999999988 699999999998 4446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~--------~~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT--------EDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc--------hHH
Confidence 234689999999999987 678999999999999999999999996432110 000000 000
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS------a~elL~hp~f~~~ 319 (619)
....+.. ... .....+++.+.+||.+||..||.+|+| ++++++||||..+
T Consensus 213 ~~~~~~~-~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILE-KQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHc-CCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0011111 111 122357889999999999999999987 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=362.06 Aligned_cols=287 Identities=40% Similarity=0.655 Sum_probs=232.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.+.|++.+.||.|+||.||+|.++.+++.+|+|.++...........+.+|+.+++.++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 4579999999999999999999999999999999975433333344577899999999999999999988543 2267
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887643 59999999999999999999999999999999999999999999999999998654332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|..+.+..+..
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345678899999988652 3468899999999999999999999999999999999999999888777654322
Q ss_pred hhHHHHHHhhcccCCccccCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
-..... ..........+...++. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 110000 00111111222344554 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=357.99 Aligned_cols=281 Identities=38% Similarity=0.669 Sum_probs=229.3
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++++.||.|++|.||+|.+..+|..||||++..... ......+.+|+.+++.++||||+++++.+. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEE
Confidence 58999999999999999999999999999999875322 223456778999999999999999999983 446789
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELMESDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+.++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988754 358999999999999999999999999999999999999999999999999997543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......++..|++||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|..+.+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678899999987652 4578899999999999999999999999999999999988888888777655431
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ..+................+.+++.+.++|.+||+.||.+||++.++|+||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 11111111111112223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.18 Aligned_cols=264 Identities=26% Similarity=0.375 Sum_probs=213.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34589999999999999999999999999999999986421 2223445678999999999999999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 567999999998 6999988764 58999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~--~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... ......+||+.|+|||++.... ..++.++|||||||++|||++|.+||.+.+.......|...
T Consensus 194 ~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------- 262 (371)
T cd05622 194 KEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--------- 262 (371)
T ss_pred cCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Confidence 2211 1123567999999999986521 23889999999999999999999999888765544444221
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~ 318 (619)
.....+ ...+.++..+++||.+||..++.+ |++++++++||||++
T Consensus 263 -----------------~~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 -----------------KNSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred -----------------CCcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 011111 123468899999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=367.18 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=208.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.++..||||++.... ........+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999997532 2223456677899999888 699999999998 3446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|...+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999977 6889999999999999999999999988775444333211
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-----~elL~hp~f~~~ 319 (619)
... .....+++.+.+||++||..||++|||+ .++++||||+..
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 1113468899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=359.01 Aligned_cols=287 Identities=38% Similarity=0.658 Sum_probs=229.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|++|.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++. +....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 5799999999999999999999999999999998654333334456788999999999999999999983 44679
Q ss_pred EEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccCC
Q 007064 103 YVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~ 179 (619)
|+||||++++|.+.+..... +++..++.++.||+.||.|||+.||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999988876543 578889999999999999999999999999999999985 567999999999754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ..+...+++.|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999987652 468899999999999999999999999988888888888888888766654322
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.. ..+................+.+++.+.+||.+||..||++||++.++|+||||.++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11 111111111111122223467889999999999999999999999999999998754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.70 Aligned_cols=295 Identities=37% Similarity=0.620 Sum_probs=232.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~--- 96 (619)
...++|.+.+.||.|+||.||+|.++.+++.+|||++............+.+|+++|+.++||||+++++++.....
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 34679999999999999999999999999999999986433322233456789999999999999999988754431
Q ss_pred CCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.....+|+||||+.++|...+.. ...+++..++.++.||++||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 23456899999999988888765 44799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC--------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 176 AFNDTPT--------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 176 ~~~~~~~--------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
....... ....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 4332211 1122345678999999987652 468899999999999999999999999999999999998888
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+.+....+.....-..... .......+..+...+..+++.+.+||.+||..||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8776655443211100000 0001111222233455667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=367.14 Aligned_cols=299 Identities=40% Similarity=0.651 Sum_probs=229.1
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-- 96 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-- 96 (619)
|+..++|.+.+.||.|+||.||+|.++.++..||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus 1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 345689999999999999999999999999999999986532 2445668899999999999999999987754321
Q ss_pred -------CCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEe
Q 007064 97 -------RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKIC 168 (619)
Q Consensus 97 -------~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~ 168 (619)
.+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 11246899999999999988864 46999999999999999999999999999999999999974 5578999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
|||+++................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997643222111112334688899999976542 5688899999999999999999999998887777766665544
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
.+..+............ ..........++....+.++.++.+||.+||..||++|||++++|.||||+.+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 237 VVREEDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CCChHHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 44433322221111111 11001111122233446788999999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=368.38 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=206.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+|+.||+|++.... ........+.+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986432 12234455666665 46789999999999988 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875322221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999876 6789999999999999999999999988765444333211
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f~~~ 319 (619)
. . ....+..+..+.+||.+||..||.+||++ .++++||||...
T Consensus 211 -------~-~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K-P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C-C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11234678899999999999999999976 599999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.00 Aligned_cols=259 Identities=23% Similarity=0.409 Sum_probs=205.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997542 2334456678899998776 799999999998 3446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|...+.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~--------~~~~~ 212 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQ--------NTEDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Cccc--------ccHHH
Confidence 234679999999999977 678999999999999999999999995321100 0000 00000
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS------a~elL~hp~f~~~ 319 (619)
....+... .. .....++..+.+||++||..||++|++ ++++++||||+++
T Consensus 213 ~~~~i~~~-~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 213 LFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHhcC-CC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00111111 11 123457889999999999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.73 Aligned_cols=285 Identities=35% Similarity=0.638 Sum_probs=222.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+++|+.++||||+++++++ .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999999865433333455678999999999999999999998 445679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 666666666679999999999999999999999999999999999999999999999999987643322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
...+.+.++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+......-......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999988652 45788999999999999999999999988877777777665554332211111000
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
....................+++++..+.+|+.+||..||++||++.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111223456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.66 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=211.5
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+|++.+.||+|+||.||+|.++.+|+.||||++..... .......+..|+.++..+. |++|+.+++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 47899999999999999999999999999999875321 2234556778999998886 56777888887 34467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------------- 216 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------------- 216 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 1 1234579999999999876 67899999999999999999999999887765444433210
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
. ......++..+.+|+.+||..||.+|++ .+++++||||..+
T Consensus 217 -------------~----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 -------------N----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -------------C----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0112356889999999999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=371.43 Aligned_cols=259 Identities=26% Similarity=0.339 Sum_probs=205.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++|+||+++++++ .+..
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 346788999999999999999999999999999998643 2334456788999999999999999999998 4556
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||.+ +|... ..+.+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 79999999995 66542 34678888999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. .....+||..|+|||++... ...++.++|||||||++|||++|+.||......+....+..
T Consensus 222 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----------- 287 (353)
T PLN00034 222 MD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----------- 287 (353)
T ss_pred cc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-----------
Confidence 11 12346799999999987431 12345689999999999999999999974332111111100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.... ........++.++.+||.+||..||++|||+.|+|+||||.+-
T Consensus 288 -------------~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 -------------ICMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -------------Hhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0000 0112234678899999999999999999999999999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.14 Aligned_cols=281 Identities=41% Similarity=0.674 Sum_probs=229.8
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++.+.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++. +....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 67899999999999999999999999999998754333333456788999999999999999999983 4467999
Q ss_pred EEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 105 VFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 105 V~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999997765 799999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+..++|....+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 11234568899999987652 45788999999999999999999999999988888888888888877665443211
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..+................+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11111222222222333456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.09 Aligned_cols=250 Identities=27% Similarity=0.442 Sum_probs=205.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999986432 12233445666665 67889999999999988 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||+ ++|...+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244679999999999876 6789999999999999999999999988765444333311
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f~~~ 319 (619)
.+ ....+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 --------KP---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred --------CC---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 01 11224567899999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=364.62 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=206.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||||+++.... ..........|..++.. ++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 469999999999999999999999999975321 12334556678888876 4899999999998 3446799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
||+. |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234579999999999876 6789999999999999999999999988765444333210
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~-elL~hp~f~~~ 319 (619)
..+ .....++..+.+||.+||..||++||++. ++++||||..+
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 211 -------DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -------CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 000 01124678999999999999999999996 89999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.00 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=203.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||+|+||+||++.++.+++.||+|++..... .......+..|+.+|+.++||||+++.+++ .....+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 7999999999999999999999999864321 222345678899999999999999999988 3446799999999
Q ss_pred C-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 110 E-SDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 110 ~-g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
. |+|...+. .+..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---
Confidence 8 58887774 245699999999999999999999999999999999999999999999999999976433221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~ 264 (619)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred cccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 1234578999999999987 6889999999999999999999999977543211111100
Q ss_pred HHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... ..+ ......+++.+.+|+.+||..||++|| +++++++||||+++
T Consensus 212 ----~~~-~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 212 ----RIL-NDS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----hhc-ccC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 000 001 112245788999999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=364.13 Aligned_cols=280 Identities=32% Similarity=0.573 Sum_probs=226.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CC----cceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PD----IVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pn----Iv~l~~v~~~~s 95 (619)
.+||.++..+|+|.||.|..+.|..++..||||+++.. ....+..+-||++|.+|.+ |+ ++.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 68999999999999999999999999999999999853 2233344569999999942 32 66666666
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC------------
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA------------ 161 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~------------ 161 (619)
+..+++|||+|.++-++++++++++ +++..+++.+.+|||++++|||+.+++|.||||+|||+.+
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 5567899999999999999999876 6889999999999999999999999999999999999732
Q ss_pred --------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007064 162 --------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (619)
Q Consensus 162 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~ 233 (619)
+..|||+|||.|+...... +..+.|+.|+|||++.+ -+|+..+||||+||||+|+.+|..+|++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2358999999998643332 45689999999999998 6899999999999999999999999999
Q ss_pred CChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhccc---------------CCccccCCCCCCC---HHHHHHHHH
Q 007064 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK---------------QPVQFSQKFPNAD---PSALRLLER 295 (619)
Q Consensus 234 ~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~---------------~~~~~~~~~~~~s---~~l~dLI~~ 295 (619)
.++.+.+..|...+|..+...+.+.. ..+|+...+-. .+.++.......+ ..+.|||++
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 99999999999999987777766552 22333221110 1111112222222 357899999
Q ss_pred hccCCCCCCCCHHHHHcCccccCCC
Q 007064 296 LLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 296 mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
||.+||.+|+|+.|+|.||||+.+.
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcCC
Confidence 9999999999999999999998753
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=365.22 Aligned_cols=263 Identities=24% Similarity=0.415 Sum_probs=213.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||++.++.+++.||+|++.+.. ........+.+|+.++..++|+||+.+++++ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986421 1223345577899999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 21 111235799999999987641 13578899999999999999999999988776554443321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~ 318 (619)
......+...+..+++.+++||.+||..++.+ |++++++++||||++
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 11112233344567899999999999976654 479999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.95 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=205.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|+++.+++.||+|++..... .......+.+|.. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 479999999999999999999999999864321 1223344555554 56889999999999988 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999975332221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999877 6799999999999999999999999988776554433321
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH----HHHcCccccC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE----EALADPYFKG 318 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~----elL~hp~f~~ 318 (619)
.+ ....+.+++.+.+||++||+.||.+|+++. ++++|+||..
T Consensus 211 --------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 211 --------KP---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred --------CC---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 00 122356789999999999999999999876 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.50 Aligned_cols=286 Identities=38% Similarity=0.673 Sum_probs=226.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|+||.||+|.++.+++.||+|+++...........+.+|+++|+.++|+||+++++++. +...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence 4799999999999999999999999999999998754444445577889999999999999999999984 34579
Q ss_pred EEEEecCCccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQ-VIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~-~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+++++.+ ++.....+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999999975544 445556799999999999999999999999999999999999999999999999999876543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....++++.+|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.............
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998762 37889999999999999999999999998888877777777766555433322211
Q ss_pred hHHHHHHhhcccCCccccCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
....-...........+...++. +++.+.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 10000000000011111222333 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=382.55 Aligned_cols=268 Identities=26% Similarity=0.383 Sum_probs=220.7
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~--- 96 (619)
...++|.+.+.||+|+||+||+|.+..+++.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 45579999999999999999999999999999999997654555667778899999999999999999887644321
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
.....+++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 11224789999999 699998864 3468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
+++........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~------ 259 (496)
T PTZ00283 189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA------ 259 (496)
T ss_pred cCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------
Confidence 99765332211 11244679999999999987 6799999999999999999999999988765444333211
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. ......+.+++.+.+||.+||..||.+||++.++|+|||++.+.
T Consensus 260 ---------------------~---~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 260 ---------------------G---RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ---------------------C---CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 0 01122356789999999999999999999999999999987643
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=347.99 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=212.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+.|++.+.||+|++|.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 5699999999999999999999999999999998643222 12345688999999999999999999998 344
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|+||+. ++|.+.+.....+++..++.+++||+.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 58999999998 59999998888899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
............++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2221111134568889999999987 5689999999999999999999999976554333222110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. ........++..+.+||.+||..||.+|||+.++|+||||
T Consensus 222 -------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 -------------QP---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------cC---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 00 0112223578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=380.33 Aligned_cols=281 Identities=25% Similarity=0.312 Sum_probs=211.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
...|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+.+|+.|+||||+++++++. ....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence 457999999999999999999999999999999643 123568999999999999999999874 3456
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999997643322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC-CCCC------hhHHHHHHHhhhCCCchh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKN------VVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF-~~~~------~~~~l~~i~~~~g~p~~e 253 (619)
.. ......+||+.|+|||++.+ ..++.++|||||||+||||++|..++ .... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 11 11234579999999999977 67999999999999999999987544 3321 123444444443332211
Q ss_pred hhhhhcchhHHHHHHhhcc----cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 254 TISRVRNDKARRYLTSMRK----KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~----~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.-..........+...... .........+..++..+.+||.+||.+||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1110000111111111000 0111111223356788999999999999999999999999999974
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=355.84 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=210.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.|++.+.||+|+||.||++.+..+++.||+|++.... ........+.+|+.+++.++||||+.+++.+. +...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence 4899999999999999999999999999999986432 22223455778999999999999999999883 34579
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+|||||. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5898887543 46999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 11 133478999999999876 67899999999999999999999999886653333222110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
+.. . .......+++.+.+||.+||..||++|| +++++++||||...
T Consensus 217 ----------~~~-~---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 ----------VKE-D---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------hhh-c---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 000 0 0112345788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=367.08 Aligned_cols=255 Identities=30% Similarity=0.397 Sum_probs=210.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcE-EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~-vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.+.....+.+.||.|+||+||++.. .|.. ||||++............+.+|+.+|..|+|||||++++++..+.
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~--- 112 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP--- 112 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC---
Confidence 3455666777899999999999964 4666 999999865555555778999999999999999999999995442
Q ss_pred CCcEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECCCC-cEEEeecCcc
Q 007064 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKNILANANC-KLKICDFGLA 173 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILi~~~~-~vKL~DFGla 173 (619)
..++||||||. |+|.+++.. ...++...+..|+.||++|+.|||+.+ ||||||||+|||++.++ ++||||||++
T Consensus 113 -~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 -GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred -CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 16899999999 799999987 678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+...... ...+...||..|||||++.+....|+.++||||||+++|||+||+.||.+.........+.....+|
T Consensus 192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp--- 265 (362)
T KOG0192|consen 192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP--- 265 (362)
T ss_pred eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---
Confidence 8754321 2234478999999999998412589999999999999999999999999988644333332111111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
......++.+..|+++||..||.+||+..+++.
T Consensus 266 --------------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 --------------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 111226789999999999999999999999865
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.45 Aligned_cols=280 Identities=39% Similarity=0.736 Sum_probs=222.8
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
|++++.||+|+||.||+|.++.++..||+|+++...... ......+|+.+++.+. ||||+++++++... ..+.+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 788999999999999999999999999999987543332 2234567999999885 99999999998543 225789
Q ss_pred EEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+||||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999988763 57899999999999999999999999999999999999999 9999999999976533222
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.....++..|+|||.+... ..++.++|||||||++|||++|.+||.+.+..+.+..+.+.++.+..+.........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345688999999976432 457889999999999999999999999999888888888888887765533221111
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...+ .........+....+.++..+.+||.+||..||++|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1000 000001111112234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=368.54 Aligned_cols=279 Identities=25% Similarity=0.328 Sum_probs=209.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
...|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++||||+++++++. ....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence 34699999999999999999999999999999975432 2356999999999999999999984 3456
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.|+|||++.++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 899999999999998865 4579999999999999999999999999999999999999999999999999997532221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCCh---------hHHHHHHHhhhCCC
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV---------VHQLDLMTDLLGTP 250 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~-~pF~~~~~---------~~~l~~i~~~~g~p 250 (619)
......||+.|+|||++.+ ..|+.++|||||||++|||+++. ++|..... ...+..+...++..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234579999999999876 67999999999999999999854 44443221 22333333444433
Q ss_pred chhhhhhhcchhHHHHHHhhcc-cCCcccc--CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRK-KQPVQFS--QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~-~~~~~~~--~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..+............++..... +.+.... ....+++..+.+||.+||.+||++|||+.|+|+||||+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2221111111111112111100 0110000 0113567788999999999999999999999999999863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.45 Aligned_cols=274 Identities=26% Similarity=0.412 Sum_probs=226.4
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
.+.||+|+|+.|-.|+...+|..||||+|.+. ..-...+++||++++.+++ |+||++++++| +++..+||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVf 155 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVF 155 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEE
Confidence 46899999999999999999999999999875 3345678999999999996 99999999999 7778899999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecCccccccCCC--
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAFNDT-- 180 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~~~~~-- 180 (619)
|-|. |.|...|.++..++|.++..++++|+.||.|||.+||.||||||+|||.... +-||||||.|..-.....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999 5999999999999999999999999999999999999999999999998654 358999999876432221
Q ss_pred --CCccccccccCCccccCccccc---ccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 181 --PTTIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 181 --~~~~~~~~~~gt~~Y~APEll~---~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..+..+.+-+|+..|||||+.. +....|+.++|.||||+|||.||.|.+||.|....+- .|
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------------GW 301 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------------GW 301 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------------Cc
Confidence 2233455678999999999753 3346799999999999999999999999988643211 01
Q ss_pred h--hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 256 S--RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 256 ~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
. .....-...+++++....-...+..|..+|.+++|||..+|..|+..|.++.++|+|||++.....
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 1 111223345566676666555667789999999999999999999999999999999999987544
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=365.05 Aligned_cols=282 Identities=23% Similarity=0.369 Sum_probs=215.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||.|+||.||+|.++.++..+|+|.+.... .......+.+|+++|+.++||||+++++++. +...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCE
Confidence 478999999999999999999999999999999887532 3344567889999999999999999999984 4457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 59999999888899999999999999999999985 7999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH-hhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT-DLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~-~~~g~p~~e~i~~~ 258 (619)
. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+. ...+.+........
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 134578999999999876 578999999999999999999999998765433221111 01111111000000
Q ss_pred cc----------------hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RN----------------DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~----------------~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. .........+.......+. ....+.++.+||.+||+.||++|||++|+|.||||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00 0000011111111110010 1235788999999999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=367.63 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=203.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
||+|+||.||+|.++.+++.||||++.... ...........|..++..+ .||||+.+++++ .+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 799999999999999999999999986421 1223344566777777665 699999999998 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
||+. ++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456799999999988652 4589999999999999999999999988765444333311
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC----CHHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP----TAEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp----Sa~elL~hp~f~~~ 319 (619)
.. ..+. ...+++.+.+||++||..||.+|| +++++++||||...
T Consensus 212 -------~~-~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 -------GK-VRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------CC-CCCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 00 0010 123688999999999999999998 79999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=357.76 Aligned_cols=289 Identities=38% Similarity=0.607 Sum_probs=220.7
Q ss_pred CeEEeEEeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTH--TGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~--tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+|.+.+.||+|+||.||+|.++. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999997532 1122345678899999999999999999998543 225
Q ss_pred cEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----CCcEEEeecC
Q 007064 101 DIYVVFELMESDLHQVIKAN-----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----NCKLKICDFG 171 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~----~~~vKL~DFG 171 (619)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh---------HHHHH
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---------HQLDL 242 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~---------~~l~~ 242 (619)
++.................++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654332212222345789999999987652 46889999999999999999999999876543 35566
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcc------ccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQ------FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+...++.+....+...................... ....+...+..+.+||.+||..||++|||+.|++.||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66777766655443222111000000000000000 011112577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.67 Aligned_cols=286 Identities=37% Similarity=0.614 Sum_probs=221.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
++..+.|++++.||+|+||.||+|.++.++..||+|.+..... ......+.+|+.+|+.++|+||+++++++. +
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~ 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIH-----T 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----c
Confidence 3566889999999999999999999999999999999864321 222345678999999999999999999983 4
Q ss_pred CCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 457999999999888887754 3568899999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+ ..+.+..+...+|.|..+...
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2211 12334678999999988652 457889999999999999999999997764 345666677777777665543
Q ss_pred hhcchhHHHHHHh-hcccCCccccCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 257 RVRNDKARRYLTS-MRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 257 ~~~~~~~~~~l~~-~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..... ..+... .....+..+...+. ..++.+.+||.+||..||++|||++|+|.||||
T Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 32210 000000 00001111111121 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=350.93 Aligned_cols=282 Identities=46% Similarity=0.758 Sum_probs=235.0
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+|+.++||||+++++++. +...+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 67889999999999999999999999999998765444445677889999999999999999999883 3467999
Q ss_pred EEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 999999999988876 4579999999999999999999999999999999999999999999999999997654332
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
.......++.+|+|||.+.+. ..++.++|+|||||++|+|++|++||++.+..+++..+...++.+..+.+...... .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL-A 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh-h
Confidence 112345688899999998762 47899999999999999999999999999999999999888888877666554331 1
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..................++.++..+.+||.+||..||.+||+++++|.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122222333344556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=360.19 Aligned_cols=257 Identities=21% Similarity=0.390 Sum_probs=205.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++..+ +||||+.+++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975422 233456688999999888 599999999988 4456799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|||. ++|..++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~--------------------~~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT--------------------EDY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc--------------------HHH
Confidence 244679999999999876 6889999999999999999999999965321110000 000
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC------HHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS------a~elL~hp~f~~~ 319 (619)
....+ ...+. .....++..+.+||.+||..||++|++ .+++++||||..+
T Consensus 211 ~~~~~-~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 211 LFQVI-LEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHH-HhCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 00001 11111 122346889999999999999999997 5799999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.50 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=211.1
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|++++.||+|+||.||++.++.+++.||+|++............+.+|+.+++.++||||+++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4999999999999999999999999999999997544444556678899999999999999999887632 234589
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+. ++|.+++.. ...+++..++.++.||+.||.+||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 589998876 3468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2234578899999999876 6788999999999999999999999987664333222211
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. .......+++.+.+||.+||..||++|||+.++|+||||
T Consensus 217 ------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 ------------GK---LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------------cC---CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 011223577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.46 Aligned_cols=281 Identities=42% Similarity=0.710 Sum_probs=233.7
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++.+.||+|.||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++. +...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 67889999999999999999999999999999865433444566788999999999999999999884 3467999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999876533221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999988652 478899999999999999999999999999999999999999988877765543322
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.+...............++..+..+.++|.+||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111222223334566778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=391.07 Aligned_cols=267 Identities=27% Similarity=0.393 Sum_probs=216.3
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
.......++|.+++.||.|+||.||+|.++.++..||+|++............+.+|+.+|+.|+||||++++++|...
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de- 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK- 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec-
Confidence 3334456799999999999999999999999999999999976545556677889999999999999999999988543
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEECC--
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-------NVYHRDLKPKNILANA-- 161 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILi~~-- 161 (619)
....+|||||||. ++|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 --~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 85 --ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred --CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 2356999999999 599998865 35799999999999999999999995 4999999999999964
Q ss_pred ---------------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh
Q 007064 162 ---------------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (619)
Q Consensus 162 ---------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt 226 (619)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3458999999997643221 123457999999999986433568999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC
Q 007064 227 GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306 (619)
Q Consensus 227 G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS 306 (619)
|..||...+...++.... .... ....+..+..+.+||.+||.+||.+||+
T Consensus 239 Gk~PF~~~~~~~qli~~l--------------------------k~~p----~lpi~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISEL--------------------------KRGP----DLPIKGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred CCCCCCcCCcHHHHHHHH--------------------------hcCC----CCCcCCCCHHHHHHHHHHhcCChhHCcC
Confidence 999997765443322111 0000 1112346789999999999999999999
Q ss_pred HHHHHcCccccCC
Q 007064 307 AEEALADPYFKGL 319 (619)
Q Consensus 307 a~elL~hp~f~~~ 319 (619)
+.++|.||||+.+
T Consensus 289 a~QlL~h~~ik~i 301 (1021)
T PTZ00266 289 ALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHhccHHHhhc
Confidence 9999999999744
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.06 Aligned_cols=294 Identities=39% Similarity=0.602 Sum_probs=233.8
Q ss_pred CCCCCCeEE-eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH------------HHHHHHHHHHHHHhcCCCCcc
Q 007064 19 YGDASRYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS------------DAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 19 ~~~~~rY~i-~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~------------~~~~i~~Ei~iL~~L~HpnIv 85 (619)
+...++|.. .+.||.|+||+||+|.++.+++.||||++........ ....+.+|+.+|+.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456678875 5779999999999999999999999999864322110 012477899999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 165 (619)
++++++. ....+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 84 ~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYV-----EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEe-----cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 9999984 34579999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccCCC-----------CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007064 166 KICDFGLARVAFNDT-----------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (619)
Q Consensus 166 KL~DFGla~~~~~~~-----------~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~ 234 (619)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334578899999988652 45789999999999999999999999999
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
+..+++..+...++.|....+....... .+ .......+..+...++..+..+.+||.+||..||.+|||++|+|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9999999999888888765543221100 00 00111122223334566788999999999999999999999999999
Q ss_pred cccCCCc
Q 007064 315 YFKGLSK 321 (619)
Q Consensus 315 ~f~~~~~ 321 (619)
||+....
T Consensus 315 ~~~~~~~ 321 (335)
T PTZ00024 315 YFKSDPL 321 (335)
T ss_pred ccCCCCC
Confidence 9986543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=375.56 Aligned_cols=256 Identities=24% Similarity=0.339 Sum_probs=212.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~t-g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..|.+.+.||+|+||.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++++ .....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCE
Confidence 3499999999999999999998887 78899997753 2334556678899999999999999999998 34467
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+|||||||. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 456899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----------- 285 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----------- 285 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 33221 112345679999999999876 6899999999999999999999999988765444433321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... ......+++.+.+||.+||..||++||+++++|.|+|++.
T Consensus 286 ----------------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 286 ----------------GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 000 0112357789999999999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=346.49 Aligned_cols=283 Identities=39% Similarity=0.678 Sum_probs=228.7
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++++.||.|+||.||+|.+..+++.+|+|++............+.+|+.+++.++||||+++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999865433444567889999999999999999999984321 267999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
||||++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999986543321
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.+..+.+....+..+..-.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112334678899999977542 468899999999999999999999999999888888888888888766654332210
Q ss_pred HHHHHhhcc--cCCccccCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 264 RRYLTSMRK--KQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 264 ~~~l~~~~~--~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+...... .....+...+.. .++.+.++|.+||..||.+||++++++.||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000000 000111122333 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=350.26 Aligned_cols=283 Identities=25% Similarity=0.370 Sum_probs=215.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||+|+||.||++.+..++..+|+|.+... ........+.+|+++++.++||||+++++++. +...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEE
Confidence 4699999999999999999999999999999998743 23344567889999999999999999999983 45679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999998 589999999999999999999999999987543221
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh----h
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI----S 256 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i----~ 256 (619)
....++++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+............ .
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134578999999999876 57889999999999999999999999876643322222111000000000 0
Q ss_pred hh-----cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 257 RV-----RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 257 ~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.. ................. .......+++++.+||.+||..||++|||+.++|+||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00 00000011111111111 0111123678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.37 Aligned_cols=292 Identities=37% Similarity=0.612 Sum_probs=229.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-----
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS----- 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s----- 95 (619)
..++|++.+.||+|+||.||+|.++.+|+.||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 346899999999999999999999999999999999754333333456778999999999999999999885432
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+...+|+|+||++++|...+... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 1123479999999999888888754 468999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
........ ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||...+..+.+..+....+.+....
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 65433211 11233567889999987642 4578899999999999999999999999998888888888888877655
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+..+............ ..........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4433211100000000 000011122345578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.01 Aligned_cols=286 Identities=22% Similarity=0.296 Sum_probs=207.9
Q ss_pred EeEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 27 IQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 27 i~~~LG~G--~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
++++||+| +|++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++. +...+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 57889999 7889999999999999999999765444455567788999999999999999999984 4457999
Q ss_pred EEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 105 VFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 105 V~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|||||. ++|.+++..+ ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 6999998653 4589999999999999999999999999999999999999999999999987544321111
Q ss_pred Cc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc-hhhhh
Q 007064 182 TT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS-LDTIS 256 (619)
Q Consensus 182 ~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~-~e~i~ 256 (619)
.. .......++..|+|||++.+....|+.++|||||||++|+|++|..||............. .+... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcccccccc
Confidence 00 0111235677899999987533468999999999999999999999998765433322221 11110 00000
Q ss_pred hhcchhHH----H------HHH--h---h-cccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKAR----R------YLT--S---M-RKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~----~------~l~--~---~-~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....+... . +.. . . ..............+++.+.+||++||+.||++|||++++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000 0 000 0 0 0000000011223467899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=348.41 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=207.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|+||+.+++.+ .+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 47889999999999999999999999999999864322 222345677899999999999999999988 344579
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 5898888643 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 11 123478999999999876 678999999999999999999999997653211111110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
..+.... ......+++.+.+||.+||+.||++||| ++|+++||||+.+
T Consensus 215 -----~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 215 -----RLVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----hhhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0000000 0122456889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=343.87 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=225.4
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCCCCCc
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
|++++.||.|+||.||+|.++.++..||+|++............+.+|+.+++.+ .||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999975433333345566788887766 5999999999986554333345
Q ss_pred EEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|++|||+.++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133467889999999876 578899999999999999999999999999888888888777665543332211
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...... ........+....+.+++.+.+||.+||..||.+||+++++|.||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSS----FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhh----cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 100000 11112222333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.92 Aligned_cols=253 Identities=27% Similarity=0.444 Sum_probs=212.3
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|.+.+.||+|+||.||+|.++.+++.|++|.+............+.+|+.+++.++||||+++++.+. +...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 488999999999999999999999999999998754445566778899999999999999999999884 446799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999998 5999999764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......++.+|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234568899999999876 5788999999999999999999999987764333322211
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. +......++..+.++|.+||+.||++||++.+++.|||+
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 011112467899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=346.11 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=214.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||.|+||.||++.+..+++.||+|++.... ........+.+|+++|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47999999999999999999999999999999986432 2234456788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999996 799999998889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
.....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 133468899999998876 5788999999999999999999999987664333332210
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 320 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~~ 320 (619)
... .....+++.+.+||++||..||.+|+ +++|+++||||..+.
T Consensus 213 -------------~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -------------GKV---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -------------CCc---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 000 11234578999999999999999999 999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.26 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=210.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
....++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+ .+
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~ 77 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LR 77 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----Ee
Confidence 34456899999999999999999999999999999998643 223445678899999999999999999988 34
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 467999999998 5999999888899999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ......|+..|+|||++.. ....++.++|+|||||++|+|++|.+||........+..+..
T Consensus 158 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----------- 223 (267)
T cd06645 158 ATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----------- 223 (267)
T ss_pred Cccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----------
Confidence 2211 1234578999999998742 124688999999999999999999999866543222211100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
....+..+ .....++..+.+||.+||..||++|||++++|+|||
T Consensus 224 --------------~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 --------------SNFQPPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------cCCCCCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000001 111246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=346.36 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=200.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||+|+||.||++.++.+|+.||+|++...... ......+..|+++|+.++||||+++++++ .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 79999999999999999999999998642221 22334456799999999999999999988 4456799999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 110 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 110 ~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 58988886533 58899999999999999999999999999999999999999999999999987643221 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.. ..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~-------------------~~ 210 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR-------------------RT 210 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH-------------------Hh
Confidence 34578999999999876 5699999999999999999999999976532111111100 00
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f~~~ 319 (619)
+ .. ........+++++.+||.+||..||++||++ ++++.||||+.+
T Consensus 211 ~----~~---~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 211 L----ED---EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred h----cc---ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 0 00 0111123578899999999999999999999 778899999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=345.57 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=213.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
....+.|++++.||.|+||.||+|.+..++..+++|.+.. ........+.+|+.+++.++||||+++++.+. .
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----W 80 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----e
Confidence 3455789999999999999999999999999999999874 33455677889999999999999999999884 3
Q ss_pred CCcEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||+.+ +|..++.+ ...+++..++.++.||+.+|.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 4579999999995 77777654 456899999999999999999999999999999999999999999999999998753
Q ss_pred cCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
..... ......++..|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+..
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 229 (292)
T cd06644 161 VKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 229 (292)
T ss_pred ccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--------
Confidence 32211 12345688899999987421 14578899999999999999999999977654332222210
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. ..........++..+.+||.+||..||++||+++++|+||||..+.
T Consensus 230 -------------------~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 230 -------------------S-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred -------------------C-CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 0001112235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.73 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=199.9
Q ss_pred CCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~ 96 (619)
++|++++.||+|+||.||+|.+ ..++..||+|++... ........+.+|+.+|..+ +||||+++++++..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK--- 82 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence 6899999999999999999975 245578999998743 2334556789999999999 89999999998742
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-------------------------------------------------------
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (619)
....+|+|||||+ |+|.+++...
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2346899999999 6999988652
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCc
Q 007064 121 -------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193 (619)
Q Consensus 121 -------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (619)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~ 240 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPL 240 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCc
Confidence 24788899999999999999999999999999999999999999999999999864322211 1112334567
Q ss_pred cccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcc
Q 007064 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 272 (619)
Q Consensus 194 ~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (619)
.|+|||++.+ ..++.++|||||||++|||++ |..||.+......+.... ..
T Consensus 241 ~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~--------------------------~~ 292 (338)
T cd05102 241 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL--------------------------KD 292 (338)
T ss_pred cccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------------------hc
Confidence 8999999876 678999999999999999997 999998765332221110 00
Q ss_pred cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 273 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 273 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+++.+.+||.+||..||++|||+.++++
T Consensus 293 ~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 GTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 0112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.86 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=210.6
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||+.+.+.+ .+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 47889999999999999999999999999999864322 223345578899999999999999999888 344579
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5888887543 36999999999999999999999999999999999999999999999999998754221
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+....
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV------------ 217 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh------------
Confidence 1 1234578999999999876 678999999999999999999999998776543333221100
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
... .....+.+++.+.+|+.+||..||++||+ +.+++.|+||+..
T Consensus 218 -----------~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 218 -----------LET----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -----------hcc----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 000 01122457789999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=331.54 Aligned_cols=290 Identities=31% Similarity=0.622 Sum_probs=236.7
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~ 94 (619)
..+||..+.|++++.+|+|.|+.||.|++..++++++||+++. ...+.|.+||+||+.|+ ||||++++++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3468999999999999999999999999999999999999874 34677999999999997 99999999998765
Q ss_pred CCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCc
Q 007064 95 SRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGl 172 (619)
.. ....|||||++. |...+.. .|+.-++++++++||.||.||||.||.|||+||.|++||.. -.++|+|+||
T Consensus 106 ~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 ES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred cc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 33 567899999995 6665553 58999999999999999999999999999999999999965 5799999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCChhHHHHHHHhhhCCCc
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~-~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
|..+-.... .+-.+.+++|--||++... ..|+.+-|+|||||+|+.|+..+ |.|.|.+..+|+.+|.+.+|+..
T Consensus 180 AEFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 987643221 2345889999999998864 78999999999999999999987 55689999999999999999866
Q ss_pred hhh-hhhhcchhHHHHHHhhcccCCccccCCCC-----CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 252 LDT-ISRVRNDKARRYLTSMRKKQPVQFSQKFP-----NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 252 ~e~-i~~~~~~~~~~~l~~~~~~~~~~~~~~~~-----~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
... +.++.-+-..++-..+.......|....+ -+++++.|||.++|..|-.+|+||.|++.||||..+.+
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 543 33333333333333333333333333221 35799999999999999999999999999999986544
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.47 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=207.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 468999999999999999999999999999999864322 223456788999999999999999999987432 23
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+++||+. ++|.+++...+.+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 56899999998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---~~~-------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQP-------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh---cCC--------
Confidence 2111111233468889999999876 578899999999999999999999997654322221110 000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
. .......+++.+.+|| +||..||++||+++|+|+||||+
T Consensus 226 ---------------~---~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 ---------------T---NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------C---CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0 0011124577889999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.41 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=213.1
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
-+...+|++++.||.|+||.||+|++..++..|++|.+.... ......+.+|+.+++.++||||+++++.+. +
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~ 88 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYL-----V 88 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----e
Confidence 345679999999999999999999999999999999987532 234566889999999999999999999884 3
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....|+||||+. ++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 457999999998 589998865 468999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 168 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~------------ 230 (296)
T cd06654 168 PEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------------ 230 (296)
T ss_pred cccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc------------
Confidence 2211 1233578899999999876 5788999999999999999999999977654332221110
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...........++..+.+||.+||..||++|||+.++|+||||...
T Consensus 231 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 231 ----------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------------CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 0000111223567889999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=347.19 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=213.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+...+|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+. ..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~ 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence 4558999999999999999999999999999999998643 2234466889999999999999999999984 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 57999999998 589998865 4589999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~--------- 232 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT--------- 232 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC---------
Confidence 221 1234578899999999876 6788999999999999999999999977654322211100 000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
........++..+.+||.+||..||++||+++++|+||||.....
T Consensus 233 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 233 ------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 001112346788999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=365.41 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=215.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.+.+.|+..||.|+||.||+|.++.++-..|.|+|.. ........++-||.||..++||+||+|++.|+. .+.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----enk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----ENK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCc
Confidence 3457888999999999999999999999999999863 345677888999999999999999999999854 356
Q ss_pred EEEEEecCCccHHH-HHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELMESDLHQ-VIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~g~L~~-~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
++|+.|||.|.-.+ ++. -...|++.+++.+++|+|.||+|||+++|||||||..|||++-+|.++|+|||.+....
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-- 181 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-- 181 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--
Confidence 99999999974444 333 35679999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.+......++|||+|||||+.... ..+|+.++||||||++|.||.-+.||-...+.+..+-+|.+
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK----------- 249 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----------- 249 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-----------
Confidence 222233568999999999986431 36799999999999999999999999988887766655532
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..|..+. ....++..+.|||++||..||..||++.++|+||||++.
T Consensus 250 ----------------SePPTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 250 ----------------SEPPTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ----------------cCCCccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 1111111 123567789999999999999999999999999999864
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.21 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=208.5
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|++.+.||.|+||.||+|.+..++..+++|.+... .......+.+|+++++.++||||+++++.+. .....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEE
Confidence 78899999999999999999999999999998642 3455667889999999999999999999884 3456899
Q ss_pred EEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 105 VFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 105 V~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
||||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999998 578777654 45799999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 183 TIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~---~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
......++..|+|||++.. ....++.++|||||||++|+|++|.+||...+.......+...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------------- 223 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------- 223 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-------------
Confidence 1234578999999998742 1245788999999999999999999999876654433322110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. ........++..+.+||.+||..||.+||+++++++||||..
T Consensus 224 --------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 --------------EP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred --------------CC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 00 001112346789999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.72 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=210.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+ .+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCE
Confidence 36899999999999999999999999999999998753 223567888999999999999999999988 34467
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|++|||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999995 899988776 78999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. ......++..|+|||++... ...++.++|+|||||++|+|++|.+||.+.+.......+....
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~----------- 220 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----------- 220 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------
Confidence 11 11345788899999998651 1268889999999999999999999998766544332221100
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
..+. .......++..+.+||++||..||.+|||+.++|.|+|
T Consensus 221 --------------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 221 --------------FPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------------CCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000 00111245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=347.11 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=214.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.+|++.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+++|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4799999999999999999999999999999999754222 23556788999999999999999999988 44567
Q ss_pred EEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999984 999998754 5799999999999999999999999999999999999999999999999999875422
Q ss_pred CCCC--------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007064 179 DTPT--------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (619)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~ 232 (619)
.... .......+|+..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1110 011124578999999999876 578999999999999999999999998
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC----HH
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT----AE 308 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS----a~ 308 (619)
+.+....+..+.. ....+. ....+++.+.+||++||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~----------------------------~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK----------------------------KEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc----------------------------CCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 8775544433211 000111 11236889999999999999999999 99
Q ss_pred HHHcCccccCC
Q 007064 309 EALADPYFKGL 319 (619)
Q Consensus 309 elL~hp~f~~~ 319 (619)
++|.||||++.
T Consensus 285 ~ll~~~~~~~~ 295 (316)
T cd05574 285 EIKQHPFFRGV 295 (316)
T ss_pred HHHcCchhhcC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=335.90 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=212.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||.|+||.||+|.+..++..+++|++....... ....+.+|+++|+.++|+||+++++.+ .+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence 47999999999999999999998899999999987543332 667889999999999999999999988 344679
Q ss_pred EEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 103 YVVFELME-SDLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~---~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
|+|||++. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5999998764 4589999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCc-cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~-~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... ......+++..|+|||.+... ..++.++|+|||||++|+|++|+.||...+....+..+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~------- 223 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---ND------- 223 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CC-------
Confidence 32221 112335688999999998763 3688999999999999999999999977654332222211 00
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.........+..+++.+.+||.+||..||++|||++++|.||||
T Consensus 224 ---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 224 ---------------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---------------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00011111134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=344.04 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=223.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|.++++||+|.||.|-+|+.+.+++.||||++++.. ....+....+.|-.+|+..+||.+..+.-.| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 4467889999999999999999999999999999998643 3345567788999999999999999988777 556
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||.. |+|+-++.....+++...+++-..|+.||.|||+.+||+||||.+|+|+|.+|++||.||||++....
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 77999999999 59999998888899999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
...+ ..++||||.|+|||++.. ..|+.++|+|.+|+++|||++|+.||...+......+|.-.
T Consensus 321 ~g~t---~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------ 383 (516)
T KOG0690|consen 321 YGDT---TKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------ 383 (516)
T ss_pred ccce---eccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------------
Confidence 3332 367899999999999987 79999999999999999999999999998876666655310
Q ss_pred cchhHHHHHHhhcccCCccccCCCC-CCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.-.|| .++++++.||..+|..||++|. .+.|+.+|+||..+
T Consensus 384 --------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 384 --------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred --------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 01233 5899999999999999999996 68999999999865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=343.39 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||.|+||.||++.+..++..+|+|.+.. ........+.+|+++++.++||||+++++.+. +...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCe
Confidence 4679999999999999999999998999999999864 34455677889999999999999999999984 3457
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999995 898888764 46999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... .....++..|+|||++... ...++.++|+|||||++|+|++|++||.+.+....+..+..
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK----------- 222 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc-----------
Confidence 211 1335688999999987421 14577899999999999999999999977654333322211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
... ........++..+.+||.+||..||.+||+++++|+||||...
T Consensus 223 ----------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 223 ----------------SEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----------------CCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0011123467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.89 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=209.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|.+.+.||+|+||.||+|.++.+++.+|+|++... ......+.+|+.+++.+ +||||+++++++........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 367799999999999999999999999999999998642 12345677899999998 79999999999865443344
Q ss_pred CcEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 57999999998 589888753 4578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCcccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~---~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
........ .....++..|+|||++.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 177 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------ 247 (291)
T cd06639 177 QLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------ 247 (291)
T ss_pred hccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc------
Confidence 64322111 12346889999999875421 2368899999999999999999999977654333322211
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
..... ......++..+.+||.+||..||++||++.++|+||||+
T Consensus 248 ---------------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 ---------------------NPPPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------------------CCCCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00000 011124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.11 Aligned_cols=262 Identities=29% Similarity=0.489 Sum_probs=215.4
Q ss_pred cCC-CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 18 EYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 18 ~~~-~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
+++ ...+|++++.||.|+||.||+|++..+++.|++|.+... .......+.+|+.+++.++||||+++++.+.
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 86 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFL---- 86 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEe----
Confidence 344 456899999999999999999999999999999998643 2234567889999999999999999999983
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+...+|+|+||+. ++|.+++... .+++.++..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 87 -~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 87 -VGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred -cCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 4457999999998 5888888654 699999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--------- 230 (296)
T cd06655 165 ITPEQSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--------- 230 (296)
T ss_pred ccccccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 4322211 133468889999999876 57889999999999999999999999887654443322110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..........+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 231 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 231 -------------------GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -------------------CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0011112345788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.20 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=208.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+..++|++++.||+|+||.||+|.++.+++.||+|++... .......+.+|+.+++.++||||+++++.+. ..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SR 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eC
Confidence 4456799999999999999999999999999999998643 2234456789999999999999999999884 34
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 57899999999 59999998888899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... ......++..|+|||.+.. ....++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------ 223 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------------
Confidence 211 1133568899999998742 124578899999999999999999999865442221111100
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
....+.. ......++..+.+||++||..||++|||++++|+|+|
T Consensus 224 -------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 -------------SNFQPPK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -------------CCCCCCC-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000000 0111346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.88 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=208.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE----HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~----~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+|++.+.||.|+||.||+|.+ .++..+|+|.+..... .......+.+|+.+|+.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 588999999999999999986 4788999998864321 123345688999999999999999999998 344
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred CC---CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 179 DT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 179 ~~---~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.. ..........++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------
Confidence 11 11112234578999999999876 5788999999999999999999999976553322211110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...........++..+.+||.+||..||.+||++.++|+||||
T Consensus 223 ------------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 ------------------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0001112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.16 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=209.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-------SDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
+|.+.+.||.|+||.||+|.+..++..+|+|.+....... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 5788999999999999999999999999999886432221 1235678999999999999999999988
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+....++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 34467899999998 49999998888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCc---cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 176 AFNDTPTT---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 176 ~~~~~~~~---~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 54221111 11123468889999999876 5788999999999999999999999987654332221110
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.........++..+.+||++||+.||.+||++.++|+||||
T Consensus 227 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 -----------------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00111223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.11 Aligned_cols=253 Identities=28% Similarity=0.493 Sum_probs=214.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++++.||.|+||.|+.+.+..+++.+++|++............+.+|+.+|+.++|+||+++++++. +...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 699999999999999999999999999999998755445566677889999999999999999999984 446799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999764 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2244578999999999876 5688899999999999999999999987665444433311
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. .+......++..+.+||.+||..||.+||+++++|+|||+
T Consensus 216 ------------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------G---NYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------C---CCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 0111124567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.64 Aligned_cols=260 Identities=24% Similarity=0.402 Sum_probs=207.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC-CC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR-DF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~-~~ 99 (619)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 467999999999999999999999999999999986432 2345678899999998 699999999998654321 13
Q ss_pred CcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999998 5999988763 46899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
..... ......|+..|+|||++.+. ...|+.++|||||||++|+|++|..||...........+..
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-------- 230 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------- 230 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------
Confidence 32211 12345789999999987531 14688899999999999999999999965443222211100
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 231 -------------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 -------------------NP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 0001123467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=339.94 Aligned_cols=280 Identities=41% Similarity=0.723 Sum_probs=226.5
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
|.+.+.||.|+||.||+|.+..+++.|+||++...... .......+|+..++.++ ||||+++++++. +....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEE
Confidence 78899999999999999999999999999998754332 23334567999999999 999999999883 356799
Q ss_pred EEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 104 VVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 104 lV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
+||||+.++|.+.+.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999998764 789999999999999999999999999999999999999999999999999976533221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.+...++..|+|||++... ..++.++|+|||||++++|++|++||++.+..+.+..+...++.+..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2346789999999987542 46789999999999999999999999999999999999998888876654321100
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ..................++..+..+.+||++||..||++|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000111111112223345557899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.71 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=210.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-CC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-RD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~-~~ 98 (619)
..++|++.+.||.|+||.||+|.++.+++.+++|++.... .....+.+|+.+++.+ .||||+++++++..... .+
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3578999999999999999999999999999999987432 2345688999999999 69999999999865543 33
Q ss_pred CCcEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 99 FKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
...+|+||||+++ +|.+++.. +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5678999999994 88888754 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
........ ......++..|+|||++... ...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 161 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 232 (275)
T cd06608 161 AQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR----- 232 (275)
T ss_pred eecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc-----
Confidence 76432221 12345688999999987431 13578899999999999999999999976544333322211
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
... ........++..+.+||.+||..||++|||++++++|||+
T Consensus 233 ----------------------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ----------------------NPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------------cCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0001112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.28 Aligned_cols=267 Identities=28% Similarity=0.470 Sum_probs=224.3
Q ss_pred CccccccCCCCCCe-EEeEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007064 12 EMEFFSEYGDASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 12 ~~~~~~~~~~~~rY-~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~--~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
....+.+-...+|| ++.++||+|+|-+||+|.|..+|..||+-.++ +........+++..|+.+|+.|+||||++++
T Consensus 28 ~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy 107 (632)
T KOG0584|consen 28 DESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFY 107 (632)
T ss_pred ccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeee
Confidence 34456666777787 56789999999999999999999999987654 3445566779999999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCC-Cc
Q 007064 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANAN-CK 164 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~-~~ 164 (619)
+.|.+.. ...+-+|+|+|. |+|.+++++.+.++...++.|++|||+||.|||+.. |+|||||.+||||+.+ |.
T Consensus 108 ~SW~d~~---n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 108 DSWVDTD---NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eheecCC---CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 9997653 267899999999 899999999999999999999999999999999986 9999999999999986 89
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~ 244 (619)
|||+|+|||....... ....+|||.|||||++.. .|++.+||||||++++||+|+..||.......|+.+-.
T Consensus 185 VKIGDLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred eeecchhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 9999999998764332 244689999999999874 89999999999999999999999998876655543221
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.....|..|... -+|++++||++||.. ..+|+|+.|+|.||||..
T Consensus 257 -------------------------~SGiKP~sl~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 -------------------------TSGIKPAALSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -------------------------HcCCCHHHhhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 111222222222 268999999999999 999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=343.20 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=212.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|++++.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 469999999999999999999999999999999875322 223456788999999999999999999988 34467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999987421111
Q ss_pred CCc------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 181 PTT------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 181 ~~~------------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 000 01122467889999999876 5789999999999999999999999987664433322211
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHHcCccccCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 319 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS---a~elL~hp~f~~~ 319 (619)
.........+.+++.+.+||++||..||++||+ +.++|+||||...
T Consensus 231 -------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 -------------------------DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -------------------------cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 000111111257889999999999999999997 8999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.84 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=210.1
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.|+..+.||+|+||.||++.+..+++.||+|++...... ......+.+|+++|+.++||||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 488899999999999999999999999999998643211 22356788999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 177 (619)
..+++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 67999999999 59999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCCc-cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~-~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 321111 11123468889999999876 578899999999999999999999997654332222221100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
. ..........+++.+.++|.+||..||.+||++.++|+||||+
T Consensus 225 ---------------~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 ---------------S--ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------c--cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0001122235678999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.76 Aligned_cols=255 Identities=32% Similarity=0.527 Sum_probs=212.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++++.||.|+||.||+|.+..++..||+|.+...........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875545556677889999999999999999999977542 335689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 104 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
++|||+. ++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 599988865 467999999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 87543321 1234578999999999876 5688999999999999999999999987764332222210
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. .+......++..+.+|+.+||..||++||++.++|+|||+
T Consensus 225 -------------------~---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------G---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------C---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0 0111223567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=373.43 Aligned_cols=286 Identities=23% Similarity=0.293 Sum_probs=205.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCC-cEEEEEEe---------------cCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKI---------------HDIFEHISDAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg-~~vAIK~i---------------~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 85 (619)
.++|++++.||+|+||.||+|..+... ..+++|.+ +...........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764322 22222211 11112223445678999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~-----~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
++++++. +....|+|+|++.++|.+++.... ......++.|+.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 9999983 445689999999999988875432 344677889999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCC--CChh
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KNVV 237 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~--~~~~ 237 (619)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..+ |.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 11234689999999999987 6799999999999999999998754 432 2344
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcc-cCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
.++..+...++.+..+... . ......++..... ..+..+...+ ..++..+.+||.+||.+||++|||+.|+|.||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~-~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPD-P-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCC-c-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 5555555555544332111 0 0111122211110 0111111111 23567889999999999999999999999999
Q ss_pred cccC
Q 007064 315 YFKG 318 (619)
Q Consensus 315 ~f~~ 318 (619)
||..
T Consensus 456 ~f~~ 459 (501)
T PHA03210 456 LFSA 459 (501)
T ss_pred hhhc
Confidence 9975
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=333.06 Aligned_cols=253 Identities=25% Similarity=0.468 Sum_probs=210.9
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++ .+....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999875433445566789999999999999999999988 4456799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+. ++|.+.+.... .+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999987643 58999999999999999999999999999999999999999999999999997653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+..+....+..
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred h---hhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 1 1123468889999999876 5788899999999999999999999977655443332211
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. ........+..+.+||.+||..||.+||++.++|+||||
T Consensus 216 ------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 ------------GS---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CC---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 011123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=333.87 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=209.1
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 57999999999999999999999999999999885322 1223456788999999999999999999987432 12
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46899999998 59999998877899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||........+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 2111111234568899999999876 578899999999999999999999997654332221111 000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
......+.++..+.++|.+||. +|++||+++++++|||+.
T Consensus 226 ------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0011223567789999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.39 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=211.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeE
Confidence 47999999999999999999999999999999987432 2344567889999999999999999999884 34679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+|+||+. ++|.+++... .+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5999998765 799999999999999999999999999999999999999999999999999977543321
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1234578889999999877 5689999999999999999999999976653322221110
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.....+. ...+++.+.++|.+||..||++|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000000 11267889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.82 Aligned_cols=261 Identities=24% Similarity=0.416 Sum_probs=211.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.+..++..||+|.+... ........+.+|+.+|+.++||||+++++.+. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeE
Confidence 4799999999999999999999999999999998643 23344567889999999999999999999874 34679
Q ss_pred EEEEecCCc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 103 YVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~---~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
|+|||||.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999995 898888763 379999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~----~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
... .....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...........+..
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 221 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------- 221 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH--------
Confidence 221 1234688899999987542 12468899999999999999999999976543322222111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.... ......+.+++++.+||.+||..||.+||++++++.||||.....
T Consensus 222 ----------------~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 222 ----------------IVDG---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ----------------Hhhc---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 0011 112233457899999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=331.66 Aligned_cols=261 Identities=30% Similarity=0.457 Sum_probs=212.6
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
||++.+.||+|+||.||+|.+..++..|++|+++...........+.+|+.+++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999976544445778899999999999999999999987 3446799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+|+||+. ++|.+++.....+++..++.|+.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 599999988878999999999999999999999999999999999999999999999999999875433322
Q ss_pred ccc-cccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 183 TIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 183 ~~~-~~~~~gt~~Y~APEll~~~~-~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
... .....++..|+|||++.+.. ..++.++|||||||++|+|++|+.||..............
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--------------- 220 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--------------- 220 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh---------------
Confidence 111 22356788999999987631 2378899999999999999999999976532111111000
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ........+..+++.+.+||.+||..||.+|||+.+++.|||+
T Consensus 221 -----------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 221 -----------A-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------c-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0000111223458899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.37 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=204.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|++..++..||+|.+... ........+.+|+.+|+.++||||+++++.+. .....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEE
Confidence 4689999999999999999999999999999998643 23344567889999999999999999999984 34568
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
++||||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 66433 358899999999999999999999999999999999999999999999999997643221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
....+++..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+.. +...
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~-------- 206 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMPL-------- 206 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cchH--------
Confidence 234578999999999876 57899999999999999999999999653211100 0000
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........... ........++++.+||.+||..||++||+++++|.||||...
T Consensus 207 ---~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 207 ---QLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ---HHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000000000 011123467899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=355.56 Aligned_cols=270 Identities=28% Similarity=0.426 Sum_probs=208.9
Q ss_pred CccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeE
Q 007064 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHI 90 (619)
Q Consensus 12 ~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v 90 (619)
..++++. ....|+++++||+||.+.||++... +...||+|++.....+......+.+||.+|.+|+ |.+||+|+++
T Consensus 352 ~~~~i~V--kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 352 ANEIIKV--KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred cCeeEEE--CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 3455544 3467999999999999999999754 3456778877666667777888999999999996 9999999998
Q ss_pred ecCCCCCCCCcEEEEEecCCccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 91 MLPPSRRDFKDIYVVFELMESDLHQVIKANDDL-TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l-~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
-.. ++.+|+|||+-+.||.++|++.... ..-.++++.+|||.+++++|..||||.||||-|+|+-. |.+||+|
T Consensus 429 Ev~-----d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLID 502 (677)
T KOG0596|consen 429 EVT-----DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLID 502 (677)
T ss_pred ecc-----CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeee
Confidence 643 5679999999889999999876543 33588999999999999999999999999999999854 5899999
Q ss_pred cCccccccCCCCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l 240 (619)
||.|.....+. +.+.....+||..||+||.+... ..+.+.++||||||||||+|+.|++||..-. +++
T Consensus 503 FGIA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~ 579 (677)
T KOG0596|consen 503 FGIANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQI 579 (677)
T ss_pred echhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHH
Confidence 99998765443 33445668999999999987431 1236789999999999999999999994421 122
Q ss_pred HHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.++..+ ..| ...+.|....++ .+++++++.||..||++|||+.++|+|||++.
T Consensus 580 aKl~aI-~~P----------------------~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 580 AKLHAI-TDP----------------------NHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHhh-cCC----------------------CccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 222110 011 111122222211 23999999999999999999999999999874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=336.23 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=211.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++.+ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 59999999999999999999999999999999975322 224567889999999999999999999887 455679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+|+||+. ++|.+++.....+++..++.|+.||++||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999887789999999999999999999999999999999999999999999999999987653322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||++.. ..++.++|+|||||++|+|++|..||...+.... ..+.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------------- 211 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIR----------------- 211 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHH-----------------
Confidence 1234568889999999876 5689999999999999999999999987663211 1100
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH--HHHHcCccc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA--EEALADPYF 316 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa--~elL~hp~f 316 (619)
..... ......+.++..+.++|.+||..||.+||++ +|+++||||
T Consensus 212 ------~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 212 ------AKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------HHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00000 0111223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=337.69 Aligned_cols=267 Identities=24% Similarity=0.409 Sum_probs=210.2
Q ss_pred cccCC-CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007064 16 FSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (619)
Q Consensus 16 ~~~~~-~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 93 (619)
|..+. ..++|++++.||+|+||.||+|.++.+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 44444 5588999999999999999999999999999999886421 2234577899999999 69999999998865
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
....+...+|+||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44345567999999998 58888775 23568999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
|||+++....... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||...+....+..+.
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~- 242 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP- 242 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc-
Confidence 9999876432211 12344689999999987531 1458889999999999999999999997665433221110
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
...... ......++..+.+||.+||..||++|||+.|+|+|+||
T Consensus 243 --------------------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 --------------------------RNPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------------------------ccCCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000000 00112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.74 Aligned_cols=257 Identities=29% Similarity=0.548 Sum_probs=218.6
Q ss_pred CCeEE--eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 23 ~rY~i--~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.-|+| .++||.|.||+||-|+++++|+.||||+|.+..........+.+|+.||+.+.||.||.+.-.| +...
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~e 636 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPE 636 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCc
Confidence 34555 4799999999999999999999999999987655555567788999999999999999998887 4445
Q ss_pred cEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecCcccc
Q 007064 101 DIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~ 175 (619)
.+++|||-+.||+.+.|-+ .++|++..-++++.|||.||.|||-+||+|+||||+|||+.+. -.+||||||+||.
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 6999999999999998854 5689999999999999999999999999999999999999765 3699999999998
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~-~~l~~i~~~~g~p~~e~ 254 (619)
.... .+....+|||.|+|||++.+ ..|+..-||||+|+|+|--|.|..||....+. +|++
T Consensus 717 IgEk----sFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ------------- 777 (888)
T KOG4236|consen 717 IGEK----SFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ------------- 777 (888)
T ss_pred cchh----hhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchhHHhh-------------
Confidence 6543 34567899999999999988 79999999999999999999999999665432 2221
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
...-.....-|..++++++|||..+|++.-.+|.|++..|.|||++++.
T Consensus 778 -----------------NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 778 -----------------NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred -----------------ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 1111122345778999999999999999999999999999999999754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=386.07 Aligned_cols=264 Identities=26% Similarity=0.415 Sum_probs=228.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|.|+++||+|+||.|.+++++.|++.||+|++++.. ....+...|..|-.+|..-..+=|+.++-+| +|.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 4578999999999999999999999999999999997632 2345566788999999988889999998888 788
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.++|+|||||. |||..++.+-+.++++.+++++..|+.||.-||+.|+|||||||+|||+|..|+|||+|||.+-....
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 89999999998 69999999888999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
+ ........+|||.|.+||++... ...|++.+|+||+||++||||.|..||...+.++++.+|++.
T Consensus 228 d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--------- 296 (1317)
T KOG0612|consen 228 D--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--------- 296 (1317)
T ss_pred C--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch---------
Confidence 3 33445667999999999998532 256999999999999999999999999999998888888642
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHHcCccccCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 319 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS---a~elL~hp~f~~~ 319 (619)
+....|.. -..+|++++|||+++|. +|+.|.. ++++-.||||.++
T Consensus 297 -----------------k~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 297 -----------------KESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred -----------------hhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 22233332 23589999999999998 8999998 9999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=333.05 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=208.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||.|+||.||+|++..++..+++|.+... .....+.+|+.+++.++||||+++++.+. +...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCc
Confidence 36799999999999999999999988999999998643 22677889999999999999999999884 3467
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+++||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999 599999875 457899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ......++..|+|||++.+ ..++.++||||||||+|+|++|++||...+.......+.
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP--------------- 212 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---------------
Confidence 21 1133457889999999876 578999999999999999999999997655432221110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ...........++..+.+||.+||..||++|||+.|+|.||||
T Consensus 213 ------------~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 213 ------------N-KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------c-CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 0000111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=347.46 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=214.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
-|.++++||+|+||.|++|+++.+|..+|||++.- .++.+.+.+||.||++++.|++|++|+.|+. ..+++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceE
Confidence 47789999999999999999999999999999863 4688999999999999999999999998843 45799
Q ss_pred EEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 104 VVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
||||||+ |++.++++. +.+|++.++..+++..|.||.|||...-+|||||..|||++.+|..||+|||.|....+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--- 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--- 181 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh---
Confidence 9999999 899999975 56899999999999999999999999999999999999999999999999999875432
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
+.....+.+||+.|||||++.. ..|+.++||||||+...||..|+|||..-.....+-.|
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------ 241 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------ 241 (502)
T ss_pred hHHhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------
Confidence 2223466799999999999988 79999999999999999999999999654332211111
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+...+ +--.+...+|.++.|||++||...|++|-||-++++|||+++.
T Consensus 242 ---------PT~PP-PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 ---------PTKPP-PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ---------cCCCC-CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 11111 1111222468899999999999999999999999999999863
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=329.22 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=209.5
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||+|+||.||+|.+..++..+|+|.+............+.+|+.+|+.++||||+++++.+. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 699999999999999999999999999999999754444455678899999999999999999999873 446799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCccccccCC
Q 007064 104 VVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFND 179 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~~~~ 179 (619)
+||||+. ++|.+++... ..+++..++.++.|++.+|.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999763 358999999999999999999999999999999999999865 46899999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 21 123568889999999876 5788999999999999999999999977664433322211
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ........+++.+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 -------------~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------G---TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------c---CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0 0111123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=335.70 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=203.7
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.++.+|+.||||.+...... .....+..|+.+ ++.+.||||+++++++. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCc
Confidence 4699999999999999999999999999999998754333 234456667765 67778999999999984 3456
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 102 IYVVFELMESDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988887754 34689999999999999999999997 9999999999999999999999999998764
Q ss_pred cCCCCCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~--~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e 253 (619)
..... .+...++..|+|||++.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+.
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 32211 1234688899999987541 1357889999999999999999999996432 112111110
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
. .....+ ....++.++.+||.+||..||.+||+++++++||||...
T Consensus 222 --------------~----~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 222 --------------E----EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --------------h----cCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 000000 012467899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.15 Aligned_cols=271 Identities=27% Similarity=0.389 Sum_probs=225.7
Q ss_pred ccCCCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcc
Q 007064 7 KKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 7 ~~~~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv 85 (619)
-|+...-+.|.--+.-..|.=++.||.|+||.||-|+|..+.+.||||++.... ......++|+.|+.+|++|+|||++
T Consensus 10 lKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnti 89 (948)
T KOG0577|consen 10 LKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTI 89 (948)
T ss_pred CCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcc
Confidence 345555666766666677888999999999999999999999999999997543 2334567899999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
.+.++|+-. ...|||||||-|+-.+++.- ..++.+.+|..|..+.|.||.|||+.+.||||||..|||+++.|.
T Consensus 90 eYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~ 164 (948)
T KOG0577|consen 90 EYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL 164 (948)
T ss_pred cccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe
Confidence 999999754 45899999999866666542 347999999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i 243 (619)
|||+|||.|..... ...++|||+|||||++.. ....|+-++||||||++..||.-.+||+-..+.+..+.-|
T Consensus 165 VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI 237 (948)
T KOG0577|consen 165 VKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 237 (948)
T ss_pred eeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence 99999999976432 256899999999998742 1367999999999999999999999998887776666555
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. +..|. -.-+.+|..+++|+..||+.-|.+|||.+++|.|+|...
T Consensus 238 AQ--------------------------NesPt---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 238 AQ--------------------------NESPT---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred Hh--------------------------cCCCC---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 32 11110 112467889999999999999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=336.31 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=208.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-C
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~-~ 97 (619)
...+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++.+ +||||+++++++..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3457899999999999999999999999999999998642 23445678899999998 69999999998864321 2
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 3467899999998 5999988753 458899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
....... ......+++.|+|||++... ...++.++|+|||||++|+|++|.+||........+..+.
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~------- 239 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------- 239 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------
Confidence 5432111 12345789999999987521 2468889999999999999999999997654322221110
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ..........++..+.+||.+||..||.+|||+.|+|.||||
T Consensus 240 --------------------~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 --------------------R--NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------h--CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 001111123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.03 Aligned_cols=262 Identities=26% Similarity=0.470 Sum_probs=209.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--------ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~--------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 588999999999999999999999999999988532111 11234677899999999999999999987
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.....+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 34467999999998 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ........++..|+|||++......++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 6432211 111234568889999999876323488999999999999999999999965443222211100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
............+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0001111122335678899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.88 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=209.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+|+..+.||+|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 58889999999999999999998999999999864321 123456788999999999999999999987 3446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|+||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ......++..|++||.+... ..++.++|+|||||++|+|++|.+||...........+..
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-------------- 216 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-------------- 216 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--------------
Confidence 2 12345688999999988652 2388999999999999999999999976553222211110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
........+.+++.+.+||.+||..||.+||++.++|.|||+
T Consensus 217 ---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 217 ---------------SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---------------cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001112234578899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=358.57 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=224.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+-|.+.+.||+|.|+.|.+|++..++..||||.|++...+....+.+.+|+++|+.|.|||||+++.++ ....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence 44679999999999999999999999999999999998877777778899999999999999999999998 3446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+||||+. |++++++.+++.+.+..++.++.|++.|++|||+++|||||||.+|||++.+..+||+|||++..+...
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 7999999998 699999999999999999999999999999999999999999999999999999999999999876422
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
....++||++.|.|||++.+. ...++.+|+||+|++||-|+.|..||.|.+..+.-...
T Consensus 209 ----~~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------- 267 (596)
T KOG0586|consen 209 ----LMLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------- 267 (596)
T ss_pred ----ccccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------
Confidence 235678999999999999884 45678999999999999999999999987642221111
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
+..+- ...-.++-++.+||++||..+|.+|++.+++..|+|.......
T Consensus 268 ----------l~gk~-----rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 268 ----------LRGKY-----RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ----------eeeee-----cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 00111 1112356789999999999999999999999999999865543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.99 Aligned_cols=266 Identities=25% Similarity=0.403 Sum_probs=212.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+-+.+||+|.+.||+|+|+.|+++.+..++..||+|++... ...+.+..++|+..-++++|||++++++..+......
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 45789999999999999999999999999999999999864 3567788999999999999999999998877665445
Q ss_pred CCcEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecC
Q 007064 99 FKDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
....||+++|.. |+|.+.|.. +..++|.++..|+.+|++||++||+.. ..||||||.|||+.+++..+|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 667999999998 899998864 347999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC------CccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007064 172 LARVAFNDTP------TTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 172 la~~~~~~~~------~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~ 244 (619)
.++...-... .-..|.....|..|+|||++.-. ....++++|||||||+||.|+.|..||.. +.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~ 245 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IY 245 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hh
Confidence 9875321111 11224455788999999997531 24578899999999999999999999932 21
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
...|.-.... ......+... ..+|+.+.+||+.||+.||.+||++.++|.+
T Consensus 246 ~~GgSlaLAv-----------------~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 246 QQGGSLALAV-----------------QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hcCCeEEEee-----------------eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111111000 0011112222 2378999999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.71 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=200.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 85 (619)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+|..++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 3457999998753 2334556788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHYQFFLYQLLRALKYIHTA 145 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-------------------~l~e~~i~~i~~QIl~aL~yLHs~ 145 (619)
++++++. +...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999984 3456899999998 59999886532 367788999999999999999999
Q ss_pred CceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007064 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLl 225 (619)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999764322211 11123355788999999876 57999999999999999998
Q ss_pred h--CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC
Q 007064 226 T--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 303 (619)
Q Consensus 226 t--G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k 303 (619)
+ +..||.+.+..+.+..+...+ . ......+....+.++..+.+||.+||..||++
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF--------------------R---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------h---hccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 567787765544433322111 0 00000111123456789999999999999999
Q ss_pred CCCHHHHHc
Q 007064 304 RPTAEEALA 312 (619)
Q Consensus 304 RpSa~elL~ 312 (619)
|||++++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.90 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=210.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+++++.++||||+++++++. ....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEE
Confidence 468889999999999999999999999999999875432 345667889999999999999999999884 34679
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+|+||+. ++|.+++... ..+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhhCCCchhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~--~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ......+
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-------------- 213 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------------
Confidence 11 12568889999999877 5889999999999999999999999966531 0001111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........ ...... +++.+.+||.+||..||++|||+.+++.||||+.+
T Consensus 214 ----------~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 214 ----------QYIVNEPP---PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ----------HHHhcCCC---CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 10001110 011111 68899999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.89 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=205.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeE-ecCCCCCC-C
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHI-MLPPSRRD-F 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v-~~~~s~~~-~ 99 (619)
.+++|.+.|.+|||+.||+|.+...|.+||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 5678999999999999999999988899999998653 5667788999999999997 9999999993 33332222 3
Q ss_pred CcEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
-.++|+||||. |.|.+++.. ...|++.++..||+|+++||.+||... |||||||-|||||+.+|.+||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46899999999 699999974 346999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCCCCcc---cc---ccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 175 VAFNDTPTTI---FW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 175 ~~~~~~~~~~---~~---~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
-......... .. -....|+.|||||+|.-. ....++|+|||+|||+||-||....||........+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------- 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------- 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-------
Confidence 5332221110 00 113578999999987421 157899999999999999999999999765321110
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
...+.| ..++.++..+++||..||+.||.+||++.+++.+
T Consensus 268 -------------------------ng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 -------------------------NGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -------------------------eccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 011111 2347889999999999999999999999999875
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.28 Aligned_cols=259 Identities=31% Similarity=0.475 Sum_probs=213.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|+.++..++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeE
Confidence 4689999999999999999999999999999998754322 456778999999999999999999999843 3679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|+||||+. ++|.+++.....+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999988654332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
.. .....++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.....+.+..
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------------- 214 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------------- 214 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------------
Confidence 21 134568889999999876 5788999999999999999999999977642111111111
Q ss_pred hhHHHHHHhhcccCCccccCCCCC-CCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~-~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+..... ...... ++..+.+||.+||..+|++|||+.++|+||||+..
T Consensus 215 ---------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 ---------ICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------HhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 000011 111223 67899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.49 Aligned_cols=258 Identities=28% Similarity=0.504 Sum_probs=210.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|.....||.|+||.||++.+..++..||||++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeE
Confidence 5566678899999999999999999999999998642 3344567889999999999999999999874 34578
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999985 78887754 4699999999999999999999999999999999999999999999999999875432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||.+.+ ..++.++|+|||||++|||++|..||.+.+....+..+...+
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 234 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-------------- 234 (292)
T ss_pred ---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 1234578999999999876 578899999999999999999999998766543332221100
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
. ........++..+.+||.+||..||.+|||++++|+||||.....
T Consensus 235 -------------~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 235 -------------P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred -------------C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0 000112346788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.36 Aligned_cols=258 Identities=28% Similarity=0.513 Sum_probs=211.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
..|...+.||.|++|.||++.+..++..+++|++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeE
Confidence 4566678999999999999999999999999998642 2334556889999999999999999999884 34568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+|+||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998 599998877 5799999999999999999999999999999999999999999999999998875433222
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
. .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 133568999999999876 57899999999999999999999999776654443332110
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
. .........++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 231 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 ------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0111112346789999999999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.17 Aligned_cols=246 Identities=21% Similarity=0.253 Sum_probs=201.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
..||+|++|.||+|.. +|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.... .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999976 68999999997543322 22466789999999999999999999885411 22356899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
||. |+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 5999999988889999999999999999999998 599999999999999999999999999998643221
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
...+++..|+|||++.+....|+.++|||||||++|||++|..||.+.+..+....+....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 238 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN------------------ 238 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------------------
Confidence 2346889999999987544579999999999999999999999998876554443332110
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......++.+.+||.+||+.||++|||++++|+
T Consensus 239 --------~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 239 --------NSL---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCC---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000 111256889999999999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.71 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=206.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||++.++.++..||+|.+... ......+.+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC-cchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 589999999999999999999999999999998643 2334567788999999999999999999998 4456799
Q ss_pred EEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 104 VVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+||||+. ++|.+++.. ...++++.+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 599998864 3458999999999999999999999999999999999999999999999999987653222
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--------------- 214 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--------------- 214 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc---------------
Confidence 1 1234678999999999876 5789999999999999999999999987664433322211
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .......++..+.+||.+||..||++|||+.++|+-
T Consensus 215 ------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 ------------GS---YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CC---CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 111223467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=336.99 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=205.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|...+.||+|+||.||++.+..++..||+|++...... .....+.+|+.++.++. ||||+++++++. +...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCc
Confidence 4577788999999999999999999999999998753222 45567889999999996 999999999884 3456
Q ss_pred EEEEEecCCccHHHHH---H--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 102 IYVVFELMESDLHQVI---K--ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~g~L~~~i---~--~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+++|||+.++|.++. . ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 8999999997655443 2 245799999999999999999999975 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~-~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ....++..|+|||++.... ..++.++|||||||++|+|++|++||...+. ....+.....
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~------ 225 (288)
T cd06616 158 LVDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK------ 225 (288)
T ss_pred hccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC------
Confidence 4332211 2346888999999987521 2688999999999999999999999976541 1111111100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...+.........++..+.+||.+||..||++|||+++++.||||+..
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 226 -----------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 000111111224578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.28 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=212.9
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
+.......+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-- 85 (307)
T cd06607 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-- 85 (307)
T ss_pred hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--
Confidence 344455677999999999999999999999999999999986432 23344567889999999999999999999984
Q ss_pred CCCCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 95 SRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+....|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++
T Consensus 86 ---~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 86 ---REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred ---eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence 3456899999999998888764 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
...... ....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 163 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------- 228 (307)
T cd06607 163 SLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 228 (307)
T ss_pred eecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------
Confidence 754221 234688899999987421 24688999999999999999999999977664433222210
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.... ......++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 --------------------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 --------------------NDSP--TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --------------------CCCC--CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 0001235678999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.37 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=202.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
+.++|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|+.++||||+++++++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 76 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVIT----- 76 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----
Confidence 3567999999999999999999765 456789999987542 2344567889999999999999999999984
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
....+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||.+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 3456899999999 5899888764 5789999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.+..
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~------- 225 (266)
T cd05064 157 DKSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------- 225 (266)
T ss_pred ccccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-------
Confidence 3211110 0112235678999999876 688999999999999999775 999998877655444332110
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ......++..+.+|+.+||..||.+||++++|++
T Consensus 226 --------------------~---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 --------------------R---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --------------------C---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0 0122456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.67 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=208.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|.+.+.||.|+||.||++.++.+|..+|+|.+............+.+|+.+++.++|+||+++++.+ .+...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 58999999999999999999999999999999865333334556778999999999999999999988 3446799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCccccccCC
Q 007064 104 VVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFND 179 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~~~ 179 (619)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||++++++ .+||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999887543 479999999999999999999999999999999999999886 4699999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1123468889999998876 5788999999999999999999999977654333221110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..+....+.++..+.++|.+||..||++|||+.++|+||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ----------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 01112234677899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.04 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=205.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 6999999999999999999999999975322 233456788999999999999999999988 3446799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007064 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (619)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (619)
. ++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888889999999999999999999999999999999999999999999999999998654332 1133
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--hhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 189 ~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~--~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||.... .......+..
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 208 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------------- 208 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc---------------------
Confidence 578899999999876 578899999999999999999999997765 2222211110
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
..... ......++.+.+||.+||..||.+||+ ++|+++||||+++
T Consensus 209 -----~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 209 -----GNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00011 111234789999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.82 Aligned_cols=260 Identities=29% Similarity=0.469 Sum_probs=212.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|.+++.||.|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+. +..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~ 89 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGD 89 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCC
Confidence 457899999999999999999999999999999998642 2334567889999999999999999999884 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..|+|+||++ ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 6899999998 5999988754 5899999999999999999999999999999999999999999999999988654322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ......+++.|++||.+.. ..++.++|+|||||++|+|++|..||...+...++..+..
T Consensus 169 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-------------- 229 (293)
T cd06647 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 229 (293)
T ss_pred cc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--------------
Confidence 21 1234568899999999876 5788999999999999999999999977654333211100
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...........++..+.+||.+||..||.+||++.+++.|+||+....
T Consensus 230 --------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 230 --------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred --------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 000001112346778999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.98 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=205.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.++|++++.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~---- 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT---- 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc----
Confidence 357999999999999999999876555 68999998743 23344567889999999999999999999983
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 159 (619)
+....|++|||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 79 -~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 79 -KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred -CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 3456899999998 6999999764 458889999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007064 160 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 238 (619)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~ 238 (619)
+.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999764322211 11234467888999998876 578999999999999999998 999998876544
Q ss_pred HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 239 ~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....+.. ... ......+++.+.+|+.+||..||.+||++.+++++
T Consensus 235 ~~~~i~~---------------------------~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 235 VIEMIRS---------------------------RQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHc---------------------------CCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3332211 110 11124578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.47 Aligned_cols=257 Identities=28% Similarity=0.512 Sum_probs=210.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.-|.....||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++.+. .....
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeE
Confidence 4455666899999999999999999999999998642 2234556889999999999999999999883 44679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999999 588887754 5699999999999999999999999999999999999999999999999999875432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 231 (297)
T cd06659 173 ---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---------------- 231 (297)
T ss_pred ---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------
Confidence 1234578999999999876 5789999999999999999999999987665444332211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
...........+++.+.++|.+||..||.+||+++++++||||.+..
T Consensus 232 ------------~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 232 ------------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ------------cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 01111122345788999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=325.53 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=210.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++.+... +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 57999999999999999999999999999999875321 1234456788999999999999999999987432 23
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+++||||+. ++|.+.+...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 46899999998 58999998877899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
........+...++..|+|||++.+ ..++.++|+|||||++|+|++|++||...........+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC--------
Confidence 2111111234578999999999876 57889999999999999999999999765433322211 1111
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
........+++.+.++|.+||. +|..||++.++|.|||.
T Consensus 226 ------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 ------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0011234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=333.44 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=210.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|+.++.||.|+||.||+|.+..++..||||++... ........+.+|+.+++.+.||||+++++++ .+...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEE
Confidence 4688899999999999999999999999999998743 2234567888999999999999999999998 344679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||++ ++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998 589998865 4699999999999999999999999999999999999999999999999999976533221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1233468889999999876 578899999999999999999999997765433222110
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
... .......++..+.+||.+||..||++||+++++|+|+||...
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----------KNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------cCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 000 111223456789999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=330.04 Aligned_cols=256 Identities=32% Similarity=0.549 Sum_probs=212.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~ 100 (619)
++|.+.+.||.|+||.||+|.++.++..||+|++.... ........+.+|+.+++.+. ||||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 47999999999999999999999999999999987532 23344567889999999998 99999999987 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 7999999996 799999998888999999999999999999999999999999999999999999999999999765433
Q ss_pred CCC-----------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 180 TPT-----------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
... ........++..|+|||.+.. ..++.++|||||||++++|++|..||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233467889999998876 5688899999999999999999999987764333322
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccc
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYF 316 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f 316 (619)
+.. .. ......+++.+.+||.+||..||.+|||+ +++|+||||
T Consensus 234 ~~~----------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK----------------------------LE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh----------------------------cC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 211 00 01123457899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.65 Aligned_cols=252 Identities=32% Similarity=0.515 Sum_probs=209.6
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
+||+|.||+||.|+|..|...+|||.|.. ....+.+.+..||.+-+.|+|.|||++++.+ ...+.+-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 69999999999999999999999999964 3445677889999999999999999999987 4556788999999
Q ss_pred C-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccCCCCCcc
Q 007064 110 E-SDLHQVIKAN-DDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 110 ~-g~L~~~i~~~-~~l--~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
. |+|..+++.. +++ .|..+-++.+|||+||+|||.+.|||||||-+|+||+. .|.+||.|||-++....-.+.+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T- 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT- 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc-
Confidence 8 5999999864 667 88999999999999999999999999999999999974 7999999999998865554433
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~ 264 (619)
.++.||..|||||++......|+.++|||||||++.||.||+|||... |.|......-
T Consensus 734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFkV------- 791 (1226)
T KOG4279|consen 734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFKV------- 791 (1226)
T ss_pred --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhhh-------
Confidence 567899999999999765688999999999999999999999999553 3332221100
Q ss_pred HHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.+-+. -......++.+++.||.+|+..||.+||+|.++|.+||++.-
T Consensus 792 ----GmyKv----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 ----GMYKV----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----cceec----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 00000 111223467789999999999999999999999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=321.30 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=212.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|.+.+.||.|+||.||++.+..++..|++|++............+.+|+++++.++|||++++.+.+.. ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 5899999999999999999999999999999997654555667788999999999999999999998843 36799
Q ss_pred EEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 104 VVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 104 lV~E~~~g-~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+|++++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999985 999998763 6799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 32 11234578899999998876 5788999999999999999999999977653322222110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. +......++..+.+++.+||..||.+|||+.++|+||||
T Consensus 218 --------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 111222567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.85 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=197.4
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHh---cCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREIKLLRL---LRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-~~~~~i~~Ei~iL~~---L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.||+|+||.||++.+..+++.+|+|.+....... .......+|..+++. ..||||+.+++.+. ..+.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 4899999999999999999999999986532221 222233455544443 47999999999884 34568999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
|||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~ 264 (619)
.....|+..|+|||.+... ..++.++|||||||++|+|++|..||.......... +..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~------------------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR------------------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH-------------------
Confidence 1234689999999988532 468899999999999999999999997643211110 000
Q ss_pred HHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCCC
Q 007064 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 320 (619)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~~ 320 (619)
...... ....+.+++.+.+||++||..||.+|+ |++++++||||+++.
T Consensus 210 -----~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 210 -----MTLTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -----HhhcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000000 112345788999999999999999999 699999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=330.07 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=209.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~s~~~~~ 100 (619)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ ||||+++++++. +..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCC
Confidence 5888999999999999999999999999999986432 2344567889999999997 999999999883 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 7899999998 4899888664 7999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 12345789999999987642 457889999999999999999999997765432221110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
...+..+. ...++.++.+||.+||..||++||++.+++.|+||+...
T Consensus 216 ------------~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000000 112678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.65 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=202.9
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||+|+||.||+|.+..+|+.||+|++..... .......+.+|+++|+.++||||+++++++ .....+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 6899999999999999999999999864322 222345667899999999999999999988 3446799999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 110 E-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 110 ~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
+ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 9 59999997755 79999999999999999999999999999999999999999999999999987643211 12
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 33467889999999876 5688999999999999999999999977653211111100
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. .. ......+.+++.+.+||++||..||.+|| ++.++++||||..+
T Consensus 209 --~~-~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 209 --RT-LE---MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred --cc-cc---ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 00 00 01122345688999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.96 Aligned_cols=253 Identities=32% Similarity=0.530 Sum_probs=213.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|++|.||++.+..++..|++|.+............+.+|+++++.++|||++++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 589999999999999999999999999999999865444456778999999999999999999999883 346799
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+|||++++ +|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 233468889999999876 458899999999999999999999997655332221110
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.. ........+++.+.++|.+||..||++|||+.++|.||||
T Consensus 213 ---------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 213 ---------QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 00 1112234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.52 Aligned_cols=250 Identities=29% Similarity=0.452 Sum_probs=199.9
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (619)
..||+|+||.||+|.+..++..|++|.+... .....+.+.+|+.+++.++|+||+++++++. ....+|+|+||
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 86 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQ 86 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEec
Confidence 5799999999999999999999999988642 3345677889999999999999999999883 44679999999
Q ss_pred CC-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccCCCCCc
Q 007064 109 ME-SDLHQVIKAN-DDL--TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 109 ~~-g~L~~~i~~~-~~l--~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~~~~~ 183 (619)
+. ++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--
Confidence 98 5999998764 445 88889999999999999999999999999999999986 67999999999876432221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
......++..|+|||++......++.++|+|||||++|+|++|.+||............
T Consensus 165 -~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-------------------- 223 (268)
T cd06624 165 -CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-------------------- 223 (268)
T ss_pred -ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--------------------
Confidence 12334688899999998653245889999999999999999999999654321110000
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..... ........+++.+.+|+.+||..||.+|||+.+++.||||
T Consensus 224 ----~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 ----VGMFK----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ----hhhhc----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000 0011223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.00 Aligned_cols=255 Identities=28% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|++++.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCce
Confidence 45778899999999999999999999999999987432 2345567889999999999999999999884 44569
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 588888865 5699999999999999999999999999999999999999999999999999876432211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1123468889999999876 578899999999999999999999997654322221110
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
... .......++..+.+||.+||..||.+||++.++|+||||..+
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 ----------KNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------cCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 000 011122467789999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=325.90 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=200.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||.|+||.||+|.+..+++.||+|.+..... .......+..|..++ ..++||||+++++++ .....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 679999999999999999999999999864321 122233445555544 455899999999998 3445799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 107 ELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123468889999999876 4589999999999999999999999987665433322211
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC---CHHHHHcCccccCC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 319 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp---Sa~elL~hp~f~~~ 319 (619)
............+++.+.+||.+||..||.+|| +++|+|.||||+++
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000011122235788999999999999999999 55899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.76 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=207.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++.+.||.|++|.||+|.+..+++.+|+|.+... .......++.+|+++++.++||||+++++++... +...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 4799999999999999999999999999999998743 2234567789999999999999999999988543 23568
Q ss_pred EEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 103 YVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHHHHHHhhhCCCchhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~--~~~l~~i~~~~g~p~~e~i 255 (619)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2211 23457889999999876 6789999999999999999999999976532 00111110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCC---CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKF---PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
++.. .....+.... ..+++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 219 ----------~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 ----------YIVN---MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ----------HHhc---CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0000 0000011000 1246789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=318.35 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=213.3
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999999765444456778899999999999999999999884331 25799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+|+|++. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988878999999999999999999999999999999999999999999999999999875443321
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.......++..|++||.+.. ..++.++|||||||++|+|++|..||..... ....+....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~--------------- 217 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIG--------------- 217 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcc---------------
Confidence 01133568889999999876 4688999999999999999999999977651 111111100
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ...........+..+.+||.+||..||.+||++.++|.||||
T Consensus 218 ---------~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 218 ---------S--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------c--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0 011112223457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.44 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=198.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|++..+ +..||+|+++... .......+.+|+.+|+.+ +||||+++++.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT--- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence 45799999999999999999986544 3579999997532 334456788999999999 8999999999883
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (619)
+...+|+|||||. |+|.+++...
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 4457999999999 6999988542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 121 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 121 ----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
..++++.+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788899999999999999999999999999999999999999999999999765332211 1
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
......++..|+|||++.. ..++.++|||||||++|+|++ |+.||........+..+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------------------ 329 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------------------ 329 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------------------
Confidence 1122335567999999876 679999999999999999997 9999977543222211110
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..... .....+++++.+||.+||..||.+|||++++++
T Consensus 330 --------~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 330 --------RGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------cccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 011235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.24 Aligned_cols=250 Identities=23% Similarity=0.437 Sum_probs=203.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
...|.+.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+|+.++||||+++++++. ....
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCC
Confidence 45699999999999999999999999999999998642 334567889999999999999999999883 4456
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999998 6999998754 3589999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||++.+..+....+...
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----------- 221 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG----------- 221 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----------
Confidence 22111 112234567999998876 678899999999999999998 99999887654433332110
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||++|||+.++++.
T Consensus 222 ----------------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 222 ----------------YR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ----------------CC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 00 01123567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.39 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=210.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||.||++.+..++..||+|++... ........+.+|+++++.++||||+++++.+. +...
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCE
Confidence 36799999999999999999999999999999988643 23345677899999999999999999999984 3467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. ++|.+++...+.+++..++.++.+|+.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999 5899999888889999999999999999999997 68999999999999999999999999998654222
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ...+++..|+|||++.+ ..++.++|||||||++|+|++|..||........... ..
T Consensus 158 ~~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~------- 215 (284)
T cd06620 158 IA-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DP------- 215 (284)
T ss_pred cc-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hh-------
Confidence 11 23478999999999876 5788999999999999999999999986553211000 00
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
......+..+.......+. ...++..+.+||.+||..||.+|||++|+++|+||..
T Consensus 216 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 216 -MGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -hHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000111111111111110 1125678999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=347.92 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=203.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.+++++.||+|.||.||.|.... ...||+|.++.. .-....+++|+++|++|+|+|||++++++. ....+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCce
Confidence 446678899999999999996542 238999999753 223456779999999999999999999993 33469
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|||||||. |+|.++++. +..+...+...|+.||++|++||+++++|||||-..||||++++.+||+|||||+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999 899999987 557999999999999999999999999999999999999999999999999999954433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
..... .+.--..-|.|||.+.. ..++.++||||||++|+||+| |+.||++.+..+.+..+......|
T Consensus 357 ~Y~~~--~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------- 424 (468)
T KOG0197|consen 357 EYTAS--EGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------- 424 (468)
T ss_pred ceeec--CCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------
Confidence 32221 12222345889999976 789999999999999999998 899999999888887775432222
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL 311 (619)
..+++++.+-+|+..||+.+|++|||++.+.
T Consensus 425 ----------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ----------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1246889999999999999999999999664
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=328.03 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=208.9
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
-|++++.||.|+||.||+|.+..+++.||||.+... ........+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence 478899999999999999999999999999988643 2234456788999999999999999999998 3446799
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+||||++ ++|.+++.. ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999999 588888865 469999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
.......++.+|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 215 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK----------------- 215 (277)
T ss_pred -hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-----------------
Confidence 11233568889999999876 5778899999999999999999999976554332222110
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
. ........++..+.++|.+||..||.+||++.++++||||...
T Consensus 216 ----------~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 ----------N---NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ----------C---CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0 0011223567899999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=340.65 Aligned_cols=286 Identities=20% Similarity=0.266 Sum_probs=205.9
Q ss_pred EEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G--~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
..||+| +||+||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++. ....+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 456666 9999999999999999999998754444555678889999999999999999999984 445689999
Q ss_pred ecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 107 ELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 107 E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 5999988764 358999999999999999999999999999999999999999999999998654332211110
Q ss_pred --cc--cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 184 --IF--WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 184 --~~--~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....++..|+|||++.+....++.++|||||||++|+|++|.+||.+......+..+.. +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCcccccc
Confidence 00 011234567999999875334588999999999999999999999988765444333222 111100000000
Q ss_pred chhHHH-------HH----Hhhcc-----cCC-ccc-cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 260 NDKARR-------YL----TSMRK-----KQP-VQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 260 ~~~~~~-------~l----~~~~~-----~~~-~~~-~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...... .. ..... ... ... ......+++.+.+||.+||..||++|||++|+|+||||..+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 00 00000 000 000 0112245778999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=345.38 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=199.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.. ........+.+|+.+|+.+ +||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---- 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHINIVNLLGAC---- 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC-cCcHHHHHHHHHHHHHHHhcCCcceeeeeeee----
Confidence 35799999999999999999964 346778999998743 2334556788999999999 899999999998
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (619)
.+....|+|||||. |+|.+++....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 34456899999999 69998886432
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 122 ----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 122 ----------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.++++.+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 4788899999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+......+..+..
T Consensus 268 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------- 331 (375)
T cd05104 268 SNYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK------------- 331 (375)
T ss_pred cccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-------------
Confidence 2111 1122345567999999876 679999999999999999998 8999977543322211110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..... ......+.++.+||.+||..||++|||+.++++.
T Consensus 332 -------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 -------------EGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -------------hCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00000 0112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.96 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=203.6
Q ss_pred eEEeEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~~ 100 (619)
|++++.||+|+||.||+|.+.. ++..||+|+++...........+.+|+.+|+.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 34789999997644445566788999999999999999999998765432 3344
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 101 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
..++||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999999 6998888432 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+.++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654322111 1112234667999999866 678999999999999999999 8999987665443322211
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .......++..+.+||.+||..||.+|||+.+++.+
T Consensus 231 --------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 --------------------GN---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------CC---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 011234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=329.12 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=196.8
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHH---HHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILRE---IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-~~~~~i~~E---i~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.||+|+||.||+|.+..+++.||||++....... ........| +.+++...||||+.+++.+ .+...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 4899999999999999999999999986432221 111223333 3445556899999999988 344579999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
|||+. ++|.+++...+.+++..++.|+.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~ 264 (619)
....+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+..........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 1235789999999998642 46889999999999999999999999775321111000
Q ss_pred HHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. ..... ......++..+.+||.+||..||.+|| ++.++++||||+..
T Consensus 209 ~~----~~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 209 RM----TLTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HH----hhccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 00 00001 112234688999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=327.93 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=203.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..+|.+.+.||+|+||.||+|.+. .++..||||.+... ........+.+|+++|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-ASNDARKDFEREAELLTNFQHENIVKFYGVCT---- 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-CCHHHHHHHHHHHHHHHhcCCCCchheeeEEe----
Confidence 456999999999999999999874 34678999998754 22334578899999999999999999999984
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND--------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~--------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 161 (619)
.....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 79 -EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred -cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 3357999999998 59999997643 4789999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007064 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240 (619)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l 240 (619)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754322111 11133456788999999876 679999999999999999998 99999877654443
Q ss_pred HHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..+.. .. .......++..+.+||.+||..||.+||++.|+++
T Consensus 235 ~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQ---------------------------GR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33311 00 01112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=323.42 Aligned_cols=253 Identities=31% Similarity=0.518 Sum_probs=206.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||.|+||.||+|.+..+|+.+++|++.... ........+.+|+.+++.++||||+++++.+ .....+|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999999999999986432 1224556788999999999999999999887 3456799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC-----c
Q 007064 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-----T 183 (619)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~-----~ 183 (619)
. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998764332110 1
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
.......++..|++||.+.. ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999876 4688899999999999999999999987765443332211
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHHcCccccCC
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYFKGL 319 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa---~elL~hp~f~~~ 319 (619)
....+.. ...+++.+.+||.+||+.||.+|||+ .++|+||||+++
T Consensus 216 ----------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ----------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ----------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0011111 11247899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.14 Aligned_cols=265 Identities=25% Similarity=0.384 Sum_probs=214.4
Q ss_pred ccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007064 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIM 91 (619)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 91 (619)
..+|......+.|...+.||+|+||.||+|.+..++..|+||++..... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 90 (313)
T cd06633 11 ADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY 90 (313)
T ss_pred HHHhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3444445555668888999999999999999999999999999864322 233456788999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 92 LPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
. +....|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+||
T Consensus 91 ~-----~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 91 L-----KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred E-----eCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeec
Confidence 4 4467899999999998888865 457899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
|++..... .....++..|+|||++.. ....++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 166 g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---- 234 (313)
T cd06633 166 GSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---- 234 (313)
T ss_pred CCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----
Confidence 98864211 134568889999998742 114688899999999999999999999977765444333211
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... .....+.++..+.+||.+||+.||.+||++.++|.||||..
T Consensus 235 ----------------------~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ----------------------NDS---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ----------------------cCC---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 01112346778999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.34 Aligned_cols=260 Identities=21% Similarity=0.364 Sum_probs=204.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++.+.||+|+||.||+|.++. .+..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 45789999999999999999997642 3458999988643 22344556789999999999999999999883
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
+....|+||||+. |+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 3356899999998 6999999753 23467788999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i 243 (619)
+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EEECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999987643322111 1122345677999999876 578999999999999999998 78899776654433322
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc------Ccccc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA------DPYFK 317 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~------hp~f~ 317 (619)
.+ .. ........++.+.+||.+||..||++|||+.++++ ||||.
T Consensus 235 ~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 235 MD---------------------------GG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred Hc---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 11 00 00111245688999999999999999999999987 99998
Q ss_pred CC
Q 007064 318 GL 319 (619)
Q Consensus 318 ~~ 319 (619)
++
T Consensus 285 ~~ 286 (288)
T cd05061 285 EV 286 (288)
T ss_pred CC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.13 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=210.3
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|++.+.||.|+||.||++.++.+++.+|+|++............+.+|+.+++.++||||+++++++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 589999999999999999999999999999999764444556677889999999999999999999884 336799
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 104 VVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 589988865 45689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123468889999999876 6788999999999999999999999987764332222110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..+......++.++.++|.+||..||++|||+.++|+||++
T Consensus 216 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 216 -----------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01111122567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.97 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=198.4
Q ss_pred EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 30 VIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
.||+|+||.||+|.+ +.++..+|+|+++...........+.+|+.+++.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999964 467789999998755444555677899999999999999999999872 235799999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
|+. ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------------------- 213 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------------------- 213 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC--------------------
Confidence 22334578999998865 578899999999999999997 9999987765444333311
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+++.+.+||.+||..||.+||++++|..
T Consensus 214 -------~~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 214 -------GER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 110 1122357889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=335.63 Aligned_cols=275 Identities=24% Similarity=0.290 Sum_probs=201.2
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-ccH
Q 007064 35 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDL 113 (619)
Q Consensus 35 ~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L 113 (619)
++|.||.+.++.+++.||||++............+.+|+.+|+.++||||+++++++. +...+|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence 4455677777789999999999765445566778999999999999999999999884 4456899999999 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC----ccccc
Q 007064 114 HQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT----TIFWT 187 (619)
Q Consensus 114 ~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~----~~~~~ 187 (619)
.+++... ..+++..+..+++||+.||+|||+.+|+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9998753 46899999999999999999999999999999999999999999999999998754322111 11123
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHH
Q 007064 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 267 (619)
Q Consensus 188 ~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l 267 (619)
...++..|+|||++......|+.++|||||||++|+|++|..||........+. ....+..... +... ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~~---~~~~~~ 240 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LDKS---TYPLYE 240 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-cccC---chhhhc
Confidence 346788899999986533468899999999999999999999998765433221 1111111100 0000 000000
Q ss_pred Hhhcc--------cCCc-cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 268 TSMRK--------KQPV-QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 268 ~~~~~--------~~~~-~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..+.. .... ........+++++.+||.+||..||.+|||++++|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000 0000 00011123467899999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.11 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=201.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++.+.||+|+||.||+|.++ .++..||||++... ........+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~---- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence 3567999999999999999999864 24568999998643 2334556788999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
.+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||+++++.
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 34457899999998 69999987532 3577889999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i 243 (619)
+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543222111 1122345778999999876 678999999999999999999 78999877654444332
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... .. .......++.+.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~---------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEG---------------------------GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcC---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 00 01113457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=315.34 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=208.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 48899999999999999999999999999999975322 456788899999999999999999998843 35689
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 104 VVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
+++||++ ++|.+++... ..+++..+..++.||+.||.+||+.|++||||+|+||+++.++.+||+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998776 5799999999999999999999999999999999999999999999999999876543321
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 134568889999999876 4688999999999999999999999977654333322211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
...........++..+.+||.+||..||++|||+.++|+|||
T Consensus 212 ------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ------------NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000011124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.94 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=202.3
Q ss_pred eEEeEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCc
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~~~ 101 (619)
|.+.+.||+|+||.||+|.+..++. .+|+|.++...........+.+|+.+|+.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578899999999999999877765 69999987654555667788999999999999999999998754321 22346
Q ss_pred EEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 102 IYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 899999998 699888742 2348899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
......... ......+++.|++||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 653322111 1122345678999999876 678999999999999999999 8999987654333222211
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... ...+.++..+.+||.+||..||++|||+++++++
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1110 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.72 Aligned_cols=262 Identities=22% Similarity=0.388 Sum_probs=208.7
Q ss_pred CeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
.|++.+.||.|+||.||+|.+. .+|..||+|++.... ........+.+|+.+|+.+ +|+||+.+++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4899999999999999999874 478999999986421 1223456678899999999 599999999888 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 4467899999999 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+.+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 322111 1234578999999999865334578899999999999999999999965432211111111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.+....+ .....+++.+.+||++||..||++|| ++++++.||||+.+
T Consensus 223 ------------~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 223 ------------RILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ------------HhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0001000 11234678999999999999999997 89999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=365.11 Aligned_cols=148 Identities=24% Similarity=0.434 Sum_probs=133.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|.+++.||.|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 46899999999999999999999999999999999743 22334456788999999999999999999887 3446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+|||||||. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.84 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=196.7
Q ss_pred CCeEEeEEe--eecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVI--GKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~L--G~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
+.|.+.+.+ |.|+||.||++.++.++..+|+|.+....... .|+.+...+ +||||+++++.+. ..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~-----~~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT-----TL 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe-----cC
Confidence 456666665 99999999999999999999999986431111 123333323 6999999999984 34
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 177 (619)
..+|+||||+. ++|.+++..+..++++.++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 57999999998 69999998888899999999999999999999999999999999999999998 99999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH-HHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~-l~~i~~~~g~p~~e~i~ 256 (619)
.. ....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 22 22468889999999976 6789999999999999999999999975442210 0000
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-a~elL~hp~f~~ 318 (619)
.... ......++.+++.+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 220 ----------~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 220 ----------LKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ----------HHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0000 0111233468899999999999999999996 599999999963
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.91 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=200.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++.+.||+|+||.||++..+ .+..+|+|.+.... .....+.+|+.+|+.++||||+++++++ .+..
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 72 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQK 72 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCC
Confidence 3467999999999999999999765 45689999876422 2245688899999999999999999988 3445
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||++ |+|.+++... +.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 6999999998 6999998753 4689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+.+..+....
T Consensus 153 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~---------- 218 (256)
T cd05114 153 DEYTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---------- 218 (256)
T ss_pred Cceec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence 22111 122345567999999876 578999999999999999999 999998877655554442210
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .....+..+.+|+.+||..||.+|||++++++
T Consensus 219 -----------------~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 219 -----------------RLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------CCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 01124678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.57 Aligned_cols=260 Identities=32% Similarity=0.509 Sum_probs=214.7
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
-+..+.|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 86 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV----- 86 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----
Confidence 3556779999999999999999999998999999999975322 45678899999999999999999999843
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 367999999999 69999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|++||++.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------- 230 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------- 230 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 32211 1123457889999999876 5789999999999999999999999977654433322211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
... ........++..+.+||.+||+.||.+|||+.++|.|+||++.
T Consensus 231 ----------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ----------------KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------------cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 0011123367899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.19 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=209.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
....+|...+.||.|+||.||+|+++.++..+|+|.+... ........++.+|+.+++.++|+|++++++++..
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 86 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----- 86 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----
Confidence 3455688899999999999999999999999999998642 2233445678899999999999999999999843
Q ss_pred CCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....|+||||+.++|.+.+.. ...+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 356899999999988887754 4568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ....++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+.+..+..
T Consensus 167 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------- 228 (308)
T cd06634 167 PA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------- 228 (308)
T ss_pred Cc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-----------
Confidence 21 234688899999987421 14578899999999999999999999876554333222210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...+ ......++..+.+||++||..+|++||++++++.|||+...
T Consensus 229 ---------------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 ---------------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 01123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.20 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=203.6
Q ss_pred EEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++. +...+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEE
Confidence 4799999999999998866 8999999997643332 4678899999999999999999999984 35679999
Q ss_pred EecCC-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 106 FELME-SDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~---------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...... ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 543321 111234567889999999876 578999999999999999999 6999988765444333321
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ........+++++.++|.+||..||.+|||+++++++
T Consensus 223 ------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------G---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------C---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0 0111223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.45 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=202.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||+|+||.||+|.++.+++.||||++... .........+.+|+.+|+.++||||+++++++. +...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 5799999999999999999999999999999988642 233445567889999999999999999999884 3457
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+|+|+||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 588887752 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh--HHHHHHHhhhCCCchhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~--~~l~~i~~~~g~p~~e~ 254 (619)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .....+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----------- 220 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----------- 220 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-----------
Confidence 32211 1234568889999999876 57889999999999999999999998654321 111111
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... ........++..+.+||.+||..||.+||++.++|+.
T Consensus 221 ----------------~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 221 ----------------EQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ----------------hcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0000 0001112456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=343.30 Aligned_cols=281 Identities=32% Similarity=0.538 Sum_probs=225.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC------CCCcceeeeEecCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR------HPDIVEIKHIMLPPSR 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~------HpnIv~l~~v~~~~s~ 96 (619)
++|.+....|+|-||+|+.|.|...|..||||+|.+. ..-.+.=++|++||++|. .-++++++..|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F----- 503 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF----- 503 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----
Confidence 6889999999999999999999999999999999853 233344568999999995 23688888777
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGl 172 (619)
...+++|||||.+.-+|.+++++-+ .|....+..+..||+.||+.|-.+||+|.||||+|||+++. ..+||||||.
T Consensus 504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 4457899999999999999998644 68999999999999999999999999999999999999975 5789999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
|.....+. .+.|..++.|+|||++.+ ..|+..+|+||+||+||||.||+.+|+|.+..+.|...+++-|..+.
T Consensus 584 A~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 584 ASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 97754432 377899999999999998 69999999999999999999999999999999999999999998877
Q ss_pred hhhhhhcc--hhH---HHHH-------------HhhcccCC-ccccC------CCC----CCCHHHHHHHHHhccCCCCC
Q 007064 253 DTISRVRN--DKA---RRYL-------------TSMRKKQP-VQFSQ------KFP----NADPSALRLLERLLAFDPKD 303 (619)
Q Consensus 253 e~i~~~~~--~~~---~~~l-------------~~~~~~~~-~~~~~------~~~----~~s~~l~dLI~~mL~~DP~k 303 (619)
..+..-.- ... -.|+ .-+....| ..+.. ..+ .+-..+++||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 76654211 000 0000 00000000 00000 011 12245789999999999999
Q ss_pred CCCHHHHHcCccccC
Q 007064 304 RPTAEEALADPYFKG 318 (619)
Q Consensus 304 RpSa~elL~hp~f~~ 318 (619)
|.|+.++|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.03 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=200.6
Q ss_pred CCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~ 96 (619)
++|++++.||.|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 58999999999999999999753 345789999987532 334456788999999999 79999999998743
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-------------------------------------------------------
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------- 120 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------- 120 (619)
+...+|++|||+. ++|.+++...
T Consensus 83 -~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 83 -PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred -CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 2356899999999 5998888542
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCcc
Q 007064 121 ------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194 (619)
Q Consensus 121 ------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~ 194 (619)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~~ 240 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLK 240 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCcc
Confidence 2578999999999999999999999999999999999999999999999999986533221 111223456678
Q ss_pred ccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhccc
Q 007064 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK 273 (619)
Q Consensus 195 Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~ 273 (619)
|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+.... ...
T Consensus 241 y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~--------------------------~~~ 292 (337)
T cd05054 241 WMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL--------------------------KEG 292 (337)
T ss_pred ccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH--------------------------hcc
Confidence 999999876 689999999999999999997 999997754322221110 000
Q ss_pred CCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 274 QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 274 ~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ......++.+.+|+.+||+.+|++||+++|+++|
T Consensus 293 ~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 293 TRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 1112457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=331.15 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=210.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.+.-..|...+.||+|+||.||++.+..++..||+|++.... ........+.+|+.+++.++|||++++++++.
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 95 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL----- 95 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----
Confidence 344456999999999999999999999999999999986432 23344567889999999999999999999984
Q ss_pred CCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+....|+||||+.|+|.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 96 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 96 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 3456899999999998888754 457999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
... ....++..|+|||++.. ....++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 176 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------- 239 (317)
T cd06635 176 SPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 239 (317)
T ss_pred CCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc---------
Confidence 221 23468889999998742 1246889999999999999999999999776544433332210
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+ ......+++.+.+||.+||..||.+||++.++++|+|+..
T Consensus 240 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 -----------------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----------------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0111246778999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.80 Aligned_cols=257 Identities=28% Similarity=0.525 Sum_probs=209.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
..|.....||+|+||.||++.++.+++.||||++... .......+.+|+.+++.++|+||+++++.+. .....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEE
Confidence 3455567899999999999999999999999998642 2334567889999999999999999999884 44679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+.+ +|.+++. ...+++..+..++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7887764 45689999999999999999999999999999999999999999999999999875433221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+...
T Consensus 172 ~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~--------------- 231 (292)
T cd06657 172 R---RKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------- 231 (292)
T ss_pred c---ccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---------------
Confidence 1 233568899999998876 57889999999999999999999999877654443322110
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.+..+ .....+++.+.+||.+||..||.+||++.++|.||||....
T Consensus 232 ------------~~~~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 232 ------------LPPKL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ------------CCccc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00011 12245688999999999999999999999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.17 Aligned_cols=252 Identities=21% Similarity=0.379 Sum_probs=201.9
Q ss_pred CCeEEeEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+.|++.+.||+|+||.||+|.+. .++..|++|.+... ........+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----Q 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----c
Confidence 57999999999999999999853 45678999998753 33345567889999999999999999999883 3
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 456899999998 6999988532 2478899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~ 239 (619)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |.+||.+.+..+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1123445677999999876 578999999999999999998 9999987664333
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
...+.. ... ......+++.+.+|+.+||..||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 332211 010 11223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=319.67 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=201.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 74 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEE 74 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCC
Confidence 4568999999999999999999864 5677999987642 22356788999999999999999999987 3445
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+++||||||+||+++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecC
Confidence 6899999997 699999865 3468899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 155 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------- 220 (261)
T cd05072 155 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---------- 220 (261)
T ss_pred CCcee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC----------
Confidence 32211 1122345678999999876 578899999999999999998 99999876654443333210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......++..+.+|+.+||..||++|||++++++
T Consensus 221 -----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 -----------------YR---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 1122356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=323.56 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=201.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 569999999999999999999877 7789999988643 22334456889999999999999999999884
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEE
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLK 166 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vK 166 (619)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+|||++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 3356799999997 59999997653 489999999999999999999999999999999999998765 599
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 007064 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~ 245 (619)
|+|||+++......... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCcccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999998653221110 1112233567999999876 579999999999999999997 9999988765443332211
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. .. ......++..+.+|+.+||..||++|||+.++|+|
T Consensus 237 ~---------------------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 G---------------------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00 01123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.74 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|..-++||+|+||.||-+..+.||+-||+|++.+... ......-.++|-.||.+++.+.||.+--+| +..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTk 257 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETK 257 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCC
Confidence 34678888999999999999999999999999999864322 222334567899999999999999998887 555
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|+|+.+|. |||+-+|.+.+ .+++..+.+++.+|+.||.+||..+||+|||||+|||+|+.|+|+|.|+|||...
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 67999999999 59999998766 7999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
....+ .+..+||..|||||++.+ ..|+...|+|||||+||||+.|+.||.........+.
T Consensus 338 ~~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE-------------- 397 (591)
T KOG0986|consen 338 PEGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE-------------- 397 (591)
T ss_pred CCCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH--------------
Confidence 43332 245599999999999988 5799999999999999999999999966432111111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
++......+..++ ...|+++++|.+.+|+.||++|. .++++-+||||+++
T Consensus 398 ----------vdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 398 ----------VDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred ----------HHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 1111112222222 45689999999999999999996 67899999999975
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.85 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=194.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (619)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+++|+.++||||+++++++. +...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEee
Confidence 46999999999999999999999999886432 3344567889999999999999999999983 44568999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 109 ME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 5999998764 368999999999999999999999999999999999999999999999999987543221110 01
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 578999999999999999997 8899866554332222110
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... ......+..+.+|+.+||..||++|||+.++++
T Consensus 212 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 212 -------GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011 112345789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.07 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
...+|++.+.||+|+||.||+|.+..+++ .||+|+++.. .......++.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--- 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---
Confidence 34679999999999999999998866665 4899998643 334456778899999999999999999998843
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
...++|+||+. |+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 81 ---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 24689999998 6999999874 468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+ .
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~-------- 225 (316)
T cd05108 158 LLGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-E-------- 225 (316)
T ss_pred cccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-h--------
Confidence 654322211 1122334667999999876 688999999999999999997 99999776543222111 0
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..... ...+.++..+.+|+.+||..||.+||++.+++.+
T Consensus 226 ------------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 ------------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 1123467789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.60 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=201.6
Q ss_pred CCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 46999999999999999999753 35567999988642 3345667889999999999999999999984
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND-------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 163 (619)
....+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 3456899999998 69999997543 489999999999999999999999999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007064 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242 (619)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~ 242 (619)
.+||+|||+++....... ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999976432221 111233456778999999876 678999999999999999998 9999987765444333
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+.. .... ......++.+.+|+.+||..||.+|||+.+++.
T Consensus 235 i~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ---------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc---------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 321 0100 111246789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.34 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=196.8
Q ss_pred EEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+|+.+.||||+++++++. ...+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876554 78999998754332 45667889999999999999999999863 2357999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 106 FELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
|||+. ++|.+++..+..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~ 263 (619)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999998876 678999999999999999998 9999977665433322211
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......++..+.+||.+||..||++||++.++++
T Consensus 214 ---------~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ---------GE---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CC---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 01122456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=318.78 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=203.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.++|++.+.||+|+||.||+|.++.+ ...||||.+... ........+.+|+.+++.++||||+++++.+. +
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----K 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----c
Confidence 46799999999999999999988654 457999988653 23344567889999999999999999999883 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||+. ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 456899999998 5999998764 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+....
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 4221111 1112334678999999876 578999999999999999998 999997665444333332110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .....+++.+.+|+.+||..||++||++++++++
T Consensus 226 -------------------~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -------------------RL---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------CC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 1123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=320.15 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=203.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
+..+|++++.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 75 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT----- 75 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 35689999999999999999998865543 79999886532 2345667889999999999999999999883
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 4456899999998 5999999764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...............++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR------ 227 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc------
Confidence 5433221111112233567999999876 578999999999999999886 9999987765444433322110
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .....+++.+.+|+.+||+.||.+||++.++++
T Consensus 228 ---------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ---------------------L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------------C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0 112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=326.28 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=206.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|++.+.||.|+||.||+|.+..++..||||.++.... ......+.+|+.++..+. ||||+++++++ .+.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 45779999999999999999999999999999999975422 234556777888776665 99999999998 344
Q ss_pred CcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 67999999999888887765 4578999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCCCccccccccCCccccCcccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCCchhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~--~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~-~~~l~~i~~~~g~p~~e~ 254 (619)
.... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 233 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--------- 233 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------
Confidence 2211 12335778899999986521 3478899999999999999999999965322 111211110
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.....+ .....++..+.+||.+||..||.+||++++++.||||..+.
T Consensus 234 ------------------~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 234 ------------------EEPPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred ------------------CCCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 000000 11124678999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=325.78 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=199.1
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
++|++.+.||+|+||.||+|.++.++. .+++|.++. .......+.+.+|+.++.++ +||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccC
Confidence 579999999999999999999887765 478888763 23344566788999999999 799999999988 344
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC
Q 007064 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 162 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~ 162 (619)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 56899999998 69999997542 48889999999999999999999999999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHH
Q 007064 163 CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLD 241 (619)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~ 241 (619)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864221111 011223456999998876 678999999999999999997 999998776544333
Q ss_pred HHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+.. .. .......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQ---------------------------GY---RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhc---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211 00 001123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=324.57 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=202.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++.+.||+|+||.||++.+... ...+|+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 86 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-- 86 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence 346899999999999999999987643 378999998753 2334556788999999999 7999999999883
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKA----------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~----------------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (619)
....+|+||||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 87 ---~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 ---QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred ---CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 3456899999998 699999864 24689999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007064 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (619)
Q Consensus 158 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~ 236 (619)
|++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 99999999999999998654322111 1122234567999998876 678999999999999999997 9999987765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+....+.. .. ........+..+.+|+.+||..||++|||+.++|++
T Consensus 241 ~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKE---------------------------GY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443332211 00 001123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.16 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=202.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|.+.+.||+|+||.||+|.++.. +..||+|.+... ........+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--- 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc---
Confidence 346899999999999999999987644 378999998643 23345567889999999999999999999984
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
+....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 80 --~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 --TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred --CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC
Confidence 3466899999998 6999998643 23678899999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i 243 (619)
+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+....+
T Consensus 158 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred EEECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 999999999765432211 11123456778999998876 578999999999999999998 99999877654433322
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .... .......+..+.+||.+||..||++|||+.++++
T Consensus 235 ~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 235 I---------------------------DGGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred h---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 0000 1112345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.65 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~--vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
.+.|++.+.||+|+||.||+|.++.++.. +++|.+... ........+.+|+.++..+ +||||+++++++ .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 45799999999999999999998877764 577776532 2334556788999999999 899999999998 34
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 161 (619)
...+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 457999999998 69999997542 4789999999999999999999999999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHH
Q 007064 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQL 240 (619)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l 240 (619)
++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999864211110 011234567999998876 568899999999999999998 99999776654333
Q ss_pred HHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+.. .. . .......++.+.+||.+||..||++||+++++|.+
T Consensus 234 ~~~~~---------------------------~~--~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLPQ---------------------------GY--R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHhc---------------------------CC--c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22210 00 0 01112467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=317.39 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=200.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||+|+||.||+|.+. ++..||+|.++... .....+.+|+.+++.++||||+++++++ .....
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCC
Confidence 357999999999999999999875 45689999987432 2345688999999999999999999987 34456
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999996 79999997654 689999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... ......+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~----------- 220 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG----------- 220 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 21111 111223457999999876 678999999999999999999 99999887654444333210
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+..+.+|+.+||..||.+||++.++++
T Consensus 221 ----------------~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 ----------------YRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------------CCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 112356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.98 Aligned_cols=264 Identities=32% Similarity=0.485 Sum_probs=203.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 95 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s------- 95 (619)
++|+.++.||+|+||.|++++++-+|..||||+|.... ......++.+|+++|.+|+|||||+++..|....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45677899999999999999999999999999998665 5667788999999999999999999986653100
Q ss_pred ----------------------------------------------C--------------------CC-----------
Q 007064 96 ----------------------------------------------R--------------------RD----------- 98 (619)
Q Consensus 96 ----------------------------------------------~--------------------~~----------- 98 (619)
. ++
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 00
Q ss_pred ----------------------C--------CcEEEEEecCCcc-HHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCC
Q 007064 99 ----------------------F--------KDIYVVFELMESD-LHQVIKANDDL-TREHYQFFLYQLLRALKYIHTAN 146 (619)
Q Consensus 99 ----------------------~--------~~lylV~E~~~g~-L~~~i~~~~~l-~e~~i~~i~~QIl~aL~yLHs~g 146 (619)
. ..+||=||||+.+ |.++|..+... ....+|.++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2479999999965 55555555433 47889999999999999999999
Q ss_pred ceeccCCCCcEEECCCCcEEEeecCcccccc------CC---------CCCccccccccCCccccCcccccccC-CCCCC
Q 007064 147 VYHRDLKPKNILANANCKLKICDFGLARVAF------ND---------TPTTIFWTDYVATRWYRAPELCGSFF-SKYTP 210 (619)
Q Consensus 147 IvHrDLKP~NILi~~~~~vKL~DFGla~~~~------~~---------~~~~~~~~~~~gt~~Y~APEll~~~~-~~y~~ 210 (619)
||||||||.||++++++.|||+|||+|.... .. .......|..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 00 01112356789999999999997742 26999
Q ss_pred cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccc-cCCCCCCCHHH
Q 007064 211 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSA 289 (619)
Q Consensus 211 ~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l 289 (619)
|+||||||+||+||+. ||... ++.... +..++. ...++ ...|.+--+..
T Consensus 798 KiDmYSLGIVlFEM~y---PF~Ts--MERa~i------------------------L~~LR~-g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTS--MERASI------------------------LTNLRK-GSIPEPADFFDPEHPEE 847 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCch--HHHHHH------------------------HHhccc-CCCCCCcccccccchHH
Confidence 9999999999999985 46432 222222 222331 22222 22344445677
Q ss_pred HHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 290 LRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 290 ~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 8999999999999999999999999985
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=323.46 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=203.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG----------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg----------------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 85 (619)
.++|++++.||+|+||.||+|.+..++ ..||+|++... ........+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 358999999999999999999876544 45899998753 2234567788999999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
++++++. +...+++|||++. ++|.+++.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999983 3457899999998 59999997665 68999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLF 231 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt--G~~pF 231 (619)
|+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999998764322211 11223456778999999876 578999999999999999998 67888
Q ss_pred CCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q 007064 232 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311 (619)
Q Consensus 232 ~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL 311 (619)
...+..+.+..+...+.. ..........+.++.++.+||.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFFRD-----------------------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcccc-----------------------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 766554443333211100 000011112245678999999999999999999999996
Q ss_pred c
Q 007064 312 A 312 (619)
Q Consensus 312 ~ 312 (619)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.55 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=202.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||.|+||.||+|.+..+|+.||+|.++.. .........+.+|+++++.++|+||+++++.+. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5799999999999999999999999999999988642 223344677889999999999999999999984 3456
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999999 599988864 345899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .. .+
T Consensus 157 ~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~-~~------------- 216 (267)
T cd08224 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY-SL------------- 216 (267)
T ss_pred cCCCc---ccceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HH-HH-------------
Confidence 32221 1234568889999998876 67899999999999999999999999654311 00 00
Q ss_pred hhcchhHHHHHHhhcccCCccccCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
....... .+... ...++..+.++|.+||..||.+|||+.++++
T Consensus 217 ----------~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 ----------CKKIEKC---DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------HhhhhcC---CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000000 00111 1256778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.55 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=221.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~ 98 (619)
...+|.++.+||+|+||.|.+|..+.+.+.||||++++.. ....+.+-.+.|-.+|.... -|.+++++.+| +.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QT 421 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QT 421 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hh
Confidence 4567999999999999999999999999999999997532 23345555667888887764 67888888888 56
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||+. |||...|++-+.+.|..+.+++..|+-||-|||++||++||||.+|||+|.+|++||+|||+++...
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 677999999999 5999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
-+..+ ..+++|||.|+|||++.- .+|+.++|+||+|++|||||.|++||.|.++.+....|++.-
T Consensus 502 ~~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------- 566 (683)
T KOG0696|consen 502 FDGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------- 566 (683)
T ss_pred cCCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence 33332 257899999999999874 799999999999999999999999999999988888775421
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
..+...+|.++.++.+.+|...|.+|.. -.+|-.||||+.+
T Consensus 567 ---------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 567 ---------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred ---------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 1223467899999999999999999964 3678899999864
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=317.51 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=199.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||.||+|.... +..+|+|.+.... .....+.+|+.+++.++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCC
Confidence 4679999999999999999997653 4569999887432 22356889999999999999999999983 3356
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 5899999764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG------------ 217 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC------------
Confidence 2111 112235567999999876 578999999999999999998 99999776654433332110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... .....+..+.+|+.+||..||.+||++.+++.+
T Consensus 218 ---------------~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 218 ---------------LRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0000 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.53 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=202.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.+.|...+.||+|+||.||+|.++.++. .+|+|++... ........+.+|+.+++.++||||+++.+++ .+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----cc
Confidence 4578999999999999999999876665 7999988643 2334566788999999999999999999998 34
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
....|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 466899999999 5999998764 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...............+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 432221111111223457999999876 578999999999999999997 999997776544444332110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+..+.+|+.+||..||.+||++.++++
T Consensus 228 -------------------~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------RL---PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 111245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=318.49 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=199.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..+|++.+.||+|+||.||+|.++ ++..+|+|++..... ....+.+|+.+++.++||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCc
Confidence 456899999999999999999875 466899999864322 2345778999999999999999999883 4456
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.|+||||++ ++|.+++..+ ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++...+.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999998 5899998764 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 217 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------ 217 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC------------
Confidence 2111 111223457999999876 678999999999999999999 89999876654433322110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......++..+.+|+.+||..+|++|||+.++++.
T Consensus 218 ---------------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 218 ---------------YR---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.78 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=201.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
...+|++++.||.|+||+||+|.+..++. .||+|++... ........+.+|+.+++.+.||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 45679999999999999999999877776 4899998643 333455678899999999999999999998843
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
...++++||+. |+|.+++..+ +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 81 ---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 24689999998 6999999764 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------- 226 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------- 226 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------
Confidence 65322211 11122335678999999876 578999999999999999998 9999976553322221110
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ....+..+..+.+||.+||..||++||++.+++.
T Consensus 227 -------------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 227 -------------------GER---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------CCc---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1122456789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.65 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=203.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
..|++++.||.|+||.||+|.++. +..+++|++... .......+.+|+.+|+.++||||+++++++. +...+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence 468999999999999999999887 889999998753 2334567889999999999999999999883 44568
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 599999975 346899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....++..|+|||.+.. ..++.++|||||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 221 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY----------- 221 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----------
Confidence 111 123345678999999876 578899999999999999998 899998877554444332100
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .......++.+.++|.+||..||.+|||+.++++
T Consensus 222 ----------------~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 ----------------R---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ----------------c---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 0112456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.81 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=202.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..+|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~---- 78 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVT---- 78 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc----
Confidence 34688899999999999999987543 5789999997532 2334566889999999999999999999984
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 159 (619)
+...+++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 79 -~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 79 -KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred -CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 3356899999998 5899888532 247888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007064 160 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 238 (619)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~ 238 (619)
+.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred cCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999998764322211 11233456778999999865 578999999999999999998 889998876554
Q ss_pred HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 239 ~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+..+... .. ......++..+.+|+.+||+.||.+||++.+++..
T Consensus 235 ~~~~i~~~---------------------------~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 235 VIEMIRNR---------------------------QV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHcC---------------------------Cc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 44433211 00 11123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.82 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=201.0
Q ss_pred CCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.. ........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCG----- 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----
Confidence 46999999999999999999753 3456789998864 23344567889999999999999999999983
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
+....++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 3456899999998 69999997543 388999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~ 239 (619)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999976433221 111234567888999999876 678999999999999999998 9999977665443
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+..+.. .. ........+..+.+|+.+||..||++|||+.++++
T Consensus 235 ~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 332211 00 01112345778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=359.39 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=202.1
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.+..+++.||||++..... ......++.+|+.+++.++||||+++++++ .+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 689999999999999999999999999999999975332 234456789999999999999999999988 44567
Q ss_pred EEEEEecCC-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 102 IYVVFELME-SDLHQVIKAN-----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-----------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
.|+|||||+ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999999 5999988641 2355677889999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCC---------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007064 170 FGLARVAFNDTPT---------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (619)
Q Consensus 170 FGla~~~~~~~~~---------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~ 234 (619)
||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999765211100 001123579999999999877 67899999999999999999999999775
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+....... ... ..+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i-------------------------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVI-------------------------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhc-------------------------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221100 000 000000 1124678899999999999999999877666654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.98 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=199.2
Q ss_pred CCe-EEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY-~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
+|| ++++.||+|+||+||++. ...++..||+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 466 999999999999998864 3457889999998753 2223456788999999999999999999987432
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2356899999999 5899988764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+ +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~---~~~~~~---- 226 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEM---IGPKQG---- 226 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhh---hccccc----
Confidence 432221111122345667999998876 57899999999999999999999998554311 1111 000000
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
................ ......++..+.+|+.+||..||++|||++++++
T Consensus 227 ---~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 ---QMTVVRLIELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ---ccchhhhhhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000101110 0112356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.39 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=198.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.+..++ .||+|++..... ....+.+|+.+++.++||||+++++.+. ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~ 73 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EE 73 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC------CC
Confidence 3467999999999999999999886654 699999875322 2346788999999999999999998762 13
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 4799999998 5999999753 358999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+......+..+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---------- 219 (262)
T cd05071 154 DNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------- 219 (262)
T ss_pred cccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC----------
Confidence 222111 122346678999998865 578999999999999999999 88999876654433332110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .....++..+.+||.+||+.||.+||++.++++
T Consensus 220 -----------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 220 -----------------YRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.76 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=199.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~ 73 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS------EE 73 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC------CC
Confidence 3467999999999999999999765 566799999875322 2346889999999999999999998762 13
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 4799999998 5999999753 358999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 219 (260)
T cd05070 154 DNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG---------- 219 (260)
T ss_pred Cccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 322111 122345667999998876 578899999999999999999 89999887655444433210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+..+.+||.+||..||.+|||+.++++
T Consensus 220 -----------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 220 -----------------YRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------CCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.96 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=200.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTG--------------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg--------------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ........+.+|+++|+.++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 35899998753 2334456788999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 89 HIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+++. ....+|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+
T Consensus 84 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 9984 3456899999998 59999886532 3688899999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt--G~~pF~~ 233 (619)
|||++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999764322111 11122345678999998876 578999999999999999988 6678877
Q ss_pred CChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 234 ~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.+..+.+..+.... . ......+....+..++.+.+|+.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFF--------------------R---NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhh--------------------h---hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66544433322111 0 00001111223456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.98 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=199.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~ 94 (619)
..++|.+++.||+|+||.||+|.+... +..||||++... ......+.+.+|+++|+.+. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE---
Confidence 356799999999999999999987433 357999999753 33345567899999999996 99999999998
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhC-----------------------------------------------------
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAN----------------------------------------------------- 120 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~----------------------------------------------------- 120 (619)
.+...+|||||||. |+|.+++..+
T Consensus 111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 34467999999998 6998887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 007064 121 -------------------------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (619)
Q Consensus 121 -------------------------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (619)
..+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007064 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (619)
Q Consensus 158 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~ 236 (619)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999999865332211 11123456778999999876 678999999999999999997 9999976543
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.+.+.... ...... .....++..+.+||.+||..||++|||+.++.+
T Consensus 346 ~~~~~~~~--------------------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKI--------------------------KSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHH--------------------------hcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22211110 000000 112356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.48 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=203.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.+.|++.+.||+|+||.||+|.++.+++ .||||.+... ........+.+|+.+++.++||||+++++++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CC
Confidence 4579999999999999999999887665 5999998753 2344567889999999999999999999988 34
Q ss_pred CCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||++ ++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 456899999998 589998875 356899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccc--ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 177 FNDTPTTIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 177 ~~~~~~~~~~~~--~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
............ ...+..|+|||.+.. ..++.++|||||||++|||++ |..||...+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------ 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------
Confidence 332221111111 112457999999876 678999999999999999886 999997776544433332110
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .....++..+.+|+.+||..||.+||++++++..
T Consensus 229 ---------------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 229 ---------------------RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred ---------------------cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 1123567889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.93 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=202.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++.+.||.|+||.||+|.++.++..+|||.+.... ........+.+|+.+++.++||||+++++.+. +...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 57899999999999999999999999999999886432 23344567889999999999999999999884 3457
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 102 IYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999999 489888863 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... .+
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~------------- 216 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL------------- 216 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HH-------------
Confidence 33221 1234578899999999876 5788999999999999999999999976432110 00
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
...+.... .........++.+.+||.+||..||.+|||+.++++
T Consensus 217 ----------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 ----------CKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------hhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00000000 001112346789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.98 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=200.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 93 (619)
.++|.+++.||+|+||.||+|.+.. +...+|+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence 4789999999999999999998643 2357999998753 2334566788999999999 7999999999983
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (619)
+...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|
T Consensus 95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 4456899999998 69999997642 48889999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007064 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~ 235 (619)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998754321111 01112234567999998876 578999999999999999998 889997765
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+....+.. ... ......++.++.+||.+||..||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4333222210 000 11223567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.24 Aligned_cols=269 Identities=23% Similarity=0.384 Sum_probs=201.0
Q ss_pred CCeEEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.+|++++.||+|+||.||+|. +..++..||+|++... .......+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---C
Confidence 479999999999999999997 4567899999998743 344566788999999999999999999987543 2
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 346899999997 6999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..++...... .... .+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~~-- 229 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQGQ-- 229 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----cccccccc--
Confidence 332211111112234456999999876 57899999999999999999998776443211 1111 11100000
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.........+..... ......++..+.+||.+||..||++|||+.++++
T Consensus 230 ----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 ----MIVYHLIELLKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ----cchHHHHHHHhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000011111111111 1123467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=344.90 Aligned_cols=244 Identities=32% Similarity=0.500 Sum_probs=202.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
....|.+...+|.|+|+.|-.+.+..++..+++|++.+. .....+|+.++... +||||+++.+++ .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCC
Confidence 356789999999999999999999999999999999764 22234577665544 699999999999 667
Q ss_pred CcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-CCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA-NANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi-~~~~~vKL~DFGla~~~~ 177 (619)
.++|+|||++.| .|.+.|.....+. .++..|+++|+.||.|||++|||||||||+|||+ +..++++|+|||.++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 889999999995 7777777766555 7888899999999999999999999999999999 688999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. +..-+-|..|.|||++.. ..|+++|||||||++||+||+|+.||........ |...++.+
T Consensus 468 ~~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~------- 529 (612)
T KOG0603|consen 468 RS------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMP------- 529 (612)
T ss_pred hh------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCC-------
Confidence 33 223467889999999985 7999999999999999999999999977654311 11111111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.+. ..+|..++|||+.||++||.+|+++.+++.||||
T Consensus 530 -------------------~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 -------------------KFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------ccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 4689999999999999999999999999999999
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.20 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=201.9
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
||.+.+.||+|+||.||++.+..++..+++|+++... ........+.+|+.+++.++||||+++++.+. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 6999999999999999999998888777777765322 12234456778999999999999999999874 345
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 101 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 6899999998 488887753 457999999999999999999999999999999999999975 5799999999876
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5432211 133467889999998865 5788899999999999999999999976654333222110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
. ........++..+.+||.+||..||.+||++.++|+||||
T Consensus 220 -----------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 -----------------G---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------C---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 0111123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=312.23 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=200.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|++.+.||.|+||.||+|.+. |+.||+|++.... ...+++.+|+.+++.++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 73 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GN 73 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CC
Confidence 3568999999999999999999764 8899999997542 256778999999999999999999999843 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 6899999999 69999998765 69999999999999999999999999999999999999999999999999998652
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... .....+..|+|||.+.. ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 154 ~~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------- 214 (256)
T cd05039 154 QGQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK----------- 214 (256)
T ss_pred ccc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----------
Confidence 221 12234567999998876 578899999999999999997 9999977654333222210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .......++.+.+||.+||..+|.+|||++++++
T Consensus 215 ----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ----------------GYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----------------CCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=311.72 Aligned_cols=245 Identities=30% Similarity=0.500 Sum_probs=203.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELM 109 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (619)
||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999998999999999875322 223556788999999999999999999887 4556799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc
Q 007064 110 E-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188 (619)
Q Consensus 110 ~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (619)
. ++|.+++.....+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998888899999999999999999999999999999999999999999999999999976543321 1234
Q ss_pred ccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHH
Q 007064 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 268 (619)
Q Consensus 189 ~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (619)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999876 5678899999999999999999999977654322222210
Q ss_pred hhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH---HHHHcCccc
Q 007064 269 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA---EEALADPYF 316 (619)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa---~elL~hp~f 316 (619)
... ......+..+.+||++||..||++||++ +++++||||
T Consensus 208 -----~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 -----DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 000 1112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.64 Aligned_cols=262 Identities=23% Similarity=0.398 Sum_probs=205.7
Q ss_pred CeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIF--EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
.|++.+.||+|+||.||++.+. .+++.||||.+.+.. ........+.+|+.++..+ +||||+.+.+.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4899999999999999999864 467899999986431 1223445678999999999 599999999887 3
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
....+|+||||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 4457899999998 599999988778999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
....... .....++..|+|||.+.+.....+.++|+|||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred ccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 3322111 123468899999999865323478899999999999999999999965432211111100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC---HHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT---AEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS---a~elL~hp~f~~~ 319 (619)
... ... ......+++.+.+||.+||+.||++||| +.++|+||||+.+
T Consensus 223 --------~~~----~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 223 --------RIL----KSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred --------HHH----ccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 000 000 1112346789999999999999999998 5778999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.27 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=201.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|.+.+.||.|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCC
Confidence 3578999999999999999999875 45779999987432 2345688999999999999999999987 3345
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 6899999998 59999997643 68999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+.....
T Consensus 155 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (261)
T cd05034 155 DDEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-------- 222 (261)
T ss_pred chhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 221111 112234567999999876 578999999999999999998 9999988766555444322110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.......+..+.+++.+||..||.+||+++++++
T Consensus 223 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112345778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=313.79 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=199.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|+++++||.|+||.||+|.++ +++.||+|.+..... ....+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCC
Confidence 467999999999999999999864 567899999874322 3456889999999999999999998762 235
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 899999998 6999998653 3689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++ |++||.+.+..+....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred CCccc--ccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 21111 122345678999999876 578899999999999999998 999998877544443332110
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .......+.++.+||.+||..||++|||++++++
T Consensus 221 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 -----------------R---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------C---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0112346778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.21 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=197.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+..+|++.+.||+|+||.||++.. .|..+|+|.+... .....+.+|+.+++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 73 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 73 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCC
Confidence 345799999999999999999965 4788999988642 234568899999999999999999987632 335
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 6899999998 59999997654 48899999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 154 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 214 (256)
T cd05082 154 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 214 (256)
T ss_pred ccC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 221 12234567999999876 678999999999999999997 9999976654333222210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ....+.+++.+.+||.+||..||++|||+.++++
T Consensus 215 ----------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 ----------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 1122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.95 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=202.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 92 (619)
...+|.+.+.||+|+||.||+|.+. .++..||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3567999999999999999999752 23457999988743 2334567789999999999 7999999999883
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
....+|+||||+. ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+
T Consensus 92 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 92 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred -----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 4457899999998 6999999753 24778889999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999865332211 11122345678999999876 578999999999999999998 88999877
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+..+....+.. ... ......++..+.+||.+||..+|.+|||+.++|+.
T Consensus 244 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 65444433211 000 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.86 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=200.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..+|.+.+.||+|+||.||++.. ..++..+|+|.+.. ........+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCT---- 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe----
Confidence 35788999999999999999964 33567899998864 23455667899999999999999999999883
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND---------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~---------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 78 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred -cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 3456899999998 69999987643 488999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~ 239 (619)
+++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999754322111 11122345678999998876 578999999999999999998 9999977665443
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+..+.. .... .....+++.+.+||.+||+.||.+||++++++.
T Consensus 234 ~~~~~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 234 IECITQ---------------------------GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHc---------------------------CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332211 0000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.87 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=200.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 93 (619)
.++|.+++.||+|+||.||+|.+.. ....+|+|.++.. ........+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 3689999999999999999997632 3457999988753 2334566788999999999 6999999999883
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (619)
+...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 3456899999998 6999999753 348899999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007064 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~ 235 (619)
||++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997643221111 0111234467999999876 678999999999999999999 899998776
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..+....+.. ... ......++..+.+||.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5444333211 000 1122456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=316.49 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=198.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++++.||+|+||+||+|.+..++. .+++|.+... ........+..|+.++..+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 4679999999999999999999877776 4777776532 22334467788999999999999999999873
Q ss_pred CCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
....++|+||+. |+|.+++.. .+.+++..+..|+.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 234789999998 799999975 45789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
..... .........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.
T Consensus 159 ~~~~~-~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05111 159 LYPDD-KKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------- 225 (279)
T ss_pred ccCCC-cccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 53322 1112233456778999999876 578999999999999999998 999998765433222211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
...... .....+..+.+++.+||..||++|||+.|+++
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 -----------------KGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001111 11124568899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=310.29 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=211.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+..+++..||.|+.|+||+++.+.+|...|||.+... .+..+.++|+..+.++... .+|+||+.+++|... .+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~d 165 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TD 165 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----ch
Confidence 3344677899999999999999999999999999864 5667788999999987665 489999999999654 45
Q ss_pred EEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
++|.||.|..-+..+++. .++++|..+-.+...++.||.||.. .||+|||+||+|||+|+.|.+||||||.+....+.
T Consensus 166 V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 899999999665555543 4579999999999999999999986 57999999999999999999999999999765433
Q ss_pred CCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .+...|-+.|||||.+.-. ...|+-.+||||||+.|+||.||+.||.+.+ +.+.+.+|.+
T Consensus 246 kA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln------------ 309 (391)
T KOG0983|consen 246 KA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN------------ 309 (391)
T ss_pred cc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh------------
Confidence 22 1345788999999988542 4679999999999999999999999999864 4455544432
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..+ +.-..-.+.|+.+.+|+..||..|+.+||...++|+|||+..+.
T Consensus 310 ---------------~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 310 ---------------EEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ---------------cCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 111 11111124789999999999999999999999999999998643
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.06 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=193.3
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 30 VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+|+.++||||+++++++. ...+|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEE
Confidence 3899999999999765 45567999998753 23344567889999999999999999999872 235899999
Q ss_pred cCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccc
Q 007064 108 LME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF 185 (619)
Q Consensus 108 ~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (619)
|+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 699998875 457999999999999999999999999999999999999999999999999999754332221111
Q ss_pred cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHH
Q 007064 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264 (619)
Q Consensus 186 ~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~ 264 (619)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 122233568999998875 578999999999999999996 9999977665443322211
Q ss_pred HHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... ...+..++++.+||.+||..||++||++.++++
T Consensus 214 --------~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 --------GKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 122456889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.55 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=198.0
Q ss_pred EEeeecCceEEEEEEECC-CC--cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTH-TG--EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~-tg--~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.||+|+||.||+|.+.. .+ ..||||.+...... ...+.+.+|+.+++.++||||+++++++. + ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEE
Confidence 468999999999998765 33 36999999764333 56678899999999999999999999884 3 568999
Q ss_pred EecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 106 FELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
|||+. ++|.+.+.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99998 69999997754 6899999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111122456778999999876 578999999999999999998 99999877655444333210
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .......+..+.+|+.+||..+|++|||+.++++
T Consensus 217 -----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 -----------GER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------CCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000 0011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=312.07 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=198.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 73 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EE 73 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CC
Confidence 346799999999999999999987655 469999876422 23456788999999999999999998872 23
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.+||+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 4799999998 5999999764 348899999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------- 219 (260)
T cd05069 154 DNEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG---------- 219 (260)
T ss_pred CCcccc--cCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 222111 122345678999998876 578999999999999999999 99999887654443333210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......+..+.+|+++||..||++||+++++++
T Consensus 220 -----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 220 -----------------YR---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------------CC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 0112356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.74 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=200.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|.+.+.||+|+||.||+|.+ ..++..||+|+++.. ........+.+|+.+++.+ +||||+++++.+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHENIVNLLGACT--- 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc-CChHHHHHHHHHHHHHHhccCCCCcceEEEEEe---
Confidence 35799999999999999999975 335568999998753 2334556788999999999 7999999999883
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
....+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||+
T Consensus 110 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 110 --IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred --cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 4456899999998 69999997543 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.+.....
T Consensus 188 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCcee-ecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 97653322111 1122356778999998876 578999999999999999998 9999977654332211110
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... .......++.+.+|+.+||..||++|||+.++++
T Consensus 259 --------------------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 --------------------EGYR---MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------cCCc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 0112345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.20 Aligned_cols=248 Identities=28% Similarity=0.446 Sum_probs=195.8
Q ss_pred EEeEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 26 KIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++.+.||.|.||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++.. ...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc-----ccc
Confidence 57899999999999999877 4567899999964 3445567889999999999999999999999962 344
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+++|||||. |+|.+++... ..+++..+..|+.||+.||.|||+.+|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999998 7999999886 6899999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ...........|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+.+.
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----------- 221 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----------- 221 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-----------
T ss_pred cccc-cccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccc-----------
Confidence 2111 11223456778999999876 568999999999999999999 78999877655444333211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......++..+.+||.+||..||++|||+.++++
T Consensus 222 ----------------~~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ----------------QR---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------------EE---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------------cc---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00 1112346788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.36 Aligned_cols=277 Identities=26% Similarity=0.404 Sum_probs=221.8
Q ss_pred cCCCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcce
Q 007064 8 KNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 8 ~~~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~ 86 (619)
|+|+.....-.-.+-+-|..++.||-|+||.||++....|...||+|.+.+. .........+..|-.||..-+.+-||+
T Consensus 614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr 693 (1034)
T KOG0608|consen 614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR 693 (1034)
T ss_pred hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence 4555555554456677799999999999999999999899999999988642 223345567788999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 165 (619)
|+-.| +|..++|+||||+. ||+..+|-..+.|.|+.+++++..+.+|+++.|..|+|||||||+|||||.+|++
T Consensus 694 LyySF-----QDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 694 LYYSF-----QDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEEEe-----ccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCce
Confidence 99888 78889999999999 5999999999999999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccc---------CCC-CC-c----------------------------cccccccCCccccCcccccccCC
Q 007064 166 KICDFGLARVAF---------NDT-PT-T----------------------------IFWTDYVATRWYRAPELCGSFFS 206 (619)
Q Consensus 166 KL~DFGla~~~~---------~~~-~~-~----------------------------~~~~~~~gt~~Y~APEll~~~~~ 206 (619)
||.||||+.-+. +.. .. + +.....+||+.|+|||++.. .
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~ 846 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--T 846 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--c
Confidence 999999984311 000 00 0 00123589999999999987 7
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCC
Q 007064 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 286 (619)
Q Consensus 207 ~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 286 (619)
.|+..||+||.|+|||||+.|++||...+..+...+|..+ +.++. .....++|
T Consensus 847 g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw-----------------~~~l~----------~~~~~~ls 899 (1034)
T KOG0608|consen 847 GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW-----------------RNFLH----------IPYQGNLS 899 (1034)
T ss_pred CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh-----------------hhccc----------cccccccC
Confidence 8999999999999999999999999877654443332211 01110 01224789
Q ss_pred HHHHHHHHHhccCCCCCCC---CHHHHHcCccccCC
Q 007064 287 PSALRLLERLLAFDPKDRP---TAEEALADPYFKGL 319 (619)
Q Consensus 287 ~~l~dLI~~mL~~DP~kRp---Sa~elL~hp~f~~~ 319 (619)
+++.+||.++.+ ++++|+ .++++-.||||+++
T Consensus 900 ~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 900 KEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 999999998655 888886 57789999999975
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.50 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=198.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 36899999999999999999984 3567899999997532 234456788999999999 68999999998743
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (619)
....+|+|||||+ |+|.+++...
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 2346899999999 6999988643
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccc
Q 007064 121 -------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187 (619)
Q Consensus 121 -------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (619)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677888899999999999999999999999999999999999999999999764322211 1112
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 188 ~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+....
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------------- 295 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---------------------- 295 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----------------------
Confidence 2345667999999876 678999999999999999996 999997754322211110
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
...... ......++.+.+++.+||..||++|||+.++++|
T Consensus 296 ----~~~~~~---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 ----KEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----hccCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000000 0112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.18 Aligned_cols=234 Identities=26% Similarity=0.415 Sum_probs=194.2
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
++-||.|+.|.||+|+ -.++.||||+++... ..+|+-|++|+||||+.++++|.. ...+|||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecC-----CceeEEeee
Confidence 5679999999999995 458999999986421 247888999999999999999943 356999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 108 LME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
||. |-|.+++++...++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++..... .+.
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk--- 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK--- 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh---
Confidence 999 899999999999999999999999999999999999999999999999999999999999999865433 221
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
-.++||..|||||++.+ .+.++|+|||||||+|||||||..||..-+. -..| +|.-+
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAII---wGVGs--------------- 325 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAII---WGVGS--------------- 325 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch---heeE---EeccC---------------
Confidence 24789999999999998 7999999999999999999999999955332 1111 11100
Q ss_pred HHhhcccCCccccC-CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 267 LTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 267 l~~~~~~~~~~~~~-~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+.- ....+++.++=||+.||.-.|..||++.+||.|
T Consensus 326 ---------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 326 ---------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ---------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 00111 112456678889999999999999999999998
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=308.26 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=201.8
Q ss_pred eEEeEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+++.+.||.|+||.||+|.+..++ ..||+|++... ........+.+|+.+|+.++|+||+++++++. +.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCC
Confidence 357889999999999999998766 89999999643 22235678889999999999999999999984 336
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|++||++. ++|.+++..... +++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 7999999998 599999976554 9999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~----------- 219 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK----------- 219 (258)
T ss_pred cccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 331111 112236788999998865 678999999999999999998 8899987665444333311
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .......+..+.+++.+||..||++|||+.++++
T Consensus 220 ----------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 220 ----------------GYR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------------CCC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000 1112336889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=323.68 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=200.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
.+|++++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 4799999999999999999986432 236899988743 2334567788999999999 7999999999983
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (619)
....+|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 3456899999998 59999987532 377888999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007064 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (619)
Q Consensus 158 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~ 236 (619)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999764332111 11122334567999999876 678999999999999999998 8899988765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+....+.. ... .......+..+.+||.+||..+|++|||+.++|++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444433311 000 01123567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=317.00 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=197.8
Q ss_pred CeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+|++.+.||+|+||.||+|.+.. ....+++|.+... ........+.+|+.+|+.++||||+++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ec
Confidence 48899999999999999998753 2357888888643 2334567788999999999999999999988 34
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 456899999999 6999988642 247889999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~ 232 (619)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999764322211 11122345678999998876 578999999999999999998 999998
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+.........+... ... .....++..+.+|+.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~-----------------------------~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTG-----------------------------YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCC-----------------------------CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76644333222110 000 112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.22 Aligned_cols=251 Identities=25% Similarity=0.427 Sum_probs=201.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
..+|.+.+.||.|+||.||+|.+... ...|+||..... ......+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987544 346899988643 224556688999999999999999999998732
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 34689999998 69999997644 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..... ...+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~---------- 223 (270)
T cd05056 158 EDESY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN---------- 223 (270)
T ss_pred ccccc--eecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------
Confidence 33311 11122334567999998865 578999999999999999986 9999988775544433211
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... ...+.+++.+.+||.+||..||.+|||+.+++..
T Consensus 224 -----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 224 -----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred -----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.64 Aligned_cols=261 Identities=29% Similarity=0.398 Sum_probs=213.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+++-...||.|.||.||.|++..+|+..|+|.|+-..........+.+|.++|..|+|||+|+++++=. +...+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----HRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----HREKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----cHHHHH
Confidence 345567899999999999999999999999998744333445566889999999999999999999863 335689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC-C
Q 007064 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT-P 181 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~-~ 181 (619)
|.||||+ |+|.+++...+..+|-..+.+..|++.||.|||+.|||||||||.|||++.+|.+|++|||.|....+.. .
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999 6999999888778888888899999999999999999999999999999999999999999998866553 2
Q ss_pred CccccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~-~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
......++.||+.|||||++.+.. .+..-+.|||||||++.||+||+.||...+..-++ |.+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--My~V-------------- 1454 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--MYHV-------------- 1454 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--HhHH--------------
Confidence 223356789999999999986632 45667999999999999999999999766543222 1110
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..... .+....+|.+.+|||++||..||++|+++.|+|+|-|-+.
T Consensus 1455 ----------~~gh~---Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 ----------AAGHK---PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred ----------hccCC---CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 01111 1122248899999999999999999999999999988664
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=315.97 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=200.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.++|++++.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.+.||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~---- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCA---- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc----
Confidence 467999999999999999999875 36789999998743 22344567889999999999999999999883
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
+...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.|++|||||
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 4456899999999 59999997432 37888899999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~ 232 (619)
|+|||++.++.+||+|||+++......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999987543222111 0122334667999998876 678999999999999999997 888987
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+.+..+....+.+ ... .......+..+.+||.+||..||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRD---------------------------GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7665443322211 000 0112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=315.74 Aligned_cols=270 Identities=24% Similarity=0.364 Sum_probs=203.4
Q ss_pred CCeEEeEEeeecCceEEEEEEE----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAID----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.-|++++.||+|+||.||+|.. +.++..||+|.++.. ........+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4578999999999999999974 467889999998743 2344456788999999999999999999988432 2
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999997 5999998664 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..............++..|+|||.+.+ ..++.++|||||||++|+|+++..|+..... ...+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccccc-
Confidence 433221112234557778999998876 5789999999999999999998876533211 11111121111100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.......+.... ....+..++..+.+||.+||+.||.+|||+++++++
T Consensus 232 ------~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 ------VTRLVRVLEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ------HHHHHHHHHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 001111111111 112235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.20 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=197.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH----------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~----------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~ 86 (619)
++|++.+.||+|+||.||++.+.. ++..+|+|++... ........+.+|+.+|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999985432 3457999998743 23345567889999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND-----------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (619)
+++++. +...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999884 3356899999998 69999987642 367788999999999999999999999999999
Q ss_pred CcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCC
Q 007064 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (619)
Q Consensus 155 ~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt--G~~pF~ 232 (619)
+|||++.++.+||+|||+++......... ......++..|++||.+.. ..++.++|||||||++|||++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999997643322111 1122344678999998765 578999999999999999998 778887
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..+..+.+..... ++... .........+.+++.+.+|+.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGE--------------------FFRDQ---GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHH--------------------HHhhc---cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6654333222111 11000 000011122346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.20 Aligned_cols=254 Identities=20% Similarity=0.349 Sum_probs=203.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35789999999999999999999876 3578999988643 3455667788999999999999999999987532
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEE
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN--------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~--------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 167 (619)
....++++||+. ++|.+++... ..+++..++.++.||+.||.|||+.+++||||||+|||++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 346799999998 6999998653 45899999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~ 246 (619)
+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+....+..
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 234 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD- 234 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-
Confidence 9999997653322111 1122345677999999876 578999999999999999998 9999977654332222111
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... + .....+++.+.+++.+||..||++|||+.++++
T Consensus 235 --------------------------~~~--~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 --------------------------GYR--L-AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------------------CCC--C-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0 112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.17 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence 4578999999999999999999754 4567999988642 2345678899999999999999999998732 4
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 5899999998 6999999763 457888999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
...... .....++..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------- 219 (260)
T cd05073 154 DNEYTA--REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---------- 219 (260)
T ss_pred CCCccc--ccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC----------
Confidence 221111 122345677999999876 578999999999999999998 99999887654443332110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ........+..+.+++.+||..||++||++.++++
T Consensus 220 -----------------~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 220 -----------------Y---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------------C---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 01122456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.14 Aligned_cols=286 Identities=28% Similarity=0.461 Sum_probs=219.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----C---CCcceeeeEecCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----H---PDIVEIKHIMLPP 94 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----H---pnIv~l~~v~~~~ 94 (619)
+||.++++||-|.|++||+|.|..+.+.||+|+.+. .....+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 899999999999999999999999999999999973 3344566789999999884 3 3599999998665
Q ss_pred CCCCCCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCC---------
Q 007064 95 SRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANAN--------- 162 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~--------- 162 (619)
. .+..++|+|+|+++.+|..+|+.. ..++...++.|++|||.||.|||. +||||-||||+|||+..+
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 4 577899999999999999999864 479999999999999999999996 799999999999996210
Q ss_pred --C-----------------------------------------------------------------------------
Q 007064 163 --C----------------------------------------------------------------------------- 163 (619)
Q Consensus 163 --~----------------------------------------------------------------------------- 163 (619)
+
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence 0
Q ss_pred ------------------------------------------------------------------------------cE
Q 007064 164 ------------------------------------------------------------------------------KL 165 (619)
Q Consensus 164 ------------------------------------------------------------------------------~v 165 (619)
+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 01
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------hhHH
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQ 239 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~------~~~~ 239 (619)
||+|||-|.-. ...+|+-+.|+.|+|||++.+ ..|+..+||||++|+++||+||..+|...+ +.+.
T Consensus 394 KIaDlGNACW~------~khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWV------HKHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhh------hhhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 22222222110 011244578999999999988 799999999999999999999999996542 5678
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCC---------CCC----HHHHHHHHHhccCCCCCCCC
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP---------NAD----PSALRLLERLLAFDPKDRPT 306 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------~~s----~~l~dLI~~mL~~DP~kRpS 306 (619)
+..|.+++|..+...+.. ...-+.|+.....-+-+.--..|+ .++ .++.|||.-||+++|++|||
T Consensus 466 iA~i~ELLG~iPr~ia~~--Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALG--GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhc--CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 999999999877665432 233344444322111111111121 223 35789999999999999999
Q ss_pred HHHHHcCccccCCCcC
Q 007064 307 AEEALADPYFKGLSKV 322 (619)
Q Consensus 307 a~elL~hp~f~~~~~~ 322 (619)
|.++|+|||+......
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999977654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.08 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+..+|++.+.||.|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++. +..
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 72 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERS 72 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCC
Confidence 3568999999999999999999875 467899998864322 2345788999999999999999999883 445
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||+. ++|.+++... ..++++.++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 6899999998 5899988764 4689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+..
T Consensus 153 ~~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------ 216 (256)
T cd05112 153 DQYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------ 216 (256)
T ss_pred Ccccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC------------
Confidence 22111 112335568999999876 578899999999999999998 9999977665443333211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..... .....+..+.+|+.+||..||++|||+.+++++
T Consensus 217 ---------------~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 ---------------GFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00000 011246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.63 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=191.5
Q ss_pred EEeeecCceEEEEEEECCCCc--EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~--~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.||+|+||.||+|.++.++. .+++|.++.. ........+.+|+.++..+ +||||+++++++. ....+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEE
Confidence 368999999999999988776 4688887642 2334556788999999999 7999999999983 34568999
Q ss_pred EecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 106 FELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
|||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999997543 47899999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
|||++........ ......+..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 226 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 226 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--
Confidence 9999863221110 111233567999999876 678999999999999999997 9999977654333322210
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .......+.++.+|+.+||..||.+|||+.+++.
T Consensus 227 -------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------------------CCC---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 0112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.14 Aligned_cols=266 Identities=17% Similarity=0.191 Sum_probs=194.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhcCCCCcceee
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDA---------ARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~---------~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... .....++..+..+.|+||+.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347899999999999999999998877 6677777643221111100 1122344456667899999999
Q ss_pred eEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
++..... ......|+++|++..++.+.+......++..++.|+.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8753321 112245788998888888888766667899999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007064 169 DFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~ 244 (619)
|||+|+......... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999998653221110 11123479999999999887 679999999999999999999999998774322211110
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ..++..+.... ...++.++.+.++++.|+..||++||+.+++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 01111111110 123456788999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.20 Aligned_cols=279 Identities=20% Similarity=0.269 Sum_probs=187.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..++|++.+.||+|+||.||+|.+..+ +..||+|++..... .....+| .++...+.++..+...+.....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 567899999999999999999999988 99999999864211 1111111 1222233334433333222111
Q ss_pred -CCCCcEEEEEecCC-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 007064 97 -RDFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKP 154 (619)
Q Consensus 97 -~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (619)
.+...+++||||+. ++|.+++..... ..+..++.|+.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 34567999999999 589998875421 12345678999999999999999999999999
Q ss_pred CcEEECC-CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccC--------------------CCCCCccc
Q 007064 155 KNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (619)
Q Consensus 155 ~NILi~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~--------------------~~y~~~~D 213 (619)
+|||++. ++.+||+|||+|+....... .....+++++.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57999999999975432211 1224578999999999653210 13455679
Q ss_pred chhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcccc---CCCCCCCHHHH
Q 007064 214 IWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS---QKFPNADPSAL 290 (619)
Q Consensus 214 IWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~s~~l~ 290 (619)
|||||||||||+++.. ...+...++..+....+.....+... .......... ..+...+..+.
T Consensus 362 VwSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVAWRKL------------VEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHHHHHh------------hccccchhhhhhhhhccccchHHH
Confidence 9999999999998654 44444444444443333321111100 0000000000 11122345678
Q ss_pred HHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 291 RLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 291 dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
|||.+||++||++|||+.++|+||||++...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999999999999987543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.98 Aligned_cols=252 Identities=22% Similarity=0.379 Sum_probs=201.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
++|++++.||.|+||.||+|..+. +...|++|.+... ........+.+|+.+|+.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----R 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----C
Confidence 679999999999999999998754 3467999987642 2223456788999999999999999999988 3
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEE
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND---------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~---------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 167 (619)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 4456899999998 69999998665 6999999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~ 246 (619)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+....+..+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 99999875432211 11233456778999998876 567889999999999999998 8889966543322222110
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....+ .....++..+.++|.+||..||.+|||+.+++.+
T Consensus 234 ---------------------------~~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 ---------------------------GKLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------------------CCcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00001 1123567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.76 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=194.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (619)
+.||.|+||.||+|... ++..+|+|++.... .......+.+|+.+++.++||||+++++++. .....|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEEC
Confidence 46899999999999864 68899999987543 2334456889999999999999999999883 34568999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 109 ME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
+. ++|.+++... ..+++..+..++.||+.+|.|||+.|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999988653 468999999999999999999999999999999999999999999999999987532221111 0
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-------------------- 209 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-------------------- 209 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 11234567999999876 578899999999999999998 9999987764433322211
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .......++..+.+|+.+||..||++||++.++++.
T Consensus 210 -------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 210 -------GY---RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -------CC---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00 011223567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.00 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=201.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..+|++++.||+|+||.||+|.++.+|+ .+|+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877665 5899987653 234456678899999999999999999998853
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...++||||+. |+|.+++..+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 46899999998 6999998764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
........ ......++..|+|||.+.. ..++.++|+|||||++|||++ |..||.+.+..+....+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 226 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK--------- 226 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---------
Confidence 54222111 1111223567999998865 578899999999999999998 9999987665433322211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... ......+..+.+++.+||..||++||++.++++
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 227 ------------------GERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 112345678999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.51 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=188.8
Q ss_pred EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|... .....+++|.+... ........+.+|+.+++.++||||+++++.+. +...+|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEE
Confidence 35899999999999643 24457888877643 23444567889999999999999999999884 345689999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 107 ELME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
||+. |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 69999997643 24677889999999999999999999999999999999999999999999986532221
Q ss_pred CCccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~-----~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
... ......++..|+|||++... ...++.++|||||||++|||++ |..||......+.+..+....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~------- 226 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ------- 226 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc-------
Confidence 110 01223456779999987431 1357889999999999999999 788997766544433322110
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
............++..+.+++..|+ .||++|||++++++
T Consensus 227 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 ------------------DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0001111222356788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=308.83 Aligned_cols=228 Identities=25% Similarity=0.357 Sum_probs=185.4
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-cc
Q 007064 34 GSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SD 112 (619)
Q Consensus 34 G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~ 112 (619)
|.||.||+|.++.+++.||+|++.... ...+|...+....||||+++++++ .+...+|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence 889999999999999999999997531 123445555556799999999988 34467999999999 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCC
Q 007064 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192 (619)
Q Consensus 113 L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt 192 (619)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 233567
Q ss_pred ccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcc
Q 007064 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 272 (619)
Q Consensus 193 ~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (619)
..|+|||.+.. ..++.++|+||+||++|+|++|..||...... + . .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~---------------~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------N---------------T 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------c---------------c
Confidence 78999999876 57889999999999999999999887432110 0 0 0
Q ss_pred cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHcCccc
Q 007064 273 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYF 316 (619)
Q Consensus 273 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-----~elL~hp~f 316 (619)
.... ...+.+++.+.+||.+||+.||.+|+++ +++++||||
T Consensus 192 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0000 1113467899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.74 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=201.0
Q ss_pred eEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC-CC
Q 007064 25 YKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD-FK 100 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~-~~ 100 (619)
|.+.+.||+|+||.||+|.++ .++..||||++............+.+|+.+|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 35789999999765555666778899999999999999999999886543221 12
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 101 DIYVVFELME-SDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
..++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888877432 24789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+........ .......++..|++||.+.. ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 865322211 11122345677999998876 578899999999999999999 8999977665433322211
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ....+..+..+.+|+.+||..+|.+|||+.+++.+
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 --------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01113567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.23 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=194.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEec
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFEL 108 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (619)
+.||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.++||||+++++++ .+....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence 469999999999999877 999999998754332 4566788999999999999999999988 344578999999
Q ss_pred CC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccc
Q 007064 109 ME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW 186 (619)
Q Consensus 109 ~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (619)
+. ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 589999865 4568999999999999999999999999999999999999999999999999987543211110 00
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~------------------- 211 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG------------------- 211 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------------------
Confidence 11233566999998876 578999999999999999999 88999776643332222110
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+..+.+|+.+||..+|.+|||++|+|+
T Consensus 212 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 --------YRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------CCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 011245789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.39 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=200.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s 95 (619)
.++|.+++.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+|..+. ||||+++++++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~--- 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT--- 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc---
Confidence 356889999999999999999853 455789999997542 3334557889999999997 999999999984
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (619)
....+|+|||||. |+|.+++..+.
T Consensus 112 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 112 --KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred --cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 3356899999999 69999986532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 007064 122 ---------------------------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (619)
Q Consensus 122 ---------------------------------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (619)
.+++..+..|+.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35677888999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007064 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~ 235 (619)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999864322211 11123456788999999876 578999999999999999998 889997655
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+.+..... .... ......++.++.+||.+||..||.+||+++++|..
T Consensus 347 ~~~~~~~~~~--------------------------~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIK--------------------------RGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHH--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4333221110 0000 01123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.21 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=204.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+...+++.||+|.||+||+|.+- | .||||+++-........+.|.+|+..|++-+|.||+-+.+++..+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~----- 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP----- 461 (678)
T ss_pred CHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----
Confidence 4567889999999999999999653 3 6999999877677778899999999999999999999999986543
Q ss_pred cEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+.||+.+|+| +|+.+|.- ...|.......|++||++|+.|||.++|||||||..|||+.++++|||+||||+....-
T Consensus 462 -~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred -eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 4999999997 89998864 34688899999999999999999999999999999999999999999999999975321
Q ss_pred CCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
- ........-.|...|||||++... ..+|++.+|||||||++|||++|..||.. +..+|+-.+ .|+
T Consensus 541 w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm---VGr-------- 607 (678)
T KOG0193|consen 541 W-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM---VGR-------- 607 (678)
T ss_pred e-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE---ecc--------
Confidence 1 111112334577889999998532 36799999999999999999999999984 333333111 111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
............+.+.++++|+..||.+++++||...+||.
T Consensus 608 --------------G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 608 --------------GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 00011112223455669999999999999999999999987
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=311.63 Aligned_cols=238 Identities=18% Similarity=0.286 Sum_probs=186.9
Q ss_pred EEeeecCceEEEEEEECCCCc-------EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 29 EVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~-------~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.||.|+||.||+|.++.++. .+++|.+... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCC
Confidence 469999999999998865544 4888887532 23445678899999999999999999999843 356
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------EEEeecC
Q 007064 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--------LKICDFG 171 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--------vKL~DFG 171 (619)
.++|||||. |+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 58999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCC
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++| .+||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 88654321 234678889999998752 4578999999999999999999 4666554432221110
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 -----------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 -----------------E---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------------H---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 000 1112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.72 Aligned_cols=238 Identities=21% Similarity=0.284 Sum_probs=185.1
Q ss_pred EEeeecCceEEEEEEECC------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 29 EVIGKGSYGVVCSAIDTH------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
+.||+|+||.||+|.... ....+++|++... .......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVR--- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 468999999999997432 2336889987642 23445578889999999999999999999843
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-------EEE
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-------LKI 167 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-------vKL 167 (619)
....++||||++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++. +|+
T Consensus 76 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 76 --DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred --CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 345799999999 578777765 456999999999999999999999999999999999999987664 899
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLl-tG~~pF~~~~~~~~l~~i~~~ 246 (619)
+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ .|..||......+.....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--- 222 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---
Confidence 999998654221 234678889999988632 57899999999999999998 588888765432211100
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ... ......++++.+||.+||..||.+||++.+||.+
T Consensus 223 ---------------------~-----~~~---~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ---------------------E-----GQC---MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------------------h-----cCc---cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 000 0112235688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.99 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=191.0
Q ss_pred EEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... ....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998643 3457999988642 2344567788999999999999999999977432 2457999
Q ss_pred EecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 106 FELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 106 ~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999999764 356788889999999999999999999999999999999999999999999997543221111
Q ss_pred -cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 184 -~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 01122345678999998876 578999999999999999999 567787655433222211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....... ....++.+.+|+.+||..||++||++.+++..
T Consensus 217 ----------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 ----------QGRRLLQ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----------cCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0011111 12346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.24 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=188.7
Q ss_pred EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+. +...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEE
Confidence 36899999999999754 4567899999875432 334457889999999999999999999883 345689999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 107 ELME-SDLHQVIKAND-----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
||+. |+|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999 69999986532 35677888999999999999999999999999999999999999999999987533221
Q ss_pred CCccccccccCCccccCcccccccC-----CCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~-----~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
. ........++..|+|||++.+.. ..++.++|||||||++|||++ |..||...+..+.+.....
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------- 224 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--------- 224 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---------
Confidence 1 11112345778899999885421 136789999999999999996 9999977654333221100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ..............++.+.+|+++|+ .||.+|||+++++.
T Consensus 225 --------------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 225 --------------E--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------c--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0 00000011111245678999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=304.52 Aligned_cols=241 Identities=25% Similarity=0.445 Sum_probs=196.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~ 72 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NG 72 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CC
Confidence 3679999999999999999985 57889999998642 234568899999999999999999998742 23
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 799999998 59999997643 589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+..
T Consensus 153 ~~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------ 212 (254)
T cd05083 153 GV------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------ 212 (254)
T ss_pred cC------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC------------
Confidence 11 12234567999998876 578899999999999999997 9999987765433322211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... .....+++.+.+|+.+||..+|++||++++++.
T Consensus 213 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 ---------------GYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.99 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=199.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---- 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---- 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----
Confidence 4568999999999999999999887776 5788887643 233344568899999999999999999998843
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...++|+||+. |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 --PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred --CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 23579999998 79999987654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11223445778999999876 678999999999999999997 8999977653332221110
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... ...+..+..+.+++.+||..||++||+++++++.
T Consensus 227 ------------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 227 ------------------GERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 1123467789999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.24 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=223.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+..+++-.||-|+||.|=++.-......+|+|++++.. -+....+.+..|-.||..++.|.||++|..| .+.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ 492 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDS 492 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccc
Confidence 3466788889999999999998766666669999987532 2334566789999999999999999999988 777
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|++||-|- |+|+..+..++.|.+...++++..+++|+.|||++|||+|||||+|++++.+|.+||.|||+|+....
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 89999999987 69999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
...+ .++||||.|.|||++.+ ...+.++|.||||+++||||+|.|||.+.+.+...+.|.+.+..
T Consensus 573 g~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------- 637 (732)
T KOG0614|consen 573 GRKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------- 637 (732)
T ss_pred CCce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------
Confidence 5432 46899999999999987 68899999999999999999999999999998888887542211
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
. .....++..+.+||+++-..+|.+|.. +.+|-.|.||.++
T Consensus 638 -----------------i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 638 -----------------I---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred -----------------h---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 0 111246678999999999999999975 8999999999864
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.95 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=193.3
Q ss_pred EEeeecCceEEEEEEECCCC------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 29 EVIGKGSYGVVCSAIDTHTG------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.||+|+||.||+|.++... ..+|||.+... ........+.+|+.+|+.++||||+++++++. +....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCe
Confidence 36999999999999876443 68999988643 22244567889999999999999999999884 34568
Q ss_pred EEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-----cEEEee
Q 007064 103 YVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-----KLKICD 169 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-----~vKL~D 169 (619)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99997643322111 1122345678999999876 578999999999999999998 9999987665443332210
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......++..+.+||.+||..+|.+||+++++++
T Consensus 229 ------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 0122356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=308.74 Aligned_cols=237 Identities=20% Similarity=0.258 Sum_probs=184.4
Q ss_pred EeeecCceEEEEEEECC------------------------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 007064 30 VIGKGSYGVVCSAIDTH------------------------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~------------------------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv 85 (619)
.||+|+||.||+|.... ....|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999997432 1235889888642 233456788899999999999999
Q ss_pred eeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 007064 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (619)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 163 (619)
++++++.. ....|+|||||+ ++|..++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++..+
T Consensus 80 ~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEe-----CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999843 356899999999 588888865 45789999999999999999999999999999999999997643
Q ss_pred -------cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH-hCCCCCCCCC
Q 007064 164 -------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKN 235 (619)
Q Consensus 164 -------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLl-tG~~pF~~~~ 235 (619)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+.+
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4899999988643221 223577889999988653 56899999999999999995 6999997665
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+....+ . .... .....++.+.+||.+||..||++|||+.++|++
T Consensus 227 ~~~~~~~~------------------------~---~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFY------------------------E---KKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHH------------------------H---hccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33221110 0 0000 011245689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.30 Aligned_cols=269 Identities=24% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCeEEeEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDT----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
..|++.+.||+|+||.||+|... .++..||+|++...... .....+.+|+++++.++||||+++++++... +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence 56889999999999999999854 35789999999754332 3567789999999999999999999987432 2
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 356899999998 59999997654 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..............++..|++||.+.+ ..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~--- 229 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ--- 229 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc---
Confidence 422221111122345567999998876 578899999999999999999999886543211 0011110000
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.........+...... .....++..+.+|+.+||..||.+|||+.|+++
T Consensus 230 ----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 ----MIVTRLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----ccHHHHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001111111111111 112345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=302.12 Aligned_cols=236 Identities=19% Similarity=0.268 Sum_probs=187.1
Q ss_pred EEeeecCceEEEEEEECCCC----------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 29 EVIGKGSYGVVCSAIDTHTG----------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg----------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 357888765321 226778899999999999999999998843
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-------cEEEee
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-------KLKICD 169 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-------~vKL~D 169 (619)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 34699999999 69999998765 799999999999999999999999999999999999999887 799999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||++...... ....++..|+|||++......++.++|||||||++|+|++ |..||...+..+......
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 9999764331 2235677899999987622378899999999999999999 577776654322111110
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... ........+.+||.+||..||.+|||+.++|+
T Consensus 221 -----------------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 -----------------------DQHR-----LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------cCCC-----CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 00112268899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.78 Aligned_cols=269 Identities=28% Similarity=0.433 Sum_probs=214.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
...+||-++..||+|+|+.||+|.|....+.||+|+-.....+. ...+...+|..|-+.|+||.||+++++|..
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl- 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL- 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-
Confidence 35678999999999999999999999999999999764332222 234567799999999999999999999853
Q ss_pred CCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECC---CCcEEEe
Q 007064 95 SRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA---NCKLKIC 168 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~---~~~vKL~ 168 (619)
+...+|.|+|||+| ||.-+++.+..+++.+++.|+.||+.||.||.... |||-||||.|||+.. -|.+||.
T Consensus 539 ---DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 539 ---DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ---ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 34568999999997 89999999999999999999999999999999765 999999999999843 4789999
Q ss_pred ecCccccccCCCCCcc----ccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 169 DFGLARVAFNDTPTTI----FWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 169 DFGla~~~~~~~~~~~----~~~~~~gt~~Y~APEll~~~--~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
||||+++..++..... ...-..||-||++||.+.-. ..+.+.++||||+|+|||.++.|+.||........+-.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999998776654421 12346799999999976321 35678899999999999999999999965432211100
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
. ..+.+.....|..+ |-+++++++||++||++.-++|..+.++-.||||.
T Consensus 696 e------------------------NTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 696 E------------------------NTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred h------------------------hchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 0 00111222233322 56899999999999999999999999999999996
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.43 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=219.3
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~ 98 (619)
+....++|.+.||.|.||.||++.++.++...|+|+...... .-..+..|+++|+.+. |||++.++++|.......
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 456789999999999999999999999999999998874332 2345667899999884 999999999998776667
Q ss_pred CCcEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+.++||||||. |+..++++. ...+.|+.+.+|++.+|.||.+||.+.++|||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 788999999999 688888764 56799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
.... .....+.+||+.|||||+|... ...|+..+|+||||++..||--|.||+...-....+-.|
T Consensus 173 ldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------- 240 (953)
T KOG0587|consen 173 LDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 240 (953)
T ss_pred eecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---------
Confidence 5322 2234678999999999998542 245788999999999999999999999665443332111
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
.+.|.+-...+.+++..+.|||..||..|.++||+..++|.|||++
T Consensus 241 -------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 241 -------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 1222222334567788999999999999999999999999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.56 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=187.2
Q ss_pred EeeecCceEEEEEEECCC--CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEe
Q 007064 30 VIGKGSYGVVCSAIDTHT--GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~t--g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (619)
.||+|+||.||++..... ...+++|.+... ........+.+|+.+++.++||||+++++.+. +...+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 599999999999975432 345677776542 23345678899999999999999999999984 3456899999
Q ss_pred cCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 108 LME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 108 ~~~-g~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
||. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 999 6999999754 2466778889999999999999999999999999999999999999999999864321111
Q ss_pred ccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 183 TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~-----~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.......+++..|+|||++... ...++.++|||||||++|||++ |.+||...+..+.+..+....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--------- 225 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ--------- 225 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc---------
Confidence 0111235678899999987531 1245789999999999999996 578887766544443321100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
............+++.+.+|+..|| .||++||+++++++
T Consensus 226 ----------------~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 226 ----------------QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000001122346788999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.21 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=199.8
Q ss_pred CeEEeEEeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChHHHHHHHHHHHHHHh-cCCCCcceeeeEecC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIF--------EHISDAARILREIKLLRL-LRHPDIVEIKHIMLP 93 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~--------~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~ 93 (619)
.|++.+.||+|+||.||+|.++. +++.+|+|.+.... .......++.+|+.++.. ++||||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 38889999999999999999987 78899999885321 223345567789998875 7999999999998
Q ss_pred CCCCCCCcEEEEEecCCc-cHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEE
Q 007064 94 PSRRDFKDIYVVFELMES-DLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKI 167 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g-~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL 167 (619)
.+....|+||||+.+ +|.+++. ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 345679999999984 8887763 24569999999999999999999996 78999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|||++....... ......++..|++||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999997644322 2245578899999999876 568999999999999999999999997665443332221100
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. . + .....+++.+.+||.+||..||++||++.|+.++
T Consensus 230 ~-------------------------~--~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 Y-------------------------E--P--LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred C-------------------------C--c--CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 0 0 0112457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=332.15 Aligned_cols=248 Identities=27% Similarity=0.433 Sum_probs=207.0
Q ss_pred CeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.-++.+.||+|+||+||+|+-. .....||||.+++. ......++|.||+++|..|+|||||+|++++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 3566789999999999999643 23457999999864 3334678899999999999999999999999 45
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND----------D----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC 163 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------~----l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~ 163 (619)
.+-+|+|||||. |||++++..+. + |+..+...|+.||+.|+.||-++.+|||||-..|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 567999999999 89999997542 3 88999999999999999999999999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 007064 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDL 242 (619)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~ 242 (619)
.|||+|||+++.....+.-.... ...-...||+||-|.- .+|+.++||||+||+|||+++ |+-||.+.+..+.++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~-~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRG-NTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccC-CceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999999765443322111 1223457999998875 799999999999999999998 8999999999888877
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
|..- + .-+...+.+.++.+|+..||+..|++||++.||
T Consensus 718 i~~g---------------------------~---lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAG---------------------------Q---LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcC---------------------------C---cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 7431 1 122234678899999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.75 Aligned_cols=263 Identities=26% Similarity=0.430 Sum_probs=193.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC-c
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK-D 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~-~ 101 (619)
+.|.-...||+|+||.||+|.-.. |..||||++....... ...+.+|+.+|..++|||+|+|+++|.. .. .
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e-----~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLE-----GGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEec-----CCce
Confidence 456666899999999999997654 4899999887543221 4459999999999999999999999943 34 5
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 102 IYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+||+|||. |+|.+++.... .++|.....|+.++++||.|||... |+|||||++|||+|++...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999 89999997655 8999999999999999999999854 99999999999999999999999999965
Q ss_pred ccCCCCCccccccc-cCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~-~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
.... ... .... .||..|+|||.+.. ...+.++||||||++|.||++|+.+........... +.++.
T Consensus 227 ~~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~~w~------- 293 (361)
T KOG1187|consen 227 GPEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LVEWA------- 293 (361)
T ss_pred CCcc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HHHHH-------
Confidence 4321 111 1122 79999999999876 678999999999999999999998876543111110 00000
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+..+.......+++..... ..++ ..-..+..+..+|++.+|++||++.|++.
T Consensus 294 ~~~~~~~~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHCcchhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0011111111111110000 0001 01123567888999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.24 Aligned_cols=270 Identities=28% Similarity=0.452 Sum_probs=201.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~ 98 (619)
+...-+...+.||+|+||.||+++++.+|+.||||.++.. ......++..+|+++|++|+|||||+++++=.... .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~-~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE-SSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhh-cccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 4455677889999999999999999999999999999764 35567788899999999999999999988742211 000
Q ss_pred CCcEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCC--cEEEeec
Q 007064 99 FKDIYVVFELME-SDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC--KLKICDF 170 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~---~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~--~vKL~DF 170 (619)
...-.+|||||. |||..++.+ ...|++.++..++..+..||.|||.+||+||||||.||++- .+| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234689999999 699999964 34799999999999999999999999999999999999863 334 4799999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHh-hhC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTD-LLG 248 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~-~l~~i~~-~~g 248 (619)
|.|+...++. .++..+||+.|++||+.... ..|+..+|.|||||++|++.||..||-...... ....+.. ..+
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 9999765443 45788999999999998742 689999999999999999999999995432211 1111111 112
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCC---CCCHH----HHHHHHHhccCCCCCCCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP---NADPS----ALRLLERLLAFDPKDRPT 306 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~~s~~----l~dLI~~mL~~DP~kRpS 306 (619)
.|+...+.. ......+..++..+| ..++. +-..|..||..||++|..
T Consensus 244 kp~~v~i~~-----------~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 244 KPSGVAIGA-----------QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred CCCceeEee-----------ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 222211111 111223444444443 23333 345778899999999983
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=296.41 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=206.8
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+..||.|+||+|.+-.++.+|+..|||.|..... ..+.++++.|+... +.-..||||+++++.+. +++.+|.|
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcWiCM 142 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCWICM 142 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCceeeeH
Confidence 4579999999999999999999999999986433 45677888999865 44569999999999854 46799999
Q ss_pred ecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 107 ELMESDLHQVIK-----ANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 107 E~~~g~L~~~i~-----~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|+|+-+|..+.+ ....++|+-+-.|..-.+.||.||.. .+|+|||+||+|||++..|.|||||||.+....+..
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 999976554432 34579999999999999999999975 689999999999999999999999999987654332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhhhhhhc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. -+--.|-+.|||||.+......|+-++|+||||++|||+.||..||.+.+ ..+|+..+. .|.|..
T Consensus 223 A----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~------- 289 (361)
T KOG1006|consen 223 A----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI------- 289 (361)
T ss_pred H----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe-------
Confidence 2 23457889999999997654579999999999999999999999997764 344443332 122211
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..+....-.++..++.+|.-||..|-.+||...+++++||++.+.
T Consensus 290 ----------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 ----------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ----------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 111222235788999999999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.87 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=203.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE---K-VAIKKIHD-IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~---~-vAIK~i~~-~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
++-.+.+.||+|+||.||+|..+..+. . ||+|..+. ..........+++|..+|+.|+|||||+++++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~----- 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV----- 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----
Confidence 445566899999999999998765422 3 89998875 3355667788999999999999999999999984
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+..-+|||||+|. |+|.+++++++ .++..+...++++.+.||.|||+++++||||-..|+|++.++.+||+|||+++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 4456999999999 59999999887 499999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
..... .. ....-....|+|||.+.. ..|+.++||||+||++||+.+ |..||++.+..+....|..-
T Consensus 312 ~~~~~-~~--~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~-------- 378 (474)
T KOG0194|consen 312 GSQYV-MK--KFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN-------- 378 (474)
T ss_pred Cccee-ec--cccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--------
Confidence 42110 00 001124567999999987 589999999999999999999 78999999877666555220
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.-+. ......+.++..++.+|+..||++|||+.++.+
T Consensus 379 ------------------~~r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ------------------GYRM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------CccC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0000 111245667889999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=283.26 Aligned_cols=242 Identities=39% Similarity=0.643 Sum_probs=197.8
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cH
Q 007064 35 SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DL 113 (619)
Q Consensus 35 ~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L 113 (619)
+||.||+|.+..+++.+|+|++........ ...+.+|+.+++.++|+||+++++.+.. ....++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCH
Confidence 589999999999999999999875322211 6788899999999999999999998843 3568999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCc
Q 007064 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193 (619)
Q Consensus 114 ~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (619)
.+++.....+++..++.++.+++.+|.+||+.+|+|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877679999999999999999999999999999999999999999999999999998754332 123456888
Q ss_pred cccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcc
Q 007064 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRK 272 (619)
Q Consensus 194 ~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (619)
.|++||.+.+ ..++.++||||||+++++|++|..||... +.......+.
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------------------------- 200 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---------------------------- 200 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----------------------------
Confidence 9999998875 57888999999999999999999999773 2222211111
Q ss_pred cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 273 KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 273 ~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
............++..+.+++.+||..||++||++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 201 KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 01111111112267899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=294.79 Aligned_cols=265 Identities=23% Similarity=0.416 Sum_probs=213.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
.+.|.++++||+|+|.+|.+++++.|.+.||+|++++..- ..++..-+..|-.+...- +||.+|.++.+| +.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 4679999999999999999999999999999999986533 334555566777777766 599999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+++|.||+. |+|.-.++....|++++++++...|+.||.|||+.||++||||.+|+|+|..|++||.|+|.++....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 56999999999 59988888888999999999999999999999999999999999999999999999999999987555
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
+..++ .++||||.|.|||++.+ ..|+..+|+|+||++++||+.|+.||.- .|....+
T Consensus 404 ~gd~t---stfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi-------------vgm~n~d----- 460 (593)
T KOG0695|consen 404 PGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI-------------VGMDNPD----- 460 (593)
T ss_pred CCccc---ccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce-------------ecCCCcc-----
Confidence 44443 67899999999999998 7999999999999999999999999932 1111100
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC------CHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP------TAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp------Sa~elL~hp~f~~~ 319 (619)
...+.|+-.+...+.+. ....+|-.+..+|+..|..||++|. ...++-.|+||+.+
T Consensus 461 --~ntedylfqvilekqir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 461 --MNTEDYLFQVILEKQIR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred --cchhHHHHHHHhhhccc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 01112221111111111 1124566788899999999999995 56899999999854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=329.86 Aligned_cols=251 Identities=23% Similarity=0.408 Sum_probs=206.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCC-C----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHT-G----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~t-g----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..-.+.+.||+|+||.||.|.-... | ..||||.+... ....+...|++|..+|+.++|||||+++++++..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 4567889999999999999975432 2 35999999754 5567788999999999999999999999999763
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
...+|++|||+ |||..+|++. ..|+..++..|+.||++|++||+++++|||||-..|+|++....|||+|
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 45899999999 6999999875 3589999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||+|+............. ..-...|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+......
T Consensus 846 FGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-- 920 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-- 920 (1025)
T ss_pred cchhHhhhhchheeccCc-cccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence 999995443322221111 122346999999987 689999999999999999998 88999999887665433221
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. -...+.++..+.+|+..||+.||++||++..|++
T Consensus 921 -------------------------gR---L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 -------------------------GR---LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -------------------------Cc---cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 00 1123467778999999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.36 Aligned_cols=278 Identities=17% Similarity=0.254 Sum_probs=188.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCChH------------HHHHHHHH
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT----------------HTGEKVAIKKIHDIFEHIS------------DAARILRE 72 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~----------------~tg~~vAIK~i~~~~~~~~------------~~~~i~~E 72 (619)
..++|.+.++||+|+||+||+|.+. ..++.||||++........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 3456899999864211100 01123347
Q ss_pred HHHHHhcCCCCc-----ceeeeEecCCC---CCCCCcEEEEEecCC-ccHHHHHHhC-----------------------
Q 007064 73 IKLLRLLRHPDI-----VEIKHIMLPPS---RRDFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (619)
Q Consensus 73 i~iL~~L~HpnI-----v~l~~v~~~~s---~~~~~~lylV~E~~~-g~L~~~i~~~----------------------- 120 (619)
+.++..++|.++ +++++++.... ..+....++||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 55666554321 112356899999999 5888887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcc
Q 007064 121 -DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199 (619)
Q Consensus 121 -~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE 199 (619)
..+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 124567788999999999999999999999999999999999999999999997543221111 11224578999999
Q ss_pred cccccCC------------------CCC--CcccchhHHHHHHHHHhCCC-CCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 200 ll~~~~~------------------~y~--~~~DIWSLG~ilyeLltG~~-pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
++..... .|+ .++||||+|||+|+|++|.. ||.+....+... ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--------------~~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--------------RQY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH--------------hhc
Confidence 8753100 122 34799999999999999874 775432211100 000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCC---CCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP---KDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP---~kRpSa~elL~hp~f~~ 318 (619)
..+ . ..+... ......+. .+...++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 447 ~~~-~-~~~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 447 DND-L-NRWRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cch-H-HHHHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 0 001111 11122222 456789999999999999876 68999999999999963
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=311.08 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=221.1
Q ss_pred ccccCCCCCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007064 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIM 91 (619)
Q Consensus 15 ~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 91 (619)
+|....+++..+|.++||.|.||.||+|+.+..|+ .||||.++.- ........|+.|..||-+++||||++|.++.
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 34444667888999999999999999999887664 6999999853 5566778899999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 92 LPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
. ...-+.||+|||+ |+|..+++.+ +.|+..++..+++.|+.|++||-+.|.|||||-..|||+|.+-.+|+.|
T Consensus 700 T-----ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 700 T-----KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred e-----cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecc
Confidence 3 4456899999999 8999999865 5799999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
|||+|...++.........---...|.|||.+.- .+++.++|+||+|+++||.++ |..||...++.+.++.|.+-+.
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR 852 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR 852 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC
Confidence 9999987665533211111112357999999875 799999999999999999775 9999999999888888876554
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.|.. .+++..+..|+..||++|-..||.+.+|+++
T Consensus 853 LPpP------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 853 LPPP------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCC------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 4432 4678899999999999999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.01 Aligned_cols=247 Identities=31% Similarity=0.448 Sum_probs=190.8
Q ss_pred eEEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG-~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.+++|.|+-| .||+|. ..|+.||||.+-. +......+||.+|+.-+ |||||+++..- .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 3578999887 568995 4588999998753 33456779999999885 99999998764 566779999
Q ss_pred EecCCccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---C--CcEEEeecCccccc
Q 007064 106 FELMESDLHQVIKAN-DD---LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---N--CKLKICDFGLARVA 176 (619)
Q Consensus 106 ~E~~~g~L~~~i~~~-~~---l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~--~~vKL~DFGla~~~ 176 (619)
.|+|..+|.+++... .. ......+.++.|+..||++||+.+||||||||+||||+. + .+++|.|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999874 11 112445788999999999999999999999999999976 3 46899999999987
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..+...-....+..||-.|+|||++.+ ..-+.++|||||||++|+.++| ..||...-.. + ..|..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~-~NIl~---------- 727 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-Q-ANILT---------- 727 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHHh-h-hhhhc----------
Confidence 655444334566789999999999987 4556799999999999999997 7899543221 1 11110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
....+...-+..+.++.|||.+||.+||..||+|.++|.||+|=.
T Consensus 728 ------------------~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 728 ------------------GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ------------------CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 111112222222338999999999999999999999999999943
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=293.65 Aligned_cols=286 Identities=28% Similarity=0.435 Sum_probs=215.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~ 96 (619)
..+.|.++++||+|.|++||+|.+.. .++.||+|.|... +.-.++.+|+++|..+. +.||+++.+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~----- 104 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF----- 104 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----
Confidence 45679999999999999999999877 7889999998643 34457999999999995 99999999998
Q ss_pred CCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCccc
Q 007064 97 RDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~ 174 (619)
...+.+.+|+||++. +..++.. .++..+++.+++.++.||.++|.+|||||||||+|+|.+.. +.-.|+|||||.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 566789999999995 6666654 37789999999999999999999999999999999999864 678899999996
Q ss_pred cccCCC--------------C-----------------Cc----------cccccccCCccccCcccccccCCCCCCccc
Q 007064 175 VAFNDT--------------P-----------------TT----------IFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (619)
Q Consensus 175 ~~~~~~--------------~-----------------~~----------~~~~~~~gt~~Y~APEll~~~~~~y~~~~D 213 (619)
...... . .. ...-...||+.|+|||++... ..-++++|
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiD 260 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAID 260 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccc
Confidence 210000 0 00 000124799999999998763 67789999
Q ss_pred chhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhhCCCchhhhhhhcch----------hHHHH---H-----HhhcccC
Q 007064 214 IWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPSLDTISRVRND----------KARRY---L-----TSMRKKQ 274 (619)
Q Consensus 214 IWSLG~ilyeLltG~~pF-~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~----------~~~~~---l-----~~~~~~~ 274 (619)
|||.|+|+..+++++.|| ...++.+.+..|..++|............. .+... + ..+.+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999998775 566777778888888776544332221111 11111 1 1111101
Q ss_pred Cc-cccCCCC-CCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 275 PV-QFSQKFP-NADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 275 ~~-~~~~~~~-~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. -....+. -.+..+.||+.+||..||.+|.||+++|.||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 10 0111222 245589999999999999999999999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=296.43 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=204.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++..++++||+|-||.|.+|+-. .+.+||+|+++.. ........+.+||++|.+|+||||++++++|... +.+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 45678999999999999999643 3689999999753 4444567899999999999999999999999643 459
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
++|+|||+ |||.+++.++. .+..+....|+.||+.|++||.+.++|||||-+.|+|++.++++||+|||.+|.....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 89999998873 3345566779999999999999999999999999999999999999999999965544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt--G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..-.. -...+-...|||+|.+.. .+++.++|+|+||+++||+++ ...||...+..+..+....++..+...
T Consensus 691 ~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---- 763 (807)
T KOG1094|consen 691 DYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---- 763 (807)
T ss_pred Cceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----
Confidence 33221 123455678999997765 689999999999999999765 678887777665555444433332221
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
......+-++..+.+||.+|+..|-++|||.+++..
T Consensus 764 -------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 -------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 111223446678899999999999999999999843
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.33 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=197.4
Q ss_pred eEEeeecCceEEEEEEECC--CC--cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 28 QEVIGKGSYGVVCSAIDTH--TG--EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~--tg--~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.+.||.|-||.||.|+-.. .| -.||||..+.. ....+.+.|+.|..+|+.++||||+++++++.. .-++
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~W 466 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPMW 466 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec------ccee
Confidence 4579999999999997432 23 36899988753 445568889999999999999999999999843 4589
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 104 VVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
||||++. |.|..+++.+ ..|+......+++||+.||.|||+.++|||||-..|||+.+...|||+||||+|...++..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999 9999999865 4789999999999999999999999999999999999999999999999999998655433
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
-.. +...-..-|||||-+.- ..++.++|||.||+++||++. |..||.|-...+.+-.|..
T Consensus 547 Yka--S~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------------- 607 (974)
T KOG4257|consen 547 YKA--SRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------------- 607 (974)
T ss_pred hhc--cccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---------------
Confidence 221 11223346999998864 789999999999999999876 8999988655443322211
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ....+++++.+-.|+.+||.+||.+||.+.++..
T Consensus 608 ------------GeR---lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 608 ------------GER---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ------------CCC---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 111 1234688999999999999999999999988743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.03 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=210.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-C--cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-G--EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-g--~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
-.++.++.+.||+|+||+||+|.++.- | -.||||++....... ....|++|+.+|..|+|||+++||++++.
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---- 182 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---- 182 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc----
Confidence 345567788999999999999987643 3 369999998643332 67789999999999999999999999964
Q ss_pred CCCcEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+.+|||++. |+|++.+.+ ...|-...+..|+.||+.|+.||.++++|||||-..|||+-....||||||||.+
T Consensus 183 --qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 183 --QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred --chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 34789999999 799999976 3468888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
..........+....-....|+|||.+.. ..++.++|+|++|++||||++ |+.||.|.+....+.+|-+.
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------- 331 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------- 331 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------
Confidence 87655443322222233456999999987 789999999999999999998 68999999987777666210
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
..-...+.++..+.++++.||..+|.+|||+..|.+.-++
T Consensus 332 -----------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 -----------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -----------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 0112235678899999999999999999999998655443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=287.89 Aligned_cols=247 Identities=23% Similarity=0.433 Sum_probs=205.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.+..+..+||.|.||.||.+++++-...||||.++ ++......|+.|..+|+.++|||+|+|+++|.. +.-+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCe
Confidence 34556789999999999999999999999999987 455678899999999999999999999999954 3458
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
|||+|||. |+|.++++..+ .++.-.+.+++.||..|+.||..+++|||||-..|+|+.++..||++||||++....+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 89999998643 4677777889999999999999999999999999999999999999999999998766
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
..+... ..--..-|.|||-+.- +.++.++|||+||++|||+.| |..||+|-+..+...++.+-
T Consensus 419 TYTAHA--GAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg------------ 482 (1157)
T KOG4278|consen 419 TYTAHA--GAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG------------ 482 (1157)
T ss_pred ceeccc--CccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc------------
Confidence 554321 1122346899998753 688999999999999999987 78999997765554443221
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL 311 (619)
.+.. ...++++.+.+|+..||++.|.+||++.|+-
T Consensus 483 -----------yRM~-------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 483 -----------YRMD-------GPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred -----------cccc-------CCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 1111 1236788999999999999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-33 Score=300.04 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=217.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
....+|+++.++|.|.||.||+|+|+.+++..|+|+++. ....+..-+..||-+++.++||||+.+++-|+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~----- 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR----- 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence 455789999999999999999999999999999999985 3445667788999999999999999999988543
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..++|+||||+ |+|.+...-.+++++.++.+..+..++||+|||+.|=+|||||--|||+++.|.+||.|||.+-.+..
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 45899999999 58888888889999999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCccccccccCCccccCcccc-cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll-~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
. ......++||++|||||+- .+....|+..+|||++|+.-.|+---++|....-....+.++.+-.-.|
T Consensus 165 t---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp------- 234 (829)
T KOG0576|consen 165 T---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP------- 234 (829)
T ss_pred h---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC-------
Confidence 2 2234678999999999974 3334689999999999999999988888865555554444443322111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+.. -..+++.+.+|++.+|..+|++|||++.+|.|||...
T Consensus 235 ------------------p~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 235 ------------------PTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------------CcccC-CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11111 1246788999999999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=290.72 Aligned_cols=200 Identities=25% Similarity=0.414 Sum_probs=173.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC----Ch--HHHHHHHHHHHHHHhcC---CCCcceeeeEec
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE----HI--SDAARILREIKLLRLLR---HPDIVEIKHIML 92 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~----~~--~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~ 92 (619)
-..|..++.+|.|+||.||+|+++.+...|+||.|.+..- +. ...-.+--||.||..|+ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 3558999999999999999999999999999999975311 11 11123456999999997 99999999999
Q ss_pred CCCCCCCCcEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 93 PPSRRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
++.+++||+||--+ | ||+++|.....++|.+++.|++|+..|+++||+.||||||||-+|+.++.+|.+||+||
T Consensus 639 ----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 ----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 77788999999877 5 99999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~ 232 (619)
|.|....+.. +..++||..|.|||++++. ...+..-|||+||++||.++....||.
T Consensus 715 gsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9997654332 2457999999999999983 344678999999999999999998885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=256.21 Aligned_cols=208 Identities=25% Similarity=0.447 Sum_probs=173.3
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh-cCCCCcceeeeEecCCCCCCCCcEEEE
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL-LRHPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~-L~HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
-+..||+|+||+|-+.++..+|...|+|.+.... +....+++++|+.+... ..+|.+|.+++.+ ..+.+++|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvwIc 123 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVWIC 123 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEEEe
Confidence 3567999999999999999999999999997543 34566788899998554 4799999999987 456789999
Q ss_pred EecCCccHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 106 FELMESDLHQV----IKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 106 ~E~~~g~L~~~----i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
||.|..+|..+ ++.++.++|..+-.|+..++.||.|||++ .|+|||+||+|||||.+|+||+||||.+-...+..
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 99999877554 45677899999999999999999999974 79999999999999999999999999997655433
Q ss_pred CCccccccccCCccccCccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCC-CChhHHHHHHH
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLMT 244 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~--~~~y~~~~DIWSLG~ilyeLltG~~pF~~-~~~~~~l~~i~ 244 (619)
.. +--.|-..|||||.+... ...|+-++||||||+.+.||.+++.||+. .+..+|+..+.
T Consensus 204 Ak----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 204 AK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred HH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 22 223577889999988532 24799999999999999999999999965 46667776664
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=319.13 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=185.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
..|...+.||+|+||.||+|.++.++..||||++...... ...|+++|+.++||||+++++++.. ....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS-----EKGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc-----CCCC
Confidence 3466678999999999999999999999999998643211 1246889999999999999999943 3568
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
|+|||||+ |+|.++++ .+++..+..|+.||+.||.||| +.+|+||||||+||+++.++..+++ ||.......
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999996 3899999999999999999999 6799999999999999999888776 665543211
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~-~~l~~i~~~~g~p~~e~i~~ 257 (619)
. ....+|+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+.......
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 895 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC---------- 895 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh----------
Confidence 1 23468899999999876 68999999999999999999999998543210 0010000000
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
........+++..... . .........++.+|+.+||..||++|||+.|+++.
T Consensus 896 ~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 896 YSDCHLDMWIDPSIRG-D---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCccchhheeCccccC-C---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000000000 0 00001112357789999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.34 Aligned_cols=268 Identities=24% Similarity=0.325 Sum_probs=201.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..-.++++.||+|.||.||+|. -+++.||||++.. .+.+.+.+|-.|.+. ++|+||++++.+-.... .+.
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccc
Confidence 4456778999999999999994 5679999999863 566778888887765 57999999987653333 224
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCcEEEee
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
..++||+||-+ |+|.++++.+ .+++.+..+++..|++||+|||+- .|+|||||..||||..|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 57999999998 8999999876 599999999999999999999964 499999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCC-----CcccchhHHHHHHHHHhCCCCCC-CCChhHHHHHH
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKNVVHQLDLM 243 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~-----~~~DIWSLG~ilyeLltG~~pF~-~~~~~~~l~~i 243 (619)
||||..+....... .....+||..|||||++.+- .+.. .++||||+|.+||||++....+. +.-..-++---
T Consensus 360 FGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 99998865433322 23447999999999998763 2222 36999999999999999876654 33333333333
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCC--CCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
.++...|+.+.+..+- ++++....+...|.+ .-..+.+.++.||..|++-|.|+.=+
T Consensus 438 ~evG~hPt~e~mq~~V----------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELV----------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHHHH----------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 3455567766654321 112222333333322 23457899999999999999998643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=260.22 Aligned_cols=270 Identities=27% Similarity=0.408 Sum_probs=205.7
Q ss_pred CCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeee
Q 007064 11 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKH 89 (619)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~ 89 (619)
-.++.+.-.+..+.|.|.+.||+|.||.+-+|.|+.++..+++|.+... ....+.+.+|...--.| .|.||+.-++
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHH
Confidence 3456677778889999999999999999999999999999999999864 34566788898875555 4899999998
Q ss_pred EecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CC-CcEE
Q 007064 90 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-AN-CKLK 166 (619)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~-~~vK 166 (619)
+.+. ..+.+++++||+. |||..-+...+ +.|...+.++.|++.||.|+|++++||||||.+||||- .| -+||
T Consensus 89 vaFq----t~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 89 VAFQ----TSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHhh----cCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEE
Confidence 8753 3456889999999 89999887754 89999999999999999999999999999999999983 33 4799
Q ss_pred EeecCccccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007064 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i 243 (619)
|||||+.+..+..... . --+..|.+||++... .-..++.+|||.||+|+|.+|+|.+||......++
T Consensus 164 lcDFG~t~k~g~tV~~----~--~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---- 233 (378)
T KOG1345|consen 164 LCDFGLTRKVGTTVKY----L--EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---- 233 (378)
T ss_pred eeecccccccCceehh----h--hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----
Confidence 9999998764322111 1 134458899987532 12457789999999999999999999964332221
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHHcCcccc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFK 317 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR---pSa~elL~hp~f~ 317 (619)
...+++.-. .+........|...++.+..++++-|..++++| .++..-....|..
T Consensus 234 ------------------~Y~~~~~w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 234 ------------------PYWEWEQWL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ------------------hHHHHHHHh-cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 111222111 122224456677789999999999999999999 4554444444543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=265.10 Aligned_cols=268 Identities=25% Similarity=0.352 Sum_probs=199.0
Q ss_pred CccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeee
Q 007064 12 EMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKH 89 (619)
Q Consensus 12 ~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~ 89 (619)
-+.++.+...+.+..+++.||+|.||.||+| +..|+.||||++.. .+...+.||-+|.+. |+|+||+.++.
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeec--cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhh
Confidence 3566667778889999999999999999999 56799999999874 344556777777654 69999999987
Q ss_pred EecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEEC
Q 007064 90 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILAN 160 (619)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~ 160 (619)
.-.... ..-..++||++|-+ |+|++++.. ..++.+....++..++.||+|||.. .|.|||||..|||+.
T Consensus 273 aD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 273 ADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred ccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 643322 33457999999999 899999987 5799999999999999999999953 399999999999999
Q ss_pred CCCcEEEeecCccccccCCCC-CccccccccCCccccCcccccccC-----CCCCCcccchhHHHHHHHHHhC-------
Q 007064 161 ANCKLKICDFGLARVAFNDTP-TTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTG------- 227 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~APEll~~~~-----~~y~~~~DIWSLG~ilyeLltG------- 227 (619)
.++.+-|+|+|||.....+.. -.+..+..+||-.|||||++.+.- ..| ..+||||||.|+||++..
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 999999999999987655532 234456789999999999986521 111 358999999999999863
Q ss_pred ---CCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCC--HHHHHHHHHhccCCCC
Q 007064 228 ---KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD--PSALRLLERLLAFDPK 302 (619)
Q Consensus 228 ---~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~l~dLI~~mL~~DP~ 302 (619)
++||.+--. ..|+.+.+.++-- . .+....+...|.+.+ ..+-.|++.||..+|.
T Consensus 430 eey~~Pyyd~Vp-----------~DPs~eeMrkVVC------v----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 430 EEYQLPYYDVVP-----------SDPSFEEMRKVVC------V----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred hhhcCCcccCCC-----------CCCCHHHHhccee------e----cccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 356644221 2233333222110 0 111122333343322 1345789999999999
Q ss_pred CCCCHHHH
Q 007064 303 DRPTAEEA 310 (619)
Q Consensus 303 kRpSa~el 310 (619)
-|.||-.+
T Consensus 489 aRltALri 496 (513)
T KOG2052|consen 489 ARLTALRI 496 (513)
T ss_pred hhhHHHHH
Confidence 99998766
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=286.57 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=196.9
Q ss_pred EEeEEeeecCceEEEEEEEC----C---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 26 KIQEVIGKGSYGVVCSAIDT----H---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~----~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
.+.+.||+|.||.||+|.-. . ....||+|.++..... .+...+..|+++|+.+. ||||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 67779999999999999632 1 1457999999865444 77888999999999985 9999999999843
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
.+.+++|+|||. |+|.++++.+. .++..++..|.+||+.|+.||++.+++||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 567999999999 89999998765 489999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccC--CccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC-h
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN-V 236 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~g--t~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~-~ 236 (619)
.+..+||+|||+|+.......... ....+ ...|||||.+.. ..|+.++||||+|++||||++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999996543332221 11122 234999999987 689999999999999999998 789998733 2
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.+.+..+ . .... ......+++++.+|++.||+.+|++||+..++..
T Consensus 529 ~~l~~~l------------------------~---~G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFL------------------------K---EGNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHH------------------------h---cCCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2222111 1 1111 1122346889999999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-29 Score=240.39 Aligned_cols=212 Identities=37% Similarity=0.628 Sum_probs=182.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC
Q 007064 31 IGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME 110 (619)
Q Consensus 31 LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~ 110 (619)
||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++.. ....+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCC
Confidence 689999999999998889999999987532221 45678899999999999999999999843 357899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccCCCCCccccc
Q 007064 111 -SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWT 187 (619)
Q Consensus 111 -g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (619)
++|.+++... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999876 57999999999999999999999999999999999999999 89999999999976543321 123
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHH
Q 007064 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL 267 (619)
Q Consensus 188 ~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l 267 (619)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 35678889999998762 3788899999999999998
Q ss_pred HhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 268 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=302.14 Aligned_cols=208 Identities=15% Similarity=0.177 Sum_probs=148.1
Q ss_pred hcCC-CCcceeeeEecCCC--CCCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 78 LLRH-PDIVEIKHIMLPPS--RRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 78 ~L~H-pnIv~l~~v~~~~s--~~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
.++| +||..+++.|.... ......++++||+++++|+++|.. ...+++.+++.|++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 57777777652221 112246888999999999999975 3469999999999999999999999999999999
Q ss_pred CCcEEECCC-------------------CcEEEeecCccccccCCCC-------------CccccccccCCccccCcccc
Q 007064 154 PKNILANAN-------------------CKLKICDFGLARVAFNDTP-------------TTIFWTDYVATRWYRAPELC 201 (619)
Q Consensus 154 P~NILi~~~-------------------~~vKL~DFGla~~~~~~~~-------------~~~~~~~~~gt~~Y~APEll 201 (619)
|+||||+.. +.+||+|||+++....... ........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4455666666543211000 00011225689999999998
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCC
Q 007064 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK 281 (619)
Q Consensus 202 ~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~ 281 (619)
.+ ..|+.++|||||||+||||++|.+||..... .+..+... . .+ ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-------------------~-------~~----~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-------------------V-------LP----PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-------------------h-------cC----hh
Confidence 77 6799999999999999999999888753211 11111000 0 00 00
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 282 FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 282 ~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+....+...+++.+||..||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123467789999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=240.26 Aligned_cols=200 Identities=38% Similarity=0.652 Sum_probs=172.5
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+. .....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEE
Confidence 67889999999999999999988999999999753222 25678889999999999999999999873 3356899
Q ss_pred EEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 105 VFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~-l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
++|++.+ +|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876443211
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~ 233 (619)
......++..|++||.+.. ...++.++|+|+|||++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234567888999999832 26788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=269.06 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=198.9
Q ss_pred EEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+..++||.|+||+||+|+..-.|+ +||||++... ...+....+++|.-+|..|+|||+++|++++....
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 345789999999999998765554 6899988643 44455678999999999999999999999996543
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+-||++||. |.|.++++.+ +.+.......|.+||++|++|||.++++||||-..|||+.+-..+||.|||+++....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 789999999 7999999864 57999999999999999999999999999999999999999999999999999986544
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
...- .....-..+-|||-|.+.. ..|+.++||||+||.+||++| |..|+.+....+.-+.+.+ +
T Consensus 852 ~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----g-------- 916 (1177)
T KOG1025|consen 852 EKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----G-------- 916 (1177)
T ss_pred cccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----c--------
Confidence 3321 1111223446888887765 789999999999999999998 8899988875444332211 0
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. -...|..+-++.-++.+||..|+..||+++++..
T Consensus 917 ---------------eR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 ---------------ER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------------cc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 00 1234567788999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=279.43 Aligned_cols=271 Identities=27% Similarity=0.365 Sum_probs=204.1
Q ss_pred CCCe-EEeEEeeecCceEEEEEEECCCCcEEEEEEecC---ccCChHHH-HHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD---IFEHISDA-ARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY-~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~---~~~~~~~~-~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
...| ...+++|.|++|.|+.+......+.++.|.... ........ ..+..|+.+-..|.||||+..+..+..
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--- 392 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--- 392 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh---
Confidence 3445 457789999999888888777777677765541 11222222 236678888889999999888777633
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
....+-+||||.+||+.++...+.++..++..++.||+.||+|||+.||.||||||+|++++.+|.+||+|||.+...
T Consensus 393 --~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 393 --IDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred --cccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 233444599999999999999888999999999999999999999999999999999999999999999999999774
Q ss_pred cCCCC-CccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 177 FNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~-~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
..... ......+.+|+..|+|||++.+ ..|++ .+||||.|+|+..|++|+.||.-....++.. .
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~----------- 536 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K----------- 536 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccch-h-----------
Confidence 33322 2244567899999999999987 56665 6899999999999999999996544322210 0
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...+. ............+..++..-+.+|.+||++||.+|.|+++||+++||+.+..
T Consensus 537 --------~~~~~--~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 537 --------TNNYS--DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred --------hhccc--cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 00000 0001111122233445677899999999999999999999999999997654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=224.65 Aligned_cols=165 Identities=22% Similarity=0.286 Sum_probs=127.3
Q ss_pred ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccc
Q 007064 111 SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189 (619)
Q Consensus 111 g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 189 (619)
|+|.+++.. ...+++..++.|++||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 689999987 446999999999999999999999998 999999999999999 9998765322 12
Q ss_pred cCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH-HHHHHhhhCCCchhhhhhhcchhHHHHHH
Q 007064 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLMTDLLGTPSLDTISRVRNDKARRYLT 268 (619)
Q Consensus 190 ~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~-l~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (619)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||........ +..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68999999999987 6899999999999999999999999966543211 111111
Q ss_pred hhcccCCccccCCCCCCCH--HHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 269 SMRKKQPVQFSQKFPNADP--SALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
.+....+.. ......++. .+.+||.+||..||.+||++.+++.|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000000000 000112222 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-25 Score=223.17 Aligned_cols=265 Identities=34% Similarity=0.520 Sum_probs=205.0
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH-HHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCcE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS-DAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~-~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~s~~~~~~l 102 (619)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+.+.+.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 889999999999999999887 8899999976544443 577889999999999988 7999999983 22348
Q ss_pred EEEEecCCc-cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcccccc
Q 007064 103 YVVFELMES-DLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 177 (619)
+++++++.+ +|.+++.... .+++.....++.|++.+|.|+|+.+++||||||+||+++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999994 8887777664 799999999999999999999999999999999999999998 79999999998543
Q ss_pred CCCCCc---cccccccCCccccCcccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhhCCC
Q 007064 178 NDTPTT---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTP 250 (619)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~Y~APEll~~~~-~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~---~~~l~~i~~~~g~p 250 (619)
...... ......+|+.+|++||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332211 1346678999999999987521 3688899999999999999999999877764 22222221111111
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
. ......... ......+.+++.+|+..+|..|.+..+...++|....
T Consensus 234 ~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 S----------------------LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred c----------------------cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0 000000000 1123578999999999999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=232.24 Aligned_cols=180 Identities=21% Similarity=0.206 Sum_probs=134.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFE---HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~~---~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..++|.+.+.||+|+||+||+|+++. ++..+|||++..... .......+.+|+++|+.|+|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 45789999999999999999998876 678889998753211 233456788999999999999998533221
Q ss_pred CCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILi~~~~~vKL~DFGla~ 174 (619)
...|||||||+| +|. .+.. .. ...++.|++++|.|||+.||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 247999999996 675 2211 11 1468899999999999999999999 9999999999999999999998
Q ss_pred cccCCCCCcc-----ccccccCCccccCcccccccCCC----CCCcccch
Q 007064 175 VAFNDTPTTI-----FWTDYVATRWYRAPELCGSFFSK----YTPAIDIW 215 (619)
Q Consensus 175 ~~~~~~~~~~-----~~~~~~gt~~Y~APEll~~~~~~----y~~~~DIW 215 (619)
.......... ..+...+++.|+|||.+...... .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7543321111 12456788889999998542122 23346777
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=223.79 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg-----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.|+++...+-+|.||.||.|+.+... +.|-+|.++.. ........++.|-.+|..+.|||+..+.++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie---- 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE---- 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----
Confidence 45777888999999999999765322 34666666532 334556778899999999999999999999853
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN--------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~--------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
+....++++.+++ |+|..++... +.++..++..+..||..|+.|||+.||||.||-..|.+||+.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4456789999999 8999999721 247778888899999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
|=.++|..+........ ...-....||+||.+.. ..|+.++|+||||+++|||+| |+.|+-.-+..+....+.+.
T Consensus 439 DsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG- 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG- 514 (563)
T ss_pred cchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence 99999987655443321 11234456999999987 789999999999999999998 78888766655544333221
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..+. ..-++++++..++--||..+|++||+.+|+..
T Consensus 515 ----------------------------yRla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ----------------------------YRLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----------------------------ceec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1111 12378899999999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-23 Score=215.87 Aligned_cols=256 Identities=21% Similarity=0.238 Sum_probs=189.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCC----CCcceeeeEecCCCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRH----PDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg-~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H----pnIv~l~~v~~~~s~~~ 98 (619)
+|++.+.||+|+||.||+|.+..++ ..+|+|.......... ..+..|+.+|..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6788888764322111 156678888888863 57888887763 23
Q ss_pred CCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CcEEEeecC
Q 007064 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-----CKLKICDFG 171 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-----~~vKL~DFG 171 (619)
...-||||++++.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3457999999999999988654 579999999999999999999999999999999999999765 469999999
Q ss_pred ccc--cccCCCCC---c--cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007064 172 LAR--VAFNDTPT---T--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 172 la~--~~~~~~~~---~--~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~ 244 (619)
+++ ........ . .....+.||..|.++....+ ...+.+.|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 43222211 1 10134569999999998887 688999999999999999999999997765432222221
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ..... .......+..+..++..+-..+...+|....+...
T Consensus 251 ~~~-----------------------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDP-----------------------RKLLT---DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHh-----------------------hhhcc---ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 100 00000 00122334567777777777888888888777554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-23 Score=205.50 Aligned_cols=214 Identities=21% Similarity=0.321 Sum_probs=170.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~ 100 (619)
.-.|+++++||+|+||+.+.|.+.-+++.||||.-... +++-.+..|....+.|. .+.|...+-+- ++..
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~ 97 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGK 97 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----cccc
Confidence 45799999999999999999999999999999976532 44556777888888885 67887765432 4445
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CcEEEeecCccc
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-----CKLKICDFGLAR 174 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-----~~vKL~DFGla~ 174 (619)
+-.||+|+++.+|.+++.- ...|+...+..++.|++.-++|+|++.+|+|||||+|+||..- ..|.|+|||+|+
T Consensus 98 ~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 98 YNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 5679999999877777753 4579999999999999999999999999999999999999754 358999999999
Q ss_pred cccCCCCCc-cc---cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007064 175 VAFNDTPTT-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 175 ~~~~~~~~~-~~---~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~ 246 (619)
.+.+..... +. .....||..||+-....+ ..-+...|+-|||.+|.+.|.|..||.|........+..++
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 865443221 11 134579999999887776 56788999999999999999999999987554444444333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=197.58 Aligned_cols=216 Identities=25% Similarity=0.351 Sum_probs=169.6
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPP 94 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~ 94 (619)
..++-..+.|++++.||.|+||.+|+|+...+|+.||||+-.....+ -.+..|.++.+.|++ ..|..+..+.
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~--- 80 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG--- 80 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc---
Confidence 34556778999999999999999999999999999999987644333 246678999999975 4566555554
Q ss_pred CCCCCCcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeec
Q 007064 95 SRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDF 170 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DF 170 (619)
.+...-.+||++++.+|.+++.- ...++...+.-++-|++.-|+|+|..+++||||||+|+|..-+ ..+.|+||
T Consensus 81 --~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 81 --TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred --cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEec
Confidence 33455689999999877777753 3469999999999999999999999999999999999997532 46999999
Q ss_pred CccccccCCCCCc-cc---cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 171 GLARVAFNDTPTT-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 171 Gla~~~~~~~~~~-~~---~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
|+|+.+.+..... +. -....||..|.+-....+ ..-+...|+-|+|.+|.++..|..||.|-......++
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 9998865433221 11 234679999998776554 4556789999999999999999999998765444433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-24 Score=240.00 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=186.7
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc--cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI--FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~--~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.|...+.||++.|=+|++|.+. .|. |+||++-+. ........+-++|++ ...++|||.+.+..+. ...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 8999999999999999999764 344 899998543 233445556667777 6778999999987765 34566
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc--CC
Q 007064 102 IYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF--ND 179 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~--~~ 179 (619)
.|+|-+|...+|++.|..+.-|..-+.+.|+.||+.||+-+|..||+|||||.+||||+.=+.+.|.||..-+... .+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8999999999999999988889999999999999999999999999999999999999998899999998765522 11
Q ss_pred CC--CccccccccCCccccCccccccc--------CCC-CCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 180 TP--TTIFWTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 180 ~~--~~~~~~~~~gt~~Y~APEll~~~--------~~~-y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
.+ ...++.+...-..|.|||.+... ... .+++-||||+||+++||++ |+|||.-. |+-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhc--
Confidence 11 12222222333469999976431 112 6788999999999999998 68988321 1111100
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.........++.+ -+..++.||..|++.||.+|.+|++.|+-
T Consensus 250 ----------~~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 ----------GNADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ----------cCccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0001111122221 13468999999999999999999999974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=233.82 Aligned_cols=239 Identities=25% Similarity=0.413 Sum_probs=195.5
Q ss_pred EeeecCceEEEEEEE---CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEE
Q 007064 30 VIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~---~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.+|.|+||.|+++.. ...|.-+|+|++++.............|-.++...+ ||.++++.-.+ +....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 379999999998753 345678999998765444444445556888888887 99999999888 455679999
Q ss_pred EecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcc
Q 007064 106 FELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184 (619)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~ 184 (619)
+++..| +|+..+.....+.+...+.+...++.++.++|+.+|+|||+|++||+++.+|.+|+.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999999988889999999999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh-hhCCCchhhhhhhcchhH
Q 007064 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISRVRNDKA 263 (619)
Q Consensus 185 ~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~-~~g~p~~e~i~~~~~~~~ 263 (619)
..|||..|||||++. ....++|.||+|++.+||++|..||.+ +....|.. .+
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------------- 204 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------------- 204 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc----------------
Confidence 228999999999986 467899999999999999999999977 23333321 11
Q ss_pred HHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCCC
Q 007064 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGLS 320 (619)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~~ 320 (619)
......+..+.+++..|+..+|..|.- +.|+++|++|..+.
T Consensus 205 ----------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 205 ----------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred ----------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 111245678999999999999999964 58999999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=235.70 Aligned_cols=226 Identities=28% Similarity=0.452 Sum_probs=172.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|..++.|..|+||.||+++|+.+...+|+ ++++. + -||+ ||..+.+
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq--~-----------lilR-----nilt~a~----------- 130 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQ--N-----------LILR-----NILTFAG----------- 130 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-ccccc--c-----------hhhh-----ccccccC-----------
Confidence 446799999999999999999999999999999 45431 1 1122 1332221
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+.++| ||-...++..+.++.+. +.+++|||+-||+|||+||+|+||+.-|++|+.|||+++......
T Consensus 131 npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 131 NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 12333 66666677666776554 778999999999999999999999999999999999997643222
Q ss_pred CCcc-----------c-cccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 181 PTTI-----------F-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 181 ~~~~-----------~-~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
.+.. + -...+||+.|+|||++.. ..|+..+|+|++|+|+||.+.|..||.|++..+.+.....-
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd-- 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh--
Confidence 2110 0 123489999999999886 78999999999999999999999999999887766544321
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHHcCccccCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 319 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR---pSa~elL~hp~f~~~ 319 (619)
.+.|.+....+.+++++||.++|..+|..| ..+-++-+|+||+.+
T Consensus 274 --------------------------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 274 --------------------------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred --------------------------hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 122333344578899999999999999999 467788899999865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=196.67 Aligned_cols=176 Identities=13% Similarity=0.134 Sum_probs=133.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HHH------HHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AAR------ILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~-~~~------i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
.++|+++++||.|+||.||++.+ ++..+|||++......... ..+ +.+|+..+.+|.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 58999999999999999999644 4678999999754332222 223 56899999999999999999886543
Q ss_pred CCC---CCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 95 SRR---DFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 95 s~~---~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
... .....+|||||++| +|.++. .++++ .+.+|+.+|..||..|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 221 12468999999997 787763 23332 466999999999999999999999999999998 999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHH
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLl 225 (619)
|.......+.... .+... ..|+.++||||||+.+..+.
T Consensus 179 g~~~~~~e~~a~d---------------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD---------------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH---------------HHHHH--hHhcccccccceeEeehHHH
Confidence 9886542211100 02222 45778999999999988764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=199.82 Aligned_cols=240 Identities=20% Similarity=0.272 Sum_probs=152.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCC----------CCcceeeeEec
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRH----------PDIVEIKHIML 92 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~H----------pnIv~l~~v~~ 92 (619)
.+...+.||.|+++.||.+.|..||+.+|+|++.... ......+.+.+|.-....+.+ -.++-.+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4667889999999999999999999999999885322 222345666666544444322 12333333322
Q ss_pred CCCC-------C--CCC---cEEEEEecCCccHHHHHHh---CCCC----CHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 93 PPSR-------R--DFK---DIYVVFELMESDLHQVIKA---NDDL----TREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 93 ~~s~-------~--~~~---~lylV~E~~~g~L~~~i~~---~~~l----~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
.... . ... +.+++|+-+.+||.+++.. .... .......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0 011 4588999999988887642 2222 122224555899999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 227 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~------~~~y~~~~DIWSLG~ilyeLltG 227 (619)
|+|+|++.+|.++|+||+......... .....+..|.+||+.... ...++.+.|.|+||+++|.|.+|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999876543221 112345779999976431 13578899999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC
Q 007064 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304 (619)
Q Consensus 228 ~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR 304 (619)
..||........ ....|...- ++++.+++||..||..||.+|
T Consensus 247 ~lPf~~~~~~~~----------------------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD----------------------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST----------------------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc----------------------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999966532100 000233333 678899999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-22 Score=193.46 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=109.2
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD------------------------AARILREIKLLRLLRHPD 83 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~------------------------~~~i~~Ei~iL~~L~Hpn 83 (619)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999643211100 122345999999998887
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEECC
Q 007064 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANA 161 (619)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILi~~ 161 (619)
+.....+.. ...+|||||++| ++...+.....++++.+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744333221 123899999996 5544444456799999999999999999999 799999999999999998
Q ss_pred CCcEEEeecCccccc
Q 007064 162 NCKLKICDFGLARVA 176 (619)
Q Consensus 162 ~~~vKL~DFGla~~~ 176 (619)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=186.13 Aligned_cols=141 Identities=23% Similarity=0.201 Sum_probs=111.6
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------------------------HHHHHHHHHHHHHHhcCCC
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------------------------SDAARILREIKLLRLLRHP 82 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~------------------------~~~~~i~~Ei~iL~~L~Hp 82 (619)
+.+.||+|+||.||+|.+. +|+.||||+++...... .....+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987532110 0012345799999999999
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEC
Q 007064 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 160 (619)
Q Consensus 83 nIv~l~~v~~~~s~~~~~~lylV~E~~~g~-L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~ 160 (619)
+|.....+... ..||||||++|. +...+.....+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 88655444321 238999999963 43332344568899999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCccccc
Q 007064 161 ANCKLKICDFGLARVA 176 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (619)
++.++|+|||++...
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=196.54 Aligned_cols=256 Identities=29% Similarity=0.363 Sum_probs=175.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCC-----------------------------------cEEEEEEecCccCChHHH
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-----------------------------------EKVAIKKIHDIFEHISDA 66 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg-----------------------------------~~vAIK~i~~~~~~~~~~ 66 (619)
.++|+|++.||+|.-..||.|....+| -+.|||.+.+. ++.+..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~ 234 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGD 234 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCch
Confidence 467999999999999999999754321 13566665432 222222
Q ss_pred HHHH----HHHH------HH--------Hh--------cCCCCcceeeeEecCCC----------------------CCC
Q 007064 67 ARIL----REIK------LL--------RL--------LRHPDIVEIKHIMLPPS----------------------RRD 98 (619)
Q Consensus 67 ~~i~----~Ei~------iL--------~~--------L~HpnIv~l~~v~~~~s----------------------~~~ 98 (619)
..|+ +|+- .+ +. -+|||||++..+|.+.- ...
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 2222 2221 11 11 25999999988775421 123
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCC--cEEEeecCccc
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC--KLKICDFGLAR 174 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~--~vKL~DFGla~ 174 (619)
...+|+||..+..+|++++-.+. .+.....-++.|+|+|+.|||..||.|||||.+|||+. +|+ .+.|+|||.+-
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 45799999999999999998765 67777788999999999999999999999999999974 443 48999999874
Q ss_pred cccCCCCCc---cccccccCCccccCcccccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 175 VAFNDTPTT---IFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 175 ~~~~~~~~~---~~~~~~~gt~~Y~APEll~~~~~~----y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
...+..-.. ....+.-|.-.-||||+......+ .-.++|.|+.|.+-||++....||.+......
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------- 465 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------- 465 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--------
Confidence 322211111 112234577788999997532111 12479999999999999999999987542211
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~ 308 (619)
+. + ..+...+......+++.+++|+..+|+.||.+|+++.
T Consensus 466 -----~~---------r-------~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 466 -----DT---------R-------TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred -----ch---------h-------hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 00 0 1111222333346789999999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=179.28 Aligned_cols=192 Identities=16% Similarity=0.065 Sum_probs=138.6
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--HHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcE
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--DAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~--~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.+...|++|+||+|+.+.. .+.+++.+.+........ ....+.+|+++|++|. |++|.+++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 3578899999999998743 678888887764322111 2335789999999996 5889998875 236
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDL-KPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|++|||+.| +|.+.+.. . ...++.|++.+|.+||+.||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 66544321 1 1357899999999999999999999 7999999999999999999998543222
Q ss_pred CCcccc--c--------cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 007064 181 PTTIFW--T--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (619)
Q Consensus 181 ~~~~~~--~--------~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~ 235 (619)
.....+ . -...++.|+.|+.-.-....--...+.++.|+-+|.++|+..++.+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 100000 0 012567788887533221222356788899999999999998876654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=178.01 Aligned_cols=136 Identities=21% Similarity=0.247 Sum_probs=106.9
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-----CCCCcceeeeEecCCCCCCCCcE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-----RHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-----~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.| .||||+++++++.... ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 46899999999995 7777776 69988642 223456789999999999 5799999999995432 12344
Q ss_pred E-EEEecCC---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEECCC----CcEEEeecCcc
Q 007064 103 Y-VVFELME---SDLHQVIKANDDLTREHYQFFLYQLLRAL-KYIHTANVYHRDLKPKNILANAN----CKLKICDFGLA 173 (619)
Q Consensus 103 y-lV~E~~~---g~L~~~i~~~~~l~e~~i~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFGla 173 (619)
| +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+.+|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 46666 46688988888 89999999999999999999743 47999995543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-20 Score=196.53 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=167.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeee-------Eec
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKH-------IML 92 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~-------v~~ 92 (619)
..+.+.+..+..+++.+....-... .+.+.-+..+. .+........+++-.+....|-+..-+.+ .+.
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 4455666677777776655433222 22333332221 12233444556666665555444433333 111
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
........++||.|++|. .+|.++|..+. ..+....+.++.|+..|++| +|.+|||+||.||+...++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 111122346899999999 69999997443 46778889999999999999 999999999999999999999999
Q ss_pred ecCccccccCCC---CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 169 DFGLARVAFNDT---PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 169 DFGla~~~~~~~---~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
|||+........ ......+..+||.|||+||.+.+ ..|+.++||||||.||+||+.- |.. ..+....
T Consensus 399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t--- 468 (516)
T KOG1033|consen 399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FST--QFERIAT--- 468 (516)
T ss_pred hhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHh---
Confidence 999987654433 11123466799999999999998 7999999999999999999972 211 1111110
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
+..++.. .+...+..-.+.-.+|+.+||...|.+||++.+.--|.|.
T Consensus 469 ---------------------~~d~r~g---~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 469 ---------------------LTDIRDG---IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---------------------hhhhhcC---CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111111 1111111223566799999999999999988777667664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=178.38 Aligned_cols=244 Identities=16% Similarity=0.247 Sum_probs=185.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+...++.+|.+...|..|++ +..|..+++|++.-........+.+..|.-.|+.+.||||+.+++.+-.+ .++
T Consensus 190 ~~lnl~tkl~e~hsgelwrg--rwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRG--RWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccc--cccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 34456678999999999999 46688888898875444445556788899999999999999999999544 568
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 103 YVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.++..||. |+|+.++.... -++..++..|+.+|++|+.|||+.. |.---|....++||++-+.+|. .+-++..+
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence 99999999 89999998654 3577888999999999999999975 4445688899999998776653 11111111
Q ss_pred CCCCCccccccccCCccccCcccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~-~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ....-.|.|++||.+..... ..-.++|+|||.++++||.|...||...+..+.-.+|.
T Consensus 342 qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------ 402 (448)
T KOG0195|consen 342 QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------ 402 (448)
T ss_pred ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------
Confidence 11 22345788999998865211 22357999999999999999999998887766544331
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
++.++ ....|+++.....|++-|+..||.+||..+.+
T Consensus 403 ----------leglr-------v~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 403 ----------LEGLR-------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------hcccc-------ccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 11111 13457899999999999999999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=179.70 Aligned_cols=146 Identities=18% Similarity=0.135 Sum_probs=112.6
Q ss_pred CCCeEEeEEeeecCceEEEEEE-ECCCCcEEEEEEecCccCCh--------------------H--HHHHHHHHHHHHHh
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAI-DTHTGEKVAIKKIHDIFEHI--------------------S--DAARILREIKLLRL 78 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~-~~~tg~~vAIK~i~~~~~~~--------------------~--~~~~i~~Ei~iL~~ 78 (619)
..-|.+.+.||+|+||.||+|. +..+|+.||||+++...... . ....+.+|+.++..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 77899999999986431100 0 11235689999999
Q ss_pred cCCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCc
Q 007064 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN-VYHRDLKPKN 156 (619)
Q Consensus 79 L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP~N 156 (619)
+.+. ++.+..++.. ...||||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 107 L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 9763 2222233311 124899999997 56555444456777778899999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCcccc
Q 007064 157 ILANANCKLKICDFGLARV 175 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~ 175 (619)
|+++ ++.++|+|||.+..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.4e-19 Score=204.03 Aligned_cols=193 Identities=24% Similarity=0.318 Sum_probs=152.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~s~~~ 98 (619)
+..|.|.+.||+|+||.||+|.+.. |+.||+|+-+....+. ++=-.+++.+|+ -+.|..+..+++..
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 4789999999999999999999876 9999999876433222 222233444444 23444444443222
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCcEEEeec
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLKICDF 170 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-------~~~vKL~DF 170 (619)
+.-+||+||.+ |+|.+++..++.+++..+.+|..|||..|++||..+|||+||||+|+||.. +--++|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 33589999999 899999998889999999999999999999999999999999999999842 235999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~ 228 (619)
|.+....--.+. ..+...++|-.+-.+|+..+ ..|+..+|.|.|+.+++-||.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 998764322222 23466788899999999988 79999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=168.85 Aligned_cols=136 Identities=22% Similarity=0.268 Sum_probs=110.3
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++.||+|++|.||+|.+ .|..+++|+........ ....++.+|+.++..+.|++|.....++. +...
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPEN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCC
Confidence 36799999999999976 67889999865322211 12346788999999999999877666553 2245
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.++||||++| +|.+++..... ....++.+|+.+|.+||+.|++||||+|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7999999986 89888865432 7788999999999999999999999999999999 78999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-19 Score=205.17 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=207.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~ 98 (619)
....|.+.+.||+|+|+.|-++.... ....+|.|.+...........++..|..+-+.+. |.|++.+++.. .+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~ 92 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SS 92 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CC
Confidence 35678999999999999998887643 4456777777654333344556667888888887 99999999887 34
Q ss_pred CCcEEEEEecCC-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCC-cEEEeecCcc
Q 007064 99 FKDIYVVFELME-SDLHQVI-KAND-DLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANC-KLKICDFGLA 173 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i-~~~~-~l~e~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILi~~~~-~vKL~DFGla 173 (619)
....++++++.. ++++..+ .... ..+......++.|+..+|.|+| ..++.||||||+|.+++.++ .+|+.|||+|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 456899999977 4888888 5554 6788889999999999999999 99999999999999999999 9999999999
Q ss_pred ccccCCCCCccccccccC-CccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g-t~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
................+| ++.|.|||...+. ....+..|+||+|+++.-|++|..||......+.
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------------- 238 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------------- 238 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc-------------
Confidence 876552233334456788 9999999998763 3567889999999999999999999855442211
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.+...+..+ ...-...|..++..+.+++.++|..+|..|.+.+++-.+||+..
T Consensus 239 ------------~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 ------------RYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------cceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111111111 11123446778899999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.9e-17 Score=160.26 Aligned_cols=137 Identities=22% Similarity=0.204 Sum_probs=105.8
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI--------------------SDAARILREIKLLRLLRHPD 83 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~--------------------~~~~~i~~Ei~iL~~L~Hpn 83 (619)
.|.+.+.||.|+||.||++.+. +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 79999999875321000 01123567999999998875
Q ss_pred c--ceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 84 I--VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 84 I--v~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
+ ...++ ....++||||++| +|..... ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 33322 1235899999996 6655432 144567899999999999999999999999999999
Q ss_pred CCCcEEEeecCccccc
Q 007064 161 ANCKLKICDFGLARVA 176 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (619)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=160.37 Aligned_cols=131 Identities=27% Similarity=0.367 Sum_probs=102.4
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCc-cCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.||+|+||.||++. .++..+++|+.... ... .....++.+|+.+++.+.|+++....-++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 38999999999997 46788999986432 111 1123567899999999998865544333321 23468
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+||||++| +|.+.+..... .++.+|+.+|.+||+.|++||||+|.||+++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-17 Score=176.08 Aligned_cols=210 Identities=23% Similarity=0.301 Sum_probs=151.8
Q ss_pred HHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccC
Q 007064 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANV-YHRDL 152 (619)
Q Consensus 76 L~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gI-vHrDL 152 (619)
|+.+.|.|+.++++.++.. ..+++|.+||. |+|.+.+.. ...++.-....++++|+.||.|||+..| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999654 56899999999 899999987 4468888889999999999999998876 99999
Q ss_pred CCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCccccccc--CC---CCCCcccchhHHHHHHHHHhC
Q 007064 153 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEVLTG 227 (619)
Q Consensus 153 KP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~--~~---~y~~~~DIWSLG~ilyeLltG 227 (619)
+..|.++|....+||.|||+......... ........-...|.|||++.+. .. .-+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccc-ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999876532100 0001112234468999998752 11 146779999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH
Q 007064 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 307 (619)
Q Consensus 228 ~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa 307 (619)
..||........-..+... +.........+.........+.+..++..||..+|.+||++
T Consensus 155 ~~~~~~~~~~~~~~eii~~--------------------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR--------------------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHHH--------------------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 9999774322111111100 00000000000001111345579999999999999999999
Q ss_pred HHHH
Q 007064 308 EEAL 311 (619)
Q Consensus 308 ~elL 311 (619)
+++-
T Consensus 215 ~~i~ 218 (484)
T KOG1023|consen 215 EQIR 218 (484)
T ss_pred HHHH
Confidence 9984
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=179.30 Aligned_cols=138 Identities=22% Similarity=0.295 Sum_probs=107.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEe-cCccCC-----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEH-----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i-~~~~~~-----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..|...+.||+|+||.||++... +..+++|+. .+.... .....++.+|+.+|+.++|++|+....+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 44567899999999999999754 344455543 221111 1234568899999999999999887665532
Q ss_pred CCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
....++||||++| +|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 2346899999985 8988875 346789999999999999999999999999999 677999999999976
Q ss_pred c
Q 007064 176 A 176 (619)
Q Consensus 176 ~ 176 (619)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.3e-16 Score=151.60 Aligned_cols=136 Identities=24% Similarity=0.266 Sum_probs=97.3
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR----------------------ILREIKLLRLLRHPD-- 83 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~----------------------i~~Ei~iL~~L~Hpn-- 83 (619)
.+.||+|+||.||+|.+. +++.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999876 8999999998643221111111 135666666665433
Q ss_pred cceeeeEecCCCCCCCCcEEEEEecCCc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEC
Q 007064 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLH-QVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILAN 160 (619)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~-~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~ 160 (619)
+.+++.+ ...++||||+.+ .+. ..+.... . ...++.++.+++.++.++|+ .||+||||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333332 235899999997 211 1121111 1 16778999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCccccc
Q 007064 161 ANCKLKICDFGLARVA 176 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (619)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.6e-15 Score=149.00 Aligned_cols=139 Identities=21% Similarity=0.285 Sum_probs=103.7
Q ss_pred EEee-ecCceEEEEEEECCCCcEEEEEEecCc------cC-----ChHHHHHHHHHHHHHHhcCCCCc--ceeeeEecCC
Q 007064 29 EVIG-KGSYGVVCSAIDTHTGEKVAIKKIHDI------FE-----HISDAARILREIKLLRLLRHPDI--VEIKHIMLPP 94 (619)
Q Consensus 29 ~~LG-~G~fG~V~~a~~~~tg~~vAIK~i~~~------~~-----~~~~~~~i~~Ei~iL~~L~HpnI--v~l~~v~~~~ 94 (619)
..|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|.|++| +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888855 3788999977421 00 11234578899999999998875 5565553221
Q ss_pred CCCCCCcEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 95 SRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g--~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
. ......++|||+++| +|.+++.. ..++++. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123599999995 88888865 3566553 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 007064 173 ARV 175 (619)
Q Consensus 173 a~~ 175 (619)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-16 Score=168.27 Aligned_cols=257 Identities=25% Similarity=0.250 Sum_probs=200.8
Q ss_pred CCeEEeEEeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGK--GSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~--G~fG~V~~a~~--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..........+=++|+.-.+.++ |+|.++.+..+ .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 34677889999 99999999988 889999999986655554445555567888777775 99999977776 5
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEECCC-CcEEEeecC
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR----ALKYIHTANVYHRDLKPKNILANAN-CKLKICDFG 171 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~-l~e~~i~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFG 171 (619)
+.+.+|+-+|+|+.+|..+...... +++..++..+.+.+. ||.++|+.+|+|-|+||.||++..+ ..++++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 5677999999999999998877655 889999999999999 9999999999999999999999999 889999999
Q ss_pred ccccccCCCCCcccc--ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC--ChhHHHHHHHhhh
Q 007064 172 LARVAFNDTPTTIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLMTDLL 247 (619)
Q Consensus 172 la~~~~~~~~~~~~~--~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~--~~~~~l~~i~~~~ 247 (619)
+............+. ..--|..-|++||++.+ -++...||++||.++.+-.+|.-++... +.+.++..+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---- 341 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---- 341 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc----
Confidence 988765443222111 11246667999999875 6889999999999999999988666444 322222111
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....+.....+..+...+..|+..||..|++++.+++|+++...
T Consensus 342 ----------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 ----------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ----------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 01112223455667779999999999999999999999998743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=132.83 Aligned_cols=131 Identities=24% Similarity=0.220 Sum_probs=106.9
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEE
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~s~~~~~~lyl 104 (619)
+++.||.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++.+++.... ..+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEE
Confidence 46889999999999998743 7899998865322 4568889999999976 58888877662 2356899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+|||+.| .+..+ +......++.+++.+|.+||.. +++|+||+|.||+++.++.++++|||+++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999996 34332 5566678899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-13 Score=151.12 Aligned_cols=184 Identities=23% Similarity=0.345 Sum_probs=136.0
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lyl 104 (619)
|.| +..+-++.+..-.|..+.++.+|.|.+.+.... .....+.+-++.|+.|+||||+++++.+ +..+.+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 555 444444444322466678899999998875422 4456677889999999999999999988 55568999
Q ss_pred EEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc
Q 007064 105 VFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT 183 (619)
Q Consensus 105 V~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~ 183 (619)
|+|-+. -|..+++. +....+..-++||+.||.||| .++++|++|.-+-|+|+..|..||++|.++........
T Consensus 87 vTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 87 VTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred Eeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 999887 23344443 347888889999999999997 68899999999999999999999999998865432221
Q ss_pred cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC
Q 007064 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (619)
Q Consensus 184 ~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG 227 (619)
......--..|..|+.+.. .. -..|.|-|||+++|++.|
T Consensus 161 -~~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 -PAKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 0111222234677776643 12 457999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.1e-15 Score=166.89 Aligned_cols=264 Identities=23% Similarity=0.267 Sum_probs=195.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-.+.+.+.+.+-+|+++.++.+.-..+|...++|+..... ....+.+.+..+-.++..-.+|.++...--+ .-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 4456788889999999999999888888777777654221 1111233444444554445566666543322 233
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+||++|+. ++|...+.+.+..+++-.+.++..+..++++||+..+.|||++|.|+|+..++..++.|||.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 56899999998 59999999888899999999999999999999999999999999999999999999999984432111
Q ss_pred CCCCc----------------------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007064 179 DTPTT----------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (619)
Q Consensus 179 ~~~~~----------------------------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p 230 (619)
-.+.. ..-...++|+.|.+||.+.+ ......+|+|++|++++|.++|.+|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10000 00123578999999999887 5778899999999999999999999
Q ss_pred CCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH--
Q 007064 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-- 308 (619)
Q Consensus 231 F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~-- 308 (619)
|.........+.| . ....++.......++.+.+++.++|..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni---------------------------~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1035 FNAETPQQIFENI---------------------------L-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCcchhhhhhcc---------------------------c-cCCCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 9877654333222 1 122233333345678999999999999999998887
Q ss_pred -HHHcCccccCC
Q 007064 309 -EALADPYFKGL 319 (619)
Q Consensus 309 -elL~hp~f~~~ 319 (619)
++-.|+||+..
T Consensus 1087 ~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDV 1098 (1205)
T ss_pred cccccCCccCCC
Confidence 88899999865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-14 Score=146.80 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=162.6
Q ss_pred EEEEEEECCCCcEEEEEEecCccCChH--HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-ccHH
Q 007064 38 VVCSAIDTHTGEKVAIKKIHDIFEHIS--DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH 114 (619)
Q Consensus 38 ~V~~a~~~~tg~~vAIK~i~~~~~~~~--~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~ 114 (619)
.||++.++..|.+|++-.+.....+.- .......-..-|-.+-|.|||+++.+|.+....+...+.+++|||. |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 356666666776666554431110000 0111111233444567999999999987766566778999999999 7999
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCccc--cccCCCCCcccc
Q 007064 115 QVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFW 186 (619)
Q Consensus 115 ~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~--~~~~~~~~~~~~ 186 (619)
++++. ...+.....++|+-||+.||.|||+.. |+|++|..+.|++..+|-+|+.--.-.. .......+ ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-AEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH-hhh
Confidence 98864 346889999999999999999999986 9999999999999999988875321111 11000000 000
Q ss_pred ccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHH
Q 007064 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265 (619)
Q Consensus 187 ~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (619)
.-..+-+.|.+||.-.. .+.+-++|||++|+...+|..|..- -.+.+....-..|..
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-------------------- 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-------------------- 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh--------------------
Confidence 11346678999997543 4567789999999999999887632 222221111111100
Q ss_pred HHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
..+..-.+.-++++.+||.-.|..||++.++|.||.+-.+..
T Consensus 298 --------------~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 298 --------------VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred --------------heeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 001111234467999999999999999999999999766543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.4e-13 Score=149.28 Aligned_cols=140 Identities=20% Similarity=0.316 Sum_probs=94.8
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---------------------------h-----HHHHHHHHH
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---------------------------I-----SDAARILRE 72 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~---------------------------~-----~~~~~i~~E 72 (619)
|.. +.||.|++|.|++|+.+.+|+.||||+++..... . .....+.+|
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 443 7899999999999999888999999999632110 0 111223344
Q ss_pred HHHHH------hc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHH--HHhCC----CCCHHHHHHHHHHH
Q 007064 73 IKLLR------LL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKAND----DLTREHYQFFLYQL 135 (619)
Q Consensus 73 i~iL~------~L----~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~--i~~~~----~l~e~~i~~i~~QI 135 (619)
+.+++ ++ .+.+.+.+-.++. +....-+||||||+| .+.++ +...+ .+.+..+..++.||
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 44433 33 2333344434442 123456899999996 77653 33333 35555566666666
Q ss_pred HHHHHHHHHCCceeccCCCCcEEECCCC----cEEEeecCccccc
Q 007064 136 LRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLARVA 176 (619)
Q Consensus 136 l~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DFGla~~~ 176 (619)
+ ..|++|+|+||.||+++.+| +++++|||++...
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5 48999999999999999988 9999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.4e-12 Score=138.61 Aligned_cols=141 Identities=21% Similarity=0.264 Sum_probs=93.7
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChH--H------------------------------H------HHH
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS--D------------------------------A------ARI 69 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~--~------------------------------~------~~i 69 (619)
.+.||.|++|.||+|+.+ +|+.||||+.+....... + . -.+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 467999999999999864 799999999853210000 0 0 013
Q ss_pred HHHHHHHHhc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHH
Q 007064 70 LREIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLR-ALKYI 142 (619)
Q Consensus 70 ~~Ei~iL~~L----~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~-~~l~e~~i~~i~~QIl~-aL~yL 142 (619)
.+|...+..+ +|.+-+.+-.++.. ....-+|||||++| +|.++.... ..+. ...++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 3444444444 23333344344421 12346999999996 676665421 1222 2345555555 46789
Q ss_pred HHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 143 Hs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
|..|++|+|+||.||+++.++.++|+|||++...
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.9e-12 Score=141.34 Aligned_cols=250 Identities=21% Similarity=0.210 Sum_probs=181.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+|..+..||.|.|+.|+.+... .++..|++|.+.+......+...-+.|+.+...+ .|.+++..+..| ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----ccc
Confidence 356788999999999999987644 6788999998876555555544556777777766 499999988777 344
Q ss_pred CcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCcccccc
Q 007064 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~~ 177 (619)
...||=-|||++ ++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||......
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 567899999984 444333333458899999999999999999999999999999999999886 788999999886411
Q ss_pred CCCCCccccccccCCcccc-CcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~-APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
-. .......-++. ..|++... ..+..+.|++|||.-+.+.++|.+.-...+....+
T Consensus 419 ~~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i---------------- 475 (524)
T KOG0601|consen 419 FS------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI---------------- 475 (524)
T ss_pred ee------cccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccceee----------------
Confidence 11 11123333444 35555543 67888999999999999999988653332211000
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
+ .......++....+..+.+.|+..|+..|+++.++..|.=|.
T Consensus 476 --~----------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 --R----------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --e----------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 000112233446788899999999999999999998887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.3e-12 Score=118.87 Aligned_cols=126 Identities=18% Similarity=0.164 Sum_probs=92.5
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcc-eeeeEecCCCCCCCCcEEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV-EIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv-~l~~v~~~~s~~~~~~lylV~ 106 (619)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence 567899999999999754 78899998754321 122456899999988755544 444332 1 1247999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEECCCCcEEEeecCccc
Q 007064 107 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANV-----YHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
|+++| ++.+. .. ....++.+++++|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 01 123467899999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.6e-11 Score=120.00 Aligned_cols=139 Identities=21% Similarity=0.260 Sum_probs=99.5
Q ss_pred eEEeeecCceEEEEEEECC------CCcEEEEEEecCc---cC-----------------ChHHHHHH----HHHHHHHH
Q 007064 28 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDI---FE-----------------HISDAARI----LREIKLLR 77 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~------tg~~vAIK~i~~~---~~-----------------~~~~~~~i----~~Ei~iL~ 77 (619)
...||.|--+.||.|.... .+..+|||+.+-. +. +......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 3579999986411 00 01112222 37999999
Q ss_pred hcCC--CCcceeeeEecCCCCCCCCcEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCC
Q 007064 78 LLRH--PDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLK 153 (619)
Q Consensus 78 ~L~H--pnIv~l~~v~~~~s~~~~~~lylV~E~~~g~-L~~~i~~~~~l~e~~i~~i~~QIl~aL~yL-Hs~gIvHrDLK 153 (619)
+|.. -++..++++. .-+|||||++++ +..-..+...++++....++.+++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8853 4566666542 248999999863 322111223466677788899999999998 89999999999
Q ss_pred CCcEEECCCCcEEEeecCccccc
Q 007064 154 PKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~ 176 (619)
+.|||++ ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.2e-10 Score=118.61 Aligned_cols=215 Identities=18% Similarity=0.236 Sum_probs=156.8
Q ss_pred eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCc--cHH
Q 007064 37 GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLH 114 (619)
Q Consensus 37 G~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g--~L~ 114 (619)
.+.|+|....+|..|++|.++..... .......-+++++++.|+|||.+.++|.... .++..+++|++|..+ +|.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence 47799999999999999999421111 1111223468899999999999999997443 355679999999984 787
Q ss_pred HHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 115 QVIKA---------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 115 ~~i~~---------------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
++.-. +...+|+.+|.|+.||..||.+||+.|+..+-|.|.+||++.+.+++|...|...+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 76522 234789999999999999999999999999999999999999999999988877665443
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. |.+.+ -.+-|.=.||.+++.|.||..--...+. .+
T Consensus 447 ~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~-------------------- 483 (655)
T KOG3741|consen 447 PT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDS-TQ-------------------- 483 (655)
T ss_pred CC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccc-hH--------------------
Confidence 21 11221 2356889999999999999632100110 00
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .....-+.++.+++++|.-+...++++ -++.++|.|
T Consensus 484 -----~s----------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 484 -----SS----------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -----HH----------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 00 001112456788999999999988887 789999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=103.31 Aligned_cols=143 Identities=22% Similarity=0.290 Sum_probs=104.6
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEec-CccCCh-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHI-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~-~~~~~~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.+..|-+|+-+.|+++ ...|+.++||.=. +...++ -...+..+|..+|.++.--.|.-..-++.+ ..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TY 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cC
Confidence 5788999999999999 4579998888642 222232 234678899999988863333322222321 22
Q ss_pred cEEEEEecCCc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEeecCcc
Q 007064 101 DIYVVFELMES--DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLA 173 (619)
Q Consensus 101 ~lylV~E~~~g--~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla 173 (619)
.-.|+|||++| ++.+++.... ....+....++.+|-+.|.-||.++|+|+||..+||++..++ .+.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34799999998 8888887643 333444478999999999999999999999999999997665 3589999998
Q ss_pred ccc
Q 007064 174 RVA 176 (619)
Q Consensus 174 ~~~ 176 (619)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-09 Score=108.41 Aligned_cols=143 Identities=17% Similarity=0.240 Sum_probs=101.7
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~s~~~~~~lylV 105 (619)
.+.|+.|..+.||++... +|+.+++|+....... .....+.+|+++++.+.+ .++.+++.+.... ...+..|+|
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEE
Confidence 367899999999999764 3688999987643211 134567889999999975 3456666654221 112356899
Q ss_pred EecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 007064 106 FELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT---------------------------------------- 144 (619)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs---------------------------------------- 144 (619)
||+++| ++.+.+.. ..++++....++.+++++|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999997 45443321 346677777777777777777773
Q ss_pred ----------------CCceeccCCCCcEEECC--CCcEEEeecCcccc
Q 007064 145 ----------------ANVYHRDLKPKNILANA--NCKLKICDFGLARV 175 (619)
Q Consensus 145 ----------------~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~ 175 (619)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.5e-09 Score=101.97 Aligned_cols=130 Identities=21% Similarity=0.307 Sum_probs=94.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEe-cCccCChH-----HHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCC
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKI-HDIFEHIS-----DAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i-~~~~~~~~-----~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~s~~~~~ 100 (619)
..+++|+-+.++.+.. -|..+++|.= .+...++. ...+..+|..+|..++- =+...++++.. .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-------~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-------D 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-------C
Confidence 4578899999998843 4556777753 33333332 23567789999988863 33344444431 2
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...|+|||.+| .|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 35799999998 566677665 145677788888889999999999999999998875 99999999974
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.6e-09 Score=105.62 Aligned_cols=144 Identities=14% Similarity=0.077 Sum_probs=96.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------HHHHHHHHHHHHHHhcCCCCcce--eeeEecCCCCC
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------SDAARILREIKLLRLLRHPDIVE--IKHIMLPPSRR 97 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~---------~~~~~i~~Ei~iL~~L~HpnIv~--l~~v~~~~s~~ 97 (619)
+.+-......|+++ ...|+.|.||......... .....+.+|...+..|..-+|.. ++.+.......
T Consensus 28 e~v~~~~~rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 33443333345555 3467789999764321110 00113678888888775333332 22222111111
Q ss_pred CCCcEEEEEecCCc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCcEE
Q 007064 98 DFKDIYVVFELMES--DLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-------NCKLK 166 (619)
Q Consensus 98 ~~~~lylV~E~~~g--~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-------~~~vK 166 (619)
....-+||||++++ +|.+++.. ....+......++.+|...+.-||.+||+|+||++.|||++. +..+.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 12457899999996 78888864 345667788899999999999999999999999999999975 46899
Q ss_pred EeecCccc
Q 007064 167 ICDFGLAR 174 (619)
Q Consensus 167 L~DFGla~ 174 (619)
|+||+.++
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.9e-10 Score=124.24 Aligned_cols=151 Identities=25% Similarity=0.352 Sum_probs=111.3
Q ss_pred HHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCcccccc--------ccCCccccCcccccccCCC
Q 007064 137 RALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD--------YVATRWYRAPELCGSFFSK 207 (619)
Q Consensus 137 ~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~--------~~gt~~Y~APEll~~~~~~ 207 (619)
.||.|+|. .++||++|.|++|.+++++.+||+.|+.+....+... ..... ......|.|||++.+ ..
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--cc
Confidence 89999995 7899999999999999999999999998865433211 11111 234567999999987 67
Q ss_pred CCCcccchhHHHHHHHHH-hCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCC
Q 007064 208 YTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD 286 (619)
Q Consensus 208 y~~~~DIWSLG~ilyeLl-tG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 286 (619)
.+.++|++||||++|.+. .|+..|.+.+.......-. ... .......-.+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------------------~~~------~~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------------------NLL------NAGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------------------ccc------ccccccccccCc
Confidence 889999999999999999 5677665553221111000 000 000001115688
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 287 PSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 287 ~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
+++++=|.++|..|+..||++.+++..|||.+
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 99999999999999999999999999999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.9e-08 Score=99.62 Aligned_cols=138 Identities=21% Similarity=0.273 Sum_probs=96.3
Q ss_pred eEEEEEEEC---CCCcEEEEEEecCccC-----ChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEEE
Q 007064 37 GVVCSAIDT---HTGEKVAIKKIHDIFE-----HISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 37 G~V~~a~~~---~tg~~vAIK~i~~~~~-----~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.+|.+... ..++.+.+|....... ......+..+|...+..|..-. ..+.+.+..... ......|||+
T Consensus 18 ~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lit 96 (206)
T PF06293_consen 18 RGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLIT 96 (206)
T ss_pred ceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEE
Confidence 344444332 3455666775432111 1123456778888887775322 333333332211 1124568999
Q ss_pred ecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEeecCcccc
Q 007064 107 ELMES--DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARV 175 (619)
Q Consensus 107 E~~~g--~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~ 175 (619)
|++++ +|.+++.....++......++.++...+.-||.+||+|+||++.|||++.++ .+.|+||+.++.
T Consensus 97 e~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 97 EALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99996 7999998755577888899999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.8e-08 Score=98.04 Aligned_cols=127 Identities=28% Similarity=0.298 Sum_probs=82.6
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------c-------CC-hHHHHHHHHHHHHHHhcCCC--CcceeeeEe
Q 007064 38 VVCSAIDTHTGEKVAIKKIHDI----------------F-------EH-ISDAARILREIKLLRLLRHP--DIVEIKHIM 91 (619)
Q Consensus 38 ~V~~a~~~~tg~~vAIK~i~~~----------------~-------~~-~~~~~~i~~Ei~iL~~L~Hp--nIv~l~~v~ 91 (619)
.||.|.. .+|..+|+|+.+.. + .. ........+|...|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 46779999986310 0 00 11224567899999999754 566666553
Q ss_pred cCCCCCCCCcEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 92 LPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKY-IHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~--g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
.-+|||||++ |.....+.... ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1379999999 63223333221 2355667788889885555 689999999999999999988 89999
Q ss_pred ecCccccc
Q 007064 169 DFGLARVA 176 (619)
Q Consensus 169 DFGla~~~ 176 (619)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-07 Score=91.98 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=101.0
Q ss_pred eecCceEEEEEEECCCCcEEEEEEecCc----cCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEE
Q 007064 32 GKGSYGVVCSAIDTHTGEKVAIKKIHDI----FEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 32 G~G~fG~V~~a~~~~tg~~vAIK~i~~~----~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~~~lylV 105 (619)
|+|+.+-|+.... .|..+-+|.-.+. .....-...+.+|+..|+.|..-+ +.++. ++-.......-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888988743 3457888876421 111224556889999999886433 33333 1110111123347899
Q ss_pred EecCCc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEeecCcccc
Q 007064 106 FELMES--DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (619)
Q Consensus 106 ~E~~~g--~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 175 (619)
+|-++| +|.+++... .+.++.....++.+|...|.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998884 999988653 34577888899999999999999999999999999999987677 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1e-07 Score=96.04 Aligned_cols=136 Identities=27% Similarity=0.283 Sum_probs=101.7
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEec-------Cc---------cCChH----HHHHHHHHHHHHHhcCCC--
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DI---------FEHIS----DAARILREIKLLRLLRHP-- 82 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~-------~~---------~~~~~----~~~~i~~Ei~iL~~L~Hp-- 82 (619)
+.++..||-|--|.||.|.+. .|.++|||.=+ +. ..+.+ ......+|.++|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999875 78899999531 00 01111 123456899999998644
Q ss_pred CcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 007064 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (619)
Q Consensus 83 nIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 161 (619)
.+.+.++. +.-.+|||+.+| .|... +++.+....++..|++-+.-+-..||||+|+.+=|||+++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55555443 345899999998 33332 2356667778888888888888999999999999999999
Q ss_pred CCcEEEeecCcccc
Q 007064 162 NCKLKICDFGLARV 175 (619)
Q Consensus 162 ~~~vKL~DFGla~~ 175 (619)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999986643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.5e-07 Score=89.64 Aligned_cols=143 Identities=20% Similarity=0.252 Sum_probs=89.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHH-HH------HHHHHHHHHHhcC---CCCcceeeeEe
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISD-AA------RILREIKLLRLLR---HPDIVEIKHIM 91 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~-~~------~i~~Ei~iL~~L~---HpnIv~l~~v~ 91 (619)
.+.|++.+++-......|.+. .-+|..+++|........... .. ...+++..+..+. --.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467999999999888888766 456789999987642211110 00 1123333333332 22222222222
Q ss_pred cCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 92 LPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
.-....-....++||||++| .|.+... +++. +...|.+++.-||..|++|+|..|.|++++.+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111222345689999998 5555431 3332 34567788999999999999999999999866 5999999
Q ss_pred Ccccc
Q 007064 171 GLARV 175 (619)
Q Consensus 171 Gla~~ 175 (619)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.6e-06 Score=90.14 Aligned_cols=261 Identities=16% Similarity=0.165 Sum_probs=156.7
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcce----eeeEecCCCCCCCCc
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVE----IKHIMLPPSRRDFKD 101 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~----l~~v~~~~s~~~~~~ 101 (619)
...+.||+|+-+.+|..-. -...+.|+.+.... ....+... .+...-.||.+-. -.... .+. +....
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp--a~~aqk~a--~la~~p~~p~~~~rvaWPqa~L-~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP--AAQAQKVA--ELAATPDAPLLNYRVAWPQATL-HGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCc--hHHHHHHH--HhccCCCCcchhhhhcccHHHh-hCC-Cccce
Confidence 3467899999999986622 12345677765321 11111111 1122224665433 11111 111 12233
Q ss_pred EEEEEecCCc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 102 IYVVFELMES--DLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 102 lylV~E~~~g--~L~~~i~~------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+-++|..+.| .++.++.. -....+..+.+..+.|+.+.+-||..|.+-+|+.++|+|+.+++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7788888885 45555432 124678888889999999999999999999999999999999999999985543
Q ss_pred ccccCCCCCccccccccCCccccCccccc-ccC--CCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCC
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~-~~~--~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
....+ ......-+|...|.+||+-. ..+ -.-+...|.|.||++++++|.| +.||.|-.. +.+ -+.
T Consensus 165 qi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~------~~~-ap~ 233 (637)
T COG4248 165 QINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL------ISD-APN 233 (637)
T ss_pred eeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc------cCC-CCC
Confidence 33211 12234458999999999753 111 2345679999999999999998 899977321 000 001
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCC--CCCCCCHHH
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD--PKDRPTAEE 309 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~D--P~kRpSa~e 309 (619)
|-...|....--.+. +.-+..++.+.+--|.-+++.+..|+.+|+..- +.-|||++-
T Consensus 234 p~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 234 PLETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cchhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111112111100000 011122333333344457889999999999853 458999865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.4e-06 Score=101.94 Aligned_cols=207 Identities=17% Similarity=0.219 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007064 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144 (619)
Q Consensus 66 ~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs 144 (619)
.....-|+..+..+.|+|++.++.+-+..-... -.+.+..++|.. ++...+..-+.++.+.++.+..++++||.|+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 334445777788889999999988765432111 134456677875 888899888899999999999999999999999
Q ss_pred CCceeccCCCC---cEEECCCCcEEEe--ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHH
Q 007064 145 ANVYHRDLKPK---NILANANCKLKIC--DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (619)
Q Consensus 145 ~gIvHrDLKP~---NILi~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ 219 (619)
....|.-|.-+ +--++..+.+.+. ||+........... ........+.++|.............|+|++|.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 97666666555 4445666777777 88887764433221 122344557788887652223333479999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCH-HHHHHHHHhcc
Q 007064 220 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADP-SALRLLERLLA 298 (619)
Q Consensus 220 ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~-~l~dLI~~mL~ 298 (619)
.+..+..|..+-.-.. .+ ....+..+. ...+++.+|+.
T Consensus 381 l~~~~~~~~~i~~~~~------~~-----------------------------------~~~l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------VP-----------------------------------VSLLDVLSTSELLDALPKCLD 419 (1351)
T ss_pred HHhhhhhcCccccccc------ch-----------------------------------hhhhccccchhhhhhhhhhcc
Confidence 9999998764311000 00 001111121 67889999999
Q ss_pred CCCCCCCCHHHHHcCccccC
Q 007064 299 FDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 299 ~DP~kRpSa~elL~hp~f~~ 318 (619)
-|+++|+++.++|.|+|.+-
T Consensus 420 ~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhhhccchhhhhhchhccc
Confidence 99999999999999999863
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-05 Score=80.16 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=80.3
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~~~lylV 105 (619)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 48999987542 45667889999998885332 45555433221 222347999
Q ss_pred EecCCc-cHHH----------------HH---HhC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 007064 106 FELMES-DLHQ----------------VI---KAN----DDLTREH------YQFF---------------LYQLLR-AL 139 (619)
Q Consensus 106 ~E~~~g-~L~~----------------~i---~~~----~~l~e~~------i~~i---------------~~QIl~-aL 139 (619)
|++++| .+.. .+ ... ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 4444 11 111 0111000 0000 111222 23
Q ss_pred HHHHH-------CCceeccCCCCcEEEC-CCCcEEEeecCccc
Q 007064 140 KYIHT-------ANVYHRDLKPKNILAN-ANCKLKICDFGLAR 174 (619)
Q Consensus 140 ~yLHs-------~gIvHrDLKP~NILi~-~~~~vKL~DFGla~ 174 (619)
..++. ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=80.78 Aligned_cols=132 Identities=17% Similarity=0.195 Sum_probs=79.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~~~lylV~ 106 (619)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+++++. .+.....+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 57899999999984 25567888875321 2345788999999886332 45555554 2334468899
Q ss_pred ecCCcc--HHHHH---------------------HhC--CCCCHHH-HHHHHHH----------HHHH-HHHHHH----C
Q 007064 107 ELMESD--LHQVI---------------------KAN--DDLTREH-YQFFLYQ----------LLRA-LKYIHT----A 145 (619)
Q Consensus 107 E~~~g~--L~~~i---------------------~~~--~~l~e~~-i~~i~~Q----------Il~a-L~yLHs----~ 145 (619)
|+++|. +...+ ..- ....... ...+..+ +... ..+|.+ .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 100 0111111 0111001 1111 122221 2
Q ss_pred CceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 146 NVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.7e-06 Score=90.78 Aligned_cols=151 Identities=22% Similarity=0.337 Sum_probs=93.5
Q ss_pred CCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---------------------------h
Q 007064 11 PEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---------------------------I 63 (619)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~---------------------------~ 63 (619)
+..+.|.+|. .+.|+.++-|.|++|+-+ +|+.||||+.+..... .
T Consensus 120 ~iee~F~eF~-------~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~ 191 (517)
T COG0661 120 PIEELFSEFE-------PEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191 (517)
T ss_pred CHHHHHHHcC-------CCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCCh
Confidence 4455666766 488999999999999875 4999999987421100 0
Q ss_pred -H----HHHH------HHHHHHHHHhc----CCCCcceeeeEecCCCCCCCCcEEEEEecCCc-cHHHH--HHhCCCCCH
Q 007064 64 -S----DAAR------ILREIKLLRLL----RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV--IKANDDLTR 125 (619)
Q Consensus 64 -~----~~~~------i~~Ei~iL~~L----~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~--i~~~~~l~e 125 (619)
. -.+. +.+|..-+.++ ++..-+.+=.+|.. ..+.-.|+|||++| .+.+. +++ ..++.
T Consensus 192 ~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~ 266 (517)
T COG0661 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKS-AGIDR 266 (517)
T ss_pred HHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHh-cCCCH
Confidence 0 0111 23344444443 23333333344422 22345899999998 45554 444 33554
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 126 EHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 126 ~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+...+.++. +..+-..|++|.|.+|.||+++.+|++-+.|||+....
T Consensus 267 k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 267 KELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 43332222211 22233489999999999999999999999999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.9e-07 Score=102.88 Aligned_cols=243 Identities=16% Similarity=0.125 Sum_probs=161.5
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~s~~~~~~l 102 (619)
-|....-+++|+++.+++.+...+...+ .+++... ..+.-++++|.+++||| .+..++ +.+.+...
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCccccc
Confidence 3566778899999999999876666555 6666432 23345889999999999 333322 33556678
Q ss_pred EEEEecCCcc--HHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 103 YVVFELMESD--LHQ-VIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 103 ylV~E~~~g~--L~~-~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.|+++++.+. ... .-...-.+.+-+...+.+.-+++|++||+.-=+||| ||+..+ +..|+.||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999842 111 111112344555566777778899999998778998 777655 58999999988654332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ..+...+++.++|||+... ..+....|.|++|.--.+|--|-+|-...- ..+.. .|...
T Consensus 385 ~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~----~g~~p-------- 444 (829)
T KOG0576|consen 385 M----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPM----IGNGP-------- 444 (829)
T ss_pred c----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCC----CCCCC--------
Confidence 2 2355789999999998877 688999999999987777777777753310 00000 00000
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHH-HHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSA-LRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l-~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....+... ..+++.. .++...|+.--|..|+....++.|.+|.+.
T Consensus 445 --------------~s~~L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 --------------NSPMLTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --------------Cccccchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00000000 0011111 147788999999999999999999999865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.6e-05 Score=76.45 Aligned_cols=136 Identities=21% Similarity=0.162 Sum_probs=92.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC--------------------ChHHH--HHHHHHHHHHHhcC--CCCc
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--------------------HISDA--ARILREIKLLRLLR--HPDI 84 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~--------------------~~~~~--~~i~~Ei~iL~~L~--HpnI 84 (619)
..|..|--+.||+|.. .++..+|+|+...... +.... .-..+|+.-|+++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666788888999964 5688999998752110 00011 11246777777774 4444
Q ss_pred ceeeeEecCCCCCCCCcEEEEEecCCccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECC
Q 007064 85 VEIKHIMLPPSRRDFKDIYVVFELMESDL--HQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANA 161 (619)
Q Consensus 85 v~l~~v~~~~s~~~~~~lylV~E~~~g~L--~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~ 161 (619)
.+.+.+. +-.|||||++.+- .=.++. -++..++...+..++++.+.-|-. +++||+||..=|||+.
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 4444443 3479999998431 111111 134455778888999999998876 9999999999999999
Q ss_pred CCcEEEeecCccccc
Q 007064 162 NCKLKICDFGLARVA 176 (619)
Q Consensus 162 ~~~vKL~DFGla~~~ 176 (619)
++.+.|+|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 779999999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.9e-05 Score=73.12 Aligned_cols=132 Identities=19% Similarity=0.273 Sum_probs=92.4
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.-+..+.|++|.+|.||++. ..|..+|+|+-.. ++....+..|.++|..+.--++..=+-.+ +..+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 34556789999999999995 4577999997643 34556788899999998866655432222 2235
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEECCCCcEEEeecCccccc
Q 007064 104 VVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLK-PKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK-P~NILi~~~~~vKL~DFGla~~~ 176 (619)
+.|||..| .|.+..... +.+ -+..+++.---|-..||-|..|. |..+++-.++.+.|+||..|+..
T Consensus 89 i~me~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 67999998 666554321 223 34456666556788999999997 66555555559999999998743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4e-05 Score=85.38 Aligned_cols=151 Identities=23% Similarity=0.355 Sum_probs=93.4
Q ss_pred CCCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------------------------
Q 007064 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------------------------- 63 (619)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~------------------------- 63 (619)
+.+.-+.|.++. -+.||.-+.|.|++|+.+. |+.||||+-+......
T Consensus 154 G~~ie~if~~f~-------~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~ 225 (538)
T KOG1235|consen 154 GAPIEDIFSEFD-------EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLV 225 (538)
T ss_pred CCCHHHHHHhcC-------cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchh
Confidence 344455666666 5789999999999998765 9999999864221111
Q ss_pred ----HHHHHHHHHHHHH----------HhcCCCCcc---eeeeEecCCCCCCCCcEEEEEecCCc----cHHHHHHhCCC
Q 007064 64 ----SDAARILREIKLL----------RLLRHPDIV---EIKHIMLPPSRRDFKDIYVVFELMES----DLHQVIKANDD 122 (619)
Q Consensus 64 ----~~~~~i~~Ei~iL----------~~L~HpnIv---~l~~v~~~~s~~~~~~lylV~E~~~g----~L~~~i~~~~~ 122 (619)
+-.+.+..|+..+ +.+.|-++. .+=.++..- ...-.|+||||+| || +.|.+.+
T Consensus 226 ~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~g- 299 (538)
T KOG1235|consen 226 WLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRG- 299 (538)
T ss_pred hHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcC-
Confidence 0112222333322 233454511 122333211 2346899999997 55 5555554
Q ss_pred CCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEECC----CCcEEEeecCccccc
Q 007064 123 LTREHYQFFLYQLLRAL-KYIHTANVYHRDLKPKNILANA----NCKLKICDFGLARVA 176 (619)
Q Consensus 123 l~e~~i~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILi~~----~~~vKL~DFGla~~~ 176 (619)
++...+. ..+.++. .-|-..|++|.|=+|.||++.. ++.+.+.|||+....
T Consensus 300 i~~~~i~---~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 300 ISPHDIL---NKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCHHHHH---HHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 5555443 3333332 2234578999999999999984 678999999998654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=74.56 Aligned_cols=71 Identities=14% Similarity=0.066 Sum_probs=46.6
Q ss_pred EEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~f-G~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.|..|.+ ..||++.. .+..+++|...... ...+.+|+.+++.+. +-.+.+++.+... .+.-++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEE
Confidence 45566666 78898854 34678888775421 335678999998884 3345566665422 23468999
Q ss_pred ecCCc
Q 007064 107 ELMES 111 (619)
Q Consensus 107 E~~~g 111 (619)
|+++|
T Consensus 72 e~i~G 76 (244)
T cd05150 72 SAVPG 76 (244)
T ss_pred EeeCC
Confidence 99987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.5e-05 Score=73.18 Aligned_cols=140 Identities=26% Similarity=0.330 Sum_probs=95.5
Q ss_pred ccccccCCCCCCeEEeEEeeecCc-eEEEEEEECCCCcEEEEEEecCc-----------cC-Ch-------HHHHHHHHH
Q 007064 13 MEFFSEYGDASRYKIQEVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDI-----------FE-HI-------SDAARILRE 72 (619)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~LG~G~f-G~V~~a~~~~tg~~vAIK~i~~~-----------~~-~~-------~~~~~i~~E 72 (619)
++.|+- ....+++++.||.|.- |.||++. -.|..||+|++... .. .. .....+..|
T Consensus 29 L~~F~~--h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E 104 (207)
T PF13095_consen 29 LEPFTH--HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE 104 (207)
T ss_pred cCCcCC--CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence 444444 2388999999999999 9999995 46889999994210 00 00 122356677
Q ss_pred HHHHHhc---CCCCc--ceeeeEecCCCC-------------CCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHH
Q 007064 73 IKLLRLL---RHPDI--VEIKHIMLPPSR-------------RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQ 134 (619)
Q Consensus 73 i~iL~~L---~HpnI--v~l~~v~~~~s~-------------~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~Q 134 (619)
....-+| .+.++ +++++++.-... .......||.||....- .++.++ +.+
T Consensus 105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~ 172 (207)
T PF13095_consen 105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQ 172 (207)
T ss_pred HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHH
Confidence 7765555 45566 888887744310 11123467888777532 234333 467
Q ss_pred HHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 135 Il~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
|++-|..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 173 ~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 888889999999999999999997 3489999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=85.60 Aligned_cols=146 Identities=16% Similarity=0.300 Sum_probs=89.2
Q ss_pred EeEEeeecCceEEEEEEECCCC--cEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCc--ceeeeEecCCCCCCCCc
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTG--EKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDI--VEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg--~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnI--v~l~~v~~~~s~~~~~~ 101 (619)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+.+|+.|. |+++ .+++.++... ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3678899999999998654332 467888764321 1122446789999999996 6664 6666665332 12345
Q ss_pred EEEEEecCCccH-H--------------------HHHH---hCC----C---------CCHHHHHHHHHH----------
Q 007064 102 IYVVFELMESDL-H--------------------QVIK---AND----D---------LTREHYQFFLYQ---------- 134 (619)
Q Consensus 102 lylV~E~~~g~L-~--------------------~~i~---~~~----~---------l~e~~i~~i~~Q---------- 134 (619)
.|+|||+++|.. . +.+. .-. . ....++..|..+
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998742 1 0111 100 0 111233333222
Q ss_pred -----HHHHHHHHHH-----------CCceeccCCCCcEEECCC-Cc-EEEeecCcccc
Q 007064 135 -----LLRALKYIHT-----------ANVYHRDLKPKNILANAN-CK-LKICDFGLARV 175 (619)
Q Consensus 135 -----Il~aL~yLHs-----------~gIvHrDLKP~NILi~~~-~~-vKL~DFGla~~ 175 (619)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233456632 249999999999999853 33 57999999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00056 Score=67.29 Aligned_cols=128 Identities=20% Similarity=0.263 Sum_probs=90.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChHHHHHHHHHHHHHHhcC------CCCcceee
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--------------EHISDAARILREIKLLRLLR------HPDIVEIK 88 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~--------------~~~~~~~~i~~Ei~iL~~L~------HpnIv~l~ 88 (619)
..||.|+.-.||.- .......||++.... ..........+|+.-...+. +..|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999888864 334456789886532 11123455667777766665 78899999
Q ss_pred eEecCCCCCCCCcEEEEEecCC---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 007064 89 HIMLPPSRRDFKDIYVVFELME---S----DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~---g----~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~ 161 (619)
++. ++...+-+|+|.+. | +|.++++.. .+++ .+ ...+-+-..||-..+|+.+||+|.||++..
T Consensus 84 G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998 45566889999874 3 688888554 4766 33 333445567788999999999999999854
Q ss_pred C--C--cEEEee
Q 007064 162 N--C--KLKICD 169 (619)
Q Consensus 162 ~--~--~vKL~D 169 (619)
+ + .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 3 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.2e-05 Score=96.13 Aligned_cols=155 Identities=19% Similarity=0.154 Sum_probs=116.0
Q ss_pred HHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 007064 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIH 143 (619)
Q Consensus 69 i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLH 143 (619)
.+.|...++...|+++.....-..+. .....|+++++|. |+++..|-++ ..+.+.-+-....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 44555666777899988766544332 3356799999999 7999998654 23444444444444477777777
Q ss_pred HCC-----ceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHH
Q 007064 144 TAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218 (619)
Q Consensus 144 s~g-----IvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG 218 (619)
+.. .+|++||+-|.+|..+-.+|+.++|+.+... +...+....++++.|+.|++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn---p~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN---PVLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccC---chHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 642 6999999999999999999999999998432 22234456688899999999876 5788889999999
Q ss_pred HHHHHHHhCCCCC
Q 007064 219 CIFAEVLTGKPLF 231 (619)
Q Consensus 219 ~ilyeLltG~~pF 231 (619)
|.+|+...|..+|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999988776
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00034 Score=70.46 Aligned_cols=29 Identities=31% Similarity=0.477 Sum_probs=25.1
Q ss_pred CceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 146 NVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999877656799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00033 Score=76.45 Aligned_cols=176 Identities=24% Similarity=0.345 Sum_probs=119.8
Q ss_pred HHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007064 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144 (619)
Q Consensus 65 ~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs 144 (619)
....++....+++.+.|+|....+++..... ....+|||+++.+|.+.++.+. +-..... .
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~ 85 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------A 85 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------c
Confidence 4556778889999999999999988764322 3489999999999999987664 3222211 1
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHH
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeL 224 (619)
.|+.| .|| ++++| -++ +. | | ....+++||||+|.|+.++
T Consensus 86 ~~~~~-----~~~-------~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 86 HGVLH-----LNI-------IYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILEL 124 (725)
T ss_pred cccce-----ehh-------hhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHHH
Confidence 22222 122 23333 000 00 1 1 1223599999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC
Q 007064 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304 (619)
Q Consensus 225 ltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR 304 (619)
..|...|......+++..|.+....+....+-.... ..+ -.++....+++++|+-..|..|
T Consensus 125 ~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~----------------~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 125 YLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQ----------------LLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHH----------------HhhhHhHHHHhccCCccccccc
Confidence 999999999988888888877655544333221111 000 1245567899999999999999
Q ss_pred CCHHHHHcCccccCC
Q 007064 305 PTAEEALADPYFKGL 319 (619)
Q Consensus 305 pSa~elL~hp~f~~~ 319 (619)
|...++.+++-|...
T Consensus 186 ~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 186 PLPMELSKRCSFTEV 200 (725)
T ss_pred cchhHHhcCccHHHH
Confidence 999999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0013 Score=65.91 Aligned_cols=72 Identities=11% Similarity=0.160 Sum_probs=45.0
Q ss_pred eEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC-CcceeeeEecCCCCCCCCcEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP-DIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp-nIv~l~~v~~~~s~~~~~~lylV 105 (619)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+... ...+++... .+ .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 5678888889999985432 357898997653211 112234788899888533 334444332 11 379
Q ss_pred EecCCc
Q 007064 106 FELMES 111 (619)
Q Consensus 106 ~E~~~g 111 (619)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.003 Score=68.71 Aligned_cols=77 Identities=19% Similarity=0.170 Sum_probs=52.8
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCc-----cCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCC
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-----FEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-----~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~s~~~~ 99 (619)
.+.||.|.+..||++.+...++.++||.-... ........+...|.+.|+.+. -..+.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 47799999999999988644468999974311 011234556777888888763 24566666652 2
Q ss_pred CcEEEEEecCCc
Q 007064 100 KDIYVVFELMES 111 (619)
Q Consensus 100 ~~lylV~E~~~g 111 (619)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 346899999974
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00088 Score=65.36 Aligned_cols=97 Identities=23% Similarity=0.225 Sum_probs=77.2
Q ss_pred HHHHHHHHhcCC-CCcceeeeEecCCCCCCCCcEEEEEecCC-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007064 70 LREIKLLRLLRH-PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQV---IKANDDLTREHYQFFLYQLLRALKYIHT 144 (619)
Q Consensus 70 ~~Ei~iL~~L~H-pnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~---i~~~~~l~e~~i~~i~~QIl~aL~yLHs 144 (619)
..|.-+|+.|.+ +++.++++.+ + -++|.||.. +++... +..-...++.....|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999976 6999999988 2 256888888 454321 1111246899999999999999999987
Q ss_pred ---CCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 145 ---ANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 145 ---~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..+.-.|++++|+-+++++++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 4488899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0018 Score=67.90 Aligned_cols=153 Identities=15% Similarity=0.128 Sum_probs=85.1
Q ss_pred ccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEec
Q 007064 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIML 92 (619)
Q Consensus 15 ~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~ 92 (619)
++..|+. +....++.++.|....||++.. . +..+++|+..... ....+..|+.+++.|.... +.+++....
T Consensus 15 ~l~~y~~-~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 15 FLDGYDL-GELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHhcCC-CCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 3444543 3455577788888889998853 3 3467888765321 1234566788888775322 333332110
Q ss_pred CC-CCCCCCcEEEEEecCCcc------HH------HHH---Hh-CCCC--------CHHHH-----H----------HHH
Q 007064 93 PP-SRRDFKDIYVVFELMESD------LH------QVI---KA-NDDL--------TREHY-----Q----------FFL 132 (619)
Q Consensus 93 ~~-s~~~~~~lylV~E~~~g~------L~------~~i---~~-~~~l--------~e~~i-----~----------~i~ 132 (619)
.. .....+..++|+||++|. .. ..+ .. ...+ ..... . ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 00 001234578999998861 11 111 00 0111 00100 0 001
Q ss_pred HHHHHHHHHHHH-------CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 133 YQLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 133 ~QIl~aL~yLHs-------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+...+.++.. .++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112334555532 579999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00082 Score=68.52 Aligned_cols=131 Identities=16% Similarity=0.248 Sum_probs=74.1
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEEec
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVFEL 108 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~~~~~lylV~E~ 108 (619)
.+..|-.+.+|+.. .++..+++|......... .....+|..+|+.+..-.+ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 35667788899885 457788898754321111 0124678899988864333 2333322 1 2689999
Q ss_pred CCc-cHH--------------HHHH---hC----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCce
Q 007064 109 MES-DLH--------------QVIK---AN----DDLTR-EHYQFFLYQL---------LRALKYIHT--------ANVY 148 (619)
Q Consensus 109 ~~g-~L~--------------~~i~---~~----~~l~e-~~i~~i~~QI---------l~aL~yLHs--------~gIv 148 (619)
++| .+. +.+. .. .+++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 986 221 1111 11 11121 2222222222 111222222 2489
Q ss_pred eccCCCCcEEECCCCcEEEeecCccc
Q 007064 149 HRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 149 HrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
|+|+.|.||+++.++ +.|+||+.|.
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccC
Confidence 999999999999887 7899999775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0027 Score=66.05 Aligned_cols=140 Identities=15% Similarity=0.066 Sum_probs=80.7
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCC--CCCCCcE
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPS--RRDFKDI 102 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s--~~~~~~l 102 (619)
-++.|..|....+|+... .+..+++|+... .....+..|+.++..|.+-. +.+++... ... ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCce
Confidence 366788888889998853 345788998753 12345677888888885332 33433211 000 0123457
Q ss_pred EEEEecCCcc-H--------H---HHH---Hh-CCCC----------CH--HHHH--------HHHHHHHHHHHHHHH--
Q 007064 103 YVVFELMESD-L--------H---QVI---KA-NDDL----------TR--EHYQ--------FFLYQLLRALKYIHT-- 144 (619)
Q Consensus 103 ylV~E~~~g~-L--------~---~~i---~~-~~~l----------~e--~~i~--------~i~~QIl~aL~yLHs-- 144 (619)
++|+++++|. + . +.+ .. ...+ .+ .... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 8999999862 1 1 111 00 0000 00 0000 011112334444443
Q ss_pred -----CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 -----ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 -----~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999998777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0097 Score=62.34 Aligned_cols=78 Identities=14% Similarity=0.139 Sum_probs=52.1
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC---CCcceeeeEecCCCCCCCCcE
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH---PDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H---pnIv~l~~v~~~~s~~~~~~l 102 (619)
.-.+.||.|..+.||..... ++ .+++|..+. ......+.+|...|+.|.. -.+.++++++... ...+.-
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~ 88 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPD 88 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCe
Confidence 34678999999999998532 23 566776432 1123467789999988853 3577777765332 123457
Q ss_pred EEEEecCCc
Q 007064 103 YVVFELMES 111 (619)
Q Consensus 103 ylV~E~~~g 111 (619)
|||||+++|
T Consensus 89 ~LVmE~i~G 97 (297)
T PRK10593 89 VLLLERLRG 97 (297)
T ss_pred EEEEeccCC
Confidence 999999886
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0037 Score=65.32 Aligned_cols=72 Identities=15% Similarity=0.105 Sum_probs=44.1
Q ss_pred eEEeeecCceEEEEEEECC------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCC
Q 007064 28 QEVIGKGSYGVVCSAIDTH------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFK 100 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~~~~ 100 (619)
++.|..|-...||++.... .++.+++|+..... .......+|+.+++.+....+ .+++..+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIF-----PN-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEe-----CC--
Confidence 4567777777889886432 25789999865422 222345678888888853333 3444433 11
Q ss_pred cEEEEEecCCc
Q 007064 101 DIYVVFELMES 111 (619)
Q Consensus 101 ~lylV~E~~~g 111 (619)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 257888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0066 Score=63.89 Aligned_cols=30 Identities=30% Similarity=0.306 Sum_probs=25.8
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976556899999774
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.013 Score=61.72 Aligned_cols=145 Identities=18% Similarity=0.214 Sum_probs=83.3
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCCCcE
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~~~l 102 (619)
-.+++.+..|....+|...+. ++++++. ...............+|+.+|+.+.--. +...+.++...+ -...
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~p 100 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTP 100 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCc
Confidence 345555655545556666544 8888888 3322233455666778899888775322 222333332211 2467
Q ss_pred EEEEecCCcc-------------------HHHHHHhC--------------CCCCHHHHHHHHHHH--------------
Q 007064 103 YVVFELMESD-------------------LHQVIKAN--------------DDLTREHYQFFLYQL-------------- 135 (619)
Q Consensus 103 ylV~E~~~g~-------------------L~~~i~~~--------------~~l~e~~i~~i~~QI-------------- 135 (619)
|.||++++|. |.++|..- +.....++..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999871 11112110 001112222222222
Q ss_pred HHHHHHHHHC--------CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 136 LRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 136 l~aL~yLHs~--------gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..-..+|+.. .++|+|+.+.||+++.++.+=|+||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2234455433 389999999999999998899999999865
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.02 Score=61.96 Aligned_cols=93 Identities=20% Similarity=0.178 Sum_probs=60.4
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEec----CccCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEe
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLLR--HP-DIVEIKHIM 91 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~----~~~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~ 91 (619)
+...+... ++.||.|.-..||++.+...+..|+||.-. ......-...+..-|...|+.+. -| .+.+++.+
T Consensus 26 ~~~~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 26 FEHAKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred CCCcccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 33344444 678999999999999875445679999642 11233455677788999998774 34 45555543
Q ss_pred cCCCCCCCCcEEEEEecCCc--cHHHHHHh
Q 007064 92 LPPSRRDFKDIYVVFELMES--DLHQVIKA 119 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g--~L~~~i~~ 119 (619)
+.....+|||+++. .|.+.+.+
T Consensus 104 ------D~e~~~~vMEdL~~~~ilR~~Li~ 127 (409)
T PRK12396 104 ------DSVMNCCVMEDLSDHTILRTALIN 127 (409)
T ss_pred ------CcHHhhHHHHhCcccHHHHHHHHc
Confidence 23446789999863 45555433
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.003 Score=65.77 Aligned_cols=136 Identities=19% Similarity=0.240 Sum_probs=93.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEec-------Cc------------cCChH-HHHHHHHHHHHHHhcC-C
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DI------------FEHIS-DAARILREIKLLRLLR-H 81 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~-------~~------------~~~~~-~~~~i~~Ei~iL~~L~-H 81 (619)
.-|.++++||-|.-+.||.+-+. .|...++|.=. +. ..+.. ..-...+|+..|+.|. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 34677899999999999999764 57788888421 00 01100 1123457889998885 3
Q ss_pred CC-cceeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 007064 82 PD-IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (619)
Q Consensus 82 pn-Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 159 (619)
.. +.+.+ +.+.-++|||++.| .|.++-.- .....+...+..-+.-|...|+||+|..-=||++
T Consensus 171 gfpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 171 GFPVPKPI---------DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCCCcc---------cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEE
Confidence 22 33332 33457999999997 66554321 2233455666666778999999999999999999
Q ss_pred CCCCcEEEeecCccc
Q 007064 160 NANCKLKICDFGLAR 174 (619)
Q Consensus 160 ~~~~~vKL~DFGla~ 174 (619)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.025 Score=58.61 Aligned_cols=30 Identities=30% Similarity=0.529 Sum_probs=25.2
Q ss_pred CceeccCCCCcEEECCCCc-EEEeecCcccc
Q 007064 146 NVYHRDLKPKNILANANCK-LKICDFGLARV 175 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~-vKL~DFGla~~ 175 (619)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.034 Score=58.07 Aligned_cols=29 Identities=24% Similarity=0.381 Sum_probs=25.3
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 578999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.031 Score=59.82 Aligned_cols=83 Identities=17% Similarity=0.108 Sum_probs=53.9
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEec----Cc-cCChHHHHHHHHHHHHHHhcC--CC-CcceeeeEecCCCCCCCCc
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH----DI-FEHISDAARILREIKLLRLLR--HP-DIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~----~~-~~~~~~~~~i~~Ei~iL~~L~--Hp-nIv~l~~v~~~~s~~~~~~ 101 (619)
.||.|....||++.+...++.|+||.-. .. ....-...+..-|...|+... -| .+.+++.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 4799999999999875444689999643 11 123445566777888887764 34 45555543 2234
Q ss_pred EEEEEecCCc--cHHHHHHh
Q 007064 102 IYVVFELMES--DLHQVIKA 119 (619)
Q Consensus 102 lylV~E~~~g--~L~~~i~~ 119 (619)
..+|||+++. .|.+.+.+
T Consensus 75 ~~~vMEdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLIE 94 (370)
T ss_pred ceehHhhCccchHHHHHHHc
Confidence 5799999963 55555543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.1 Score=55.90 Aligned_cols=139 Identities=15% Similarity=0.141 Sum_probs=76.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRR 97 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~ 97 (619)
+... ++.|-.|-...+|++.... .++.|++|+...... .... -.+|+.+++.+..-++ .++++.+ .
T Consensus 37 ~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~-----~ 107 (344)
T PLN02236 37 EALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFD-RDDEIRTFECMSRHGQGPRLLGRF-----P 107 (344)
T ss_pred CcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeec-hHHHHHHHHHHHHcCCCCceEEEE-----C
Confidence 3444 4556668888999985322 347899997754221 1112 2568888888863333 2344443 1
Q ss_pred CCCcEEEEEecCCc-cHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH-----------------
Q 007064 98 DFKDIYVVFELMES-DLH-----------QV---IK---AND------DLTREHYQFFLYQLL----------------- 136 (619)
Q Consensus 98 ~~~~lylV~E~~~g-~L~-----------~~---i~---~~~------~l~e~~i~~i~~QIl----------------- 136 (619)
+ ..|.||++| .|. .+ +. ... ....+.+..++.++.
T Consensus 108 ~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 108 N----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred C----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 1 147888774 221 11 11 111 111233334432221
Q ss_pred HHHHHH----H----HCCceeccCCCCcEEECC-CCcEEEeecCccc
Q 007064 137 RALKYI----H----TANVYHRDLKPKNILANA-NCKLKICDFGLAR 174 (619)
Q Consensus 137 ~aL~yL----H----s~gIvHrDLKP~NILi~~-~~~vKL~DFGla~ 174 (619)
..+..| . ...++|+||++.|||++. ++.+.|+||..+.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111122 1 225899999999999986 4689999998774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.08 Score=55.61 Aligned_cols=30 Identities=17% Similarity=0.128 Sum_probs=27.5
Q ss_pred CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 146 NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
++||+|+.++|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999997753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.079 Score=56.34 Aligned_cols=28 Identities=32% Similarity=0.444 Sum_probs=24.7
Q ss_pred ceeccCCCCcEEECC-CCcEEEeecCccc
Q 007064 147 VYHRDLKPKNILANA-NCKLKICDFGLAR 174 (619)
Q Consensus 147 IvHrDLKP~NILi~~-~~~vKL~DFGla~ 174 (619)
++|.||.+.|||+++ ++.++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.13 Score=55.95 Aligned_cols=76 Identities=16% Similarity=0.164 Sum_probs=50.1
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-----CChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCC
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-----EHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-----~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~s~~~ 98 (619)
-.+.||.|....||+..+. +..++||.-.... ...-...+...|...|+.+. ..++.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 3678999999999998763 4568899754111 11123455566777777664 246777777652
Q ss_pred CCcEEEEEecCCc
Q 007064 99 FKDIYVVFELMES 111 (619)
Q Consensus 99 ~~~lylV~E~~~g 111 (619)
..-+++||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 235788999975
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.051 Score=57.75 Aligned_cols=139 Identities=23% Similarity=0.320 Sum_probs=89.5
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCc---c-------------------CChHHHHHH--HHHHHHHHhcCC
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI---F-------------------EHISDAARI--LREIKLLRLLRH 81 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~---~-------------------~~~~~~~~i--~~Ei~iL~~L~H 81 (619)
.|-..|..|--+.||.|.. .+|..+|||+.+.. | .++...-++ ..|+.-|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3445677888899999864 57888999987411 0 011111122 356666777754
Q ss_pred CCcceeeeEecCCCCCCCCcEEEEEecCCcc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEE
Q 007064 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESD--LHQVIKANDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNIL 158 (619)
Q Consensus 82 pnIv~l~~v~~~~s~~~~~~lylV~E~~~g~--L~~~i~~~~~l~e~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NIL 158 (619)
-.|.-..-+++ ..-.|||++++.+ -.-.| +.-.++...+..+-.|++.-+.-| |.+++||.||.-=|+|
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 44432222222 2247999999842 11112 223577777777777777777666 5689999999999999
Q ss_pred ECCCCcEEEeecCccc
Q 007064 159 ANANCKLKICDFGLAR 174 (619)
Q Consensus 159 i~~~~~vKL~DFGla~ 174 (619)
+-+ |.|.|+|.+-+.
T Consensus 298 yhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSV 312 (520)
T ss_pred EEC-CEEEEEEccccc
Confidence 854 589999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.37 Score=52.41 Aligned_cols=29 Identities=31% Similarity=0.326 Sum_probs=24.2
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
...+|.||-+.|||.+.+ .++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 457999999999997655 69999998663
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.2 Score=53.29 Aligned_cols=73 Identities=23% Similarity=0.358 Sum_probs=56.7
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+.|++|++-.+.|.- ++ .-..+++..|+++.+..|.-+..+ ..-||||..+||||+ +|.|-|+||-++|..
T Consensus 298 ~~y~yl~~kdhgt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 35678899988775542 22 235677788888888777777653 589999999999999 999999999999853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.4 Score=47.84 Aligned_cols=99 Identities=20% Similarity=0.246 Sum_probs=63.9
Q ss_pred EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEEEEEecCCc--cHHHHHHhCCCCCHHH
Q 007064 50 KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREH 127 (619)
Q Consensus 50 ~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g--~L~~~i~~~~~l~e~~ 127 (619)
...+|++....... ...-+.++..++.++. .|+++.. .+.-.+-++.|.|-. .+.
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------- 143 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------- 143 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch-------------
Confidence 34556665322221 2233467888887764 4666652 234457799999973 111
Q ss_pred HHHHHHHHHHHHHHHHH--CCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 128 YQFFLYQLLRALKYIHT--ANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 128 i~~i~~QIl~aL~yLHs--~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
..++.-=+.+|.-.|+ .+.+|+|-.|+||+-|+.|.+||.|-+.
T Consensus 144 -~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 -SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 0112222456777884 4699999999999999999999999874
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.16 Score=53.58 Aligned_cols=75 Identities=25% Similarity=0.315 Sum_probs=46.1
Q ss_pred EEEEEecCCcc-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCCCcEEECCC----------
Q 007064 102 IYVVFELMESD-----LHQVIKANDDLTREHYQFFLYQLLRALKYIH----TANVYHRDLKPKNILANAN---------- 162 (619)
Q Consensus 102 lylV~E~~~g~-----L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH----s~gIvHrDLKP~NILi~~~---------- 162 (619)
-.|||++..++ +....+-+-..-.+-+++++.||+.-.--+- -.+.+|-||||+|||+-++
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 45889887642 2222222112234556788888875442232 3468999999999997322
Q ss_pred --------CcEEEeecCccccc
Q 007064 163 --------CKLKICDFGLARVA 176 (619)
Q Consensus 163 --------~~vKL~DFGla~~~ 176 (619)
-.++|.||.++++.
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 23678888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.51 E-value=0.96 Score=50.15 Aligned_cols=28 Identities=32% Similarity=0.672 Sum_probs=23.8
Q ss_pred CceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 146 NVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 146 gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++|.|+-+.|||.+.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 479999999999987654 9999998763
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.67 E-value=0.22 Score=51.39 Aligned_cols=44 Identities=32% Similarity=0.418 Sum_probs=32.8
Q ss_pred HHHHHHHHHHHHHC--CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 132 LYQLLRALKYIHTA--NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 132 ~~QIl~aL~yLHs~--gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+..+-.++.-+|.. -+||+|+.|+|+|.++.+.++|+||..|..
T Consensus 138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33344444444433 489999999999999999999999987753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.30 E-value=0.14 Score=49.75 Aligned_cols=28 Identities=25% Similarity=0.394 Sum_probs=25.0
Q ss_pred ceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 147 VYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 147 IvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998887 99999998753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.05 E-value=0.36 Score=47.56 Aligned_cols=30 Identities=40% Similarity=0.594 Sum_probs=21.3
Q ss_pred CceeccCCCCcEEE-CCCCcEEEeecCcccc
Q 007064 146 NVYHRDLKPKNILA-NANCKLKICDFGLARV 175 (619)
Q Consensus 146 gIvHrDLKP~NILi-~~~~~vKL~DFGla~~ 175 (619)
-++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.02 E-value=0.96 Score=49.05 Aligned_cols=60 Identities=20% Similarity=0.201 Sum_probs=40.2
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCcEEECC
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK-YIHTANVYHRDLKPKNILANA 161 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~-yLHs~gIvHrDLKP~NILi~~ 161 (619)
+..+|-+|+.| .+..+++.. ..+++..+.+..-...||- .|--.+++|.||.|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 34566667777 677666543 3555555666655555543 345678999999999999843
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=90.72 E-value=2 Score=44.78 Aligned_cols=74 Identities=15% Similarity=0.125 Sum_probs=42.7
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--C-CCcceeeeEecCCCCCCCCc
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--H-PDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--H-pnIv~l~~v~~~~s~~~~~~ 101 (619)
-+-.+.|+.|....+|+.. .++..+.+|+-.. .....+..|..-|+.|. . -.+.+++.+-... ..
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CC
Confidence 4446789999999999885 6788899997652 22234667888888774 2 3355566554222 23
Q ss_pred EEEEEecCC
Q 007064 102 IYVVFELME 110 (619)
Q Consensus 102 lylV~E~~~ 110 (619)
-||||||++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 619 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-83 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-83 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-79 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-79 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-79 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-79 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-79 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-79 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-79 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-79 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-79 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-79 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-79 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-79 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-79 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-79 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-78 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-78 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-78 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-78 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-78 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-78 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-77 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-77 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-77 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-75 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-72 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-71 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-71 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-69 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-69 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-69 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-69 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-69 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-69 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-69 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-69 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-69 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-69 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-69 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-69 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-68 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-68 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-68 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-68 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-68 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-68 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-68 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-68 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-68 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-68 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-68 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-68 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-68 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-68 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-68 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-68 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-68 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-68 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-68 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-68 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-68 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-68 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-68 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-68 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-68 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-68 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-68 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-68 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-67 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-67 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-67 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-67 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-67 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-67 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-67 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-66 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-66 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-65 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-65 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-64 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-63 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-63 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-62 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-59 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-55 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-51 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-51 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-51 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-51 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-51 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-51 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-51 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-51 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-50 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-50 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-50 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-50 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-50 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-50 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-50 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-50 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-50 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-50 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-50 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-50 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-50 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-50 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-50 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-50 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-49 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-49 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-49 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-49 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-49 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-48 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-48 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-48 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-48 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-47 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-47 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-41 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-41 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-41 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-41 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-41 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-41 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-41 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-41 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-41 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-41 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-41 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-41 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-41 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-41 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-41 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-41 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-41 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-41 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-41 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-41 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-41 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-40 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-40 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-40 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-40 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-40 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-40 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-40 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-40 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-40 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-40 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-40 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-40 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-40 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-40 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-39 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-39 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-37 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-37 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-37 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-37 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-37 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-37 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-37 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-36 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-36 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-36 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-36 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-36 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-36 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-36 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-36 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-36 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-34 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-33 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-32 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-32 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-32 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-32 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-32 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-32 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-32 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-32 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-32 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-32 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-32 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-28 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-24 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-23 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-22 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-21 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-20 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-20 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-20 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-18 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-05 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 619 | |||
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 0.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 0.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 0.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 0.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 0.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 0.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 0.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 0.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 0.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 0.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 0.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-180 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-164 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-152 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-150 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-143 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-133 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-120 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-113 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-103 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-103 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-103 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-102 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-101 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-101 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-101 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-100 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-100 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-100 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-86 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-80 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-66 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-66 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-64 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-63 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-63 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-62 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-62 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-61 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-60 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-59 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-58 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-58 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-57 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-57 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 4e-57 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-57 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-56 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-56 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-55 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-54 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-53 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-53 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-53 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-52 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-52 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-52 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-52 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-51 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-51 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-51 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 9e-51 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-50 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-50 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-50 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-50 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-49 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-49 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-49 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-49 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-49 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-48 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-48 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-48 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-48 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-48 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-47 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-47 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-47 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-47 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-47 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-47 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-47 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-46 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-46 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-46 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-46 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-46 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-45 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-45 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-45 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-45 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 4e-45 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-45 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-44 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-44 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-44 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-44 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-44 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-43 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-43 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-43 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-43 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-42 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-42 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-42 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 7e-42 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 9e-42 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-41 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-41 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-41 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-41 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-41 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-39 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-39 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-38 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-38 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-38 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-38 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-38 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-38 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-37 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-37 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-37 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-36 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-36 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-36 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-36 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-36 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-36 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-36 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-36 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-34 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-34 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-33 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-33 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-32 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-32 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-32 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-31 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-31 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-30 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-29 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-29 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-29 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-29 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-29 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-28 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-28 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-28 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-27 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-27 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 3e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-27 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-27 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-26 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-26 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-26 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-26 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-26 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-26 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 9e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-25 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-25 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-25 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-24 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-24 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-24 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-23 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-23 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-23 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 7e-23 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-22 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-22 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-22 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-22 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-21 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-21 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-21 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-21 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-20 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-19 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-19 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-19 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-19 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-18 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-17 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-17 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-17 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 9e-17 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-16 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-16 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-15 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-15 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-15 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 5e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-14 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-12 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-11 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-09 |
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 580 bits (1497), Expect = 0.0
Identities = 137/426 (32%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQQDHRKKNSPEMEFFSEYGD---ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
M H + E +F + Y I+ +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI 117
+FE + D RILREI +L L+ I+ + +++P F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
K LT EH + LY LL +IH + + HRDLKP N L N +C +K+CDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 NDTPTTI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
++ T I T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KNVVHQLDLMTDLLGTP 250
CIFAE+L PLFPG K+ QL+++ +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
+ D + + + +Y+ ++P+ QK+P+ + LLE +L F+P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNG 370
L PY K + K + E + F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 TERTNF 376
NF
Sbjct: 419 IHENNF 424
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 574 bits (1483), Expect = 0.0
Identities = 164/362 (45%), Positives = 225/362 (62%), Gaps = 5/362 (1%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
PEM + RY IG+G+YG+VCSA D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
H + R LREIK+L RH +I+ I I+ P+ KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
L+ +H +FLYQ+LR LKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDP 301
+ +LG+PS + ++ + N KAR YL S+ K V +++ FPNAD AL LL+++L F+P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
R E+ALA PY + EP + +F+ E + KE ++ELIF E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 QL 363
Sbjct: 361 GY 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 569 bits (1469), Expect = 0.0
Identities = 148/355 (41%), Positives = 221/355 (62%), Gaps = 13/355 (3%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE 72
M Y +S ++++ ++G+G+YGVVCSA TGE VAIKKI + F+ A R LRE
Sbjct: 1 MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLRE 59
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
IK+L+ +H +I+ I +I P S +F ++Y++ ELM++DLH+VI L+ +H Q+F+
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFI 118
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND-------TPTTIF 185
YQ LRA+K +H +NV HRDLKP N+L N+NC LK+CDFGLAR+ T
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
++VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG++ HQL L+
Sbjct: 179 MVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 246 LLGTPSLD-TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
++GTP D + + + +AR Y+ S+ + FP +P + LL+R+L FDP R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 305 PTAEEALADPYFKGLSKVEREPSCQPISKMEFEF--ERRRVTKEDIRELIFREIL 357
TA+EAL PY + EP +PI FEF + +T +D+++LI+ EI
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 548 bits (1415), Expect = 0.0
Identities = 136/386 (35%), Positives = 217/386 (56%), Gaps = 43/386 (11%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
+Y++ + +GKG+YG+V +ID TGE VA+KKI D F++ +DA R REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+IV + +++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQL++ +KY
Sbjct: 69 ENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARV------------------AFNDTPTT 183
+H+ + HRD+KP NIL NA C +K+ DFGL+R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 185 PILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF----------------PNAD 286
+ ++ PS + + +++ A+ + S+++K ++ S K + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 287 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 346
AL LL++LL F+P R +A +AL P+ EP+C I + + + + +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSID 361
Query: 347 DIRELIFREILEYHPQLLKDYMNGTE 372
D R L++ EI +L+ + +
Sbjct: 362 DYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 546 bits (1408), Expect = 0.0
Identities = 122/367 (33%), Positives = 184/367 (50%), Gaps = 21/367 (5%)
Query: 6 RKKNSPEMEFFSE-YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHD------ 58
K + + +E + S Y +Q I GSYG VC+ +D+ G VAIK++ +
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGR 62
Query: 59 ---IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQ 115
I R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL Q
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 116 VIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
VI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + ICDF LAR
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 183 EDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL-TSMRKKQPVQFSQKFPNADPSALRLL 293
+QL+ + +++GTP ++ + + AR YL S+ ++ P ADP AL L+
Sbjct: 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI 297
Query: 294 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIF 353
++L F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 298 AKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIFT 354
Query: 354 REILEYH 360
E+ ++
Sbjct: 355 AEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 544 bits (1403), Expect = 0.0
Identities = 134/341 (39%), Positives = 208/341 (60%), Gaps = 12/341 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKHIMLP-PSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P + DF D Y+V M +DL +++K L + QF +YQ+L+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
++ +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R+++D
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 362
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 543 bits (1400), Expect = 0.0
Identities = 133/340 (39%), Positives = 199/340 (58%), Gaps = 12/340 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y +G G+YG VCSAID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P S R+F D Y+V M++DL +++ + E Q+ +YQ+L+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+A V HRDLKP N+ N +C+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
S+ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P + + ++ +
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
A+ Y+ S+ + F+Q FP A P A LLE++L D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
E E Q + E ++T ++ ++ I++EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 546 bits (1409), Expect = 0.0
Identities = 142/417 (34%), Positives = 208/417 (49%), Gaps = 57/417 (13%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
Q K + S++ RY+I+ +IG GSYG VC A D VAIKKI +FE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND 121
+ D RILREI +L L H +V++ I++P F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA----- 176
LT H + LY LL +KY+H+A + HRDLKP N L N +C +K+CDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKNVV--------------------HQLDLMTDL 246
GCIFAE+L PLFPG + QL+++ ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
LGTPS + I + + A+RY+ K++ +++FP + A+ LL+R+L F+P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 363
E LA P+FK + E E + ++ F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 541 bits (1397), Expect = 0.0
Identities = 140/372 (37%), Positives = 215/372 (57%), Gaps = 18/372 (4%)
Query: 1 MQQDHRKKNSPEMEFFS------EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK 54
M H + F+ + RY+ +G G+YG VC+A DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P S +F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ ++K LT +H QF +YQ+LR LKYIH+A++ HRDLKP N+ N +C+LKI DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R + T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 293
+ + QL L+ L+GTP + + ++ ++ AR Y+ S+ + + F+ F A+P A+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIF 353
E++L D R TA +ALA YF + EP P + E R + ++ + L +
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQLLK 365
E++ + P L
Sbjct: 350 DEVISFVPPPLD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 133/451 (29%), Positives = 221/451 (49%), Gaps = 56/451 (12%)
Query: 1 MQQDHRKKNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK 54
+ + K+ + +F+S E GD+ RY+ + IG G+ G+VC+A D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP-PSRRDFKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + ++ P + +F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
QVI+ +L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA-------- 285
++ + Q + + + LGTP + + ++ R Y+ + K + F + FP++
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERR 341
A LL ++L DP R + ++AL PY P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RVTKEDIRELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGP 401
T E+ +ELI++E++ + + G P
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQPS---------------------------P 416
Query: 402 VIPPERKHVSLPRSTIVHSNTVPPKEQQNLS 432
SLP S+ V+ + +Q S
Sbjct: 417 SGAAVNSSESLPPSSSVNDISSMSTDQTLAS 447
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 522 bits (1346), Expect = 0.0
Identities = 124/374 (33%), Positives = 201/374 (53%), Gaps = 29/374 (7%)
Query: 8 KNSPEMEFFS-EYGDA-----SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
++ + F+S E GD+ RY+ + IG G+ G+VC+A D VAIKK+ F+
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKAN 120
+ + A R RE+ L++ + H +I+ + ++ P S +F+D+Y+V ELM+++L QVI+
Sbjct: 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 122
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+L E + LYQ+L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A
Sbjct: 123 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 177
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPS 288
+ + + LGTP + + ++ R Y+ + K F + FP+
Sbjct: 236 NKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQ 294
Query: 289 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDI 348
A LL ++L D R + +EAL PY + P + + + R T E+
Sbjct: 295 ARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEW 353
Query: 349 RELIFREILEYHPQ 362
+ELI++E+++
Sbjct: 354 KELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 512 bits (1321), Expect = e-180
Identities = 120/315 (38%), Positives = 172/315 (54%), Gaps = 15/315 (4%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
SRY + +G G G+V SA+D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKHIMLPPSRR---------DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL 132
+IV++ I+ P + + +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
YQLLR LKYIH+ANV HRDLKP N+ N + LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ L+ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
+ + + Y+ + + +Q P A+ LE++L F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLSKVEREP 326
+ PY S EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-164
Identities = 111/365 (30%), Positives = 177/365 (48%), Gaps = 27/365 (7%)
Query: 7 KKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
N+ + R++++ + G+G++G V + TG VAIKK+ +
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFR 63
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY--VVFELMESDLHQVIK----AN 120
R L+ ++ L +L HP+IV+++ RD +DIY VV E + LH+ +
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQ 123
Query: 121 DDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN-ANCKLKICDFGLARVAF 177
+ FL+QL+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
P Y+ +R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N
Sbjct: 184 PSEPNV----AYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF----PNADPSALRLL 293
QL + +LG PS + + ++ L + + +S F A LL
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLL 295
Query: 294 ERLLAFDPKDRPTAEEALADPYFKGL-SKVEREPSCQPISKMEFEFERR--RVTKEDIRE 350
LL + P++R EAL PYF L + P+ + + + F F V E +
Sbjct: 296 SALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKA 355
Query: 351 LIFRE 355
+ R+
Sbjct: 356 KLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-152
Identities = 116/376 (30%), Positives = 194/376 (51%), Gaps = 31/376 (8%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLR 137
++V++K ++D + +V E + +++ K + + ++YQLLR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+L YIH+ + HRD+KP+N+L + LK+ DFG A++ P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG++ + QL + +LGTPS + I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ + + +P FS+ F P P A+ L+ RLL + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 315 YFKGLSKVE-REPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTER 373
+F L E R P+ + + + F + + + +R + ++ H + + G +
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
Query: 374 TNFLYPSAVDQFRKQF 389
NF P ++ +
Sbjct: 379 HNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-150
Identities = 99/383 (25%), Positives = 178/383 (46%), Gaps = 67/383 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKHIM---------------------------------LPPSRRDFKDIYVVFEL 108
+I+++ + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQL RA+ +IH+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF 282
E++ GKPLF G+ + QL + ++GTP+ + + R+ + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 283 PNADPS-ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKME------ 335
P PS A+ LLE++L ++P R EA+A P+F L +
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 336 ---FEF---ERRRVTKEDIRELI 352
F F E + + ++
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-143
Identities = 106/339 (31%), Positives = 173/339 (51%), Gaps = 25/339 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKHIMLPPS-RRDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRA 138
IV +++ ++D + +V + + +++V + A L + + ++YQL R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
+ + + + +++ F P P A+ L RLL + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLSKVE-REPSCQPISKM-EFEFERRRVTKEDIRELI 352
F L + P+ + + F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 392 bits (1008), Expect = e-133
Identities = 91/315 (28%), Positives = 159/315 (50%), Gaps = 24/315 (7%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
E+G+ Y++ +G+G Y V AI+ EKV +K + + +I REIK+L
Sbjct: 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILE 85
Query: 78 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
LR P+I+ + I+ P V + +D Q+ + LT +F++Y++L
Sbjct: 86 NLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEIL 140
Query: 137 RALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R++
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYF 196
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSL-D 253
+ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L D
Sbjct: 197 KGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPN-----ADPSALRLLERLLAFDPKDRPTAE 308
I + + R+ + + ++ + + P AL L++LL +D + R TA
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 309 EALADPYFKGLSKVE 323
EA+ PYF + K +
Sbjct: 316 EAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-120
Identities = 104/306 (33%), Positives = 162/306 (52%), Gaps = 12/306 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYI 142
+V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LC 201
H N HRD+KP+NIL + +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
G ++Y P +D+W+IGC+FAE+L+G PL+PGK+ V QL L+ LG +
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+ + + KFPN AL LL+ L DP +R T E+ L PYF+ + +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 322 VEREPS 327
+E
Sbjct: 294 IEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-113
Identities = 95/318 (29%), Positives = 156/318 (49%), Gaps = 12/318 (3%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
H + +Y+ ++G+GSYG+V + TG VAIKK + +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63
Query: 62 HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-N 120
+REIKLL+ LRH ++V + + + K Y+VFE ++ + ++
Sbjct: 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFP 118
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ L + Q +L+Q++ + + H+ N+ HRD+KP+NIL + + +K+CDFG AR
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA- 176
Query: 181 PTTIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
P ++ D VATRWYRAPEL G KY A+D+W+IGC+ E+ G+PLFPG + + Q
Sbjct: 177 PGEVY-DDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233
Query: 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 299
L + LG + + K+ +++P + L ++ L
Sbjct: 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHI 293
Query: 300 DPKDRPTAEEALADPYFK 317
DP RP E L +F+
Sbjct: 294 DPDKRPFCAELLHHDFFQ 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-103
Identities = 121/325 (37%), Positives = 173/325 (53%), Gaps = 24/325 (7%)
Query: 4 DHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G +Y+ E +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-N 120
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L + +LYQLLR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLMTDLLGTPSLDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296
L + +LGTP+ + + K R + + + +S P + LL +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 LAFDPKDRPTAEEALADPYFKGLSK 321
L FDP R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-103
Identities = 99/309 (32%), Positives = 142/309 (45%), Gaps = 30/309 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI-----LREIKLLR 77
SRY+ IG G+YG V A D H+G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 78 LLR---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFL 132
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q LR L ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 252 LDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
D + + + P P + S +LL +L F+P R +A
Sbjct: 240 EDDWPRDVSLPR-------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 309 EALADPYFK 317
AL Y
Sbjct: 293 RALQHSYLH 301
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 114/301 (37%), Positives = 164/301 (54%), Gaps = 19/301 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL +
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
Y H V HRDLKP+N+L N +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
+ +Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 230 --ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
Query: 320 S 320
+
Sbjct: 288 N 288
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-101
Identities = 109/333 (32%), Positives = 161/333 (48%), Gaps = 25/333 (7%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARI--LREIKLLRL 78
A RY+ + +G+G + V A D +T + VAIKKI D LREIKLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT-- 254
PE L G+ Y +D+W++GCI AE+L P PG + + QL + + LGTP+ +
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 255 -ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+ + + + + + F A L L++ L F+P R TA +AL
Sbjct: 239 DMCSLPDYV------TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 314 PYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 346
YF P E + +
Sbjct: 293 KYFSNRPG-PTPGCQLPRPNCPVETLKEQSNPA 324
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-101
Identities = 111/329 (33%), Positives = 168/329 (51%), Gaps = 26/329 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + +G+G+Y V T VA+K+I + E A +RE+ LL+ L+H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKY 141
+IV + I+ + +VFE ++ DL Q + + + + + FL+QLLR L Y
Sbjct: 61 NIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-L 200
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDIL 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT---ISR 257
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ +T I
Sbjct: 173 LGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
K Y K + P D LL +LL F+ ++R +AE+A+ P+F
Sbjct: 231 NEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 318 GL----SKVEREPSCQPISKMEFEFERRR 342
L K+ S + +++ + E
Sbjct: 287 SLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-101
Identities = 112/303 (36%), Positives = 163/303 (53%), Gaps = 19/303 (6%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALK 140
+IV + ++ + + +VFE + DL + + N DL E + FL+QLL+ L
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG +V QL + LLGTP+ + +
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
K Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 231 T--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 319 LSK 321
Sbjct: 289 FCP 291
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-100
Identities = 110/340 (32%), Positives = 161/340 (47%), Gaps = 28/340 (8%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ S+Y+ IG+G++G V A TG+KVA+KK+ E+ + I LREIK+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKHIM---LPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---VA 191
LL L YIH + HRD+K N+L + LK+ DFGLAR AF+ Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL L++ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SLDT---ISRVRNDKARRYLTSMRKKQPVQFSQKFPN--ADPSALRLLERLLAFDPKDRP 305
+ + + + K Q + + DP AL L+++LL DP R
Sbjct: 249 TPEVWPNVDNYELYEKLEL----VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 306 TAEEALADPYFKGL---SKVEREPSCQPISKMEFEFERRR 342
+++AL +F S ++ S S E+ RR
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-100
Identities = 112/309 (36%), Positives = 166/309 (53%), Gaps = 29/309 (9%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLR 80
RY+ +G+G+YG V AIDT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YIHTANVYHRDLKPKNILANANCK-----LKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 ---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNA-DPSALRLLERLLAFDPKDRPTAEEA 310
++ + + + S K + + D L LL +L DP R +A+ A
Sbjct: 262 WPGVTALPD-----WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 311 LADPYFKGL 319
L PYF
Sbjct: 317 LEHPYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-100
Identities = 98/326 (30%), Positives = 155/326 (47%), Gaps = 34/326 (10%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 79
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LLR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P +
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 T---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
+ + K + + D LL + L F+P R +A A
Sbjct: 242 DWPRDVALPR-------QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 311 LADPYFKGLSKVEREPSCQPISKMEF 336
L+ PYF+ L C+
Sbjct: 295 LSHPYFQDL------ERCKENLDSHL 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 1e-98
Identities = 108/314 (34%), Positives = 171/314 (54%), Gaps = 33/314 (10%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 80
+S++K E +G G+Y V ++ TG VA+K++ D E A +REI L++ L+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELK 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQ 134
H +IV + ++ ++ + +VFE M++DL + + + L ++F +Q
Sbjct: 62 HENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LL+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T W
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLW 173
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
YRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL L+ D++GTP+
Sbjct: 174 YRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 254 T---ISRVRNDKARRYLTSMRKKQPVQFSQKFPNA-----DPSALRLLERLLAFDPKDRP 305
++++ Y +++++ P Q D + + L LL +P R
Sbjct: 232 LWPSVTKLPK-----YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286
Query: 306 TAEEALADPYFKGL 319
+A++AL P+F
Sbjct: 287 SAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 7e-86
Identities = 111/361 (30%), Positives = 169/361 (46%), Gaps = 53/361 (14%)
Query: 26 KIQEVIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+G+G+YG V A D + A+K+I IS +A REI LLR L+HP+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRELKHPN 79
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD---------LTREHYQFFLYQ 134
++ ++ + L + + ++++F+ E DL +IK + L R + LYQ
Sbjct: 80 VISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 135 LLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIF-WTDY 189
+L + Y+H V HRDLKP NIL ++KI D G AR FN +
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPV 195
Query: 190 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN---------VVHQ 239
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F + Q
Sbjct: 196 VVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 240 LDLMTDLLGTPSLDT---------ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 290
LD + +++G P+ S + D R T+ + ++ + D A
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME--KHKVKPDSKAF 311
Query: 291 RLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQP-ISKMEFEFERRRVTKEDIR 349
LL++LL DP R T+E+A+ DPYF E + + + +R E+
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKREFLTEEEP 366
Query: 350 E 350
+
Sbjct: 367 D 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 9e-80
Identities = 92/400 (23%), Positives = 151/400 (37%), Gaps = 67/400 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHP 82
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALKY 141
+++ + +D + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 IHTANVYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE L T +DI+S GC+F V++ G F
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------------- 230
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+R + + + D A L+E+++A DP+ RP+A+ L P
Sbjct: 231 -----GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 315 YFKGLSK-----------VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILE----- 358
+F L K +E+E PI K + E R V K D RE I +
Sbjct: 286 FFWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKF 344
Query: 359 --YHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENV 396
Y ++D + Y + R+ L ++
Sbjct: 345 RTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 96/331 (29%), Positives = 155/331 (46%), Gaps = 46/331 (13%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A RY++ +VIGKGS+G V A D + VA+K + + + A EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 139 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
L +H + H DLKP+NIL +K+ DFG + + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-HQRVYT-----YIQSRFYR 266
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE + G+ +Y ID+WS+GCI AE+LTG PL PG++ QL M +LLG PS +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 256 SRVRN-------------------DKARRYLTSMRKK----QPVQFSQKFPNADPSALR- 291
+ L R + + S+++ NA
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 292 ----LLERLLAFDPKDRPTAEEALADPYFKG 318
L++ L +DP R T +AL P+ +
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 3e-66
Identities = 54/346 (15%), Positives = 91/346 (26%), Gaps = 61/346 (17%)
Query: 12 EMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARI 69
E S R K+ E + G VV D E A+K S+ R+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 70 LREIKLLRLLRHPDIVEI-------------------KHIMLPPSRRDFK--DIYVVFEL 108
L E L P + D+ + ++
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 109 MESDLHQVIKANDDLTREHY-------QFFLYQLLRALKYIHTANVYHRDLKPKNILANA 161
DL + D + QL+R + + + H P N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229
Query: 162 NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ +L + D P + Y E + + +T A++ W +G
Sbjct: 230 DGRLMLGDVSALWKVGTRGPAS------SVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 222 AEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK 281
V F + L P D+++
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA----------------------FGS 321
Query: 282 FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327
L+ R L FD + R EA+ P F +++ E S
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 8e-64
Identities = 73/327 (22%), Positives = 114/327 (34%), Gaps = 47/327 (14%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
+ + F S Y I + IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
+ + + +L A+ IH + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T T++ V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 T-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 290
F + + + + ++F +
Sbjct: 239 FQQI--------------INQISKLHAI-----------IDPNHEIEFP---DIPEKDLQ 270
Query: 291 RLLERLLAFDPKDRPTAEEALADPYFK 317
+L+ L DPK R + E LA PY +
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 70/341 (20%), Positives = 139/341 (40%), Gaps = 59/341 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ + + +G G++G V + A+K + +I + + +A+I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+A
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 139 LKYIHTANVYHRDLKPKNIL-------------------------ANANCKLKICDFGLA 173
L Y+ ++ H DLKP+NIL + +K+ DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 174 RVAF-NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
F +D + + TR YRAPE + + + D+WS GC+ AE+ TG LF
Sbjct: 210 --TFKSDYHGS-----IINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 232 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYL-------------TSMRKKQPVQF 278
+ L +M ++ + + +Y+ +S+ + V+
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319
Query: 279 SQKFPNA--DPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
L +L DP RP+ E L + +
Sbjct: 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-63
Identities = 92/336 (27%), Positives = 150/336 (44%), Gaps = 51/336 (15%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY+I +IGKGS+G V A D E VAIK I + + + A+I E++LL L+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQI--EVRLLELMNK 109
Query: 82 PDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRA 138
D +I+ F++ + +VFE++ +L+ +++ + ++ + F Q+ A
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 139 LKYIHT--ANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L ++ T ++ H DLKP+NIL +KI DFG + Y+ +R+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIYQ-----YIQSRF 223
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q++ + ++LG P
Sbjct: 224 YRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281
Query: 255 I--------------------------SRVRNDKARRYLTSMRKKQ---PVQFSQKFPNA 285
+ R R L ++ + P
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 286 DPSALR----LLERLLAFDPKDRPTAEEALADPYFK 317
+ L+ R+L +DPK R AL +FK
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-62
Identities = 94/344 (27%), Positives = 144/344 (41%), Gaps = 51/344 (14%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
RY+I +G+G++G V +D G +VA+K I ++ +AAR+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 81 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
D +L +F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 138 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 177
AL+++H + H DLKP+NIL + N +++ DFG A F
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFD 192
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
++ TT VATR YR PE + + D+WSIGCI E G LF
Sbjct: 193 HEHHTT-----IVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244
Query: 237 VHQLDLMTDLLGTPSLDTISRVR------NDKARRYLTSMRKKQPVQFSQKFPNA----- 285
L +M +LG I R R S + + + +
Sbjct: 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304
Query: 286 --DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327
L+ R+L FDP R T EAL P+F GL+ ER
Sbjct: 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-62
Identities = 92/339 (27%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
++RY+I + +G+G++G V ID G VA+K + ++ + +AAR EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKHIMLPPSRRDFKD-IYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
D + + I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVAF- 177
++ ++H+ + H DLKP+NIL N +K+ DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
++ +T V+TR YRAPE + ++ D+WSIGCI E G +FP +
Sbjct: 188 DEHHST-----LVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239
Query: 237 VHQLDLMTDLLGTPSLDTISRVRNDK--------------ARRYLTSMRKKQPVQFSQKF 282
L +M +LG I + R K A RY++ K +F
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EFMLSQ 298
Query: 283 PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
L++++L +DP R T EAL P+F L K
Sbjct: 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 73/331 (22%), Positives = 116/331 (35%), Gaps = 49/331 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP- 82
Y I + IG G V ++ + AIK ++ EI L L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 83 -DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ + + IY+V E DL+ +K + + + +L A+
Sbjct: 69 DKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL- 200
IH + H DLKP N L + LK+ DFG+A DT T++ V T Y PE
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAI 181
Query: 201 --------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
G SK +P D+WS+GCI + GK F
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------------ 229
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEAL 311
+ +FP+ + +L+ L DPK R + E L
Sbjct: 230 -----------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 312 ADPYFKGLSKVEREPSCQPISKMEFEFERRR 342
A PY + + + + +M++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 6e-60
Identities = 85/398 (21%), Positives = 133/398 (33%), Gaps = 59/398 (14%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE 61
D K +S E S G Y I + IG G V ++ + AIK ++
Sbjct: 37 TDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 93
Query: 62 HISDAARILREIKLLRLLRHP--DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + IY+V E DL+ +K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK 148
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179
+ + + +L A+ IH + H DLKP N L + LK+ DFG+A D
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 180 TPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T T++ V Y PE G SK +P D+WS+GCI + GK
Sbjct: 208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 290
F + + + + ++F +
Sbjct: 267 FQQI--------------INQISKLHAI-----------IDPNHEIEFP---DIPEKDLQ 298
Query: 291 RLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRE 350
+L+ L DPK R + E LA PY +++ P Q E K + +
Sbjct: 299 DVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKGTTEEM------KYVLGQ 348
Query: 351 LIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQ 388
L+ + K S+ F K+
Sbjct: 349 LVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 386
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 1e-59
Identities = 75/335 (22%), Positives = 126/335 (37%), Gaps = 49/335 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+RY + +G G + V A D VA+K + + ++AA EIKLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKHIMLPPSRR-----DFKDIYV-----VFELMESDLHQVIKANDD--LTREHY 128
D + + + + K VFE++ +L +IK + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 129 QFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCK------LKICDFGLARVAFNDTP 181
+ QLL L Y+H + H D+KP+N+L +KI D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY- 192
Query: 182 TTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---- 236
T+ + TR YR+PE L G+ + DIWS C+ E++TG LF
Sbjct: 193 -----TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 237 --VHQLDLMTDLLGTPSLDTISRVR----------NDKARRYLTSMRKKQPVQFSQKFPN 284
+ + +LLG + + + L + + KF
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 285 ADPSALR-LLERLLAFDPKDRPTAEEALADPYFKG 318
+ + L +L DP+ R A + P+ K
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-58
Identities = 78/318 (24%), Positives = 124/318 (38%), Gaps = 56/318 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
AS ++ V+G+G++G V A + AIKKI E + IL E+ LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTE--EKLSTILSEVMLLASLNH 61
Query: 82 PDIVEIKH--------IMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFF 131
+V + + + +++ E E L+ +I + N + R+ Y
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFW----- 186
Q+L AL YIH+ + HRDLKP NI + + +KI DFGLA+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN-- 236
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAF 299
++ L + ++F F N +++ L+
Sbjct: 237 -ILKKL-------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDH 270
Query: 300 DPKDRPTAEEALADPYFK 317
DP RP A L +
Sbjct: 271 DPNKRPGARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-58
Identities = 77/356 (21%), Positives = 142/356 (39%), Gaps = 48/356 (13%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDA-SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M H + ++ + Y + +Y + IG+GS+G T G + IK+I+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-- 58
Query: 60 FEHISDAAR--ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV 116
+S R RE+ +L ++HP+IV+ + S + +Y+V + E DL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKR 113
Query: 117 IK-ANDDLTREHY-QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174
I L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+AR
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
V T + T +Y +PE+C + Y DIW++GC+ E+ T K F
Sbjct: 174 VL---NSTVELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 294
+ M +L + ++ + + +S + L+
Sbjct: 229 S-------MKNL--------VLKIISGSFPPV--------SLHYSYDLRS-------LVS 258
Query: 295 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRE 350
+L +P+DRP+ L + + P F + +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-57
Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 49/307 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
D I + +Y F + + AL L+++LL DPK R T EEAL
Sbjct: 355 DQI------TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
Query: 312 ADPYFKG 318
P+ +
Sbjct: 399 RHPWLQD 405
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-57
Identities = 59/314 (18%), Positives = 113/314 (35%), Gaps = 26/314 (8%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 139
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
IS V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLSKV 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-57
Identities = 71/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIVEIKH-------IMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF---F 131
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT---------PT 182
Q+ A++++H+ + HRDLKP NI + +K+ DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERV----- 234
Query: 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPK 302
T++ VRN K F F P +++ +L+ P
Sbjct: 235 ----------RTLTDVRNLK---------------FPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLSKVEREP 326
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-57
Identities = 75/319 (23%), Positives = 113/319 (35%), Gaps = 63/319 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVEIKH-----------IMLPPSRRDFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV SR K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
Q+ + + YIH+ + +RDLKP NI ++KI DFGL ND T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
F +K LL++LL+ P+DRP
Sbjct: 232 -----------------------RDGIISDIFDKKEKT-------LLQKLLSKKPEDRPN 261
Query: 307 AEEALADPYFKGLSKVERE 325
E L S + E
Sbjct: 262 TSEILRTLTVWKKSPEKNE 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-56
Identities = 71/297 (23%), Positives = 105/297 (35%), Gaps = 46/297 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 81
++ +G GSYG V G A+K+ F D AR L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLRALK 140
P V ++ + + +Y+ EL L Q +A E +L L AL
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
Y A D++S+G EV L G QL
Sbjct: 228 LQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------------------- 264
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P +F+ +L +L DPK R TAE LA P +
Sbjct: 265 ---------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRH 81
Y++ IG GSYG G+ + K++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK----ANDDLTREHYQFFLYQLL 136
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 137 RALKYIHTAN-----VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
ALK H + V HRDLKP N+ + +K+ DFGLAR+ T F +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVG 178
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F + +L
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKEL----- 224
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
++R K RR P ++S + ++ R+L RP+ EE L
Sbjct: 225 ---AGKIREGKFRRI--------PYRYSDELNE-------IITRMLNLKDYHRPSVEEIL 266
Query: 312 ADPYFK 317
+P
Sbjct: 267 ENPLIL 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-56
Identities = 90/307 (29%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARILREIKLLR 77
Y + + +G G+ G V A + T +KVAIK I A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLL 136
L HP I++IK+ D +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 229
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
D I F + + AL L+++LL DPK R T EEAL
Sbjct: 230 DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
Query: 312 ADPYFKG 318
P+ +
Sbjct: 274 RHPWLQD 280
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 67/357 (18%), Positives = 129/357 (36%), Gaps = 28/357 (7%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + +++G+G+ V TG+ AIK + + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN---DDLTREHYQFFLYQLLRAL 139
IV++ I + + ++ E L+ V++ L + L ++ +
Sbjct: 69 IVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLG 248
P++ KY +D+WSIG F TG F P + ++M ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
IS V+ + S S +L +L D + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-LEYHPQLL 364
+ A+ V S Q ++ + T EL++++ + Q L
Sbjct: 299 QFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQEL 354
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-54
Identities = 84/339 (24%), Positives = 128/339 (37%), Gaps = 61/339 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 247
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+T R++ Y P + P A L++++L DP RPT E L
Sbjct: 248 ETYLRIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLN 291
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 351
D +F R P F + + + L
Sbjct: 292 DEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 82/317 (25%), Positives = 124/317 (39%), Gaps = 62/317 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY +GKG + D T E A K + + ++ EI + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+V D ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H V HRDLK N+ N + ++KI DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------------- 221
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+T R++ Y P + P A L++++L DP RPT E L
Sbjct: 222 ETYLRIKK---NEY------SIPKHIN-------PVAASLIQKMLQTDPTARPTINELLN 265
Query: 313 DPYF-KGLSKVEREPSC 328
D +F G +C
Sbjct: 266 DEFFTSGYIPARLPITC 282
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-53
Identities = 94/336 (27%), Positives = 139/336 (41%), Gaps = 48/336 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G A RY I ++GKGS+G V D T ++ A+K I+
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD 122
D + ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFND 179
+ + Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ F
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQ 176
Query: 180 TPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
D + T +Y APE L G Y D+WS G I +L+G P F GKN
Sbjct: 177 NTK---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN--- 226
Query: 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLL 297
+ + F ++ A L+ ++L
Sbjct: 227 -------------------------EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 298 AFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 333
F P R TA + L P+ + S S P +
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-53
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLR 80
+ ++I++ IG+G + V A G VA+KK+ IF+ + AR ++EI LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFF-------- 131
HP++++ S + ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
QL AL+++H+ V HRD+KP N+ A +K+ D GL R + T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G D + S
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG-----------DKMNLYS 245
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
L ++ + +S++ L+ + DP+ RP
Sbjct: 246 L--CKKIEQCDYPPLPSD-------HYSEELRQ-------LVNMCINPDPEKRPDVTYVY 289
Query: 312 ADPY 315
Sbjct: 290 DVAK 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 95/375 (25%), Positives = 159/375 (42%), Gaps = 66/375 (17%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
+ +P M S+ G + Y+ + +G G+YG V D T + AIK I S
Sbjct: 21 QATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTR 125
+++L E+ +L+LL HP+I+++ D ++ Y+V E + +L I
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE 135
Query: 126 EHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPT 182
+ Q+L + Y+H N+ HRDLKP+N+L + +KI DFGL+ V F +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK 194
Query: 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242
+ + T +Y APE+ KY D+WSIG I +L G P F G+
Sbjct: 195 ---MKERLGTAYYIAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT------- 241
Query: 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDP 301
+ + +K F S ++ N A L++++L FD
Sbjct: 242 ---------------------DQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 302 KDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE----FERRR--------------V 343
+ R +A++AL P+ K + + P E F+ +
Sbjct: 281 QRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLT 340
Query: 344 TKEDIREL--IFREI 356
++E+ +EL IFR I
Sbjct: 341 SQEETKELTDIFRHI 355
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 83/333 (24%), Positives = 139/333 (41%), Gaps = 47/333 (14%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISD 65
+P M + RYK Q V+GKGS+G V D TG++ A+K I + +D
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 66 AARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLT 124
+LRE++LL+ L HP+I+++ D Y+V E+ +L I + +
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ Q+L + Y+H + HRDLKP+N+L + + ++I DFGL+ F +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASK 183
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
D + T +Y APE+ Y D+WS G I +L+G P F G N
Sbjct: 184 K---MKDKIGTAYYIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN------ 231
Query: 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFD 300
+ +K F ++ SA L+ ++L +
Sbjct: 232 ----------------------EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQPISK 333
P R +A +AL + + +K + +
Sbjct: 270 PSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 95/326 (29%), Positives = 142/326 (43%), Gaps = 48/326 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI 63
H +S E G A RY I ++GKGS+G V D T ++ A+K I+
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD 122
D + ILRE++LL+ L HP+I+++ I+ D Y+V EL +L I
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFND 179
+ + Q+ + Y+H N+ HRDLKP+NIL +C +KI DFGL+ +
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 180 TPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
T D + T +Y APE L G Y D+WS G I +L+G P F GKN
Sbjct: 178 T----KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN--- 226
Query: 239 QLDLMTD-LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 297
+ D++ G + D ++ A L+ ++L
Sbjct: 227 EYDILKRVETGKYAFD-------------------------LPQWRTISDDAKDLIRKML 261
Query: 298 AFDPKDRPTAEEALADPYFKGLSKVE 323
F P R TA + L P+ + S E
Sbjct: 262 TFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-52
Identities = 84/347 (24%), Positives = 129/347 (37%), Gaps = 81/347 (23%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 79
+Y ++ IG+GSYGVV AI+ T AIK + + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF-------- 130
HP+I + + D + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQLLRALKYIHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275
S G + +L G FPG N DTIS+V +
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN---------------DADTISQV-------------LNKK 292
Query: 276 VQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+ F + + P A LL LL + +R A AL P+ S
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 1e-51
Identities = 78/357 (21%), Positives = 131/357 (36%), Gaps = 68/357 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRH 81
+ ++++G GS G V + G VA+K++ F I L EIKLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF-------FLYQ 134
P+++ + +Y+ EL +L ++++ + L Q
Sbjct: 69 PNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 135 LLRALKYIHTANVYHRDLKPKNIL-------------ANANCKLKICDFGLAR-VAFNDT 180
+ + ++H+ + HRDLKP+NIL N ++ I DFGL + + +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 181 PTTIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ T +RAPEL + T +IDI+S+GC+F +L+ GK F K
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 294
S + + A L+
Sbjct: 244 Y-----------------SRESNIIRGI---------FSLDEMKCLHDRSLIAEATDLIS 277
Query: 295 RLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIREL 351
+++ DP RPTA + L P F SK + +S E E R + +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y ++ IG+GS+G V A+ T + A KKI + D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ + D DIY+V EL +L + + + +L A+ Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 142 IHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
H NV HRDLKP+N L + + LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL-GTPSLDTIS 256
+ L G Y P D WS G + +L G P F ++M + GT +
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP--- 227
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ + N P A L+ RLL PK R T+ +AL +F
Sbjct: 228 ----------------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 317 KG 318
+
Sbjct: 266 EK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-51
Identities = 77/316 (24%), Positives = 131/316 (41%), Gaps = 50/316 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 69 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LKI DFG + A + T + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + +D+WS+G + E L GKP F +T R+
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETYKRIS 220
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYF-K 317
V+F FP+ A L+ RLL +P RP E L P+
Sbjct: 221 R---------------VEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
Query: 318 GLSKVEREPSCQPISK 333
SK + + SK
Sbjct: 264 NSSKPSNCQNKESASK 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-51
Identities = 72/324 (22%), Positives = 129/324 (39%), Gaps = 46/324 (14%)
Query: 3 QDHRKKNSPEME----FFSEYGDASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
Q+ R + ++E + R+ K IG+GS+ V +DT T +VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQV 116
D S+ R E ++L+ L+HP+IV + K I +V ELM S L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTY 119
Query: 117 IKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLA 173
+K + + + + Q+L+ L+++HT + HRDLK NI +KI D GLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ + T + APE+ KY ++D+++ G E+ T + +
Sbjct: 180 TLKRASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSE 231
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 293
Q+ Y +P F + A P ++
Sbjct: 232 CQNAAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEII 263
Query: 294 ERLLAFDPKDRPTAEEALADPYFK 317
E + + +R + ++ L +F+
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 90/337 (26%), Positives = 131/337 (38%), Gaps = 59/337 (17%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---------- 56
+P M + G Y +G G+YG V + + + AIK I
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 57 -HDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLH 114
D I EI LL+ L HP+I+++ + D K Y+V E E +L
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELF 134
Query: 115 QVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFG 171
+ I + Q+L + Y+H N+ HRD+KP+NIL N+ +KI DFG
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 172 LARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
L+ F+ D + T +Y APE L KY D+WS G I +L G P
Sbjct: 195 LSSF-FSKDYK---LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSA 289
F G+N D I +V K F + N A
Sbjct: 247 FGGQNDQ---------------DIIKKVEKGK-------------YYFDFNDWKNISDEA 278
Query: 290 LRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 326
L++ +L +D R TAEEAL + K + +
Sbjct: 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 3e-50
Identities = 96/463 (20%), Positives = 164/463 (35%), Gaps = 38/463 (8%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++++E +G G +G V I TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKHIMLPPSRRDFKD-IYVVFELMES-DLHQVIKANDD---LTREHYQFFLYQLLRA 138
+V + + + D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + KI D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APEL KYT +D WS G + E +TG F Q +
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
V +D S P S R L+ +L + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLS---GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREI-----LEYHPQLLKDYMNG 370
F+ L + ++ + VT+ + + + + + Q L
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGL 360
Query: 371 TER-----TNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVHSNTVPP 425
T ++ V R+ L V P+ + P S V P
Sbjct: 361 ALNSAQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPES--VSIVLQDP 418
Query: 426 KEQQNLSRDRQAAEEVFNKNSKESEGIPANLSRTLPAQQRFPL 468
K + R+ +++ + + +R L Q+ +
Sbjct: 419 KRPLTYTHLRRVWGQIWQ----TIRALKEDCARLLQGQRTSMV 457
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-50
Identities = 84/318 (26%), Positives = 137/318 (43%), Gaps = 56/318 (17%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y ++E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ-----FFLYQLL 136
+IV + + ++ Y+VF+L+ +L + I A RE Y + Q+L
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQIL 115
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTP 171
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 251
Y +PE L Y+ +DIW+ G I +L G P F ++ Q L G
Sbjct: 172 GYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYD 225
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
S ++ P A L++ +L +PK R TA++AL
Sbjct: 226 YP-------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260
Query: 312 ADPYFKGLSKVEREPSCQ 329
P+ +V Q
Sbjct: 261 KVPWICNRERVASAIHRQ 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 80/325 (24%), Positives = 137/325 (42%), Gaps = 54/325 (16%)
Query: 4 DHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
H +S E G + + +G G++G V + +G + IK I +
Sbjct: 2 HHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRS 60
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND 121
+I EI++L+ L HP+I++I + D+ ++Y+V E E +L + I +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQ 115
Query: 122 DLTREHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLA 173
+ + Q++ AL Y H+ +V H+DLKP+NIL + + +KI DFGLA
Sbjct: 116 A-RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ +D T+ T Y APE T DIWS G + +LTG F
Sbjct: 175 ELFKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRL 292
G + + ++ + ++ + P A+ L
Sbjct: 227 GTS-LEEV-----------QQKA----------------TYKEPNYAVECRPLTPQAVDL 258
Query: 293 LERLLAFDPKDRPTAEEALADPYFK 317
L+++L DP+ RP+A + L +FK
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 75/303 (24%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
+K+ ++GKGS+ V A HTG +VAIK I R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALK 140
I+E+ + D +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 72 SILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRWY 195
Y+H+ + HRDL N+L N +KI DFGLA P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+PE+ S + D+WS+GC+F +L G+P F V +T+
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---------------NTL 221
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADP 314
++V + + P+ A L+ +LL +P DR + L P
Sbjct: 222 NKVVL---------------ADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 315 YFK 317
+
Sbjct: 265 FMS 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 77/318 (24%), Positives = 130/318 (40%), Gaps = 51/318 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKL 75
Y+ +E++G+G VV I T ++ A+K I E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLG 248
Y APE + S Y +D+WS G I +L G P F + Q+ ++ + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 244
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308
S ++ + + L+ R L P+ R TAE
Sbjct: 245 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279
Query: 309 EALADPYFKGLSKVEREP 326
EALA P+F+ E
Sbjct: 280 EALAHPFFQQYVVEEVRH 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 49/313 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
+ I +GKG +G V A + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + + D K IY++ E +L++ ++ + + F+ +L AL
Sbjct: 74 PNILRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LKI DFG + A + T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + +D+W G + E L G P F + +T R+
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---------------ETHRRIV 225
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPN-ADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
N V KFP + L+ +LL + P R + + P+ K
Sbjct: 226 N---------------VDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 319 LSKVEREPSCQPI 331
S+ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-49
Identities = 96/404 (23%), Positives = 162/404 (40%), Gaps = 66/404 (16%)
Query: 6 RKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHIS 64
++ + + Y ++E +GKG++ VV + TG + A K I+
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDL 123
D ++ RE ++ R L+HP+IV + + ++ Y+VF+L+ +L + I A
Sbjct: 71 DFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA---- 121
Query: 124 TREHYQ-----FFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV 175
RE Y + Q+L ++ Y H+ + HR+LKP+N+L +K+ DFGLA
Sbjct: 122 -REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180
Query: 176 AFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
ND+ W + T Y +PE L Y+ +DIW+ G I +L G P F +
Sbjct: 181 -VNDSE---AWHGFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 235 NVVHQLDLMTD-LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLL 293
+ Q L G S ++ P A L+
Sbjct: 234 D---QHRLYAQIKAGAYDYP-------------------------SPEWDTVTPEAKSLI 265
Query: 294 ERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIF 353
+ +L +PK R TA++AL P+ +V Q +F RR K I +
Sbjct: 266 DSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325
Query: 354 --REILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN 395
R + LL G PS + + + +++N
Sbjct: 326 ATRNLSNLGRNLLNKKEQGP-------PSTIKESSESSQTIDDN 362
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-48
Identities = 64/303 (21%), Positives = 106/303 (34%), Gaps = 43/303 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y + +G+G + V H G A+K+I + D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRA 138
I+ + L R + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT------IFWTDYVAT 192
L+ IH HRDLKP NIL + + D G A + W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QK 252
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
D+++ ++ + Q + S LL ++ DP RP L
Sbjct: 253 GDSVALAVQNQ-------LSIPQSPRHSSALWQ-------LLNSMMTVDPHQRPHIPLLL 298
Query: 312 ADP 314
+
Sbjct: 299 SQL 301
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 49/315 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+RHP+I+ + I + D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G+ + + +
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL---------T 221
Query: 254 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
IS V D F + F N A + RLL DPK R T ++L
Sbjct: 222 NISAVNYD----------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 313 DPYFKGLSKVEREPS 327
+ K + +
Sbjct: 266 HSWIKAIRRRNVRGE 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 84/331 (25%), Positives = 135/331 (40%), Gaps = 55/331 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQLL 136
+IV + + + Y++F+L+ +L + I A RE+Y + Q+L
Sbjct: 71 NIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQQIL 120
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A+ + H V HR+LKP+N+L +K+ DFGLA + W + T
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTP 177
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPS 251
Y +PE L Y +D+W+ G I +L G P F ++ Q L G
Sbjct: 178 GYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD 231
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
S ++ P A L+ ++L +P R TA EAL
Sbjct: 232 FP-------------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 312 ADPYFKGLSKVEREPSCQPISKMEFEFERRR 342
P+ S V Q +F RR
Sbjct: 267 KHPWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-48
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 49/323 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
++HP+++ + + + D+ ++ EL+ +L + + LT E FL Q+L
Sbjct: 71 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + + T
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTP 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G T L
Sbjct: 182 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQET-------LA 227
Query: 254 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+S V + F + F N A + RLL DPK R T +++L
Sbjct: 228 NVSAVNYE----------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 313 DPYFKGLSKVEREPSCQPISKME 335
P+ K + ME
Sbjct: 272 HPWIKPKDTQQALSRKASAVNME 294
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-48
Identities = 55/336 (16%), Positives = 121/336 (36%), Gaps = 50/336 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH---------------DIFEHISDAAR 68
Y+I + +G + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREH 127
E++++ +++ + + I+ ++ ++Y+++E ME+ + + + L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 128 YQ--------FFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
+ +L + YIH N+ HRD+KP NIL + N ++K+ DFG + +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 179 DTPTTIFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237
T +++ PE + S +DIWS+G + F K +
Sbjct: 205 KKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 297
+L + I + + + + + L+ L
Sbjct: 259 VEL-----------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL 307
Query: 298 AFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISK 333
+P +R T+E+AL + + + + + K
Sbjct: 308 RKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 74/333 (22%), Positives = 132/333 (39%), Gaps = 49/333 (14%)
Query: 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAAR 68
ME F + Y I E +G G + +V + TG + A K I
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
I RE+ +LR + H +++ + + + D+ ++ EL+ +L + + L+ E
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE 116
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTT 183
F+ Q+L + Y+HT + H DLKP+NI+ +K+ DFGLA +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
+ + T + APE+ + D+WSIG I +L+G F G + + +
Sbjct: 175 --FKNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL 227
Query: 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPK 302
I+ V D F + F + A + +LL + +
Sbjct: 228 ---------ANITSVSYD----------------FDEEFFSHTSELAKDFIRKLLVKETR 262
Query: 303 DRPTAEEALADPYFKGLSKVEREPSCQPISKME 335
R T +EAL P+ + + + + +E
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 74/313 (23%), Positives = 125/313 (39%), Gaps = 60/313 (19%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLL 76
+Y ++VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQ----- 129
R + HP I+ + +++VF+LM +L + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETR 203
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
+ LL A+ ++H N+ HRDLKP+NIL + N ++++ DFG + +
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLREL 259
Query: 190 VATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
T Y APE L S Y +D+W+ G I +L G P F + Q+ ++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316
Query: 246 -LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
+ G S ++ + + L+ RLL DP+ R
Sbjct: 317 IMEGQYQFS-------------------------SPEWDDRSSTVKDLISRLLQVDPEAR 351
Query: 305 PTAEEALADPYFK 317
TAE+AL P+F+
Sbjct: 352 LTAEQALQHPFFE 364
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-47
Identities = 72/367 (19%), Positives = 123/367 (33%), Gaps = 104/367 (28%)
Query: 22 ASR----YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
ASR ++ + +G+G +GVV A + AIK+I + +++RE+K L
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALA 59
Query: 78 LLRHPDIV-------------------------------------------------EIK 88
L HP IV
Sbjct: 60 KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS 119
Query: 89 HIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQ---FFLYQLLRALKY 141
+ ++ M+ +L + L + Q+ A+++
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND---------TPTTIFWTDYVAT 192
+H+ + HRDLKP NI + +K+ DFGL D P T V T
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
+ Y +PE + Y+ +DI+S+G I E+L V
Sbjct: 240 KLYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVR-------------- 281
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
I+ VRN ++F F P +++ +L+ P +RP A + +
Sbjct: 282 -IITDVRN---------------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
Query: 313 DPYFKGL 319
+ F+ L
Sbjct: 326 NAIFENL 332
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 73/323 (22%), Positives = 128/323 (39%), Gaps = 49/323 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+ HP+I+ + + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA + + + T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIFGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
+ APE+ + D+WSIG I +L+G F G + + +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL---------A 228
Query: 254 TISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
I+ V D F + F A + +LL + + R T +EAL
Sbjct: 229 NITAVSYD----------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 313 DPYFKGLSKVEREPSCQPISKME 335
P+ + + + + +E
Sbjct: 273 HPWITPVDTQQAMVRRESVVNLE 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 42/307 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
++ +D+WS G + +L G+ + D
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPW-----------------------------D 209
Query: 262 KARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-KGL 319
+ + + + D + L LL ++L +P R T + D ++ K L
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 320 SKVEREP 326
K + P
Sbjct: 270 KKGAKRP 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 7e-47
Identities = 82/338 (24%), Positives = 132/338 (39%), Gaps = 63/338 (18%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---HDIFEHISDAARILREIKLLRLL 79
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFF------- 131
+HP IVE+ +Y+VFE M+ +DL I R F
Sbjct: 84 KHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVK-----RADAGFVYSEAVAS 133
Query: 132 --LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFW 186
+ Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V T + APE + Y +D+W G I +L+G F G +L
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERL----- 240
Query: 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDR 304
+ I + + + +++ + SA L+ R+L DP +R
Sbjct: 241 ------FEGIIKGK----------------YKMNPRQWSHISESAKDLVRRMLMLDPAER 278
Query: 305 PTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRR 342
T EAL P+ K + + + +F RR
Sbjct: 279 ITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-47
Identities = 67/326 (20%), Positives = 131/326 (40%), Gaps = 74/326 (22%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------------------------HDI 59
+Y +++ IGKGSYGVV A + + A+K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK 118
+ ++ +EI +L+ L HP++V++ ++ P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPT 130
Query: 119 A---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
++D R ++Q L++ ++Y+H + HRD+KP N+L + +KI DFG++
Sbjct: 131 LKPLSEDQARFYFQ----DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGK 234
+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKK---QPVQFSQKFPNADPSALR 291
++ + K Q ++F P+
Sbjct: 244 RIM-------------------------------CLHSKIKSQALEFP-DQPDIAEDLKD 271
Query: 292 LLERLLAFDPKDRPTAEEALADPYFK 317
L+ R+L +P+ R E P+
Sbjct: 272 LITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 81/366 (22%), Positives = 139/366 (37%), Gaps = 72/366 (19%)
Query: 5 HRKKNSPEMEFFSEYGDASRYKI-------QEVIGKGSYGVVCSAIDTHTGEKVAIKKIH 57
H +S +E + + +Y + ++V+G G G V TG+K A+K +
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL- 62
Query: 58 DIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQ 115
D+ + +E+ + P IV I + + + ++ E ME +L
Sbjct: 63 ------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFS 115
Query: 116 VIKANDDLTREHYQF-------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKL 165
I+ R F + + A++++H+ N+ HRD+KP+N+L + L
Sbjct: 116 RIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
K+ DFG A+ + T T +Y APE+ G KY + D+WS+G I +L
Sbjct: 171 KLTDFGFAKETTQNALQTP-----CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILL 223
Query: 226 TGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA 285
G P F M R+ + Q+ FPN
Sbjct: 224 CGFPPFYSNTGQAISPGM--------------------------KRRIRLGQYG--FPNP 255
Query: 286 D-----PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFER 340
+ A +L+ LL DP +R T + + P+ V + P E +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315
Query: 341 RRVTKE 346
V +E
Sbjct: 316 DEVKEE 321
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-46
Identities = 81/339 (23%), Positives = 149/339 (43%), Gaps = 54/339 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y++ + IGKG++ V A TG +VAIK I + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
F KY P +D+WS+G I +++G F G+N+ L
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------------KEL------- 222
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK-G 318
R + + + P S LL+R L +P R T E+ + D + G
Sbjct: 223 ----RERVLRGKYRIPFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 319 LSKVEREPSCQPISKMEFEF-----ERRRVTKEDIRELI 352
+ E +P +P + + ++E+I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 6e-46
Identities = 73/348 (20%), Positives = 134/348 (38%), Gaps = 46/348 (13%)
Query: 3 QDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH 62
+D KK P+ + Y I E +G G++GVV ++ TG K I+ +
Sbjct: 31 EDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PY 88
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKAN 120
D + EI ++ L HP ++ + D ++ ++ E + +L ++ +
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAED 143
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFN 178
++ ++ Q LK++H ++ H D+KP+NI+ +KI DFGLA
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-- 201
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 238
P I AT + APE+ D+W+IG + +L+G F G++ +
Sbjct: 202 -NPDEIVKVT-TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL- 256
Query: 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLL 297
+T+ V+ +F F + P A ++ LL
Sbjct: 257 --------------ETLQNVKRCD-------------WEFDEDAFSSVSPEAKDFIKNLL 289
Query: 298 AFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTK 345
+P+ R T +AL P+ KG + + +
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 57/306 (18%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
++++ +G+G+ +V T + A+K + + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHP 108
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 136
+I+++K I +I +V EL+ +L I + +Y + Q+L
Sbjct: 109 NIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVE-----KGYYSERDAADAVKQIL 158
Query: 137 RALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
A+ Y+H + HRDLKP+N+L + LKI DFGL+++ + T
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTP 214
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE L G Y P +D+WS+G I +L G F + +
Sbjct: 215 GYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----------F 260
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
I + + +A L+ +L+ DPK R T +AL
Sbjct: 261 RRILNCEYYFISPW---------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305
Query: 313 DPYFKG 318
P+ G
Sbjct: 306 HPWVTG 311
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-46
Identities = 72/318 (22%), Positives = 127/318 (39%), Gaps = 46/318 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K I D+ + I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ + Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
++ +D+WS G + +L G+ +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPW---------------------------- 208
Query: 260 NDKARRYLTSMRKKQPVQFSQ-KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF-K 317
D+ + + + D + L LL ++L +P R T + D ++ K
Sbjct: 209 -DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 318 GLSKVEREPSCQPISKME 335
L K + P E
Sbjct: 268 PLKKGAKRPRVTSGGVSE 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 78/351 (22%), Positives = 138/351 (39%), Gaps = 60/351 (17%)
Query: 8 KNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA 67
K+SP F+ Y + +G+GS+ + + + + A+K I A
Sbjct: 2 KDSP---FYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEA 50
Query: 68 RILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR 125
+EI L+L HP+IV++ + D ++V EL+ +L + IK +
Sbjct: 51 NTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKK-----K 100
Query: 126 EHY-----QFFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAF 177
+H+ + + +L+ A+ ++H V HRDLKP+N+L N N ++KI DFG AR+
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
D T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 161 PDNQP---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
Query: 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLER 295
+++ +++ F + + N A L++
Sbjct: 215 SLTCTSAVEIM--------KKIKKGD-------------FSFEGEAWKNVSQEAKDLIQG 253
Query: 296 LLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 346
LL DP R + + + S++ P P K
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 44/314 (14%)
Query: 24 RYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-H 81
Y++Q +V+G+G++ V + I+ T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQL 135
+++E+ + Y+VFE M + I R H+ + +
Sbjct: 71 RNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHK-----RRHFNELEASVVVQDV 120
Query: 136 LRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARV----AFNDTPTTIFWTD 188
AL ++H + HRDLKP+NIL N +KICDF L +T
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240
Query: 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDR 304
++ K +F + + + +A L+ +LL D K R
Sbjct: 241 ACPACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
Query: 305 PTAEEALADPYFKG 318
+A + L P+ +G
Sbjct: 288 LSAAQVLQHPWVQG 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 49/348 (14%), Positives = 96/348 (27%), Gaps = 82/348 (23%)
Query: 12 EMEFFSEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---------------- 54
SE G+ R V+G+ A D TGE +
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 55 -------KIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFE 107
++ ++ A LR I L++ P ++ + L + ++
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 108 LMESDLHQVIKANDDLTREHYQF-------FLYQLLRALKYIHTANVYHRDLKPKNILAN 160
M+S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL---------CGSFFSKYTPA 211
+ + F V + +R + PEL + T +
Sbjct: 241 QRGGVFLTGFEHL-VRDGARVVS------SVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMR 271
D W++G + + +
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAA----------------------------LGGSEWI 325
Query: 272 KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
+ LLE L + +DR +A+ P ++ L
Sbjct: 326 FRSCKNIP-------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 64/318 (20%), Positives = 121/318 (38%), Gaps = 52/318 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + A + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRAL 139
+++++ ++ + + +Y+V E + +++ + QL+ L
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVATRW 194
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
PE+ + ++ +DIWS G + TG F G N+ L
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------------YKL- 221
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+ P P LL+ +L ++P R + +
Sbjct: 222 ----------FENIGKGSYAIPGDCG-------PPLSDLLKGMLEYEPAKRFSIRQIRQH 264
Query: 314 PYF-KGLSKVEREPSCQP 330
+F K E P
Sbjct: 265 SWFRKKHPPAEAPVPIPP 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 57/325 (17%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLR 80
+ + E IG G +G V + G AIK+ D LRE+ L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTR----EHYQFFLYQL 135
H +V + + + + E L I N + + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYIHTANVYHRDLKPKNIL-------------------ANANCKLKICDFGLARVA 176
R L+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR- 183
Query: 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296
H++ R+ + + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 297 LAFDPKDRPTAEEALADPYFKGLSK 321
+ DP+ RP+A + S+
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 81/366 (22%), Positives = 134/366 (36%), Gaps = 63/366 (17%)
Query: 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 73
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREV 105
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 130
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 159
Query: 131 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ +
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
T T +Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 220 ----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273
Query: 242 LMTD--LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 299
M +G + ++ L+ LL
Sbjct: 274 GMKTRIRMGQYEFP-------------------------NPEWSEVSEEVKMLIRNLLKT 308
Query: 300 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEY 359
+P R T E + P+ +KV + P E + V +E L +
Sbjct: 309 EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 368
Query: 360 HPQLLK 365
++ K
Sbjct: 369 QIKIKK 374
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 78/305 (25%), Positives = 126/305 (41%), Gaps = 61/305 (20%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+++ ++ P+ D ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 193
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE+ Y P +DIWS G I +L G F ++V P+L
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------------PTL 219
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ + P + S LL +L DP R T ++
Sbjct: 220 -----------FKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIKDIRE 261
Query: 313 DPYFK 317
+FK
Sbjct: 262 HEWFK 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-44
Identities = 69/325 (21%), Positives = 125/325 (38%), Gaps = 46/325 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDL-HQVIKANDDLTREHYQFFLYQLLRALK 140
+V + D ++ +++E M +L +V ++ ++ + ++ Q+ + L
Sbjct: 215 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 141 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++H N H DLKP+NI+ + +LK+ DFGL T + AP
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAP 325
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTISR 257
E+ D+WS+G + +L+G F G+N + + + ++D
Sbjct: 326 EVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD---- 376
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
F + +LL DP R T +AL P+
Sbjct: 377 ---------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
Query: 318 GLSKVEREPSCQPISKMEFEFERRR 342
+ R+ + +
Sbjct: 416 PGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-44
Identities = 45/329 (13%), Positives = 86/329 (26%), Gaps = 70/329 (21%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR-- 80
V+G+ A D TGE + + + ++ E+ LRLLR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 81 --------------------HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
P ++ + L + ++ M+S+L +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 121 DDLTREHYQ-------FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
A A + + T A D W++G +
Sbjct: 259 VRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL 290
+ + P
Sbjct: 317 NTDDAAL---------------GGSEWIFRSCKN-----------------IP---QPVR 341
Query: 291 RLLERLLAFDPKDRPTAEEALADPYFKGL 319
LLE L + +DR +A+ P ++ L
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEYEQL 370
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 60/323 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHP 82
Y+++E IG GSY V I T + A+K I EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHY-----QFFLYQLL 136
+I+ +K + D K +YVV ELM+ +L I ++ + L+ +
Sbjct: 77 NIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR-----QKFFSEREASAVLFTIT 126
Query: 137 RALKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ ++Y+H V HRDLKP NIL + ++ICDFG A+ T
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYT 183
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
+ APE L Y A DIWS+G + +LTG F +++
Sbjct: 184 ANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA------- 233
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
R+ + K + + +A L+ ++L DP R TA
Sbjct: 234 -----RIGSGK-------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
Query: 311 LADPYFKGLSKVEREPSCQPISK 333
L P+ ++ + + +
Sbjct: 276 LRHPWIVHWDQLPQYQLNRQDAP 298
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 95/416 (22%), Positives = 153/416 (36%), Gaps = 67/416 (16%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
M + +M + RY + IG G++GV D T E VA+K I
Sbjct: 1 MDRAPVTTGPLDMPIMHDSD---RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER-- 55
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKA 119
D + REI R LRHP+IV K ++L P+ + ++ E +L++ I
Sbjct: 56 GAAID-ENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIIMEYASGGELYERICN 109
Query: 120 NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAF 177
+ + +FF QLL + Y H+ + HRDLK +N L + +LKICDFG ++ +
Sbjct: 110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 178 NDT-PTTIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPG 233
+ P + V T Y APE+ +Y D+WS G +L G F
Sbjct: 170 LHSQPKS-----TVGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
Query: 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNAD---PSAL 290
TI R+ + V++ P+ P
Sbjct: 221 PEEPRDYR-----------KTIQRILS---------------VKY--SIPDDIRISPECC 252
Query: 291 RLLERLLAFDPKDRPTAEEALADPYF-KGLSKVEREPSCQPISKMEFEFERRRVTKEDIR 349
L+ R+ DP R + E +F K L S E E + + + I
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSL--DTIM 310
Query: 350 ELIFREILEYHPQLLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPP 405
++I P + ++ N D + E ++ SG ++
Sbjct: 311 QIISEAT---IPAVRNRCLDDFMTDNLD---LDDDMDDFDSESEIDIDSSGEIVYA 360
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 63/305 (20%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRALK 140
+I+ + +++ ++FE + D+ ++ + +L +++Q+ AL+
Sbjct: 62 NILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 141 YIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++H+ N+ H D++P+NI+ + +KI +FG AR + Y AP
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAP 172
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD-LLGTPSLDTIS 256
E + A D+WS+G + +L+G F + ++ + + + D
Sbjct: 173 EVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD--- 223
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ F A+ ++RLL + K R TA EAL P+
Sbjct: 224 ----------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
Query: 317 KGLSK 321
K +
Sbjct: 262 KQKIE 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 85/304 (27%), Positives = 134/304 (44%), Gaps = 60/304 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y I+E +G+GS+G V A T +KVA+K I + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATRW 194
H + HRDLKP+N+L + N +KI DFGL+ + + +P
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------------ 172
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
Y APE+ Y P +D+WS G + +L G+ F + + P+L
Sbjct: 173 YAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-------------PNL- 216
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+ + S P S P A L+ R++ DP R T +E D
Sbjct: 217 ----------FKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRD 259
Query: 314 PYFK 317
P+F
Sbjct: 260 PWFN 263
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 71/315 (22%), Positives = 118/315 (37%), Gaps = 49/315 (15%)
Query: 17 SEYGDASR-YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL 75
EY + Q +G+GS+G V D TG + A+KK+ E E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVA 103
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 133
L P IV + + R+ + + EL+E S L Q+IK L + ++L
Sbjct: 104 CAGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLG 157
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLA-RVAFNDTPTTIFWTDYVA 191
Q L L+Y+HT + H D+K N+L +++ + +CDFG A + + ++ DY+
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 192 -TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
T + APE+ +DIWS C+ +L G + Q L
Sbjct: 218 GTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPW------TQYFRGPLCLKIA 269
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
S R + P + P + ++ L +P R +A E
Sbjct: 270 SEPPPIR---------------EIPPSCA-------PLTAQAIQEGLRKEPVHRASAMEL 307
Query: 311 LADPYFKGLSKVERE 325
+
Sbjct: 308 RRKVGKALQEVGGLK 322
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 74/347 (21%), Positives = 120/347 (34%), Gaps = 84/347 (24%)
Query: 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREI 73
+Y +V+G G G V + T EK A+K + D + RE+
Sbjct: 14 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREV 61
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQF- 130
+L R + P IV I + K + +V E ++ +L I+ R F
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RGDQAFT 115
Query: 131 ------FLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTP 181
+ + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------- 166
Query: 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
A E G KY + D+WS+G I +L G P F + +
Sbjct: 167 ---------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208
Query: 242 LMTD--LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 299
M +G + ++ L+ LL
Sbjct: 209 GMKTRIRMGQYEFP-------------------------NPEWSEVSEEVKMLIRNLLKT 243
Query: 300 DPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKE 346
+P R T E + P+ +KV + P E + V +E
Sbjct: 244 EPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 62/328 (18%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRL 78
+ Y++ ++GKG +G V + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 79 LR----HPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFL 132
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----ALLHDEPY-TDFDG 200
Query: 192 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
TR Y PE +Y +WS+G + +++ G F
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPF------------------- 239
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
+ + + P S P L+ R LA P RP+ EE
Sbjct: 240 --ERDQEILEAELH---------FPAHVS-------PDCCALIRRCLAPKPSSRPSLEEI 281
Query: 311 LADPYFK-GLSKVEREPSCQPISKMEFE 337
L DP+ + V PS + + +
Sbjct: 282 LLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG T++ TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVY-TDFDGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPF---------------------E 250
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+ + + S L+ LA P DRPT EE
Sbjct: 251 HDEEIIRGQVFF---------RQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 57/316 (18%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDDLTREHYQFFLYQLL 136
H +IV+ S + I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFNDTPT------TIFWTDY 189
LKY+H + HRD+K N+L N + LKI DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249
APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM------ 235
Query: 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRPTAE 308
+ M K P + P + A + + DP R A
Sbjct: 236 ----------------FKVGMFKVHP-----EIPESMSAEAKAFILKCFEPDPDKRACAN 274
Query: 309 EALADPYFKGLSKVER 324
+ L D + K SK ++
Sbjct: 275 DLLVDEFLKVSSKKKK 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-42
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 52/314 (16%)
Query: 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLH-QVIKANDDLTREHYQFFLYQLLRA 138
H +++++ DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 139 LKYIHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTP-TTIFWTDYVATRWY 195
++++H + H DLKP+NIL ++KI DFGLAR F T +
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE-----F 254
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE + F + D+WS+G I +L+G F G N +T
Sbjct: 255 LAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------------ET 296
Query: 255 ISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
++ + + ++F + A + +LL + R +A EAL
Sbjct: 297 LNNILACR-------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343
Query: 314 PYFKGLSKVEREPS 327
P+ R +
Sbjct: 344 PWLSDHKLHSRLSA 357
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 54/307 (17%)
Query: 23 SRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
+ Y + + +G+G + VV I TG++ A K + A IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHY-----QFFLYQ 134
P ++ + + + +I ++ E ++ + E + Q
Sbjct: 88 CPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQ 139
Query: 135 LLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +KI DFG++R + + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIMG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T Y APE+ + T A D+W+IG I +LT F G++ +
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY-------- 242
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
IS+V V + + F + A ++ LL +P+ RPTAE
Sbjct: 243 -LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285
Query: 311 LADPYFK 317
L+ + +
Sbjct: 286 LSHSWLQ 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 61/308 (19%), Positives = 114/308 (37%), Gaps = 56/308 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HP 82
R +++ V+ +G + V A D +G + A+K++ + I++E+ ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVI---KANDDLTREHYQFFLYQLL 136
+IV+ L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA--- 191
RA++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243
T YR PE+ +S DIW++GCI + + F +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 303
R+ N K Y F + L+ +L +P++
Sbjct: 260 -------------RIVNGK---Y----SIPPHDTQYTVFHS-------LIRAMLQVNPEE 292
Query: 304 RPTAEEAL 311
R + E +
Sbjct: 293 RLSIAEVV 300
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 70/357 (19%), Positives = 121/357 (33%), Gaps = 52/357 (14%)
Query: 5 HRKKNSPEMEFFSEYGD-ASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKI---HD 58
H + + S + Y++ VIGKG V A TGE V +++I
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 59 IFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQV 116
E ++ + E+ + +L HP+IV + + + +++VV M S +
Sbjct: 66 SNEMVTF---LQGELHVSKLFNHPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDL 116
Query: 117 IKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG--- 171
I D + + L +L+AL YIH HR +K +IL + + K+ +
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 172 -LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP- 229
+ F V + +PE+ Y DI+S+G E+ G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
Query: 230 ---------LF------------PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLT 268
L +L + S + S +
Sbjct: 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 269 SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 325
S FS F + +E+ L +P RP+A L +FK + + E
Sbjct: 297 SPSHPYHRTFSPHFHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 71/354 (20%), Positives = 129/354 (36%), Gaps = 72/354 (20%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI------HDIFEHISDAARILREIKLLR 77
+Y +G G++G V +A+D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES--DLHQVIKANDDLTREHYQFFLYQL 135
+ H +I+++ I + +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ Y P +++WS+G L T +
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVT---------------------LYTLVFEENPF 230
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ P S + L+ LL P+ R T E+ +
Sbjct: 231 CELEET---VEAAI------HPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLKD 366
DP+ QP++ ++ +E + ++ LE + L D
Sbjct: 275 DPWVT-----------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD 317
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-41
Identities = 95/450 (21%), Positives = 162/450 (36%), Gaps = 83/450 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+++ ++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND--------TPTTIFWTDYVATR 193
H V HRDLKP+N+L +A+ KI DFGL+ + + +P
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 180
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE+ Y P +DIWS G I +L G F +V P+L
Sbjct: 181 -YAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------------PTL 224
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ + P + PS + LL+ +L DP R T ++
Sbjct: 225 -----------FKKICDGIFYTPQYLN-------PSVISLLKHMLQVDPMKRATIKDIRE 266
Query: 313 DPYFKGLSKVEREPSCQPISKMEFEFERRR-------VTKEDIRELIFREILEYHPQ--- 362
+FK P S + E + ++E++ ++ +
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNR--NHQDPLAV 324
Query: 363 ---LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEENVGKSGPVIPPERKHVSLPRSTIVH 419
L+ D + A D + PER + +
Sbjct: 325 AYHLIIDN-------RRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRAR 377
Query: 420 SNTVPPKEQQNLSRDRQAAEEVFNKNSKES 449
Q++ + + A+ S+
Sbjct: 378 HTLDELNPQKSKHQGVRKAKWHLGIRSQSR 407
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 61/312 (19%), Positives = 117/312 (37%), Gaps = 45/312 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIK-LLRL 78
+ + + +G G+ G V TG +A+K++ + + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHY-QFFLYQLLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ + Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253
APE Y D+WS+G E+ TG+ + +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--------------TDFE 237
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+++V ++ + FS F + ++ L D + RP + L
Sbjct: 238 VLTKVLQEEPP------LLPGHMGFSGDFQS-------FVKDCLTKDHRKRPKYNKLLEH 284
Query: 314 PYFKGLSKVERE 325
+ K +E +
Sbjct: 285 SFIKRYETLEVD 296
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 44/297 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+IV S +++VV E + L V+ + + L+AL++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H+ V HRD+K NIL + +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 202 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
Y P +DIWS+G I A E++ G+P + +N + L L+ GTP L
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL-------- 236
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ P + S F + L R L D + R +A+E L + K
Sbjct: 237 ------------QNPEKLSAIFRD-------FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 80/314 (25%), Positives = 132/314 (42%), Gaps = 39/314 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ Y++QEVIG G+ VV +A EKVAIK+I ++ + + +L+EI+ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD-----LTREHYQFF 131
HP+IV + ++++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDY 189
L ++L L+Y+H HRD+K NIL + ++I DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249
V T + APE+ Y DIWS G E+ TG + H+ M L+ T
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLT 239
Query: 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
+ND K+ ++ + F ++ L DP+ RPTA E
Sbjct: 240 L--------QNDPPSLETGVQDKEMLKKYGKSFRK-------MISLCLQKDPEKRPTAAE 284
Query: 310 ALADPYFKGLSKVE 323
L +F+ E
Sbjct: 285 LLRHKFFQKAKNKE 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 78/342 (22%), Positives = 136/342 (39%), Gaps = 65/342 (19%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
M D ++ E++ + A +++ E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 61 EHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFKD-IYVVFELME----SDLH 114
+ + I +EI +L+ H +I + + D +++V E +DL
Sbjct: 62 DEEEE---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 115 QVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA- 173
+ K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 119 KNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 174 --------RVAFNDTPTTIFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA 222
R F TP +W APE C + Y D+WS+G I A
Sbjct: 178 QLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-ITA 224
Query: 223 -EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK 281
E+ G P + + L L+ P L + ++S+K
Sbjct: 225 IEMAEGAPPLCDMHPMRALFLIPR-NPAPRL---------------------KSKKWSKK 262
Query: 282 FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323
F + +E L + RP E+ + P+ +
Sbjct: 263 FQS-------FIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 70/312 (22%), Positives = 122/312 (39%), Gaps = 44/312 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLL 79
A K IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIKANDDLTREHY-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 LLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ + +I T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
Y APE + Y D+WS+G E+ TG+ +P N
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN--------------SV 235
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
D +++V + + + +FS F N + L D RP +E L
Sbjct: 236 FDQLTQVVKGDPPQ----LSNSEEREFSPSFIN-------FVNLCLTKDESKRPKYKELL 284
Query: 312 ADPYFKGLSKVE 323
P+ +
Sbjct: 285 KHPFILMYEERA 296
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
IG+GS G+VC A + H+G +VA+K + + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
++VE+ S ++++V+ E ++ L ++ L E +L+AL Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H V HRD+K +IL + ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 202 GSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
S Y +DIWS+G I E++ G+P + + V + + D P L
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKL-------- 261
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
K + S + LER+L DP++R TA+E L P+
Sbjct: 262 ------------KNSHKVSPVLRD-------FLERMLVRDPQERATAQELLDHPFLL 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 88/356 (24%), Positives = 140/356 (39%), Gaps = 68/356 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D +++EV+G+G++GVVC A + VAIK+I S+ + E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVN 59
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI---KANDDLTREHYQFFLYQLL 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYIHTAN---VYHRDLKPKNILANANCK-LKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LKICDFG A T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEEAL 311
+ V N +P P + L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHNG-----------TRP-----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255
Query: 312 A-----DPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ 362
YF G + + P + E RV +R H +
Sbjct: 256 KIMTHLMRYFPGADEPLQYPCQHSLPPG----EDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 62/302 (20%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-----DIFEHISDAARILREIKLLRLLR 80
+ ++ IGKG +G+V VAIK + E I RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI-KANDDLTREHYQFFLYQLLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYIHTAN--VYHRDLKPKNIL-----ANANCKLKICDFGLARVAFNDTPT---TIFWTD 188
++Y+ N + HRDL+ NI NA K+ DFGL++ + + W
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM- 193
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
APE G+ YT D +S I +LTG+ F +
Sbjct: 194 --------APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---------- 235
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTA 307
+ I+ +R + R P P P LR ++E + DPK RP
Sbjct: 236 ---IKFINMIREEGLR----------P-----TIPEDCPPRLRNVIELCWSGDPKKRPHF 277
Query: 308 EE 309
Sbjct: 278 SY 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 82/374 (21%), Positives = 136/374 (36%), Gaps = 91/374 (24%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY + +G G + V + D + VA+K + EH ++ A EI+LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKHIMLPPSRRDFKD-------IYVVFELMESDLHQVIKANDD--LTREHYQFFL 132
D + M+ DFK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQLLRALKYIHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
K+KI D G A + T + TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWV-HKHFTED-----IQTRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTIS 256
S Y DIWS C+ E+ TG LF + + L+ +LLG I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 RVRNDKARRYLTS---MRKKQPVQFSQ---------KFPNAD-PSALRLLERLLAFDPKD 303
++ + T ++ ++ ++ + L +L P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 304 RPTAEEALADPYFK 317
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 71/319 (22%), Positives = 125/319 (39%), Gaps = 30/319 (9%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
++ +G G+ GVV +G +A K IH + + +I+RE+++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECN 89
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRAL 139
P IV +I + E M+ L QV+K + + +++ L
Sbjct: 90 SPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 140 KYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +P
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSP 199
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E L G + Y+ DIWS+G E+ G+ P + + + + +T R
Sbjct: 200 ERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 258 VRNDKARRYLTSMRKKQPV---QFSQKFPNADPSALRLLERLLAF----------DPKDR 304
R M + P+ + N P L L F +P +R
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 305 PTAEEALADPYFKGLSKVE 323
++ + + K E
Sbjct: 317 ADLKQLMVHAFIKRSDAEE 335
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 78/328 (23%), Positives = 139/328 (42%), Gaps = 51/328 (15%)
Query: 2 QQDHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
++ ++ +++ S + + E +G+GSYG V AI TG+ VAIK++ +
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQV 116
+ + I++EI +++ P +V+ + D+++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG VA
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VA 172
Query: 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKN 235
T T + T ++ APE+ Y DIWS+G I A E+ GKP + +
Sbjct: 173 GQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKPPYADIH 229
Query: 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 295
+ + ++ P+ ++P +S F + +++
Sbjct: 230 PMRAIFMIPT-NPPPTF--------------------RKPELWSDNFTD-------FVKQ 261
Query: 296 LLAFDPKDRPTAEEALADPYFKGLSKVE 323
L P+ R TA + L P+ + V
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 67/305 (21%), Positives = 124/305 (40%), Gaps = 46/305 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLL 79
A + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELM----ESDLHQVIKANDDLTREHYQFFLYQL 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
Y APE Y+ DIWS+G E+ + FP + + ++ PS
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ +FS +F + + L + K+RPT E +
Sbjct: 233 -------------------QLPADKFSAEFVD-------FTSQCLKKNSKERPTYPELMQ 266
Query: 313 DPYFK 317
P+F
Sbjct: 267 HPFFT 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 85/341 (24%), Positives = 131/341 (38%), Gaps = 82/341 (24%)
Query: 1 MQQDHRKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M + P M+ + D + E IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQ--NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQ 115
E + I +EI +L P + + L + ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVL 225
R F TP FW APE+ S Y DIWS+G I A E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELA 213
Query: 226 TGKPLFPGKNVVHQLDLMTDLL-----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ 280
G+P +L M L P+L+ +S+
Sbjct: 214 RGEPPH------SELHPMKVLFLIPKNNPPTLEG----------------------NYSK 245
Query: 281 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+E L +P RPTA+E L + +K
Sbjct: 246 PLKE-------FVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 76/322 (23%), Positives = 126/322 (39%), Gaps = 57/322 (17%)
Query: 6 RKKNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHI 63
P++ D + IG GS+G V A D E VAIKK+ +
Sbjct: 36 GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 64 SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDL 123
I++E++ L+ LRHP+ ++ + L ++V E +++ +
Sbjct: 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHKKP 150
Query: 124 TREHY-QFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA-----RVAF 177
+E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +F
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210
Query: 178 NDTPTTIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLFPGKN 235
TP +W APE+ +Y +D+WS+G I E+ KP N
Sbjct: 211 VGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMN 257
Query: 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLER 295
+ L + +P+L Q +S+ F N ++
Sbjct: 258 AMSALYHIAQ-NESPAL---------------------QSGHWSEYFRN-------FVDS 288
Query: 296 LLAFDPKDRPTAEEALADPYFK 317
L P+DRPT+E L +
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVL 310
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 48/366 (13%), Positives = 101/366 (27%), Gaps = 75/366 (20%)
Query: 3 QDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIH 57
Q P+ EF + + ++G+G++ V A D +K +K
Sbjct: 48 QCKLPAIKPKTEF---QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 58 DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQV 116
+ + + ++ L+ ++ L +V EL L
Sbjct: 105 P--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNA 157
Query: 117 IK-----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL-----------AN 160
I + + F ++L ++ +H + H D+KP N + +
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217
Query: 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGC 219
+ L + D G + TIF T ++ E L + ID + +
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAA 273
Query: 220 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS 279
+L G + + +P
Sbjct: 274 TVYCMLFGTYMK----------------------------------VKNEGGECKPEGLF 299
Query: 280 QKFPNADPSALRLLERLLAFDPKDRPTAEEALA---DPYFKGLSKVEREPSCQPISKMEF 336
++ P+ D +L + + L F+ + + +
Sbjct: 300 RRLPHLDMWN-EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLL 358
Query: 337 EFERRR 342
E +R R
Sbjct: 359 ECKRSR 364
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 69/339 (20%), Positives = 120/339 (35%), Gaps = 55/339 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
S EV+GKG +G TGE + +K++ E L+E+K++R L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLE 65
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLR 137
HP++++ I + + + E ++ L +IK+ D F +
Sbjct: 66 HPNVLKFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT-----------PTTIFW 186
+ Y+H+ N+ HRDL N L N + + DFGLAR+ ++ P
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
V ++ APE+ Y +D++S G + E++ P
Sbjct: 180 YTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------- 230
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
D + + P PN PS + R DP+ RP+
Sbjct: 231 --------------DFGLNVRGFLDRYCP-------PNCPPSFFPITVRCCDLDPEKRPS 269
Query: 307 AEE---ALADPYFKGLSKVEREPSCQPISKMEFEFERRR 342
+ L + P + + + +E RR
Sbjct: 270 FVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 49/288 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
I+E IG GS+G V A G VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 IHTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ D++S G I E+ T + + N ++ V
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN---------------PAQVVAAVG 252
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPT 306
R + P + ++E +P RP+
Sbjct: 253 FKCKR----------L-----EIPRNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 68/339 (20%), Positives = 124/339 (36%), Gaps = 54/339 (15%)
Query: 2 QQDHRKKNSPEMEFFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
+ +K S F E+ + +I E+IGKG +G V GE VAI+ I
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIER 67
Query: 61 EHISDAARILREIKLLRLLRHPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVI- 117
++ RE+ R RH ++V + M PP + ++ L + L+ V+
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP------HLAIITSLCKGRTLYSVVR 121
Query: 118 KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
A L + ++++ + Y+H + H+DLK KN+ + N K+ I DFGL ++
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 178 NDTPTTIFWTDYVATRWYR--APEL-------CGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
+ W APE+ ++ D++++G I+ E+ +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 288
F + + I + L+
Sbjct: 241 WPFKTQP----------------AEAIIWQMGTGMKPNLSQ-------------IGMGKE 271
Query: 289 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327
+L AF+ ++RPT + + + L K R S
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLS 308
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 78/339 (23%), Positives = 135/339 (39%), Gaps = 78/339 (23%)
Query: 8 KNSPEMEFFSEYGD-ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA 66
+ S E E D ++I +G G++G V A + TG A K I + + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ET-KSEEEL 60
Query: 67 ARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME----SDLHQVIKANDD 122
+ EI++L HP IV++ ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA--------- 173
LT Q Q+L AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGKP 229
R +F TP +W APE+ K Y DIWS+G I E+ +P
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 230 LFPGKNVVHQLDLMTDLL-----GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN 284
P H+L+ M LL P+L P ++S +F +
Sbjct: 221 --P----HHELNPMRVLLKIAKSDPPTL--------------------LTPSKWSVEFRD 254
Query: 285 ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323
L+ L +P+ RP+A + L P+ ++ +
Sbjct: 255 -------FLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 63/313 (20%), Positives = 118/313 (37%), Gaps = 39/313 (12%)
Query: 1 MQQDHRKKNSPEMEFFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI 59
M++ H + + ++ + + + IG GS+G V G+ VA+K ++
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVT 57
Query: 60 FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK 118
E+ +LR RH +I+ P + +V + E S L+ +
Sbjct: 58 APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAIVTQWCEGSSLYHHLH 111
Query: 119 ANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
A++ + Q R + Y+H ++ HRDLK NI + + +KI DFGLA
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-K 170
Query: 178 NDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 236
+ + + + + APE + + Y+ D+++ G + E++TG+ + N
Sbjct: 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
Query: 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERL 296
Q+ I V L+ +R N RL+
Sbjct: 231 RDQI--------------IEMVGRGSLSPDLSKVR-----------SNCPKRMKRLMAEC 265
Query: 297 LAFDPKDRPTAEE 309
L +RP+
Sbjct: 266 LKKKRDERPSFPR 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 72/300 (24%), Positives = 118/300 (39%), Gaps = 62/300 (20%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAAR--ILREIKLLRLLRHPD 83
++E+IG G +G V A G++VA+K + + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKHI-MLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
I+ ++ + + P ++ +V E L++V+ + + + Q+ R + Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 142 IHTANVY---HRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTTIFWTDYV 190
+H + HRDLK NIL +N LKI DFGLAR T +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
W APE+ + S ++ D+WS G + E+LTG+ F G +
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRPTAEE 309
L V +K P+ P L+E DP RP+
Sbjct: 219 GLAVAYGVAMNKLA----------L-----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 71/308 (23%), Positives = 130/308 (42%), Gaps = 57/308 (18%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + I + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
V++ + +D + +Y + + ++ ++ TR F+ +++
Sbjct: 91 FFVKLYF-----TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR----FYTAEIVS 141
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+Y+H + HRDLKP+NIL N + ++I DFG A+V ++ + +V T Y +
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVS 200
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL + D+W++GCI +++ G P F N +
Sbjct: 201 PELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------------YLIFQK 243
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT------AEEAL 311
+ + F +KF P A L+E+LL D R
Sbjct: 244 IIKLE-------------YDFPEKF---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 312 ADPYFKGL 319
A P+F+ +
Sbjct: 288 AHPFFESV 295
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 40/288 (13%), Positives = 89/288 (30%), Gaps = 50/288 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVI--KANDDLTREHYQFFLYQLLRALKYI 142
+ P ++ M L+ V+ N + + F + R + ++
Sbjct: 71 PVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 143 HTAN--VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPE 199
HT + L ++++ + + +I + + W APE
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------APE 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
L + D+WS + E++T + F + +++ +V
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMKV 223
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
+ +R P P P +L++ + DP RP
Sbjct: 224 ALEG-------LRPTIP-------PGISPHVSKLMKICMNEDPAKRPK 257
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 79/324 (24%), Positives = 117/324 (36%), Gaps = 37/324 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A + ++ + IGKG YG V GEKVA+K E S EI L+R
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT-EEASWFRE--TEIYQTVLMR 89
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
H +I+ I + +Y++ + E+ L+ +K+ L + Y +
Sbjct: 90 HENILGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146
Query: 139 LKYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARVAFNDT-PTTIFWTDY 189
L ++HT HRDLK KNIL N I D GLA +DT I
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 190 VATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V T+ Y PE L S + + D++S G I EV G +QL
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDL 265
Query: 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP 305
+ PS + + + K R +L+ A +P R
Sbjct: 266 VPSDPSYEDMREIVCIKKLR--------PSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 306 TAEEALADPYFKGLSKVEREPSCQ 329
TA K L+K+ +
Sbjct: 318 TALRVK-----KTLAKMSESQDIK 336
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 76/329 (23%), Positives = 122/329 (37%), Gaps = 47/329 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A +QE IGKG +G V GE+VA+K R EI +LR
Sbjct: 40 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLR 94
Query: 81 HPDIV-----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQ 134
H +I+ + K +++V + E L + +T E
Sbjct: 95 HENILGFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALS 147
Query: 135 LLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT-TIF 185
L ++H + HRDLK KNIL N I D GLA + T T I
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 186 WTDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 241
V T+ Y APE L S K+ + DI+++G +F E+ + G + +QL
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLP 266
Query: 242 LMTDLLGTPSLDTISR-VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
+ PS++ + + V K R + + + A +++ +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCE---------ALRVMAKIMRECWYAN 317
Query: 301 PKDRPTAEEALADPYFKGLSKVEREPSCQ 329
R TA K LS++ ++ +
Sbjct: 318 GAARLTALRIK-----KTLSQLSQQEGIK 341
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 52/299 (17%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRLLR 80
Y+++ ++G+G G V A DT VA+K + + SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 81 HPDIVEIKHIMLPPSRRDFKDI----YVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 135
P +V I DF +I YV L+ DL +++ L + Q+
Sbjct: 93 EPHVVPI---------HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A D T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE S T DI+++ C+ E LTG P + G D +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALAD 313
S ++ + S P + ++ R +A +P+DR T + A
Sbjct: 241 S-----VMGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 87
IGKGS+G VC T + A+K ++ E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
+ S +D +D+++V +L+ DL ++ N E + F+ +L+ AL Y+
Sbjct: 81 WY-----SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL + + + I DF +A + +T T T+ Y APE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSSRKG 191
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+ Y+ A+D WS+G E+L G+ + +R+ + +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPY-------------------------HIRSSTSSK 226
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 319
+ + V + + + LL++LL +P R + PY +
Sbjct: 227 EIVHTFETTVVTYPSAW---SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 82/307 (26%), Positives = 123/307 (40%), Gaps = 62/307 (20%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 78
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 79 LRHPDIVEIKHIMLPPSRRDF----KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLY 133
L H +IV + D Y+V E +E L + I+++ L+ + F
Sbjct: 68 LSHQNIVSM---------IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYV-AT 192
Q+L +K+ H + HRD+KP+NIL ++N LKI DFG+A+ A ++T T T++V T
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLGT 175
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLMTDLL 247
Y +PE DI+SIG + E+L G+P F G+ V H
Sbjct: 176 VQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--------- 224
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-T 306
++ P + + S ++ R D +R T
Sbjct: 225 ----------------------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262
Query: 307 AEEALAD 313
+E D
Sbjct: 263 IQEMKDD 269
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 73/312 (23%), Positives = 116/312 (37%), Gaps = 59/312 (18%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
A +Y+++ I G G + A+D + G V +K + + A + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
HP IV+I + + R Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + T A DI+++G A + P G+ V + L S
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG------ 298
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALADPYFKG 318
RLL R + DP+ R TAEE A
Sbjct: 299 -------------------------------RLLRRAIDPDPRQRFTTAEEMSAQ----- 322
Query: 319 LSKVEREPSCQP 330
L+ V RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 64/306 (20%), Positives = 110/306 (35%), Gaps = 42/306 (13%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ E +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYIHTANVY--------HRDLKPKNILANANCKLKICDFGLARV-AFNDTPTTIFWTDYV 190
++H HRDLK KNIL N + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR-LLERLLAFDPKDRP 305
PS + + +V +R P ++ F + ++L L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 306 TAEEAL 311
TA
Sbjct: 289 TALRIK 294
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 55/306 (17%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA---ARILREIKLLRL 78
+ RY++ E++G G V A D VA+K + + D R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 79 LRHPDIVEI--------KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQ 129
L HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
+ +AL + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 190 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248
V T Y +PE D++S+GC+ EVLTG+P F G + V +
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQ----- 230
Query: 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TA 307
VR D P+ S + ++ + LA +P++R TA
Sbjct: 231 --------HVRED-------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 308 EEALAD 313
E AD
Sbjct: 270 AEMRAD 275
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 34/305 (11%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ ++ EV +G +G V A E VA+K + + E+ L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 138
H +I++ I S D++++ E L +KAN ++ + R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYIHTANVY----------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD 188
L Y+H HRD+K KN+L N I DFGLA F +
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSAL-RLLERLLAFDPKDR 304
+ PSL+ + V K +R PV +A + L +E D + R
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 305 PTAEE 309
+A
Sbjct: 304 LSAGC 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 65
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEP 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 177 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K + +GKG++G V + +TGE VA+KK+ REI++L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEIL 96
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L+H +IV+ K + RR+ + ++ E + L ++ + + + + Q
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ T HRDL +NIL ++KI DFGL +V D Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEP 207
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 208 GESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 67/320 (20%), Positives = 124/320 (38%), Gaps = 59/320 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKI--HDIFEHISDAARILREIKLLRLLRHPDIVEI 87
V+G+G +G V + TG+ A KK+ + + + E K+L + IV +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSL 250
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL----HQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ + + +V +M D+ + V + N F+ Q++ L+++
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPEL 200
H N+ +RDLKP+N+L + + ++I D GLA A Y T + APEL
Sbjct: 306 HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-----YAGTPGFMAPEL 360
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
+Y ++D +++G E++ + F + + + RV
Sbjct: 361 LLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-----------RVLE 407
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPY 315
V + KF P++ E LL DP+ R + + P
Sbjct: 408 Q-------------AVTYPDKFS---PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 316 FKGLS--KVER---EPSCQP 330
F+ +S ++E P P
Sbjct: 452 FRDISWRQLEAGMLTPPFVP 471
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 49/303 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRHPDIVEI 87
VIG+G++ V TG+ A+K ++ D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 88 KHIMLPPSRRDFKDIYVVFELMES-DL-HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ +D +Y+V E DL + K + + E +F+L +++ A+ +H
Sbjct: 127 HF-----AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA-RVAFNDTPTTIFWTDYVATRWYRAPEL---- 200
HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEILQAV 238
Query: 201 -CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
G Y P D W++G E+ G+ F + +T ++
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---------------ETYGKI- 282
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYF 316
+ K+ + A ++RLL P+ R A + P+F
Sbjct: 283 ----------VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331
Query: 317 KGL 319
GL
Sbjct: 332 FGL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-29
Identities = 70/335 (20%), Positives = 140/335 (41%), Gaps = 52/335 (15%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIKK 55
++ + + + F+ R ++ VIG+G++G V + + A+K
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 56 IH--DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-D 112
++ ++ + ++ A E +L I + + + +D ++Y+V + D
Sbjct: 107 LNKWEMLKR-AETACFREERDVLVNGDSKWITTLHY-----AFQDDNNLYLVMDYYVGGD 160
Query: 113 L-HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171
L + K D L E +F+L +++ A+ +H + HRD+KP NIL + N +++ DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 172 LA-RVAFNDTPTTIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTG 227
++ + T + V T Y +PE+ +Y P D WS+G E+L G
Sbjct: 221 SCLKLMEDGTVQS--SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 228 KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADP 287
+ F +++V +T ++ M K+ QF + +
Sbjct: 278 ETPFYAESLV---------------ETYGKI-----------MNHKERFQFPTQVTDVSE 311
Query: 288 SALRLLERLLAFDPKDR---PTAEEALADPYFKGL 319
+A L+ RL+ + R E+ P+F G+
Sbjct: 312 NAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGI 345
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 75/343 (21%), Positives = 123/343 (35%), Gaps = 63/343 (18%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-------DIFEHISDAARILREIKLLRLLRHP 82
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV + + P + + + +LM DLH + + + +F+ +++ L++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H V +RDLKP NIL + + ++I D GLA P V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
Y + D +S+GC+ ++L G F R
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPF-------------------------RQHKT 396
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYF 316
K + + M V+ F P LLE LL D R A+E P+F
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
Query: 317 KGL--SKVER---EPSCQPISKM---EFEFERRRVTKEDIREL 351
+ L V P P F+ +ED + +
Sbjct: 454 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI 496
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 75/315 (23%), Positives = 128/315 (40%), Gaps = 52/315 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + A L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 89 HIMLPPSRRDFKDIYVVFELMES-DL--HQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ + +V LM DL H F+ ++ L+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
+ +RDLKP+NIL + + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+YT + D W++GC+ E++ G+ F + + + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------------- 399
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGLS 320
+ K+ P ++S++F P A L +LL DP +R +A E P FK L+
Sbjct: 400 ----LVKEVPEEYSERFS---PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
Query: 321 --KVER---EPSCQP 330
++ EP +P
Sbjct: 453 FKRLGAGMLEPPFKP 467
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAAR--ILREIK 74
+ K +G+G +G V +TGE+VA+K + + +EI+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIE 75
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+LR L H +IV+ K I I ++ E + S L + + N + + + +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q+ + + Y+ + HRDL +N+L + ++KI DFGL + D Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVK 186
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK+ A D+WS G E+LT
Sbjct: 187 DDRDSPVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D S + IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRA 138
HP +V++ + L + I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +K+ DFG+ R +D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + ++ VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQL 135
HP++V++ + PP Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTD 188
A++Y+ N HRDL +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 180 --------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 76/341 (22%), Positives = 132/341 (38%), Gaps = 60/341 (17%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILRE--IKLLRLLRHPD 83
K+ E+IG+G YG V + VA+K ++ + E I + L+ H +
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSF-----ANRQNFINEKNIYRVPLMEHDN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I + + +V E + L + + + + + R L Y+
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYL 127
Query: 143 HTANVY---------HRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY---- 189
HT HRDL +N+L + I DFGL+ + D
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 190 -VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVV-HQLD 241
V T Y APE L G+ +D++++G I+ E+ LFPG++V +Q+
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 242 LMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNA---DPSALRLLERLL- 297
T++ P+ + + + + + +R P KFP A + A+R L+ +
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQR---------P-----KFPEAWKENSLAVRSLKETIE 293
Query: 298 ---AFDPKDRPTA---EEALADPYFKGLSKVEREPSCQPIS 332
D + R TA EE +A + + ER S P +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA----ELMMIWERNKSVSPTA 330
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ K +GKG++G V +TG VA+K++ REI++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQIL 78
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
+ L IV+ + + P R + + +V E + S L ++ + L + Q
Sbjct: 79 KALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + ++Y+ + HRDL +NIL + +KI DFGLA++ D YV
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREP 189
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE + ++ D+WS G + E+ T
Sbjct: 190 GQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 79/333 (23%), Positives = 132/333 (39%), Gaps = 58/333 (17%)
Query: 7 KKNSPEMEFFSEYGDAS------RYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIKK 55
+KN F S Y D R K ++ VIG+G++G V T + A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 56 IH--DIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SD 112
+ ++ + SD+A E ++ P +V++ + + +D + +Y+V E M D
Sbjct: 102 LSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQLFY-----AFQDDRYLYMVMEYMPGGD 155
Query: 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L ++ N D+ + +F+ +++ AL IH+ HRD+KP N+L + + LK+ DFG
Sbjct: 156 LVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 173 A-RVAFNDTPTTIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ T V T Y +PE Y D WS+G E+L G
Sbjct: 215 CMKMNKEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 289
F ++V T S++ M K + F + A
Sbjct: 272 PFYADSLV---------------GTYSKI-----------MNHKNSLTFP-DDNDISKEA 304
Query: 290 LRLLERLLAFDPKDR---PTAEEALADPYFKGL 319
L+ L D + R EE +FK
Sbjct: 305 KNLICAFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 64
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 122
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 183 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 236 ---VVHQLD 241
+ L+
Sbjct: 225 ASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRA 138
HP +V+ + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ ++ + HRDL +N L + + +K+ DFG+ R +D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 33/238 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
DA+ I +V+G G +G VCS +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
+ HP+I+ ++ ++ K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N K+ DFGL RV +D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + + V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 54/239 (22%), Positives = 94/239 (39%), Gaps = 34/239 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLL 76
++ E +G GS+GVV + VA+K + D+ +RE+ +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
L H +++ + ++L P + +V EL L ++ + + Q
Sbjct: 76 HSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEH 183
Query: 193 -----RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 184 RKVPFAWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+ASR I+++IG G G VC G+ VAIK + ++ R L E +
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASI 103
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
+ HP+I+ ++ ++ + +V E ME+ L ++ +D T L
Sbjct: 104 MGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
+ ++Y+ HRDL +N+L ++N K+ DFGL+RV +D Y T
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTG 213
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + V+ ++
Sbjct: 214 GKIPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 34/238 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLL 76
+ + +V+G G +G V + GE V IK I D S A + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAI 69
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 25/227 (11%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPD 83
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRAL 139
IV + + P IY+V EL++ D ++ L + + +
Sbjct: 174 IVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+Y+ + HRDL +N L LKI DFG++R + V +W APE
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE 285
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+ + +Y+ D+WS G + E + G +P + ++
Sbjct: 286 ---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 29/228 (12%)
Query: 28 QEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV 85
+ +G G++G V VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ I S +V E+ E L++ ++ N + ++ ++Q+ +KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRA 197
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
A++Y+ N HR+L +N L N +K+ DFGL+R+ DT T I WT
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 55/252 (21%), Positives = 97/252 (38%), Gaps = 38/252 (15%)
Query: 7 KKNSPEMEFFSEYG---DASRYKIQEVIGKGSYGVVCSAIDTHTGE-KVAIKKIHDIFEH 62
KN+P D + +G G +GVV G+ VAIK I E
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIK---EG 59
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND 121
+ E K++ L H +V++ + + I+++ E M + L ++
Sbjct: 60 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMR 114
Query: 122 D-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ + A++Y+ + HRDL +N L N +K+ DFGL+R +D
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD- 173
Query: 181 PTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+Y ++ RW PE +SK++ DIW+ G + E+ + GK +
Sbjct: 174 -------EYTSSVGSKFPVRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223
Query: 233 GKN---VVHQLD 241
+
Sbjct: 224 RFTNSETAEHIA 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 63/240 (26%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARI--LREIK 74
S Q+VIG G +G V + + K VAIK + ++ R+ L E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAG 98
Query: 75 LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
++ H +I+ ++ ++ +K + ++ E ME+ L + ++ D + L
Sbjct: 99 IMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D Y +
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTS 208
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
RW APE + + K+T A D+WS G + EV+T G+ + + V+ ++
Sbjct: 209 GGKIPIRWT-APE---AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 237
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 348
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 349 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 30/215 (13%)
Query: 26 KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLL 79
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE K+ A D+WS G E+LT
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 36/249 (14%)
Query: 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHIS 64
N + E + +K +V+G G++G V + GEK VAIK++ +
Sbjct: 5 NQALLRILKE----TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-K 59
Query: 65 DAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD- 122
IL E ++ + +P + + I L + + ++ +LM L ++ + D
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDN 113
Query: 123 LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182
+ ++ + Q+ + + Y+ + HRDL +N+L +KI DFGLA++ +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 183 TIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235
Y A +W A E YT D+WS G E++T G + G
Sbjct: 174 ------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 236 ---VVHQLD 241
+ L+
Sbjct: 225 ASEISSILE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 72/312 (23%), Positives = 126/312 (40%), Gaps = 71/312 (22%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
++I +G GS+G V H G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
I+ + + +D + I+++ + +E S L + + + + + F+ ++
Sbjct: 67 FIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAEVCL 117
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT-----DYVAT 192
AL+Y+H+ ++ +RDLKP+NIL + N +KI DFG A+ + T +T DY+
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI-- 170
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
APE+ + Y +ID WS G + E+L G F N + +L
Sbjct: 171 ----APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKIL----- 216
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTA 307
++F F + LL RL+ D R
Sbjct: 217 --------------------NAELRFPPFF---NEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 308 EEALADPYFKGL 319
E+ P+FK +
Sbjct: 254 EDVKNHPWFKEV 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 27 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + + VAIK + E ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYI 72
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 195
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLR 320
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M L +K L Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T I WT
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 431
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + E+ T G+ +PG + V+ Q++
Sbjct: 432 ------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + A L E ++ LR
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK---NDATAQA-FLAEASVMTQLR 244
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 63/287 (21%), Positives = 116/287 (40%), Gaps = 56/287 (19%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHP 82
+ + +G GS+G V +G A+K + + L E ++L+ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-KQIEHTLNEKRILQAVNFP 101
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-----SDLHQVIKANDDLTREHYQFFLYQLLR 137
+V+++ S +D ++Y+V E + S L ++ + ++ R F+ Q++
Sbjct: 102 FLVKLEF-----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR----FYAAQIVL 152
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T WT T A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WT-LCGTPEALA 206
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y A+D W++G + E+ G P F + +
Sbjct: 207 PEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------------IQIYEK 249
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304
+ + K V+F F LL LL D R
Sbjct: 250 IVSGK-------------VRFPSHF---SSDLKDLLRNLLQVDLTKR 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+ E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLL 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT---- 192
+ +I N HRDL+ NIL + KI DFGLAR+ ++ +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 77
D + + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + + DFGL++ I+ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
+W A E S YT D+W+ G E+ T G +PG +
Sbjct: 204 RQGRIAKMPVKWI-AIE---SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 238 HQLD 241
L
Sbjct: 260 DYLL 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 77/307 (25%), Positives = 126/307 (41%), Gaps = 64/307 (20%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+GKG YG V +TG+ A+K K I + D A E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 85 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
V++ + + +Y++ EL + ++ + F+L ++ A
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D T + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E L S + A+D WS+G + ++LTG P F G+N
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGEN---------------------- 225
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALA 312
R+ K + A LL++LL + R P A E A
Sbjct: 226 ------RKKTIDKILKCKLNLPPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 313 DPYFKGL 319
P+F+ +
Sbjct: 277 HPFFRHI 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 35/235 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+++ +G G +G V A KVA+K + L E +++ L+
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQ 241
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLR 137
H +V++ ++ + IY++ E M L +K+++ F Q+
Sbjct: 242 HDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-------IFWTDYV 190
+ +I N HRDL+ NIL +A+ KI DFGLARV ++ T I WT
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT--- 352
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQLD 241
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 ------APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILREIKLLR 77
+ EVIG+G +G V K A+K ++ I + I + ++ L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQL 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT--- 192
+ +K++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + E++T G P +P N + L
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 44/258 (17%)
Query: 9 NSPEMEFFSEY---GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEH 62
+S + + + VIGKG +GVV + + AIK + I E
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE- 62
Query: 63 ISDAARILREIKLLRLLRHPDIVEIKHIML---PPSRRDFKDIYVVFELMES-DLHQVIK 118
+ LRE L+R L HP+++ + IML +V+ M DL Q I+
Sbjct: 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIR 115
Query: 119 AND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
+ + T + F Q+ R ++Y+ HRDL +N + + + +K+ DFGLAR
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-- 173
Query: 178 NDTPTTIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
I +Y + +W A E ++T D+WS G + E+LT
Sbjct: 174 ------ILDREYYSVQQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 227 GKPLFPGKN---VVHQLD 241
G P + + + H L
Sbjct: 225 GAPPYRHIDPFDLTHFLA 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 27 IQEVIGKGSYGVVCSAIDTHTGE--KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
+G G++G V + + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFLYQLLRALKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWY 195
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARI--LREIKL 75
R ++ IG+G +G V I VAIK SD+ R L+E
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALT 444
Query: 76 LRLLRHPDIVEIKHIML-PPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 445 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 133 YQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
YQL AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + Y
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 549
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 550 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/244 (22%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMES-DLHQVIKAN------DDLTREHYQ 129
HP + ++ + L ++ V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189
F+ + ++Y+ + N HRDL +N + + + + DFGL+R I+ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
+ +W A E + YT D+W+ G E++T G+ + G +
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 238 HQLD 241
+ L
Sbjct: 250 NYLI 253
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K + I + A + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN 146
K+ R + V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 147 VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE-LCGSFF 205
V +RD+K +N++ + + +KI DFGL + +D T + T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--- 179
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+ Y A+D W +G + E++ G+ F ++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------------------HE 211
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFKGL 319
L + + ++F + P A LL LL DPK R A+E + +F +
Sbjct: 212 RLFELILMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 36/291 (12%), Positives = 66/291 (22%), Gaps = 65/291 (22%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLR 80
RY++ G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRAL 139
P + + ++ VV E + L +V + + + L A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
P DI IG +L + P V L
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ--------- 221
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
P++ + + + R + D R +
Sbjct: 222 ---------------PIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 64/297 (21%), Positives = 114/297 (38%), Gaps = 51/297 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRL-LRHPDIVE 86
++GKGS+G V A T + AIK K + D + E ++L L HP +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTH 82
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ ++ V E + DL I++ F+ +++ L+++H+
Sbjct: 83 MFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ +RDLK NIL + + +KI DFG+ + + + T + T Y APE+
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-----FCGTPDYIAPEILLG 192
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
KY ++D WS G + E+L G+ F G++
Sbjct: 193 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---------------------------- 222
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-PTAEEALADPYFKGL 319
L + + + A LL +L +P+ R + P F+ +
Sbjct: 223 EEELFHSIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 40/244 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 73
E +G+G++ + + G+ +V +K + H + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAA 63
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD-LTREHYQFF 131
++ L H +V + + + +V E ++ L +K N + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL--------ANANCKLKICDFGLARVAFNDTPTT 183
QL A+ ++ + H ++ KNIL +K+ D G++
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---- 174
Query: 184 IFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN---VV 237
D W PE C A D WS G E+ + G + +
Sbjct: 175 ----DILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 238 HQLD 241
+
Sbjct: 229 QFYE 232
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 66/307 (21%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDI 84
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 85 VEIKHIMLPPSRRDFKDIYVVF------ELMESDLHQVIKANDDLTREHYQFFLYQLLRA 138
V++ + + +Y++ +L + L + + ++ + F+L +L A
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAELALA 138
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L ++H+ + +RDLKP+NIL + +K+ DFGL++ + + + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + +T + D WS G + E+LTG F GK+
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD---------------------- 230
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALA 312
R+ +M K + Q P A LL L +P +R EE
Sbjct: 231 ------RKETMTMILKAKLGMPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281
Query: 313 DPYFKGL 319
+F +
Sbjct: 282 HSFFSTI 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 51/299 (17%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K K I + A L E ++L+ RHP + +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTAL 213
Query: 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA- 145
K+ R + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 214 KYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + + +KI DFGL + D T + T Y APE+
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 323
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARR 265
+ Y A+D W +G + E++ G+ F ++
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----------------------------HE 355
Query: 266 YLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYFKGL 319
L + + ++F + P A LL LL DPK R A+E + +F G+
Sbjct: 356 KLFELILMEEIRFPRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 70/318 (22%), Positives = 124/318 (38%), Gaps = 54/318 (16%)
Query: 20 GDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILRE 72
G +Q+ VIG+GSY V T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 73 IK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQF 130
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTD 188
+ ++ AL Y+H + +RDLK N+L ++ +K+ D+G+ + + DT +T
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST----- 169
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
+ T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 170 FCGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------ 220
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR--- 304
YL + ++ ++ + A +L+ L DPK+R
Sbjct: 221 -------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGC 264
Query: 305 ---PTAEEALADPYFKGL 319
+ P+F+ +
Sbjct: 265 HPQTGFADIQGHPFFRNV 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 64/335 (19%), Positives = 123/335 (36%), Gaps = 62/335 (18%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK-- 54
+ +K + + F G+ R K+ + V+GKGS+G V + T E A+K
Sbjct: 315 TKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL 374
Query: 55 KIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-D 112
K + + D + E + L + P + ++ R +Y V E + D
Sbjct: 375 KKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGD 428
Query: 113 LHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L I+ H F+ ++ L ++ + + +RDLK N++ ++ +KI DFG+
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 173 AR--VAFNDTPTTIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ + T T + T Y APE + Y ++D W+ G + E+L G+
Sbjct: 489 CKENIWDGVTTKT-----FCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 289
F G++ L + V + + A
Sbjct: 541 PFEGED----------------------------EDELFQSIMEHNVAYPKSMS---KEA 569
Query: 290 LRLLERLLAFDPKDR-----PTAEEALADPYFKGL 319
+ + + L+ P R + +F+ +
Sbjct: 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 63/305 (20%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
V+GKGS+G V + T E A+K K + + D + E + L + P + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQ 85
Query: 87 IKHIMLPPSRRDFKDIYVVFE------LMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
+ R +Y V E LM H I+ H F+ ++ L
Sbjct: 86 LHSCFQTMDR-----LYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE- 199
++ + + +RDLK N++ ++ +KI DFG+ + D TT + T Y APE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEI 192
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ Y ++D W+ G + E+L G+ F G++
Sbjct: 193 IAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGED------------------------ 225
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADP 314
L + V + + A+ + + L+ P R P +
Sbjct: 226 ----EDELFQSIMEHNVAYPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278
Query: 315 YFKGL 319
+F+ +
Sbjct: 279 FFRYI 283
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 67/303 (22%), Positives = 120/303 (39%), Gaps = 49/303 (16%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
VIG+GSY V T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ SR ++ V E + DL ++ L EH +F+ ++ AL Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPE-LCG 202
+ +RDLK N+L ++ +K+ D+G+ + + DT +T + T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-----FCGTPNYIAPEILRG 227
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y ++D W++G + E++ G+ F D
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------------------QN 265
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADPYF 316
YL + ++ ++ + A +L+ L DPK+R + P+F
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
Query: 317 KGL 319
+ +
Sbjct: 323 RNV 325
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 64/302 (21%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 30 VIGKGSYG---VVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLRH-PD 83
V+G G+YG +V TG+ A+K + I + E ++L +R P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+V + + ++ ++++ + + +L + + T Q ++ +++ AL+++
Sbjct: 121 LVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPDIVR 233
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
S + A+D WS+G + E+LTG F
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG------------------------EKN 269
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR----PT-AEEALADPYFK 317
++ ++ K + Q+ A L++RLL DPK R P A+E +F+
Sbjct: 270 SQAEISRRILKSEPPYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326
Query: 318 GL 319
+
Sbjct: 327 KI 328
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 70/304 (23%), Positives = 113/304 (37%), Gaps = 60/304 (19%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIK--KIHDIFEHISDAARILREIK-LLRLLRHPDIVE 86
V+GKGS+G V A TG+ A+K K I + D + E + L HP + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQ 88
Query: 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA 145
+ P R ++ V E + DL I+ + +F+ +++ AL ++H
Sbjct: 89 LFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 146 NVYHRDLKPKNILANANCKLKICDFGLA--RVAFNDTPTTIFWT-DYVATRWYRAPE-LC 201
+ +RDLK N+L + K+ DFG+ + T T T DY+ APE L
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI------APEILQ 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
Y PA+D W++G + E+L G F +N
Sbjct: 198 E---MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------------------------- 228
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR------PTAEEALADPY 315
L V + A +L+ + +P R L P+
Sbjct: 229 --EDDLFEAILNDEVVYPTWLH---EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283
Query: 316 FKGL 319
FK +
Sbjct: 284 FKEI 287
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 78/339 (23%), Positives = 125/339 (36%), Gaps = 69/339 (20%)
Query: 1 MQQDHRKKNSPEMEFFSEYGDASRYKIQE-----VIGKGSYGVVCSAIDTHTGEKVAIK- 54
M + +P + K + VIGKGS+G V A A+K
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 55 -KIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVF------ 106
+ I + + I+ E LL+ ++HP +V + + +Y V
Sbjct: 71 LQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-----LYFVLDYINGG 124
Query: 107 ELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLK 166
EL H ++ +F+ ++ AL Y+H+ N+ +RDLKP+NIL ++ +
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179
Query: 167 ICDFGLAR--VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+ DFGL + + N T +T + T Y APE+ Y +D W +G + E+
Sbjct: 180 LTDFGLCKENIEHNSTTST-----FCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEM 232
Query: 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN 284
L G P F +N M D +P+Q
Sbjct: 233 LYGLPPFYSRNT----AEMYD------------------------NILNKPLQLKPNIT- 263
Query: 285 ADPSALRLLERLLAFDPKDR----PTAEEALADPYFKGL 319
SA LLE LL D R E + +F +
Sbjct: 264 --NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 55/256 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
++ +G+G++G V A VA+K + + S++AR RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 122
+LL +L+H IV + + + + +VFE M DL++ ++++
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 123 -----LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
L Q+ + Y+ + HRDL +N L +KI DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 NDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKN---VVHQLD 241
+ + + +
Sbjct: 259 QPWYQLSNTEAIDCIT 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 61/271 (22%)
Query: 7 KKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFE 61
++ +G+G++G V A T VA+K + D
Sbjct: 4 HSGIHVQHI-----KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-- 56
Query: 62 HISDAARI--LREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIK 118
+ AAR RE +LL L+H IV+ + D + +VFE M+ DL++ ++
Sbjct: 57 --TLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLR 109
Query: 119 AN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN 162
A+ +L Q+ + Y+ + + HRDL +N L AN
Sbjct: 110 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 169
Query: 163 CKLKICDFGLARVAFNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDI 214
+KI DFG++R ++ TDY RW PE + K+T D+
Sbjct: 170 LLVKIGDFGMSRD--------VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 218
Query: 215 WSIGCIFAEVLT-GKPLFPGKN---VVHQLD 241
WS G I E+ T GK + + V+ +
Sbjct: 219 WSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 51/238 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
S + E +G+ +G V + VAIK + + R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------ 120
L L+HP++V + ++ + + ++F DLH+ +
Sbjct: 64 MLRARLQHPNVVCLLGVVT-----KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 121 ----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
L + + Q+ ++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FNDTPTTIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
++ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 89.6 bits (221), Expect = 1e-19
Identities = 51/349 (14%), Positives = 89/349 (25%), Gaps = 75/349 (21%)
Query: 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH------DIFEHISDAARI 69
FS + + E IG+G +G V I HT VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 70 LREIKLLRLL---------RHPDIVEIKHIML-------------------------PPS 95
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKP 154
+++V E + + + L+QL +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK-------ARRYL 267
+F +V + LF G +Q D + L+ + + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 TSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
+ + +L F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 51/242 (21%), Positives = 93/242 (38%), Gaps = 56/242 (23%)
Query: 26 KIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKLLRL 78
+ +G+GS+G+V + + +VAIK ++ E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN----------DDLTREH 127
+V + ++ + V+ ELM DL +++ +
Sbjct: 85 FNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
++ + Y++ HRDL +N + + +KI DFG+ R I+ T
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------IYET 191
Query: 188 DYVATRWYR------------APELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
DY YR +PE S +T D+WS G + E+ T + + G
Sbjct: 192 DY-----YRKGGKGLLPVRWMSPE---SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 234 KN 235
+
Sbjct: 244 LS 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 63/260 (24%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDI 59
H KN+P+ + D + K Q+VIG+G++G V A G + AIK++
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-- 61
Query: 60 FEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME 110
E+ S E+++L +L HP+I+ +L +Y+ E
Sbjct: 62 -EYASKDDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAP 109
Query: 111 S-DLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153
+L ++ + L+ + F + R + Y+ HRDL
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFS 206
+NIL N KI DFGL+R + YV RW A E +S
Sbjct: 170 ARNILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYS 216
Query: 207 KYTPAIDIWSIGCIFAEVLT 226
YT D+WS G + E+++
Sbjct: 217 VYTTNSDVWSYGVLLWEIVS 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 132
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 182
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KN---VVHQLD 241
K+ V+ +
Sbjct: 249 KSNQEVLEFVT 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 32/168 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + A L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 131
I ++ + K +V EL+ L +DL + F
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSL-------EDLFDLCDRTFSLKTVLMI 110
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL-----ANANCKLKICDFGLAR 174
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 111 AIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 50/251 (19%), Positives = 88/251 (35%), Gaps = 49/251 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREI 73
+ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFL 132
++ H +IV + L +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQLL-------RALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAFNDTPT 182
LL +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
I+ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KN---VVHQLD 241
K+ V+ +
Sbjct: 290 KSNQEVLEFVT 300
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 23 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 75
R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 178 NDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 229 PLFPGKNVVHQL 240
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+RY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRA 138
I I+ + +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 139 LKYIHTANVYHRDLKPKNIL----ANANCKLKICDFGLAR 174
++YIH+ N HRD+KP N L N + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 33/168 (19%), Positives = 66/168 (39%), Gaps = 21/168 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ + + IG G +G++ A T+ EK A + E+ + + E+K + + D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAKKD 94
Query: 84 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 129
++ Y +V E + DL ++ N +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 130 FFLYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
++L L+YIH H D+K N+L N + ++ + D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 73/251 (29%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + IG+G++G V A + + VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKHIML--PPSRRDFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
L+ Q+ + Y+ HRDL +N L N +KI
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFNDTPTTIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R I+ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT 226
+ G + E+ +
Sbjct: 261 AYGVVLWEIFS 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE A L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFL------- 132
I + + ++ +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQLLRALKYIHTANVYHRDLKPKNIL------ANANCKLKICDFGLAR 174
Q+L ++ IH ++ +RD+KP N L NAN + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 61/255 (23%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + + +G G++G V A G+ KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME---------------SDL 113
+ L +H +IV +L P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 114 HQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173
AN + F Q+ + + ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 174 RVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 227 -GKPLFPGKNVVHQL 240
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 79/270 (29%)
Query: 23 SRYKIQEVIGKGSYGVVCSA----IDTHTGE-KVAIKKIHDIFEHISDAARI--LREIKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN-------- 120
L+ + HP +++ + P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 121 ----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164
LT F +Q+ + ++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 165 LKICDFGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 215
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 216 SIGCIFAEVLT--GKPLFPG---KNVVHQL 240
S G + E++T G P +PG + + + L
Sbjct: 237 SFGVLLWEIVTLGGNP-YPGIPPERLFNLL 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 81/295 (27%)
Query: 1 MQQDHRKKNSPEMEFFSEYG---------DASRYKIQEVIGKGSYGVVCSA----IDTHT 47
H P + SEY + + + +G+G++G V A ID
Sbjct: 4 SHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63
Query: 48 GE---KVAIKKIHDIFEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPS 95
+ VA+K + + ++ + E++++ + +H +I+ +L P
Sbjct: 64 PKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIIN----LLGACTQDGP- 115
Query: 96 RRDFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHYQFFLYQLLRA 138
+YV+ E +L + ++A + +T + YQL R
Sbjct: 116 ------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVAT----- 192
++Y+ + HRDL +N+L N +KI DFGLAR I D Y T
Sbjct: 170 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRL 221
Query: 193 --RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKNVVHQL 240
+W APE + F YT D+WS G + E+ T G P P + + L
Sbjct: 222 PVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/294 (22%), Positives = 116/294 (39%), Gaps = 81/294 (27%)
Query: 2 QQDHRKKNSPEMEFFSEYG---------DASRYKIQEVIGKGSYGVVCSA----IDTHTG 48
+ ++P + SEY + + + +G+G +G V A ID
Sbjct: 51 TRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKP 110
Query: 49 E---KVAIKKIHDIFEHISDAARI--LREIKLL-RLLRHPDIVEIKHIML------PPSR 96
+ VA+K + + ++ + E++++ + +H +I+ +L P
Sbjct: 111 KEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKHKNIIN----LLGACTQDGP-- 161
Query: 97 RDFKDIYVVFELMES-DLHQVIKAN----------------DDLTREHYQFFLYQLLRAL 139
+YV+ E +L + ++A + +T + YQL R +
Sbjct: 162 -----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 140 KYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVAT------ 192
+Y+ + HRDL +N+L N +KI DFGLAR I D Y T
Sbjct: 217 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--------INNIDYYKKTTNGRLP 268
Query: 193 -RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KNVVHQL 240
+W APE + F YT D+WS G + E+ T G +PG + + L
Sbjct: 269 VKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 64/260 (24%), Positives = 94/260 (36%), Gaps = 67/260 (25%)
Query: 23 SRYKIQEVIGKGSYGVV--CSAIDTHTGE---KVAIKKIHDIFEHISDAARI--LREIKL 75
+R + +G G++G V +A + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN------- 120
L L H +IV +L P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 121 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
L E F YQ+ + + ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 170 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 222 AEVLT-GKPLFPGKNVVHQL 240
E+ + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 23 SRYKIQEVIGKGSYGVV--CSAIDTHTGE-----KVAIKKIHDIFEHISDAARI--LREI 73
R + + +G+G++G V AI + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 74 KLL-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 121 -----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 170 FGLARVAFNDTPTTIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 220
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 221 FAEVLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 30/166 (18%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL-REIKLLRLLR 80
+++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFF-------- 131
I ++ + +V +L+ L +DL +
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSL-------EDLFNFCSRKLSLKTVLML 108
Query: 132 LYQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
Q++ ++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 74/266 (27%)
Query: 23 SRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARI--LREIKL 75
+ +V+G G++G V +A T +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 76 L-RLLRHPDIVEIKHIML------PPSRRDFKDIYVVFELME------------------ 110
+ +L H +IV +L P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 111 ------SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164
+ + + LT E F YQ+ + ++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 165 LKICDFGLAR-VAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 215
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 216 SIGCIFAEVLT-GKPLFPGKNVVHQL 240
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 35/175 (20%), Positives = 67/175 (38%), Gaps = 32/175 (18%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+K+ IG+G +G + A D ++ E V + SD + E+K + P+
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 84 IVEIKHIMLPPSRRDFKDIY--------------VVFELMESDLHQVIKANDDLTREHYQ 129
++ + ++ + SDL ++ +AN +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------KR 148
Query: 130 FFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
F ++L L+YIH H D+K N+L N + ++ + D+GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 58/240 (24%), Positives = 89/240 (37%), Gaps = 86/240 (35%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKI-------HDIFEHISDAARILREIKLLRLLRHP 82
+IG G +G V + G KVA+K+ + F EI+ L RHP
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCRHP 95
Query: 83 DIV-------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+V E ++L +++ ME N +L + H LY
Sbjct: 96 HLVSLIGFCDERNEMIL------------IYKYME---------NGNL-KRH----LYGS 129
Query: 136 L-------------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176
R L Y+HT + HRD+K NIL + N KI DFG+++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 177 FNDTPTTIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKP 229
T +++T Y PE +F + T D++S G + EVL +
Sbjct: 190 TELDQT------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.6 bits (177), Expect = 2e-13
Identities = 94/640 (14%), Positives = 180/640 (28%), Gaps = 190/640 (29%)
Query: 43 IDTHTGE-KVAIKKIHDIFE----------HISDAAR-ILREIKLLRLLRHPDIVEIKHI 90
+D TGE + K I +FE + D + IL + EI HI
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHI 54
Query: 91 MLPPSRRDFKDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQL--------LRALKY 141
++ +F + S ++++ +++ R +Y+F + + + Y
Sbjct: 55 IMSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112
Query: 142 IHTANVYHRD-----------LKPKNILANANCKLK----ICDFG--------LARVAFN 178
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 179 DTPTT------IFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEV 224
IFW + + +PE L +T D S +
Sbjct: 173 SYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 225 LTGKP--LFPGKNVVHQLDLMTDLLGTPSLDTI---SRV----RNDKARRYLTSMRKKQP 275
+ + L K + L ++ ++ + + ++ R + +L++
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 276 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA-DPYFKGLSKVEREPSCQPISKM 334
LL + L P+D P E L +P + I++
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSI-----------IAES 336
Query: 335 EFEFERRRVTKEDIRELIFREILEYHPQLLKDYMNGTERT--NFLYPSAVDQFRKQFAHL 392
IR+ + + + D + + N L P ++RK F L
Sbjct: 337 -------------IRDGLAT--WDNWKHVNCDKLTTIIESSLNVLEP---AEYRKMFDRL 378
Query: 393 EENVGKSGPVIPPERKHVSLPRSTIV----HSNTVPPKEQQNLSRDRQAAEEVFNKNSKE 448
+ P +P + N E K KE
Sbjct: 379 ---------SVFPP--SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE----KQPKE 423
Query: 449 SE-GIP-------------ANLSRTLPAQQRFPLAKPGKVVGPVV--------------- 479
S IP L R++ P + P
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 480 --PYENASVRRDAY-DPRTF----IRSTVLPQAIPAAYC--------YRKSSTGKQEMDS 524
E ++ R + D R F IR + Y+ +
Sbjct: 484 IEHPERMTLFRMVFLDFR-FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC-DNDPKY 541
Query: 525 EREMPSQVKHVPQCG---MAAKFATDI---AINMDSNPFF 558
ER + + + +P+ + +K+ TD+ A+ + F
Sbjct: 542 ERLVNAILDFLPKIEENLICSKY-TDLLRIALMAEDEAIF 580
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 25/180 (13%), Positives = 60/180 (33%), Gaps = 42/180 (23%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTG--------EKVAIKKIHDIFEHISDAARILREIKL 75
++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQNF 95
Query: 76 L-RLLRHPDIVEIKHIMLPPS----------RRDFKDIYVVFELMESDLHQVIKANDDLT 124
R + + + K + P K ++V + L + +
Sbjct: 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 125 REHYQFFL-------YQLLRALKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLAR 174
+LL AL+++H H ++ +NI + + ++ + +G A
Sbjct: 156 -----LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS-QVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFNDTPTTIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKNVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 73/234 (31%)
Query: 30 VIGKGSYGVV-CSAIDTHTGEKVAIKKIHDIFEHISDAARI--LREIKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL--- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 137 ---------------RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181
+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 182 TTIFWTDYVATRW-----YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + +R Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 T------VMTSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 51/223 (22%)
Query: 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIV---- 85
++G+G +G V G VA+K++ + + E++++ + H +++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 94
Query: 86 ---EIKHIMLPPSRRDFKDIYVVFELM-----ESDLHQVIKANDDL---TREHYQFFLYQ 134
+L V+ M S L + ++ L R +
Sbjct: 95 FCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKR-------QR 135
Query: 135 LL----RALKYIH---TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
+ R L Y+H + HRD+K NIL + + + DFGLA++ + T + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-T 193
Query: 188 DYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 194 AVRGTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 619 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.0 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.73 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-67 Score=565.97 Aligned_cols=341 Identities=49% Similarity=0.877 Sum_probs=299.5
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC-CCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP-SRR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~-s~~ 97 (619)
+...++|++++.||+|+||+||+|+++.+|+.||||++++........+++++|+.+|+.|+|||||++++++... .+.
T Consensus 50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 4456799999999999999999999999999999999987766777788899999999999999999999998654 334
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+...+|||||||+|+|.+++..++.+++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCC-CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDT-PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~-~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ......++++||++|||||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|....|.|..+.+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 322 122234678999999999998763 568999999999999999999999999999999999999999999999988
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhh
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEF 336 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~ 336 (619)
.+.......++..+....+..+...+++++++++|||.+||.+||++|||++|+|+||||+.+..+..+|.+.+ .+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~ 366 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDF 366 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCC
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCC
Confidence 88888888888888888888888889999999999999999999999999999999999999988877776654 3456
Q ss_pred hHhhhcCCHHHHHHHHHHHHHHhCch
Q 007064 337 EFERRRVTKEDIRELIFREILEYHPQ 362 (619)
Q Consensus 337 ~~e~~~~~~e~~~~~~~~ei~~~~~~ 362 (619)
.++...++.+++++++++|+.+||..
T Consensus 367 ~~~~~~~~~~~~k~~i~~ei~~~~~~ 392 (398)
T 4b99_A 367 AFDREALTRERIKEAIVAEIEDFHAR 392 (398)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcCHHHHHHHHHHHHHHHHHH
Confidence 67778889999999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-60 Score=503.09 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=222.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++++++ .+.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 569999999999999999999999999999999964322 2345688999999999999999999999 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|||||||+ |+|.+++.. +.+++++++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999 599999876 4699999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.+..
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------- 286 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 286 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------------
Confidence 2356799999999999987 689999999999999999999999999988877766654311
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
......+..+|+++++||.+||..||++|||++|+|+||||++..
T Consensus 287 --------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 --------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 011123456899999999999999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=504.81 Aligned_cols=260 Identities=25% Similarity=0.447 Sum_probs=221.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
|...++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|+.|+|||||++++++ .+
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~ 94 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EE 94 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EE
Confidence 3456899999999999999999999999999999999987656667778899999999999999999999999 45
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+.+|||||||+ |+|.++|... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 174 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEccccccee
Confidence 567999999999 6999999754 3579999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... ....+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...
T Consensus 175 ~~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 240 (350)
T 4b9d_A 175 LNST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--------- 240 (350)
T ss_dssp CCHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------
T ss_pred ecCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------
Confidence 5321 112355789999999999987 68999999999999999999999999999887776665331
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.+...+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 241 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 ---------------------SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 011234568999999999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-60 Score=484.92 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=207.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||+||+|+++.+|+.||||++++.... .....++.+|+.+|+.|+|||||++++++ .+.
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 457899999999999999999999999999999999754322 23356789999999999999999999999 455
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+.+|||||||+|+|.+++.+++.+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCccccccccCCccccCcccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~-y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. ..++.+||+.|+|||++.+ .. ++.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 166 ~----~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------ 227 (275)
T 3hyh_A 166 N----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------ 227 (275)
T ss_dssp -------------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred C----ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------
Confidence 2 2345789999999999987 45 468999999999999999999999988766555544320
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. .....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 228 ----------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 ----------------VY---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----------------CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----------------CC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 01 112457899999999999999999999999999999973
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-60 Score=495.78 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=225.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||++++++ ++.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 3467999999999999999999999999999999997432 1223356789999999999999999999999 556
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+.+|||||||+ |+|.++|.+.+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 78999999999 59999999988999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....+.+||+.|||||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|...
T Consensus 185 ~~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------ 249 (311)
T 4aw0_A 185 ESK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL------------ 249 (311)
T ss_dssp TTT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred CCC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 322 223456799999999999987 68999999999999999999999999998877766665321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e------lL~hp~f~~~ 319 (619)
... ....+|+++++||.+||..||++|||++| +++||||+++
T Consensus 250 ----------------~~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 250 ----------------EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp ----------------CCC---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ----------------CCC---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 011 12357899999999999999999999987 6899999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=511.50 Aligned_cols=348 Identities=40% Similarity=0.736 Sum_probs=288.6
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
...+...++|++++.||+|+||+||+|+++.+++.||||++..........+++.+|+.+|+.|+||||+++++++....
T Consensus 46 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 46 HSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CSSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 34566779999999999999999999999999999999999877777778889999999999999999999999997766
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.++...+|+||||++++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 56678899999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCC------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-----
Q 007064 176 AFNDTPT------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT----- 226 (619)
Q Consensus 176 ~~~~~~~------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt----- 226 (619)
....... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 5422211 1134667899999999986432 579999999999999999999
Q ss_pred ------CCCCCCCCC--------------------hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccC
Q 007064 227 ------GKPLFPGKN--------------------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ 280 (619)
Q Consensus 227 ------G~~pF~~~~--------------------~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~ 280 (619)
|+++|++.+ ..+++..|.+.+|.|..+.+..+.......++..+.......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 889998876 368999999999999999999999999999999888888888889
Q ss_pred CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhC
Q 007064 281 KFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYH 360 (619)
Q Consensus 281 ~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 360 (619)
.++.+++++.+||++||.+||++|||++|+|+||||+++.....++.........|+ +...++.+++++.+++|+..|+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~ 443 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYH 443 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTC
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999999999998776665544322222222 2356789999999999999999
Q ss_pred chhHH
Q 007064 361 PQLLK 365 (619)
Q Consensus 361 ~~~~~ 365 (619)
|+...
T Consensus 444 ~~~~~ 448 (458)
T 3rp9_A 444 PEIQL 448 (458)
T ss_dssp TTCCC
T ss_pred ccccC
Confidence 87533
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=501.72 Aligned_cols=347 Identities=37% Similarity=0.699 Sum_probs=298.2
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
+..+...++|++++.||+|+||.||+|.++.+++.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 19 IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp GGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 55677889999999999999999999999999999999999877777778889999999999999999999999997765
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
......+|||||||+++|.+++.....+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 55567899999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCc-------------------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh----------
Q 007064 176 AFNDTPTT-------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT---------- 226 (619)
Q Consensus 176 ~~~~~~~~-------------------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt---------- 226 (619)
........ ...+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccc
Confidence 54332110 124678999999999986442 679999999999999999998
Q ss_pred -CCCCCCCCC-----------------hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHH
Q 007064 227 -GKPLFPGKN-----------------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPS 288 (619)
Q Consensus 227 -G~~pF~~~~-----------------~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~ 288 (619)
|.++|++.+ ..+++..|.+.+|.|..+.+..+.......++.......+..+...++.+++.
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 677787765 47899999999999999999999999999999988888888888889999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCchhH
Q 007064 289 ALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLL 364 (619)
Q Consensus 289 l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~ 364 (619)
+.+||++||.+||++|||++|+|+||||+++.....++.+.......|+ +...++.+++++.+++|+..|+|+..
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999998877666544322222222 22568899999999999999999754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=504.98 Aligned_cols=257 Identities=29% Similarity=0.498 Sum_probs=223.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.+.|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|. +.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCE
Confidence 357999999999999999999999999999999997532 233456889999999999999999999994 4567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||+ |+|.++++.. .+++.+++.|++||+.||.|||++||+||||||+||||+.+|.|||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 5999999764 69999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. ..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------- 363 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------- 363 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 2356799999999999987 689999999999999999999999999988877766653311
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
......+..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus 364 ---------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 364 ---------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 11123346789999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=479.64 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=219.2
Q ss_pred CCCCe-EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY-~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++| ++.+.||+|+||+||+|.++.++..||||++..........+++.+|+.+|+.|+|||||++++++.... ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence 34565 7888999999999999999999999999999866566677788999999999999999999999985432 234
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECC-CCcEEEeecCcccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANA-NCKLKICDFGLARV 175 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~-~~~vKL~DFGla~~ 175 (619)
..+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 56899999999 699999999889999999999999999999999999 999999999999985 78999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... ..+..+||+.|||||++.+ .|+.++|||||||+||||++|++||.+.+....+......
T Consensus 182 ~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~--------- 244 (290)
T 3fpq_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred CCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc---------
Confidence 4322 2356799999999999864 6999999999999999999999999876654443222110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
...+ .......++++.+||.+||..||++|||++|+|+||||++
T Consensus 245 ----------------~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 ----------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0001 1112346789999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=489.17 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=216.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.+.++|++++.||+|+||+||+|++. .+++.||||++++.........++.+|+.+|+.|+|||||++++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~----- 95 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF----- 95 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----
Confidence 35678999999999999999999884 4788999999975433333344678899999999999999999999
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+.+.+|||||||+ |+|.++|...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 44567999999999 69999999988999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...... .....+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 176 ~~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 241 (304)
T 3ubd_A 176 SIDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--------- 241 (304)
T ss_dssp -----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred ccCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence 433222 2356789999999999987 68999999999999999999999999999887776665321
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. .....+|+++++||++||+.||++||| ++|+|+||||+++
T Consensus 242 -------------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 -------------------KL---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------------CC---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 01 112457999999999999999999998 5899999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=480.00 Aligned_cols=334 Identities=40% Similarity=0.756 Sum_probs=285.0
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~ 97 (619)
+...++|++++.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.++||||+++++++.... ..
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45678999999999999999999999999999999999776666677788999999999999999999999997653 23
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+...+|+|||||+++|.+++.. ..+++.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 4467899999998899999987 569999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .+.+++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|...+|.|..+.+..
T Consensus 180 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 22 2557899999999988652 5799999999999999999999999999999999999999999999999999
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+.......++..+.......+...++.+++.+.+||.+||.+||.+|||++|+|+||||+.+...+.++...+ +++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~~ 329 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDS 329 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCCC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCCC
Confidence 9988899999888887778888889999999999999999999999999999999999999988777776653 4556
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCchh
Q 007064 338 FERRRVTKEDIRELIFREILEYHPQL 363 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 363 (619)
++....+.+++++++++|+..++|+.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 330 FDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC--
T ss_pred hhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 67778899999999999999998874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-58 Score=482.78 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=218.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++ .+..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~-----~~~~ 123 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAV-----REGP 123 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEE-----EETT
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 34679999999999999999999999999999999975321 24799999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~~ 178 (619)
.+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+| .+||+|||+|+....
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 7999999999 59999999988999999999999999999999999999999999999999987 699999999987543
Q ss_pred CCCCc--cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 179 DTPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 179 ~~~~~--~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
+.... ......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..|..
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----------- 270 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----------- 270 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-----------
T ss_pred CCcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-----------
Confidence 32211 11234689999999999987 6899999999999999999999999988776554444422
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH-------------HcCccccCCCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA-------------LADPYFKGLSK 321 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el-------------L~hp~f~~~~~ 321 (619)
.+.++...++.+++.+.+||.+||+.||++|||+.|+ |+|||+..+.+
T Consensus 271 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 -----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp -----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred -----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1222334567899999999999999999999999998 57999987654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=481.55 Aligned_cols=338 Identities=39% Similarity=0.744 Sum_probs=273.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.++.+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 36899999999999999999999999999999999877777788889999999999997 99999999998543 335
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.+|+|||||+++|.+++... .+++.+++.+++||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 79999999999999999874 69999999999999999999999999999999999999999999999999998643211
Q ss_pred ------------------CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 181 ------------------PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 181 ------------------~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567999999999998652 5799999999999999999999999999999999999
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccC---CccccCCC-------------CCCCHHHHHHHHHhccCCCCCCCC
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQ---PVQFSQKF-------------PNADPSALRLLERLLAFDPKDRPT 306 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~---~~~~~~~~-------------~~~s~~l~dLI~~mL~~DP~kRpS 306 (619)
|...++.|..+.+..+.......++..+.... ...+...+ ..+++.+.+||.+||.+||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999998877776666666554332 22222222 278899999999999999999999
Q ss_pred HHHHHcCccccCCCcCcCCCCCCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCchhHH
Q 007064 307 AEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLK 365 (619)
Q Consensus 307 a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~~~~ 365 (619)
++|+|+||||+.+.....++.+.......+. +....+.+++++.++.++.+++++...
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELIS 380 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhh
Confidence 9999999999999888777766544333322 234678899999999999998887644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=479.40 Aligned_cols=285 Identities=27% Similarity=0.451 Sum_probs=224.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++++.||+|+||+||+|.++ .+++.||||++... ....++.+|+++|+.+ .||||+++++++ .
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 468999999999999999999875 46789999998653 2345688999999998 699999999999 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~ 175 (619)
+.+.+|||||||+ |+|.++++ .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 5567999999998 69999983 59999999999999999999999999999999999999887 7999999999976
Q ss_pred ccCCCCC-------------------------ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007064 176 AFNDTPT-------------------------TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (619)
Q Consensus 176 ~~~~~~~-------------------------~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p 230 (619)
....... ....+..+||++|+|||++.+. ..|+.++||||+|||+|||++|++|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 4322110 1123456899999999998762 4699999999999999999999988
Q ss_pred C-CCCChhHHHHHHHhhhCCCchhhhhhhcc-----------hhHHHHHHhhccc------------CCccccCCCCCCC
Q 007064 231 F-PGKNVVHQLDLMTDLLGTPSLDTISRVRN-----------DKARRYLTSMRKK------------QPVQFSQKFPNAD 286 (619)
Q Consensus 231 F-~~~~~~~~l~~i~~~~g~p~~e~i~~~~~-----------~~~~~~l~~~~~~------------~~~~~~~~~~~~s 286 (619)
| .+.+..+++..|...+|++.......... ...+.....+... ........|..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 66788899999999999765544332110 1111111111100 0111223567899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 287 PSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 287 ~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
++++|||++||++||++|+|++|+|+||||+++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=478.91 Aligned_cols=334 Identities=40% Similarity=0.797 Sum_probs=281.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RR 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~ 97 (619)
+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... ..
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 45668999999999999999999999999999999999876666777888999999999999999999999986542 23
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+...+|+|||+++++|.+++.. ..+++..++.+++||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 4467899999999999998876 579999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+..
T Consensus 184 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 184 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp -------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2457899999999998752 5789999999999999999999999999999999999999999999999999
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+.......++..+.......+...++..++.+.+||.+||.+||.+|||++|+|+||||+.+.....++...+ +++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~ 333 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 333 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGG
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcc
Confidence 9988888998888777777788888999999999999999999999999999999999999988777776554 4566
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCchh
Q 007064 338 FERRRVTKEDIRELIFREILEYHPQL 363 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 363 (619)
++......+++++++++|+..|+|..
T Consensus 334 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 334 LESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp GSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred hhhccCCHHHHHHHHHHHHHHhccCc
Confidence 67778899999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=483.47 Aligned_cols=331 Identities=35% Similarity=0.670 Sum_probs=265.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~ 99 (619)
..++|++++.||+|+||.||+|++..+++.||||++...........++.+|+.+|+.++||||+++++++..... .+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3588999999999999999999999999999999998766677778899999999999999999999999976532 455
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|||||||+++|.+.+.. .+++.+++.|++||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 140 ~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp CEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred CeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 78999999999999988854 4999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
...+.++||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|..+.+..+.
T Consensus 218 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 218 ----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ----cccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 12356789999999999987 689999999999999999999999999999999999999999999999887764
Q ss_pred chhHHHHHHhhcccCCccccCCCCCC------------CHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~------------s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~ 327 (619)
.....++..........+...++.. ++++++||.+||.+||++|||++|+|+||||+.+........
T Consensus 292 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~ 370 (464)
T 3ttj_A 292 -PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 370 (464)
T ss_dssp -HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC
T ss_pred -hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC
Confidence 3455555544444444444444332 578999999999999999999999999999998765443221
Q ss_pred CCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 328 CQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 328 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
. +....++.++....+.+++++++++|+..++.
T Consensus 371 ~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 371 P-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp C-C-----------CCCHHHHHHHHHHHHHC---
T ss_pred C-CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 1 11234556677788999999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=458.41 Aligned_cols=341 Identities=47% Similarity=0.830 Sum_probs=291.9
Q ss_pred cCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 18 ~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.+...++|++++.||+|+||.||+|.+..++..||||++... ........+.+|+.+|+.++||||+++++++......
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 356678999999999999999999999999999999999743 4455667899999999999999999999999766555
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|+||||++++|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 56789999999999999999765 59999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.|..+.+..
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 433333334567899999999987542 5689999999999999999999999999999999999999999999999988
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
+.......+...........+...++++++.+.+||.+||..||++|||++|+|+||||+++.....++.... .+.++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~ 336 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFD 336 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcc
Confidence 8888888888777777777777888899999999999999999999999999999999998876555544332 23344
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCchh
Q 007064 338 FERRRVTKEDIRELIFREILEYHPQL 363 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~~~ 363 (619)
.+...+.++++++++++|+..++|..
T Consensus 337 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 337 MELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp -----CCHHHHHHHHHHHTGGGCC--
T ss_pred cccccCCHHHHHHHHHHHHHHhhhhc
Confidence 56667889999999999998888753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=453.55 Aligned_cols=262 Identities=26% Similarity=0.451 Sum_probs=201.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC------
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------ 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~------ 96 (619)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.|+|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3599999999999999999999999999999999743 334556789999999999999999999999864321
Q ss_pred -CCCCcEEEEEecCC-ccHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 97 -RDFKDIYVVFELME-SDLHQVIKANDDL---TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 97 -~~~~~lylV~E~~~-g~L~~~i~~~~~l---~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
.+...+|||||||. |+|.+++.....+ .+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 12345899999998 6999999876544 456688999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc---------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 172 LARVAFNDTPTT---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 172 la~~~~~~~~~~---------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
+|+......... ...+..+||+.|||||++.+ ..|+.++||||||||||||++ ||.+. .+....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 998754332211 12345689999999999987 689999999999999999996 67543 222222
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+...... .+...++..++.+.+||++||+.||++|||++|+|+||||+++
T Consensus 237 ~~~~~~~---------------------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 237 LTDVRNL---------------------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTT---------------------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHhcC---------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 2211110 1111223346788999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=482.26 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=227.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||+||+|+++.+|+.||||++.. ....+...+.+|+.+|+.|+|||||+++++| .+...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 3689999999999999999999999999999999975 3455677889999999999999999999999 45678
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~--~~vKL~DFGla~~~~ 177 (619)
+|||||||. |+|+++|.. .+.+++.+++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999 599999964 4679999999999999999999999999999999999999864 899999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .....+||++|||||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|......
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-------- 374 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-------- 374 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--------
Confidence 322 2356789999999999987 68999999999999999999999999999988777666432111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.....++.+|+++++||++||..||.+|||++|+|+||||+....
T Consensus 375 -------------------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 375 -------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 112345678999999999999999999999999999999987544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=445.96 Aligned_cols=331 Identities=40% Similarity=0.762 Sum_probs=281.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
+...++|.+++.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 345689999999999999999999999999999999998766666677889999999999999999999999965432 2
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 223459999999999998874 359999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+.+..
T Consensus 196 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 22 2456899999999988652 5789999999999999999999999999999999999999999999999888
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCC-CCcchhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQ-PISKMEF 336 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~-~~~~~~~ 336 (619)
+.......+...+.......+...++.+++.+.+||.+||+.||++|||++|+|+||||+.+.....+.... ++. .
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~---~ 345 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD---D 345 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC---C
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC---c
Confidence 877777777777766666666777888999999999999999999999999999999999887655443322 222 2
Q ss_pred hHhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 337 EFERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 337 ~~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
..+....+.+++++.+++|+.+|+|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred chhhcccchHHHHHHHHHHHHhccc
Confidence 3355667899999999999999876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=439.58 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=218.2
Q ss_pred ccccccCCCCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCccee
Q 007064 13 MEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI 87 (619)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l 87 (619)
++.|...-..++|.+.+.||+|+||.||+|.+. .++..||||+++. ......+.+.+|+.+|+.|+|||||++
T Consensus 3 ~d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 3 MDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp GGGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred chhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccE
Confidence 455555556678999999999999999999864 4678999999975 345566789999999999999999999
Q ss_pred eeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 007064 88 KHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
++++. +...+|||||||+ |+|.++|... ..+++.++..|+.||+.||.|||+++|+|||||
T Consensus 81 ~g~~~-----~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlK 155 (299)
T 4asz_A 81 YGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLA 155 (299)
T ss_dssp EEEEC-----SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEe-----eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccC
Confidence 99994 4467999999999 6999999764 369999999999999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~ 232 (619)
|+|||++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.
T Consensus 156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 156 TRNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred HhhEEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865432221 11234579999999999987 689999999999999999998 899999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+.+..+.+..+... .. ......+++++.+||.+||+.||++|||++++
T Consensus 233 ~~~~~~~~~~i~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i-- 280 (299)
T 4asz_A 233 QLSNNEVIECITQG---------------------------RV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI-- 280 (299)
T ss_dssp TSCHHHHHHHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--
T ss_pred CCCHHHHHHHHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--
Confidence 98876655554321 00 11234678999999999999999999999999
Q ss_pred CccccCCC
Q 007064 313 DPYFKGLS 320 (619)
Q Consensus 313 hp~f~~~~ 320 (619)
|+||+++.
T Consensus 281 ~~~L~~~~ 288 (299)
T 4asz_A 281 HTLLQNLA 288 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 45776543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=478.67 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=214.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~----~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ..........+++.+++.++|||||+++++| +
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence 467999999999999999999999999999999996421 1112222333456677778999999999999 5
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|||||||. |+|.++|...+.+++..+++|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 5678999999999 699999999899999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ....+||+.|||||++... ..|+.++||||||||||||++|.+||.+.+..+....+..
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~----------- 405 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 405 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-----------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------
Confidence 4332 2457999999999998641 5799999999999999999999999977543322211100
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
... .. ...+..+|+++++||.+||..||.+|++ ++||++||||+++
T Consensus 406 -------------i~~-~~---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 406 -------------TLT-MA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp -------------HHH-CC---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred -------------hcC-CC---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 000 01 1223568999999999999999999998 8999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=436.36 Aligned_cols=338 Identities=43% Similarity=0.796 Sum_probs=278.3
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..+...++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3456678999999999999999999999999999999999642 345566778899999999999999999999876655
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
.+...+|+||||+.++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 55678999999999999999977 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCc-------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 177 FNDTPTT-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 177 ~~~~~~~-------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
....... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+++..+....|.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 4322111 112346899999999987542 57899999999999999999999999999999999999999998
Q ss_pred Cchhh-hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCC
Q 007064 250 PSLDT-ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 328 (619)
Q Consensus 250 p~~e~-i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~ 328 (619)
|.... +..........++..+.......+...++.+++.+.+||.+||..||++|||++|+|+||||+.+.....++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~ 321 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG 321 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence 87433 33334444555555554444445556678899999999999999999999999999999999988776655555
Q ss_pred CCCcc--hhhhHhhhcCCHHHHHHHHHHHHH
Q 007064 329 QPISK--MEFEFERRRVTKEDIRELIFREIL 357 (619)
Q Consensus 329 ~~~~~--~~~~~e~~~~~~e~~~~~~~~ei~ 357 (619)
.++.. +++......++.+++++++++|+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 322 EPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 55443 444556667899999999999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=438.55 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=209.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++.+.||+|+||+||+|..+ ..||||+++.........+.+.+|+.+|+.|+|||||++++++.. .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 4678999999999999999999753 369999998665666777889999999999999999999998732 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|||||||+ |+|.++|... ..+++.++..|+.||+.||.|||+++|+||||||+|||+++++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 5899999999 6999999764 5799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... ....+..+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 185 ~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~----------- 252 (307)
T 3omv_A 185 WSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR----------- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----------
T ss_pred CCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 221 1223556899999999998642 246999999999999999999999999887765544333211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
......+...++++++.+.+||.+||+.||++|||+.|++++
T Consensus 253 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 253 --------------GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp --------------TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred --------------CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011112234456789999999999999999999999988654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=436.42 Aligned_cols=331 Identities=40% Similarity=0.752 Sum_probs=281.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~ 98 (619)
...++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 34578999999999999999999999999999999998765666667889999999999999999999999865432 12
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|+||||+.++|.+++.. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 335799999999999887743 599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. ....++|+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+++..+....|.|..+.+..+
T Consensus 179 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 179 E------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp -----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred C------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 2446899999999988652 57899999999999999999999999999999999999999999999988888
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 338 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (619)
.......++..+.......+...++.+++.+.+||.+||..||++|||++++|+||||+.+...+.++.... .+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~ 329 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSL 329 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccch
Confidence 777777777777666666677778889999999999999999999999999999999998876554443321 223344
Q ss_pred hhhcCCHHHHHHHHHHHHHHhCc
Q 007064 339 ERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 339 e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
+...++.+++++.+++|+.++.+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 330 EHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTCCCCHHHHHHHHHHHHHTCCC
T ss_pred hhccCCHHHHHHHHHHHHHhhcc
Confidence 56678899999999999988765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=429.60 Aligned_cols=301 Identities=38% Similarity=0.632 Sum_probs=240.5
Q ss_pred CCCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007064 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
.|...+-...-+..++|++++.||+|+||.||+|.+. +|+.||+|++............+.+|+.+|+.++||||++++
T Consensus 7 ~~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp --------CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeee
Confidence 3444444455678899999999999999999999985 589999999976544444567788999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEE
Q 007064 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKI 167 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL 167 (619)
+++ .+...+|+|||||+++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 86 ~~~-----~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 86 DVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp EEE-----CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEE-----ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEE
Confidence 998 4456799999999999999987654 5999999999999999999999999999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|||+++....... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+...+
T Consensus 161 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 236 (311)
T 3niz_A 161 ADFGLARAFGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236 (311)
T ss_dssp CCCTTCEETTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred ccCcCceecCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence 99999986533222 12456789999999988652 568999999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
+.+....+.......... ...........+....+.+++++.+||.+||+.||++|||++|+|+||||+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCTTTSGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred CCCChHHhhhhhccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 999887766543221110 000111122223344567899999999999999999999999999999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=436.12 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=205.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.++|.+.+.||+|+||+||+|..+ .++..||||+++. ......+.+.+|+.+|+.|+|||||++++++.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~---- 113 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCT---- 113 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 357899999999999999999864 4688999999975 34556778999999999999999999999994
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~---------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
+...+|||||||+ |+|.+++... +++++.++..|+.||+.||.|||+.+|+||||||+|||++
T Consensus 114 -~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 114 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp -SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred -ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 4467999999999 6999999754 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHH
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~ 239 (619)
.++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999865433221 12245689999999999987 689999999999999999998 8999999887666
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+..+... ... .....+++++.+||.+||+.||++|||++|++++
T Consensus 270 ~~~i~~g---------------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQG---------------------------REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHT---------------------------CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcC---------------------------CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5554321 000 1224678999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=440.18 Aligned_cols=331 Identities=35% Similarity=0.661 Sum_probs=256.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357999999999999999999999999999999999866566677788999999999999999999999986543 2344
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+|||||+++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred cceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 57999999999999999863 5999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+++..+...++.|..+.+..+.
T Consensus 181 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 181 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp -------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 2345689999999999987 679999999999999999999999999999999999999999999888776553
Q ss_pred chhHHHHHHhhcccCCccccCCCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPN------------ADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPS 327 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~ 327 (619)
. ....++..........+...++. .++.+++||.+||..||++|||++|+|+||||+.+........
T Consensus 255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~ 333 (371)
T 2xrw_A 255 P-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 333 (371)
T ss_dssp H-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred h-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence 2 22333332222221222111111 1567999999999999999999999999999997654321111
Q ss_pred CCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 328 CQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 328 ~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
..+ .......+....+.++++++++.++..+.-
T Consensus 334 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 2xrw_A 334 PPP-KIPDKQLDEREHTIEEWKELIYKEVMDLEH 366 (371)
T ss_dssp CCC-CCCTTTTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred CCC-CCCChhhccccCcHHHHHHHHHHHHHHHhh
Confidence 111 111233455667889999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=432.24 Aligned_cols=254 Identities=21% Similarity=0.316 Sum_probs=210.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..+.+++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|+.|+|||||++++++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--- 99 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT--- 99 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE---
Confidence 346799999999999999999985 3467899999997542 2334567999999999999999999999994
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (619)
+...+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+.+|+||||||+|||
T Consensus 100 --~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp --SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 3456899999999 6999999753 35899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChh
Q 007064 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVV 237 (619)
Q Consensus 159 i~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~ 237 (619)
+++++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+..
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ECCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999875433221 12345689999999999987 689999999999999999998 89999998876
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+.+..+... .. .....++++.+.+|+.+||+.||++|||+.||+++
T Consensus 255 ~~~~~i~~~---------------------------~~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIRNR---------------------------QV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHTT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcC---------------------------CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 665544321 10 11234678899999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=419.09 Aligned_cols=287 Identities=36% Similarity=0.591 Sum_probs=238.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 6899999999999999999999999999999999765555566678899999999999999999999983 45679
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+|||||+++|.+.+.. ++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 56899999999999999999999999999999999999999999999999999986532221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+...++.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456899999999998762 4589999999999999999977655 888888999999999999998877654432
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
... +................+.+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 110 0000000111223344567899999999999999999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=417.72 Aligned_cols=284 Identities=38% Similarity=0.635 Sum_probs=233.7
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.+ .+++.||+|++............+.+|+.+|+.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 6899999999999999999998 67999999999754333333467889999999999999999999984 44679
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999986532211
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....++|+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12445789999999998652 46899999999999999999999999999999999999999998877665433211
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+........+..+......+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1111112222333444556778999999999999999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=422.10 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=225.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++ .+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 45689999999999999999999999999999999987666677788899999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||+ ++|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 7999999997 699999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y-~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 229 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------ 229 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 2 2356789999999999876 454 58999999999999999999999998876655544321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.. .....+++.+.+||++||..||.+|||++|+|+||||+....
T Consensus 230 --------------~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 230 --------------KY-----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp --------------CC-----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred --------------CC-----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 00 111246889999999999999999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=431.77 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=211.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|.+..+ ++.||||+++.. ......+.+.+|+.+|..++| ||||++++++...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 347899999999999999999987654 368999999753 344566789999999999975 8999999998432
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (619)
...+|||||||+ |+|.++|+.. ..+++.++..|+.||+.||.|||+++||||||||+||
T Consensus 141 ----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 141 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 346899999999 6999999753 3489999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007064 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (619)
Q Consensus 158 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~ 236 (619)
|++.++.+||+|||+|+....+... ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |.+||.+.+.
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999875443322 22345689999999999987 689999999999999999998 9999988765
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+.+..+.. ..... .....+++++.+||.+||+.||++|||+.||++|
T Consensus 294 ~~~~~~~i~--------------------------~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLK--------------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHH--------------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHH--------------------------cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 443322211 00000 1223578999999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=422.59 Aligned_cols=332 Identities=36% Similarity=0.659 Sum_probs=263.7
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---------CChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---------EHISDAARILREIKLLRLLRHPDIVEIKHI 90 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---------~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 90 (619)
...++|++++.||+|+||.||+|.+.. |..||||++.... ......+.+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 356899999999999999999999865 9999999986432 223345789999999999999999999999
Q ss_pred ecCCCCCCCCcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 91 MLPPSRRDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
+..........+|+|||||.|+|.+.+.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8665545556799999999999999987653 699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
||+++....... .....+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975432221 2456799999999988653 57899999999999999999999999999999999999999999
Q ss_pred CchhhhhhhcchhHHHHHHhhcc-cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRK-KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 328 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~ 328 (619)
|..+.+..........++..... .....+....+..++.+.+||.+||..||.+|||++|+|+||||+.+.........
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 99888776666655555433222 22223344557789999999999999999999999999999999987654332211
Q ss_pred CCCcchhhhHhhhcCCHHHHHHHHHHHHHHhC
Q 007064 329 QPISKMEFEFERRRVTKEDIRELIFREILEYH 360 (619)
Q Consensus 329 ~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~ 360 (619)
. ...+.++....+..++++.++.|+.+++
T Consensus 333 ~---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 L---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp C---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred c---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1 1123445566678899999999998765
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=422.65 Aligned_cols=300 Identities=35% Similarity=0.547 Sum_probs=227.2
Q ss_pred CCCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceee
Q 007064 9 NSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
++......+.-...++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||++++
T Consensus 20 ~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (329)
T 3gbz_A 20 GSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99 (329)
T ss_dssp ------------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEE
T ss_pred CcceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEE
Confidence 33344444455667899999999999999999999999999999999976544444556778999999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-----CCC
Q 007064 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-----ANC 163 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-----~~~ 163 (619)
+++. +...+|||||||+++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++ .++
T Consensus 100 ~~~~-----~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 174 (329)
T 3gbz_A 100 SVIH-----HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174 (329)
T ss_dssp EEEE-----ETTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CC
T ss_pred EEEe-----cCCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccc
Confidence 9983 456799999999999999999998999999999999999999999999999999999999994 455
Q ss_pred cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 007064 164 KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i 243 (619)
.+||+|||+++....... .....++|+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 250 (329)
T 3gbz_A 175 VLKIGDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250 (329)
T ss_dssp EEEECCTTHHHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eEEECcCCCccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence 699999999986532221 12456789999999998752 45899999999999999999999999999999999999
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...++.|....+........ +...........+... ...+++++.+||.+||..||++|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 251 FEVLGLPDDTTWPGVTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHHCCCCTTTSTTGGGSTT--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred HHHhCCCchhhhhhhhhhhh--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 99999888766544321100 0000000000000000 01268899999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=413.33 Aligned_cols=289 Identities=36% Similarity=0.650 Sum_probs=232.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++. +...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCe
Confidence 46899999999999999999999999999999999765555556677889999999999999999999983 4467
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999995 778888878889999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.........+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456899999999988652 5789999999999999999999999999999999999988888776554332221
Q ss_pred hhHHHHHHhhcc---cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 261 DKARRYLTSMRK---KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 261 ~~~~~~l~~~~~---~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
.. ++..... .........++++++.+.+||.+||..||.+|||++|+|+||||+++...
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQ---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CG---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cc---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 11 1111000 01111223456889999999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=423.51 Aligned_cols=288 Identities=34% Similarity=0.619 Sum_probs=233.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.++.+++.||||++.... .......+.+|+.+|+.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEE
Confidence 68999999999999999999999999999999997432 1112224567999999999999999999983 45679
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+|||||+++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998654 599999999999999999999999999999999999999999999999999976432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+...++.|..+.+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22456789999999988652 56899999999999999999999999999999999999999999988877655433
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...... .............++.+++.+.+||.+||+.||.+|||++|+|+||||.++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 221111 11111222233445678999999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=417.15 Aligned_cols=287 Identities=34% Similarity=0.568 Sum_probs=234.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH---ISDAARILREIKLLRLL---RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~---~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57999999999999999999999999999999998643211 11123456777777666 4999999999986554
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
......+|+||||++++|.+++..... +++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 333446899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86533222 245689999999999876 679999999999999999999999999999999999999999998877
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.+........ .......+..+....+.+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 242 DWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp TSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 6543221110 011122233334456788999999999999999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=420.73 Aligned_cols=289 Identities=34% Similarity=0.610 Sum_probs=222.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence 468999999999999999999999999999999997432 223345678999999999999999999998 44567
Q ss_pred EEEEEecCCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 102 IYVVFELMESDLHQVIKAN------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+|+|||||+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999998753 3599999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 543221 12456799999999998652 46899999999999999999999999999999999999999999887665
Q ss_pred hhhcchhHHHHHHhhcccCCccc-----cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQF-----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
..+.... .+...+....+..+ ......+++.+.+||.+||..||++|||++|+|+||||+++...
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 234 PSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 5432110 00000000000000 01123578899999999999999999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=423.31 Aligned_cols=268 Identities=27% Similarity=0.432 Sum_probs=228.0
Q ss_pred cccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeee
Q 007064 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKH 89 (619)
Q Consensus 14 ~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~ 89 (619)
+.|..-...++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++
T Consensus 3 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 82 (361)
T 2yab_A 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82 (361)
T ss_dssp -CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence 44555566788999999999999999999999999999999997543221 13467889999999999999999999
Q ss_pred EecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----c
Q 007064 90 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----K 164 (619)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~ 164 (619)
++ .+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .
T Consensus 83 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 83 VY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EE-----ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCC
T ss_pred EE-----EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccC
Confidence 98 44567999999997 69999998888999999999999999999999999999999999999998877 7
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~ 244 (619)
+||+|||+++...... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|.
T Consensus 158 vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp EEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred EEEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322 1245689999999999876 689999999999999999999999999988777666654
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...... ....|+.+++.+++||.+||..||.+|||++|+|+||||+..
T Consensus 232 ~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 232 AVSYDF---------------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TTCCCC---------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred hcCCCC---------------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 321111 112345788999999999999999999999999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=425.80 Aligned_cols=286 Identities=36% Similarity=0.662 Sum_probs=233.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~~~ 101 (619)
.+|++++.||+|+||+||+|.+..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 569999999999999999999987776 88888754211 12369999999999999999999865432 33445
Q ss_pred EEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEeecCccccc
Q 007064 102 IYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~DFGla~~~ 176 (619)
+|+|||||.+++.+.+. ....+++..++.|++||+.||.|||+.||+||||||+|||++ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999987766554 356899999999999999999999999999999999999999 7999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ...+++|++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|...+|+|..+.+.
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999988652 569999999999999999999999999999999999999999999998876
Q ss_pred hhcchhHHHHHHhhcccCCccccCCC-CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
......... .........+...+ +.+++++.+||.+||.+||.+|||+.|+|+||||+++....
T Consensus 268 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 268 TMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp HHCGGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hhChhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 543221110 11112222333333 35899999999999999999999999999999999886644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=430.63 Aligned_cols=287 Identities=34% Similarity=0.625 Sum_probs=232.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~~~ 101 (619)
.+|++++.||+|+||.||+|.++.+|+.||||++..... ...+|+++|+.|+||||+++++++..... .+...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 369999999999999999999999999999999864311 23479999999999999999998854321 23345
Q ss_pred EEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCccccc
Q 007064 102 IYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVA 176 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGla~~~ 176 (619)
+++|||||.++|.+++. ....+++..++.|++||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877664 35689999999999999999999999999999999999999965 57899999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|...+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456899999999998652 479999999999999999999999999999999999999999999988776
Q ss_pred hhcchhHHHHHHhhcccCCccccCC-CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQK-FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
........ + .+.......+... .+.+++++.+||.+||.+||.+|||+.|+|+||||+.+....
T Consensus 283 ~~~~~~~~-~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 283 EMNPNYTE-F--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHCSCCCC-C--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhChhhhh-h--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 54221100 0 0001111112222 246789999999999999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=431.49 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=225.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+|+.||+|++........+...+.+|+.+|+.|+||||+++++++ .+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 34679999999999999999999999999999999976555555677899999999999999999999998 4557
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFGla~~~ 176 (619)
.+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 7999999998 59999999999999999999999999999999999999999999999998 4578999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..+...
T Consensus 164 ~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 228 (444)
T 3soa_A 164 EGEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG---------- 228 (444)
T ss_dssp CTTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred cCCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC----------
Confidence 43322 2355789999999999976 68999999999999999999999999988876655554321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........|+.+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 229 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 229 -----------------AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 1112234467789999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=436.84 Aligned_cols=267 Identities=32% Similarity=0.519 Sum_probs=224.4
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
...-...++|++++.||+|+||+||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~---- 90 (486)
T 3mwu_A 15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL---- 90 (486)
T ss_dssp TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE----
Confidence 3333456889999999999999999999999999999999964333333456788999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEeecC
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFG 171 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFG 171 (619)
.+...+|+|||||. ++|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|||
T Consensus 91 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 91 -EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp -ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred -EcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 44567999999998 59999998888899999999999999999999999999999999999995 45679999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.....
T Consensus 170 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--- 239 (486)
T 3mwu_A 170 LSTCFQQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--- 239 (486)
T ss_dssp CTTTBCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred cCeECCCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence 998654322 2345689999999999875 599999999999999999999999999887766665533111
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
......|..+++.+++||.+||..||.+|||+.++|+||||+....
T Consensus 240 ------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 240 ------------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ------------------------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ------------------------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 1111234567899999999999999999999999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=412.81 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=219.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 4689999999999999999999999999999999964311 122356788999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 7999999998 599999998888999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......|...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 21 2345789999999999987 68999999999999999999999999888765554444210
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. .....+++++.+||.+||..||++|| +++|+++||||+++
T Consensus 221 ---------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 221 ---------------EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ---------------CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------CC---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 00 11235789999999999999999999 99999999999865
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=435.42 Aligned_cols=258 Identities=31% Similarity=0.508 Sum_probs=216.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.++.++..||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 479999999999999999999999999999999976443334456788999999999999999999999 445679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecCccccccC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVAFN 178 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~~~ 178 (619)
|+|||||. |+|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 5999999888889999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 253 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK----------- 253 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 22 2345689999999999864 69999999999999999999999999988766665553311
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.......|..+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 254 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 254 ----------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ----------------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ----------------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 111223456789999999999999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=419.19 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=216.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence 4578999999999999999999999999999999997431 1223456678999999988 699999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 567999999998 5999999988899999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 176 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 239 (353)
T 3txo_A 176 CNGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------- 239 (353)
T ss_dssp C------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 2221 2345689999999999876 57999999999999999999999999998877766655321
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa------~elL~hp~f~~~ 319 (619)
.. .....+++.+.+||++||..||.+||++ +++++||||+++
T Consensus 240 -----------------~~---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 240 -----------------EV---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 00 1113478899999999999999999999 999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=420.62 Aligned_cols=286 Identities=32% Similarity=0.674 Sum_probs=231.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC----
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR---- 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~---- 96 (619)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 35789999999999999999999999999999999864321 12379999999999999999999865432
Q ss_pred -----------------------------CCCCcEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 007064 97 -----------------------------RDFKDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIH 143 (619)
Q Consensus 97 -----------------------------~~~~~lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLH 143 (619)
.+...+|+|||||+++|.+.+. ....+++..++.|++||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2345589999999998777765 4578999999999999999999999
Q ss_pred HCCceeccCCCCcEEEC-CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHH
Q 007064 144 TANVYHRDLKPKNILAN-ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (619)
Q Consensus 144 s~gIvHrDLKP~NILi~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ily 222 (619)
+.||+||||||+|||++ .++.+||+|||+++....... ....++|+.|+|||++.+. ..|+.++|||||||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999998 688999999999986533322 2456889999999988752 46899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCC-CCCCHHHHHHHHHhccCCC
Q 007064 223 EVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF-PNADPSALRLLERLLAFDP 301 (619)
Q Consensus 223 eLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~l~dLI~~mL~~DP 301 (619)
+|++|++||.+.+..+++..|...+|.|..+.+.......... .........+...+ ..+++.+.+||.+||..||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999988776543221100 00011111122222 3578999999999999999
Q ss_pred CCCCCHHHHHcCccccCCC
Q 007064 302 KDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 302 ~kRpSa~elL~hp~f~~~~ 320 (619)
.+|||+.|+|+||||+.+.
T Consensus 311 ~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHH
T ss_pred hhCCCHHHHhcCHHHHHHH
Confidence 9999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=412.83 Aligned_cols=290 Identities=36% Similarity=0.582 Sum_probs=231.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
...++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 81 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF----- 81 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence 34678999999999999999999999999999999987432211 1124678999999999999999999998
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+...+|+|||||+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 3446789999999999999987653 699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...... .....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.|..+.+
T Consensus 162 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 543221 23456899999999998652 46899999999999999999999999999999999999999999887766
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
........ ++ ........++...+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 238 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 238 PDMCSLPD--YV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp SSTTSSTT--CC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhhccCcc--cc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 54322100 00 00011112223345678899999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=415.65 Aligned_cols=299 Identities=34% Similarity=0.538 Sum_probs=237.3
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~--- 96 (619)
+..++|++++.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 56789999999999999999999999999999999987544444445567899999999999999999999865321
Q ss_pred CCCCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...+.+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 114568999999999998888764 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 542221 12223556899999999988652 5689999999999999999999999999999999999999999888776
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
+...........+..... ....+...+ ...++.+.+||.+||..||++|||++|+|+||||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhcccccccc-cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 654432211100000000 000000000 01367899999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=415.72 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=223.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+|+.|+||||+++++++ .+...+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 579999999999999999999999999999999986555666778899999999999999999999998 455679
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEeecCccccccC
Q 007064 103 YVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLARVAFN 178 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~~~~~ 178 (619)
|+|||||. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 59999998888899999999999999999999999999999999999998654 599999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+.......+...
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 245 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 2345689999999999987 68999999999999999999999999988766555444321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........|..+++.+.+||.+||..||++|||++++|+||||...
T Consensus 246 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 246 ---------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1111122345678999999999999999999999999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=404.77 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=219.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+..++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++. +.
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----EC
Confidence 456789999999999999999999999999999999864322 23456889999999999999999999984 34
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 56999999997 6999999775 599999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+.... .+
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~-------- 234 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP-------- 234 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC--------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC--------
Confidence 322 2245689999999999877 689999999999999999999999998887665554432210 00
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.......+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 235 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 -------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 011123578899999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=404.10 Aligned_cols=301 Identities=39% Similarity=0.622 Sum_probs=235.5
Q ss_pred cCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC--
Q 007064 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-- 95 (619)
Q Consensus 18 ~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-- 95 (619)
.+...++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 34567899999999999999999999999999999999864 34556778899999999999999999999885432
Q ss_pred -------CCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEE
Q 007064 96 -------RRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKI 167 (619)
Q Consensus 96 -------~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL 167 (619)
..+...+|+||||++|+|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 134467999999999999999865 5799999999999999999999999999999999999997 5679999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998654322222223455789999999987542 578999999999999999999999999999988888888877
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
..+..+....+... ...++..........+...++.+++.+.+||.+||..||++|||++|+|+||||+.+..+.
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 77666554433221 1112222112222333445678899999999999999999999999999999999765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=411.67 Aligned_cols=291 Identities=32% Similarity=0.568 Sum_probs=233.5
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
+...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++ .+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KK 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ec
Confidence 5667899999999999999999999999999999999976555556667788999999999999999999998 34
Q ss_pred CCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 5679999999996 666666767789999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||++|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.........
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 12456799999999998752 4789999999999999999999999999999999999988888776554332
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
+.......-...............++.+++.+.+||.+||..||.+|||++|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2111100000000001112222345678999999999999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=416.58 Aligned_cols=298 Identities=21% Similarity=0.284 Sum_probs=222.7
Q ss_pred CCCCCCeEEeEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 19 YGDASRYKIQEVIGKG--SYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G--~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.+..++|++++.||+| +||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---- 96 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI---- 96 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE----
Confidence 3677899999999999 9999999999999999999999866556666778889999999999999999999984
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+...+|+|||||. ++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 97 -ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp -ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred -ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 4467999999998 6999999875 67999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCC----ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC-
Q 007064 174 RVAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG- 248 (619)
Q Consensus 174 ~~~~~~~~~----~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g- 248 (619)
......... .......+||+.|+|||++.+....|+.++|||||||++|+|++|++||.+.+....+..+....-
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 654322111 111233479999999999876335789999999999999999999999998776655543321100
Q ss_pred -------CCchhhhhhhcc----hhHHHHHH---hhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 249 -------TPSLDTISRVRN----DKARRYLT---SMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 249 -------~p~~e~i~~~~~----~~~~~~l~---~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
.+..+....... ......+. .............+..+++.+.+||.+||+.||++|||++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000000000 00000000 0000011111223456889999999999999999999999999999
Q ss_pred cccCCCc
Q 007064 315 YFKGLSK 321 (619)
Q Consensus 315 ~f~~~~~ 321 (619)
||+++..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=406.93 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=221.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+|+.++||||+++++++ .+..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCC
Confidence 457899999999999999999999999999999998742 34556788999999999999999999998 3446
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~ 176 (619)
.+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 7999999998 59999997653 7999999999999999999999999999999999999987 789999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 222 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF------ 222 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC------
Confidence 4322 2345679999999999876 568999999999999999999999999988776666554321111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....++.+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 223 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 223 ---------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 112345788999999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=428.15 Aligned_cols=318 Identities=26% Similarity=0.369 Sum_probs=245.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------HHHHHHHHHHHHHHhcCCCCcceeee
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-----------SDAARILREIKLLRLLRHPDIVEIKH 89 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-----------~~~~~i~~Ei~iL~~L~HpnIv~l~~ 89 (619)
..++|++++.||+|+||.||+|.++.++..||||++....... .....+.+|+.+|+.|+||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999999999999999997532211 23467889999999999999999999
Q ss_pred EecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cE
Q 007064 90 IMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KL 165 (619)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~v 165 (619)
++ .+...+|||||||. |+|.+.+.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 99 45567999999998 59999998888899999999999999999999999999999999999999876 69
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
||+|||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 999999998654322 2345689999999999864 689999999999999999999999999887776666543
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVERE 325 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~ 325 (619)
.... .....|..+++.+++||.+||..||.+|||++|+|+||||+.......
T Consensus 262 ~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~- 313 (504)
T 3q5i_A 262 GKYY---------------------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN- 313 (504)
T ss_dssp CCCC---------------------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCC-
T ss_pred CCCC---------------------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhccc-
Confidence 2111 111234578899999999999999999999999999999986543210
Q ss_pred CCCCCCcchhhhHhhhcCCHHHHHHHHHHHHHHhCch-hHHhhhcccccccccChhHHHHHHHHHHHHHhh
Q 007064 326 PSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQ-LLKDYMNGTERTNFLYPSAVDQFRKQFAHLEEN 395 (619)
Q Consensus 326 ~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ei~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 395 (619)
... ...+ ......+..+... .++..........++++....++++.|+.+|.+
T Consensus 314 -------~~~---------~~~~-~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d 367 (504)
T 3q5i_A 314 -------KSD---------QKTL-CGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKN 367 (504)
T ss_dssp -------GGG---------HHHH-HHHHHHHHHCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTT
T ss_pred -------ccc---------hhhH-HHHHHHHHHHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCC
Confidence 000 0011 1122233333332 122211111223445778889999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=418.66 Aligned_cols=281 Identities=32% Similarity=0.551 Sum_probs=231.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc------CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL------RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L------~HpnIv~l~~v~~~~ 94 (619)
...+|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+ .|+||+.+++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-- 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-- 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE--
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc--
Confidence 45789999999999999999999999999999999974 234456677899988887 5779999999984
Q ss_pred CCCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEeec
Q 007064 95 SRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDF 170 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~DF 170 (619)
....+|+|||||.++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+||
T Consensus 170 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 170 ---FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ---ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred ---cCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 346799999999999999998754 4999999999999999999999999999999999999999987 999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..+.+.+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999754322 234689999999999887 679999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcchhHHHHHHhhcccC-----------------------------CccccCC-CCCCCHHHHHHHHHhccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQ-----------------------------PVQFSQK-FPNADPSALRLLERLLAFD 300 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~-----------------------------~~~~~~~-~~~~s~~l~dLI~~mL~~D 300 (619)
..+.+..... ...++....... ...+... ....++.+.+||++||++|
T Consensus 319 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 319 SQKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CHHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CHHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 9887654322 122221100000 0000001 1234788999999999999
Q ss_pred CCCCCCHHHHHcCccccCC
Q 007064 301 PKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 301 P~kRpSa~elL~hp~f~~~ 319 (619)
|++|||++|+|+||||++.
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=411.80 Aligned_cols=257 Identities=32% Similarity=0.510 Sum_probs=214.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI-SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~-~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++||||+++++++. +.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TP 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 3478999999999999999999999999999999986421111 12346889999999999999999999984 44
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|+||||++|+|.+++...+.+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 67999999999999999988889999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y-~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
. .....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|..||.+.+.....
T Consensus 162 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------ 217 (336)
T 3h4j_B 162 N----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------ 217 (336)
T ss_dssp B----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------------
T ss_pred c----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------------
Confidence 2 2345689999999999876 344 78999999999999999999999775432110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.............+++.+.+||++||..||.+|||++|+|+||||+.-
T Consensus 218 -------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 -------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000011112234578999999999999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=405.00 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=222.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
...++|++.+.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 83 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---- 83 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence 34467999999999999999999999999999999997543221 1356788999999999999999999998
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEeec
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDF 170 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DF 170 (619)
.+...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 84 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 -ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred -EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 34567999999997 69999998888899999999999999999999999999999999999999887 8999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 163 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~- 235 (326)
T 2y0a_A 163 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE- 235 (326)
T ss_dssp TTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC-
T ss_pred CCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC-
Confidence 99987532221 245679999999999876 68999999999999999999999999988876666555332111
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.....++.+++.+.+||.+||..||++|||++|+|+||||+.
T Consensus 236 --------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 236 --------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp --------------------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred --------------------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 111223567899999999999999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=404.68 Aligned_cols=254 Identities=26% Similarity=0.466 Sum_probs=219.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 4689999999999999999999999999999999974311 112345678999999999999999999998 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......|...
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------- 218 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 218 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 134689999999999987 68999999999999999999999999988776655554321
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. ...+.+++++.+||++||..||.+|| +++++++||||+++
T Consensus 219 ---------------~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 219 ---------------EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp ---------------CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ---------------CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 00 11235789999999999999999999 99999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=410.11 Aligned_cols=273 Identities=23% Similarity=0.236 Sum_probs=194.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.+|.+.+.||+|+||+||+|.+ +|+.||||+++.. ........+|+..+..|+|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 45799999999999999999976 6899999999742 122222345666677899999999999985432 12246
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCCCcEEEeecCc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
+|||||||+ |+|.++++.. .++++.+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 6999999765 599999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCc-cccccccCCccccCcccccccC----CCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 173 ARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~Y~APEll~~~~----~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
|+......... ......+||++|||||++.+.. ..|+.++|||||||+||||+||.+||.......
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~--------- 225 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ--------- 225 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC---------
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc---------
Confidence 98764433221 1223568999999999986521 136789999999999999999998875543211
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcc-cCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRK-KQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.|....... ..........+.. .....+...+ ...+..+.+|+.+||..||++|||+.|+++.
T Consensus 226 -~p~~~~~~~--~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 226 -LPYYDLVPS--DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp -CTTTTTSCS--SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred -ccchhcccc--cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 011000000 0000000111100 0001111111 1233568899999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=407.27 Aligned_cols=281 Identities=22% Similarity=0.408 Sum_probs=229.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----CCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----HPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----HpnIv~l~~v~~~~s 95 (619)
..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+. ||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~--- 106 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM--- 106 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE---
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee---
Confidence 45899999999999999999999999999999999974 2345566788999999997 999999999984
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC------------
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA------------ 161 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~------------ 161 (619)
....+|+|||||.++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 107 --~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 107 --YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp --ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred --ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 345799999999889999998754 5999999999999999999999999999999999999975
Q ss_pred -------------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC
Q 007064 162 -------------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (619)
Q Consensus 162 -------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~ 228 (619)
++.+||+|||+++...... ...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCC
Confidence 7899999999998643221 34679999999999987 68999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcc---------------ccCCCCCCCHHHHHHH
Q 007064 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQ---------------FSQKFPNADPSALRLL 293 (619)
Q Consensus 229 ~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~---------------~~~~~~~~s~~l~dLI 293 (619)
+||.+.+..+.+..+....+.+....+..........++.........+ ........++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9999999999999999988887776654432221111111000000000 0000012357888999
Q ss_pred HHhccCCCCCCCCHHHHHcCcccc
Q 007064 294 ERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 294 ~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
.+||+.||.+|||++|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=429.62 Aligned_cols=261 Identities=31% Similarity=0.495 Sum_probs=223.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 4689999999999999999999999999999999964322 234567789999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 176 (619)
.+|+|||||. ++|.+.+...+.+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 7999999998 6999999998899999999999999999999999999999999999999 56789999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .....+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 180 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 245 (484)
T 3nyv_A 180 EASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT------- 245 (484)
T ss_dssp CCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred cccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4322 1245689999999999875 6899999999999999999999999998877666655331111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.....|..+++.+++||.+||..||.+|||++|+|+||||+....
T Consensus 246 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 246 --------------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111234567899999999999999999999999999999986543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=405.50 Aligned_cols=266 Identities=22% Similarity=0.403 Sum_probs=216.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
.++|++++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 468999999999999999999999999999999997543 3445567788999999988 899999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999986332
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.......... .
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~------ 221 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------Q------ 221 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------c------
Confidence 221 2345789999999999987 689999999999999999999999996532111000 0
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa------~elL~hp~f~~~ 319 (619)
.........+... .. .....+++.+.+||++||..||.+||++ +|+++||||+++
T Consensus 222 --~~~~~~~~~i~~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 222 --NTEDYLFQVILEK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp ---CHHHHHHHHHHC-CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred --ccHHHHHHHHHcC-CC---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 0000000111111 11 1224578999999999999999999995 899999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=410.83 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=219.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
-..++|++++.||+|+||.||+|.++.+|+.||||++++... .......+.+|..+|..+ +||||+++++++ .
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence 356789999999999999999999999999999999974311 112345677899999876 899999999998 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 4567999999998 599999998888999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 169 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------- 233 (345)
T 1xjd_A 169 MLGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------- 233 (345)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred ccCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC----------
Confidence 32221 2355789999999999987 68999999999999999999999999988876655544220
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~-elL~hp~f~~~ 319 (619)
.. .....+++.+.+||.+||..||++||++. ++++||||+++
T Consensus 234 -----------------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 234 -----------------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp -----------------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -----------------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 00 11234789999999999999999999998 99999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=388.01 Aligned_cols=265 Identities=28% Similarity=0.488 Sum_probs=226.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 45789999999999999999999999999999999976656666778899999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGla~~~ 176 (619)
..|+||||+. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 7899999998 599999988888999999999999999999999999999999999999987655 999999999765
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------- 222 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc----------
Confidence 3322 1245679999999999887 67899999999999999999999999888766555444221
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
........+..+++.+.+||.+||..||++|||++|+|+||||++.....
T Consensus 223 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 223 -----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp -----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred -----------------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 11112233457889999999999999999999999999999998765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=413.60 Aligned_cols=267 Identities=21% Similarity=0.396 Sum_probs=214.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|+++.+++.||||++++... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 45789999999999999999999999999999999975432 223445678899999887 899999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|||||||. |+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 567999999998 5999999988899999999999999999999999999999999999999999999999999998533
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+....+....
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------------- 264 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------------- 264 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------
T ss_pred cCCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------------
Confidence 2222 2356789999999999987 6899999999999999999999999975432111000
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH------HHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA------EEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa------~elL~hp~f~~~ 319 (619)
.........+.. ... .....+++.+.+||++||+.||.+||++ +|+++||||+++
T Consensus 265 ---~~~~~~~~~i~~-~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 265 ---NTEDYLFQVILE-KQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp ---CCHHHHHHHHHH-CCC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ---hhHHHHHHHHhc-ccc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 000000011111 111 1224578999999999999999999985 899999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=400.13 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=211.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
-..++|++++.||+|+||.||+|.+. .+++.||+|+++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-- 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--
Confidence 35678999999999999999999985 6899999999975422 2234566789999999999999999999983
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 92 ---TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp ---CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred ---cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 4567999999998 599999998888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 169 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------- 236 (327)
T 3a62_A 169 KESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC------- 236 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------
T ss_pred cccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------
Confidence 75432221 1245689999999999876 67899999999999999999999999988776655544321
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
. ....+.+++.+.+||.+||..||.+|| +++|+|+||||+++
T Consensus 237 ---------------------~---~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 237 ---------------------K---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ---------------------C---CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ---------------------C---CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 0 011245789999999999999999999 89999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=418.05 Aligned_cols=291 Identities=34% Similarity=0.578 Sum_probs=216.7
Q ss_pred CCeEE-eEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKI-QEVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i-~~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+.|.+ .++||+|+||.||+|.++ .+++.||||++..... ...+.+|+.+|+.|+||||+++++++... ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH---AD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---TT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---CC
Confidence 45776 458999999999999966 5788999999975322 23577899999999999999999998542 34
Q ss_pred CcEEEEEecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEE
Q 007064 100 KDIYVVFELMESDLHQVIKAN---------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLK 166 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~---------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vK 166 (619)
..+|||||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 579999999999999988632 249999999999999999999999999999999999999 6778999
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---------h
Q 007064 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---------V 237 (619)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~---------~ 237 (619)
|+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+. .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999998754332222233557899999999998752 4589999999999999999999999987665 4
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHH-HHHHhhcccCC--c----cccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKAR-RYLTSMRKKQP--V----QFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~-~~l~~~~~~~~--~----~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
+++..|...+|.|....|..+...... ........... . .+.......++.+.+||.+||.+||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 889999999999998877665332111 11111111000 0 0011123447899999999999999999999999
Q ss_pred HcCccccCCCc
Q 007064 311 LADPYFKGLSK 321 (619)
Q Consensus 311 L~hp~f~~~~~ 321 (619)
|+||||.+...
T Consensus 332 L~hp~f~~~~~ 342 (405)
T 3rgf_A 332 MQDPYFLEDPL 342 (405)
T ss_dssp HTSGGGTSSSC
T ss_pred hcChhhccCCC
Confidence 99999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=408.02 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=219.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.++.+++.||||++++... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 45789999999999999999999999999999999974311 112345678899999887 799999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 567999999998 5999999988889999999999999999999999999999999999999999999999999998633
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 236 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 236 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cCCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2345789999999999987 68999999999999999999999999998876665555320
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. .....+++++.+||.+||..||.+|| +++++++||||+++
T Consensus 237 -----------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 237 -----------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 00 11235789999999999999999999 47999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=396.39 Aligned_cols=291 Identities=33% Similarity=0.572 Sum_probs=236.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~ 96 (619)
..++|++++.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999864332222223456777777666 89999999999853322
Q ss_pred CCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3456799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|..+.
T Consensus 169 ~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 64321 12345679999999999876 5799999999999999999999999999999999999999999887766
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
+........ ..........+...++.+++.+.+||.+||..||.+|||+.|+|+||||+++..
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 543211100 011112223344556788999999999999999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=406.77 Aligned_cols=256 Identities=21% Similarity=0.393 Sum_probs=220.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34578999999999999999999999999999999996421 1112346788999999999999999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 567999999997 6999999988889999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|...
T Consensus 193 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 253 (350)
T 1rdq_E 193 GR------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------- 253 (350)
T ss_dssp SC------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CC------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 32 134689999999999987 68999999999999999999999999988776655554320
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
.. .....+++.+.+||.+||..||.+||+ ++++++||||+++
T Consensus 254 -----------------~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 -----------------KV---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -----------------CC---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 00 112357899999999999999999998 9999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=422.98 Aligned_cols=266 Identities=24% Similarity=0.405 Sum_probs=222.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+|..++||||+++++++ .+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence 45789999999999999999999999999999999964210 011123378899999999999999999998 455
Q ss_pred CcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 67999999997 699999987 5689999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~---~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
.... ...+..+||++|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+....|....
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 297 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 297 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-------
Confidence 3322 22345689999999999862 11568999999999999999999999999998877776664310
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~~ 319 (619)
....+...+..+++++++||++||..+|++ |++++|+++||||+++
T Consensus 298 -------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 298 -------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp -------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred -------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 011233344678999999999999999988 9999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=402.84 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=215.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++++.||+|+||.||+|.++.+++.||||++.... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~ 77 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REG 77 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence 34678999999999999999999999999999999986432 222345688999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. ++|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..........
T Consensus 158 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------------- 222 (323)
T 3tki_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222 (323)
T ss_dssp TTE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-------------
T ss_pred CCc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------------
Confidence 221 1223456899999999998762 2347799999999999999999999987654322111100
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
........+..+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 223 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 223 ---------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ---------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00111122356789999999999999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=410.69 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=213.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++. +
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 467999999999999999999999999999999986321 11113567889999999999999999999983 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEeec
Q 007064 99 FKDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDF 170 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DF 170 (619)
...+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 467999999999 6998877542 35899999999999999999999999999999999999987654 999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+. .....+..
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~----- 246 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK----- 246 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH-----
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc-----
Confidence 99987543221 2245689999999999987 6799999999999999999999999987532 22222211
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.........++.+++.+.+||.+||..||++|||+.|+|+||||+..
T Consensus 247 ----------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 247 ----------------------GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 01111112345678999999999999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=396.52 Aligned_cols=267 Identities=26% Similarity=0.426 Sum_probs=225.1
Q ss_pred ccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007064 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHI 90 (619)
Q Consensus 15 ~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v 90 (619)
.+..-...++|++++.||+|+||.||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||++++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 4 PFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp CCBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3444445678999999999999999999999999999999997532221 135678899999999999999999999
Q ss_pred ecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cE
Q 007064 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KL 165 (619)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~v 165 (619)
+ .+...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 84 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 84 Y-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp E-----ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred E-----ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence 8 44567999999997 69999999888899999999999999999999999999999999999999888 79
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 159 kl~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 232 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232 (321)
T ss_dssp EECCCTTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred EEccCccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 9999999986543221 245679999999999876 6889999999999999999999999998887666655533
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..... ....+..+++.+.+||.+||..||++|||++|+|+||||+..
T Consensus 233 ~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 233 VSYDF---------------------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TCCCC---------------------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccccc---------------------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 21111 111234678899999999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=406.54 Aligned_cols=262 Identities=28% Similarity=0.411 Sum_probs=204.2
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
....++|++++.||+|+||.||+|.++.+++.||||++..... ....+.+|+.+++.++||||+++++++. +
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 87 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVIL-----T 87 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----e
Confidence 4567899999999999999999999999999999999975322 2345779999999999999999999994 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--EEEeecCcccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 175 (619)
...+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 467999999997 599999988888999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~-~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
..... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+.......+..
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~--------- 232 (361)
T 3uc3_A 168 SVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ--------- 232 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---------
T ss_pred ccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---------
Confidence 32221 1244679999999999876 45554 49999999999999999999987654322222111
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.+... ... ......+++.+.+||.+||..||++|||++|+|+||||...
T Consensus 233 --------------~~~~~-~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 233 --------------RILSV-KYS-IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --------------HHHTT-CCC-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --------------HHhcC-CCC-CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00000 000 01123578999999999999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=405.31 Aligned_cols=292 Identities=33% Similarity=0.581 Sum_probs=225.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC--CCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--RDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~--~~~ 99 (619)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ....+..+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 468999999999999999999999999999999986432 222345678888899999999999999865332 223
Q ss_pred CcEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEECC-CCcEEEeecCc
Q 007064 100 KDIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILANA-NCKLKICDFGL 172 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILi~~-~~~vKL~DFGl 172 (619)
..+|+|||||.++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3488999999998776654 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
++....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.|..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 986543322 2356789999999988652 45899999999999999999999999999999999999999999988
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCC----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQK----FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 324 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~ 324 (619)
+.+..+........ ........+... ....++.+.+||.+||+.||.+|||+.|+|+||||+++.....
T Consensus 254 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 254 EVLRKLNPSHTDVD---LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHCTTCCCGG---GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHhcccchhhcc---ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 87765432211100 001111122222 2346789999999999999999999999999999998765443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=409.41 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=217.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 87 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDE 87 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 3578999999999999999999999999999999986421 1122346788999999999999999999998 455
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. |+|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 67999999997 59999999988999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....+||+.|+|||++... ...|+.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 168 ~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------ 231 (384)
T 4fr4_A 168 ET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------ 231 (384)
T ss_dssp TC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------------
T ss_pred CC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 22 23567899999999998642 14689999999999999999999999986543222111110
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-HHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-AEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-a~elL~hp~f~~~ 319 (619)
+.. . .......+++.+.+||.+||..||.+||+ ++++++||||+++
T Consensus 232 ------------~~~-~---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 232 ------------FET-T---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ------------HHH-C---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ------------Hhh-c---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 000 0 01122457899999999999999999998 9999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=396.02 Aligned_cols=289 Identities=31% Similarity=0.595 Sum_probs=226.9
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 95 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s 95 (619)
.+++..++|++++.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~- 103 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP- 103 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccC-
Confidence 3456778999999999999999999999999999999998742 2456889999999997 99999999998542
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla 173 (619)
.....|+||||+. ++|.+++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 104 --~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 104 --VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp --TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 2457899999999 58888874 499999999999999999999999999999999999999777 8999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC-CCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF-~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+....... ....++|+.|+|||++.+. ..++.++|||||||++|+|++|..|| .+.+..+++..+...++.+..
T Consensus 179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 179 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 86543222 2445799999999998652 57899999999999999999999888 556777778888777775443
Q ss_pred hhhh-hhcchhHHHHHHhhcccCCccccCC-----CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 253 DTIS-RVRNDKARRYLTSMRKKQPVQFSQK-----FPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 253 e~i~-~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.... .........+...........+... ...+++.+.+||.+||..||++|||++|+|+||||+++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 2221 1111111111111111111111111 1237899999999999999999999999999999997653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=407.89 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=212.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHH-HHhcCCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKL-LRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~i-L~~L~HpnIv~l~~v~~~~s~~ 97 (619)
...++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|..+ ++.++||||+++++++ .
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence 345789999999999999999999999999999999975432 23345567778776 5778999999999998 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 4567999999998 599999998888999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....|...
T Consensus 190 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------- 254 (373)
T 2r5t_A 190 IEHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---------- 254 (373)
T ss_dssp BCCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred ccCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence 33222 1245789999999999987 68999999999999999999999999988876665555320
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH----HHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA----EEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa----~elL~hp~f~~~ 319 (619)
.. ...+.+++.+.+||++||..||.+||++ +++++||||+++
T Consensus 255 ------------------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 255 ------------------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ------------------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ------------------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01 1224678999999999999999999986 799999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=407.65 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=220.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+|+.||+|++... ...+...+.+|+.+|+.|+||||+++++++ .+..
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSS
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCC
Confidence 346899999999999999999999999999999999753 334556788999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~ 176 (619)
.+|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 7999999998 59999997654 7999999999999999999999999999999999999974 477999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 202 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---------- 265 (387)
T 1kob_A 202 NPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------- 265 (387)
T ss_dssp CTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC----------
T ss_pred CCCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 43221 234579999999999987 67999999999999999999999999998876665554321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........+..+++.+.+||.+||..||++|||++|+|+||||++.
T Consensus 266 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 -----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp -----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1111123456789999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=386.22 Aligned_cols=262 Identities=25% Similarity=0.335 Sum_probs=219.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.....|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4566799999999999999999999999999999999876666677888999999999999999999999875432 234
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCcEEEeecCcccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARV 175 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~-~~~~vKL~DFGla~~ 175 (619)
..+|+||||++ ++|.+++.....+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 67999999997 599999998888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+......
T Consensus 182 ~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------- 244 (290)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---------
T ss_pred ccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc---------
Confidence 43221 234679999999998864 6899999999999999999999999876544333221110
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... ........++.+.+||.+||..||.+|||++++|+||||++
T Consensus 245 ----------------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 245 ----------------GVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------TCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------cCC---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 000 11112345789999999999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=417.77 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=211.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++. +.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence 3478999999999999999999999999999999997432 22334567789999999999999999999983 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|||||||+ ++|.+++.....+++..++.|+.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 67999999998 5999999888899999999999999999999998 999999999999999999999999999997533
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 301 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 364 (446)
T 4ejn_A 301 KDGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----------- 364 (446)
T ss_dssp C--------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred CCCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2221 2355789999999999977 68999999999999999999999999988776555544220
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. .....+++.+.+||.+||..||.+|| |++|+|+||||+++
T Consensus 365 -----------------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 365 -----------------EI---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 00 11235789999999999999999999 99999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=403.20 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=213.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++..... ...+|+.+|..+ +||||+++++++ .+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~ 88 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVY-----DDG 88 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEE-----EcC
Confidence 34679999999999999999999999999999999975432 234688888887 799999999998 455
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CcEEEeecCccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN----CKLKICDFGLAR 174 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~----~~vKL~DFGla~ 174 (619)
..+|+|||||. |+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+|||+..+ +.+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 67999999998 5999999988899999999999999999999999999999999999998543 359999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh---hHHHHHHHhhhCCCc
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV---VHQLDLMTDLLGTPS 251 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~---~~~l~~i~~~~g~p~ 251 (619)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+... .+.+..|
T Consensus 169 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i-------- 235 (342)
T 2qr7_A 169 QLRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-------- 235 (342)
T ss_dssp ECBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH--------
T ss_pred cCcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH--------
Confidence 6543322 1245689999999999876 5688999999999999999999999976432 1222221
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
...........|+.+++.+.+||++||..||++|||++++|+||||.++..
T Consensus 236 -------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 236 -------------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp -------------------HHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred -------------------ccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 111112223356788999999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=416.24 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=219.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.++.+++.||+|++.+... .......+.+|+.+|+.++||||+++++++ .+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EE
Confidence 355789999999999999999999999999999999964210 011123477899999999999999999999 45
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|||||||. |+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++...
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 567999999997 6999999764 69999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCccccccccCCccccCcccccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~--~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
... .......+||+.|+|||++.+... .|+.++|||||||++|||++|++||.+.+..+....|.....
T Consensus 220 ~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------- 290 (410)
T 3v8s_A 220 KEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------- 290 (410)
T ss_dssp TTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------
T ss_pred cCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-------
Confidence 322 112346789999999999875211 188999999999999999999999999887777666643100
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCC--CCCHHHHHcCccccCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD--RPTAEEALADPYFKGL 319 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~k--RpSa~elL~hp~f~~~ 319 (619)
... ...+..+++++++||.+||..+|.+ |++++||++||||+++
T Consensus 291 -------------------~~~-~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 291 -------------------SLT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp -------------------HCC-CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred -------------------ccc-CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 000 0123468999999999999999988 9999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=394.78 Aligned_cols=252 Identities=27% Similarity=0.310 Sum_probs=208.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||+||+|.++.+|+.||||++..............+|+..+..+ +||||+++++++ .+...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 579999999999999999999999999999999876656666666677777776655 899999999998 34567
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||+++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999987653322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+...... +..
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--------------- 266 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--------------- 266 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT---------------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc---------------
Confidence 1 234579999999999875 689999999999999999999877755432211 100
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
. .........+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 267 ------------~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 267 ------------G--YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ------------T--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ------------c--CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 0 0001122457899999999999999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=391.89 Aligned_cols=261 Identities=25% Similarity=0.472 Sum_probs=209.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hHHHHHHHHHHHHH
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------------------------ISDAARILREIKLL 76 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~------------------------~~~~~~i~~Ei~iL 76 (619)
..++|++++.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999999999999999998643211 11235688999999
Q ss_pred HhcCCCCcceeeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 77 ~~L~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+.++||||+++++++... ....+|+|||||+ ++|.+++ ....+++..++.++.||+.||.|||+.||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999998542 2467999999998 5777654 3457999999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~-~y~~~~DIWSLG~ilyeLltG~~pF~~~ 234 (619)
|||++.++.+||+|||+++....... .....+||+.|+|||++.+... .++.++|||||||++|+|++|..||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999986543221 2345689999999999876211 1478899999999999999999999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
+.......+.. ....+ ...+.+++.+.+||.+||..||++|||++|+|+||
T Consensus 244 ~~~~~~~~~~~----------------------------~~~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 244 RIMCLHSKIKS----------------------------QALEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SHHHHHHHHHH----------------------------CCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred cHHHHHHHHhc----------------------------ccCCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 65443333211 00011 12356889999999999999999999999999999
Q ss_pred ccc
Q 007064 315 YFK 317 (619)
Q Consensus 315 ~f~ 317 (619)
||+
T Consensus 295 ~~~ 297 (298)
T 2zv2_A 295 WVT 297 (298)
T ss_dssp HHH
T ss_pred ccc
Confidence 996
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=391.05 Aligned_cols=283 Identities=31% Similarity=0.534 Sum_probs=230.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE-CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEecC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID-THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIMLP 93 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~-~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~~ 93 (619)
..++|++++.||+|+||.||+|.+ +.+++.||||++.. .......+.+|+.+++.++|++ |+++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-- 86 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-- 86 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE--
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc--
Confidence 357999999999999999999998 56889999999974 2345667889999999987654 89999988
Q ss_pred CCCCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----------
Q 007064 94 PSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---------- 161 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---------- 161 (619)
.+...+|+|||||+++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 87 ---~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 87 ---EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ---EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ---ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 3446799999999999999998765 6899999999999999999999999999999999999987
Q ss_pred ---------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007064 162 ---------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (619)
Q Consensus 162 ---------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~ 232 (619)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999764322 134579999999999987 689999999999999999999999999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchh--------------HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhcc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDK--------------ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 298 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~ 298 (619)
+.+..+.+..+....+......+....... ...+..... .....+.......++.+.+||.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHhC
Confidence 999999999999988887776655432211 111111110 00111111122345789999999999
Q ss_pred CCCCCCCCHHHHHcCccccCCC
Q 007064 299 FDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 299 ~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.||.+|||++|+|+||||+.+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=414.90 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=218.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++ .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 4578999999999999999999999999999999996421 1112234478899999999999999999998 455
Q ss_pred CcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|||||||. |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 67999999997 6999999874 479999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~-----~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
.... ......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+....|....
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 3221 112346899999999998621 1468999999999999999999999999988777666654310
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC---CCHHHHHcCccccCC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR---PTAEEALADPYFKGL 319 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR---pSa~elL~hp~f~~~ 319 (619)
....+......+++++++||++||. ||.+| ++++|+++||||+++
T Consensus 287 ---------------------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 287 ---------------------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---------------------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ---------------------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 0011112234689999999999999 99998 599999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=399.74 Aligned_cols=264 Identities=26% Similarity=0.463 Sum_probs=194.9
Q ss_pred CCeEEe---EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQ---EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~---~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~ 98 (619)
++|++. +.||+|+||.||+|.++.+++.||||++... ....+.+|+.+|+.+. ||||+++++++ .+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~ 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HD 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----Ec
Confidence 357765 7899999999999999999999999999642 3456778999999997 99999999998 45
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEeecCccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFGLAR 174 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFGla~ 174 (619)
...+|+|||||+ ++|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 567999999998 59999999998999999999999999999999999999999999999998765 89999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 218 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-------------- 218 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------------
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------------
Confidence 6433221 2345678999999999977 68999999999999999999999999875431100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
......+..+...........+..+++++.+||.+||..||.+|||++|+|+||||++...
T Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 219 ------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp ------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred ------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 0000111111111111122234568899999999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.08 Aligned_cols=258 Identities=30% Similarity=0.486 Sum_probs=211.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|.+.+.||+|+||.||+|.++.++..||+|++..... ......+.+|+.+|+.++||||+++++++ .+.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecC
Confidence 455789999999999999999999999999999999975432 23456788999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecC
Q 007064 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFG 171 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFG 171 (619)
..+|+|||||. ++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 67999999998 499988853 3679999999999999999999999999999999999999 456789999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------ 239 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------ 239 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------
Confidence 9976433221 244679999999999864 689999999999999999999999988775544333211
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
....+......+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 240 ----------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 ----------------------KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------------CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------------CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011111222347899999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=399.60 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=202.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||+|+||.||+|.++.+++.||||++... ...+.+.+|+.+|+.++||||+++++++. +...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~ 122 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTE 122 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCe
Confidence 36799999999999999999999999999999999753 23456788999999999999999999983 4467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGla~~~~ 177 (619)
+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999998 599999988888999999999999999999999999999999999999975 8899999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~-~l~~i~~~~g~p~~e~i~ 256 (619)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~------------ 264 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------------ 264 (349)
T ss_dssp --------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH------------
T ss_pred ccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH------------
Confidence 321 1245679999999999887 679999999999999999999999997765433 222221
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..........++.++..+.+||.+||..||++|||++|+|+||||.+..
T Consensus 265 ---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 265 ---------------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1111122334567899999999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=382.48 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=219.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||+|+||.||+|.++.++..||+|++..... .....+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCe
Confidence 4679999999999999999999999999999999975432 2356788999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~~ 177 (619)
+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998 5999999888889999999999999999999999999999999999999 788999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 226 (277)
T 3f3z_A 161 PGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF------- 226 (277)
T ss_dssp TTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred Ccc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 322 1245679999999999865 58999999999999999999999999887766655543321111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
....+..+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 227 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 227 --------------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp --------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred --------------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 111234678999999999999999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=402.76 Aligned_cols=283 Identities=27% Similarity=0.406 Sum_probs=226.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--------CCCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--------HPDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--------HpnIv~l~~v~~~ 93 (619)
.++|++++.||+|+||.||+|++..+++.||||++.. .......+.+|+.+|+.++ ||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999999999999999999974 3445677889999999986 7889999998853
Q ss_pred CCCCCCCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCC-------
Q 007064 94 PSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANC------- 163 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~------- 163 (619)
.. .+...+|+|||||+++|.+.+... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 134579999999999888888764 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEeecCccccccCCCCCccccccccCCccccCcccc
Q 007064 164 ------------------------------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201 (619)
Q Consensus 164 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll 201 (619)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2445799999999999
Q ss_pred cccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCC
Q 007064 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN------VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275 (619)
Q Consensus 202 ~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~------~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~ 275 (619)
.+ ..|+.++|||||||++|+|++|++||.+.+ ..+.+..+...+|.+....+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 679999999999999999999999998765 56778888899998877665332111 011100000000
Q ss_pred ccc-------------cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 276 VQF-------------SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 276 ~~~-------------~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... .......++.+.+||.+||..||++|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0001123467899999999999999999999999999973
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=397.54 Aligned_cols=268 Identities=29% Similarity=0.451 Sum_probs=215.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF---EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~---~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 467999999999999999999999999999999986421 1334567889999999999999999999998 44
Q ss_pred CCcEEEEEecCC-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 007064 99 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHYQFFLYQLLR 137 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~----------------------------------------~~~l~e~~i~~i~~QIl~ 137 (619)
...+|+|||||+ |+|.+++.. ...+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 567999999997 699998842 112467889999999999
Q ss_pred HHHHHHHCCceeccCCCCcEEECCCC--cEEEeecCccccccCCCC-CccccccccCCccccCcccccccCCCCCCcccc
Q 007064 138 ALKYIHTANVYHRDLKPKNILANANC--KLKICDFGLARVAFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (619)
Q Consensus 138 aL~yLHs~gIvHrDLKP~NILi~~~~--~vKL~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DI 214 (619)
||.|||+.||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986533221 111234568999999999986533678999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHH
Q 007064 215 WSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 294 (619)
Q Consensus 215 WSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~ 294 (619)
|||||++|+|++|+.||.+.+..+.+..+.... .......+..+++.+.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK---------------------------LCFENPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------CCTTSGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc---------------------------cccCCcccccCCHHHHHHHH
Confidence 999999999999999999988766655543211 11111223457899999999
Q ss_pred HhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 295 RLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 295 ~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
+||..||.+|||+.++|+||||+++..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=390.80 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=214.5
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.|...+.||+|+||.||+|.++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++. ....+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYL-----VGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 4888999999999999999999999999999986432 233566889999999999999999999984 345699
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 589988764 46999999999999999999999999999999999999999999999999999865433221
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--------------- 257 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--------------- 257 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 245689999999999876 678999999999999999999999998877655544432210
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.........+++.+.+||.+||..||++|||++++|+||||.+.
T Consensus 258 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 258 -------------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00011123468899999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=413.71 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=219.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|.+++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~ 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TP 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence 45789999999999999999999999999999999964211 1123457889999999999999999999984 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 67999999997 69999998888999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 169 ~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 169 GE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp TC----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred cc----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 22 23456899999999998762 234789999999999999999999999887665554443210
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
......+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 233 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01123478899999999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=397.94 Aligned_cols=280 Identities=32% Similarity=0.534 Sum_probs=227.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCC-----cceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD-----IVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hpn-----Iv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.++.+++.||||++.. .......+.+|+.+++.++ |++ |+.+++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 4789999999999999999999999999999999974 2344566778999998885 553 899999884
Q ss_pred CCCCCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEEEC--CCCcEEEee
Q 007064 96 RRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIH--TANVYHRDLKPKNILAN--ANCKLKICD 169 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILi~--~~~~vKL~D 169 (619)
....+|||||||+++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 127 --~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 --FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp --ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred --cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 34679999999999999999875 46999999999999999999999 57999999999999995 478899999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875322 245689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCC---------cccc-CC------------------CCC-------CCHHHHHHHH
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQP---------VQFS-QK------------------FPN-------ADPSALRLLE 294 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~---------~~~~-~~------------------~~~-------~s~~l~dLI~ 294 (619)
|....+... ...+.++..+..... ..+. .. ... .++.+++||.
T Consensus 277 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 887766532 222333322211000 0000 00 000 0147899999
Q ss_pred HhccCCCCCCCCHHHHHcCccccCC
Q 007064 295 RLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 295 ~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+||++||++|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=385.19 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=217.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|.+++.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCE
Confidence 46899999999999999999999999999999999753 223345688999999999999999999998 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~~ 177 (619)
+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999998 5999999888889999999999999999999999999999999999999 778899999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 161 ~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------- 223 (304)
T 2jam_A 161 NG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY---------- 223 (304)
T ss_dssp CB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC----------
T ss_pred CC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC----------
Confidence 22 1234579999999999876 679999999999999999999999998887655554443211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.......+..+++.+.+||.+||..||++|||++++|+||||++..
T Consensus 224 -----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 224 -----------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111233457889999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=393.63 Aligned_cols=262 Identities=25% Similarity=0.420 Sum_probs=206.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC------
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR------ 96 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~------ 96 (619)
++|++++.||+|+||.||+|.++.+|+.||||++.... .....+.+.+|+.+|+.|+||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57999999999999999999999999999999997532 34456788999999999999999999998854321
Q ss_pred ----------------------------------------------CCCCcEEEEEecCC-ccHHHHHHhCCC---CCHH
Q 007064 97 ----------------------------------------------RDFKDIYVVFELME-SDLHQVIKANDD---LTRE 126 (619)
Q Consensus 97 ----------------------------------------------~~~~~lylV~E~~~-g~L~~~i~~~~~---l~e~ 126 (619)
.....+|+|||||+ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999999 499999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCc---------cccccccCCccccC
Q 007064 127 HYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT---------IFWTDYVATRWYRA 197 (619)
Q Consensus 127 ~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~A 197 (619)
.++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998754432111 12244679999999
Q ss_pred cccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcc
Q 007064 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQ 277 (619)
Q Consensus 198 PEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~ 277 (619)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+...... .
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~---------------------------~ 290 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL---------------------------K 290 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT---------------------------C
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc---------------------------C
Confidence 999887 6899999999999999999998766411 11111110000 1
Q ss_pred ccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 278 FSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 278 ~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
+...+...++.+.+||.+||..||++|||++|+|+||||+++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 111122346788999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=391.58 Aligned_cols=281 Identities=25% Similarity=0.382 Sum_probs=209.8
Q ss_pred CCCCeEEe-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~-~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|..+ +||||+++++++. +
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~ 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----E 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----e
Confidence 45789995 78999999999999999999999999997532 23456788999999885 7999999999984 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEeecCccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGLAR 174 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGla~ 174 (619)
...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 467999999998 699999998888999999999999999999999999999999999999998776 9999999987
Q ss_pred cccCCCC----CccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 175 VAFNDTP----TTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
....... ........+||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~------- 235 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG------- 235 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC-------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc-------
Confidence 6432211 11112345799999999998631 135788999999999999999999999876532100
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
-...+. ...........+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 236 -~~~~~~----~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 -WDRGEA----CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -C----C----CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred -cccccc----chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000000 00000111111111111111223356889999999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=382.27 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=215.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCC
Confidence 4689999999999999999999999999999999864211 112245688999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 7999999999 599999988888999999999999999999999999999999999999999999999999998653322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 1 234579999999999877 678999999999999999999999998887655554442210
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
. .....+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 224 ----------------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 ----------------F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ----------------C---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ----------------C---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0 112346889999999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=405.96 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=205.8
Q ss_pred CCCCCeEEe-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~-~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~~s~~ 97 (619)
...++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++ +.++||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 345678887 7899999999999999999999999999632 3466888887 4558999999999884311 2
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEeecC
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFG 171 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFG 171 (619)
+...+|||||||. |+|.+++...+ .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 3457999999998 59999998754 5999999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH----HHHHHHhhh
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLMTDLL 247 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~----~l~~i~~~~ 247 (619)
+++...... ..+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+... ....+
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---- 279 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---- 279 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----
Confidence 998643221 2345689999999999976 689999999999999999999999998765321 11111
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
...........|..+++++.+||++||..||++|||++|+|+||||.+..
T Consensus 280 -----------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 280 -----------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -----------------------HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -----------------------HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 01111111234567899999999999999999999999999999998643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=392.76 Aligned_cols=270 Identities=24% Similarity=0.350 Sum_probs=216.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 356789999999999999999999999999999999975432 3445667889999999999999999999885432 12
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 234699999998 6999999988899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~----------- 234 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----------- 234 (311)
T ss_dssp --------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred ccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----------
Confidence 43322222345679999999999877 68999999999999999999999999988765554333221
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...........+++.+.+||.+||..||++||++.++|.|+|++..
T Consensus 235 ----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 ----------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----------------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111222345688999999999999999999999999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=395.24 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=217.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++. +
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 125 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----R 125 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence 3446799999999999999999999999999999999754322 334567899999999999999999999984 3
Q ss_pred CCcEEEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMESDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|||||||.|+|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 126 ~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 45799999999999998885 45679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.. ...+||+.|+|||++.+ ....++.++|||||||++|||++|.+||.+.+....+..+...
T Consensus 206 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------- 268 (348)
T 1u5q_A 206 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------- 268 (348)
T ss_dssp SB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred CC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------
Confidence 21 34579999999998742 1257899999999999999999999999887765554433211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+ ......+++.+.+||.+||..||++|||++++|+||||..
T Consensus 269 ----------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 269 ----------------ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------------CCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 000 0112357889999999999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=400.13 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=212.9
Q ss_pred CCeEE--eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 23 SRYKI--QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 23 ~rY~i--~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|+++. ........+.+|+.+|+.|+||||+++++++ .+..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc--cccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence 34555 6789999999999999999999999999975 2345667889999999999999999999998 3456
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE--CCCCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA--NANCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi--~~~~~vKL~DFGla~~~ 176 (619)
.+|||||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 7999999998 5998888654 469999999999999999999999999999999999999 56789999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~------- 306 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD------- 306 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-------
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 43221 234579999999999876 67899999999999999999999999998877776665432111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.....++.+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 307 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 307 --------------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp --------------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred --------------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1123346789999999999999999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=387.98 Aligned_cols=283 Identities=31% Similarity=0.522 Sum_probs=228.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC------cceeeeEecC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD------IVEIKHIMLP 93 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg-~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn------Iv~l~~v~~~ 93 (619)
..++|++++.||+|+||.||+|.+..++ ..||+|++.. .......+.+|+.+|+.++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-- 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-- 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE--
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee--
Confidence 3579999999999999999999998877 6899999974 2345667889999999998766 88888887
Q ss_pred CCCCCCCcEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE------------
Q 007064 94 PSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA------------ 159 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi------------ 159 (619)
.....+|||||||+++|.+.+.... .+++..++.|+.||+.||.|||+.||+||||||+|||+
T Consensus 92 ---~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 ---NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ---EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ---eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 3446799999999999998887654 69999999999999999999999999999999999999
Q ss_pred -------CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 007064 160 -------NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (619)
Q Consensus 160 -------~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~ 232 (619)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999998643221 34579999999999976 689999999999999999999999999
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchh--------------HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhcc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDK--------------ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLA 298 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~--------------~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~ 298 (619)
+.+..+.+..+...++.+....+....... ..+++..... ............++.+.+||.+||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhc
Confidence 999999999999999888776654432211 1111111100 0000011112235688999999999
Q ss_pred CCCCCCCCHHHHHcCccccCCC
Q 007064 299 FDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 299 ~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.||.+|||++|+|+||||+++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=392.20 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=208.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++. +
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----e
Confidence 457899999999999999999987 468899999997655566667889999999999986 99999999984 4
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|||||++.++|.+++.....+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 46799999988889999999999999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhC
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLG 248 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~---------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~-~~l~~i~~~~g 248 (619)
... .......+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---- 234 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---- 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH----
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh----
Confidence 221 1123456899999999997531 146889999999999999999999999764321 1111110
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..... .......+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 235 ----------------------~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 ----------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------cCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00011 11123456789999999999999999999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=378.29 Aligned_cols=265 Identities=28% Similarity=0.425 Sum_probs=224.5
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
...-...++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--- 84 (294)
T 2rku_A 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--- 84 (294)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred eeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee---
Confidence 344567789999999999999999999999999999999986543 3345567788999999999999999999998
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
.+...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 85 --~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 85 --EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162 (294)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred --ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCc
Confidence 34567999999999 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 163 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------- 229 (294)
T 2rku_A 163 TKVEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-------- 229 (294)
T ss_dssp EECCSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------
T ss_pred eecccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh--------
Confidence 865322221 244679999999999876 6789999999999999999999999988775544333211
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.. ......+++.+.+||.+||..||++|||++++|+||||.....
T Consensus 230 --------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 230 --------------------NE---YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp --------------------TC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred --------------------cc---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 00 0112357889999999999999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=407.54 Aligned_cols=255 Identities=17% Similarity=0.217 Sum_probs=202.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHH---HHHhcCCCCcceee-------e
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIK---LLRLLRHPDIVEIK-------H 89 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~---iL~~L~HpnIv~l~-------~ 89 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++... .......+.+.+|+. +|+.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 347899999999999999999999999999999999743 233446678889995 45555799999998 5
Q ss_pred EecCCCC-------CCCC-----cEEEEEecCCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 007064 90 IMLPPSR-------RDFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHYQFFLYQLLRALKYIHTANVYHR 150 (619)
Q Consensus 90 v~~~~s~-------~~~~-----~lylV~E~~~g~L~~~i~~~~~l~e-------~~i~~i~~QIl~aL~yLHs~gIvHr 150 (619)
++..... .+.. ..|||||||+|+|.+++...+.+++ ..++.|+.||+.||.|||+.||+||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5432210 0111 3899999999999999987655655 7888899999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCC-----------CCCCcccchhHHH
Q 007064 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGC 219 (619)
Q Consensus 151 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~-----------~y~~~~DIWSLG~ 219 (619)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999985321 2245577 99999999876 4 6899999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccC
Q 007064 220 IFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 299 (619)
Q Consensus 220 ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~ 299 (619)
++|||++|+.||.+.+...... .....++.+++.+.+||.+||..
T Consensus 302 il~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp HHHHHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCS
T ss_pred HHHHHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCHHHHHHHHHHcCC
Confidence 9999999999997654321110 01122357889999999999999
Q ss_pred CCCCCCCHHHHHcCccccCC
Q 007064 300 DPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 300 DP~kRpSa~elL~hp~f~~~ 319 (619)
||++|||+.++|+||||+++
T Consensus 347 dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 347 PKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp SGGGCCCHHHHHTSHHHHHH
T ss_pred CchhCCCHHHHhhChHHHHH
Confidence 99999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=386.91 Aligned_cols=265 Identities=28% Similarity=0.421 Sum_probs=224.6
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
.......++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--- 110 (335)
T 2owb_A 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--- 110 (335)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 334456789999999999999999999999999999999986542 3445667788999999999999999999998
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
.+...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 111 --~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 111 --EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188 (335)
T ss_dssp --ECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred --ecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCc
Confidence 34567999999999 599999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 189 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------- 256 (335)
T 2owb_A 189 TKVEYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 256 (335)
T ss_dssp EECCSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------
T ss_pred eecccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------
Confidence 865432221 244679999999999876 67899999999999999999999999887755444333210
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.. .....+++.+.+||.+||..||++|||++|+|+||||.....
T Consensus 257 ---------------------~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 257 ---------------------EY---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ---------------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ---------------------CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 112357889999999999999999999999999999986543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=390.15 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=220.0
Q ss_pred CCCCCeEEe-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~-~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~ 97 (619)
...++|.+. +.||+|+||.||+|.++.+++.||+|++............+.+|+.+|+.+. ||||+++++++ .
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~ 99 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----E 99 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 345778888 8999999999999999999999999999865544455677899999999995 69999999998 4
Q ss_pred CCCcEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEeecC
Q 007064 98 DFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFG 171 (619)
Q Consensus 98 ~~~~lylV~E~~~g-~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFG 171 (619)
+...+|+|||||.+ +|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 55679999999985 999988543 67999999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 180 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--- 250 (327)
T 3lm5_A 180 MSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV--- 250 (327)
T ss_dssp GCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred cccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc---
Confidence 9986543221 234679999999999976 6899999999999999999999999999887666555433211
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
......+..+++.+.+||.+||..||.+|||++++|+||||+++.
T Consensus 251 ------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 251 ------------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp ------------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred ------------------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 112234467889999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=377.06 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=208.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.++..+ +||||+++++++. +...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 579999999999999999999999999999999986655566778889999999999 8999999999984 4457
Q ss_pred EEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--------------
Q 007064 102 IYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-------------- 162 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-------------- 162 (619)
+|+|||||++ +|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999985 999999764 679999999999999999999999999999999999999844
Q ss_pred -----CcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh
Q 007064 163 -----CKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 237 (619)
Q Consensus 163 -----~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~ 237 (619)
..+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|.++|......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 47999999999865432 223699999999998762 36678999999999999999999887544321
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
..+. .. ........+++.+.+||.+||..||++|||++++|+||||.
T Consensus 238 ---~~~~---------------------------~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 ---HEIR---------------------------QG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp ---HHHH---------------------------TT---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred ---HHHH---------------------------cC---CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1110 00 01122346789999999999999999999999999999998
Q ss_pred CC
Q 007064 318 GL 319 (619)
Q Consensus 318 ~~ 319 (619)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 63
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=377.39 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=217.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
++|++++.||+|+||.||+|.++.+++.||+|+++...... .....+.+|+.+|+.++||||+++++++. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 57999999999999999999999999999999987532221 13567889999999999999999999984 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEeecCcc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDFGLA 173 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DFGla 173 (619)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 467999999997 69999998888899999999999999999999999999999999999998877 8999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 229 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYD---- 229 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccC----
Confidence 86533221 234579999999999876 67899999999999999999999999988766655544321111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.....++.+++.+.+||.+||..||++|||++++|+||||+.+.
T Consensus 230 -----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 230 -----------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -----------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -----------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11122356788999999999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=426.77 Aligned_cols=258 Identities=22% Similarity=0.384 Sum_probs=221.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.++.+++.||||++++.. ........+.+|..+|..+ +||+|+.+++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4578999999999999999999999999999999997421 1122345678899999887 699999999998 45
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 567999999998 5999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred cCCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 2222 2356789999999999987 68999999999999999999999999998877766655321
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA-----EEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa-----~elL~hp~f~~~ 319 (619)
.. .....+++++.+||++||..||.+||++ +||++||||+++
T Consensus 558 -----------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 558 -----------------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred -----------------CC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 01 1123578999999999999999999997 999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=406.01 Aligned_cols=260 Identities=33% Similarity=0.535 Sum_probs=205.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~------~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
.++|.+.+.||+|+||.||+|.++.+++.||||++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 47899999999999999999999999999999998643211 122335789999999999999999999873
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cEEEeecC
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KLKICDFG 171 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~vKL~DFG 171 (619)
...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 235899999998 59999998888999999999999999999999999999999999999997544 59999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhhCC
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLMTDLLGT 249 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l-~~i~~~~g~ 249 (619)
+++...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|.+||.+......+ ..+.
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~----- 358 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----- 358 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-----
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-----
Confidence 998653321 2345689999999998753 1256888999999999999999999999775432222 1111
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..........+..+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 359 ----------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 359 ----------------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11111122334568899999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=380.13 Aligned_cols=265 Identities=29% Similarity=0.353 Sum_probs=214.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..++..||+|++.... .......++.+|+.+++.++||||+++++++ .+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 3578999999999999999999999999999999985432 3445567889999999999999999999998 455
Q ss_pred CcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+|||||+| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 679999999985 9999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 164 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------- 226 (294)
T 4eqm_A 164 TSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------- 226 (294)
T ss_dssp -------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS-------------
T ss_pred cccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-------------
Confidence 2211 1234679999999999877 6789999999999999999999999998876544322211
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
...+.......+.+++.+.+||.+||..||.+||+..+.|.+.|..-+.
T Consensus 227 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 -------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111223456889999999999999999999766677777765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=379.44 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=218.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++. +.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence 45789999999999999999999999999999999864211 1112456889999999999999999999983 45
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 67999999998 59999999888899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------ 227 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------ 227 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred cc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------
Confidence 21 234579999999999887 67899999999999999999999999887765544333210
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
.. ...+.+++.+.+||.+||..||.+|||++++|+||||+....
T Consensus 228 ----------------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 ----------------DL---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ----------------CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ----------------cc---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 112457889999999999999999999999999999986443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=377.49 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=220.7
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC---C----hHHHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---H----ISDAARILREIKLLRLLR-HPDIVEIKHIM 91 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~---~----~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~ 91 (619)
+..++|++.+.||+|+||.||+|.++.+|+.||||++..... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456899999999999999999999999999999999964321 1 123456789999999996 99999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 92 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
.+...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 94 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 -----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp -----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred -----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 44567999999998 699999998888999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~----~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~ 246 (619)
|++........ .....+++.|+|||++.+ ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99976543221 244679999999998752 1246889999999999999999999999888765555444321
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. .......++.+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 245 ~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 N---------------------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp C---------------------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred C---------------------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1 1111123346788999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=379.20 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=198.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+|+.||+|++............+.++..+++.++||||+++++++. +..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 357899999999999999999999999999999999764333333444445555688889999999999984 445
Q ss_pred cEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 101 DIYVVFELMESDLHQVIK----ANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~----~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+|+|||||+++|.+++. ....+++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 799999999998877765 356899999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCCCccccccccCCccccCcccccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCCch
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSL 252 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~--~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~-~~~l~~i~~~~g~p~~ 252 (619)
...... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||..... ...+..+..
T Consensus 160 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 228 (290)
T 3fme_A 160 LVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE------- 228 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH-------
T ss_pred cccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc-------
Confidence 543322 133479999999999631 125789999999999999999999999976432 222221111
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
... .......+++.+.+||.+||..||++|||++|+|+||||+.
T Consensus 229 -------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 229 -------------------EPS---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------------------SCC---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------------cCC---CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 000 01112357889999999999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=389.64 Aligned_cols=259 Identities=28% Similarity=0.488 Sum_probs=217.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------hHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH------ISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~------~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
++|++.+.||.|+||.||+|.++.+|+.||||++...... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 5799999999999999999999999999999998643221 12245678999999999 7999999999983
Q ss_pred CCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 96 RRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
....+|+|||||+| +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 44679999999985 999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~----~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
....... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~- 323 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ- 323 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-
Confidence 6543221 2456899999999987531 135889999999999999999999999887766555544321111
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
.....+..+++.+.+||.+||..||++|||++++|+||||+
T Consensus 324 --------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 324 --------------------------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp --------------------------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 11122346788999999999999999999999999999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=377.84 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=192.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence 44689999999999999999999999999999999864211 111246788999999999999999999998 345
Q ss_pred CcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 67999999998 5999999875 579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------- 224 (278)
T 3cok_A 164 MPHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------------- 224 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--------------
T ss_pred CCCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--------------
Confidence 22211 134578999999999876 67899999999999999999999999876543322111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. . .......+++.+.+||.+||..||++|||++++|+||||.+.
T Consensus 225 -------------~~-~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 -------------VL-A---DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------CS-S---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------hh-c---ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 0 011223578899999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=379.53 Aligned_cols=267 Identities=22% Similarity=0.405 Sum_probs=217.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 478999999999999999999999999999999997431 1123456789999999999999999999998532 33
Q ss_pred CcEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|+|||||.++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 57899999999888888875 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------------ 227 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------------ 227 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------------
Confidence 22211 12245679999999999875323357899999999999999999999988776544433321
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVE 323 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~ 323 (619)
. . ......+++.+.+||.+||..||.+|||++|+|+||||+......
T Consensus 228 ---------------~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 228 ---------------G-S---YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------C-C---CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------C-C---CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 0 012245788999999999999999999999999999998765543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=393.79 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=211.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------HHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI------SDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~------~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|+++.+++.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--- 98 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--- 98 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 3468999999999999999999999999999999997542211 1334567899999999999999999998
Q ss_pred CCCCCCcEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 95 SRRDFKDIYVVFELME-S-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
.+...+|+||||+. | +|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 99 --~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 99 --ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp --ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred --eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 45567999999986 5 9999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y-~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
++....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||......
T Consensus 177 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------- 236 (335)
T 3dls_A 177 AAYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------- 236 (335)
T ss_dssp CEECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------
T ss_pred ceECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------
Confidence 986543322 244679999999999876 444 88999999999999999999999652210
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
. . . .......+++.+.+||.+||..||++|||++++|+||||++.
T Consensus 237 ------------------~-~-~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 ------------------V-E-A---AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------------------T-T-T---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------------------H-h-h---ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 0 0 001123478999999999999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=396.29 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=209.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~s~~~~ 99 (619)
..+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|+ ||||+++++++. ..
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~ 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence 3569999999999999999999865 899999999765555667788999999999997 599999999984 34
Q ss_pred CcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 100 KDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
..+|||||++.++|.+++.....+++.+++.|+.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 5699999977789999999988999999999999999999999999999999999999995 579999999999865432
Q ss_pred CCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCC
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGT 249 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~---------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~-~~~l~~i~~~~g~ 249 (619)
.. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|.+||.+... ...+..+..
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 21 1123456899999999998541 13689999999999999999999999976532 122211110
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..... ......+..+.+||.+||..||.+|||++|+|+||||+..
T Consensus 283 ----------------------~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 283 ----------------------PNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp ----------------------TTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----------------------ccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 00111 1112346789999999999999999999999999999854
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=376.53 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=215.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++. +...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 57999999999999999999999999999999986432 2345577889999999999999999999983 44678
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999985 9999998777899999999999999999999999999999999999999999999999999976432221
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhhCCCchhhhhhhcc
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l-~~i~~~~g~p~~e~i~~~~~ 260 (619)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..... ..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1123456799999999998762 23477899999999999999999999876543221 11100
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. ......+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 224 ------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 224 ------------K--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ------------T--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------c--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 0 001112346788999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=379.89 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=213.2
Q ss_pred cCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 18 ~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.....++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 86 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYY----- 86 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----
Confidence 456778999999999999999999999999999999998743 2334567889999999999999999999984
Q ss_pred CCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+...+|+|||||+ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 3457999999998 489888865 56799999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCCCccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~---~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
..... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||...+....+..+...
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 237 (302)
T 2j7t_A 167 NLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------ 237 (302)
T ss_dssp HHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------
T ss_pred ccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc------
Confidence 32111 01134579999999998731 1157889999999999999999999999887765544333211
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.. ........++..+.+||.+||..||.+|||++++|+||||+.+.
T Consensus 238 ---------------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 ---------------------DP-PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------------CC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------------CC-cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00 00111234678999999999999999999999999999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=400.50 Aligned_cols=269 Identities=17% Similarity=0.137 Sum_probs=195.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhc--CCCCcceee-------eEec
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLL--RHPDIVEIK-------HIML 92 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L--~HpnIv~l~-------~v~~ 92 (619)
..|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 449999999999999999999999999999999986543 234556677886555555 699988755 3332
Q ss_pred CCCCC------------CCCcEEEEEecCCccHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHHCCceeccCC
Q 007064 93 PPSRR------------DFKDIYVVFELMESDLHQVIKAN-DDLTREHY------QFFLYQLLRALKYIHTANVYHRDLK 153 (619)
Q Consensus 93 ~~s~~------------~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i------~~i~~QIl~aL~yLHs~gIvHrDLK 153 (619)
..... ....+|||||||+++|.+++... ..+.+... ..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 01458999999999999999863 33454444 5777999999999999999999999
Q ss_pred CCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 007064 154 PKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (619)
Q Consensus 154 P~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~ 233 (619)
|+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865321 114567799999999865324789999999999999999999999987
Q ss_pred CChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 234 KNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 234 ~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+.... ..+... ..............++.+++.+.+||.+||..||++|||++++|+|
T Consensus 296 ~~~~~~-------------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIK-------------GSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCT-------------TCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCcccc-------------cchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 642100 000000 0000001111112345789999999999999999999999999999
Q ss_pred ccccCC
Q 007064 314 PYFKGL 319 (619)
Q Consensus 314 p~f~~~ 319 (619)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=388.67 Aligned_cols=288 Identities=24% Similarity=0.360 Sum_probs=225.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeee
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKH 89 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~ 89 (619)
..++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35789999999999999999999999999999999974 3345567889999999886 899999999
Q ss_pred EecCCCCCCCCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEC------
Q 007064 90 IMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILAN------ 160 (619)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~------ 160 (619)
++.... .+...+++|||++.++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 985432 223478999999988999999863 4599999999999999999999998 999999999999994
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----- 235 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~----- 235 (619)
..+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999765432 234579999999999987 679999999999999999999999998765
Q ss_pred -hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcccc-------------CCCCCCCHHHHHHHHHhccCCC
Q 007064 236 -VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFS-------------QKFPNADPSALRLLERLLAFDP 301 (619)
Q Consensus 236 -~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~-------------~~~~~~s~~l~dLI~~mL~~DP 301 (619)
..+.+..+.+.+|.+....+..... ...++............ .....+++.+.+||.+||..||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 5667888888888877665543221 11111110000000000 0112346788999999999999
Q ss_pred CCCCCHHHHHcCccccCCCcC
Q 007064 302 KDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 302 ~kRpSa~elL~hp~f~~~~~~ 322 (619)
.+|||++|+|+||||++....
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTTC
T ss_pred cccCCHHHHhhChhhhcccCc
Confidence 999999999999999976443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=378.07 Aligned_cols=261 Identities=33% Similarity=0.538 Sum_probs=219.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+++.||||++............+.+|+.+|+.++||||+++++++. +..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCC
Confidence 346899999999999999999999999999999999755444455678899999999999999999999983 456
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---CKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---~~vKL~DFGla~~~ 176 (619)
.+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 7999999998 5999999887889999999999999999999999999999999999999764 46999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 175 ~~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 237 (287)
T 2wei_A 175 QQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG---------- 237 (287)
T ss_dssp CCCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred cCCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 43221 234568999999999875 5899999999999999999999999988766555444221
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
........+..+++.+.+||.+||..||.+|||++++|+||||+++.
T Consensus 238 -----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 -----------------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -----------------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -----------------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00011123356789999999999999999999999999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=390.62 Aligned_cols=284 Identities=22% Similarity=0.341 Sum_probs=219.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..++..||+|++... ........+.+|+.+|+.++||||+++++++. +..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECC
Confidence 457899999999999999999999999999999999754 34456678899999999999999999999984 346
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+|||||++ +|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 79999999985 9999999888899999999999999999999996 999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh-
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR- 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~- 257 (619)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..............
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234579999999999987 6899999999999999999999999988775544322211110000000000
Q ss_pred --------------hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 --------------VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 --------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.........+..+....... .....+++++.+||.+||..||.+|||++|+|+||||++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000111112111111111 1123478899999999999999999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=416.43 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=215.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence 45779999999999999999999999999999999964211 112345678999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|+|||||. |+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 67999999997 69999998754 4999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+..
T Consensus 337 ~~~~----~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQ----TIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTC----CEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCc----cccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 4322 1245689999999999987 6799999999999999999999999987653211111110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.+.. .+. .....+++.+.+||.+||..||.+|| +++|+++||||+++
T Consensus 400 ---------~i~~----~~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 400 ---------LVKE----VPE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHH----CCC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------Hhhc----ccc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 0000 111 12246789999999999999999999 89999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=409.98 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=215.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeC
Confidence 45789999999999999999999999999999999964321 112345688999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 67999999998 5999999764 369999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
........ ....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+.......+..
T Consensus 338 ~~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--------- 403 (543)
T 3c4z_A 338 ELKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------- 403 (543)
T ss_dssp ECCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---------
T ss_pred eccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---------
Confidence 75433221 244689999999999987 6899999999999999999999999987642111111100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
..+ . ... .....+++.+.+||++||..||.+||+ ++++++||||+++
T Consensus 404 ----------~i~----~-~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 404 ----------RVL----E-QAV---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ----------HHH----H-CCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ----------HHh----h-ccc---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 000 0 011 122467899999999999999999995 5999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=378.83 Aligned_cols=266 Identities=23% Similarity=0.385 Sum_probs=211.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCC-
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSR- 96 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~- 96 (619)
-...++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+|+.+ +||||+++++++.....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356789999999999999999999999999999999986432 2345688999999999 79999999999865321
Q ss_pred CCCCcEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 97 RDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
.....+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 114679999999985 999999864 57999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
........ ......||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 177 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 249 (326)
T 2x7f_A 177 AQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---- 249 (326)
T ss_dssp C----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----
T ss_pred eecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----
Confidence 76432211 12345799999999998621 156889999999999999999999999887655444332110
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. .......+++.+.+||.+||..||.+|||++++|+||||++.
T Consensus 250 ----------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 ----------------------PA---PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ----------------------CC---CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ----------------------cc---ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00 011234578999999999999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=383.79 Aligned_cols=260 Identities=33% Similarity=0.541 Sum_probs=208.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~------~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 3579999999999999999999999999999999975321 11223457899999999999999999999832
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEeecC
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFG 171 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFG 171 (619)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred ----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 23899999998 599999988889999999999999999999999999999999999999987654 9999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHH-HHHHhhhCC
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL-DLMTDLLGT 249 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l-~~i~~~~g~ 249 (619)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+..
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---- 234 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---- 234 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH----
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh----
Confidence 99865322 11234579999999998732 1257899999999999999999999999775432211 11111
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.........+..+++.+.+||.+||..||++|||++++|+||||++
T Consensus 235 -----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 235 -----------------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0011111223567899999999999999999999999999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=373.32 Aligned_cols=260 Identities=30% Similarity=0.460 Sum_probs=216.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+++.||+|++..........+.+.+|+.+|+.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 35689999999999999999999999999999999976555566778899999999999999999999987432 235
Q ss_pred cEEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCcEEEeec
Q 007064 101 DIYVVFELMES-DLHQVIKAN----DDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~----~~l~e~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILi~~~~~vKL~DF 170 (619)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 79999999984 999999753 34999999999999999999999999 999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---- 231 (279)
T 2w5a_A 161 GLARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---- 231 (279)
T ss_dssp CHHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred chheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc----
Confidence 9997653321 11234578999999999876 57899999999999999999999999887754444333210
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
. +......+++.+.+||.+||..||++|||++|+|+|+|+.+
T Consensus 232 -----------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 -----------------------K---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -----------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -----------------------c---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 0 11122357889999999999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.77 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=207.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence 34789999999999999999999999999999999864211 1123457889999999999999999999983 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 67999999998 59999998888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.. ......+|+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 164 ~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 225 (276)
T 2h6d_A 164 GE----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------- 225 (276)
T ss_dssp -----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred Cc----ceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-------------
Confidence 21 12345789999999998762 2236899999999999999999999988765444433321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. . .....++..+.+||.+||..||.+|||++++|+||||++.
T Consensus 226 --------------~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 --------------GV-F---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------CC-C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------Cc-c---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00 0 1123467899999999999999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=379.63 Aligned_cols=273 Identities=27% Similarity=0.402 Sum_probs=195.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VK 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEE-----SS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ec
Confidence 45689999999999999999999999999999999986432 2234567889999999999999999999984 34
Q ss_pred CcEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 100 KDIYVVFELME-SDLHQVIKA--------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~--------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 56999999997 599999874 456999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC--CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 171 GLARVAFNDTP--TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 171 Gla~~~~~~~~--~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
|++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-- 242 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--
Confidence 99976433211 11112345799999999988642 46899999999999999999999999887665544322110
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.+.. .............+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 243 ~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 243 DPPS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp SCCC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCCc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0000 0000111233456889999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=393.33 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=211.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFE--HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~--~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.+|+.+ .||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 378999999999999999999984 5899999999874321 112334567899999999 6999999999983
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
+...+|||||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred --eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 4467999999998 5999999988889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ......+||+.|+|||++.+....++.++|||||||++|+|++|..||...........+..
T Consensus 208 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------- 276 (355)
T 1vzo_A 208 EFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 276 (355)
T ss_dssp ECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------
T ss_pred ecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---------
Confidence 6432211 12345689999999999875334688999999999999999999999976543222111111
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
... .. .......+++.+.+||.+||..||++|| |++|+|+||||+.+
T Consensus 277 ----------~~~----~~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 277 ----------RIL----KS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ----------HHH----HC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ----------HHh----cc----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 000 00 0122346788999999999999999999 99999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=376.71 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=209.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++. +..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCC
Confidence 457899999999999999999999999999999999753 23456889999999999999999999984 345
Q ss_pred cEEEEEecCCc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELMES-DLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 79999999985 9999997 456899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 240 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------------ 240 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Confidence 221 1244679999999999877 57899999999999999999999999877654433222110
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. ........+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 241 ---------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 241 ---------------PP-PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---------------CC-CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---------------CC-cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00 0001123467899999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.15 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=206.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++. +..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----STT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence 346899999999999999999976 5889999999876556667788999999999999999999999983 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 101 DIYVVFELME-SDLHQVIKANDD---LTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~---l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+|+|||||. ++|.+++..... +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 6899999998 599999987653 999999999999999999999999 9999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 188 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~------- 255 (309)
T 3p86_A 188 LKASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------- 255 (309)
T ss_dssp -----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-------
T ss_pred ccccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------
Confidence 5432211 1245679999999999987 678999999999999999999999998877654443331100
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc--CccccC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFKG 318 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~--hp~f~~ 318 (619)
. .......+++.+.+||.+||..||.+|||++++++ ++|++.
T Consensus 256 -------------------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 256 -------------------K---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -------------------C---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 11223467899999999999999999999999987 455543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=378.75 Aligned_cols=278 Identities=21% Similarity=0.357 Sum_probs=211.7
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++... +.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CC
Confidence 34678999999999999999999999999999999997532 123356678999999999999999999998543 23
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEeecC
Q 007064 100 KDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFG 171 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFG 171 (619)
..+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 47899999998 69999998644 39999999999999999999999999999999999999 788889999999
Q ss_pred ccccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMT 244 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~-~~l~~i~ 244 (619)
+++....... ....+||+.|+|||++... ...++.++|||||||++|||++|..||...... .....+.
T Consensus 162 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9987543322 2346799999999987520 157899999999999999999999999754321 1122222
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCC-------CCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK-------FPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
..+.......+..+... ......+... ...+++.+.+||.+||+.||++|||++|+|+||-
T Consensus 238 ~~~~~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 238 KIITGKPSGAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHCCTTCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcc----------cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22211111111111000 0011111111 1234567899999999999999999999999973
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=371.45 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=217.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++. +.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KD 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cC
Confidence 45577999999999999999999999999999999997542 2234677889999999999999999999984 34
Q ss_pred CcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
..+|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 579999999985 99998865 5799999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 221 1245679999999999876 6789999999999999999999999987765443332211
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. .......++..+.+||.+||..||.+|||++++|+||||..
T Consensus 234 --------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 --------------NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------------SC---CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------------CC---CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 01 11223467889999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.43 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=211.1
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
-..++|++.+.||+|+||.||+|.+..++. .||||+++.. ........+.+|+.+|+.++||||+++++++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 119 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVV----- 119 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 346789999999999999999999986655 5999999753 3445667899999999999999999999998
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+...+|+|||||+ ++|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 34466899999998 5999999754 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR----- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-----
Confidence 76544333323344567889999999876 578999999999999999999 9999988876655544432110
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
......+++.+.+||.+||..||.+|||+.++++.
T Consensus 273 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 273 -------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11224678899999999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=375.56 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=196.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
-..++|++++.||+|+||.||+|.+..++. .||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 456789999999999999999999887765 89999997654455667889999999999999999999999865432
Q ss_pred C-CCCcEEEEEecCCc-cHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 97 R-DFKDIYVVFELMES-DLHQVIKAND------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 97 ~-~~~~lylV~E~~~g-~L~~~i~~~~------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
. .....|+|||||.+ +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 11235999999994 9999986532 59999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 180 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~- 255 (323)
T 3qup_A 180 DFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG- 255 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred eccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-
Confidence 99999865432211 11233457889999999877 679999999999999999999 99999887766555443221
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-------HHHHHcCccccCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-------AEEALADPYFKGL 319 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-------a~elL~hp~f~~~ 319 (619)
. .....+.+++.+.+||.+||..||++||| +++++.|||+...
T Consensus 256 --------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 --------------------------N---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp --------------------------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred --------------------------C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 01223467889999999999999999999 7778899999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.46 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=209.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~ 93 (619)
.++|++++.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-
Confidence 468999999999999999999874 34568999999754 3445667899999999999 8999999999983
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (619)
+...+|+|||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 158 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 4456999999998 59999998753 48999999999999999999999999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 007064 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKN 235 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~ 235 (619)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432211 11234567889999999876 689999999999999999999 999998877
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+....+... . .......+++.+.+||.+||..||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEG---------------------------H---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTT---------------------------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---------------------------C---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55444333210 0 011234678899999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=370.36 Aligned_cols=262 Identities=21% Similarity=0.321 Sum_probs=195.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++............+.++..+++.++||||+++++++. +..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 457899999999999999999999999999999999754333333334445556788889999999999984 445
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||+++.+..+... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 7999999997777666654 56799999999999999999999995 999999999999999999999999999976433
Q ss_pred CCCCccccccccCCccccCcccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-hhHHHHHHHhhhCCCchhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-VVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~---~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-~~~~l~~i~~~~g~p~~e~ 254 (619)
... .....+|+.|+|||++.. ....++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234579999999999842 12568899999999999999999999997643 3222222211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.. .........+++.+.+||.+||..||.+|||++++|+||||+++
T Consensus 245 ------------------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 245 ------------------EE-PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ------------------SC-CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------cC-CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 01 11112234678999999999999999999999999999999854
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=372.31 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=210.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++. +..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCC
Confidence 45789999999999999999999999999999999864 34566778999999999999999999999984 446
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+|||||. ++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 7999999998 599999987 56799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCc-----------cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 179 DTPTT-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 179 ~~~~~-----------~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------- 231 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------- 231 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------
Confidence 32211 01124689999999999987 68999999999999999999999998764321100
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
. .......+.. ...+.+++.+.+||.+||..||++|||++++++ |++.
T Consensus 232 -------~----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 232 -------F----GLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp -------S----SBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred -------H----hhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 0 0000111110 112467889999999999999999999999987 4543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=364.23 Aligned_cols=263 Identities=28% Similarity=0.415 Sum_probs=203.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC------
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------ 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s------ 95 (619)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999964 2345677889999999999999999999875431
Q ss_pred --CCCCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 96 --RRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 96 --~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
..+...+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 123467999999998 59999998644 68899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHH
Q 007064 172 LARVAFNDTP-----------TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQ 239 (619)
Q Consensus 172 la~~~~~~~~-----------~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-~~~~~ 239 (619)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976432210 01122456799999999998752 468999999999999999998 44322 11111
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
+..+. ..............++.+.+||.+||..||.+|||++++|+||||+.
T Consensus 238 ~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLR---------------------------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHH---------------------------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhcc---------------------------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111 11111111223456788999999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=375.88 Aligned_cols=269 Identities=25% Similarity=0.384 Sum_probs=189.3
Q ss_pred ccccCCCCCCeEEeE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007064 15 FFSEYGDASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (619)
Q Consensus 15 ~~~~~~~~~rY~i~~-~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 93 (619)
....+...++|.+++ .||+|+||.||+|.++.+|+.||||++... .... .+....++.+.||||+++++++..
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhh
Confidence 344567778999965 699999999999999999999999998642 1211 122334677899999999999854
Q ss_pred CCCCCCCcEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEE
Q 007064 94 PSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKI 167 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g-~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL 167 (619)
.. .+...+|||||||+| +|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 94 ~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 94 MH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred cc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 22 224568999999985 9999998754 6999999999999999999999999999999999999986 455999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|||+++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 173 ~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 173 TDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp CCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred eccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 9999997643222 234578999999999876 6788999999999999999999999977654322111100
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.+...........+..+++.+.+||.+||..||++|||++|+|+||||++..
T Consensus 244 ---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 244 ---------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ---------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0001111112233467899999999999999999999999999999998744
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=374.07 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=193.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHH-HHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~-iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++. +.
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~ 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence 4588999999999999999999999999999999997542 3344556666776 677789999999999984 44
Q ss_pred CcEEEEEecCCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 100 KDIYVVFELMESDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTA-NVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-----~~~l~e~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 67999999999998888863 56799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~--~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
+....... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+.... .+
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-------- 239 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QL-------- 239 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HH--------
Confidence 76543221 233479999999999832 115689999999999999999999999976542110 00
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccc-cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..........+ ......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 240 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 240 ----------------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00001111111 12335688999999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=379.48 Aligned_cols=273 Identities=20% Similarity=0.333 Sum_probs=212.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---------------HHHHHHHHHHHHHHhcCCCCcce
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---------------SDAARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~---------------~~~~~i~~Ei~iL~~L~HpnIv~ 86 (619)
.++|++++.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 89999999986421111 11267889999999999999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQV------IKA--NDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKN 156 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~------i~~--~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~N 156 (619)
+++++. +...+|+|||||++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 999984 44679999999995 99988 655 5689999999999999999999999 999999999999
Q ss_pred EEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCC
Q 007064 157 ILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKN 235 (619)
Q Consensus 157 ILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~-~~DIWSLG~ilyeLltG~~pF~~~~ 235 (619)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23456899999999998762 25666 9999999999999999999998877
Q ss_pred h-hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 236 V-VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 236 ~-~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
. .+....+......... .... +.. .............+++.+.+||.+||..||.+|||++|+|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~-~~~~--------~~~---~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPL-DRNH--------FLY---PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCC-SSSS--------STT---TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCcc-chhh--------hhc---cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 6 4444433221000000 0000 000 0000001112356889999999999999999999999999999
Q ss_pred cccCC
Q 007064 315 YFKGL 319 (619)
Q Consensus 315 ~f~~~ 319 (619)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.91 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=205.0
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
+|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++. +...+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEE
Confidence 344455899999999999999999999999998753 2344567889999999999999999999983 445799
Q ss_pred EEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCcEEEeecCccccccC
Q 007064 104 VVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-NCKLKICDFGLARVAFN 178 (619)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-~~~vKL~DFGla~~~~~ 178 (619)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 69999998652 5679999999999999999999999999999999999987 89999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ......||+.|+|||++.+....++.++|||||||++|+|++|..||.............
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------- 238 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-------------- 238 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--------------
Confidence 221 124467999999999986532348899999999999999999999996543221110000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.... ........+++.+.+||.+||..||++|||++++|+||||+...
T Consensus 239 ----------~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 239 ----------GMFK----VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------HHHC----CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------cccc----ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 01122346789999999999999999999999999999998543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=376.24 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=210.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 45789999999999999999998 5567789999999753 3445567899999999999 799999999998532
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCC---------------------------------------------------
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDD--------------------------------------------------- 122 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------------------------------------- 122 (619)
...+|+|||||. |+|.+++.....
T Consensus 99 ----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 99 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 345899999999 599999986543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccc
Q 007064 123 ---------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187 (619)
Q Consensus 123 ---------------l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (619)
+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhcc
Confidence 89999999999999999999999999999999999999999999999999986543322 12234
Q ss_pred cccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHH
Q 007064 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRY 266 (619)
Q Consensus 188 ~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (619)
...||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+......
T Consensus 254 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------------------- 311 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-------------------- 311 (359)
T ss_dssp -CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH--------------------
T ss_pred ccCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc--------------------
Confidence 5678999999999876 689999999999999999998 99999887654433222110
Q ss_pred HHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 267 LTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ......+++.+.+||.+||..||.+|||++|+++|
T Consensus 312 ------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 312 ------GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 000 11224578899999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=382.09 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=210.6
Q ss_pred CCCeEEeEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence 4689999999999999999999 5567889999999743 34456667889999999999999999999984
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---cE
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC---KL 165 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~---~v 165 (619)
+....|+|||||. |+|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 3456799999997 59999997643 589999999999999999999999999999999999999655 59
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHH
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMT 244 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~ 244 (619)
||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754322111 11234568999999999876 689999999999999999998 999999887665554443
Q ss_pred hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 245 DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
... . ......+++.+.+||.+||+.||.+|||++++++|.|+.
T Consensus 301 ~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGG---------------------------R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTC---------------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------------------------C---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 210 0 111245788999999999999999999999999998764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.58 Aligned_cols=262 Identities=26% Similarity=0.339 Sum_probs=207.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ ||||+++++++. +
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence 4567999999999999999999885 5889999999765556667788999999999997 599999999984 4
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+|+|||++.++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++. +.+||+|||+++....
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 457999999877899999999889999999999999999999999999999999999999964 7999999999986543
Q ss_pred CCCCccccccccCCccccCccccccc---------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChh-HHHHHHHhhhC
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLMTDLLG 248 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~---------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~-~~l~~i~~~~g 248 (619)
... ........||+.|+|||++.+. ...++.++|||||||++|+|++|..||...... ..+..+.
T Consensus 179 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---- 253 (313)
T 3cek_A 179 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---- 253 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH----
T ss_pred ccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH----
Confidence 221 1122345799999999998641 136888999999999999999999999765321 1111110
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
..... .......+..+.+||.+||..||.+|||++|+|+||||+..
T Consensus 254 ----------------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 254 ----------------------DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ----------------------CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ----------------------hcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00011 11123457889999999999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=366.32 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=211.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe---
Confidence 3578999999999999999999883 45689999999753 34556778999999999999999999999983
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHYQFFLYQLLRALKYIHTANVYHR 150 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~------------------------l~e~~i~~i~~QIl~aL~yLHs~gIvHr 150 (619)
+...+|+|||||. ++|.+++..... +++..++.++.||+.||.|||+.||+||
T Consensus 97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 97 --QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred --cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 4456899999998 699999987543 8999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007064 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (619)
Q Consensus 151 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~ 229 (619)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999986543221 111234567889999999876 578999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 007064 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309 (619)
Q Consensus 230 pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e 309 (619)
||.+.+.......+... . .......+++.+.+||.+||..||.+|||+++
T Consensus 252 p~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTG---------------------------H---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhcC---------------------------C---cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99887755444333210 0 11223467899999999999999999999999
Q ss_pred HHcC
Q 007064 310 ALAD 313 (619)
Q Consensus 310 lL~h 313 (619)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.35 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=208.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+|+.++||||+++++++ .+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 4578999999999999999999986 5778999999754322 35688999999999999999999998 3446
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 6999999998 5999999754 4689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 159 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred cc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc----------
Confidence 21 111234467888999999876 679999999999999999999 999998887665554442210
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. .......++.+.+||.+||..||++|||++++++|
T Consensus 225 -----------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 -----------------R---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -----------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------c---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 01123468899999999999999999999999886
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=374.83 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=210.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhcC--CCCcceeeeEecC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLLR--HPDIVEIKHIMLP 93 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~ 93 (619)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++ ||||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 45688999999999999999999999999999999996432211 12245678999999996 599999999984
Q ss_pred CCCCCCCcEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEeec
Q 007064 94 PSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICDF 170 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~--g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~DF 170 (619)
+...+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 4467999999997 69999999888999999999999999999999999999999999999999 7789999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+. +..
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~----- 257 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR----- 257 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-----
Confidence 9998754322 2446799999999988752 3347889999999999999999999965321 000
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. .. .....+++.+.+||.+||..||++|||++++|+||||++..
T Consensus 258 ---------------------~--~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 ---------------------G--QV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---------------------C--CC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------------------c--cc---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 00 11245789999999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=360.94 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=199.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..++|++++.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+|+.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-----
Confidence 457899999999999999999998654 457999998753 34456678899999999999999999999972
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 245799999999 49999998654 699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-------- 233 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------- 233 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC--------
Confidence 5432211 1233457789999999876 689999999999999999996 99999887765554443211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. .....+.+++.+.+||.+||..||++|||+.+++++
T Consensus 234 -------------------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 234 -------------------E---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------C---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 012235678999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.77 Aligned_cols=271 Identities=21% Similarity=0.355 Sum_probs=206.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 45789999999999999999998 667899999999975 3455667899999999999999999999998432
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
+...+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2245899999997 59999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc
Confidence 75433322222334567888999999877 68999999999999999999999998653211 111122211111
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ........+...... .....+++.+.+||.+||..||++|||++|+++
T Consensus 236 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 001111111111111 223467899999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=362.27 Aligned_cols=259 Identities=18% Similarity=0.228 Sum_probs=209.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +|+||+.+++++ .+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCC
Confidence 4578999999999999999999999999999999986432 223477899999999 799999999988 445
Q ss_pred CcEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----EEEeecCcc
Q 007064 100 KDIYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLA 173 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-----vKL~DFGla 173 (619)
...|+||||+.++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 6799999999889999998754 5999999999999999999999999999999999999987776 999999999
Q ss_pred ccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 174 RVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-- 234 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 234 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH--
Confidence 8754432211 11245679999999999877 678999999999999999999999998854322221111100
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ...........+.+++.+.+||.+||..||++|||++++++.
T Consensus 235 ------------------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 235 ------------------E---KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp ------------------H---HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ------------------h---hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 000111222345678999999999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.72 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=205.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+|+.| +||||+++++++. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ET
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cC
Confidence 45789999999999999999999999999999999864322 23577899999999 8999999999983 44
Q ss_pred CcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-----EEEeecCcc
Q 007064 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK-----LKICDFGLA 173 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~-----vKL~DFGla 173 (619)
..+|+|||||.++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 67899999998899999986 467999999999999999999999999999999999999999887 999999999
Q ss_pred ccccCCCCCcc----ccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 174 RVAFNDTPTTI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 174 ~~~~~~~~~~~----~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
+.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~- 234 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD- 234 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH-
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh-
Confidence 87543322111 1245689999999999987 6799999999999999999999999988653333222211100
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ............+ +.+.+||.+||..||.+||+++++++
T Consensus 235 -----------~-----------~~~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 -----------T-----------KRATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------H-----------HHHSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------h-----------hccCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 0000011111223 38999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=363.17 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=201.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++. +
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----I 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----E
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----e
Confidence 355789999999999999999999999999999999975432 3344577889999999999999999999984 4
Q ss_pred CCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 99 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 4679999999995 999999988889999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 186 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------- 248 (309)
T 2h34_A 186 DEKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN------------- 248 (309)
T ss_dssp -------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------------
T ss_pred cccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------------
Confidence 3221 11245679999999999876 678999999999999999999999998765432211111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-CHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-Sa~elL~ 312 (619)
..........+.+++.+.+||.+||..||++|| |++++++
T Consensus 249 ---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 ---------------QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------------SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------------cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112233467889999999999999999999 7888765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.47 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=207.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.+|+.++||||+++++++ .+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 4578999999999999999999775 577899999975332 235688999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 7999999998 68999997654 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 221 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----------- 221 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----------
Confidence 322 12234456788999999876 578999999999999999999 99999887765544433211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .......++.+.+||.+||..||.+|||+.++|++
T Consensus 222 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 ----------------HR---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CC---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123467899999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.03 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=208.9
Q ss_pred CCCCCCeEEeE-EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 19 YGDASRYKIQE-VIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 19 ~~~~~rY~i~~-~LG~G~fG~V~~a~~--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
+-+.++|++.+ .||+|+||.||+|.+ ..+++.||||++............+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 88 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--- 88 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---
Confidence 34567899998 999999999999954 567889999999865444455678999999999999999999999982
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 89 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 89 ---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ---CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 245899999998 6999999998889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
................+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------- 235 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------- 235 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------
T ss_pred eeccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------
Confidence 75443322222233456788999999876 578899999999999999999 9999988776544333321
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......+++.+.+||.+||..||.+|||+.++++
T Consensus 236 -------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 -------------------GE---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------TC---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 01123467899999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.44 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=210.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++++.||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA--- 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc---
Confidence 4578999999999999999999987 45589999999753 34455678899999999999999999999983
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHYQFFLYQLLRALKYIHTANVYHR 150 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHr 150 (619)
+...+|+|||||. ++|.+++... ..+++.+++.|+.||+.||.|||+.||+||
T Consensus 121 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred --cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4466899999998 5999999864 569999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007064 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (619)
Q Consensus 151 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~ 229 (619)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999765322111 11234568899999999876 679999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 007064 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309 (619)
Q Consensus 230 pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e 309 (619)
||.+.+..+....+.+ .. .......+++.+.+||.+||..||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GN---ILACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9988776554433321 00 01122467889999999999999999999999
Q ss_pred HHcC
Q 007064 310 ALAD 313 (619)
Q Consensus 310 lL~h 313 (619)
++++
T Consensus 326 ~~~~ 329 (343)
T 1luf_A 326 IHRI 329 (343)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=359.88 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=206.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+|+.++||||+++++++ .+.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecC
Confidence 35679999999999999999999876 6778999999754322 35688999999999999999999998 445
Q ss_pred CcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+|+|||||. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 67999999997 699999976 5679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 172 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 239 (283)
T 3gen_A 172 DDE--YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------- 239 (283)
T ss_dssp CHH--HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred ccc--cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------
Confidence 221 111233457788999999876 579999999999999999998 9999988876655544432110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.......++.+.+||.+||..||.+|||++++|+|
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ----------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123457899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=372.55 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=211.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-------GEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 92 (619)
..++|++++.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 347899999999999999999997543 357999999754 4455667899999999999 8999999999984
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+...+|+|||||. |+|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+
T Consensus 146 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 146 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 4456899999998 59999998754 4999999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432211 12234567889999999876 689999999999999999999 99999888
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+..+....+... .. ......+++.+.+||.+||..||++|||++|++++
T Consensus 298 ~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEG---------------------------HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTT---------------------------CC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcC---------------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 765544433211 00 11224578899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.22 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=202.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----HHHHHHHHHHHHHHhc----CCCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----SDAARILREIKLLRLL----RHPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----~~~~~i~~Ei~iL~~L----~HpnIv~l~~v~~ 92 (619)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4578999999999999999999999999999999996532211 2334466899999999 8999999999983
Q ss_pred CCCCCCCCcEEEEEec-CC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCcEEEee
Q 007064 93 PPSRRDFKDIYVVFEL-ME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN-ANCKLKICD 169 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~-~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~-~~~~vKL~D 169 (619)
+...+|+|||+ +. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 109 -----~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 -----TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred -----cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 44568999998 55 69999999888899999999999999999999999999999999999999 889999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +..
T Consensus 184 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~---- 247 (312)
T 2iwi_A 184 FGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE---- 247 (312)
T ss_dssp CSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----
T ss_pred cchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh----
Confidence 99998754322 2456799999999988752 2334589999999999999999999965321 100
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
. . ......+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 248 ----------------------~--~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 248 ----------------------A--E---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp ----------------------T--C---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ----------------------h--c---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 0 012245788999999999999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=362.73 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=202.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
-..++|.+.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+|+.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 355789999999999999999998765 55689999998655566667889999999999999999999999876544
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKA------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
......|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 33446799999999 599999843 35699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 191 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-- 265 (313)
T 3brb_A 191 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-- 265 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--
T ss_pred cCcceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC--
Confidence 9999765332211 11233467889999999876 689999999999999999999 99999887765544333211
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||.+|||+++++++
T Consensus 266 -------------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 -------------------------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------------------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 11224678899999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.01 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=210.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--
Confidence 347899999999999999999985 457789999999753 3445667899999999999 8999999999984
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+...+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 98 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ---cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 4456899999998 49999998654 4899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999875443221 12234567889999999876 689999999999999999998 99999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.....+..+... ... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKE--------------------------GFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHH--------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhcc--------------------------CCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 654333222110 000 01124578899999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=370.66 Aligned_cols=276 Identities=22% Similarity=0.234 Sum_probs=208.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-..++|++++.||+|+||.||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence 45678999999999999999999775 799999999642 234455667999999999999999999986532 123
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEEECCCCcEEEe
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------NVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
..+|+|||||. |+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 46899999998 5999999775 599999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
|||+++........ ......+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+......+.....
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999875433221 123446899999999998652 12456688999999999999999999988654333322223
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCC--CCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFP--NADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..+.+..+.+... . ........+...+. ..++.+.+||.+||..||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 253 IGQHPSLEDMQEV--------V--VHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HCSSCCHHHHHHH--------H--TTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCchhhhhhh--------h--hcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3333333322211 0 00111111111111 124569999999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=357.52 Aligned_cols=250 Identities=22% Similarity=0.422 Sum_probs=211.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.++.++..||+|++... ......+.+|+.+|+.++||||+++++++ .+..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 567899999999999999999999999999999999742 34567788999999999999999999998 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 7999999999 6999999864 459999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+...
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---------- 228 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---------- 228 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc----------
Confidence 3322 12234567889999999876 679999999999999999999 99999887755444333211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .......+++.+.+||.+||..||.+|||++++++
T Consensus 229 -----------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 -----------------Y---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------C---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0 01123467899999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=362.80 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=205.0
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIM 91 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 91 (619)
|...-..++|++.+.||+|+||.||+|.++.++ ..||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 333456789999999999999999999887553 46999999753 3445566789999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 92 LPPSRRDFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g-~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
.+...+|||||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 116 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 116 -----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp -----CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred -----ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECC
Confidence 445679999999985 999999764 5799999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||+++................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~- 267 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF- 267 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred CCcchhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-
Confidence 9999875433222222233456789999999876 689999999999999999998 999998877654443332110
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ......+++.+.+||.+||..||.+||++.+++++
T Consensus 268 --------------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 --------------------------R---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------------C---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------c---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123578899999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.95 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=200.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-..++|++.+.||+|+||.||+|.+. ..||+|+++...........+.+|+.+|+.++||||+.++++. ..
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TA 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cC
Confidence 35678999999999999999999753 3599999987666667778899999999999999999999965 23
Q ss_pred CcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
..+++|||||. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 45799999999 699999854 4569999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 172 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------- 240 (289)
T 3og7_A 172 RWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR---------- 240 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH----------
T ss_pred cccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc----------
Confidence 2211 1123456799999999988521 156888999999999999999999999887655444333211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
......+......+++.+.+||.+||..||.+|||++++++.
T Consensus 241 ---------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 241 ---------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp ---------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111122233445788999999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=386.34 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=194.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.+|.+.+.||+|+||.||. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++ .+...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence 4699999999999999763 4467899999999964321 2356799999999 799999999988 44567
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCcEEEeecCcccc
Q 007064 102 IYVVFELMESDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLARV 175 (619)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-----~~~vKL~DFGla~~ 175 (619)
+|||||||.|+|.+++.... .+.+..++.|+.||+.||.|||+.||+||||||+|||++. ...+||+|||+++.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999999999999998654 4666677899999999999999999999999999999953 33688999999987
Q ss_pred ccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
..............+||++|+|||++.+. ...++.++|||||||++|||++ |..||...... +...+ .+..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~---~~~~--- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANIL---LGAC--- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHH---TTCC---
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHH---hccC---
Confidence 54332222233557899999999998632 2567889999999999999999 89999654332 21111 1111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...........+..+.+||.+||..||.+|||++++|+||||..+
T Consensus 246 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ---------------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000111112235668999999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.52 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHH-----HHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-----ARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~-----~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
-..++|++.+.||+|+||.||+|.+..+++.||+|++.......... +.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34688999999999999999999999999999999986433222211 6788999999999999999999998432
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCc-----E
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCK-----L 165 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~-----v 165 (619)
.++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 6998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH--HHHH
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLM 243 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~--l~~i 243 (619)
||+|||+++..... .....||+.|+|||++......++.++|||||||++|+|++|..||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999999753321 245689999999999854335688999999999999999999999977653322 1111
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .. ........+++.+.+||.+||..||.+|||++++++
T Consensus 243 ~~--------------------------~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE--------------------------EG---LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH--------------------------SC---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc--------------------------cC---CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 00 011223467899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=363.99 Aligned_cols=259 Identities=22% Similarity=0.349 Sum_probs=191.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCC---C
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSR---R 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~---~ 97 (619)
..+|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.+. ||||+++++++..... .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4589999999999999999999999999999999854 34456677899999999996 9999999999853321 3
Q ss_pred CCCcEEEEEecCCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCc
Q 007064 98 DFKDIYVVFELMESDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~---~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
....+|+|||||.|+|.+++.. .+.+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4456899999999999998864 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------cccccccCCccccCcccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 173 ARVAFNDTPTT---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~Y~APEll~~-~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
++......... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754332211 01124569999999999831 115788999999999999999999999976543211100
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
... .......++.+.+||.+||+.||.+|||++|+++|-+
T Consensus 265 ------------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ------------------------------KYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------------ccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 000 0112345678999999999999999999999998743
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.16 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=207.0
Q ss_pred ccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 007064 15 FFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHI 90 (619)
Q Consensus 15 ~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~----vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v 90 (619)
.+...-..++|++++.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 344455678899999999999999999999888875 7777765321 12223456789999999999999999998
Q ss_pred ecCCCCCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 91 MLPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
+. ...+|+|||||. |+|.+++... +.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 84 ~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~ 157 (325)
T 3kex_A 84 CP------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157 (325)
T ss_dssp EC------BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEEC
T ss_pred Ec------CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEEC
Confidence 83 245899999998 6999999764 579999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 158 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~- 233 (325)
T 3kex_A 158 DFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG- 233 (325)
T ss_dssp SCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-
T ss_pred CCCcccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-
Confidence 99999875433222 22345678889999999876 679999999999999999999 99999887654444333210
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 234 --------------------------~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 --------------------------ER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------------------CB---CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------------------CC---CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01122356788999999999999999999999886
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.85 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=206.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|.+ ..++..||||++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 457899999999999999999997 346678999999743 2334456789999999999 8999999999984
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHR 150 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHr 150 (619)
+...+|+|||||+ |+|.+++.... .+++..++.|+.||+.||.|||+.||+||
T Consensus 120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 3456899999998 59999998653 37999999999999999999999999999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 007064 151 DLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (619)
Q Consensus 151 DLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~ 229 (619)
||||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999865443321 12234567889999999876 679999999999999999998 999
Q ss_pred CCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 007064 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309 (619)
Q Consensus 230 pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e 309 (619)
||.+.+....+..+.. .... ......+++.+.+||.+||..||.+|||+.+
T Consensus 274 p~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988764433322211 0000 1122457889999999999999999999999
Q ss_pred HHcCc
Q 007064 310 ALADP 314 (619)
Q Consensus 310 lL~hp 314 (619)
+++|-
T Consensus 325 l~~~l 329 (344)
T 1rjb_A 325 LTSFL 329 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=365.19 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=200.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~----vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
-..++|++++.||+|+||.||+|.+..+++. ||+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence 4567899999999999999999999888775 477776532 222345678899999999999999999999853
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
...++|+|++. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 89 ----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ----SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ----CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 24789999998 699999987 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+........ .......+|..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------ 235 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ 235 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC------
Confidence 875433221 12234567889999999887 689999999999999999999 99999887655443333211
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ....+.++..+.+||.+||..||.+|||+.+++++
T Consensus 236 ---------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 ---------------------ER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------CC---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 11234578899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.89 Aligned_cols=254 Identities=19% Similarity=0.350 Sum_probs=209.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++.+.||+|+||.||+|.++ .++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--- 98 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 98 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc---
Confidence 3478999999999999999999876 46788999999753 34455667899999999999999999999983
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
+...+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 99 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 99 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred --cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 4456899999998 5999998752 35799999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i 243 (619)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999765332211 11233467889999999876 679999999999999999999 89999887765444333
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ........+++.+.+||.+||..||.+|||+.|+++|
T Consensus 254 ~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEG------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 210 0112234678899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=359.01 Aligned_cols=251 Identities=18% Similarity=0.277 Sum_probs=203.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 93 (619)
..++|++.+.||+|+||.||+|.++.++ ..||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-
Confidence 4578999999999999999999998877 47999998653 3345567899999999999999999999984
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-------
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK------- 164 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~------- 164 (619)
+....|+|||||. ++|.+++..... +++..++.|+.||+.||.|||+.||+||||||+|||++.++.
T Consensus 83 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 83 ----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp ----CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred ----eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 3456799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred -EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHH
Q 007064 165 -LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDL 242 (619)
Q Consensus 165 -vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~ 242 (619)
+||+|||++...... ....+|+.|+|||++.+. ..++.++|||||||++|+|++| .+||...+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998654211 234688899999998752 4689999999999999999995 555555443322211
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
... ........++.+.+||.+||+.||.+|||++++++| |+.+.
T Consensus 231 ~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~ 274 (289)
T 4fvq_A 231 YED--------------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLF 274 (289)
T ss_dssp HHT--------------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC
T ss_pred hhc--------------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhc
Confidence 110 001123456789999999999999999999999987 44443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=373.95 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=198.5
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~---~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
.-..++|++.+.||+|+||.||+|.++ .++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--- 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT--- 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---
Confidence 345678999999999999999999876 46778999999753 34456678999999999999999999999983
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+...+|+|||||+ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 117 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 117 --KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred --eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 4456899999997 69999998754 6999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+................++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~----- 267 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----- 267 (373)
T ss_dssp -------------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-----
T ss_pred cccccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 875433222211222345778999999876 689999999999999999998 999998877655443332110
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ......++..+.+||.+||..||++||+++++++
T Consensus 268 ----------------------~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 ----------------------R---LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------E---CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------C---CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0112356789999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.73 Aligned_cols=250 Identities=14% Similarity=0.193 Sum_probs=207.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+|+.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 4578999999999999999999874 88999999987655666778899999999999999999999998543 225
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 6899999998 59999998765 4899999999999999999999999 99999999999999999999999988754
Q ss_pred ccCCCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
... ....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 163 ~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 226 (271)
T 3kmu_A 163 FQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-------- 226 (271)
T ss_dssp TSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS--------
T ss_pred ecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc--------
Confidence 221 234789999999998652 123344899999999999999999999887765544333211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......+++.+.+||.+||..||++|||++++++
T Consensus 227 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 227 ------------------GL---RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 01223467899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=357.73 Aligned_cols=257 Identities=19% Similarity=0.232 Sum_probs=203.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+. .+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----EET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeec----CCC
Confidence 45688999999999999999999999999999999875432 2234778999999999998888777663 234
Q ss_pred CcEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCcccc
Q 007064 100 KDIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARV 175 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~ 175 (619)
...|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 57899999998899999984 4579999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH---HHHHHHhhhC
Q 007064 176 AFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLMTDLLG 248 (619)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~---~l~~i~~~~g 248 (619)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 233 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 233 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc--
Confidence 54432211 11235689999999999987 679999999999999999999999998754321 11111100
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
....+.......+++.+.+||.+||+.||++|||++++++
T Consensus 234 ------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 ------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ------------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ------------------------cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0001111223567889999999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=354.58 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=206.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+. .+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~ 78 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 78 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCcccccc----CCCC
Confidence 467899999999999999999999999999999998653222 35788999999999998877776653 2345
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCccccc
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 176 (619)
.+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 6899999998899999974 5579999999999999999999999999999999999999 47889999999999875
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh---HHHHHHHhhhCC
Q 007064 177 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLMTDLLGT 249 (619)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~---~~l~~i~~~~g~ 249 (619)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 233 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--- 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---
T ss_pred cccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc---
Confidence 4432211 11245689999999999887 67999999999999999999999999874321 122222110
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..........+.+++.+.+||.+||+.||.+|||++++++
T Consensus 234 -----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 -----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0001111223567899999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=366.07 Aligned_cols=276 Identities=22% Similarity=0.330 Sum_probs=215.7
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIM 91 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 91 (619)
...+-..++|++++.||+|+||.||+|. +..+++.||||++.. ......+.+.+|+.+|+.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 3344566789999999999999999998 567899999999975 3455667789999999999999999999988
Q ss_pred cCCCCCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 92 LPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
... +...+|+|||||+ ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 94 ~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 94 YGP---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp ECS---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred ecC---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc
Confidence 542 3467999999997 699999976 45699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
||+++................+|..|+|||++.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~ 243 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGC 243 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC-
T ss_pred cccceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccc
Confidence 9999876444333333345678899999999876 57899999999999999999999998664321110 0000
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ...........+..... ....+.+++.+.+||.+||..||.+|||+++++++
T Consensus 244 ~~-------~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 244 ER-------DVPALSRLLELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ----------CCHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cc-------ccccHHHHHHHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00011111222211111 12245688999999999999999999999999765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=373.60 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=207.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.++.+++.||||+++.. ........+.+|+.+|+.++||||+++++++. +..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCC
Confidence 457899999999999999999999999999999998753 33445567889999999999999999999983 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+|||||+ |+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 6899999998 69999997643 699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 266 ~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 330 (377)
T 3cbl_A 266 GVYAA-SGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------ 330 (377)
T ss_dssp SEEEC-CSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT------------
T ss_pred Cceee-cCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 21100 0111235678999999876 578999999999999999998 9999988776544333321
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... .....+++.+.+||.+||..||++|||++++++
T Consensus 331 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 ---------------GGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 112346789999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.88 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=210.2
Q ss_pred CCCCeEEeE-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQE-VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~-~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 80 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ----- 80 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----
Confidence 456788877 9999999999999864 56788999999754 34556778999999999999999999999982
Q ss_pred CCCcEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELMES-DLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~g-~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp -SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 2358999999995 999998653 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--------- 228 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 228 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred eccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---------
Confidence 5433322222233457889999999876 578999999999999999998 9999988776544433321
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~ 315 (619)
.. .....+.+++.+.+||.+||..||++|||+.++++|.+
T Consensus 229 ------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 ------------------GK---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------TC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------CC---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 00 01223567899999999999999999999999998744
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=358.78 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~-----~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 457899999999999999999985 457789999999754 3445567789999999999 699999999998432
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDD----------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNI 157 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~----------------l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (619)
...+|+|||||. ++|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 345899999999 599999987654 89999999999999999999999999999999999
Q ss_pred EECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCh
Q 007064 158 LANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNV 236 (619)
Q Consensus 158 Li~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~ 236 (619)
|++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 122344568899999999876 679999999999999999998 9999987664
Q ss_pred hHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 237 VHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 237 ~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+.+..... .... ......+++.+.+||.+||..||.+|||++++++|
T Consensus 257 ~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLK--------------------------EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHH--------------------------HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhc--------------------------cCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333221111 0000 11223578899999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.08 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=207.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAI-----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~-----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL--- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc---
Confidence 45789999999999999999998 5678889999999743 34456678899999999999999999999984
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND-------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~ 164 (619)
+...+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. +..
T Consensus 104 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 --QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 3456899999996 69999998753 4899999999999999999999999999999999999994 446
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i 243 (619)
+||+|||+++......... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997643322111 1234568899999999876 679999999999999999998 99999887765544433
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
... . .......+++.+.+||.+||..||.+|||++++++|.|+-
T Consensus 259 ~~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSG---------------------------G---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC---------------------------C---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 211 0 0112346788999999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.49 Aligned_cols=272 Identities=23% Similarity=0.358 Sum_probs=210.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
-...+|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED- 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC-
Confidence 345679999999999999999998 57789999999997532 223456788999999999999999999998543
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+...+|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 96 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 --GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred --CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 2256899999998 59999995 4567999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
.................+|..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ 246 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc
Confidence 876544332223345678899999999876 578899999999999999999998864321 2222222222111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ........+..... ....+.+++.+.+||.+||..||.+|||++++++
T Consensus 247 ~-------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 M-------TVTRLVNTLKEGKR---LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp G-------HHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred c-------CHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1 11112222222211 1233568899999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=349.53 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=194.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH--ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~--~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+.+++.++||||+++++++. +
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 77 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----K 77 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----c
Confidence 4578999999999999999999874 889999998643222 123467889999999999999999999984 4
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECC--------CCcEE
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN---VYHRDLKPKNILANA--------NCKLK 166 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILi~~--------~~~vK 166 (619)
...+|+||||++ ++|.+++. ...+++..++.++.||+.||.|||+.| |+||||||+|||++. ++.+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 456899999998 58888875 457999999999999999999999999 899999999999986 67899
Q ss_pred EeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhh
Q 007064 167 ICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246 (619)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~ 246 (619)
|+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 l~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~- 228 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM- 228 (271)
T ss_dssp ECCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-
T ss_pred EccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-
Confidence 999999976433221 24579999999999876 6789999999999999999999999988775444332211
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.... ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 229 -------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 -------------------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0000 11224578899999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=348.98 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=207.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 4578999999999999999999986 6788999999754322 356889999999999999999999984 345
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 6899999998 5999999865 5689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~----------- 221 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------- 221 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-----------
Confidence 11 111233467889999999876 678999999999999999999 89999887765544433211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||++|||+++++++
T Consensus 222 ----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 222 ----------------FR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------Cc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01123468899999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=360.81 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=208.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-------HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-------~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 92 (619)
..++|++++.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 4578999999999999999999975 46778999999753 3445667889999999999 8999999999983
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+...+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 112 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 112 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp -----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 4457899999998 59999998654 3899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999986543221 111233467889999999876 578999999999999999999 99999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+..+....+... . .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEG---------------------------H---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcC---------------------------C---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 765444333211 0 011234678899999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=351.86 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=204.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence 45789999999999999999998654 3456999998754 344567789999999999999999999999732
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 85 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 --EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred --CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 34699999999 6999999764 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 163 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-------- 230 (281)
T 3cc6_A 163 IEDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-------- 230 (281)
T ss_dssp C-----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT--------
T ss_pred ccccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC--------
Confidence 5432211 1233467889999999876 679999999999999999998 99999876655444333211
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 231 -------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 -------------------DR---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CC---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 00 11123578899999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=358.66 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=208.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.+|+.+ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACT-- 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 45789999999999999999999977664 7999999753 3445667889999999999 8999999999983
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKA--------------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~--------------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 159 (619)
+...+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 121 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ---cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 4456899999998 599999864 3468999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhH
Q 007064 160 NANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVH 238 (619)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~ 238 (619)
+.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999865433221 12234567889999999876 679999999999999999998 999998866443
Q ss_pred HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 239 QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 239 ~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.+..+... ... .......++.+.+||.+||..||.+|||+++++++
T Consensus 275 ~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKD--------------------------GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHH--------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc--------------------------CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33222110 000 01123467899999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.10 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=207.3
Q ss_pred CCCccccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEE--EEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcce
Q 007064 10 SPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVE 86 (619)
Q Consensus 10 ~~~~~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~v--AIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~ 86 (619)
.+....|+.+. .++|++.+.||+|+||.||+|.++.++..+ |+|.+... ........+.+|+.+|+.+ +||||++
T Consensus 13 ~~~~~~~p~~~-~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 13 NPDPTIYPVLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp ---CCCSSBCC-GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCC
T ss_pred CCCCccccccc-HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhh
Confidence 33444455433 478999999999999999999999888865 99988743 2334556788999999999 8999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYH 149 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvH 149 (619)
+++++ .+...+|+|||||+ ++|.+++.... .+++..++.|+.||+.||.|||+.||+|
T Consensus 91 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 165 (327)
T 1fvr_A 91 LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165 (327)
T ss_dssp EEEEE-----EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hceee-----eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 99998 34467999999997 59999998654 6999999999999999999999999999
Q ss_pred ccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CC
Q 007064 150 RDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228 (619)
Q Consensus 150 rDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~ 228 (619)
|||||+|||++.++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~ 239 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGG 239 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCC
Confidence 9999999999999999999999997432111 1133457889999999876 578999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 007064 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE 308 (619)
Q Consensus 229 ~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~ 308 (619)
.||.+.+..+....+.. .. .......+++.+.+||.+||..||.+|||++
T Consensus 240 ~pf~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 289 (327)
T 1fvr_A 240 TPYCGMTCAELYEKLPQ---------------------------GY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFA 289 (327)
T ss_dssp CTTTTCCHHHHHHHGGG---------------------------TC---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHhhc---------------------------CC---CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 99988775444332211 00 0112246788999999999999999999999
Q ss_pred HHHcC
Q 007064 309 EALAD 313 (619)
Q Consensus 309 elL~h 313 (619)
+++++
T Consensus 290 ell~~ 294 (327)
T 1fvr_A 290 QILVS 294 (327)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=367.87 Aligned_cols=269 Identities=16% Similarity=0.159 Sum_probs=202.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChHHH---------HHHHHHHHHHHhcCCCCcce
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHT-----GEKVAIKKIHDIFEHISDA---------ARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~t-----g~~vAIK~i~~~~~~~~~~---------~~i~~Ei~iL~~L~HpnIv~ 86 (619)
..++|++++.||+|+||.||+|.+..+ ++.||||++.......... ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 5789999986432111110 12345666777888999999
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCC
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANC 163 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~ 163 (619)
+++++.... .+...+|||||||.++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999985432 223568999999977999999876 6799999999999999999999999999999999999999 889
Q ss_pred cEEEeecCccccccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHH
Q 007064 164 KLKICDFGLARVAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 239 (619)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~ 239 (619)
.+||+|||+++......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999997653322111 11234569999999999987 5799999999999999999999999986443222
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
......... .......+.... ...++++.+.+||..||..||.+||+++++++
T Consensus 270 ~~~~~~~~~-----------~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRY-----------RENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHH-----------HHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHh-----------hhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111000 001111111100 01467889999999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.56 Aligned_cols=266 Identities=15% Similarity=0.160 Sum_probs=201.7
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChHH---------HHHHHHHHHHHHhcCCCCcceee
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIHDIFEHISD---------AARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~---tg~~vAIK~i~~~~~~~~~---------~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
..++|++++.||+|+||.||+|.+.. ++..||||++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 7889999998753211111 12366788999999999999999
Q ss_pred eEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC--cEE
Q 007064 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC--KLK 166 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~--~vK 166 (619)
+++.... .+...+|+|||||.++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9985532 2356799999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred EeecCccccccCCCC----CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh--hHHH
Q 007064 167 ICDFGLARVAFNDTP----TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQL 240 (619)
Q Consensus 167 L~DFGla~~~~~~~~----~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~--~~~l 240 (619)
|+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999976532211 1111245689999999999887 5799999999999999999999999965321 1111
Q ss_pred HHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....... ...+..+.... ..+++.+.+||.+||..||++|||++++++.
T Consensus 272 ~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLL------------------------DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHH------------------------HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhc------------------------ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111100 00000011111 2678899999999999999999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=354.12 Aligned_cols=248 Identities=28% Similarity=0.437 Sum_probs=194.2
Q ss_pred cccCCCCCCeEEe-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHH-HhcCCCCcceeeeEecC
Q 007064 16 FSEYGDASRYKIQ-EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL-RLLRHPDIVEIKHIMLP 93 (619)
Q Consensus 16 ~~~~~~~~rY~i~-~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL-~~L~HpnIv~l~~v~~~ 93 (619)
+......++|.++ +.||+|+||.||+|.++.+++.||||++.. ...+.+|+.++ +.++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3444566789888 789999999999999999999999999864 23466888887 66689999999998843
Q ss_pred CCCCCCCcEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEE
Q 007064 94 PSRRDFKDIYVVFELMES-DLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKI 167 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g-~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL 167 (619)
.. .+...+|||||||.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 83 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl 161 (299)
T 3m2w_A 83 LY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 161 (299)
T ss_dssp EE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred hc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEE
Confidence 11 224679999999984 9999998754 6999999999999999999999999999999999999998 789999
Q ss_pred eecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhh
Q 007064 168 CDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~ 247 (619)
+|||++.... + ..|+.++|||||||++|+|++|..||.+.+.......+.
T Consensus 162 ~Dfg~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--- 211 (299)
T 3m2w_A 162 TDFGFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--- 211 (299)
T ss_dssp CCCTTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---
T ss_pred eccccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---
Confidence 9999886421 1 357789999999999999999999997765322110000
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
..............+..+++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus 212 --------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 212 --------------------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp --------------------CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred --------------------HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 000000000011122567899999999999999999999999999999987544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.75 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=196.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDI-FEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~-~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++. +
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----E 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----E
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----c
Confidence 4557899999999999999999999999999999999753 234556678899999999999999999999984 3
Q ss_pred CCcEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 99 FKDIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
...+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 4579999999995 99998864 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChh--HHHHHHHhhhCCCc
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLMTDLLGTPS 251 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~--~~l~~i~~~~g~p~ 251 (619)
........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 250 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-------- 250 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH--------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh--------
Confidence 76533221 1234578999999999876 67899999999999999999999999765321 111111
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..... .......+++.+.+||.+||..||.+|||+++++++
T Consensus 251 -------------------~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 251 -------------------EQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp -------------------HTTCS--CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------hcccC--CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00000 011124578899999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=360.90 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=201.8
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEE----EEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKV----AIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP 94 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~v----AIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~ 94 (619)
.-..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-
Confidence 345678999999999999999999998888754 66666532 223446678899999999999999999999853
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
...++|+|++. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 89 -----~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 89 -----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp -----SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred -----CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 23789999998 699999976 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCc
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPS 251 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~ 251 (619)
++........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 164 a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~----- 235 (327)
T 3lzb_A 164 AKLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----- 235 (327)
T ss_dssp -----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-----
T ss_pred eeEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----
Confidence 9865432221 12234567889999999887 689999999999999999999 99999887765544333211
Q ss_pred hhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. .....+.+++.+.+||.+||..||.+|||+.|+|+.
T Consensus 236 ----------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 236 ----------------------E---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------C---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------C---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 011234578899999999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.66 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.+ +++.||||++.. .....+.+|.+++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 467899999999999999999977 689999999864 234456677777777 78999999999865432 33
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCcEEEee
Q 007064 99 FKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
...+|+|||||+ |+|.++++. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 456899999998 599999954 47999999999999999999999 99999999999999999999999999
Q ss_pred cCccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhC----------CCCCCCC
Q 007064 170 FGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (619)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gt~~Y~APEll~~~~~----~y~~~~DIWSLG~ilyeLltG----------~~pF~~~ 234 (619)
||+++......... ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332221 11234589999999999876211 345789999999999999999 7888553
Q ss_pred ChhH-HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 235 NVVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 235 ~~~~-~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.... ....+.. ...........+........++.+.+||.+||..||++|||++++++
T Consensus 237 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRK--------------------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHH--------------------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhH--------------------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2110 0000100 00000000000000011124568999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.45 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=204.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
...+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 97 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR---- 97 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----
Confidence 4467999999999999999999875433 46899998753 445567789999999999999999999998643
Q ss_pred CCCcEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELMES-DLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~g-~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+....|+|||||.+ +|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 33568999999995 99999976 44689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 176 AFNDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
...... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~------- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT-------
T ss_pred ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC-------
Confidence 433221 1112244578889999999876 689999999999999999999 67888777655444333211
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 249 --------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 --------------------RR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112346789999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=376.42 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=193.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~ 99 (619)
..+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~ 81 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTD 81 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecC
Confidence 4567888899999999999875 4568999999998642 234577899999876 899999999988 445
Q ss_pred CcEEEEEecCCccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----------
Q 007064 100 KDIYVVFELMESDLHQVIKANDDL-------TREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN---------- 162 (619)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l-------~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~---------- 162 (619)
..+|||||||+|+|.+++...... ++..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 679999999999999999876533 233457899999999999999999999999999999754
Q ss_pred ---CcEEEeecCccccccCCCCC-ccccccccCCccccCccccccc-----CCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 007064 163 ---CKLKICDFGLARVAFNDTPT-TIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (619)
Q Consensus 163 ---~~vKL~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~APEll~~~-----~~~y~~~~DIWSLG~ilyeLlt-G~~pF~ 232 (619)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 48999999999875433211 1122456899999999998641 2468999999999999999999 999997
Q ss_pred CCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 233 GKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 233 ~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+..... ..+... .. ..... .......+++++.+||.+||..||.+|||+.++|+
T Consensus 242 ~~~~~~--~~i~~~--~~---------------------~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYSRE--SNIIRG--IF---------------------SLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTTHH--HHHHHT--CC---------------------CCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhH--HHHhcC--CC---------------------Ccccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 654322 111110 00 00000 00001234578999999999999999999999999
Q ss_pred CccccC
Q 007064 313 DPYFKG 318 (619)
Q Consensus 313 hp~f~~ 318 (619)
||||..
T Consensus 296 hp~f~~ 301 (434)
T 2rio_A 296 HPLFWP 301 (434)
T ss_dssp SGGGSC
T ss_pred CCccCC
Confidence 999964
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.99 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=204.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.+|.+.+.||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----E 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----C
Confidence 457888999999999999998765554 7999998753 4445677889999999999999999999998532 2
Q ss_pred CcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...|+||||+. ++|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 33589999997 699999986 4578999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 178 NDTP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 178 ~~~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... .........+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC---------
Confidence 2211 1111234578899999999977 688999999999999999999 55666665554443333211
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......+++.+.+||.+||..||.+|||++++++.
T Consensus 245 ------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 245 ------------------RR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 11123568899999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.36 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=205.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 46789999999999999999999999999999999864 34556778899999999999999999999985321 2345
Q ss_pred cEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 101 DIYVVFELMES-DLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.+|+|||||.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999995 99999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------cccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 176 AFNDTPTT------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|..||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 42111100 011234679999999998652 1237889999999999999999999994311000
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
........ .... ....+.+++.+.+||.+||..||.+|||+++++++
T Consensus 254 ------------~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 254 ------------DSVALAVQ---NQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------SCHHHHHH---CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------chhhHHhh---ccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00000000 0000 11235678999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.32 Aligned_cols=258 Identities=14% Similarity=0.175 Sum_probs=201.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC--------CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCccee------
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT--------GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEI------ 87 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t--------g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l------ 87 (619)
.++|++++.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999874 889999998743 357899999999999999984
Q ss_pred ---------eeEecCCCCCCCCcEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 007064 88 ---------KHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKN 156 (619)
Q Consensus 88 ---------~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (619)
++++. .+...+|+|||||.++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CCccCccchhhccc----cCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 34432 124678999999988999999876 789999999999999999999999999999999999
Q ss_pred EEECCCC--cEEEeecCccccccCCCCC----ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 007064 157 ILANANC--KLKICDFGLARVAFNDTPT----TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (619)
Q Consensus 157 ILi~~~~--~vKL~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p 230 (619)
||++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 8999999999765432211 111234589999999999987 5799999999999999999999999
Q ss_pred CCCCC-hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 007064 231 FPGKN-VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309 (619)
Q Consensus 231 F~~~~-~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e 309 (619)
|.+.. ....+..... .+.... .........+..+++.+.+||.+||..||++|||+++
T Consensus 268 f~~~~~~~~~~~~~~~-------------------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQ-------------------KFVDKP--GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp TGGGTTCHHHHHHHHH-------------------HHHHSC--CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred cccCCcCHHHHHHHHH-------------------hccCCh--hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 97754 2222111110 000000 0000011123467899999999999999999999999
Q ss_pred HHcC
Q 007064 310 ALAD 313 (619)
Q Consensus 310 lL~h 313 (619)
+++.
T Consensus 327 l~~~ 330 (352)
T 2jii_A 327 LRNN 330 (352)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=366.52 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=206.5
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DER 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCT
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCC
Confidence 3558899999999999999999986 47899999998753 334567789999999999999999999998 344
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..+|+|||||+ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 67899999998 59999886543 58999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-------- 256 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-------- 256 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT--------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh--------
Confidence 64322211 12244568999999999876 57899999999999999999999999775432211110000
Q ss_pred hhhhcchhHHHHHHhhccc-CCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 255 ISRVRNDKARRYLTSMRKK-QPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
...... ..+... .+.......+..+..+.+||.+||..||++|||+.|+|++.
T Consensus 257 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 257 VESHNN-------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHHTT-------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhcccc-------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000000 000000 00000111223456789999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=348.37 Aligned_cols=248 Identities=29% Similarity=0.377 Sum_probs=204.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-------
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS------- 95 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s------- 95 (619)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+|+.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999997432 24678999999999999999999874311
Q ss_pred ----CCCCCcEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 96 ----RRDFKDIYVVFELMES-DLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 96 ----~~~~~~lylV~E~~~g-~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
......+|+|||||++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 0123558999999995 999999754 579999999999999999999999999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~--------- 227 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSK--F--------- 227 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--H---------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHHH--H---------
Confidence 9999987543321 234579999999999876 6789999999999999999999988732110 0
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
...+... .....+++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 228 ------------------~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 ------------------FTDLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ------------------HHHHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------HHHhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0001000 11234688999999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.69 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT------QE 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc------CC
Confidence 3478999999999999999999875 567899999975322 3457889999999999999999999873 23
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 4799999997 69999986543 69999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 161 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------- 226 (279)
T 1qpc_A 161 DNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---------- 226 (279)
T ss_dssp SSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred Cccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc----------
Confidence 3221 11233457889999999876 578999999999999999999 99999887765544333211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+++.+.+||.+||..||++|||++++++
T Consensus 227 -----------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 227 -----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------cC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0112457889999999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.98 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=202.0
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECC-CCc--EEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEe
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTH-TGE--KVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIM 91 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~-tg~--~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~ 91 (619)
.+..-..++|++++.||+|+||.||+|.+.. ++. .||+|+++... ........+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3344567899999999999999999998643 333 68999987432 2334567889999999999999999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEee
Q 007064 92 LPPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
... ..++||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 91 ~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred ccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 432 3799999998 6999998764 5699999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhC
Q 007064 170 FGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g 248 (619)
||++.................+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-- 240 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-- 240 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS--
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc--
Confidence 9999876443332222334567889999999876 578899999999999999999 99999888765554433211
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 241 ------------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 241 ------------------------GE---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ------------------------CC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CC---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 011234678999999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=380.57 Aligned_cols=250 Identities=22% Similarity=0.422 Sum_probs=209.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|+.|+||||+++++++. +..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~ 289 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP 289 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence 3467999999999999999999999999999999997532 23567899999999999999999999983 445
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 6899999999 6999999864 459999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 370 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------- 435 (495)
T 1opk_A 370 GDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---------- 435 (495)
T ss_dssp TCCEE--CCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----------
T ss_pred CCcee--ecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----------
Confidence 32211 1233456788999999876 678999999999999999999 99999887755444333210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+++.+.+||.+||..||++|||+.++++
T Consensus 436 -----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 -----------------YR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 00 1123467889999999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.14 Aligned_cols=244 Identities=23% Similarity=0.397 Sum_probs=197.0
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+ +|+.||+|++... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCC
Confidence 458899999999999999999976 4889999998743 245678899999999999999999998743 234
Q ss_pred cEEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+||||+++ +|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 68999999985 99999976543 8999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----------- 229 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 229 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 221 22357889999999876 678999999999999999998 9999987765444332211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ----------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 ----------------GY---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CC---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00 01223467899999999999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.12 Aligned_cols=254 Identities=17% Similarity=0.179 Sum_probs=196.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCC-CCcce---------eeeEe
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRH-PDIVE---------IKHIM 91 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~H-pnIv~---------l~~v~ 91 (619)
..|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+.| +|+.. ..++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34899999999999999999999999999999987322 222235678899999999987 32211 11111
Q ss_pred cC------------CCCCCCCcEEEEEecCCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 007064 92 LP------------PSRRDFKDIYVVFELMESDLHQVIKA-------NDDLTREHYQFFLYQLLRALKYIHTANVYHRDL 152 (619)
Q Consensus 92 ~~------------~s~~~~~~lylV~E~~~g~L~~~i~~-------~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDL 152 (619)
.. ........++++|+++.++|.+++.. ...+++..+..|+.||+.||.|||+.||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 11111345899999999999998851 235788899999999999999999999999999
Q ss_pred CCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccc--------cCCCCCCcccchhHHHHHHHH
Q 007064 153 KPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEV 224 (619)
Q Consensus 153 KP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~--------~~~~y~~~~DIWSLG~ilyeL 224 (619)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.. ....|+.++|||||||++|||
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764322 244577 99999999831 114688899999999999999
Q ss_pred HhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCC
Q 007064 225 LTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR 304 (619)
Q Consensus 225 ltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kR 304 (619)
++|+.||.+.+...... ......+.+++.+.+||.+||..||++|
T Consensus 311 ltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHHHccCChhhC
Confidence 99999997765321110 0011234678999999999999999999
Q ss_pred CCHHHHHcCccccC
Q 007064 305 PTAEEALADPYFKG 318 (619)
Q Consensus 305 pSa~elL~hp~f~~ 318 (619)
||+.++|+||||+.
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999974
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=356.95 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=206.7
Q ss_pred CCCe-EEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRY-KIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY-~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
.++| ++++.||+|+||.||++. +..+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence 4455 999999999999998775 4458899999999754 3445677899999999999999999999998543
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
+...+|+|||||. ++|.+++... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred -CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 2357899999998 5999999765 499999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~- 255 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM- 255 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-
T ss_pred ccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-
Confidence 6443322222345578889999999876 57889999999999999999999998653221 111111111100
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
........+..... ......+++.+.+||.+||..||++|||++++++
T Consensus 256 ------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 ------TVLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------HHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hHHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00111111111111 1223567899999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=371.72 Aligned_cols=275 Identities=21% Similarity=0.359 Sum_probs=207.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++... +..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCC
Confidence 4678999999999999999999999999999999997532 123356678999999999999999999998543 234
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCcEEEeecCc
Q 007064 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA----NANCKLKICDFGL 172 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi----~~~~~vKL~DFGl 172 (619)
.+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 6899999998 59999997543 39999999999999999999999999999999999999 7788899999999
Q ss_pred cccccCCCCCccccccccCCccccCccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHh
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTD 245 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~-~~~l~~i~~ 245 (619)
++...... .....+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+... ......+..
T Consensus 163 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred ceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 98653321 22456799999999987531 03577899999999999999999999965332 111222222
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccC-------CCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQ-------KFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.++......+..+... ......+.. ....+++.+.+||.+||..||++|||+++++++
T Consensus 239 ~~~~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheec----------cCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2222222111111100 001111111 112345678999999999999999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=386.56 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=204.3
Q ss_pred CeEEe-EEeeecCceEEEEEEE--CCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 24 RYKIQ-EVIGKGSYGVVCSAID--THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 24 rY~i~-~~LG~G~fG~V~~a~~--~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.|+||||+++++++.. .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------E 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 34443 4899999999999954 4677899999998655555567789999999999999999999999832 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||. |+|.+++.....+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 4899999998 599999999889999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
.......+...+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~------------ 588 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------------ 588 (635)
T ss_dssp ------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------
T ss_pred ccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 322222334567889999999976 689999999999999999998 99999988776555444221
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+++++.+||.+||..||++|||++++++
T Consensus 589 ---------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 589 ---------------ER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------------CC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------CC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 1122457899999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.03 Aligned_cols=270 Identities=20% Similarity=0.307 Sum_probs=204.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+|+.++||||+++++++. +.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TP 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CS
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEe-----cC
Confidence 3567899999999999999999974 4689999999875321 112235889999999999999999999984 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCcEEEeecC
Q 007064 100 KDIYVVFELME-SDLHQVIKAND----DLTREHYQFFLYQLLRALKYIHTA---NVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----~l~e~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
...|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 56899999998 59999998643 499999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----hhHHHHHHHhh
Q 007064 172 LARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN-----VVHQLDLMTDL 246 (619)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~-----~~~~l~~i~~~ 246 (619)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+...
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9986533222 22345679999999999876 578999999999999999999999995311 11111111100
Q ss_pred hCCCchhhhhhhcchhHHHHHHhhcccCCccc-cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQF-SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
+....... ...... ....+..+..+.+||.+||..||.+|||++|+|+|-+-..
T Consensus 256 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEA------------------LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTT------------------SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhh------------------hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 00000000 000000 0111223467999999999999999999999999865433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=369.92 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=203.6
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
-..++|++++.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 259 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EK 259 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TT
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CC
Confidence 35678999999999999999999774 7899999997532 35678899999999999999999999743 23
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~--l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
..+|||||||. |+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 46999999998 599999987543 799999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 340 ~~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------- 402 (450)
T 1k9a_A 340 SSTQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------- 402 (450)
T ss_dssp C------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---------
T ss_pred cccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence 3211 22357889999999976 689999999999999999998 99999887655444333210
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 403 ------------------~~---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 ------------------YK---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 1122467899999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.03 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=205.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|+.|+||||+++++++. ..
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~ 255 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE 255 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence 4578999999999999999999885 46789999997532 23567899999999999999999999983 24
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 5899999998 6999999754 368999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .......++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+.....
T Consensus 336 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 403 (454)
T 1qcf_A 336 DNEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------- 403 (454)
T ss_dssp CHHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--------
T ss_pred CCce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 2211 11123456788999999876 679999999999999999999 9999998876655544422110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
......+++.+.+||.+||..||++|||++++++
T Consensus 404 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 0112357889999999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=357.46 Aligned_cols=281 Identities=22% Similarity=0.296 Sum_probs=198.8
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHH--HHhcCCCCcceeeeEecCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKL--LRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~i--L~~L~HpnIv~l~~v~~~~s~~ 97 (619)
-..++|++++.||+|+||.||+|.+ +++.||||++... ....+..|.++ +..++||||+++++.+......
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 3568999999999999999999965 6899999998642 22333344444 5568999999999765433334
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCcEEE
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------NVYHRDLKPKNILANANCKLKI 167 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILi~~~~~vKL 167 (619)
+...+|+|||||+ |+|.+++.... +++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 4557899999997 59999997754 69999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCC-----CccccccccCCccccCcccccccC-----CCCCCcccchhHHHHHHHHHhCCCC-CCCCCh
Q 007064 168 CDFGLARVAFNDTP-----TTIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNV 236 (619)
Q Consensus 168 ~DFGla~~~~~~~~-----~~~~~~~~~gt~~Y~APEll~~~~-----~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~ 236 (619)
+|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|||++|..| |++.+.
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999986543221 111223567999999999986510 2456789999999999999999655 444332
Q ss_pred hHHHHHHH-hhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCC---CCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 237 VHQLDLMT-DLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPN---ADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 237 ~~~l~~i~-~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.+....+. .....|..+.+.. ... .......+...++. +++.+.+||.+||..||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQV--------LVS--REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHH--------HHT--TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHh--------hhc--ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 11111111 1112222221111 111 11111222222222 4567999999999999999999999954
Q ss_pred ------CccccC
Q 007064 313 ------DPYFKG 318 (619)
Q Consensus 313 ------hp~f~~ 318 (619)
++|-++
T Consensus 312 ~L~~ll~~~~~~ 323 (336)
T 3g2f_A 312 RMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHCCCC-
T ss_pred HHHHHHHHHHhc
Confidence 666554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=348.84 Aligned_cols=244 Identities=30% Similarity=0.454 Sum_probs=194.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++.+.||+|+||.||+|.+. ++.||||++.. ......+.+|+.+|+.++||||+++++++. +
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~ 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL-------N 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------C
Confidence 5678999999999999999999764 78999999864 245677889999999999999999999873 2
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEEECCCCc-EEEeecCc
Q 007064 101 DIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHT---ANVYHRDLKPKNILANANCK-LKICDFGL 172 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILi~~~~~-vKL~DFGl 172 (619)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3699999998 59999998765 37899999999999999999999 89999999999999998886 79999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--------- 214 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM--------- 214 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH---------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH---------
Confidence 9754322 133469999999999977 68999999999999999999999999764321110 00
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....... .......+++.+.+||.+||..||.+|||+++++++
T Consensus 215 ---------------~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 215 ---------------WAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ---------------HHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------HHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0000000 112235678999999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.27 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=196.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CC
Confidence 45899999999999999999875432 46899998753 344567789999999999999999999998743 23
Q ss_pred CcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
...|+|||||. ++|.+++... ..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 56899999998 5999999864 458999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 178 NDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..... ........+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------
Confidence 32211 111234567889999999876 689999999999999999999 7889987665444332211
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ......+++.+.+||.+||..||++|||+++++++
T Consensus 312 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 -----------------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01123578899999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.08 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=205.9
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
|.....|...+.||+|+||.||+|.+ ++..||+|++.... ........+.+|+.+|+.++||||+++++++.
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 100 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS---- 100 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe----
Confidence 44555667779999999999999975 68899999987532 23345677899999999999999999999983
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKA---NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~---~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
+...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 101 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 101 -DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred -cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 4456899999997 699999874 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 180 ~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 254 (307)
T 2nru_A 180 ARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE- 254 (307)
T ss_dssp CEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-
T ss_pred ccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-
Confidence 986543222 112234679999999999865 578999999999999999999999987654332222221110000
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.....++. ..+.......+..+.+||.+||..||.+|||+++++++
T Consensus 255 --------~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 255 --------KTIEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --------CCHHHHSC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------hhhhhhcc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000100 00111122345678999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=359.23 Aligned_cols=246 Identities=15% Similarity=0.174 Sum_probs=194.8
Q ss_pred CCCCeEEeEEeeecCceEEEEE-----EECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a-----~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~ 92 (619)
..++|.+.+.||+|+||.||+| .+..+++.||||++... ....+.+|+.+++.++ |+||+.+++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3577999999999999999999 46788999999999752 2345677888888887 999999999984
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKA-----NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA----- 161 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~-----~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~----- 161 (619)
.....|||||||+ |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.
T Consensus 138 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 138 -----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp -----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred -----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 4456899999998 699999973 557999999999999999999999999999999999999998
Q ss_pred ------CCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 007064 162 ------NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 235 (619)
Q Consensus 162 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~ 235 (619)
++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999976432222 223456789999999999987 579999999999999999999999995432
Q ss_pred hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCc
Q 007064 236 VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314 (619)
Q Consensus 236 ~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp 314 (619)
.... .....+... ..++.+.+|+.+||..||.+|++..+.|.+.
T Consensus 290 ~~~~---------------------------------~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 290 GGEC---------------------------------KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TTEE---------------------------------EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred CCce---------------------------------eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 1000 000000011 2356788999999999999996655555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.43 Aligned_cols=271 Identities=21% Similarity=0.358 Sum_probs=208.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAI----DTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~----~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
..++|++++.||+|+||.||+|. +..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45679999999999999999998 467899999999975 34456678899999999999999999999985432
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 246899999998 5999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 175 VAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 75443322222234567888999999876 578899999999999999999999885431 11112222221111
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. .......+...... .....+++.+.+||.+||..||++|||+.++++
T Consensus 267 ~~------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 MI------VFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH------HHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh------HHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 10 00111111111111 123567899999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=369.74 Aligned_cols=259 Identities=18% Similarity=0.247 Sum_probs=204.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.|+|++++..+..+. .+..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 357899999999999999999999999999999988643222 24778999999999865555544442 3345
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE---CCCCcEEEeecCccccc
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA---NANCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi---~~~~~vKL~DFGla~~~ 176 (619)
..|||||||.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 7899999998899999985 5679999999999999999999999999999999999999 68899999999999875
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 177 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
....... ......+||+.|+|||++.+ ..++.++||||||||||||++|+.||.+.........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----- 229 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 229 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH-----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh-----
Confidence 5433211 11235689999999999987 679999999999999999999999998865433322221110
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
..... .........+++++.+||.+||..||++||++++|++
T Consensus 230 -------~~~~~-----------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 230 -------EKKVA-----------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------HHHHH-----------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------hcccc-----------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00000 0011122456889999999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=368.01 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=200.8
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.|+||||+++++++.. .
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~ 251 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 251 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence 44689999999999999999999864 46799999975332 24568899999999999999999999832 4
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|||||||. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 5899999998 599999964 3469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
..... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+.+..+....
T Consensus 332 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------- 398 (452)
T 1fmk_A 332 DNEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------- 398 (452)
T ss_dssp -------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred CCcee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 32211 1133456788999999876 689999999999999999999 999999887655544432110
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. ....+.+++.+.+||.+||..||++|||++++++
T Consensus 399 ------------------~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 399 ------------------R---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------------------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------C---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 0112467889999999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=377.80 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=201.5
Q ss_pred CCCCeEEeE-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQE-VIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~-~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..+.|.+.+ .||+|+||.||+|.++ .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 345566666 8999999999999875 35667999999754 233456778999999999999999999999842
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 35899999998 5999999654 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...............+++.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------- 555 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------- 555 (613)
T ss_dssp CC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT--------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--------
Confidence 5433221111123345688999999876 689999999999999999998 99999988766554444221
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.. ....+.+++.+.+||.+||..||++||+++++++
T Consensus 556 -------------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 556 -------------------KR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -------------------CC---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -------------------CC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 1122467899999999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=350.66 Aligned_cols=268 Identities=26% Similarity=0.354 Sum_probs=194.9
Q ss_pred cccccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc--CCCCcceeeeEe
Q 007064 14 EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLL--RHPDIVEIKHIM 91 (619)
Q Consensus 14 ~~~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L--~HpnIv~l~~v~ 91 (619)
.....-...++|++++.||+|+||.||+|.+. ++.||||++... ......+|.+++..+ +||||+++++++
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 33334445578999999999999999999875 899999998632 233445566666554 899999999998
Q ss_pred cCCCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEEECCC
Q 007064 92 LPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA--------NVYHRDLKPKNILANAN 162 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILi~~~ 162 (619)
.... .....+|+|||||+ |+|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+|||++.+
T Consensus 101 ~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 101 IKGT-GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EESC-GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred ccCC-CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 5432 12257999999998 5999999765 699999999999999999999999 99999999999999999
Q ss_pred CcEEEeecCccccccCCCCCc-cccccccCCccccCcccccccCCCCCCc------ccchhHHHHHHHHHhC--------
Q 007064 163 CKLKICDFGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG-------- 227 (619)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APEll~~~~~~y~~~------~DIWSLG~ilyeLltG-------- 227 (619)
+.+||+|||+++......... ......+||+.|+|||++.+ ..+... +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999997654332211 11234689999999999876 344444 9999999999999999
Q ss_pred --CCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCC--CCCCCHHHHHHHHHhccCCCCC
Q 007064 228 --KPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQK--FPNADPSALRLLERLLAFDPKD 303 (619)
Q Consensus 228 --~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~s~~l~dLI~~mL~~DP~k 303 (619)
..||....... +....+ ..... . ......+... ...+++.+.+||.+||..||.+
T Consensus 257 ~~~~p~~~~~~~~-----------~~~~~~--------~~~~~-~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 315 (337)
T 3mdy_A 257 EYQLPYHDLVPSD-----------PSYEDM--------REIVC-I-KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315 (337)
T ss_dssp CCCCTTTTTSCSS-----------CCHHHH--------HHHHT-T-SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGG
T ss_pred cccccHhhhcCCC-----------Cchhhh--------HHHHh-h-hccCccccccchhhHHHHHHHHHHHHhhhhChhh
Confidence 55654432100 000000 00000 0 0000111111 1235567999999999999999
Q ss_pred CCCHHHHHcC
Q 007064 304 RPTAEEALAD 313 (619)
Q Consensus 304 RpSa~elL~h 313 (619)
|||++++++|
T Consensus 316 Rps~~ell~~ 325 (337)
T 3mdy_A 316 RLTALRVKKT 325 (337)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 9999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=389.65 Aligned_cols=285 Identities=25% Similarity=0.329 Sum_probs=211.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 347899999999999999999999999999999998753 34556778999999999999999999999875421 1235
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc---EEEeecCc
Q 007064 100 KDIYVVFELME-SDLHQVIKAND---DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK---LKICDFGL 172 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~---~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~---vKL~DFGl 172 (619)
...|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999997 59999998754 6999999999999999999999999999999999999997765 99999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......... .......
T Consensus 171 a~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~ 241 (676)
T 3qa8_A 171 AKELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSN 241 (676)
T ss_dssp CCBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC----
T ss_pred ccccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccc
Confidence 987543321 245689999999999876 6899999999999999999999999977543221100 0000000
Q ss_pred hhhhhhcchhHHHHHHhhcc-cCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 253 DTISRVRNDKARRYLTSMRK-KQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..+...... ...... ............+++.+.+||.+||.+||++|||++++|+||||+.+.
T Consensus 242 ~~~~~~~~l-----~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 242 EHIVVYDDL-----TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp --CCSCCCC-----SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhhhhhh-----ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000000000 000000 000001112234678899999999999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.47 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=205.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.|+||||+++++++.. .
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 334 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 334 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence 45789999999999999999999865 46799999975332 24568899999999999999999999832 4
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|||||||. |+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 5899999998 599999964 3469999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ........++..|+|||++.. ..++.++|||||||+||||++ |..||.+.+..+.+..+....
T Consensus 415 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~--------- 481 (535)
T 2h8h_A 415 DNE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------- 481 (535)
T ss_dssp CHH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred CCc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 211 111123456788999999876 679999999999999999999 999999887655554432210
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ......+++.+.+||.+||..||++|||+++|++.
T Consensus 482 ------------------~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 482 ------------------R---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp ------------------C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------C---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 01124578899999999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.05 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=203.2
Q ss_pred ccccC-CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007064 15 FFSEY-GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (619)
Q Consensus 15 ~~~~~-~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 93 (619)
+..++ -..++|++++.||+|+||.||+|.+.. .+|+|+++...........+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM- 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-
Confidence 33444 356899999999999999999998753 4999998754333344456778999999999999999999984
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecC
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFG 171 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFG 171 (619)
+...+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus 100 ----~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 100 ----SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ----CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ----cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 3456999999998 59999997654 699999999999999999999999999999999999998 6799999999
Q ss_pred ccccccCCCC--CccccccccCCccccCccccccc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHH
Q 007064 172 LARVAFNDTP--TTIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 242 (619)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gt~~Y~APEll~~~-------~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~ 242 (619)
+++....... .........||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9875421111 11122345689999999998641 13578999999999999999999999988775544433
Q ss_pred HHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 243 MTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+... .. .......++..+.+||.+||..||++|||++++++.
T Consensus 255 ~~~~---------------------------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 255 MGTG---------------------------MK--PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHTT---------------------------CC--CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred hccC---------------------------CC--CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3210 00 011123567889999999999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.07 Aligned_cols=255 Identities=19% Similarity=0.174 Sum_probs=192.3
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChHHHHHHHHHHHHHHhcC---------CCCc
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE------HISDAARILREIKLLRLLR---------HPDI 84 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~------~~~~~~~i~~Ei~iL~~L~---------HpnI 84 (619)
-..++|++++.||+|+||.||+|++ +|+.||||++..... .......+.+|+.+|+.|+ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4467899999999999999999987 689999999975321 2233467889999998886 7777
Q ss_pred ceeeeEecCCC-------------------------CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 007064 85 VEIKHIMLPPS-------------------------RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 138 (619)
Q Consensus 85 v~l~~v~~~~s-------------------------~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~a 138 (619)
+++.+++.... ..+...+|||||||. |++.+.+.. +.+++..++.|++||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 77776643110 112567999999997 555555533 568999999999999999
Q ss_pred HHHHH-HCCceeccCCCCcEEECCCC--------------------cEEEeecCccccccCCCCCccccccccCCccccC
Q 007064 139 LKYIH-TANVYHRDLKPKNILANANC--------------------KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197 (619)
Q Consensus 139 L~yLH-s~gIvHrDLKP~NILi~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~A 197 (619)
|.||| +.||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTC
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccC
Confidence 99999 99999999999999999887 8999999999875421 3479999999
Q ss_pred cccccccCCCCCCcccchhHHHH-HHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCC
Q 007064 198 PELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQP 275 (619)
Q Consensus 198 PEll~~~~~~y~~~~DIWSLG~i-lyeLltG~~pF~~~~~~~-~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~ 275 (619)
||++.+ .. +.++||||||++ .++++.|..||.+..... ....+. ... ....
T Consensus 246 PE~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~-----------------------~~~-~~~~ 298 (336)
T 2vuw_A 246 EDLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML-----------------------KQM-TFKT 298 (336)
T ss_dssp SGGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH-----------------------HTC-CCSS
T ss_pred hhhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh-----------------------hhh-ccCc
Confidence 999986 23 889999998777 788888999984321100 111111 000 0111
Q ss_pred ccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHH-cCcccc
Q 007064 276 VQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL-ADPYFK 317 (619)
Q Consensus 276 ~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL-~hp~f~ 317 (619)
......++.+++++++||++||++| |++|+| +||||+
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 1111223456789999999999987 999999 999995
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=372.57 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=205.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t---g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
.++|++++.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46799999999999999999998654 457999998753 344556789999999999999999999998832
Q ss_pred CCcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+.+|+|||||. |+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 35799999999 69999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332211 1233467789999999876 689999999999999999997 99999988766555444221
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ....+.+++.+.+||.+||..||.+|||+.++++.
T Consensus 609 ------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 609 ------------------ER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp ------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 11234678999999999999999999999999763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=344.65 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=198.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHh--cCCCCcceeeeEecCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRL--LRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~--L~HpnIv~l~~v~~~~s~~~ 98 (619)
..++|++++.||+|+||.||+|.+ +++.||||++.. .....+.+|+++++. ++||||+++++++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence 346899999999999999999987 589999999864 234567789999988 78999999999986543 12
Q ss_pred CCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEEECCCCcEEEee
Q 007064 99 FKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH--------TANVYHRDLKPKNILANANCKLKICD 169 (619)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILi~~~~~vKL~D 169 (619)
...+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 2479999999995 999999765 6999999999999999999999 89999999999999999999999999
Q ss_pred cCccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhC----------CCCCCCC
Q 007064 170 FGLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (619)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gt~~Y~APEll~~~~~----~y~~~~DIWSLG~ilyeLltG----------~~pF~~~ 234 (619)
||++.......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 99998754332211 11244579999999999875211 233689999999999999999 6777554
Q ss_pred ChhH-HHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHH
Q 007064 235 NVVH-QLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEAL 311 (619)
Q Consensus 235 ~~~~-~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL 311 (619)
...+ ....+.. .+. .......+...+ ...++.+.+||.+||..||++|||+++++
T Consensus 271 ~~~~~~~~~~~~--------------------~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 271 VPSDPSVEEMRK--------------------VVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp SCSSCCHHHHHH--------------------HHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CcCcccHHHHHH--------------------HHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 2110 0000000 000 000011111111 12345789999999999999999999998
Q ss_pred cC
Q 007064 312 AD 313 (619)
Q Consensus 312 ~h 313 (619)
+|
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.55 Aligned_cols=229 Identities=17% Similarity=0.092 Sum_probs=186.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..++||||+++++++. +.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TR 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----EC
Confidence 347899999999999999999999999999999999754332 455678899999999999999999999983 44
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+.+|+|||||+ ++|.++++.+ ....++..|+.||+.||.|||+.||+||||||+|||++.+|.+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 67999999998 5999998543 5667789999999999999999999999999999999999999998554
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+....
T Consensus 175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------------- 215 (286)
T 3uqc_A 175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------------- 215 (286)
T ss_dssp ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------------
T ss_pred ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------------
Confidence 222 36789999999999999999999998866422110000
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..............+.+++.+.+||.+||..||++| |++|+++.
T Consensus 216 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 216 ----------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ----------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ----------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000111112223446789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=374.80 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=199.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~-tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999999999976 7899999998653 3445566788999999999999999999998654322222
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+ ++|.+++.. .+++..++.|+.||+.||.|||+.||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 488887754 69999999999999999999999999999999999999986 8999999999865322
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.... +.+..
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~------- 287 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED------- 287 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT-------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc-------
Confidence 34579999999999875 4588999999999999999999998653210 00000
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
......++.+.+||.+||..||.+||+..++|.|+|+.-
T Consensus 288 --------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 --------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000113568899999999999999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=315.93 Aligned_cols=186 Identities=18% Similarity=0.133 Sum_probs=134.1
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccC--------ChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCCCCC
Q 007064 30 VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--------HISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 30 ~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~--------~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++.|+.|.+..++....|+.|++|++..... .....+.+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 35677777777777778899999999964321 123446789999999999 699999999998 6778
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+| +|.++|...+++++. .|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 89999999996 999999999999876 47899999999999999999999999999999999999999999875433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCC
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~ 229 (619)
.. ..+..+||+.|+|||++.+ .+..++|+||+|+++++|.++..
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 22 2356789999999999875 56778999999999998876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=267.43 Aligned_cols=189 Identities=20% Similarity=0.264 Sum_probs=142.3
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-h-----HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-I-----SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~-----~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...+.||+|+||.||+| ...+..+++|+....... . ...+++.+|+++|+.++||||+.+..+... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence 45679999999999999 566889999987532221 1 124568999999999999999944333321 2
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...|||||||+ ++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+++....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 34599999998 699999865 5689999999999999999999999999999999 999999999987533
Q ss_pred CCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 007064 179 DTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (619)
Q Consensus 179 ~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF 231 (619)
..... ......+||++|+|||++......|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21111 012456899999999998764457888999999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.6e-24 Score=220.41 Aligned_cols=146 Identities=16% Similarity=0.184 Sum_probs=115.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------HHHHHHHHHHHHHHhcCCCCcce
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI----------------SDAARILREIKLLRLLRHPDIVE 86 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~----------------~~~~~i~~Ei~iL~~L~HpnIv~ 86 (619)
..|.+++.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4466669999999999999999 889999999996321110 13567889999999999 4 55
Q ss_pred eeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcE
Q 007064 87 IKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKL 165 (619)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~v 165 (619)
+.+++. .+..|+|||||+| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.+
T Consensus 166 v~~~~~------~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYA------WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEE------EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEe------ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 555542 1346999999985 8887 41 134567999999999999999999999999999999 9999
Q ss_pred EEeecCccccccCCCCCccccccccCCccccCccccc
Q 007064 166 KICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202 (619)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~ 202 (619)
||+|||+|+. +..++|||++.
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHH
Confidence 9999999863 33478899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=190.45 Aligned_cols=140 Identities=17% Similarity=0.143 Sum_probs=110.4
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcE--EEEEEecCccCC----------------------hHHHHHHHHHHHHHHh
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEH----------------------ISDAARILREIKLLRL 78 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~--vAIK~i~~~~~~----------------------~~~~~~i~~Ei~iL~~ 78 (619)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4588999999999999999998778999 999987532111 0112367899999999
Q ss_pred cCCCCc--ceeeeEecCCCCCCCCcEEEEEecCC--c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcee
Q 007064 79 LRHPDI--VEIKHIMLPPSRRDFKDIYVVFELME--S----DLHQVIKANDDLTREHYQFFLYQLLRALKYIH-TANVYH 149 (619)
Q Consensus 79 L~HpnI--v~l~~v~~~~s~~~~~~lylV~E~~~--g----~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLH-s~gIvH 149 (619)
|.|++| ..+++. ...||||||++ | .|.+++.. +++..+..++.||+.+|.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 988864 333332 23589999995 2 67776532 345678899999999999999 999999
Q ss_pred ccCCCCcEEECCCCcEEEeecCccccc
Q 007064 150 RDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 150 rDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=170.66 Aligned_cols=137 Identities=16% Similarity=0.167 Sum_probs=98.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC---------------ChHH---HH--HHHHHHHHHHhcCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE---------------HISD---AA--RILREIKLLRLLRHP 82 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~---------------~~~~---~~--~i~~Ei~iL~~L~Hp 82 (619)
.-|.+++.||.|+||.||+|.+. +|+.||||+++.... .... .. ...+|+..|..|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999874 699999998752100 0000 01 123567777777544
Q ss_pred Ccc--eeeeEecCCCCCCCCcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 007064 83 DIV--EIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILA 159 (619)
Q Consensus 83 nIv--~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi 159 (619)
++. ..++. ...+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||+
T Consensus 174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEE---------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred CCCCCeeeec---------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence 432 22222 123799999996 664432 223456788999999999999999999999999999
Q ss_pred CCCC----------cEEEeecCcccc
Q 007064 160 NANC----------KLKICDFGLARV 175 (619)
Q Consensus 160 ~~~~----------~vKL~DFGla~~ 175 (619)
+.++ .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8876 389999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.2e-11 Score=122.40 Aligned_cols=138 Identities=12% Similarity=0.121 Sum_probs=106.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..|++...++.|+.+.||++.. .+..+++|....... .....+.+|+.+|+.|. +..+.+++++.. +.+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 3589999999999999999964 368999999864211 11235788999999985 677888888763 3456
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 007064 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT------------------------------------ 144 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs------------------------------------ 144 (619)
.|+|||+++| +|.+.+ .+......++.++.++|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 8999999997 776652 1223345788999999999998
Q ss_pred -----------------------CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 -----------------------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 -----------------------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876566799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=119.32 Aligned_cols=184 Identities=17% Similarity=0.253 Sum_probs=120.0
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCC--cceeeeEecCCCCCCCCcEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPD--IVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-Hpn--Iv~l~~v~~~~s~~~~~~lyl 104 (619)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +.. +.+++.... ........|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~--~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM--PSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC--CCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecC--CCCCCCcceE
Confidence 4569999999999872 5688998653 244567889999999884 333 233333221 1111234589
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 007064 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------------------------------------- 144 (619)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs--------------------------------------- 144 (619)
|||+++| .|..... ..++.++...++.++...|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247888888889999999998886
Q ss_pred -------------------CCceeccCCCCcEEECC--CCcEEEeecCccccccCCCCCccccccccCCccc---cCccc
Q 007064 145 -------------------ANVYHRDLKPKNILANA--NCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY---RAPEL 200 (619)
Q Consensus 145 -------------------~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y---~APEl 200 (619)
..++|+|++|.||+++. ++.+.|+||+.+.... .... ......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~--~~~D-----l~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD--PDND-----FISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC--TTHH-----HHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC--hHHH-----HHHHHhhccccCHHH
Confidence 13699999999999998 4568899999986531 1111 1111111 22332
Q ss_pred ccccCCCCC------------CcccchhHHHHHHHHHhCCCCC
Q 007064 201 CGSFFSKYT------------PAIDIWSIGCIFAEVLTGKPLF 231 (619)
Q Consensus 201 l~~~~~~y~------------~~~DIWSLG~ilyeLltG~~pF 231 (619)
.......|. .-.+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 211101111 1258999999999999998766
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=3e-10 Score=113.05 Aligned_cols=134 Identities=15% Similarity=0.083 Sum_probs=95.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~~~~ 99 (619)
...|.+....+.|..+.||++. ..+|..+++|..... ....+.+|+.+|+.+.+.+ +.+++.+.. +.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~ 87 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EA 87 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CS
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CC
Confidence 3456765544566679999985 456778999987642 1234678999999886444 455777653 23
Q ss_pred CcEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 007064 100 KDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN-------------------------------- 146 (619)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g-------------------------------- 146 (619)
+..|+|||+++| +| . . ...+. ..++.++...|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l-~-~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDL-L-S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEET-T-T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCccc-C-c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 458999999997 55 3 1 11222 256677777888888653
Q ss_pred --------------------------ceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 147 --------------------------VYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 147 --------------------------IvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=8.9e-10 Score=116.18 Aligned_cols=144 Identities=13% Similarity=0.211 Sum_probs=104.0
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCCCCCCC
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--DIFEHISDAARILREIKLLRLLR--HPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~--~~~~~~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~s~~~~~ 100 (619)
..-++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+|+.|. +..+.+++.++... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 344788999999999998643 5688888765 21 11123456788999999997 45577888776432 1224
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHT----------------------------------- 144 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs----------------------------------- 144 (619)
..|+|||+++| .+.+. .-..+++.+...++.++.+.|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 44221 12347888889999999999999997
Q ss_pred -----------------------CCceeccCCCCcEEECCCCc--EEEeecCcccc
Q 007064 145 -----------------------ANVYHRDLKPKNILANANCK--LKICDFGLARV 175 (619)
Q Consensus 145 -----------------------~gIvHrDLKP~NILi~~~~~--vKL~DFGla~~ 175 (619)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.3e-06 Score=88.22 Aligned_cols=133 Identities=23% Similarity=0.231 Sum_probs=91.1
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCCCcEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDFKDIYV 104 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~s~~~~~~lyl 104 (619)
++.++.|....||+. +..+++|+.. .......+.+|..+|+.|.+. .+.+++.+.. ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 466899999999988 5678888753 233456788999999999753 2444444432 12345789
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 007064 105 VFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA-------------------------------------- 145 (619)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~-------------------------------------- 145 (619)
|||+++| .|..... ..++.++...+..++...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1245555555566666666555542
Q ss_pred ----------------------CceeccCCCCcEEECC---CCcE-EEeecCcccc
Q 007064 146 ----------------------NVYHRDLKPKNILANA---NCKL-KICDFGLARV 175 (619)
Q Consensus 146 ----------------------gIvHrDLKP~NILi~~---~~~v-KL~DFGla~~ 175 (619)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=4.7e-06 Score=83.50 Aligned_cols=132 Identities=18% Similarity=0.216 Sum_probs=91.9
Q ss_pred EEeeecCce-EEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCcEEEEE
Q 007064 29 EVIGKGSYG-VVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 29 ~~LG~G~fG-~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (619)
+.+..|..| .||+......+..+++|.-.. .....+.+|..+|+.|. +-.+.+++.+. .+.+..|+||
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvm 99 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLT 99 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEE
Confidence 345556555 689887777778899997642 34567889999999885 33355666665 2335689999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 007064 107 ELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA---------------------------------------- 145 (619)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~---------------------------------------- 145 (619)
|+++| ++.+..... ......+..++...|.-||+.
T Consensus 100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99997 666554321 122334555666666666632
Q ss_pred ------------------CceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 146 ------------------NVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 146 ------------------gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16999999999999987767799999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.1e-05 Score=85.76 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=48.7
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C---hHHHHHHHHHHHHHHhcCC--CC-cceeeeEecCCCCCC
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE--H---ISDAARILREIKLLRLLRH--PD-IVEIKHIMLPPSRRD 98 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~--~---~~~~~~i~~Ei~iL~~L~H--pn-Iv~l~~v~~~~s~~~ 98 (619)
-++.||.|..+.||++.+..++..+++|....... . .....++.+|..+|+.+.. |. +.+++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------
Confidence 36789999999999997666678999998653211 0 0123456789999988742 33 33454432
Q ss_pred CCcEEEEEecCCc
Q 007064 99 FKDIYVVFELMES 111 (619)
Q Consensus 99 ~~~lylV~E~~~g 111 (619)
....++|||+++|
T Consensus 107 ~~~~~lvmE~l~g 119 (397)
T 2olc_A 107 TEMAVTVMEDLSH 119 (397)
T ss_dssp TTTTEEEECCCTT
T ss_pred CCccEEEEEeCCC
Confidence 1234899999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=2e-05 Score=81.29 Aligned_cols=30 Identities=23% Similarity=0.345 Sum_probs=27.1
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=2.6e-05 Score=81.53 Aligned_cols=85 Identities=8% Similarity=0.138 Sum_probs=52.3
Q ss_pred eEEeEEe-eecCceEEEEEEECC------CCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcC-C--CCcceeeeEecC
Q 007064 25 YKIQEVI-GKGSYGVVCSAIDTH------TGEKVAIKKIHDIFE-HISDAARILREIKLLRLLR-H--PDIVEIKHIMLP 93 (619)
Q Consensus 25 Y~i~~~L-G~G~fG~V~~a~~~~------tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~-H--pnIv~l~~v~~~ 93 (619)
...++.| +.|....+|++.... ++..+++|....... .......+.+|+.+|+.|. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 889899999885431 266889987653210 0001134677888888874 2 346667666532
Q ss_pred CCCCCCCcEEEEEecCCc
Q 007064 94 PSRRDFKDIYVVFELMES 111 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g 111 (619)
.+ ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00092 Score=71.64 Aligned_cols=31 Identities=13% Similarity=0.271 Sum_probs=27.5
Q ss_pred HCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 144 TANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 144 s~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 46799999999999999876 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00048 Score=70.22 Aligned_cols=68 Identities=13% Similarity=0.043 Sum_probs=41.8
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~~~~~lylV~ 106 (619)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+..-.+ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~-----~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--P-----ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T-----TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--C-----CCCEEEE
Confidence 788999999999998 468888775321 111122458888877752222 3444432 1 1236899
Q ss_pred ecC-Cc
Q 007064 107 ELM-ES 111 (619)
Q Consensus 107 E~~-~g 111 (619)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0023 Score=62.21 Aligned_cols=96 Identities=18% Similarity=0.134 Sum_probs=65.5
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCCccccccc
Q 007064 112 DLHQVIKA-NDDLTREHYQFFLYQLLRALKYI-HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDY 189 (619)
Q Consensus 112 ~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 189 (619)
+|.+++.. +.+++|+++|.+++|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999975 56899999999999999998876 222222333457899999999987764 2111
Q ss_pred cCCccccCcccccccCCCCCCcccchhHHHHHHHHHh
Q 007064 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (619)
Q Consensus 190 ~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt 226 (619)
.....+.+||... ...+.+.=|+|||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888764 355678899999999999885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0041 Score=63.53 Aligned_cols=150 Identities=13% Similarity=0.110 Sum_probs=80.0
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPP 94 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~ 94 (619)
..|+. +...-++.|+.|....||++... +| .+++|..... .....+..|+.+++.|.... +.+++... ..
T Consensus 17 ~~~~~-~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g 88 (322)
T 2ppq_A 17 TQYDV-GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DG 88 (322)
T ss_dssp TTBCC-CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TC
T ss_pred HhCCC-CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CC
Confidence 34454 34445677888988999998643 33 6889987642 12234566888887774222 23332210 00
Q ss_pred C--CCCCCcEEEEEecCCcc-H-----------HHH---HH-hCCC--------CCHHHHHHH---------------HH
Q 007064 95 S--RRDFKDIYVVFELMESD-L-----------HQV---IK-ANDD--------LTREHYQFF---------------LY 133 (619)
Q Consensus 95 s--~~~~~~lylV~E~~~g~-L-----------~~~---i~-~~~~--------l~e~~i~~i---------------~~ 133 (619)
. ....+..++||++++|. + .+. +. .... ......... -.
T Consensus 89 ~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~ 168 (322)
T 2ppq_A 89 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 168 (322)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHH
Confidence 0 00124578999999862 1 011 11 1111 111110000 01
Q ss_pred HHHHHHHHHHH-------CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 134 QLLRALKYIHT-------ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 134 QIl~aL~yLHs-------~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.+...+..++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 169 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13444555553 368999999999999987656899999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0036 Score=64.56 Aligned_cols=74 Identities=16% Similarity=0.104 Sum_probs=54.1
Q ss_pred EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC---CCCcceeeeEecCCCCCCCCcE
Q 007064 26 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR---HPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 26 ~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~---HpnIv~l~~v~~~~s~~~~~~l 102 (619)
.-.+.|+.|....+|+... ++..+++|..... ....+.+|...|+.|. ...+.+++.+.. ..+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCce
Confidence 3467899999999999863 4678899976531 2556788999998884 245667766652 23568
Q ss_pred EEEEecCCc
Q 007064 103 YVVFELMES 111 (619)
Q Consensus 103 ylV~E~~~g 111 (619)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0038 Score=64.31 Aligned_cols=31 Identities=26% Similarity=0.438 Sum_probs=26.9
Q ss_pred CCceeccCCCCcEEECCC----CcEEEeecCcccc
Q 007064 145 ANVYHRDLKPKNILANAN----CKLKICDFGLARV 175 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~----~~vKL~DFGla~~ 175 (619)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.012 Score=59.17 Aligned_cols=76 Identities=12% Similarity=0.016 Sum_probs=51.6
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCC---CcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP---DIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hp---nIv~l~~v~~~~s~~~~ 99 (619)
.+..-++.+|.|..+.||++.. .+|+.|++|+-..... .....+.+|...|+.|.-- .+.+++.+-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 3556688999999999999964 5789999998653211 1123466899999988522 234444432
Q ss_pred CcEEEEEecCC
Q 007064 100 KDIYVVFELME 110 (619)
Q Consensus 100 ~~lylV~E~~~ 110 (619)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 1378999987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.013 Score=62.94 Aligned_cols=72 Identities=14% Similarity=0.130 Sum_probs=48.2
Q ss_pred EeEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCC
Q 007064 27 IQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRD 98 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~~ 98 (619)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|+.+++.|...++ .+++..+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 35678899999999997542 3578999987431 11 1345579999988853333 5566554 11
Q ss_pred CCcEEEEEecCCc
Q 007064 99 FKDIYVVFELMES 111 (619)
Q Consensus 99 ~~~lylV~E~~~g 111 (619)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999985
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0041 Score=65.14 Aligned_cols=72 Identities=7% Similarity=0.002 Sum_probs=41.9
Q ss_pred eEEeeecCceEEEEEEECC--------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC-cceeeeEecCCCCCC
Q 007064 28 QEVIGKGSYGVVCSAIDTH--------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD-IVEIKHIMLPPSRRD 98 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~--------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn-Iv~l~~v~~~~s~~~ 98 (619)
++.|+.|....+|++.... .+..+++|+..... .......+|..+|+.|...+ ..+++... .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C-
Confidence 5678888889999987542 13688888765321 11112356888888875333 34565543 1
Q ss_pred CCcEEEEEecCCc
Q 007064 99 FKDIYVVFELMES 111 (619)
Q Consensus 99 ~~~lylV~E~~~g 111 (619)
-++||||++|
T Consensus 109 ---~~~v~e~i~G 118 (369)
T 3c5i_A 109 ---GGRIEEWLYG 118 (369)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CcEEEEEecC
Confidence 1689999986
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0073 Score=61.83 Aligned_cols=76 Identities=13% Similarity=0.062 Sum_probs=45.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCC--cceeeeEecCCCC--CCCCcEEE
Q 007064 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD--IVEIKHIMLPPSR--RDFKDIYV 104 (619)
Q Consensus 29 ~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~Hpn--Iv~l~~v~~~~s~--~~~~~lyl 104 (619)
..|+ |....||++.. .+|+.+++|....... ....+..|+.+++.|.... +.+++.. .+.. ...+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 77888998743 3466799998863211 2345667888888775222 3333332 1110 11345688
Q ss_pred EEecCCc
Q 007064 105 VFELMES 111 (619)
Q Consensus 105 V~E~~~g 111 (619)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0067 Score=64.26 Aligned_cols=139 Identities=12% Similarity=0.165 Sum_probs=81.5
Q ss_pred CCeEEeEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~ 94 (619)
+... ++.|..|-...+|++.... ++..+++|+.... ......+.+|..+++.|. +.-..+++..+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--- 123 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF--- 123 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc---
Confidence 3344 4678888888999986532 3578999985321 112345568999998885 33335566554
Q ss_pred CCCCCCcEEEEEecCCc-cH-----------HH---HH---HhCC-----CC--CHHHHHHHHHHHHH------------
Q 007064 95 SRRDFKDIYVVFELMES-DL-----------HQ---VI---KAND-----DL--TREHYQFFLYQLLR------------ 137 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L-----------~~---~i---~~~~-----~l--~e~~i~~i~~QIl~------------ 137 (619)
.+ .+||||++| .| .. .+ .... .. -...+..|+.++..
T Consensus 124 --~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 124 --PE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp --TT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred --CC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 22 289999985 11 11 11 1111 11 24566666655432
Q ss_pred -------HHHHHH----HC----CceeccCCCCcEEECCC----CcEEEeecCccc
Q 007064 138 -------ALKYIH----TA----NVYHRDLKPKNILANAN----CKLKICDFGLAR 174 (619)
Q Consensus 138 -------aL~yLH----s~----gIvHrDLKP~NILi~~~----~~vKL~DFGla~ 174 (619)
.+..|. .. .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 22 48999999999999876 789999999774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.074 Score=57.67 Aligned_cols=72 Identities=19% Similarity=0.207 Sum_probs=45.8
Q ss_pred eEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCc-ceeeeEecCCCCCCCCcEEEEE
Q 007064 28 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI-VEIKHIMLPPSRRDFKDIYVVF 106 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnI-v~l~~v~~~~s~~~~~~lylV~ 106 (619)
++.|+.|-...+|++.....+..+++|+.........+ ..+|..+|+.|...++ .+++.++ .+ .+||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFF-----TN----GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEE
Confidence 56788899999999976544578999986432111111 2479999999875444 4566655 11 2599
Q ss_pred ecCCc
Q 007064 107 ELMES 111 (619)
Q Consensus 107 E~~~g 111 (619)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99985
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.017 Score=60.01 Aligned_cols=31 Identities=19% Similarity=0.310 Sum_probs=27.4
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.22 Score=53.37 Aligned_cols=72 Identities=10% Similarity=-0.023 Sum_probs=45.2
Q ss_pred eEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCC
Q 007064 28 QEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 28 ~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~ 99 (619)
++.|..|-...+|++.... .+..+++|+....... .-...+|..+++.|. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~-----~-- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF-----P-- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE-----T--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc-----C--
Confidence 5667788888999987642 1578999986432111 112346888888775 33334455433 1
Q ss_pred CcEEEEEecCCc
Q 007064 100 KDIYVVFELMES 111 (619)
Q Consensus 100 ~~lylV~E~~~g 111 (619)
-+.||||++|
T Consensus 145 --~~~I~efI~G 154 (424)
T 3mes_A 145 --EGRIEEFIDG 154 (424)
T ss_dssp --TEEEEECCCS
T ss_pred --CCEEEEEeCC
Confidence 1689999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.3 Score=51.67 Aligned_cols=29 Identities=31% Similarity=0.427 Sum_probs=24.8
Q ss_pred ceeccCCCCcEEE------CCCCcEEEeecCcccc
Q 007064 147 VYHRDLKPKNILA------NANCKLKICDFGLARV 175 (619)
Q Consensus 147 IvHrDLKP~NILi------~~~~~vKL~DFGla~~ 175 (619)
++|+|+.+.|||+ +.+..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 619 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-98 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-89 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-88 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-73 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-72 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-72 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-67 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-65 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-65 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-64 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 300 bits (769), Expect = 8e-98
Identities = 160/342 (46%), Positives = 219/342 (64%), Gaps = 5/342 (1%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
RY IG+G+YG+VCSA D +VAIKKI FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+I+ I I+ P+ KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N C LKICDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS + ++ + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
KAR YL S+ K V +++ FPNAD AL LL+++L F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQL 363
EP + +F+ E + KE ++ELIF E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (713), Expect = 2e-89
Identities = 138/346 (39%), Positives = 211/346 (60%), Gaps = 12/346 (3%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
+ + RY+ +G G+YG VC+A DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+ ++H +++ + + P S +F D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
LR LKYIH+A++ HRDLKP N+ N +C+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + + QL L+ L+GTP + +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
++ ++ AR Y+ S+ + + F+ F A+P A+ LLE++L D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
F + EP P + FE R + ++ + L + E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (707), Expect = 2e-88
Identities = 134/340 (39%), Positives = 210/340 (61%), Gaps = 12/340 (3%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+ Y+ + +G G+YG VCSA+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 83 DIVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
+++ + + P + DF D Y+V M +DL +++K ++ L + QF +YQ+L+ L+Y
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRY 136
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N +C+LKI DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWYRAPEVI 190
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP + + R+++D
Sbjct: 191 LN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
+A+ Y+ + + + F+ NA P A+ LLE++L D + R TA EALA PYF+ L
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 322 VEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHP 361
E EP Q + F+ T ++ + + ++E+L + P
Sbjct: 310 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 2e-77
Identities = 118/354 (33%), Positives = 192/354 (54%), Gaps = 23/354 (6%)
Query: 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLL 76
S + RY+ + IG G+ G+VC+A D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKHIMLPPSR-RDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQL 135
+ + H +I+ + ++ P +F+D+Y+V ELM+++L QVI+ D E + LYQ+
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LKI DFGLAR A T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
RAPE+ Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP + +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNA------------DPSALRLLERLLAFDPKD 303
++ R Y+ + K + F + FP++ A LL ++L DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 304 RPTAEEALADPYFKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREIL 357
R + ++AL PY + P + + + R T E+ +ELI++E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 6e-77
Identities = 104/301 (34%), Positives = 152/301 (50%), Gaps = 7/301 (2%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
S+Y+ IG+G++G V A TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKHIML---PPSRRDFKDIYVVFELMESDLHQV-IKANDDLTREHYQFFLYQLLRA 138
++V + I P R IY+VF+ E DL + T + + LL
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 197
L YIH + HRD+K N+L + LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL Y P ID+W GCI AE+ T P+ G HQL L++ L G+ + +
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNDKARRYLTSMR-KKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
V N + L ++ +K+ V+ K DP AL L+++LL DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-75
Identities = 101/330 (30%), Positives = 165/330 (50%), Gaps = 19/330 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKHIMLPP-SRRDFKDIYVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRA 138
IV +++ ++D + +V + + +++V +A L + + ++YQL R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYIHTANVYHRDLKPKNILANANCKL-KICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PEL YT +ID+WS GC+ AE+L G+P+FPG + V QL + +LGTP+ + I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ + ++ + P P A+ L RLL + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKV--FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 318 GLSKVEREPSCQPISKMEFEFERRRVTKED 347
L + + F F + ++
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 5e-73
Identities = 64/310 (20%), Positives = 121/310 (39%), Gaps = 28/310 (9%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV +I + E M+ L QV+K + + +++ L Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 143 HTAN-VYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ Y+ DIWS+G E+ G+ P + + + + +T R R
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 262 KARRYLTSMRKKQPVQFSQKFPNA-------------DPSALRLLERLLAFDPKDRPTAE 308
M + P+ + + + L +P +R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 309 EALADPYFKG 318
+ + + K
Sbjct: 294 QLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 6e-72
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 13/300 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAND--DLTREHYQFFLYQLLRALKY 141
IV++ ++ +Y+VFE + DL + + A+ + + +L+QLL+ L +
Sbjct: 63 IVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP D +
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP--DEVVWPGVT 231
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321
Y S K FS+ P D LL ++L +DP R +A+ ALA P+F+ ++K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 7e-72
Identities = 97/306 (31%), Positives = 152/306 (49%), Gaps = 16/306 (5%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL--- 79
+Y+ IG+G+YG V A D G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQFFLYQLLR 137
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P + R
Sbjct: 184 PEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+ + K + + D LL + L F+P R +A AL+ PYF+
Sbjct: 242 DVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
Query: 318 GLSKVE 323
L + +
Sbjct: 298 DLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 1e-71
Identities = 98/305 (32%), Positives = 150/305 (49%), Gaps = 18/305 (5%)
Query: 29 EVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAA---RILREIKLLRLLRHPDIV 85
+ +G+G + V A D +T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 EIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYIHT 144
+ +I +VF+ ME+D + + LT H + ++ L+ L+Y+H
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 145 ANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSF 204
+ HRDLKP N+L + N LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKAR 264
Y +D+W++GCI AE+L P PG + + QL + + LGTP+ + + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 265 RYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVER 324
+ + + F A L L++ L F+P R TA +AL YF ++
Sbjct: 235 ---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS--NRPGP 289
Query: 325 EPSCQ 329
P CQ
Sbjct: 290 TPGCQ 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 225 bits (574), Expect = 1e-69
Identities = 106/295 (35%), Positives = 155/295 (52%), Gaps = 13/295 (4%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+YGVV A + + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELM-ESDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV++ ++ K + +VFE + + + L + FL QLL + Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
+Y + +P+ + D S + LL ++L DP R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 8e-69
Identities = 104/297 (35%), Positives = 148/297 (49%), Gaps = 11/297 (3%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV + ++ D K V + N DL E + FL+QLL+ L + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFG 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
Y+ +ID+WS GCIFAE+ PLFPG +V QL + LLGTP+ + + K
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TK 232
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
Y P + + LL+ LL +P R +AEEAL PYF
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 5e-68
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+ + + +G+G+YG V A++ T E VA+K + D+ + I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLH-QVIKANDDLTREHYQFFLYQLLRALKYI 142
+V+ + Y+ E I+ + + Q F +QL+ + Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--------------------- 216
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
K+ + + D + L LL ++L +P R T + D ++
Sbjct: 217 -------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 5e-68
Identities = 70/294 (23%), Positives = 125/294 (42%), Gaps = 40/294 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A+D TG++VAI++++ + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
IV +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGS 203
+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKA 263
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----------------------- 225
Query: 264 RRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
YL + +Q +K L R L D + R +A+E L + K
Sbjct: 226 --YLIATNGTPELQNPEKLS---AIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (561), Expect = 2e-67
Identities = 79/327 (24%), Positives = 138/327 (42%), Gaps = 43/327 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y ++V+G G++ V A D T + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
IV + I +Y++ +L+ +L I T ++Q+L A+KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + + K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAPE 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ Y+ A+D WSIG I +L G P F +N +
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------------------ 219
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
+ K + S + + SA + L+ DP+ R T E+AL P+ G
Sbjct: 220 ---------QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 320 SKVEREPSCQPISKMEFEFERRRVTKE 346
+ +++ +++ F + + +
Sbjct: 271 TALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 220 bits (560), Expect = 4e-67
Identities = 93/314 (29%), Positives = 159/314 (50%), Gaps = 26/314 (8%)
Query: 18 EYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
E+G+ Y++ +G+G Y V AI+ EKV +K + + + +I REIK+L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKILE 84
Query: 78 LLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQL 135
LR P+I+ + I+ P R +VFE + +D Q+ + LT +F++Y++
Sbjct: 85 NLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEI 138
Query: 136 LRALKYIHTANVYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA + VA+R+
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY 194
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLMTDLLGTPSLD 253
++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT L
Sbjct: 195 FKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 254 TISRVRNDKARRYLTSMRKKQPVQFSQKF------PNADPSALRLLERLLAFDPKDRPTA 307
N + + + + ++F P AL L++LL +D + R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 308 EEALADPYFKGLSK 321
EA+ PYF + K
Sbjct: 314 REAMEHPYFYTVVK 327
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-66
Identities = 72/333 (21%), Positives = 145/333 (43%), Gaps = 48/333 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
+Y I E +G+G +G+V ++T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKAND-DLTREHYQFFLYQLLRALKY 141
I+ + +++ ++FE + D+ + I + +L +++Q+ AL++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H+ N+ H D++P+NI+ + +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ + A D+WS+G + +L+G F + ++ + + T
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
+ F A+ ++RLL + K R TA EAL P+ K
Sbjct: 224 -------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK-- 262
Query: 320 SKVEREPSCQPISKMEFEFERRRVTKEDIRELI 352
K+ER S + I ++ + K+D+ ++
Sbjct: 263 QKIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (555), Expect = 2e-66
Identities = 77/352 (21%), Positives = 136/352 (38%), Gaps = 52/352 (14%)
Query: 11 PEM-EFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAAR 68
P++ E F + + IG GS+G V A D E VAIKK+ +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 69 ILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREH 127
I++E++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 128 YQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWT 187
+ L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------N 169
Query: 188 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDL 246
+V T ++ APE + +Y +D+WS+G E+ KP N + L +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--- 226
Query: 247 LGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT 306
+ + P S + ++ L P+DRPT
Sbjct: 227 -----------------------AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPT 260
Query: 307 AEEALADPYFKGLSKVEREPS-CQPISKMEFEF--ERRRVTKEDIRELIFRE 355
+E L + ER P+ + + + E + +++++F+E
Sbjct: 261 SEVLLKHRFVLR----ERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 215 bits (549), Expect = 3e-66
Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 49/307 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDA-------ARILREIKLL 76
Y+ +E++G+G VV I T ++ A+K I A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
LL + +H N+ HRDLKP+NIL + + +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------- 226
Query: 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310
+ S ++ + + L+ R L P+ R TAEEA
Sbjct: 227 -------------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 217 bits (554), Expect = 7e-66
Identities = 72/335 (21%), Positives = 127/335 (37%), Gaps = 47/335 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVI-KANDDLTREHYQFFLYQLLRALKY 141
+V + D ++ +++E M +L + + ++ ++ + ++ Q+ + L +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H N H DLKP+NI+ + +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ D+WS+G + +L+G F G+N L +
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 245
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319
F + +LL DP R T +AL P+
Sbjct: 246 -------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286
Query: 320 SKVERE---PSCQPISKMEFEFERRRVTKEDIREL 351
+ R+ PS + + + E + L
Sbjct: 287 NAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 45/298 (15%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P+I+ + D +Y++ E +++ ++ + ++ +L AL
Sbjct: 66 PNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LKI DFG + A + TT T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
+ +D+WS+G + E L GKP F ++ + T
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--------- 224
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
A L+ RLL +P RP E L P+
Sbjct: 225 ----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-65
Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 43/300 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
++I +G G++G V A + T A K I + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVI--KANDDLTREHYQFFLYQLLRALKY 141
IV++ +++++ E + + LT Q Q L AL Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRDLK NIL + +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
SK Y D+WS+G E+ +P N + L +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318
K + + L++ L + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 6e-65
Identities = 84/350 (24%), Positives = 141/350 (40%), Gaps = 46/350 (13%)
Query: 24 RYKI-QEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIK-LLRLLRH 81
YK+ +V+G G G V + T EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDD--LTREHYQFFLYQLLRA 138
P IV I + K + +V E ++ +L I+ D T + + A
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 139 LKYIHTANVYHRDLKPKNIL---ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPYY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE+ G KY + D+WS+G I +L G P F + + M
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPY 315
T +R Q + ++ L+ LL +P R T E + P+
Sbjct: 226 -----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274
Query: 316 FKGLSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFREILEYHPQLLK 365
+KV + P ++ + ER KE++ + ++Y +K
Sbjct: 275 IMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (547), Expect = 8e-65
Identities = 74/336 (22%), Positives = 130/336 (38%), Gaps = 45/336 (13%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
Y I E +G G++GVV ++ TG K I+ + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRALKY 141
++ + D ++ ++ E + +L I A D ++ ++ Q LK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 142 IHTANVYHRDLKPKNIL--ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPE 199
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+ D+W+IG + +L+G F G++ + L + D
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------ 250
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG- 318
F + P A ++ LL +P+ R T +AL P+ KG
Sbjct: 251 ---------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
Query: 319 LSKVEREPSCQPISKMEFEFERRRVTKEDIRELIFR 354
S + +K+ + + + + I R
Sbjct: 290 HSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGR 325
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-64
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 41/297 (13%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDI 84
K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+HP+I
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 85 VEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIH 143
V + K I +V ELM S L +K + + + + Q+L+ L+++H
Sbjct: 71 VRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 144 TAN--VYHRDLKPKNIL-ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
T + HRDLK NI +KI D GLA + + + T + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFMAPEM 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
+ KY ++D+++ G E+ T + + Q+
Sbjct: 185 ---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------------------- 221
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317
Y +P F A P ++E + + +R + ++ L +F+
Sbjct: 222 -----YRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 6e-64
Identities = 82/304 (26%), Positives = 122/304 (40%), Gaps = 48/304 (15%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A Y++ IG GSYG G+ + K++ ++ ++ E+ LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----LTREHYQFFLYQLL 136
P+IV ++ R +Y+V E E DL VI L E + QL
Sbjct: 63 PNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYIH-----TANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ +DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------- 224
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
++R K RR P ++S ++ R+L RP+ EE L
Sbjct: 225 -----KIREGKFRRI--------PYRYS-------DELNEIITRMLNLKDYHRPSVEEIL 264
Query: 312 ADPY 315
+P
Sbjct: 265 ENPL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-62
Identities = 73/305 (23%), Positives = 127/305 (41%), Gaps = 47/305 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
V++ +D + +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + ++I DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
+ D+W++GCI +++ G P F N +
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA------LADPY 315
K F +KF P A L+E+LL D R EE A P+
Sbjct: 223 ----------IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGLS 320
F+ ++
Sbjct: 270 FESVT 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-59
Identities = 60/295 (20%), Positives = 106/295 (35%), Gaps = 38/295 (12%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + + IG GS+G V VA+K ++ E+ +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-LTREHYQFFLYQLLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +KI DFGLA V + + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E + + Y+ D+++ G + E++TG+ + N Q+ M
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
R S+ N + RL+ L +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 73/304 (24%), Positives = 118/304 (38%), Gaps = 47/304 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRA 138
+HP+++ + + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 139 LKYIHTANVYHRDLKPKNILAN----ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
+ APE+ D+WSIG I +L+G F G L ++ +
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--- 236
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADP 314
+ F N A + RLL DPK R T +++L P
Sbjct: 237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272
Query: 315 YFKG 318
+ K
Sbjct: 273 WIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 194 bits (493), Expect = 5e-58
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 33/293 (11%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHP 82
RY++ E++G G V A D VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 83 DIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKY 141
IV + + Y+V E ++ L ++ +T + + +AL +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 142 IHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELC 201
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261
D++S+GC+ EVLTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------------- 227
Query: 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-TAEEALAD 313
++ P+ S + ++ + LA +P++R TA E AD
Sbjct: 228 ----------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-57
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 57/307 (18%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLR 77
S+Y++ ++G G +G V S I VAIK + + + + R+ E+ LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGLARVAFNDTPTTIFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
+ V F Q+ L+ LA P DRPT EE
Sbjct: 217 -------------------IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 313 DPYFKGL 319
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 61/300 (20%), Positives = 116/300 (38%), Gaps = 45/300 (15%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLL-RLLRH 81
+ + +++GKGS+G V A T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALK 140
P + + + ++++ V E + DL I++ F+ +++ L+
Sbjct: 63 PFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
++H+ + +RDLK NIL + + +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260
KY ++D WS G + E+L G+ F G++
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH------------------- 213
Query: 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 319
+ + + A LL +L +P+ R + P F+ +
Sbjct: 214 ---------SIRMDNPFYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 68/302 (22%), Positives = 129/302 (42%), Gaps = 48/302 (15%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
+ +++GKG++G V + TG A+K + ++ + A + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELMESD-LHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ +K+ R + V E L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ +V +RD+K +N++ + + +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+ Y A+D W +G + E++ G+ F ++ +L+
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFK 317
+ ++F + P A LL LL DPK R A+E + +F
Sbjct: 218 ---------LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 318 GL 319
+
Sbjct: 266 SI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 184 bits (467), Expect = 3e-53
Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 49/306 (16%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH----DIFEHISDAARILREIKLLRLL 79
+ + +IG+G +G V TG+ A+K + + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRA 138
P IV + + P + + + +LM DLH + + + +F+ +++
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
L+++H V +RDLKP NIL + + ++I D GLA P T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258
E+ Y + D +S+GC+ ++L G F + ++
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------- 218
Query: 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALAD 313
M V+ F P LLE LL D R A+E
Sbjct: 219 ----------RMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 314 PYFKGL 319
P+F+ L
Sbjct: 266 PFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 180 bits (458), Expect = 2e-52
Identities = 80/359 (22%), Positives = 145/359 (40%), Gaps = 64/359 (17%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLLRHPD 83
++I +G GS+G V H G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
I+ + +D + I+++ + +E +L +++ + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262
+ Y +ID WS G + E+L G F N + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDR-----PTAEEALADPYFK 317
++F F LL RL+ D R E+ P+FK
Sbjct: 214 ---------LNAELRFPPFFN---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 G------LSKVEREPSCQPISKMEF---EFERRRVTKEDIRELIFREILEYHPQLLKDY 367
LS+ P PI + + +F++ +EDI + E + + L +D+
Sbjct: 262 EVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY--PEEDINYGVQGE--DPYADLFRDF 316
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-51
Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 52/295 (17%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ K+ + IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD--LTREHYQFFLYQLLR 137
H ++V++ +++ + +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + K+ DFGL + A + T + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE K++ D+WS G + E+ + G+ +P + D +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------------DVVP 211
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
RV + P P+ +++ D RP+ +
Sbjct: 212 RVEKGY--------KMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 5e-50
Identities = 57/309 (18%), Positives = 116/309 (37%), Gaps = 46/309 (14%)
Query: 21 DASRYKIQE-VIGKGSYGVVCSAI--DTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
D +++ +G G++G V + VA+K + + + +L E +++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLL 136
L +P IV + I + + +V E+ E L++ ++ N + ++ ++Q+
Sbjct: 64 QLDNPYIVRMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYR 196
+KY+ +N HRDL +N+L KI DFGL++ D T +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
APE K++ D+WS G + E + G+ + G +
Sbjct: 178 APECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM------------- 222
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALA 312
+ K + + P L+ +D ++RP L
Sbjct: 223 --------------LEKGERMGCPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLR 265
Query: 313 DPYFKGLSK 321
+ Y+ +++
Sbjct: 266 NYYYDVVNE 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 9e-50
Identities = 56/323 (17%), Positives = 117/323 (36%), Gaps = 58/323 (17%)
Query: 2 QQDHRKKNSPEMEFFSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH-DIF 60
+ + +N+ +++ ++ + +G GS+G V +G A+K +
Sbjct: 29 KWETPSQNTAQLD---------QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
+ L E ++L+ + P +V+++ + + V+ + ++ ++
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
+ H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
T APE+ S Y A+D W++G + E+ G P F +
Sbjct: 196 WTLCGTP------EALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 241 DLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFD 300
+ V+F F LL LL D
Sbjct: 248 E----------------------------KIVSGKVRFPSHFS---SDLKDLLRNLLQVD 276
Query: 301 PKDR-----PTAEEALADPYFKG 318
R + +F
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 59/308 (19%), Positives = 124/308 (40%), Gaps = 46/308 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKIH--DIFEHISDAARILREIKLLRL 78
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 79 LRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLR 137
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
AL+++H + +RD+K +NIL ++N + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
+ G S + A+D WS+G + E+LTG F + +
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------- 244
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFP-NADPSALRLLERLLAFDPKDRP-----TAEEAL 311
++ ++ +P A L++RLL DPK R A+E
Sbjct: 245 --------------SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 70/316 (22%), Positives = 113/316 (35%), Gaps = 55/316 (17%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMKKLR 70
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME---SDLHQVIKANDDLTREHYQFFLYQLLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N K+ DFGLAR+ ++ T + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE ++T D+WS G + E+ T G+ +PG LD + P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DP 314
S L+ + +P++RPT E A +
Sbjct: 241 ------------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 315 YFKGLSKVEREPSCQP 330
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 2e-49
Identities = 71/321 (22%), Positives = 122/321 (38%), Gaps = 51/321 (15%)
Query: 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEK---VAIKKIHDIFEHISDAARILRE 72
F++ D S KI++VIG G +G VCS G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD--LTREHYQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT--PTTIFWTD 188
L + +KY+ N HRDL +NIL N+N K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247
+ AP + K+T A D+WS G + EV++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 307
P + +L+ D RP
Sbjct: 251 RLPPPMDCP------------------------------SALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEALADPYFKGLSKVEREPSC 328
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 4e-49
Identities = 53/305 (17%), Positives = 98/305 (32%), Gaps = 44/305 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPD 83
RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGV 63
Query: 84 IVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYI 142
+ + +V EL+ S + + + Q++ ++YI
Sbjct: 64 GIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 143 HTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAFNDTPTTIFW----TDYVATRWY 195
H+ N HRD+KP N L + I DFGLA+ + + T Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255
+ + + D+ S+G + G + G
Sbjct: 180 ASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------------------- 218
Query: 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE---EALA 312
K ++Y KK L + D+P +
Sbjct: 219 ----ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
Query: 313 DPYFK 317
+ + +
Sbjct: 275 NLFHR 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-49
Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 30/304 (9%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
A +QE IGKG +G V GE+VA+K + EI +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YIHTA--------NVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTT-IFWTDYVA 191
++H + HRDLK KNIL N I D GLA + T T I V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLL 247
T+ Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTA 307
PS++ + +V ++ R + + A +++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQKLRP--------NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 308 EEAL 311
Sbjct: 286 LRIK 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 170 bits (431), Expect = 7e-49
Identities = 47/298 (15%), Positives = 96/298 (32%), Gaps = 43/298 (14%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDD-LTREHYQFFLYQLLRALK 140
+ + ++ +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YIHTANVYHRDLKPKNILANANC-----KLKICDFGLARVAFNDTPTTIFW----TDYVA 191
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------------- 219
Query: 252 LDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE 309
++Y KKQ + + + P +
Sbjct: 220 ---------TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-48
Identities = 64/309 (20%), Positives = 118/309 (38%), Gaps = 48/309 (15%)
Query: 24 RYKIQEV-IGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLLR 80
I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRA 138
+P IV + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E K++ D+WS G E L+ G+ + + ++
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---------------GPEVMAF 224
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALADP 314
+ K R + P P P L+ + +DRP +
Sbjct: 225 IEQGK--------RMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
Query: 315 YFKGLSKVE 323
Y+ SKVE
Sbjct: 270 YYSLASKVE 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-48
Identities = 68/323 (21%), Positives = 124/323 (38%), Gaps = 69/323 (21%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKL 75
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170
LT E F YQ+ + ++++ + HRDL +N+L +KICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR +D+ + + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSA 289
+PG V + ++N + QP A
Sbjct: 266 PYPGIPVDANFYKL--------------IQNGF--------KMDQP-------FYATEEI 296
Query: 290 LRLLERLLAFDPKDRPTAEEALA 312
+++ AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 9e-48
Identities = 56/296 (18%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D + +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 138
H +V++ + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +K+ DFGL+R +D T+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E+ SK++ DIW+ G + E+ + GK + + +
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------- 214
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
+R +P A ++ +RPT + L++
Sbjct: 215 ---------AQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (427), Expect = 1e-47
Identities = 66/340 (19%), Positives = 114/340 (33%), Gaps = 47/340 (13%)
Query: 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 83 DIVE------------IKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQF 130
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQLLRALKYIHTA-NVYHRDLKPKNILANAN------CKLKICDFGLARVAFNDTPTT 183
QLL L Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV------V 237
+T+ + TR YR+PE+ + + DIWS C+ E++TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 238 HQLDLMTDLLGTPSLDTISRVRNDK----ARRYLTSMRKKQPVQFSQKF-------PNAD 286
+ + +LLG + + + +R L ++ K + +
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 287 PSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREP 326
L +L DP+ R A + P+ K +E
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 57/295 (19%), Positives = 105/295 (35%), Gaps = 44/295 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIH-DIFEHISDAARILREIKLLRLL 79
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 80 RHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLR 137
H +++ + ++L P + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE + ++ A D W G E+ T G+ + G N +
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------QILH 225
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
++ + R + + ++ + A P+DRPT
Sbjct: 226 KIDKEGER--------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-47
Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
K+ E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDL---HQVIKANDDLTREHYQFFLYQLLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ +I N HRDL+ NIL + KI DFGLAR+ ++ T + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
PE + +T D+WS G + E++T G+ +PG + +
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----------- 225
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DP 314
R +P N +L+ P+DRPT + + +
Sbjct: 226 ------------GYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 315 YF 316
+F
Sbjct: 267 FF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 165 bits (419), Expect = 3e-47
Identities = 56/292 (19%), Positives = 114/292 (39%), Gaps = 40/292 (13%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
+ + ++ +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 71
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +K+ DFGL+R+ DT T + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259
+K++ D+W+ G + E+ T G +PG ++ +L
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----------------- 228
Query: 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
+ K ++ + P L+ ++P DRP+ E
Sbjct: 229 ----------LEKDYRMERPEGCP---EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-47
Identities = 67/294 (22%), Positives = 110/294 (37%), Gaps = 46/294 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
D S + IG G +G+V +KVAIK I E + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLS 58
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRA 138
HP +V++ + L + I +VFE ME + E +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +K+ DFG+ R +D T+ T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT--KFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257
E+ FS+Y+ D+WS G + EV + GK + ++ ++ +
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------- 215
Query: 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEAL 311
T R +P A +++ P+DRP L
Sbjct: 216 ---------STGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-45
Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 43/298 (14%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK----VAIKKIHDIFEHISDAARILREIKLL 76
S Q+VIG G +G V + + K VAIK + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQ 134
H +I+ ++ ++ +K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 LLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N K+ DFGL+RV +D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
+ APE K+T A D+WS G + EV+T + H++
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
M+ + + +L+ + + RP + ++
Sbjct: 223 ---------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 8e-45
Identities = 65/346 (18%), Positives = 123/346 (35%), Gaps = 58/346 (16%)
Query: 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLR 77
+ +K +V+G G++G V + GE VAIK++ + ++ IL E ++
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLR 137
+ +P + + I L + + + L V + D++ ++ + Q+ +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 138 ALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +KI DFGLA++ + A
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMA 181
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
E YT D+WS G E++T G + G ++
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------- 228
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316
R QP P ++ + D RP E + +
Sbjct: 229 ------------GERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIE--- 266
Query: 317 KGLSKVEREPSC----------QPISKMEFEFERRRVTKEDIRELI 352
SK+ R+P S + F R + +ED+ +++
Sbjct: 267 --FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 47/299 (15%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHT---GEKVAIKKIHDIFEHISDAARILREIKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQL 135
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R + T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254
APE ++T A D+W G E+L G F G D
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---------------DV 218
Query: 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313
I R+ N + R P PN P+ L+ + A+DP RP E A
Sbjct: 219 IGRIENGE--------RLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-44
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 63/313 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLL-R 77
D + K Q+VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
L+ + F + R + Y+ HRDL +NIL N KI DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAF 299
+ + R ++P N D L+ +
Sbjct: 236 YEKLPQ-----------------------GYRLEKP-------LNCDDEVYDLMRQCWRE 265
Query: 300 DPKDRPTAEEALA 312
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-43
Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 64/317 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKL 75
+R + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL KICDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
ND+ + + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 294
V + M +++ + + P +++
Sbjct: 252 PVDSKFYKM--------------------------IKEGFRMLSPEHAP---AEMYDIMK 282
Query: 295 RLLAFDPKDRPTAEEAL 311
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-43
Identities = 60/296 (20%), Positives = 107/296 (36%), Gaps = 44/296 (14%)
Query: 24 RYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR 80
EVIG+G +G V A+K ++ I I + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFS 86
Query: 81 HPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQ--FFLYQLLRA 138
HP+++ + I L R VV M+ + N+ F Q+ +
Sbjct: 87 HPNVLSLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 139 LKYIHTANVYHRDLKPKNILANANCKLKICDFGLAR-VAFNDTPTTIFWTDYVATRWYRA 197
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256
E + K+T D+WS G + E++T G P +P N
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------------- 241
Query: 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312
D L R QP ++ + + RP+ E ++
Sbjct: 242 ----DITVYLLQGRRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 2e-43
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 70/320 (21%)
Query: 23 SRYKIQEVIGKGSYGVVCSA-----IDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR 77
+ + IG+G++G V A + VA+K + + A RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172
L+ Q+ + Y+ HRDL +N L N +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R ++ D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALR 291
G + + R + + P
Sbjct: 244 YGMAHEEVIYYV---------------------------RDGNILACPENCP---LELYN 273
Query: 292 LLERLLAFDPKDRPTAEEAL 311
L+ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 53/323 (16%), Positives = 109/323 (33%), Gaps = 62/323 (19%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKL 75
+ + +G+GS+G+V + +VAIK +++ + L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTI 184
++ + Y++ HRDL +N + + +KI DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLM 243
+ + +PE +T D+WS G + E+ T + + G + L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKD 303
+ K N L+ ++PK
Sbjct: 249 ME------------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKM 278
Query: 304 RPTAEEALA------DPYFKGLS 320
RP+ E ++ +P F+ +S
Sbjct: 279 RPSFLEIISSIKEEMEPGFREVS 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 60/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGE-------KVAIKKIHDIFEHISDAARILREI 73
R + + +G+G++G V A + KVA+K + D + ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +KI DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ + +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLE 294
V L+ + R +P N ++
Sbjct: 242 PVEELFKLLKE-----------------------GHRMDKP-------SNCTNELYMMMR 271
Query: 295 RLLAFDPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-41
Identities = 64/314 (20%), Positives = 114/314 (36%), Gaps = 59/314 (18%)
Query: 21 DASRYKIQEVIGKGSYGVVCSAID-----THTGEKVAIKKIHDIFEHISDAARILREIKL 75
R K+ + +G+G++G V A T T VA+K + + H A + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +KICDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLL 297
+ RR R + P P + +
Sbjct: 244 EEF----------------------CRRLKEGTRMRAP-------DYTTPEMYQTMLDCW 274
Query: 298 AFDPKDRPTAEEAL 311
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (251), Expect = 4e-25
Identities = 27/210 (12%), Positives = 62/210 (29%), Gaps = 30/210 (14%)
Query: 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIH--------DIFEHISDAARILREIKLL 76
I +++G+G V + + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLL 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTD-YVATRWY 195
+ + + H DL N+L + + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
Y DI S +L
Sbjct: 173 S---------RTYRTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 619 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.7 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-60 Score=499.20 Aligned_cols=332 Identities=40% Similarity=0.765 Sum_probs=280.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
|...++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++..... .
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 456789999999999999999999999999999999998766666778889999999999999999999999976532 3
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
....+|||||||+++|..+++. +.+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 4456899999998888888765 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .+..+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+..
T Consensus 173 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred Cc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 32 2456899999999998653 5678999999999999999999999999999999999999999999999988
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
........+...........+...+++++++++|||.+||..||.+|||++|+|+||||+.+...+.+|..+. .++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~---~~~~ 322 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDS 322 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCCC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC---CCCc
Confidence 8887777777777777777788888899999999999999999999999999999999999887777766553 3445
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 338 FERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
++....+.+++++++++|+++++|
T Consensus 323 ~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 323 FDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC
T ss_pred hhhhhcCHHHHHHHHHHHhhcCCC
Confidence 556667889999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=487.06 Aligned_cols=340 Identities=47% Similarity=0.826 Sum_probs=286.3
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
|...++|++++.||+|+||+||+|.++.+|+.||||++... ......+++++|+.+|+.|+||||+++++++.......
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 56678999999999999999999999999999999999753 34566778999999999999999999999997766556
Q ss_pred CCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 99 FKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
...+||++++++|+|.+++..+ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6678999888889999999765 699999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
...........+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.+........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 43333334567899999999998653 57899999999999999999999999999999999999999999998887776
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhhH
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFEF 338 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 338 (619)
...................+...++++++++++||.+||..||.+|||++|+|+||||+.......++.... ..+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~~ 318 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDM 318 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC----
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCCh
Confidence 666667777777777777777888999999999999999999999999999999999998776665554333 234556
Q ss_pred hhhcCCHHHHHHHHHHHHHHhCchh
Q 007064 339 ERRRVTKEDIRELIFREILEYHPQL 363 (619)
Q Consensus 339 e~~~~~~e~~~~~~~~ei~~~~~~~ 363 (619)
+......+++++++++|...++|+.
T Consensus 319 ~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 319 ELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp ----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 6777889999999999999988863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-58 Score=482.94 Aligned_cols=332 Identities=41% Similarity=0.809 Sum_probs=285.5
Q ss_pred CCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-C
Q 007064 19 YGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-R 97 (619)
Q Consensus 19 ~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~ 97 (619)
|...+||++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.|+||||+++++++..... +
T Consensus 14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 445689999999999999999999999999999999998766677778889999999999999999999999876543 3
Q ss_pred CCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 98 DFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+...+|+++++++|+|.+++.. +.+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 3445667766666899998855 469999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+....
T Consensus 173 ~~------~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp GG------GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cc------cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 2456899999999987652 4678999999999999999999999999999999999999999999988877
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCCCCCcchhhh
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSCQPISKMEFE 337 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~ 337 (619)
........+...........+...+.+++++++|||.+||..||++|||++|+|+||||+++..+..++...+. +++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~~ 322 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQS 322 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CCG
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CCc
Confidence 77777777776666666666667778899999999999999999999999999999999998887777766544 456
Q ss_pred HhhhcCCHHHHHHHHHHHHHHhCc
Q 007064 338 FERRRVTKEDIRELIFREILEYHP 361 (619)
Q Consensus 338 ~e~~~~~~e~~~~~~~~ei~~~~~ 361 (619)
++......+++++++++|+.++.|
T Consensus 323 ~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 323 FESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp GGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred ccchhcCHHHHHHHHHHHhhccCC
Confidence 778889999999999999998876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=471.42 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=215.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.|+||||+++++++ .+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCce
Confidence 467999999999999999999999999999999997532 223345788999999999999999999999 44567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|||||||+ |+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999 5999999888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~-y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ....+..+||+.|+|||++.+ .. ++.++|||||||++|||++|++||.+.+..........
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-------------- 220 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 2 222456789999999999876 44 46789999999999999999999987654333221110
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
........++.+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 221 --------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 --------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011112234567899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=462.94 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=220.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECC
Confidence 357999999999999999999999999999999986421 1122345688999999999999999999999 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+ |+|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 7999999999 699999998889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
. ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 160 ~-----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------- 219 (263)
T d2j4za1 160 R-----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------- 219 (263)
T ss_dssp C-----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------
T ss_pred c-----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 2 245689999999999987 68999999999999999999999999998876666554321
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.. .....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 220 ---------------~~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 ---------------EF---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---------------CC---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 01 112357899999999999999999999999999999973
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=469.12 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=220.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++. +.+
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~ 90 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYL-----VGD 90 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECC
Confidence 34689999999999999999999999999999999975322 23467899999999999999999999994 446
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||. |+|.+++..+ .+++.+++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 7999999999 5999988764 6999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+
T Consensus 170 ~~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~--------- 234 (293)
T d1yhwa1 170 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP--------- 234 (293)
T ss_dssp TC---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC---------
T ss_pred cc---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC---------
Confidence 22 2355689999999999987 689999999999999999999999999888766655543210 00
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
....++.+++.+++||.+||..||++|||++|+|+||||+.
T Consensus 235 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 ------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 01223457899999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=470.23 Aligned_cols=283 Identities=34% Similarity=0.553 Sum_probs=230.9
Q ss_pred EeEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---HHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcEE
Q 007064 27 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHI---SDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIY 103 (619)
Q Consensus 27 i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~---~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ly 103 (619)
.+++||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++|||||++++++ .+.+.+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 4789999999999999999999999999996432221 1235688999999999999999999999 4456799
Q ss_pred EEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCCC
Q 007064 104 VVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPT 182 (619)
Q Consensus 104 lV~E~~~g~L~~~i-~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~~ 182 (619)
||||||.+++...+ ..+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 99999997554444 44667999999999999999999999999999999999999999999999999999765433222
Q ss_pred ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcchh
Q 007064 183 TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNDK 262 (619)
Q Consensus 183 ~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~ 262 (619)
....+||++|+|||++... ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2456899999999988652 578999999999999999999999999999999999999999999887765433211
Q ss_pred HHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 263 ARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
... .........+...++.+++++++||.+||+.||++|||++|+|+||||++...
T Consensus 233 ~~~---~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DYV---TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TCC---CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhh---hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 111 01111223334456788999999999999999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-57 Score=459.17 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=211.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.+++|++++.||+|+||.||+|+++.+|+.||||++..........+.+.+|+++|+.++||||+++++++... ...
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~ 78 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 78 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCC
Confidence 35689999999999999999999999999999999987656666778899999999999999999999998542 235
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEEECCCCcEEEeec
Q 007064 101 DIYVVFELME-SDLHQVIKA----NDDLTREHYQFFLYQLLRALKYIHTAN-----VYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~e~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILi~~~~~vKL~DF 170 (619)
.+|||||||+ |+|.+++.. +..+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 6899999998 599998853 467999999999999999999999976 999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+|+....... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....|...
T Consensus 159 G~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~---- 229 (269)
T d2java1 159 GLARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---- 229 (269)
T ss_dssp HHHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----
T ss_pred cceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC----
Confidence 99987543322 2356789999999999977 68999999999999999999999999988876655444220
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccc
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYF 316 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f 316 (619)
.+......+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus 230 --------------------------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 230 --------------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0112234678999999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=456.45 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=217.1
Q ss_pred CCe-EEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY-~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+|| ++.+.||+|+||+||+|+++.++..||+|++..........+.+.+|+++|+.|+|||||++++++.... .+...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCE
Confidence 455 7888999999999999999999999999999876566677788999999999999999999999985432 23467
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEC-CCCcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTAN--VYHRDLKPKNILAN-ANCKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILi~-~~~~vKL~DFGla~~~~ 177 (619)
+|||||||+ |+|.+++.....+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999998 599999998889999999999999999999999999 99999999999997 47899999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+....+......
T Consensus 167 ~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----------- 227 (270)
T d1t4ha_ 167 AS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----------- 227 (270)
T ss_dssp TT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----------
T ss_pred CC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-----------
Confidence 22 2245689999999999864 6999999999999999999999999876544433221110
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
...+ .......++++.+||++||..||++|||++|+|+||||+
T Consensus 228 --------------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 --------------GVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------TCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------CCCC---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0001 111234688999999999999999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=462.70 Aligned_cols=289 Identities=38% Similarity=0.632 Sum_probs=238.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||+||+|.++.+|+.||||+++...........+.+|+++|+.++||||+++++++ .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 589999999999999999999999999999999975433333456788999999999999999999999 445679
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELMESDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|+|||||.+++.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777653 4569999999999999999999999999999999999999999999999999998754332
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23556899999999987652 4568999999999999999999999999999999999999999988776654322
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
. ..+...........+...++.+|++++|||++||..||++|||++|+|+||||+++.++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 1 11111122222233344567889999999999999999999999999999999987553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-56 Score=465.47 Aligned_cols=259 Identities=30% Similarity=0.476 Sum_probs=207.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.|+||||+++++++ .+.+.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 45699999999999999999999999999999999754222 2345678999999999999999999999 45577
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC---CCCcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN---ANCKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~---~~~~vKL~DFGla~~~~ 177 (619)
+|||||||+ |+|.+++...+.+++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999 69999999988999999999999999999999999999999999999995 57899999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+....|..
T Consensus 162 ~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------------ 223 (307)
T d1a06a_ 162 PGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK------------ 223 (307)
T ss_dssp ---------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT------------
T ss_pred CCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc------------
Confidence 322 1245689999999999987 6899999999999999999999999999887666555432
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.........++++|+++.+||.+||..||++|||++|+|+||||++.
T Consensus 224 ---------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 ---------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---------------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11112223456789999999999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=475.77 Aligned_cols=282 Identities=22% Similarity=0.361 Sum_probs=217.9
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||++++++. +...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence 468999999999999999999999999999999997542 3445678899999999999999999999994 4567
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|||||||. |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 59999999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhH-HHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~-~l~~i~~~~g~p~~e~i~~~ 258 (619)
. .+.++||++|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+ +...+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999987 689999999999999999999999998876433 22222222332221110000
Q ss_pred c--------------chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 R--------------NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~--------------~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
. .......+.......+..+. ...+|++++|||.+||..||++|||++|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 00001111111111111111 1236889999999999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=469.85 Aligned_cols=326 Identities=36% Similarity=0.666 Sum_probs=255.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC-CCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR-RDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~-~~~~ 100 (619)
.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++..... ++..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999999999999999998776667777889999999999999999999999965532 3557
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 101 DIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.+|+|||||.+++.+.+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 899999999998888774 469999999999999999999999999999999999999999999999999987643322
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
..+..++|+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+...++..+...++.+..+.+.....
T Consensus 174 ----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 174 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -----------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 2356689999999999987 6899999999999999999999999999999999999999999998887766532
Q ss_pred hhHHHHHHhhcccCCccccCCC------------CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcCcCCCCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKF------------PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKVEREPSC 328 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~------------~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~~~~~~~ 328 (619)
....+...........+...+ ...++++++||++||.+||++||||+|+|+||||+...........
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~ 326 (355)
T d2b1pa1 248 -TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP 326 (355)
T ss_dssp -HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCC
T ss_pred -hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCC
Confidence 223333322222111111111 1246789999999999999999999999999999976543332222
Q ss_pred CCCcchhhhHhhhcCCHHHHHHHHHHHHH
Q 007064 329 QPISKMEFEFERRRVTKEDIRELIFREIL 357 (619)
Q Consensus 329 ~~~~~~~~~~e~~~~~~e~~~~~~~~ei~ 357 (619)
.+ ...+.+.+++..+.++|+++|++|++
T Consensus 327 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 327 PP-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp CC--------CCCCCCHHHHHHHHHHHHH
T ss_pred CC-CCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 22 22344667788899999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-57 Score=463.38 Aligned_cols=260 Identities=27% Similarity=0.466 Sum_probs=219.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
..++|++++.||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+++|+.|+||||+++++++ .+.
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EEC
Confidence 3467999999999999999999999999999999996421 1122346788999999999999999999998 455
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 77999999999 59999999989999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|...
T Consensus 161 ~~~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------------ 225 (288)
T d1uu3a_ 161 ESK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------ 225 (288)
T ss_dssp ----------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------------
T ss_pred CCc-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC------------
Confidence 222 122355789999999999987 68999999999999999999999999998876666555321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH------HHcCccccCC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE------ALADPYFKGL 319 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e------lL~hp~f~~~ 319 (619)
.. .....+++++++||++||+.||++|||++| +++||||+++
T Consensus 226 ----------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 226 ----------------EY---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp ----------------CC---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ----------------CC---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 01 112357899999999999999999999987 5889999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=467.06 Aligned_cols=257 Identities=25% Similarity=0.453 Sum_probs=223.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 4679999999999999999999999999999999974321 123456788999999999999999999999 5567
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||. |+|.+++...+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 8999999999 699999999999999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. .....+||++|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+....+..
T Consensus 159 ~~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------------- 219 (337)
T d1o6la_ 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------- 219 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred Cc---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--------------
Confidence 22 2356789999999999987 6899999999999999999999999999887665554422
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
... ..+..+|+++++||++||+.||.+|++ ++|+|+||||+++
T Consensus 220 --------------~~~---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 220 --------------EEI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------------CCC---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CCC---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 011 123468999999999999999999994 9999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=461.94 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=218.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
+.|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+++|+.|+|||||++++++. +.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeE
Confidence 5699999999999999999999999999999999753 3344567889999999999999999999994 45679
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 103 YVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
|||||||+ |+|.+++.. .+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 599998765 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CCccccccccCCccccCccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~---~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
......+||+.|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..+...
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~----------- 230 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS----------- 230 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------
Confidence 122456899999999988421 256899999999999999999999999998877666555321
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
. .+.....+.+++++.+||++||+.||++|||++|+|+||||+.
T Consensus 231 ----------------~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 ----------------E-PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ----------------C-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ----------------C-CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 0111223467899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.4e-56 Score=467.70 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=225.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|+++.+|+.||||++.. ....+.+.+.+|+.+|+.|+|||||++++++ .+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 96 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDN 96 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETT
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc--cchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 45689999999999999999999999999999999975 3455677889999999999999999999998 4556
Q ss_pred cEEEEEecCC-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCcEEEeecCccccc
Q 007064 101 DIYVVFELME-SDLHQVIK-ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA--NCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~-~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~--~~~vKL~DFGla~~~ 176 (619)
.+|||||||+ |+|.+++. ..+.+++.+++.|++||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 7999999999 59999985 4567999999999999999999999999999999999999964 678999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... .....+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+
T Consensus 177 ~~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 244 (350)
T d1koaa2 177 DPKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM------ 244 (350)
T ss_dssp CTTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred cccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 4322 2345789999999999987 689999999999999999999999999998877776664322111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
....++.+|+++++||.+||..||++|||++|+|+||||+....
T Consensus 245 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 245 ---------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp ---------------------CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ---------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 12234568899999999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=458.12 Aligned_cols=290 Identities=33% Similarity=0.582 Sum_probs=237.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChHHHHHHHHHHHHHHhc---CCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKIHDIFEHISDAARILREIKLLRLL---RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~t-g~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L---~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999999766 66799999975433333344566788877766 799999999998655445
Q ss_pred CCCcEEEEEecCCccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELMESDLHQVIK--ANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~--~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
....+|++||+|++++..+.. ....+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 567899999999976555443 345799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...+|.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23356789999999999877 68999999999999999999999999999999999999999999987766
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCc
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSK 321 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~ 321 (619)
......... .............+..+++.+++||.+||++||++|||++|+|+||||+++..
T Consensus 240 ~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPRQ----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCGG----GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchhh----hhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 533221111 11122333444556788999999999999999999999999999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=455.40 Aligned_cols=262 Identities=28% Similarity=0.439 Sum_probs=224.0
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
...++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+.+|+.+|+.|+|||||++++++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~---- 82 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY---- 82 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence 3446899999999999999999999999999999999643221 12356789999999999999999999999
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----cEEEeec
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC----KLKICDF 170 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~----~vKL~DF 170 (619)
.+...+|||||||+ |+|.++|...+.+++..++.|++||+.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus 83 -~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 83 -ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred -EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 45578999999999 69999999888999999999999999999999999999999999999998876 4999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
|+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...-..
T Consensus 162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~- 234 (293)
T d1jksa_ 162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE- 234 (293)
T ss_dssp TTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-
T ss_pred hhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-
Confidence 9998753322 2245689999999999987 68999999999999999999999999998887776665432111
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
.....++++|+.+++||++||..||++|||++|+|+||||+..
T Consensus 235 --------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 235 --------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp --------------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred --------------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1112235688999999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9e-56 Score=468.18 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=225.7
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
...++|++++.||+|+||.||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||++++++ .+.
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~ 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDK 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECS
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EEC
Confidence 3446799999999999999999999999999999999753 345567788999999999999999999999 455
Q ss_pred CcEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC--CCCcEEEeecCcccc
Q 007064 100 KDIYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN--ANCKLKICDFGLARV 175 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~--~~~~vKL~DFGla~~ 175 (619)
..+|||||||+ |+|.+.+...+ .+++.+++.|++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 77999999999 69999876544 699999999999999999999999999999999999998 578999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|....
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------- 244 (352)
T d1koba_ 179 LNPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-------- 244 (352)
T ss_dssp CCTTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC--------
T ss_pred cCCCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 54332 2345689999999999987 689999999999999999999999999998877766664321
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.......++++++++.+||++||+.||.+|||++|+|+||||++..
T Consensus 245 -------------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 -------------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -------------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1112344578899999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-55 Score=458.72 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=217.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-ISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..+|++++.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|+.|+|||||++++++. +..
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECC
Confidence 34699999999999999999999999999999999754332 344567899999999999999999999984 446
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||.+ +|..++..++.+++.+++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 79999999995 6766777778899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhh
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRV 258 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~ 258 (619)
....+||+.|+|||++.+. ...|+.++|||||||++|||++|..||.+.+..+.+..+...
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~------------ 229 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------ 229 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 1346899999999998642 246899999999999999999999999988776665544321
Q ss_pred cchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 259 RNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+. .....+|+.+.+||.+||+.||++|||++|+|+||||..
T Consensus 230 --------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 230 --------------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1111 112457899999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-55 Score=451.13 Aligned_cols=284 Identities=38% Similarity=0.635 Sum_probs=236.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++. +.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 69999999999999999999985 7899999999765444444578899999999999999999999994 45679
Q ss_pred EEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g~L~~~i-~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
|++||++.+.+...+ ...+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997555555 5577899999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcch
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRND 261 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~ 261 (619)
.....++++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22455799999999998753 56899999999999999999999999999999999999999999988776543221
Q ss_pred hHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 262 KARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
..+..........++...++.+++.+.|||++||+.||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1222222333444555667789999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-55 Score=454.78 Aligned_cols=253 Identities=26% Similarity=0.469 Sum_probs=221.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 56999999999999999999999999999999996432 1223356788999999999999999999999 45568
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
+|+|||||. |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999 599999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------------- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------
Confidence 234689999999999987 68999999999999999999999999998876666555321
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
.. ...+.+++++.+||.+||..||.+|+ |++++|+||||+++
T Consensus 217 --------------~~---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 --------------EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp --------------CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------------CC---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 00 12246789999999999999999996 99999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-54 Score=442.96 Aligned_cols=262 Identities=28% Similarity=0.448 Sum_probs=223.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hHHHHHHHHHHHHHHhcC-CCCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH-------ISDAARILREIKLLRLLR-HPDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~-------~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~ 93 (619)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.|+ ||||+++++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 79 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-- 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence 47899999999999999999999999999999999653221 122346889999999997 99999999999
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCc
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGL 172 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGl 172 (619)
.+.+.+|||||||+ |+|.++|+.++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 80 ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ---ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ---ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 45578999999998 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhC
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLG 248 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~----~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g 248 (619)
++...... ..+..+||+.|+|||++.+ ....|+.++||||+||+||+|++|+.||.+.+..+....|...
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~-- 230 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-- 230 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--
Confidence 98754322 2255789999999998853 1245789999999999999999999999998877666555331
Q ss_pred CCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 249 TPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
........++++|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 231 -------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 -------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111122345789999999999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-55 Score=460.99 Aligned_cols=254 Identities=21% Similarity=0.391 Sum_probs=221.5
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++ .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 368999999999999999999999999999999986421 1223356788999999999999999999998 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|+|||||. |+|.+++...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 7999999999 599999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..|...
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------- 253 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------- 253 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-------------
Confidence 234689999999999987 68999999999999999999999999998876666555321
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~ 319 (619)
. ......+++++.+||++||..||.+|+ |++++|+||||+++
T Consensus 254 --------------~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 --------------K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 112346889999999999999999995 99999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=454.77 Aligned_cols=285 Identities=34% Similarity=0.601 Sum_probs=234.1
Q ss_pred CeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC-CCCCCcE
Q 007064 24 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS-RRDFKDI 102 (619)
Q Consensus 24 rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s-~~~~~~l 102 (619)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.|+||||+++++++.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975322 2347999999999999999999986543 2345678
Q ss_pred EEEEecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcccccc
Q 007064 103 YVVFELMESDLHQVI----KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLARVAF 177 (619)
Q Consensus 103 ylV~E~~~g~L~~~i----~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla~~~~ 177 (619)
|||||||++++.+.+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997655544 3566799999999999999999999999999999999999999875 89999999998654
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.+..+.+..
T Consensus 175 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 322 22456899999999987652 5799999999999999999999999999999999999999999999888765
Q ss_pred hcchhHHHHHHhhcccCCcccc-CCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCCcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFS-QKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLSKV 322 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~~~ 322 (619)
.........+ .......+. ...+..++++.+||.+||.+||++|||++|+|+||||+++...
T Consensus 250 ~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC---CCCC---CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchhhccc---cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 5432211111 111111121 2345789999999999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=451.37 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=221.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+++|+.++||||+++++++ .+.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 46899999999999999999999999999999999753 24455688999999999999999999999 45567
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CcEEEeecCcccccc
Q 007064 102 IYVVFELME-SDLHQVIKAND-DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN--CKLKICDFGLARVAF 177 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~--~~vKL~DFGla~~~~ 177 (619)
+|||||||+ |+|.++|...+ .+++++++.|+.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999 59999998765 79999999999999999999999999999999999999854 589999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|......
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------- 221 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT-------- 221 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 322 2245679999999999887 68999999999999999999999999999887777666432111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
.....++.+|+++++||.+||..||++|||++|+|+||||++
T Consensus 222 -------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 222 -------------------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -------------------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 112234568999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-54 Score=456.95 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=214.2
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc----CChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF----EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~----~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. .......+..+|+.+|+.++||||+++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 468999999999999999999999999999999986421 1112222333457777778899999999998 4
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
+.+.+|||||||. |+|.++|.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 5567999999999 699999999889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ....+||+.|+|||++... ..|+.++|||||||+||||++|++||.+.+..+....+..
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------- 220 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 220 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 4332 2446899999999998642 5799999999999999999999999988664333221111
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHHcCccccCC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPT-----AEEALADPYFKGL 319 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpS-----a~elL~hp~f~~~ 319 (619)
........+..+|+++++||.+||..||++||| ++|+|+||||+++
T Consensus 221 -----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 221 -----------------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -----------------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -----------------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 001111233468999999999999999999999 8999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=449.30 Aligned_cols=297 Identities=34% Similarity=0.546 Sum_probs=232.9
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC---
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR--- 96 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~--- 96 (619)
.+.++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 45789999999999999999999999999999999997654445556778899999999999999999999865421
Q ss_pred CCCCcEEEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 97 RDFKDIYVVFELMESDLHQVI-KANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i-~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
.....+|+|||||.+.+...+ .....+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 224569999999997665554 4456799999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC-ccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPT-TIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~-~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
....... .......+||++|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+.+..+...++.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 4332211 1122446899999999998753 5789999999999999999999999999999999999999999998877
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccC
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALADPYFKG 318 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~ 318 (619)
+...........+...... ...+...+ ...++.++|||.+||.+||++|||++|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 6655443333222221111 11111111 124778999999999999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=434.92 Aligned_cols=287 Identities=36% Similarity=0.567 Sum_probs=239.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCcE
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDI 102 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~l 102 (619)
++|++++.||+|+||+||+|.++.+|+.||||+++..........++.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 689999999999999999999999999999999976555566778899999999999999999999999 445679
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCCC
Q 007064 103 YVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTP 181 (619)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~~ 181 (619)
++|+|++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7787888888999999999999999999999999999999999999999999999999999987543322
Q ss_pred CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCCCchhhhhhhcc
Q 007064 182 TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGTPSLDTISRVRN 260 (619)
Q Consensus 182 ~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~ 260 (619)
......++++|+|||++... ..++.++|||||||++|||++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22445788999999988762 4579999999999999999999876 677888888999999999887766543321
Q ss_pred hhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 261 DKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
.. .+................+.+++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 10 00000001112233345567899999999999999999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=448.08 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=218.9
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-EHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
++|++++.||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++. .++||||+++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999999999999999996421 11223455667777665 68999999999999 4556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+ |+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 599999999889999999999999999999999999999999999999999999999999999864332
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2355789999999999987 6899999999999999999999999999887766655521
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHH-HHHcCccccCC
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAE-EALADPYFKGL 319 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~-elL~hp~f~~~ 319 (619)
..+ .....+|+++.+||++||..||.+|||++ ++++||||+++
T Consensus 218 -------------~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 -------------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -------------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------------CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 111 11235789999999999999999999995 89999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=437.38 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=210.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hHHHHHHHHHHHHHHhcC--CCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----ISDAARILREIKLLRLLR--HPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~----~~~~~~i~~Ei~iL~~L~--HpnIv~l~~v~~~~s 95 (619)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... .....++.+|+.+|+.++ ||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 57899999999999999999999999999999998643211 112344678999999997 89999999999
Q ss_pred CCCCCcEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CcEEEeecCc
Q 007064 96 RRDFKDIYVVFELME--SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANAN-CKLKICDFGL 172 (619)
Q Consensus 96 ~~~~~~lylV~E~~~--g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~-~~vKL~DFGl 172 (619)
.+.+.+|+||||+. +++.+++..+..+++++++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 45567999999997 4899999888899999999999999999999999999999999999999854 7999999999
Q ss_pred cccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 173 ARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+. +..
T Consensus 158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------- 218 (273)
T d1xwsa_ 158 GALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 218 (273)
T ss_dssp CEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred ceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-------
Confidence 9864332 23567899999999998762 3456789999999999999999999976321 100
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
... ...+.+|+++++||++||..||++|||++|+|+||||+++.
T Consensus 219 ---------------------~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 ---------------------GQV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ---------------------CCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---------------------ccc---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 000 11246789999999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=448.20 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=209.7
Q ss_pred CCCeEEeE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHH-hcCCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQE-VIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLR-LLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~-~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~-~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
.++|++++ .||+|+||+||+|+++.+++.||||++++. ..+.+|+.++. .++||||++++++|.... ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 46899875 699999999999999999999999999642 34678999865 458999999999984321 234
Q ss_pred CcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEeecCcc
Q 007064 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLA 173 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGla 173 (619)
..+|||||||+ |+|.++|... ..+++.+++.|++||+.||+|||+.||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67999999998 5999999874 36999999999999999999999999999999999999986 467999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+....... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+....
T Consensus 162 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------ 229 (335)
T d2ozaa1 162 KETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------ 229 (335)
T ss_dssp EECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC------
T ss_pred eeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH------
Confidence 87543322 245689999999999987 689999999999999999999999998876544443332111
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGL 319 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~ 319 (619)
...........++.+|+++.+||.+||+.||++|||++|+|+||||.+.
T Consensus 230 -----------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 -----------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -----------------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -----------------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0011111112234578999999999999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-52 Score=429.83 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=214.1
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 5789999999999999999999999999999999976433 3455678999999999999999999999985432 2234
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 101 DIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
.+|||||||+ ++|.+++...+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 5899999999 599999998889999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 180 TPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
..........+||+.|+|||++.+ ..|++++|||||||++|||++|++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 433334466789999999999977 6899999999999999999999999999887665544422
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCcccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFK 317 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~ 317 (619)
..+......++++|+.+.+||.+||+.||.+||+..+.|.|+|++
T Consensus 229 -------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 -------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 222233445678899999999999999999999444444566653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=438.02 Aligned_cols=288 Identities=31% Similarity=0.579 Sum_probs=227.2
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCC
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPS 95 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s 95 (619)
.+++..++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+++.+|+.+|+.++ ||||+++++++...
T Consensus 29 ~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~- 102 (328)
T d3bqca1 29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP- 102 (328)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT-
T ss_pred cCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec-
Confidence 3467788999999999999999999999999999999999752 2456889999999996 99999999998543
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-cEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANC-KLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~-~vKL~DFGla 173 (619)
....+|+|||||. ++|.++. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 103 --~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 103 --VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp --TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred --CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence 3357999999999 4776653 4699999999999999999999999999999999999998655 6999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-NVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~-~~~~~l~~i~~~~g~p~~ 252 (619)
+....... ....++|+.|+|||++.+. ..|+.++|||||||++|+|++|..||... +..++...+...+|.|..
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 178 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eeccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 86543322 2456899999999998763 56899999999999999999999998654 566777888888887655
Q ss_pred hhhhhhcch-hHHHHHHhhcccCCccc-----cCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcCccccCCC
Q 007064 253 DTISRVRND-KARRYLTSMRKKQPVQF-----SQKFPNADPSALRLLERLLAFDPKDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 253 e~i~~~~~~-~~~~~l~~~~~~~~~~~-----~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~hp~f~~~~ 320 (619)
..+...... ....+...........+ ......++++++|||++||.+||++|||++|+|+||||+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 443221111 11111111111111111 112235789999999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=421.12 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=209.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++++.||+|+||.||+|.. +..||||+++.........+.+.+|+.+|+.++|||||++++++. ..
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------AP 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------cc
Confidence 467899999999999999999964 346999999765555667788999999999999999999999863 23
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 5899999999 6999999764 5699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCccccccccCCccccCccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~-~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
... ....+...||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+...++..+...
T Consensus 157 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----------- 224 (276)
T d1uwha_ 157 WSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----------- 224 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-----------
T ss_pred cCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence 222 1223556899999999998642 245899999999999999999999999887765554333211
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
......+.....++++.+.+||.+||..||++|||++|++++
T Consensus 225 --------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 --------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233456788999999999999999999999999886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=421.12 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=207.2
Q ss_pred eEEe-EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 25 YKIQ-EVIGKGSYGVVCSAIDT--HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 25 Y~i~-~~LG~G~fG~V~~a~~~--~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.+. +.||+|+||.||+|.++ .+++.||||+++.........+.+.+|+.+|+.|+|||||++++++.. ..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 4444 47999999999999764 456789999997654555566789999999999999999999999832 34
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCCC
Q 007064 102 IYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~~ 180 (619)
.|||||||+ |+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999999 6999999999999999999999999999999999999999999999999999999999999998765443
Q ss_pred CCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhhhc
Q 007064 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISRVR 259 (619)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~~~ 259 (619)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33333345679999999999876 679999999999999999997 8999998876555444321
Q ss_pred chhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---HcCcccc
Q 007064 260 NDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFK 317 (619)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el---L~hp~f~ 317 (619)
... ......+++++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 226 -------------~~~---~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 -------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------CCC---CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 011 11224678999999999999999999999998 4566653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-51 Score=420.31 Aligned_cols=256 Identities=21% Similarity=0.414 Sum_probs=210.0
Q ss_pred ccccCC-CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecC
Q 007064 15 FFSEYG-DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLP 93 (619)
Q Consensus 15 ~~~~~~-~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~ 93 (619)
.|.+|. +.++|++++.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+.|+|||||++++++.
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~- 83 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCT- 83 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEe-
Confidence 344443 4578999999999999999999999999999999997532 23557899999999999999999999994
Q ss_pred CCCCCCCcEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 94 PSRRDFKDIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
+...+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 84 ----~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 84 ----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred ----eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence 4466899999999 6999999754 57899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCC-CCCCChhHHHHHHHhhhCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~p-F~~~~~~~~l~~i~~~~g~ 249 (619)
|+|+........ ..+...|++.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.......+..
T Consensus 160 G~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~---- 231 (287)
T d1opja_ 160 GLSRLMTGDTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---- 231 (287)
T ss_dssp CCTTTCCSSSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----
T ss_pred cceeecCCCCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc----
Confidence 999875433222 2244568899999999887 6899999999999999999996555 555443332222211
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... ......+++.+.+||.+||+.||++|||++|+++
T Consensus 232 -----------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 -----------------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -----------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 000 1223467899999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=419.07 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=203.1
Q ss_pred cccCCCCCCeEEeEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007064 16 FSEYGDASRYKIQEVIGKGSYGVVCSAIDTHTGE---KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIML 92 (619)
Q Consensus 16 ~~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~tg~---~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 92 (619)
|+..-+.++|++.+.||+|+||+||+|.++.+++ .||||++... ......+.+.+|+.+|+.|+|||||++++++.
T Consensus 19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4444566889999999999999999999987765 5889988643 34456678999999999999999999999984
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
+...+|+|||||+ |+|.+++... +.+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 98 -----~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 98 -----KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp -----SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred -----eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCc
Confidence 3456899999999 5999988764 57999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCc--cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhh
Q 007064 171 GLARVAFNDTPTT--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLL 247 (619)
Q Consensus 171 Gla~~~~~~~~~~--~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~ 247 (619)
|+|+......... .......||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+.+..+....
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250 (299)
T ss_dssp -----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred ccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9998754332221 11223568999999999876 689999999999999999998 899999888766555443210
Q ss_pred CCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 248 GTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. .....++++.+.+||.+||+.||++|||+.|++++
T Consensus 251 ---------------------------~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 ---------------------------R---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------------C---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------C---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 01234678899999999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=411.74 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=199.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+.++|++++.||+|+||.||+|+++ ++..||||+++.... ..+.+.+|+++|+.++||||+++++++.. ..
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceecc-----CC
Confidence 5678999999999999999999976 567899999975332 23568899999999999999999999943 45
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|||||||. |+|.+++... ..++++.+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 6899999998 6999998754 5689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
..... .....||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------- 219 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 219 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC----------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 32221 234678999999999987 689999999999999999999 577787777655554443210
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......++++.+||.+||+.||++|||++|+|+|
T Consensus 220 -----------------~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 -----------------RL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 1123467899999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=416.91 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=214.4
Q ss_pred CCCCeEEeEE-eeecCceEEEEEEECC--CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEV-IGKGSYGVVCSAIDTH--TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~-LG~G~fG~V~~a~~~~--tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~ 97 (619)
..++|.+.+. ||+|+||.||+|.++. ++..||||+++.. ......+++.+|+++|+.|+|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 3457888885 9999999999998754 4558999999754 345667889999999999999999999999832
Q ss_pred CCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccc
Q 007064 98 DFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARV 175 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~ 175 (619)
..+|||||||+ |+|.+++.. +..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 34899999999 599998765 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhh
Q 007064 176 AFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDT 254 (619)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~ 254 (619)
...............||+.|+|||++.. ..|+.++|||||||++|||++ |++||.+.+..+.+..|..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~--------- 227 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 227 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---------
T ss_pred ccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------
Confidence 6544333333345678999999999876 689999999999999999998 9999998876655544422
Q ss_pred hhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH---HcCcccc
Q 007064 255 ISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA---LADPYFK 317 (619)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el---L~hp~f~ 317 (619)
... ....+.+++++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 228 ------------------~~~---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 ------------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------CCC---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 000 12235688999999999999999999999888 6788875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=423.41 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=208.4
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGE-----KVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~-----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||+||+|++..+++ .||+|++... ........+.+|+.+|+.+ +|||||++++++
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE----
Confidence 4689999999999999999999876554 6999998643 2334556788999999988 899999999999
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 151 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (619)
.+.+.+|||||||+ |+|.++|+... .+++..++.|+.||+.||+|||++||+|||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 44567999999999 69999997642 489999999999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCC
Q 007064 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (619)
Q Consensus 152 LKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~p 230 (619)
|||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+|
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CchhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999875443322 22345678999999999876 689999999999999999997 8999
Q ss_pred CCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 231 F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
|.+.+....+..+... ... ......+++++.+||.+||+.||++|||++||
T Consensus 267 f~~~~~~~~~~~~~~~--------------------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN--------------------------GFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp STTCCCSHHHHHHHHT--------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHhc--------------------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9887765554443221 000 01234678999999999999999999999999
Q ss_pred HcC
Q 007064 311 LAD 313 (619)
Q Consensus 311 L~h 313 (619)
++|
T Consensus 318 ~~~ 320 (325)
T d1rjba_ 318 TSF 320 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=412.93 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.++ ++..||||+++.... ..+.+.+|+.+|+.++|||||++++++.. .
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~ 80 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E 80 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------C
Confidence 3478999999999999999999975 678899999975332 34568999999999999999999998732 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAN--DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 4799999999 6999877433 369999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....+...||+.|+|||++.+ ..|+.++|||||||++|||+|| .+||...+..+.+..+...
T Consensus 161 ~~~--~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~---------- 226 (272)
T d1qpca_ 161 DNE--YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---------- 226 (272)
T ss_dssp SSC--EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred CCc--cccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----------
Confidence 322 122345678999999999876 6799999999999999999995 6667666655444433211
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc--Ccccc
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFK 317 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~--hp~f~ 317 (619)
.. ......+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 227 -----------------~~---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -----------------YR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------CC---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 00 0112457889999999999999999999999998 78885
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=424.81 Aligned_cols=266 Identities=24% Similarity=0.385 Sum_probs=216.9
Q ss_pred CCCCeEEeEEeeecCceEEEEEEE---CCCCcEEEEEEecCcc--CChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAID---THTGEKVAIKKIHDIF--EHISDAARILREIKLLRLLRH-PDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~---~~tg~~vAIK~i~~~~--~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||+||+|++ +.+|+.||||+++... ......+.+.+|+++|++++| |||+++++++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--- 98 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--- 98 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE---
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee---
Confidence 347799999999999999999987 4578999999986432 122234567899999999976 8999999998
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
.+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 99 --~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 --QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp --EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred --ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 44567999999999 699999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCchh
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSLD 253 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~e 253 (619)
+........ ......|++.|+|||.+.+....++.++|||||||+||+|++|..||.+.+..+....+....
T Consensus 177 ~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~------ 248 (322)
T d1vzoa_ 177 KEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------ 248 (322)
T ss_dssp EECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH------
T ss_pred hhhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc------
Confidence 765332221 234568999999999987643468889999999999999999999998876554443332110
Q ss_pred hhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHHcCccccCCC
Q 007064 254 TISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRP-----TAEEALADPYFKGLS 320 (619)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRp-----Sa~elL~hp~f~~~~ 320 (619)
. .. .......+++++.+||++||..||.+|| |++|+|+||||+++.
T Consensus 249 -------------~----~~----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 249 -------------L----KS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -------------H----HC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------------c----cC----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 00 1122346899999999999999999999 589999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=405.49 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=211.6
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
+++.|++++.||+|+||+||+|+++ ++..||||+++..... ...+.+|+++++.++||||+++++++. +..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEe-----eCC
Confidence 4678999999999999999999974 7889999999754332 356889999999999999999999983 446
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 101 DIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
.+|+|||||. |+|.+++.. ...+++..++.|+.||++||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 7999999998 689888764 45799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---------- 218 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---------- 218 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 3222 2244679999999999987 689999999999999999998 899999988766655543210
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ......++.+.+||++||+.||++|||++++|+|
T Consensus 219 -----------------~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 -----------------RL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 1123567899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=405.72 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=199.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 68999999999999999999987544 56899988643 344556789999999999999999999999832
Q ss_pred CcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
+.+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 45899999999 689888765 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
.... ...+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 160 ~~~~--~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~---------- 225 (273)
T d1mp8a_ 160 DSTY--YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------
T ss_pred CCcc--eeccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence 3222 12244578999999999986 689999999999999999998 89999988876665544321
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
. ....++++++.+.+||.+||..||++|||++|+++|
T Consensus 226 -----------------~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 -----------------E---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------C---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1 112346789999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=402.99 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=198.2
Q ss_pred CCCCCeEEeEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 20 GDASRYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 20 ~~~~rY~i~~~LG~G~fG~V~~a~~~~tg----~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
-..+.|++.+.||+|+||.||+|.++.++ ..||||+++.. ........+.+|+.+|+.|+|||||++++++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--- 79 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--- 79 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe---
Confidence 34578999999999999999999877655 47999999753 34455667899999999999999999999984
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLA 173 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla 173 (619)
+...+|+|||||. ++|.+.+... ..+++.++..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 80 --~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 80 --KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp --SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred --cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence 4456999999999 5788877654 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCch
Q 007064 174 RVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
+................||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~------- 228 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND------- 228 (283)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-------
Confidence 876544333322345678999999999877 6899999999999999999996 455555554433333321
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
... .....++++.+.+||.+||..||++|||+.|+++
T Consensus 229 --------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 --------------------GFR---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------TCC---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------cCC---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 101 1122357789999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=401.37 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=204.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
.++|++.+.||+|+||.||+|+++.+ ..||||+++.... ..+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 46899999999999999999998755 5799999975433 24568999999999999999999998832 34
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccC
Q 007064 102 IYVVFELME-SDLHQVIKA--NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFN 178 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~--~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~ 178 (619)
+|+|||||. |+|..++.. ...+++.++..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 688888753 35699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHHHhhhCCCchhhhhh
Q 007064 179 DTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.... ..+...||+.|+|||++.. ..++.++|||||||+||||++| .+||.+.+..+.+..+...
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~----------- 230 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG----------- 230 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 3221 2244679999999999976 6899999999999999999995 5666666655555444221
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc--CccccCC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA--DPYFKGL 319 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~--hp~f~~~ 319 (619)
.. ....+.+++++.+||.+||+.||++|||++++++ ++||...
T Consensus 231 ----------------~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 ----------------YR---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------CC---CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 00 1233567899999999999999999999999988 8898764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=400.58 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=203.5
Q ss_pred ccCCCCCCeEEeEEeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChHHHHHHHHHHHHHHhcCCCCcceeeeEec
Q 007064 17 SEYGDASRYKIQEVIGKGSYGVVCSAIDTH-TG--EKVAIKKIHDIFE-HISDAARILREIKLLRLLRHPDIVEIKHIML 92 (619)
Q Consensus 17 ~~~~~~~rY~i~~~LG~G~fG~V~~a~~~~-tg--~~vAIK~i~~~~~-~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~ 92 (619)
|.+-+.++|++++.||+|+||.||+|.... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455567889999999999999999997643 33 3689999875432 3344578999999999999999999999984
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeec
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
. ..+|+|||||+ |+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred e------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 3 34799999999 688877654 457999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCC
Q 007064 171 GLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGT 249 (619)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~ 249 (619)
|+++................|+.+|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~-- 231 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-- 231 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC--
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC--
Confidence 999986555444444455678889999999987 689999999999999999998 899999988777665553210
Q ss_pred CchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 250 PSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .....+.+++.+.+||.+||..||++|||++|+++
T Consensus 232 ------------------------~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 ------------------------E---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------C---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 01223567899999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=399.98 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=199.3
Q ss_pred CCCeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPS 95 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s 95 (619)
.++|++++.||+|+||.||+|.+.. +++.||||+++.. ......+.+.+|+.++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc--
Confidence 3689999999999999999998754 4568999998753 3345566788888888776 68999999998743
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNIL 158 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (619)
+...+|+|||||+ |+|.+++... ..+++.++..|+.||+.||+|||++||+||||||+|||
T Consensus 89 --~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp --TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred --CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 3356899999999 6999999753 24899999999999999999999999999999999999
Q ss_pred ECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChh
Q 007064 159 ANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 237 (619)
Q Consensus 159 i~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~ 237 (619)
++.++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp ECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999986543322 222345689999999999987 6899999999999999999986 5788877654
Q ss_pred HHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 238 HQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 238 ~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
+.+..+... ... ......+++++.+||.+||+.||++|||++|+|+|
T Consensus 244 ~~~~~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKE--------------------------GTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHH--------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhc--------------------------CCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443322110 000 11234578999999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=403.02 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=201.0
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRD 98 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~----~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~ 98 (619)
++|++++.||+|+||+||+|.+..+|+ +||+|+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----- 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 569999999999999999999988876 5888888643 223345678999999999999999999999853
Q ss_pred CCcEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccc
Q 007064 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVA 176 (619)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~ 176 (619)
...++++|+|. ++|.+.+.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 24678888877 688887765 457999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhh
Q 007064 177 FNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTI 255 (619)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i 255 (619)
..... ........||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEK-EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred ccccc-cccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 43322 222244578999999999877 689999999999999999998 89999887765544333210
Q ss_pred hhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 256 SRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
.. ....+.+++.+.+||.+||..||++|||+.|+++|
T Consensus 230 ------------------~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ------------------ER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CC---CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 00 11224678899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=396.84 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=208.6
Q ss_pred CCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSR 96 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~ 96 (619)
-++|++++.||+|+||+||+|..+ .+++.||||+++.. .......++.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---- 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA---- 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec----
Confidence 357999999999999999999875 35678999999753 34455678999999999999999999999994
Q ss_pred CCCCcEEEEEecCC-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 007064 97 RDFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHYQFFLYQLLRALKYIHTANVYHRD 151 (619)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (619)
+...+++|||||. |+|.+++.... .+++..+..|+.||+.||+|||+.||+|||
T Consensus 87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 3456899999998 69999997543 388999999999999999999999999999
Q ss_pred CCCCcEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CC
Q 007064 152 LKPKNILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 230 (619)
Q Consensus 152 LKP~NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~-~p 230 (619)
|||+|||++.++.+||+|||+|+........ ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999999999999999865433221 12345678999999999987 68999999999999999999985 78
Q ss_pred CCCCChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 007064 231 FPGKNVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEA 310 (619)
Q Consensus 231 F~~~~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~el 310 (619)
|.+.+..+.+..+.+. . .......+++++.+||.+||+.||++|||+.|+
T Consensus 243 ~~~~~~~e~~~~v~~~---------------------------~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDG---------------------------N---ILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcC---------------------------C---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9888776655544221 1 112234678999999999999999999999999
Q ss_pred Hc
Q 007064 311 LA 312 (619)
Q Consensus 311 L~ 312 (619)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=390.41 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=198.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
..++|++++.||+|+||.||+|.+ +|..||||++++. ...+.+.+|+++|++++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~ 74 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG 74 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CC
Confidence 456799999999999999999987 4789999999753 3456789999999999999999999988532 24
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCcccccc
Q 007064 101 DIYVVFELME-SDLHQVIKAND--DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAF 177 (619)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~ 177 (619)
.+|+|||||+ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 5899999998 69999996543 58999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCChhHHHHHHHhhhCCCchhhhh
Q 007064 178 NDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLMTDLLGTPSLDTIS 256 (619)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~~~~~~l~~i~~~~g~p~~e~i~ 256 (619)
... ....+|..|+|||++.+ ..|++++|||||||++|||++ |++||.+.+..+....+..
T Consensus 155 ~~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~----------- 215 (262)
T d1byga_ 155 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215 (262)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-----------
T ss_pred CCC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-----------
Confidence 322 33468899999999876 689999999999999999998 7899988766555444311
Q ss_pred hhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 257 RVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
... ....+.+++.+.+||++||..||++|||+.+++++
T Consensus 216 ----------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ----------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111 12234678999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=391.17 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=205.1
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEec
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTG-------EKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIML 92 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg-------~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~ 92 (619)
..++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|...+..+ +|||||++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4579999999999999999999876554 47999999754 3445567788999999888 7999999999994
Q ss_pred CCCCCCCCcEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 93 PPSRRDFKDIYVVFELME-SDLHQVIKAND----------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+...+|+|||||+ |+|.++|.... .+++..++.|+.||+.||+|||+.||+||||||+
T Consensus 90 -----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp -----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred -----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 4467999999999 69999997543 4899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++........ ......++|+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999876543322 22345679999999999877 689999999999999999998 79999887
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+.......+.. .... .....+++.+.+||.+||+.||++|||+.|+|+
T Consensus 242 ~~~~~~~~i~~---------------------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKE---------------------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHT---------------------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHc---------------------------CCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 76544433321 1111 122457899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=397.34 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=204.5
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPPSRR 97 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~--vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~s~~ 97 (619)
+.++|++.+.||+|+||.||+|.++.+|.. ||||+++.. ......+.+.+|+++|+.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~----- 81 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 81 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----
Confidence 557999999999999999999999888874 778887543 2234566789999999999 6999999999994
Q ss_pred CCCcEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 007064 98 DFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILAN 160 (619)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~ 160 (619)
+.+.+|||||||+ |+|.++|... ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 4467999999999 6999999754 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCChhHH
Q 007064 161 ANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQ 239 (619)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~-~pF~~~~~~~~ 239 (619)
.++.+||+|||+++....... .....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp GGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999976432221 134568999999999976 68999999999999999999965 67887776554
Q ss_pred HHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 240 LDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 240 l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
...+.+ ... .....++++++.+||.+||+.||++|||++|+|+|
T Consensus 236 ~~~i~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQ---------------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGG---------------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHh---------------------------cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 433311 000 12234678999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=391.72 Aligned_cols=253 Identities=19% Similarity=0.342 Sum_probs=211.3
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTH-----TGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPS 95 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~-----tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s 95 (619)
+.++|++++.||+|+||.||+|.++. ++..||||+++.. ........+.+|+.+|+.++||||+++++++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--- 93 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 93 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe---
Confidence 45899999999999999999998753 4578999999754 34556677899999999999999999999993
Q ss_pred CCCCCcEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 007064 96 RRDFKDIYVVFELME-SDLHQVIKAN----------DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCK 164 (619)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~ 164 (619)
....+++|||||. |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+++
T Consensus 94 --~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 94 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred --cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 3456899999998 7999988542 24789999999999999999999999999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCChhHHHHHH
Q 007064 165 LKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLM 243 (619)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG-~~pF~~~~~~~~l~~i 243 (619)
+||+|||+|+....... .......+||+.|+|||.+.+ ..|+.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus 172 ~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999987543322 222344578999999999887 6899999999999999999998 5889888776666554
Q ss_pred HhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 244 TDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
.+. . .....+.+++.+.+||.+||+.||++|||++++++
T Consensus 249 ~~~---------------------------~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhC---------------------------C---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 321 0 11122467889999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=387.84 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=211.2
Q ss_pred CCCCeEEeEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChHHHHHHHHHHHHHHhc-CCCCcceeeeEecCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKIHDIFEHISDAARILREIKLLRLL-RHPDIVEIKHIMLPP 94 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~-----~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L-~HpnIv~l~~v~~~~ 94 (619)
..++|++++.||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+++.+ +|||||++++++.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-- 97 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT-- 97 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--
Confidence 3479999999999999999999863 46679999999754 4456677899999999999 6999999999994
Q ss_pred CCCCCCcEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 007064 95 SRRDFKDIYVVFELME-SDLHQVIKAND------------------DLTREHYQFFLYQLLRALKYIHTANVYHRDLKPK 155 (619)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (619)
+...+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+
T Consensus 98 ---~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ---eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 4456899999998 69999987543 5899999999999999999999999999999999
Q ss_pred cEEECCCCcEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCC
Q 007064 156 NILANANCKLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (619)
Q Consensus 156 NILi~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLlt-G~~pF~~~ 234 (619)
|||++.++.+||+|||+++....... ....+..+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987654332 223355789999999999876 689999999999999999998 77888777
Q ss_pred ChhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 235 NVVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 235 ~~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
+..+.+..+...- .. ......+++.+.+||.+||+.||++|||+++||+
T Consensus 252 ~~~~~~~~~i~~~--------------------------~~---~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEG--------------------------FR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHT--------------------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcC--------------------------CC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7655554442210 00 0112356889999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=388.13 Aligned_cols=265 Identities=19% Similarity=0.233 Sum_probs=205.4
Q ss_pred CCCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCC
Q 007064 21 DASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 21 ~~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~ 100 (619)
.+++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+++++.++|+|++..+..+. .+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEE----ecCC
Confidence 34789999999999999999999999999999999875322 234778999999999887666655542 3446
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCcEEEeecCccccc
Q 007064 101 DIYVVFELMESDLHQVIKA-NDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA---NCKLKICDFGLARVA 176 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~---~~~vKL~DFGla~~~ 176 (619)
..++|||||+++|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+..
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 7899999999988777754 557999999999999999999999999999999999999764 457999999999876
Q ss_pred cCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCCch
Q 007064 177 FNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSL 252 (619)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p~~ 252 (619)
....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----- 229 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----- 229 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-----
Confidence 4332211 12245689999999999987 679999999999999999999999998876544333221100
Q ss_pred hhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHH---HHcCccccC
Q 007064 253 DTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEE---ALADPYFKG 318 (619)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~e---lL~hp~f~~ 318 (619)
......+.....+++++++.+||.+||..||++||++++ +|+|+|.+.
T Consensus 230 ------------------~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 ------------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------------HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000011122334578899999999999999999999875 567877643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=381.02 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=200.1
Q ss_pred eEEeEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCCCCCCCCc
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg---~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~~~ 101 (619)
+.+.++||+|+||+||+|.+..++ ..||||+++.. .......++.+|+++|++|+||||+++++++.. ....
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCc
Confidence 345789999999999999986543 36999999753 456677889999999999999999999998743 2356
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEeecCccccccCC
Q 007064 102 IYVVFELME-SDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFND 179 (619)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~DFGla~~~~~~ 179 (619)
+|+|||||+ |+|.+++... ..+++..+..|+.||+.||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 6999988754 45778899999999999999999999999999999999999999999999999875433
Q ss_pred CC-CccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCh-hHHHHHHHhhhCCCchhhhhh
Q 007064 180 TP-TTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-VHQLDLMTDLLGTPSLDTISR 257 (619)
Q Consensus 180 ~~-~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~-~~~l~~i~~~~g~p~~e~i~~ 257 (619)
.. .........||+.|+|||++.. ..++.++|||||||++|||++|..||..... .+....+.
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~------------- 248 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------- 248 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 22 2222345679999999999876 6899999999999999999997777654332 11111111
Q ss_pred hcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 258 VRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
..... ...+.+++.+.+||.+||..||++|||+.|+++|
T Consensus 249 --------------~g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 --------------QGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------cCCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01110 1124578899999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-45 Score=389.13 Aligned_cols=282 Identities=24% Similarity=0.335 Sum_probs=212.2
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-----------CCCcceeeeEe
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-----------HPDIVEIKHIM 91 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-----------HpnIv~l~~v~ 91 (619)
+||++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 6799999999999999999999999999999999743 334456788999988875 57899998887
Q ss_pred cCCCCCCCCcEEEEEecCC--ccHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC---
Q 007064 92 LPPSRRDFKDIYVVFELME--SDLHQVI--KANDDLTREHYQFFLYQLLRALKYIHT-ANVYHRDLKPKNILANANC--- 163 (619)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~--g~L~~~i--~~~~~l~e~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILi~~~~--- 163 (619)
... .....+++++++. ++..... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2244566666654 3433333 344579999999999999999999998 8999999999999998765
Q ss_pred ---cEEEeecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----
Q 007064 164 ---KLKICDFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN----- 235 (619)
Q Consensus 164 ---~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~----- 235 (619)
.+||+|||.+....... ...+||+.|+|||++.. ..|+.++||||+||++++|++|+.||.+.+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 49999999997643222 34579999999999886 689999999999999999999999997643
Q ss_pred -hhHHHHHHHhhhCCCchhhhhhhcchhHHHHHHhhcccCCcc-------------ccCCCCCCCHHHHHHHHHhccCCC
Q 007064 236 -VVHQLDLMTDLLGTPSLDTISRVRNDKARRYLTSMRKKQPVQ-------------FSQKFPNADPSALRLLERLLAFDP 301 (619)
Q Consensus 236 -~~~~l~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-------------~~~~~~~~s~~l~dLI~~mL~~DP 301 (619)
..+.+..+...+|.+..+.+..... ...++.......... ........++++.|||.+||.+||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccc--cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 3456777788889887766543221 111111000000000 001122356789999999999999
Q ss_pred CCCCCHHHHHcCccccCCC
Q 007064 302 KDRPTAEEALADPYFKGLS 320 (619)
Q Consensus 302 ~kRpSa~elL~hp~f~~~~ 320 (619)
.+|||++|+|+||||++..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999999654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-45 Score=378.38 Aligned_cols=257 Identities=18% Similarity=0.238 Sum_probs=206.0
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC-CCcceeeeEecCCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH-PDIVEIKHIMLPPSRRDFK 100 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H-pnIv~l~~v~~~~s~~~~~ 100 (619)
.++|++++.||+|+||+||+|++..+|+.||||++.... +...+.+|+++++.|+| +||+.+++++ .+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence 479999999999999999999999999999999986432 22346789999999975 8999999887 4456
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----CCcEEEeecCccc
Q 007064 101 DIYVVFELMESDLHQVIKAN-DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANA-----NCKLKICDFGLAR 174 (619)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~-----~~~vKL~DFGla~ 174 (619)
..|+|||||+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 78999999999999999765 47999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCCc----cccccccCCccccCcccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHhhhCCC
Q 007064 175 VAFNDTPTT----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTP 250 (619)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~~~g~p 250 (619)
......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~--- 229 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 229 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH---
Confidence 754332211 12345689999999999987 689999999999999999999999998765433322211100
Q ss_pred chhhhhhhcchhHHHHHHhhcccCCccccCCCCCCCHHHHHHHHHhccCCCCCCCCHHHHHc
Q 007064 251 SLDTISRVRNDKARRYLTSMRKKQPVQFSQKFPNADPSALRLLERLLAFDPKDRPTAEEALA 312 (619)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~l~dLI~~mL~~DP~kRpSa~elL~ 312 (619)
. .+.........+++++++.+|++.|+..+|++||+.+.+.+
T Consensus 230 ---------~-----------~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 230 ---------E-----------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ---------H-----------HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------h-----------ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 00111122334567899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=378.87 Aligned_cols=272 Identities=24% Similarity=0.269 Sum_probs=194.7
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHH--HHHHHHHhcCCCCcceeeeEecCCCCCCC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARIL--REIKLLRLLRHPDIVEIKHIMLPPSRRDF 99 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~--~Ei~iL~~L~HpnIv~l~~v~~~~s~~~~ 99 (619)
+.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ...... +|+..+..++||||+++++++.... ...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccc
Confidence 46799999999999999999975 6899999998642 122333 4555566789999999999986543 233
Q ss_pred CcEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEEECCCCcEEEeec
Q 007064 100 KDIYVVFELME-SDLHQVIKANDDLTREHYQFFLYQLLRALKYIHT--------ANVYHRDLKPKNILANANCKLKICDF 170 (619)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILi~~~~~vKL~DF 170 (619)
..+|+|||||. |+|.+++++. .++++....++.|++.||.|||+ +||+||||||+||||+.++.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 46899999998 6999999875 59999999999999999999996 59999999999999999999999999
Q ss_pred CccccccCCCCCc-cccccccCCccccCcccccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 007064 171 GLARVAFNDTPTT-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTD 245 (619)
Q Consensus 171 Gla~~~~~~~~~~-~~~~~~~gt~~Y~APEll~~~~~----~y~~~~DIWSLG~ilyeLltG~~pF~~~~~~~~l~~i~~ 245 (619)
|+++......... ......+||+.|+|||++.+... .++.++|||||||+||||++|.+||......... ....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhc
Confidence 9998765433222 22345789999999999865211 2677899999999999999999887543321100 0000
Q ss_pred hhCCCchhhhhhhcchhHHHHHHhhcccCCccccCCC--CCCCHHHHHHHHHhccCCCCCCCCHHHHHcC
Q 007064 246 LLGTPSLDTISRVRNDKARRYLTSMRKKQPVQFSQKF--PNADPSALRLLERLLAFDPKDRPTAEEALAD 313 (619)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~l~dLI~~mL~~DP~kRpSa~elL~h 313 (619)
....+..+.+ ...... ......+...+ ......+.+|+.+||..||++|||+.|++++
T Consensus 232 ~~~~~~~~~~--------~~~~~~--~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 232 VPSDPSVEEM--------RKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHH--------HHHHTT--SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHH--------HHHHhc--cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0011111111 111100 00001111111 1123458899999999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=9.8e-25 Score=209.06 Aligned_cols=172 Identities=16% Similarity=0.105 Sum_probs=122.7
Q ss_pred eEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hHHHHHHHHHHHHHHhcCCCCcceee
Q 007064 25 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEH----------------ISDAARILREIKLLRLLRHPDIVEIK 88 (619)
Q Consensus 25 Y~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~----------------~~~~~~i~~Ei~iL~~L~HpnIv~l~ 88 (619)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ......+.+|+..|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999985 7899999987521100 01123456789999999999999887
Q ss_pred eEecCCCCCCCCcEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCcEEEe
Q 007064 89 HIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168 (619)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILi~~~~~vKL~ 168 (619)
++. ..++||||+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 764 12799999997422 125666778899999999999999999999999999999966 59999
Q ss_pred ecCccccccCCCCCccccccccCCccccCcccccccCCCCCCcccchhHHHHH
Q 007064 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (619)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APEll~~~~~~y~~~~DIWSLG~il 221 (619)
|||+|.......... .+...+. .-.+.+. ..|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~----~~~~~f~---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVR----NIITYFS---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHH----HHHHHHH---HHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHH----HHHHHHc---CCCCCcccHHHHHHHH
Confidence 999997643221110 0000000 0011111 4688899999986433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=1e-06 Score=85.56 Aligned_cols=138 Identities=13% Similarity=0.136 Sum_probs=87.3
Q ss_pred CCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCCCCCCCCc
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPPSRRDFKD 101 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~s~~~~~~ 101 (619)
..|++++..+.++.+.||+.. .++..+++|........ ....+.+|..+|+.|. +-.+.+++.+. .+.+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 467777776666667899874 56677889987643221 2334677888888775 33355566554 23356
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q 007064 102 IYVVFELMES-DLHQVIKANDDLTREHYQFFLYQLLRALKYIHTA----------------------------------- 145 (619)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~e~~i~~i~~QIl~aL~yLHs~----------------------------------- 145 (619)
.|+||++++| .+.+..... .. ...+..++.+.|..||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999997 444332111 11 112233333333333321
Q ss_pred ------------------------CceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 146 ------------------------NVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 146 ------------------------gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 27999999999999987666799999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=5.2e-05 Score=78.36 Aligned_cols=82 Identities=17% Similarity=0.056 Sum_probs=48.8
Q ss_pred CCCeEEeEEeeecCceEEEEEEECCCCcEEEEEEecCcc-----CChHHHHHHHHHHHHHHhcC-C--CCcceeeeEecC
Q 007064 22 ASRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF-----EHISDAARILREIKLLRLLR-H--PDIVEIKHIMLP 93 (619)
Q Consensus 22 ~~rY~i~~~LG~G~fG~V~~a~~~~tg~~vAIK~i~~~~-----~~~~~~~~i~~Ei~iL~~L~-H--pnIv~l~~v~~~ 93 (619)
..... .+.||.|....||++.+..+++.+++|.-.... .......+...|...|+.+. + ..+.+++.+.
T Consensus 26 ~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-- 102 (392)
T d2pula1 26 KSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-- 102 (392)
T ss_dssp --CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--
T ss_pred CCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--
Confidence 33344 567899999999999887778899999643210 11122345667888888763 2 2355555432
Q ss_pred CCCCCCCcEEEEEecCCc
Q 007064 94 PSRRDFKDIYVVFELMES 111 (619)
Q Consensus 94 ~s~~~~~~lylV~E~~~g 111 (619)
....++|||++++
T Consensus 103 -----~~~~~lvmE~L~~ 115 (392)
T d2pula1 103 -----TEMAVTVMEDLSH 115 (392)
T ss_dssp -----TTTTEEEECCCTT
T ss_pred -----CCCCEEEEeccCC
Confidence 1234789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.40 E-value=0.00013 Score=69.63 Aligned_cols=72 Identities=8% Similarity=0.012 Sum_probs=46.1
Q ss_pred EEeeecCc-eEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCC--CCcceeeeEecCCCCCCCCcEEEE
Q 007064 29 EVIGKGSY-GVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRH--PDIVEIKHIMLPPSRRDFKDIYVV 105 (619)
Q Consensus 29 ~~LG~G~f-G~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~H--pnIv~l~~v~~~~s~~~~~~lylV 105 (619)
+.+..|.. +.||+... ..+..+++|..... ....+.+|...|+.|.. -.+.+++.+. .+.+..++|
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v 84 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLL 84 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEE
Confidence 34555554 67898864 45667888876532 12346678888887743 2355566655 233568999
Q ss_pred EecCCc
Q 007064 106 FELMES 111 (619)
Q Consensus 106 ~E~~~g 111 (619)
|++++|
T Consensus 85 ~~~i~G 90 (255)
T d1nd4a_ 85 LGEVPG 90 (255)
T ss_dssp EECCSS
T ss_pred EEeeec
Confidence 999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0042 Score=63.36 Aligned_cols=75 Identities=15% Similarity=0.115 Sum_probs=49.8
Q ss_pred CCeEEeEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChHHHHHHHHHHHHHHhcC-CCCcceeeeEecCC
Q 007064 23 SRYKIQEVIGKGSYGVVCSAIDTH-------TGEKVAIKKIHDIFEHISDAARILREIKLLRLLR-HPDIVEIKHIMLPP 94 (619)
Q Consensus 23 ~rY~i~~~LG~G~fG~V~~a~~~~-------tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~-HpnIv~l~~v~~~~ 94 (619)
+..+ ++.|+.|-.-.+|++.... .++.|++++.-.. .. .....+|..+++.+. +.-..+++.++
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~--- 114 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF--- 114 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE---
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEc---
Confidence 3444 4678989999999987643 3467877776532 22 234557999999885 43345677766
Q ss_pred CCCCCCcEEEEEecCCc
Q 007064 95 SRRDFKDIYVVFELMES 111 (619)
Q Consensus 95 s~~~~~~lylV~E~~~g 111 (619)
.+ .+|+||++|
T Consensus 115 --~~----g~I~efi~g 125 (395)
T d1nw1a_ 115 --SG----GRLEEYIPS 125 (395)
T ss_dssp --TT----EEEECCCCE
T ss_pred --CC----ceEEEEecc
Confidence 21 688999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.33 E-value=0.0071 Score=59.91 Aligned_cols=72 Identities=14% Similarity=0.062 Sum_probs=42.0
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChHHHHHHHHHHHHHHhcCCCCcceeeeEecCC--CCCCCCcEEEEEecCCc
Q 007064 36 YGVVCSAIDTHTGEKVAIKKIHDIFEHISDAARILREIKLLRLLRHPDIVEIKHIMLPP--SRRDFKDIYVVFELMES 111 (619)
Q Consensus 36 fG~V~~a~~~~tg~~vAIK~i~~~~~~~~~~~~i~~Ei~iL~~L~HpnIv~l~~v~~~~--s~~~~~~lylV~E~~~g 111 (619)
--.||++.. .+|..|++|+..... .....+..|+..|..|..-.|.-..-+.... ........+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999864 578889999875321 1245577899998888533222111111111 11223457889999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.70 E-value=0.011 Score=57.76 Aligned_cols=30 Identities=30% Similarity=0.293 Sum_probs=26.5
Q ss_pred CCceeccCCCCcEEECCCCcEEEeecCccc
Q 007064 145 ANVYHRDLKPKNILANANCKLKICDFGLAR 174 (619)
Q Consensus 145 ~gIvHrDLKP~NILi~~~~~vKL~DFGla~ 174 (619)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 369999999999999998777899999774
|